ss_tst_tp,vrnt_d,ss_tp,src_ss_d,crtd_b,cnfdnc_scr,ss_ctgr,td,chmbl_d,tss_d,ss_d,ss_rgnsm,ss_cll_tp,ss_tx_d,rltnshp_tp,ss_tss,src_d,cll_d,dscrptn,ss_sbclllr_frctn,b_frmt,dc_d,ss_strn
In vivo,,A,,Intermediate,1,,50597,CHEMBL618647,2113.0,7524,Rattus norvegicus,,10116.0,N,Kidney,1,,Biodistribution in normal rat kidney in the presence of 0.005 M Gd/0.01 M lig at 2 hr,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618648,2113.0,7525,Rattus norvegicus,,10116.0,N,Kidney,1,,Biodistribution in normal rat kidney in the presence of 0.01 M Gd/0.05 M lig,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618649,2113.0,7526,Rattus norvegicus,,10116.0,N,Kidney,1,,Biodistribution in normal rat kidney in the presence of NAC Gd 0.01 M lig at 2 hr,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618650,2107.0,7527,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution in normal rat liver in the presence of 0.005 M Gd/0.01 M lig at 2 hr,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618651,2107.0,7528,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution in normal rat liver in the presence of 0.01 M Gd/0.05 M lig,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL876497,2107.0,7529,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution in normal rat liver in the presence of NAC Gd 0.01 M lig at 2 hr,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618652,2048.0,7530,Rattus norvegicus,,10116.0,N,Lung,1,,Biodistribution in normal rat lung in the presence of 0.005 M Gd/0.01 M lig at 2 hr,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618653,2048.0,7531,Rattus norvegicus,,10116.0,N,Lung,1,,Biodistribution in normal rat lung in the presence of 0.01 M Gd/0.05 M lig,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618654,2048.0,7532,Rattus norvegicus,,10116.0,N,Lung,1,,Biodistribution in normal rat lung in the presence of NAC Gd 0.01 M lig at 2 hr,,BAO_0000218,9866,
,,A,,Intermediate,1,,50597,CHEMBL618655,,7533,Rattus norvegicus,,10116.0,N,,1,,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats; Not tested,,BAO_0000218,6351,
,,A,,Intermediate,1,,50597,CHEMBL618656,,7534,Rattus norvegicus,,10116.0,N,,1,,Compound was tested for solubility in water,,BAO_0000218,1465,
,,P,,Intermediate,0,,22229,CHEMBL618657,,7535,,,,U,,1,,Solubility in phosphate buffered saline (1% DMSO) at pH 6.5 (24 hr equilibration),,BAO_0000100,5182,
,,A,,Intermediate,1,,50597,CHEMBL618658,,7536,Rattus norvegicus,,10116.0,N,,1,,Solubility was determined,,BAO_0000218,17847,
,,A,,Intermediate,1,,50597,CHEMBL618659,,7537,Rattus norvegicus,,10116.0,N,,1,,solubility in water (ug/mL) at 37 degree C.,,BAO_0000218,15339,
,,A,,Intermediate,1,,50597,CHEMBL618660,,7538,Rattus norvegicus,,10116.0,N,,1,,First pass metabolism and metabolic bioavailability using rat hepatic microsomes,,BAO_0000218,5202,
,,A,,Intermediate,1,,50597,CHEMBL618661,,7539,Rattus norvegicus,,10116.0,N,,1,,In vitro stability relative to (+)-AJ76 in rat hepatocyte assay,,BAO_0000218,1088,
,,A,,Intermediate,1,,50597,CHEMBL873807,,7540,Rattus norvegicus,,10116.0,N,,1,,Half life in rats,,BAO_0000218,3169,
,,A,,Intermediate,1,,50597,CHEMBL618662,,7541,Rattus norvegicus,,10116.0,N,,1,,Half life in Dawley rat,,BAO_0000218,5353,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618663,,7542,Rattus norvegicus,,10116.0,N,,1,,Half life period after 3 mg/kg iv administration,,BAO_0000218,2864,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618664,,7543,Rattus norvegicus,,10116.0,N,,1,,Half life period after 3 mg/kg iv administration in rat,,BAO_0000218,2864,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618665,,7544,Rattus norvegicus,,10116.0,N,,1,,Half life period after 3 mg/kg iv administration in the rat,,BAO_0000218,2864,
,,A,,Intermediate,1,,50597,CHEMBL876498,,7545,Rattus norvegicus,,10116.0,N,,1,,Half life period in female Sprague-Dawley rats,,BAO_0000218,6362,
,,A,,Intermediate,1,,50597,CHEMBL618666,,7546,Rattus norvegicus,,10116.0,N,,1,,Half life period in rat,,BAO_0000218,6249,
,,A,,Intermediate,1,,50597,CHEMBL620440,,7547,Rattus norvegicus,,10116.0,N,,1,,Half-life in rats was determined,,BAO_0000218,3169,
,,A,,Intermediate,1,,50597,CHEMBL620441,,7548,Rattus norvegicus,,10116.0,N,,1,,Half-life in rats with metabolic oxidation,,BAO_0000218,3169,
,,A,,Intermediate,1,,50597,CHEMBL620442,,7549,Rattus norvegicus,,10116.0,N,,1,,Half-life in rats,,BAO_0000218,3169,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620443,,7550,Rattus norvegicus,,10116.0,N,,1,,T 1/2 at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,BAO_0000218,17260,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620444,,7551,Rattus norvegicus,,10116.0,N,,1,,T 1/2 at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,BAO_0000218,17260,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620445,,7552,Rattus norvegicus,,10116.0,N,,1,,T max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,BAO_0000218,17260,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620446,,7553,Rattus norvegicus,,10116.0,N,,1,,T max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,BAO_0000218,17260,
,,A,,Intermediate,1,,50597,CHEMBL620447,1969.0,7554,Rattus norvegicus,,10116.0,N,Plasma,1,,Biological half-life measured in plasma of rat,,BAO_0000218,2879,
,,A,,Intermediate,1,,50597,CHEMBL621129,1969.0,7555,Rattus norvegicus,,10116.0,N,Plasma,1,,Biological half-life measured in plasma of rat; 22-25,,BAO_0000218,2879,
,,A,,Intermediate,1,,50597,CHEMBL621130,1969.0,7556,Rattus norvegicus,,10116.0,N,Plasma,1,,Biological half-life measured in plasma of rat; 9-16,,BAO_0000218,2879,
In vivo,,A,,Intermediate,1,,50597,CHEMBL873808,,7557,Rattus norvegicus,,10116.0,N,,1,,Compound was evaluated for its half life when administered intravenously in rat,,BAO_0000218,3184,
In vivo,,A,,Intermediate,1,,50597,CHEMBL876598,,7558,Rattus norvegicus,,10116.0,N,,1,,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 8 h,,BAO_0000218,4891,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621131,,7559,Rattus norvegicus,,10116.0,N,,1,,Evaluated for pharmacokinetic parameter half-life in rat at the dose 50 mg/kg,,BAO_0000218,429,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621132,,7560,Rattus norvegicus,,10116.0,N,,1,,Half life (T1/2) after oral administration in rat,,BAO_0000218,5656,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621133,,7561,Rattus norvegicus,,10116.0,N,,1,,Half life of compound after iv administration of 20 mg/kg dose in rat,,BAO_0000218,4413,
In vivo,,A,,Expert,1,,50597,CHEMBL621312,,7562,Rattus norvegicus,,10116.0,N,,1,,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,,BAO_0000218,3598,
,,A,,Intermediate,1,,50597,CHEMBL621313,,7563,Rattus norvegicus,,10116.0,N,,1,,Half life of compound was determined in rat,,BAO_0000218,17267,
,,A,,Intermediate,1,,50597,CHEMBL621314,178.0,7564,Rattus norvegicus,,10116.0,N,Blood,1,,Half life of compound was determined in rat blood,,BAO_0000218,4727,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621315,,7565,Rattus norvegicus,,10116.0,N,,1,,Half life at 1 mg/kg was determined in rat,,BAO_0000218,17651,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621316,,7566,Rattus norvegicus,,10116.0,N,,1,,Half life at 10 mg/kg was determined in rat,,BAO_0000218,17651,
,,A,,Intermediate,1,,50597,CHEMBL621317,,7567,Rattus norvegicus,,10116.0,N,,1,,Half life in rats,,BAO_0000218,401,
,,A,,Intermediate,1,,50597,CHEMBL621318,,7568,Rattus norvegicus,,10116.0,N,,1,,Half life in rats in hours,,BAO_0000218,4942,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621319,,7569,Rattus norvegicus,,10116.0,N,,1,,Half life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,,BAO_0000218,17735,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621377,,7570,Rattus norvegicus,,10116.0,N,,1,,Half life was calculated at a single intravenous administration of 20 mg/kg in rat,,BAO_0000218,6056,
,,A,,Intermediate,1,,50597,CHEMBL621378,,7571,Rattus norvegicus,,10116.0,N,,1,,Half life was determined,,BAO_0000218,5213,
In vivo,,A,,Intermediate,1,,50597,CHEMBL876599,,7572,Rattus norvegicus,,10116.0,N,,1,,Half life after i.v. administration,,BAO_0000218,6616,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621379,,7573,Rattus norvegicus,,10116.0,N,,1,,Half life in rat after intravenous administration at a concentration 0.5 mg/kg,,BAO_0000218,5937,
,,A,,Intermediate,1,,50597,CHEMBL621380,1969.0,7574,Rattus norvegicus,,10116.0,N,Plasma,1,,Half life in rat plasma,,BAO_0000218,5819,
,,A,,Intermediate,1,,50597,CHEMBL621381,1969.0,7575,Rattus norvegicus,,10116.0,N,Plasma,1,,Half life in rat plasma; Not detected,,BAO_0000218,5819,
,,A,,Intermediate,1,,50597,CHEMBL618515,,7576,Rattus norvegicus,,10116.0,N,,1,,Half life in rats,,BAO_0000218,6803,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618516,,7577,Rattus norvegicus,,10116.0,N,,1,,Half life period of compound was determined after peroral administration,,BAO_0000218,17804,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618517,,7578,Rattus norvegicus,,10116.0,N,,1,,Half life period of compound was determined at a dose of 3 mg/kg by intravenous administration,,BAO_0000218,17804,
,,A,,Intermediate,1,,50597,CHEMBL618518,,7579,Rattus norvegicus,,10116.0,N,,1,,Half life period in rat,,BAO_0000218,5948,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618519,,7580,Rattus norvegicus,,10116.0,N,,1,,Half life period was evaluated against Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,,BAO_0000218,1916,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618698,,7581,Rattus norvegicus,,10116.0,N,,1,,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,,BAO_0000218,1916,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618862,,7582,Rattus norvegicus,,10116.0,N,,1,,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration; Not available,,BAO_0000218,1916,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618863,,7583,Rattus norvegicus,,10116.0,N,,1,,Half life period was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,,BAO_0000218,4890,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618864,,7584,Rattus norvegicus,,10116.0,N,,1,,Half life period was determined for compound after intravenous administration in rats at 24 uM/kg,,BAO_0000218,17764,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618865,,7585,Rattus norvegicus,,10116.0,N,,1,,Half life time in rat the dose of 2 mg/kg,,BAO_0000218,4727,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618866,,7586,Rattus norvegicus,,10116.0,N,,1,,Half-life 24 hr after 10 mg/kg iv administration in rats,,BAO_0000218,17509,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618867,,7587,Rattus norvegicus,,10116.0,N,,1,,Half-life 24 hr after 2 mg/kg iv administration in rats,,BAO_0000218,17509,
,,A,,Intermediate,1,,50597,CHEMBL875828,,7588,Rattus norvegicus,,10116.0,N,,1,,Half-life consistent with the observed metabolic steady state in rats,,BAO_0000218,6597,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618868,,7589,Rattus norvegicus,,10116.0,N,,1,,Half-life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,,BAO_0000218,17735,
,,A,,Intermediate,1,,50597,CHEMBL618869,,7590,Rattus norvegicus,,10116.0,N,,1,,Half-life for oxidative metabolic stability was determined using male human,,BAO_0000218,6597,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618870,,7591,Rattus norvegicus,,10116.0,N,,1,,"Half-life in fischer rats at 5 mg/kg dose, administered intravenously",,BAO_0000218,17670,
,,A,,Intermediate,1,,50597,CHEMBL618871,1969.0,7592,Rattus norvegicus,,10116.0,N,Plasma,1,,Half-life in rat plasma,,BAO_0000218,1696,
,,A,,Intermediate,1,,50597,CHEMBL618872,1969.0,7593,Rattus norvegicus,,10116.0,N,Plasma,1,,Half-life in rat plasma was determined,,BAO_0000218,1742,
,,A,,Intermediate,1,,50597,CHEMBL873816,,7594,Rattus norvegicus,,10116.0,N,,1,,Half-life in rats was determined,,BAO_0000218,17800,
,,A,,Autocuration,0,,22224,CHEMBL618873,,7595,,,,U,,1,,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by gavage method in dog,,BAO_0000218,12923,
,,A,,Autocuration,0,,22224,CHEMBL621602,,7596,,,,U,,1,,Area under curve after oral dose of 0.1 mg//kg,,BAO_0000019,11954,
,,A,,Autocuration,0,,22224,CHEMBL621603,,7597,,,,U,,1,,Area under curve after oral dose of 0.3 mg/kg,,BAO_0000218,11954,
,,A,,Autocuration,0,,22224,CHEMBL621604,,7598,,,,U,,1,,Area under curve after oral dose of 1 mg/kg,,BAO_0000218,11954,
,,A,,Autocuration,0,,22224,CHEMBL621605,,7599,,,,U,,1,,Area under curve after oral dose of 10 mg/kg,,BAO_0000218,11954,
,,A,,Autocuration,0,,22224,CHEMBL621606,,7600,,,,U,,1,,Area under curve after oral dose of 23.4 mg/kg,,BAO_0000218,11954,
,,A,,Autocuration,0,,22224,CHEMBL621607,,7601,,,,U,,1,,Area under curve after oral dose of 3 mg/kg,,BAO_0000218,11954,
,,A,,Autocuration,0,,22224,CHEMBL621608,,7602,,,,U,,1,,Area under curve after oral dose of 3.87 mg/kg,,BAO_0000218,11954,
,,A,,Autocuration,0,,22224,CHEMBL621609,,7603,,,,U,,1,,Area under curve was determined,,BAO_0000019,5237,
,,A,,Autocuration,0,,22224,CHEMBL621610,,7604,,,,U,,1,,Area under curve at a dose of 10 mg/kg,,BAO_0000218,4026,
,,A,,Intermediate,1,,50597,CHEMBL621611,,7605,Rattus norvegicus,,10116.0,N,,1,,Area under curve was determined; ND=No data,,BAO_0000218,5237,
,,A,,Intermediate,1,,50597,CHEMBL621612,,7606,Rattus norvegicus,,10116.0,N,,1,,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,,BAO_0000218,14793,
,,A,,Intermediate,1,,50597,CHEMBL622308,,7607,Rattus norvegicus,,10116.0,N,,1,,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,,BAO_0000218,14793,
,,A,,Intermediate,1,,50597,CHEMBL622309,,7608,Rattus norvegicus,,10116.0,N,,1,,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,,BAO_0000218,14793,
,,A,,Intermediate,1,,50597,CHEMBL622310,,7609,Rattus norvegicus,,10116.0,N,,1,,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for infinite hours,,BAO_0000218,14793,
,,A,,Intermediate,1,,50597,CHEMBL622311,,7610,Rattus norvegicus,,10116.0,N,,1,,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,,BAO_0000218,14793,
,,A,,Intermediate,1,,50597,CHEMBL622312,,7611,Rattus norvegicus,,10116.0,N,,1,,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for infinite hours; Not calculated,,BAO_0000218,14793,
,,A,,Intermediate,1,,50597,CHEMBL622931,,7612,Rattus norvegicus,,10116.0,N,,1,,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,,BAO_0000218,14793,
,,A,,Intermediate,1,,50597,CHEMBL622932,,7613,Rattus norvegicus,,10116.0,N,,1,,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for infinite hours; Not calculated,,BAO_0000218,14793,
,,A,,Intermediate,1,,50597,CHEMBL622736,1969.0,7614,Rattus norvegicus,,10116.0,N,Plasma,1,,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,,BAO_0000218,14793,
,,A,,Intermediate,1,,50597,CHEMBL622737,1969.0,7615,Rattus norvegicus,,10116.0,N,Plasma,1,,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,,BAO_0000218,14793,
,,A,,Intermediate,1,,50597,CHEMBL622738,1969.0,7616,Rattus norvegicus,,10116.0,N,Plasma,1,,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,,BAO_0000218,14793,
,,A,,Intermediate,1,,50597,CHEMBL622739,1969.0,7617,Rattus norvegicus,,10116.0,N,Plasma,1,,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for infinite hours,,BAO_0000218,14793,
,,A,,Intermediate,1,,50597,CHEMBL622740,1969.0,7618,Rattus norvegicus,,10116.0,N,Plasma,1,,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,,BAO_0000218,14793,
,,A,,Intermediate,1,,50597,CHEMBL622741,1969.0,7619,Rattus norvegicus,,10116.0,N,Plasma,1,,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for infinite hours,,BAO_0000218,14793,
,,A,,Intermediate,1,,50597,CHEMBL622742,1969.0,7620,Rattus norvegicus,,10116.0,N,Plasma,1,,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,,BAO_0000218,14793,
,,A,,Intermediate,1,,50597,CHEMBL622743,1969.0,7621,Rattus norvegicus,,10116.0,N,Plasma,1,,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for infinite hours,,BAO_0000218,14793,
,,A,,Intermediate,1,,50594,CHEMBL622744,1969.0,7622,Mus musculus,,10090.0,N,Plasma,1,,AUC in mice,,BAO_0000218,11637,
,,A,,Autocuration,0,,22224,CHEMBL624134,,7623,,,,U,,1,,Area under curve was measured from the graph obtained from concentration Vs time,,BAO_0000019,11149,
,,A,,Autocuration,0,,22224,CHEMBL624135,,7624,,,,U,,1,,Area under curve value of compound per hour after oral administration,,BAO_0000019,10016,
,,A,,Intermediate,1,,50597,CHEMBL624136,,7625,Rattus norvegicus,,10116.0,N,,1,,Area under curve was determined after oral administration in rats,,BAO_0000218,17796,
,,A,,Intermediate,1,,50597,CHEMBL624137,,7626,Rattus norvegicus,,10116.0,N,,1,,Area under curve was determined after oral administration in rats; No data,,BAO_0000218,17796,
,,A,,Intermediate,1,,50597,CHEMBL624320,,7627,Rattus norvegicus,,10116.0,N,,1,,Area under curve was determined after oral administration in rats;No data,,BAO_0000218,17796,
,,A,,Intermediate,1,,50588,CHEMBL624321,,7628,Canis lupus familiaris,,9615.0,N,,1,,Area under curve was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,,BAO_0000218,12923,
,,A,,Intermediate,1,,50597,CHEMBL624322,,7629,Rattus norvegicus,,10116.0,N,,1,,Area under curve was determined for the compound after iv dose of 4.74 mg/kg in rats,,BAO_0000218,15372,
,,A,,Intermediate,1,,50597,CHEMBL624323,,7630,Rattus norvegicus,,10116.0,N,,1,,Area under curve was determined for the compound after iv dose of 5.06 in rats,,BAO_0000218,15372,
,,A,,Intermediate,1,,50597,CHEMBL624324,,7631,Rattus norvegicus,,10116.0,N,,1,,Area under curve was determined for the compound after iv dose of 5.10 mg/kg in rats,,BAO_0000218,15372,
,,A,,Intermediate,1,,50597,CHEMBL624325,,7632,Rattus norvegicus,,10116.0,N,,1,,Area under curve was determined for the compound after po dose of 5.01 mg/kg in rats,,BAO_0000218,15372,
,,A,,Intermediate,1,,50597,CHEMBL624326,,7633,Rattus norvegicus,,10116.0,N,,1,,Area under curve was determined for the compound after po dose of 5.03 mg/kg in rats,,BAO_0000218,15372,
,,A,,Intermediate,1,,50597,CHEMBL624327,,7634,Rattus norvegicus,,10116.0,N,,1,,Area under curve was determined for the compound after po dose of 5.22 mg/kg in rats,,BAO_0000218,15372,
,,A,,Intermediate,1,,50597,CHEMBL624328,,7635,Rattus norvegicus,,10116.0,N,,1,,Area under curve was determined for the compound after po dose of 5.46 mg/kg in rats,,BAO_0000218,15372,
,,A,,Intermediate,1,,50588,CHEMBL627848,,7636,Canis lupus familiaris,,9615.0,N,,1,,Area under curve was determined in Dogs after peroral administration,,BAO_0000218,14169,
,,A,,Intermediate,1,,50597,CHEMBL627849,,7637,Rattus norvegicus,,10116.0,N,,1,,Area under curve was determined in Rats after peroral administration,,BAO_0000218,14169,
,,A,,Intermediate,1,,50597,CHEMBL627850,,7638,Rattus norvegicus,,10116.0,N,,1,,Area under curve was determined in carotid blood of rat when administered intradermally,,BAO_0000218,14258,
,,A,,Intermediate,1,,50597,CHEMBL627851,,7639,Rattus norvegicus,,10116.0,N,,1,,Area under curve was determined in portal blood of rat when administered intradermally,,BAO_0000218,14258,
,,A,,Intermediate,1,,50594,CHEMBL627852,,7640,Mus musculus,,10090.0,N,,1,,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,,BAO_0000218,15011,
,,A,,Intermediate,1,,50594,CHEMBL627853,,7641,Mus musculus,,10090.0,N,,1,,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,,BAO_0000218,15011,
,,A,,Intermediate,1,,50594,CHEMBL627854,,7642,Mus musculus,,10090.0,N,,1,,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),,BAO_0000218,15011,
,,A,,Intermediate,1,,50594,CHEMBL627855,,7643,Mus musculus,,10090.0,N,,1,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,,BAO_0000218,15011,
,,A,,Intermediate,1,,50594,CHEMBL627856,,7644,Mus musculus,,10090.0,N,,1,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg (run time 7 hr),,BAO_0000218,15011,
,,A,,Intermediate,1,,50594,CHEMBL875339,,7645,Mus musculus,,10090.0,N,,1,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,,BAO_0000218,15011,
,,A,,Intermediate,1,,50594,CHEMBL627857,,7646,Mus musculus,,10090.0,N,,1,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (Run time = 7 hr),,BAO_0000218,15011,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627858,2106.0,7647,Rattus norvegicus,,10116.0,N,Spleen,1,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 65 mins after i.v. administration,,BAO_0000218,11195,
,,A,,Intermediate,1,,50597,CHEMBL627859,178.0,7648,Rattus norvegicus,,10116.0,N,Blood,1,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in blood; Expressed as percent dose/organ,,BAO_0000218,10130,
,,A,,Intermediate,1,,50597,CHEMBL627860,955.0,7649,Rattus norvegicus,,10116.0,N,Brain,1,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in brain; Expressed as percent dose/organ,,BAO_0000218,10130,
,,A,,Intermediate,1,,50597,CHEMBL627019,948.0,7650,Rattus norvegicus,,10116.0,N,Heart,1,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in heart; Expressed as percent dose/organ,,BAO_0000218,10130,
,,A,,Intermediate,1,,50597,CHEMBL627020,2107.0,7651,Rattus norvegicus,,10116.0,N,Liver,1,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in liver; Expressed as percent dose/organ,,BAO_0000218,10130,
,,A,,Intermediate,1,,50597,CHEMBL627021,2048.0,7652,Rattus norvegicus,,10116.0,N,Lung,1,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in lung; Expressed as percent dose/organ,,BAO_0000218,10130,
,,A,,Intermediate,1,,50597,CHEMBL627022,2385.0,7653,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in muscle; Expressed as percent dose/organ,,BAO_0000218,10130,
,,A,,Intermediate,1,,50597,CHEMBL627023,,7654,Rattus norvegicus,,10116.0,N,,1,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in skin; Expressed as percent dose/organ,,BAO_0000218,10130,
,,A,,Intermediate,1,,50597,CHEMBL627024,2106.0,7655,Rattus norvegicus,,10116.0,N,Spleen,1,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in spleen; Expressed as percent dose/organ,,BAO_0000218,10130,
,,A,,Intermediate,1,,50597,CHEMBL627025,2046.0,7656,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in thyroid; Expressed as percent dose/organ,,BAO_0000218,10130,
,,A,,Intermediate,1,,50597,CHEMBL627026,2113.0,7657,Rattus norvegicus,,10116.0,N,Kidney,1,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in kidney; Expressed as percent dose/organ,,BAO_0000218,10130,
,,A,,Intermediate,1,,50597,CHEMBL627027,178.0,7658,Rattus norvegicus,,10116.0,N,Blood,1,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in blood; Expressed as percent dose/organ,,BAO_0000218,10130,
,,A,,Intermediate,1,,50597,CHEMBL627028,955.0,7659,Rattus norvegicus,,10116.0,N,Brain,1,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in brain; Expressed as percent dose/organ,,BAO_0000218,10130,
,,A,,Intermediate,1,,50597,CHEMBL627029,948.0,7660,Rattus norvegicus,,10116.0,N,Heart,1,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in heart; Expressed as percent dose/organ,,BAO_0000218,10130,
,,A,,Intermediate,1,,50597,CHEMBL627030,2113.0,7661,Rattus norvegicus,,10116.0,N,Kidney,1,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in kidney; Expressed as percent dose/organ,,BAO_0000218,10130,
,,A,,Intermediate,1,,50597,CHEMBL627031,2107.0,7662,Rattus norvegicus,,10116.0,N,Liver,1,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in liver; Expressed as percent dose/organ,,BAO_0000218,10130,
,,A,,Intermediate,1,,50597,CHEMBL627032,2048.0,7663,Rattus norvegicus,,10116.0,N,Lung,1,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in lung; Expressed as percent dose/organ,,BAO_0000218,10130,
,,A,,Intermediate,1,,50597,CHEMBL627033,2385.0,7664,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in muscle; Expressed as percent dose/organ,,BAO_0000218,10130,
,,A,,Intermediate,1,,50597,CHEMBL627034,,7665,Rattus norvegicus,,10116.0,N,,1,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in skin; Expressed as percent dose/organ,,BAO_0000218,10130,
,,A,,Intermediate,1,,50597,CHEMBL627035,2106.0,7666,Rattus norvegicus,,10116.0,N,Spleen,1,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in spleen; Expressed as percent dose/organ,,BAO_0000218,10130,
,,A,,Intermediate,1,,50597,CHEMBL627036,2046.0,7667,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in thyroid; Expressed as percent dose/organ,,BAO_0000218,10130,
,,A,,Intermediate,1,,50597,CHEMBL875340,178.0,7668,Rattus norvegicus,,10116.0,N,Blood,1,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in blood; Expressed as percent dose/organ,,BAO_0000218,10130,
,,A,,Intermediate,1,,50597,CHEMBL627037,948.0,7669,Rattus norvegicus,,10116.0,N,Heart,1,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in heart; Expressed as percent dose/organ,,BAO_0000218,10130,
,,A,,Intermediate,1,,50597,CHEMBL627038,2113.0,7670,Rattus norvegicus,,10116.0,N,Kidney,1,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in kidney; Expressed as percent dose/organ,,BAO_0000218,10130,
,,A,,Intermediate,1,,50597,CHEMBL627039,2107.0,7671,Rattus norvegicus,,10116.0,N,Liver,1,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in liver; Expressed as percent dose/organ,,BAO_0000218,10130,
,,A,,Intermediate,1,,50597,CHEMBL627040,2385.0,7672,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in muscle; Expressed as percent dose/organ,,BAO_0000218,10130,
,,A,,Intermediate,1,,50597,CHEMBL624663,2106.0,7673,Rattus norvegicus,,10116.0,N,Spleen,1,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in spleen; Expressed as percent dose/organ,,BAO_0000218,10130,
,,A,,Intermediate,1,,50597,CHEMBL625963,2046.0,7674,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in thyroid; Expressed as percent dose/organ,,BAO_0000218,10130,
,,A,,Intermediate,1,,50597,CHEMBL876799,955.0,7675,Rattus norvegicus,,10116.0,N,Brain,1,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in brain; Expressed as percent dose/organ,,BAO_0000218,10130,
,,A,,Intermediate,1,,50597,CHEMBL626133,2048.0,7676,Rattus norvegicus,,10116.0,N,Lung,1,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in lung; Expressed as percent dose/organ,,BAO_0000218,10130,
,,A,,Intermediate,1,,50597,CHEMBL626134,,7677,Rattus norvegicus,,10116.0,N,,1,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in skin; Expressed as percent dose/organ,,BAO_0000218,10130,
,,A,,Intermediate,1,,50597,CHEMBL626135,,7678,Rattus norvegicus,,10116.0,N,,1,,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,,BAO_0000218,6295,
,,A,,Intermediate,1,,50597,CHEMBL626136,,7679,Rattus norvegicus,,10116.0,N,,1,,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,,BAO_0000218,6296,
,,A,,Intermediate,1,,50597,CHEMBL626137,,7680,Rattus norvegicus,,10116.0,N,,1,,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg; Below detection limit,,BAO_0000218,6296,
,,A,,Intermediate,1,,50597,CHEMBL626138,,7681,Rattus norvegicus,,10116.0,N,,1,,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,,BAO_0000218,6295,
,,A,,Intermediate,1,,50597,CHEMBL626139,,7682,Rattus norvegicus,,10116.0,N,,1,,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,,BAO_0000218,6296,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626140,,7683,Rattus norvegicus,,10116.0,N,,1,,C max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,BAO_0000218,17260,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626141,,7684,Rattus norvegicus,,10116.0,N,,1,,C max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,BAO_0000218,17260,
,,A,,Intermediate,1,,50597,CHEMBL626142,,7685,Rattus norvegicus,,10116.0,N,,1,,C24h in rat p.o. at 20 mg/kg concentration,,BAO_0000218,17686,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627930,2385.0,7686,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Biodistribution in normal rat muscle in the presence of 0.005 M Gd/0.01 M lig at 2 hr,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627931,2385.0,7687,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Biodistribution in normal rat muscle in the presence of 0.01 M Gd/0.05 M lig,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627932,2385.0,7688,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Biodistribution in normal rat muscle in the presence of NAC Gd 0.01 M lig at 2 hr,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627933,2106.0,7689,Rattus norvegicus,,10116.0,N,Spleen,1,,Biodistribution in normal rat spleen in the presence of 0.005 M Gd/0.01 M lig at 2 hr,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627934,2106.0,7690,Rattus norvegicus,,10116.0,N,Spleen,1,,Biodistribution in normal rat spleen in the presence of 0.01 M Gd/0.05 M lig,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627935,2106.0,7691,Rattus norvegicus,,10116.0,N,Spleen,1,,Biodistribution in normal rat spleen in the presence of NAC Gd 0.01 M lig at 2 hr,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627936,178.0,7692,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution in rat blood in the presence of 0.001 M/0.008 M GdDTPA-AEP,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627937,178.0,7693,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution in rat blood in the presence of 0.01 M GdDTPA-BDP,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627938,178.0,7694,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution in rat blood in the presence of 0.01 M/0.01 M GdDTPA-AEP,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627939,178.0,7695,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution in rat blood in the presence of 0.05 M Gd/0.15 M lig,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627940,178.0,7696,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution in rat blood in the presence of 0.05 M GdDTPA-BDP,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627941,178.0,7697,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution in rat blood in the presence of 0.05 M/0.05 M GdDTPA-AEP,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL876800,178.0,7698,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution in rat blood in the presence of 0.05 M/0.08 M GdDTPA-HPDP,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627942,178.0,7699,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution in rat blood in the presence of 0.10 M GdDTPA-BDP,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627943,178.0,7700,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution in rat blood in the presence of 0.10 M/0.11 M GdDTPA-AEP,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627944,178.0,7701,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution in rat blood in the presence of 50 Gd/kg at 15 min,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627945,178.0,7702,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution in rat blood in the presence of 50 Gd/kg at 2 hr,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628584,178.0,7703,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution in rat blood in the presence of 50 Gd/kg at 6 hr,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628585,178.0,7704,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution in rat blood in the presence of GdDTPA at 15 min,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628586,178.0,7705,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution in rat blood in the presence of GdDTPA at 1 hr,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628587,178.0,7706,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution in rat blood in the presence of GdDTPA at 30 min,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628588,178.0,7707,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution in rat blood in the presence of GdDTPA at 4 hr,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628589,178.0,7708,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution in rat blood in the presence of GdDTPA-BDP at 15 min,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625304,178.0,7709,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution in rat blood in the presence of GdDTPA-BDP at 30 min,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625305,178.0,7710,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution in rat blood in the presence of GdDTPA-BDP at 4 hr,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625306,178.0,7711,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution in rat blood in the presence of GdDTPA-BDPat 1 hr,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625307,178.0,7712,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 15 min,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625308,178.0,7713,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 30 min,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627740,178.0,7714,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 4 hr,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627741,178.0,7715,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution in rat blood in the presence of GdDTPA-HPDPat 1 hr,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627742,178.0,7716,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution in rat blood in the presence of NAC Gd/0.01 M GdDTPA-HPDP,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627743,178.0,7717,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution in rat blood in the presence of NCA Gd/0.01 M lip,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627744,178.0,7718,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution in rat blood in the presence of NCAGd/0.01 M lig,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627745,10000001.0,7719,Rattus norvegicus,,10116.0,N,Bone,1,,Biodistribution in rat bone in the presence of 0.01 M GdDTPA-BDP,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627746,10000001.0,7720,Rattus norvegicus,,10116.0,N,Bone,1,,Biodistribution in rat bone in the presence of 0.01 M/0.01 M GdDTPA-AEP,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627747,10000001.0,7721,Rattus norvegicus,,10116.0,N,Bone,1,,Biodistribution in rat bone in the presence of 0.01 M/0.08 M GdDTPA-AEP,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL876810,10000001.0,7722,Rattus norvegicus,,10116.0,N,Bone,1,,Biodistribution in rat bone in the presence of 0.05 M Gd/0.15 M lig,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627748,10000001.0,7723,Rattus norvegicus,,10116.0,N,Bone,1,,Biodistribution in rat bone in the presence of 0.05 M GdDTPA-BDP,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627749,10000001.0,7724,Rattus norvegicus,,10116.0,N,Bone,1,,Biodistribution in rat bone in the presence of 0.05 M/0.05 M GdDTPA-AEP,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627750,10000001.0,7725,Rattus norvegicus,,10116.0,N,Bone,1,,Biodistribution in rat bone in the presence of 0.05 M/0.08 M GdDTPA-HPDP,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618728,10000001.0,7726,Rattus norvegicus,,10116.0,N,Bone,1,,Biodistribution in rat bone in the presence of 0.10 M GdDTPA-BDP,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618729,10000001.0,7727,Rattus norvegicus,,10116.0,N,Bone,1,,Biodistribution in rat bone in the presence of 0.10 M/0.11 M GdDTPA-AEP,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618730,10000001.0,7728,Rattus norvegicus,,10116.0,N,Bone,1,,Biodistribution in rat bone in the presence of GdDTPA at 15 min,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618731,10000001.0,7729,Rattus norvegicus,,10116.0,N,Bone,1,,Biodistribution in rat bone in the presence of GdDTPA at 1 hr,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618732,10000001.0,7730,Rattus norvegicus,,10116.0,N,Bone,1,,Biodistribution in rat bone in the presence of GdDTPA at 30 min,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618733,10000001.0,7731,Rattus norvegicus,,10116.0,N,Bone,1,,Biodistribution in rat bone in the presence of GdDTPA at 4 hr,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618734,10000001.0,7732,Rattus norvegicus,,10116.0,N,Bone,1,,Biodistribution in rat bone in the presence of GdDTPA-BDP at 15 min,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618735,10000001.0,7733,Rattus norvegicus,,10116.0,N,Bone,1,,Biodistribution in rat bone in the presence of GdDTPA-BDP at 1 hr,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL876602,10000001.0,7734,Rattus norvegicus,,10116.0,N,Bone,1,,Biodistribution in rat bone in the presence of GdDTPA-BDP at 30 min,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618736,10000001.0,7735,Rattus norvegicus,,10116.0,N,Bone,1,,Biodistribution in rat bone in the presence of GdDTPA-BDP at 4 hr,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618737,10000001.0,7736,Rattus norvegicus,,10116.0,N,Bone,1,,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 15 min,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618738,10000001.0,7737,Rattus norvegicus,,10116.0,N,Bone,1,,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 1 hr,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618739,10000001.0,7738,Rattus norvegicus,,10116.0,N,Bone,1,,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 30 min,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618740,10000001.0,7739,Rattus norvegicus,,10116.0,N,Bone,1,,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 4 hr,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618741,10000001.0,7740,Rattus norvegicus,,10116.0,N,Bone,1,,Biodistribution in rat bone in the presence of NAC Gd/0.01 M GdDTPA-HPDP,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618742,10000001.0,7741,Rattus norvegicus,,10116.0,N,Bone,1,,Biodistribution in rat bone in the presence of NCA Gd/0.01 M lip,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618743,10000001.0,7742,Rattus norvegicus,,10116.0,N,Bone,1,,Biodistribution in rat bone in the presence of NCAGd/0.01 M lig,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618744,1969.0,7743,Rattus norvegicus,,10116.0,N,Plasma,1,,Half-life from rat plasma at a single oral dose of 25 mg/kg,,BAO_0000218,17752,
,,A,,Intermediate,1,,50597,CHEMBL618745,,7744,Rattus norvegicus,,10116.0,N,,1,,Half-life in male rat,,BAO_0000218,5610,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620479,,7745,Rattus norvegicus,,10116.0,N,,1,,Half-life in rat after peroral administration at 10 mg/kg concentration,,BAO_0000218,5939,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620480,,7746,Rattus norvegicus,,10116.0,N,,1,,Half-life in rat after peroral administration at 5 mg/kg concentration,,BAO_0000218,5939,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620481,,7747,Rattus norvegicus,,10116.0,N,,1,,Half-life in rat at a dose of 3 mg/kg,,BAO_0000218,17771,
,,A,,Intermediate,1,,50597,CHEMBL620482,,7748,Rattus norvegicus,,10116.0,N,,1,,Half-life was evaluated in rats,,BAO_0000218,1974,
,,A,,Intermediate,1,,50597,CHEMBL876603,,7749,Rattus norvegicus,,10116.0,N,,1,,Half-life was measured in rat,,BAO_0000218,4239,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620483,,7750,Rattus norvegicus,,10116.0,N,,1,,Half-life period for the compound was determined in rats at 50 mg/kg dose,,BAO_0000218,6681,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620484,,7751,Rattus norvegicus,,10116.0,N,,1,,Half-life period in rats after intravenous administration at 5 mg/kg,,BAO_0000218,17752,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620485,,7752,Rattus norvegicus,,10116.0,N,,1,,Half-life period in rat at 10 mg/kg,,BAO_0000218,6046,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620486,,7753,Rattus norvegicus,,10116.0,N,,1,,"Half-life period was determined in rats at 10 mg/kg, p.o. dose",,BAO_0000218,6685,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620487,,7754,Rattus norvegicus,,10116.0,N,,1,,"Half-life period was determined in rats at 20 mg/kg, i.p. dose",,BAO_0000218,6685,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620488,,7755,Rattus norvegicus,,10116.0,N,,1,,"Half-life period was determined in rats at 2 mg/kg, i.v. dose",,BAO_0000218,6685,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620489,,7756,Rattus norvegicus,,10116.0,N,,1,,Half-life time in rat the dose of 2 mg/kg,,BAO_0000218,4727,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620490,,7757,Rattus norvegicus,,10116.0,N,,1,,Half-life was estimated from the elimination phase of the oral [C] vs time curves in 4 rats,,BAO_0000218,1088,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620491,,7758,Rattus norvegicus,,10116.0,N,,1,,In vivo activity against Staphylococcus aureus when administered orally for 1 hr in rat at a dose of 15 mg/kg,,BAO_0000218,5610,
In vivo,,A,,Intermediate,1,,50597,CHEMBL876604,1969.0,7759,Rattus norvegicus,,10116.0,N,Plasma,1,,"In vivo half life of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",,BAO_0000218,3032,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620492,,7760,Rattus norvegicus,,10116.0,N,,1,,Oral half life was determined,,BAO_0000218,5199,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620493,,7761,Rattus norvegicus,,10116.0,N,,1,,"Pharmacokinetic Parameter, half life period measured in Female Wistar Rats at 100 mg/kg by po administration",,BAO_0000218,14941,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620494,,7762,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic property (t1/2) in rat,,BAO_0000218,4408,
,,A,,Intermediate,1,,50597,CHEMBL620495,1969.0,7763,Rattus norvegicus,,10116.0,N,Plasma,1,,Plasma elimination half-life was determined,,BAO_0000218,2552,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620496,1969.0,7764,Rattus norvegicus,,10116.0,N,Plasma,1,,Plasma elimination half-life was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,,BAO_0000218,5199,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620497,1969.0,7765,Rattus norvegicus,,10116.0,N,Plasma,1,,Plasma half life was observed after intravenous administration in rat,,BAO_0000218,15662,
,,A,,Intermediate,1,,50597,CHEMBL620498,1969.0,7766,Rattus norvegicus,,10116.0,N,Plasma,1,,Plasma half-life was determined,,BAO_0000218,1465,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620499,1969.0,7767,Rattus norvegicus,,10116.0,N,Plasma,1,,Plasma half-life following oral administration in Fisher rats,,BAO_0000218,1446,
,,A,,Intermediate,1,,50597,CHEMBL620500,1969.0,7768,Rattus norvegicus,,10116.0,N,Plasma,1,,Plasma half-life in rat,,BAO_0000218,6824,
In vivo,,A,,Intermediate,1,,50597,CHEMBL873809,1969.0,7769,Rattus norvegicus,,10116.0,N,Plasma,1,,Plasmatic Half-life after intravenous administration to rat,,BAO_0000218,17533,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620501,,7770,Rattus norvegicus,,10116.0,N,,1,,T1/2 (half life) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,,BAO_0000218,5979,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620502,,7771,Rattus norvegicus,,10116.0,N,,1,,Terminal half life after intravenous administration (1 mg/kg) in rat,,BAO_0000218,4689,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620503,,7772,Rattus norvegicus,,10116.0,N,,1,,Terminal half life in Rat at a oral dose of 5 mg/kg,,BAO_0000218,4689,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620504,,7773,Rattus norvegicus,,10116.0,N,,1,,Terminal phase half-life was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,,BAO_0000218,2463,
In vivo,,A,,Intermediate,1,,50597,CHEMBL876605,,7774,Rattus norvegicus,,10116.0,N,,1,,Tested for half life value after intravenous administration at dose of 0.2 mg/kg in rat,,BAO_0000218,4883,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620505,,7775,Rattus norvegicus,,10116.0,N,,1,,Tested for half life value after oral administration at dosage of 4 mg/kg in rat,,BAO_0000218,4883,
In vivo,,A,,Intermediate,1,,50597,CHEMBL873811,1969.0,7776,Rattus norvegicus,,10116.0,N,Plasma,1,,plasma half life was observed after intravenous administration in rat,,BAO_0000218,15662,
In vivo,,A,,Expert,1,,50597,CHEMBL624016,,7777,Rattus norvegicus,,10116.0,N,,1,,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,,BAO_0000218,3598,
,,A,,Intermediate,1,,50597,CHEMBL624017,,7778,Rattus norvegicus,,10116.0,N,,1,,Half life of compound determined in rat,,BAO_0000218,4576,
,,A,,Intermediate,1,,50597,CHEMBL624018,,7779,Rattus norvegicus,,10116.0,N,,1,,Mean residence time determined in rat,,BAO_0000218,4576,
,,A,,Intermediate,1,,50597,CHEMBL624019,,7780,Rattus norvegicus,,10116.0,N,,1,,Plasma half life determined in rat,,BAO_0000218,4576,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624020,955.0,7781,Rattus norvegicus,,10116.0,N,Brain,1,,Compound was evaluated for Tmax in brain after intravenous administration in male rats,,BAO_0000218,4910,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624201,,7782,Rattus norvegicus,,10116.0,N,,1,,Compound was evaluated for pharmacokinetic parameter maximum time period,,BAO_0000218,4891,
In vivo,,A,,Intermediate,1,,50597,CHEMBL872528,,7783,Rattus norvegicus,,10116.0,N,,1,,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,,BAO_0000218,429,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624202,,7784,Rattus norvegicus,,10116.0,N,,1,,In vivo Tmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,BAO_0000218,5974,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624203,,7785,Rattus norvegicus,,10116.0,N,,1,,In vivo Tmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,BAO_0000218,5974,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624350,,7786,Rattus norvegicus,,10116.0,N,,1,,In vivo Tmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,BAO_0000218,5974,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621320,,7787,Rattus norvegicus,,10116.0,N,,1,,In vivo Tmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,BAO_0000218,5974,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621321,,7788,Rattus norvegicus,,10116.0,N,,1,,In vivo maximum time required for clearance of compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,,BAO_0000218,17582,
,,A,,Intermediate,1,,50597,CHEMBL621322,,7789,Rattus norvegicus,,10116.0,N,,1,,Maximum time (Tmax) required to reach Cmax in rats,,BAO_0000218,4026,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621323,,7790,Rattus norvegicus,,10116.0,N,,1,,Maximum time constant was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,,BAO_0000218,4890,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621324,,7791,Rattus norvegicus,,10116.0,N,,1,,Maximum time of clearance of compound in rats after peroral administration,,BAO_0000218,6571,
,,A,,Intermediate,1,,50597,CHEMBL621325,,7792,Rattus norvegicus,,10116.0,N,,1,,Maximum time at the dose of 2 mg/kg in rat,,BAO_0000218,4727,
In vivo,,A,,Intermediate,1,,50597,CHEMBL875837,1969.0,7793,Rattus norvegicus,,10116.0,N,Plasma,1,,Maximum time to achieve peak plasma concentration was determined in rat at 1 mg/kg,,BAO_0000218,17651,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621326,1969.0,7794,Rattus norvegicus,,10116.0,N,Plasma,1,,Maximum time to achieve peak plasma concentration was determined in rat at 10 mg/kg,,BAO_0000218,17651,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621327,,7795,Rattus norvegicus,,10116.0,N,,1,,Tmax in Guinea pig (PO dose),,BAO_0000218,14465,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621328,,7796,Rattus norvegicus,,10116.0,N,,1,,"Pharmacokinetic Parameter, Tmax is the time at which maximum concentration (Cmax) is reached in Female Wistar Rats at 100 mg/kg by po administration",,BAO_0000218,14941,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621329,,7797,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic parameter (Tmax) in rat,,BAO_0000218,5960,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621330,,7798,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic parameter (Tmax) was estimated,,BAO_0000218,5022,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621331,,7799,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic property (Tmax) in rat,,BAO_0000218,4408,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621332,,7800,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic property (Tmax) was measured in rat at the dose of 0.32 mg/kg p.o.,,BAO_0000218,5983,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621333,,7801,Rattus norvegicus,,10116.0,N,,1,,T max in Rat at a oral dose of 5 mg/kg,,BAO_0000218,4689,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621334,,7802,Rattus norvegicus,,10116.0,N,,1,,T max was determined at 10 mg/kg po dose in rats,,BAO_0000218,2792,
,,A,,Intermediate,1,,50594,CHEMBL621335,,7803,Mus musculus,,10090.0,N,,1,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (run time 7 hr),,BAO_0000218,15011,
,,A,,Intermediate,1,,50588,CHEMBL621336,,7804,Canis lupus familiaris,,9615.0,N,,1,,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in dogs,,BAO_0000218,14180,
,,A,,Intermediate,1,,50597,CHEMBL621337,,7805,Rattus norvegicus,,10116.0,N,,1,,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in rats,,BAO_0000218,14180,
,,A,,Intermediate,1,,50588,CHEMBL621338,,7806,Canis lupus familiaris,,9615.0,N,,1,,Area under curve was measured after i.v. administration into Beagle dog.,,BAO_0000218,14599,
,,A,,Intermediate,1,,50588,CHEMBL875838,,7807,Canis lupus familiaris,,9615.0,N,,1,,Area under curve was measured after iv administration into Beagle dog,,BAO_0000218,14599,
,,A,,Intermediate,1,,50588,CHEMBL621339,,7808,Canis lupus familiaris,,9615.0,N,,1,,Area under curve was measured after po administration into Beagle dog,,BAO_0000218,14599,
,,A,,Intermediate,1,,50588,CHEMBL621340,,7809,Canis lupus familiaris,,9615.0,N,,1,,Area under curve was measured after po administration into Beagle dog.,,BAO_0000218,14599,
,,A,,Autocuration,0,,22224,CHEMBL621341,,7810,,,,U,,1,,Area under curve was measured at peroral dose of 3 mg/kg,,BAO_0000218,15675,
,,A,,Autocuration,0,,22224,CHEMBL621342,,7811,,,,U,,1,,Area under curve was measured by using concentration Vs time,,BAO_0000019,12706,
,,A,,Autocuration,0,,22224,CHEMBL621343,,7812,,,,U,,1,,Area under curve was measured by using concentration Vs time; not tested,,BAO_0000019,12706,
,,A,,Intermediate,1,,50594,CHEMBL621344,,7813,Mus musculus,,10090.0,N,,1,,Area under curve(AUC) was measured in mice after oral administration (50 mg/kg),,BAO_0000218,9750,
,,A,,Intermediate,1,,50594,CHEMBL621345,,7814,Mus musculus,,10090.0,N,,1,,Area under curve(AUC) was measured in mice after oral administration.,,BAO_0000218,9750,
,,A,,Autocuration,0,,22224,CHEMBL621346,,7815,,,,U,,1,,Area under curve(AUC) value of the compound,,BAO_0000019,14691,
,,A,,Autocuration,0,,22224,CHEMBL621347,,7816,,,,U,,1,,Area under curve(AUC) value of the compound in dogs at 0.5 mg/kg dose upon oral administration,,BAO_0000218,14691,
,,A,,Intermediate,1,,50588,CHEMBL621348,,7817,Canis lupus familiaris,,9615.0,N,,1,,Area under curve(AUC) value of the compound in dogs at 1 mg/kg dose upon oral administration,,BAO_0000218,14691,
,,A,,Autocuration,0,,22224,CHEMBL621349,178.0,7818,,,,U,Blood,1,,Area under curve(carotid artery) was determined by the availability in blood,,BAO_0000019,2939,
,,A,,Autocuration,0,,22224,CHEMBL621350,178.0,7819,,,,U,Blood,1,,Area under curve(carotid artery) was determined by the availability in blood; ND means no data,,BAO_0000019,2939,
,,A,,Autocuration,0,,22224,CHEMBL875839,178.0,7820,,,,U,Blood,1,,Area under curve(carotid artery) was determined by the availability in blood; No data,,BAO_0000019,2939,
,,A,,Autocuration,0,,22224,CHEMBL620211,178.0,7821,,,,U,Blood,1,,Area under curve(portal vein) was determined by the availability in blood,,BAO_0000019,2939,
,,A,,Autocuration,0,,22224,CHEMBL620212,178.0,7822,,,,U,Blood,1,,Area under curve(portal vein) was determined by the availability in blood; ND means no data,,BAO_0000019,2939,
,,A,,Autocuration,0,,22224,CHEMBL620213,178.0,7823,,,,U,Blood,1,,Area under curve(portal vein) was determined by the availability in blood; No data,,BAO_0000019,2939,
,,A,,Intermediate,1,,50797,CHEMBL620214,1969.0,7824,Macaca mulatta,,9544.0,N,Plasma,1,,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",,BAO_0000218,9552,
,,A,,Intermediate,1,,50797,CHEMBL620215,1969.0,7825,Macaca mulatta,,9544.0,N,Plasma,1,,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",,BAO_0000218,9552,
,,A,,Intermediate,1,,50797,CHEMBL620216,1969.0,7826,Macaca mulatta,,9544.0,N,Plasma,1,,Area under plasma concentration vs time curve observed in Rhesus monkeys after oral administration of single 30 mg/kg dose,,BAO_0000218,9552,
,,A,,Intermediate,1,,50588,CHEMBL620888,1969.0,7827,Canis lupus familiaris,,9615.0,N,Plasma,1,,"Area under plasma concentration vs time curve observed in female mongrel dogs after, iv administration of single 15 mg/kg dose",,BAO_0000218,9552,
,,A,,Intermediate,1,,50588,CHEMBL620889,1969.0,7828,Canis lupus familiaris,,9615.0,N,Plasma,1,,"Area under plasma concentration vs time curve observed in female mongrel dogs after, oral administration of single 15 mg/kg dose",,BAO_0000218,9552,
,,A,,Autocuration,0,,22224,CHEMBL620890,1969.0,7829,,,,U,Plasma,1,,Area under plasma concentration vs time curve observed in rats for 0-3 h,,BAO_0000019,9552,
,,A,,Intermediate,1,,50597,CHEMBL620891,1969.0,7830,Rattus norvegicus,,10116.0,N,Plasma,1,,Area under plasma time curve determined in male rat,,BAO_0000218,11911,
,,A,,Autocuration,0,,22224,CHEMBL620892,,7831,,,,U,,1,,Area under the MAP curve measured over 5 min.,,BAO_0000019,16618,
,,A,,Intermediate,1,,50594,CHEMBL621079,,7832,Mus musculus,,10090.0,N,,1,,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through iv route in mice,,BAO_0000218,14387,
,,A,,Intermediate,1,,50594,CHEMBL621080,,7833,Mus musculus,,10090.0,N,,1,,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through oral route in mice,,BAO_0000218,14387,
,,A,,Intermediate,1,,50588,CHEMBL621081,,7834,Canis lupus familiaris,,9615.0,N,,1,,Area under the concentration vs time curve in dog at 10 mg/kg oral dose,,BAO_0000218,12836,
,,A,,Intermediate,1,,100712,CHEMBL621082,,7835,Cricetinae,,10026.0,N,,1,,Area under the concentration vs time curve in hamster at 10 mg/kg oral dose,,BAO_0000218,12836,
,,A,,Intermediate,1,,50597,CHEMBL621083,,7836,Rattus norvegicus,,10116.0,N,,1,,Area under the concentration vs time curve in rat at 10 mg/kg oral dose,,BAO_0000218,12836,
,,A,,Intermediate,1,,50588,CHEMBL621084,,7837,Canis lupus familiaris,,9615.0,N,,1,,Area under the concentration-time curve from time zero to infinity after intravenous administration of 2.5 mg/kg in dogs,,BAO_0000218,14339,
,,A,,Intermediate,1,,50588,CHEMBL621085,,7838,Canis lupus familiaris,,9615.0,N,,1,,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fasted dogs,,BAO_0000218,14339,
,,A,,Intermediate,1,,50588,CHEMBL621086,,7839,Canis lupus familiaris,,9615.0,N,,1,,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fed dogs,,BAO_0000218,14339,
,,A,,Intermediate,1,,50588,CHEMBL621087,,7840,Canis lupus familiaris,,9615.0,N,,1,,Area under the concentration/ time determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),,BAO_0000218,10524,
,,A,,Intermediate,1,,50588,CHEMBL622607,,7841,Canis lupus familiaris,,9615.0,N,,1,,Area under the concentration/ time in plasma after oral administration in dog (25 mg/kg),,BAO_0000218,9994,
,,A,,Intermediate,1,,50588,CHEMBL622608,,7842,Canis lupus familiaris,,9615.0,N,,1,,Serum AUC in marmosets (IV dose),,BAO_0000218,11325,
,,A,,Autocuration,0,,22224,CHEMBL624481,,7843,,,,U,,1,,Area under the curve after intravenous administration at a dose of 10 umol/kg,,BAO_0000019,12536,
,,A,,Autocuration,0,,22224,CHEMBL624482,,7844,,,,U,,1,,Area under the curve after intravenous administration at a dose of 2 umol/kg,,BAO_0000019,12536,
,,A,,Autocuration,0,,22224,CHEMBL624483,,7845,,,,U,,1,,Area under the curve after intravenous administration at a dose of 4 umol/kg,,BAO_0000019,12536,
,,A,,Autocuration,0,,22224,CHEMBL624484,,7846,,,,U,,1,,Area under the curve after intravenous administration at a dose of 40 umol/kg,,BAO_0000019,12536,
,,A,,Autocuration,0,,22224,CHEMBL624485,,7847,,,,U,,1,,Area under the curve after intravenous administration at a dose of 5 umol/kg,,BAO_0000019,12536,
,,A,,Intermediate,1,,50597,CHEMBL624486,,7848,Rattus norvegicus,,10116.0,N,,1,,Area under the curve for fumarate salt was evaluated in F344 Rats.,,BAO_0000218,15556,
,,A,,Autocuration,0,,22224,CHEMBL624487,,7849,,,,U,,1,,Area under the curve for the compound was calculated.,,BAO_0000019,2809,
,,A,,Autocuration,0,,22224,CHEMBL624488,,7850,,,,U,,1,,Area under the curve in concentration/ time,,BAO_0000019,9511,
,,A,,Intermediate,1,,50597,CHEMBL624489,,7851,Rattus norvegicus,,10116.0,N,,1,,Area under the curve administered intraintestinal in rats.,,BAO_0000218,12818,
,,A,,Intermediate,1,,50597,CHEMBL625184,,7852,Rattus norvegicus,,10116.0,N,,1,,Area under the curve administered intravenously in rats.,,BAO_0000218,12818,
,,A,,Autocuration,0,,22224,CHEMBL625185,,7853,,,,U,,1,,Area under the curve during intravenous administration,,BAO_0000019,15118,
,,A,,Autocuration,0,,22224,CHEMBL875954,,7854,,,,U,,1,,Area under the curve during intravenous administration; Not determined,,BAO_0000019,15118,
,,A,,Autocuration,0,,22224,CHEMBL625186,,7855,,,,U,,1,,Area under the curve during systemic administration,,BAO_0000019,15118,
,,A,,Autocuration,0,,22224,CHEMBL625187,,7856,,,,U,,1,,Area under the curve during systemic administration; Not determined,,BAO_0000019,15118,
,,A,,Autocuration,0,,22224,CHEMBL625188,,7857,,,,U,,1,,Area under the curve was calculated for the compound.,,BAO_0000019,2632,
,,A,,Intermediate,1,,50588,CHEMBL625189,,7858,Canis lupus familiaris,,9615.0,N,,1,,Area under the curve was determined after intravenous administration of 1.8 mg/kg in male Beagle dogs,,BAO_0000218,14346,
,,A,,Intermediate,1,,50588,CHEMBL625190,,7859,Canis lupus familiaris,,9615.0,N,,1,,Area under the curve was determined after intravenous administration of 10 mg/kg in male Beagle dogs,,BAO_0000218,14346,
,,A,,Intermediate,1,,50597,CHEMBL621733,,7860,Rattus norvegicus,,10116.0,N,,1,,Area under the curve was determined after intravenous administration of 2.5 mg/kg in male Dawley rats,,BAO_0000218,14346,
,,A,,Intermediate,1,,50597,CHEMBL621734,,7861,Rattus norvegicus,,10116.0,N,,1,,Area under the curve was determined after intravenous administration of 2.6 mg/kg in male Dawley rats,,BAO_0000218,14346,
,,A,,Intermediate,1,,50597,CHEMBL621735,,7862,Rattus norvegicus,,10116.0,N,,1,,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate after oral administration to male F344 rats,,BAO_0000218,11149,
,,A,,Intermediate,1,,50597,CHEMBL621736,1969.0,7863,Rattus norvegicus,,10116.0,N,Plasma,1,,Clearance of the drug was measured in the plasma of rat; No data,,BAO_0000218,17796,
,,A,,Intermediate,1,,50597,CHEMBL621737,1969.0,7864,Rattus norvegicus,,10116.0,N,Plasma,1,,The pharmacokinetic parameter plasma clearance in vivo in rats,,BAO_0000218,5247,
,,A,,Intermediate,1,,50597,CHEMBL621738,,7865,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance at the dose of 2 mg/kg in rat,,BAO_0000218,4727,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622806,,7866,Rattus norvegicus,,10116.0,N,,1,,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,,BAO_0000218,5654,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623519,,7867,Rattus norvegicus,,10116.0,N,,1,,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,,BAO_0000218,5654,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623520,,7868,Rattus norvegicus,,10116.0,N,,1,,CL at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,BAO_0000218,17260,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623521,,7869,Rattus norvegicus,,10116.0,N,,1,,Clearance measured after intravenous bolus administration of 50 mg/kg of compound to rats,,BAO_0000218,17065,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623522,,7870,Rattus norvegicus,,10116.0,N,,1,,Clearance in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,BAO_0000218,17671,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623523,,7871,Rattus norvegicus,,10116.0,N,,1,,Clearance rate in rat,,BAO_0000218,6672,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623690,,7872,Rattus norvegicus,,10116.0,N,,1,,Clearance rate in rat,,BAO_0000218,6673,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623691,,7873,Rattus norvegicus,,10116.0,N,,1,,Clearance (Cl) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,,BAO_0000218,5978,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623692,,7874,Rattus norvegicus,,10116.0,N,,1,,Clearance (Cl) of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,,BAO_0000218,5978,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623693,,7875,Rattus norvegicus,,10116.0,N,,1,,Clearance (Cl) of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,,BAO_0000218,5978,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623694,,7876,Rattus norvegicus,,10116.0,N,,1,,Clearance (Cl) of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,,BAO_0000218,5978,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623695,,7877,Rattus norvegicus,,10116.0,N,,1,,Clearance of compound after iv administration of 20 mg/kg dose in rat,,BAO_0000218,4413,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623696,,7878,Rattus norvegicus,,10116.0,N,,1,,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to female wistar rats,,BAO_0000218,2661,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623697,,7879,Rattus norvegicus,,10116.0,N,,1,,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to male wistar rats,,BAO_0000218,2661,
In vivo,,A,,Intermediate,0,,22224,CHEMBL623698,1969.0,7880,Macaca mulatta,,9544.0,U,Plasma,1,,Compound was tested for its plasma clearance rate in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,,BAO_0000218,5005,
In vivo,,A,,Intermediate,0,,22224,CHEMBL623699,1969.0,7881,Rattus norvegicus,,10116.0,U,Plasma,1,,Compound was tested for its plasma clearance rate in Sprague Dawley rats,,BAO_0000218,5005,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623700,,7882,Rattus norvegicus,,10116.0,N,,1,,Mean (%CV) PK parameters for CL(mL/min/kg).,,BAO_0000218,15765,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623701,,7883,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic studies were carried out to determine the clearance after administration at 20 mg/kg intravenously in rat,,BAO_0000218,3747,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623702,1969.0,7884,Rattus norvegicus,,10116.0,N,Plasma,1,,Pharmacokinetic parameter plasma clearance was determined at when a dose of 1 mg/kg is administered,,BAO_0000218,16366,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623703,,7885,Rattus norvegicus,,10116.0,N,,1,,Plasma Clearance measured at steady-state following iv infusion at 0.6 mg/kg/h in rats,,BAO_0000218,4199,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623704,,7886,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance in rat was determined,,BAO_0000218,17267,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623705,,7887,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance in rat after administration of 2 mg/kg iv,,BAO_0000218,6535,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623706,,7888,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance in rat after administration of 2 mg/kg iv,,BAO_0000218,6535,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623707,,7889,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance was determined,,BAO_0000218,5041,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623708,,7890,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance in rat,,BAO_0000218,5960,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623709,,7891,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance in rat after intravenous administration at a concentration 0.5 mg/kg,,BAO_0000218,5937,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623710,,7892,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance in rat by iv administration,,BAO_0000218,5871,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623711,,7893,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance in rat by iv administration at a dose of 3 mg/kg,,BAO_0000218,5874,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623712,,7894,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance in rat p.o.,,BAO_0000218,6504,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623713,,7895,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance in rats,,BAO_0000218,6803,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623714,,7896,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance was determined; ND denotes no data,,BAO_0000218,5041,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623715,,7897,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance was determined; ND denotes not determined,,BAO_0000218,5041,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623716,,7898,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,,BAO_0000218,1916,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622980,,7899,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,,BAO_0000218,5199,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622981,,7900,Rattus norvegicus,,10116.0,N,,1,,Plasma administration to rats,,BAO_0000218,16367,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622982,,7901,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance of the compound in female Sprague-Dawley rats,,BAO_0000218,6362,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622983,,7902,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance was observed after intravenous administration in rat,,BAO_0000218,15662,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622984,,7903,Rattus norvegicus,,10116.0,N,,1,,Systemic clearance after intravenous administration (5.0 mg/kg) was determined in rat,,BAO_0000218,6215,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622985,,7904,Rattus norvegicus,,10116.0,N,,1,,Tested for systemic clearance upon intravenous administration of 5.0 mg/Kg dose in rat,,BAO_0000218,1466,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623631,1969.0,7905,Rattus norvegicus,,10116.0,N,Plasma,1,,plasma clearance was observed after intravenous administration in rat,,BAO_0000218,15662,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623632,,7906,Rattus norvegicus,,10116.0,N,,1,,In vivo CL/F determined,,BAO_0000218,4723,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623633,1969.0,7907,Rattus norvegicus,,10116.0,N,Plasma,1,,Pharmacokinetic parameter plasma clearance was determined at 2 mg/kg i.v. dose in rats,,BAO_0000218,2792,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623634,1969.0,7908,Rattus norvegicus,,10116.0,N,Plasma,1,,Pharmacokinetic parameter plasma clearance was determined at 5 mg/kg i.v. dose in rats,,BAO_0000218,2792,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623635,,7909,Rattus norvegicus,,10116.0,N,,1,,Compound was tested for the lower blood clearance in rat,,BAO_0000218,5213,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621195,,7910,Rattus norvegicus,,10116.0,N,,1,,Evaluated for the low clearance in rat (in vivo),,BAO_0000218,4687,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621196,,7911,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic property (CLb)of the compound was determined in rat,,BAO_0000218,3371,
In vivo,,A,,Intermediate,1,,50597,CHEMBL875287,,7912,Rattus norvegicus,,10116.0,N,,1,,Rapid clearance after intravenous administration in rat was determined,,BAO_0000218,4690,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621197,,7913,Rattus norvegicus,,10116.0,N,,1,,Clearance measured in rat,,BAO_0000218,5702,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621198,1969.0,7914,Rattus norvegicus,,10116.0,N,Plasma,1,,Compound was evaluated for plasma clearance in rat,,BAO_0000218,740,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621199,1969.0,7915,Rattus norvegicus,,10116.0,N,Plasma,1,,Low plasma clearance was calculated in rat,,BAO_0000218,4853,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621200,,7916,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic property (Clp) in rat,,BAO_0000218,5789,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621201,,7917,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance in dog at a dose of 1 uM/kg in rat was determined,,BAO_0000218,4527,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621202,,7918,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance in rat at a dose of 10 uM/kg in rat was determined,,BAO_0000218,4527,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621203,,7919,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance after IV dosing at 0.5 mg/kg in rat,,BAO_0000218,6518,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621204,,7920,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance after IV dosing at 1 mg/kg in rat,,BAO_0000218,6518,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621205,948.0,7921,Rattus norvegicus,,10116.0,N,Heart,1,,Biodistribution in rat heart in the presence of 0.01 M Gd/0.01 M GdDTPA-AEP,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621206,948.0,7922,Rattus norvegicus,,10116.0,N,Heart,1,,Biodistribution in rat heart in the presence of 0.01 M GdDTPA-BDP,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621207,948.0,7923,Rattus norvegicus,,10116.0,N,Heart,1,,Biodistribution in rat heart in the presence of 0.01 M/0.08 M GdDTPA-AEP,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621208,948.0,7924,Rattus norvegicus,,10116.0,N,Heart,1,,Biodistribution in rat heart in the presence of 0.05 M /0.05 M GdDTPA-AEP,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621209,948.0,7925,Rattus norvegicus,,10116.0,N,Heart,1,,Biodistribution in rat heart in the presence of 0.05 M Gd/0.15 M lig,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL876484,948.0,7926,Rattus norvegicus,,10116.0,N,Heart,1,,Biodistribution in rat heart in the presence of 0.05 M GdDTPA-BDP,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621210,948.0,7927,Rattus norvegicus,,10116.0,N,Heart,1,,Biodistribution in rat heart in the presence of 0.05 M/0.08 M GdDTPA-HPDP,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621211,948.0,7928,Rattus norvegicus,,10116.0,N,Heart,1,,Biodistribution in rat heart in the presence of 0.10 M GdDTPA-BDP,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621212,948.0,7929,Rattus norvegicus,,10116.0,N,Heart,1,,Biodistribution in rat heart in the presence of 0.10 M/0.11 M GdDTPA-AEP,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621213,948.0,7930,Rattus norvegicus,,10116.0,N,Heart,1,,Biodistribution in rat heart in the presence of GdDTPA at 15 min,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621214,948.0,7931,Rattus norvegicus,,10116.0,N,Heart,1,,Biodistribution in rat heart in the presence of GdDTPA at 1 hr,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621215,948.0,7932,Rattus norvegicus,,10116.0,N,Heart,1,,Biodistribution in rat heart in the presence of GdDTPA at 30 min,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621216,948.0,7933,Rattus norvegicus,,10116.0,N,Heart,1,,Biodistribution in rat heart in the presence of GdDTPA at 4 hr,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621217,948.0,7934,Rattus norvegicus,,10116.0,N,Heart,1,,Biodistribution in rat heart in the presence of GdDTPA-BDP at 1 hr,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621218,948.0,7935,Rattus norvegicus,,10116.0,N,Heart,1,,Biodistribution in rat heart in the presence of GdDTPA-BDP at 30 min,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621219,948.0,7936,Rattus norvegicus,,10116.0,N,Heart,1,,Biodistribution in rat heart in the presence of GdDTPA-BDP at 4 hr,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621220,948.0,7937,Rattus norvegicus,,10116.0,N,Heart,1,,Biodistribution in rat heart in the presence of GdDTPA-BDPat 15 min,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621221,948.0,7938,Rattus norvegicus,,10116.0,N,Heart,1,,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 1 hr,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621222,948.0,7939,Rattus norvegicus,,10116.0,N,Heart,1,,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 30 min,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621223,948.0,7940,Rattus norvegicus,,10116.0,N,Heart,1,,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 4 hr,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL876485,948.0,7941,Rattus norvegicus,,10116.0,N,Heart,1,,Biodistribution in rat heart in the presence of GdDTPA-HPDPat 15 min,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621224,948.0,7942,Rattus norvegicus,,10116.0,N,Heart,1,,Biodistribution in rat heart in the presence of NAC Gd/0.01 M GdDTPA-HPDP,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621225,948.0,7943,Rattus norvegicus,,10116.0,N,Heart,1,,Biodistribution in rat heart in the presence of NCA Gd/0.01 M lip,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621226,948.0,7944,Rattus norvegicus,,10116.0,N,Heart,1,,Biodistribution in rat heart in the presence of NCAGd/0.01 M lig,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621227,2113.0,7945,Rattus norvegicus,,10116.0,N,Kidney,1,,Biodistribution in rat kidney in the presence of 0.01 M GdDTPA-BDP,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621228,2113.0,7946,Rattus norvegicus,,10116.0,N,Kidney,1,,Biodistribution in rat kidney in the presence of 0.01 M/0.01 M GdDTPA-AEP,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621229,2113.0,7947,Rattus norvegicus,,10116.0,N,Kidney,1,,Biodistribution in rat kidney in the presence of 0.01 M/0.08 M GdDTPA-AEP,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621230,2113.0,7948,Rattus norvegicus,,10116.0,N,Kidney,1,,Biodistribution in rat kidney in the presence of 0.05 M Gd/0.15 M lig,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621231,2113.0,7949,Rattus norvegicus,,10116.0,N,Kidney,1,,Biodistribution in rat kidney in the presence of 0.05 M GdDTPA-BDP; ND=No data,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621232,2113.0,7950,Rattus norvegicus,,10116.0,N,Kidney,1,,Biodistribution in rat kidney in the presence of 0.05 M/0.05 M GdDTPA-AEP,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621233,2113.0,7951,Rattus norvegicus,,10116.0,N,Kidney,1,,Biodistribution in rat kidney in the presence of 0.05 M/0.08 M GdDTPA-HPDP,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621234,2113.0,7952,Rattus norvegicus,,10116.0,N,Kidney,1,,Biodistribution in rat kidney in the presence of 0.10 M GdDTPA-BDP,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621235,2113.0,7953,Rattus norvegicus,,10116.0,N,Kidney,1,,Biodistribution in rat kidney in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621236,2113.0,7954,Rattus norvegicus,,10116.0,N,Kidney,1,,Biodistribution in rat kidney in the presence of NAC Gd/0.01 M GdDTPA-HPDP,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621237,2113.0,7955,Rattus norvegicus,,10116.0,N,Kidney,1,,Biodistribution in rat kidney in the presence of NCA Gd/0.01 M lip,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL876486,2113.0,7956,Rattus norvegicus,,10116.0,N,Kidney,1,,Biodistribution in rat kidney in the presence of NCAGd/0.01 M lig,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622436,160.0,7957,Rattus norvegicus,,10116.0,N,Intestine,1,,Biodistribution in rat l. intestine in the presence of 0.01 M carrier at 1 hr,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622437,160.0,7958,Rattus norvegicus,,10116.0,N,Intestine,1,,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 2 hr,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622438,160.0,7959,Rattus norvegicus,,10116.0,N,Intestine,1,,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 6 hr,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622439,2107.0,7960,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution in rat liver by in the presence 50 Gd/kg at 15 min,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622440,2107.0,7961,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution in rat liver by in the presence of 0.05 M Gd/0.15 M lig,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622441,2107.0,7962,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution in rat liver by in the presence of NCAGd/0.01 M lig,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622442,2107.0,7963,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution in rat liver in the presence of 0.001 M/0.008 M GdDTPA-AEP,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622443,2107.0,7964,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution in rat liver in the presence of 0.01 M GdDTPA-BDP,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622444,2107.0,7965,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution in rat liver in the presence of 0.01 M/0.01 M GdDTPA-AEP,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622445,2107.0,7966,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution in rat liver in the presence of 0.05 M GdDTPA-BDP,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622446,2107.0,7967,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution in rat liver in the presence of 0.05 M/0.05 M GdDTPA-AEP,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622447,2107.0,7968,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution in rat liver in the presence of 0.05 M/0.08 M GdDTPA-HPDP,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622448,2107.0,7969,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution in rat liver in the presence of 0.10 M GdDTPA-BDP,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622449,2107.0,7970,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution in rat liver in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622450,2107.0,7971,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution in rat liver in the presence of 50 Gd/kg at 2 hr,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622451,2107.0,7972,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution in rat liver in the presence of 50 Gd/kg at at 6 hr,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622452,2107.0,7973,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution in rat liver in the presence of GdDTPA at 15 min,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622453,2107.0,7974,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution in rat liver in the presence of GdDTPA at 1 hr,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622454,2107.0,7975,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution in rat liver in the presence of GdDTPA at 30 min,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622455,2107.0,7976,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution in rat liver in the presence of GdDTPA at 4 hr,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL876024,2107.0,7977,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution in rat liver in the presence of GdDTPA-BDP at 15 min,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622456,,7978,Rattus norvegicus,,10116.0,N,,1,,T max was determined at 3 mg/kg po dose in rats,,BAO_0000218,2792,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622457,,7979,Rattus norvegicus,,10116.0,N,,1,,"The Tmax value in female wistar rat at 100 mg/kg, p.o. dose",,BAO_0000218,15078,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622458,,7980,Rattus norvegicus,,10116.0,N,,1,,"The Tmax value in male wistar rat at 100 mg/kg, p.o. dose",,BAO_0000218,15078,
,,A,,Intermediate,1,,50597,CHEMBL622459,,7981,Rattus norvegicus,,10116.0,N,,1,,The time to reach maximum concentration of compound was measured at the dose of 100 umol/kg,,BAO_0000218,15022,
,,A,,Intermediate,1,,50597,CHEMBL873343,,7982,Rattus norvegicus,,10116.0,N,,1,,The time to reach maximum concentration of compound was measured at the dose of 300 umol/kg,,BAO_0000218,15022,
,,A,,Intermediate,1,,50597,CHEMBL622460,,7983,Rattus norvegicus,,10116.0,N,,1,,The time to reach maximum concentration of compound was measured at the dose of 30 umol/kg,,BAO_0000218,15022,
,,A,,Intermediate,1,,50597,CHEMBL622461,1969.0,7984,Rattus norvegicus,,10116.0,N,Plasma,1,,Time for maximum plasma concentration determined in rat,,BAO_0000218,4576,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622462,1969.0,7985,Rattus norvegicus,,10116.0,N,Plasma,1,,Time for maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,,BAO_0000218,6681,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622463,,7986,Rattus norvegicus,,10116.0,N,,1,,Time of maximum concentration of the drug when administered orally a dose of 10 mg/kg to a fasting rat,,BAO_0000218,16365,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622464,,7987,Rattus norvegicus,,10116.0,N,,1,,Time of maximum concentration of the drug when administered orally a dose of 1 mg/kg to a fasting rat,,BAO_0000218,16365,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622465,,7988,Rattus norvegicus,,10116.0,N,,1,,Time of maximum concentration of the drug when administered orally a dose of 30 mg/kg,,BAO_0000218,16365,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622466,,7989,Rattus norvegicus,,10116.0,N,,1,,Time of maximum concentration of the drug when administered orally a dose of 3 mg/kg to a fasting rat,,BAO_0000218,16365,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622467,,7990,Rattus norvegicus,,10116.0,N,,1,,Time of maximum concentration of the drug when administered orally at dose of 3 mg/kg,,BAO_0000218,16365,
,,A,,Intermediate,1,,50597,CHEMBL622468,1969.0,7991,Rattus norvegicus,,10116.0,N,Plasma,1,,Time of maximum plasma concentration in rat,,BAO_0000218,6824,
,,A,,Intermediate,1,,50597,CHEMBL876025,1969.0,7992,Rattus norvegicus,,10116.0,N,Plasma,1,,"Time required by compound for reaching maximum plasma concentration was determined in rats at 10 mg/kg, p.o. dose",,BAO_0000218,6685,
,,A,,Intermediate,1,,50597,CHEMBL622469,1969.0,7993,Rattus norvegicus,,10116.0,N,Plasma,1,,"Time required by compound for reaching maximum plasma concentration was determined in rats at 20 mg/kg, i.p. dose",,BAO_0000218,6685,
,,A,,Intermediate,1,,50597,CHEMBL622470,1969.0,7994,Rattus norvegicus,,10116.0,N,Plasma,1,,"Time required by compound for reaching maximum plasma concentration was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",,BAO_0000218,6685,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622471,,7995,Rattus norvegicus,,10116.0,N,,1,,Time required to reach maximum concentration (Cmax) after oral administration in rat,,BAO_0000218,15662,
,,A,,Intermediate,1,,50597,CHEMBL622472,1969.0,7996,Rattus norvegicus,,10116.0,N,Plasma,1,,Time required to reach maximum concentration in rat plasma,,BAO_0000218,1742,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622473,1969.0,7997,Rattus norvegicus,,10116.0,N,Plasma,1,,Time taken by the compound to achieve maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,,BAO_0000218,2774,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624282,1969.0,7998,Rattus norvegicus,,10116.0,N,Plasma,1,,Time taken by the compound to achieve maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,,BAO_0000218,5199,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624283,1969.0,7999,Rattus norvegicus,,10116.0,N,Plasma,1,,Time taken for maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,,BAO_0000218,12873,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624284,1969.0,8000,Rattus norvegicus,,10116.0,N,Plasma,1,,Time taken for maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,,BAO_0000218,12873,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624285,1969.0,8001,Rattus norvegicus,,10116.0,N,Plasma,1,,Time taken to reach maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,,BAO_0000218,1916,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624286,,8002,Rattus norvegicus,,10116.0,N,,1,,Time to reach Cmax after oral administration to rats,,BAO_0000218,16367,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624287,,8003,Rattus norvegicus,,10116.0,N,,1,,Time to reach Cmax when a dose of 1 mg/kg is administered orally,,BAO_0000218,16366,
,,A,,Intermediate,1,,50597,CHEMBL624288,,8004,Rattus norvegicus,,10116.0,N,,1,,Time to reach maximum concentration following oral administration of 200 mg/kg in rat; value ranges from 2-4,,BAO_0000218,216,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624289,1969.0,8005,Rattus norvegicus,,10116.0,N,Plasma,1,,Time to reach maximum plasma concentration was evaluated at an intravenous dose of 3 mg/kg; Not applicable,,BAO_0000218,6410,
In vivo,,A,,Intermediate,1,,50597,CHEMBL873344,1969.0,8006,Rattus norvegicus,,10116.0,N,Plasma,1,,Time to reach maximum plasma concentration was evaluated at an oral dose of 30 mg/kg,,BAO_0000218,6410,
In vivo,,A,,Intermediate,1,,50597,CHEMBL619623,,8007,Rattus norvegicus,,10116.0,N,,1,,Tmax after peroral administration (10 mg/kg) was determined in rat,,BAO_0000218,6215,
In vivo,,A,,Expert,1,,50597,CHEMBL621399,,8008,Rattus norvegicus,,10116.0,N,,1,,Tmax of compound determined in rat after iv administration at a dose of 10 mg/kg,,BAO_0000218,3598,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621400,,8009,Rattus norvegicus,,10116.0,N,,1,,Tmax by oral administration at a dose of 100 uM/kg in rat was determined,,BAO_0000218,4527,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621401,,8010,Rattus norvegicus,,10116.0,N,,1,,"Tmax in fischer rats at 5 mg/kg dose, administered intravenously",,BAO_0000218,17670,
,,A,,Intermediate,1,,50597,CHEMBL621402,,8011,Rattus norvegicus,,10116.0,N,,1,,Tmax was determined,,BAO_0000218,1465,
,,A,,Intermediate,1,,50597,CHEMBL621403,,8012,Rattus norvegicus,,10116.0,N,,1,,Tmax was determined,,BAO_0000218,2552,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621121,,8013,Rattus norvegicus,,10116.0,N,,1,,Tmax after oral administration in rat,,BAO_0000218,5656,
In vivo,,A,,Intermediate,1,,50597,CHEMBL872525,,8014,Rattus norvegicus,,10116.0,N,,1,,Tmax after peroral administration in rats at 2.4 uM/kg,,BAO_0000218,17764,
,,A,,Intermediate,1,,50597,CHEMBL621122,,8015,Rattus norvegicus,,10116.0,N,,1,,Tmax in male rat,,BAO_0000218,5610,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621123,,8016,Rattus norvegicus,,10116.0,N,,1,,Tmax in rat at 10 mg/kg,,BAO_0000218,6046,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621124,,8017,Rattus norvegicus,,10116.0,N,,1,,Tmax in rat by po administration at a dose of 40 mg/kg,,BAO_0000218,5874,
,,A,,Intermediate,1,,50597,CHEMBL621125,,8018,Rattus norvegicus,,10116.0,N,,1,,Tmax in rats,,BAO_0000218,17596,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621126,,8019,Rattus norvegicus,,10116.0,N,,1,,Tmax was measured in rats after peroral administration at 5 mg/kg,,BAO_0000218,17804,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621127,,8020,Rattus norvegicus,,10116.0,N,,1,,Tmax value after oral dose at a dose of 10 mg/kg in rats.,,BAO_0000218,1908,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621128,,8021,Rattus norvegicus,,10116.0,N,,1,,Tmax value after administration of 20 mg/Kg oral dose in rat,,BAO_0000218,2959,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618263,,8022,Rattus norvegicus,,10116.0,N,,1,,Tmax value at a dose of 10 mg/kg in male SD rats,,BAO_0000218,6757,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618264,,8023,Rattus norvegicus,,10116.0,N,,1,,Tmax value at a dose of 100 mg/kg in male SD rats,,BAO_0000218,6757,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618265,,8024,Rattus norvegicus,,10116.0,N,,1,,Tmax value at a dose of 50 mg/kg in male SD rats,,BAO_0000218,6757,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618266,1969.0,8025,Rattus norvegicus,,10116.0,N,Plasma,1,,Total concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,,BAO_0000218,4186,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618267,,8026,Rattus norvegicus,,10116.0,N,,1,,time required to reach maximum concentration (Cmax) after oral administration in rat,,BAO_0000218,15662,
,,A,,Intermediate,1,,50597,CHEMBL618450,1088.0,8027,Rattus norvegicus,,10116.0,N,Urine,1,,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg ( 0-24 hr ),,BAO_0000218,429,
,,A,,Intermediate,1,,50597,CHEMBL618451,1088.0,8028,Rattus norvegicus,,10116.0,N,Urine,1,,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg (0-24 hr),,BAO_0000218,429,
,,A,,Intermediate,1,,50597,CHEMBL618452,,8029,Rattus norvegicus,,10116.0,N,,1,,Unbound plasma was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,,BAO_0000218,5546,
,,A,,Intermediate,1,,50597,CHEMBL618453,1088.0,8030,Rattus norvegicus,,10116.0,N,Urine,1,,Amount of urine output was measured in rat at a dose of 1 mg/kg/po,,BAO_0000218,3173,
,,A,,Intermediate,1,,50597,CHEMBL618454,1088.0,8031,Rattus norvegicus,,10116.0,N,Urine,1,,Amount of urine output was measured in rat at a dose of 10 mg/kg/po,,BAO_0000218,3173,
,,A,,Intermediate,1,,50597,CHEMBL618455,1088.0,8032,Rattus norvegicus,,10116.0,N,Urine,1,,Amount of urine output was measured in rat at a dose of 10 mg/kg/po; NT-Not tested,,BAO_0000218,3173,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618456,,8033,Rattus norvegicus,,10116.0,N,,1,,Volume of distribution was determined in rat after a 3 mg/kg of iv dose,,BAO_0000218,4257,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618457,,8034,Rattus norvegicus,,10116.0,N,,1,,Compound distribution in rat tissues was determined,,BAO_0000218,6011,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618458,,8035,Rattus norvegicus,,10116.0,N,,1,,Volume of distribution was evaluated in rat,,BAO_0000218,5472,
,,A,,Intermediate,1,,50597,CHEMBL618459,,8036,Rattus norvegicus,,10116.0,N,,1,,Area under the curve was determined after intravenous administration of 2.7 mg/kg in male Dawley rats,,BAO_0000218,14346,
,,A,,Intermediate,1,,50597,CHEMBL876733,,8037,Rattus norvegicus,,10116.0,N,,1,,Area under the curve was determined after intravenous administration of 2.8 mg/kg in male Dawley rats,,BAO_0000218,14346,
,,A,,Intermediate,1,,50588,CHEMBL618460,,8038,Canis lupus familiaris,,9615.0,N,,1,,Area under the curve was determined after intravenous administration of 4.9 mg/kg in male Beagle dogs,,BAO_0000218,14346,
,,A,,Intermediate,1,,50597,CHEMBL618461,,8039,Rattus norvegicus,,10116.0,N,,1,,Area under the curve was determined after intravenous administration of 5.1 mg/kg in male Dawley rats,,BAO_0000218,14346,
,,A,,Autocuration,0,,22224,CHEMBL618462,,8040,,,,U,,1,,Area under the curve was determined after oral administration (300 uM/Kg),,BAO_0000019,15469,
,,A,,Intermediate,1,,50597,CHEMBL618463,,8041,Rattus norvegicus,,10116.0,N,,1,,Area under the curve was determined after peroral administration of 5.0 mg/kg in male Dawley rats,,BAO_0000218,14346,
,,A,,Intermediate,1,,50597,CHEMBL618464,,8042,Rattus norvegicus,,10116.0,N,,1,,Area under the curve was determined after peroral administration of 5.1 mg/kg in mal Dawley rats,,BAO_0000218,14346,
,,A,,Intermediate,1,,50597,CHEMBL618465,,8043,Rattus norvegicus,,10116.0,N,,1,,Area under the curve was determined after peroral administration of 5.1 mg/kg in male Dawley rats,,BAO_0000218,14346,
,,A,,Intermediate,1,,50597,CHEMBL618466,,8044,Rattus norvegicus,,10116.0,N,,1,,Area under the curve was determined after peroral administration of 5.2 mg/kg in mal Dawley rats,,BAO_0000218,14346,
,,A,,Intermediate,1,,50597,CHEMBL618467,,8045,Rattus norvegicus,,10116.0,N,,1,,Area under the curve was determined after peroral administration of 5.2 mg/kg in male Dawley rats,,BAO_0000218,14346,
,,A,,Intermediate,1,,50597,CHEMBL618468,,8046,Rattus norvegicus,,10116.0,N,,1,,Area under the curve was determined for the compound after iv dose of 4.97 mg/kg in rats,,BAO_0000218,15372,
,,A,,Intermediate,1,,50588,CHEMBL618469,1969.0,8047,Canis lupus familiaris,,9615.0,N,Plasma,1,,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 100 mg/kg,,BAO_0000218,12935,
,,A,,Intermediate,1,,50588,CHEMBL618470,1969.0,8048,Canis lupus familiaris,,9615.0,N,Plasma,1,,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 20 mg/kg,,BAO_0000218,12935,
,,A,,Autocuration,0,,22224,CHEMBL618471,,8049,,,,U,,1,,Plasma drug AUC in rat (PO dose),,BAO_0000218,14813,
,,A,,Intermediate,1,,50594,CHEMBL618472,,8050,Mus musculus,,10090.0,N,,1,,Area under the tumor growth curve (AUC) in the B-6 Melanoma Model in C57/b1 mice at the dose of 1 mg/kg.,,BAO_0000218,15792,
,,A,,Autocuration,0,,22224,CHEMBL618473,,8051,,,,U,,1,,Area under was determined at a dose of 30 mg/kg,,BAO_0000218,3579,
,,A,,Intermediate,1,,50506,CHEMBL621699,,8052,Mustela putorius furo,,9669.0,N,,1,,Average area under curve for compound at 1 mg/kg dose intravenous administration to Ferret,,BAO_0000218,12487,
,,A,,Intermediate,1,,50597,CHEMBL621700,,8053,Rattus norvegicus,,10116.0,N,,1,,Average area under curve for the compound at 10 mg/kg dose after intraduodenal administration to rat,,BAO_0000218,12487,
,,A,,Intermediate,1,,50597,CHEMBL621701,,8054,Rattus norvegicus,,10116.0,N,,1,,Average area under curve for the compound at 1 mg/kg dose after intravenous administration to rat,,BAO_0000218,12487,
,,A,,Intermediate,1,,50506,CHEMBL621702,,8055,Mustela putorius furo,,9669.0,N,,1,,Average area under curve at 10 mg/kg dose after intraduodenal administration to Ferret,,BAO_0000218,12487,
,,A,,Intermediate,1,,50588,CHEMBL621703,,8056,Canis lupus familiaris,,9615.0,N,,1,,Average area under curve at 10 mg/kg intraduodenal administration to salt depleted dog,,BAO_0000218,12487,
,,A,,Intermediate,1,,50588,CHEMBL621704,,8057,Canis lupus familiaris,,9615.0,N,,1,,Average area under curve at 1 mg/kg intravenous administration to salt depleted dog,,BAO_0000218,12487,
,,A,,Intermediate,1,,50597,CHEMBL624259,,8058,Rattus norvegicus,,10116.0,N,,1,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 1.0(pmol/g/h)",,BAO_0000218,12902,
,,A,,Intermediate,1,,50597,CHEMBL624260,,8059,Rattus norvegicus,,10116.0,N,,1,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 2.0(pmol/g/h)",,BAO_0000218,12902,
,,A,,Intermediate,1,,50597,CHEMBL624430,,8060,Rattus norvegicus,,10116.0,N,,1,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 4.0(pmol/g/h)",,BAO_0000218,12902,
,,A,,Intermediate,1,,50597,CHEMBL624431,,8061,Rattus norvegicus,,10116.0,N,,1,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 5.0(pmol/g/h)",,BAO_0000218,12902,
,,A,,Intermediate,1,,50597,CHEMBL624432,,8062,Rattus norvegicus,,10116.0,N,,1,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 54.0(pmol/g/h)",,BAO_0000218,12902,
,,A,,Intermediate,1,,50597,CHEMBL624433,,8063,Rattus norvegicus,,10116.0,N,,1,,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 10.0(pmol/g/h)",,BAO_0000218,12902,
,,A,,Intermediate,1,,50597,CHEMBL624434,,8064,Rattus norvegicus,,10116.0,N,,1,,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 20.0(pmol/g/h)",,BAO_0000218,12902,
,,A,,Intermediate,1,,50597,CHEMBL624435,,8065,Rattus norvegicus,,10116.0,N,,1,,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 40.0(pmol/g/h)",,BAO_0000218,12902,
,,A,,Intermediate,1,,50594,CHEMBL618570,,8066,Mus musculus,,10090.0,N,,1,,Bioavailability in mouse brain after intravenous administration of 105.1 mg/kg of dose,,BAO_0000218,12745,
,,A,,Intermediate,1,,50594,CHEMBL618571,,8067,Mus musculus,,10090.0,N,,1,,Bioavailability in mouse brain after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,BAO_0000218,12745,
,,A,,Intermediate,1,,50594,CHEMBL618572,,8068,Mus musculus,,10090.0,N,,1,,Bioavailability in mouse brain after oral administration of 100 mg/kg of dose,,BAO_0000218,12745,
,,A,,Intermediate,1,,50594,CHEMBL618573,,8069,Mus musculus,,10090.0,N,,1,,Bioavailability in mouse brain after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,BAO_0000218,12745,
,,A,,Intermediate,1,,50594,CHEMBL619267,,8070,Mus musculus,,10090.0,N,,1,,Bioavailability in mouse serum after intravenous administration of 105.1 mg/kg of dose,,BAO_0000218,12745,
,,A,,Intermediate,1,,50594,CHEMBL619431,,8071,Mus musculus,,10090.0,N,,1,,Bioavailability in mouse serum after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,BAO_0000218,12745,
,,A,,Intermediate,1,,50594,CHEMBL619432,,8072,Mus musculus,,10090.0,N,,1,,Bioavailability in mouse serum after oral administration of 100 mg/kg of dose,,BAO_0000218,12745,
,,A,,Intermediate,1,,50594,CHEMBL619433,,8073,Mus musculus,,10090.0,N,,1,,Bioavailability in mouse serum after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,BAO_0000218,12745,
,,A,,Autocuration,0,,22224,CHEMBL619434,1969.0,8074,,,,U,Plasma,1,,AUC in mice after oral dose (50 mg/kg),,BAO_0000218,13298,
,,A,,Intermediate,1,,50594,CHEMBL619435,1977.0,8075,Mus musculus,,10090.0,N,Serum,1,,Blood level after oral administration in mice (50 mg/kg) was determined by bioassay procedure and represent total activity present in the serum,,BAO_0000218,12226,
,,A,,Autocuration,0,,22224,CHEMBL619436,1969.0,8076,,,,U,Plasma,1,,AUC (0-4 hr) ug/ml/h,,BAO_0000019,12634,
,,A,,Intermediate,1,,50597,CHEMBL619437,,8077,Rattus norvegicus,,10116.0,N,,1,,Compound at a dose of 10 mg/kg was orally administered to rats and Area under curve was reported,,BAO_0000218,14810,
,,A,,Autocuration,0,,22224,CHEMBL619438,,8078,,,,U,,1,,Compound evaluated for AUC = Area under the nucleoside serum or brain concentration versus time curve after iv administration,,BAO_0000218,13889,
,,A,,Intermediate,1,,50594,CHEMBL619439,,8079,Mus musculus,,10090.0,N,,1,,Compound was evaluated for Area under curve in mice,,BAO_0000218,10018,
,,A,,Intermediate,1,,50597,CHEMBL619440,,8080,Rattus norvegicus,,10116.0,N,,1,,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,,BAO_0000218,8758,
,,F,,Autocuration,0,,22224,CHEMBL619441,,8081,,,,U,,1,,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,,BAO_0000218,8758,
,,A,,Intermediate,1,,50597,CHEMBL619442,,8082,Rattus norvegicus,,10116.0,N,,1,,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,,BAO_0000218,8758,
,,A,,Autocuration,0,,22224,CHEMBL875156,,8083,,,,U,,1,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 1,,BAO_0000019,2249,
,,A,,Autocuration,0,,22224,CHEMBL619443,,8084,,,,U,,1,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 4,,BAO_0000019,2249,
,,A,,Autocuration,0,,22224,CHEMBL619444,,8085,,,,U,,1,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 1,,BAO_0000019,2249,
,,A,,Autocuration,0,,22224,CHEMBL623464,,8086,,,,U,,1,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 4,,BAO_0000019,2249,
,,A,,Intermediate,1,,50594,CHEMBL623465,,8087,Mus musculus,,10090.0,N,,1,,Compound was evaluated for area under curve when administered through oral route in mouse,,BAO_0000218,15115,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623466,,8088,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance after oral administration at a dose of 2 mg/kg in rat; no data,,BAO_0000218,6518,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623467,,8089,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance after oral administration at a dose of 4 mg/kg in rat; no data,,BAO_0000218,6518,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623468,,8090,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance in rat,,BAO_0000218,6249,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622660,,8091,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,,BAO_0000218,2463,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622661,,8092,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance rate in Sprague-Dawley rats,,BAO_0000218,4969,
In vivo,,F,,Intermediate,1,,50597,CHEMBL622662,,8093,Rattus norvegicus,,10116.0,N,,1,,CLtot at a dose of 4 mg/kg in Rat Plasma after iv administration,,BAO_0000218,17720,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622663,,8094,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic property (total body clearance) in rat,,BAO_0000218,3457,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622664,,8095,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic property (CLtot)of the compound was measured in rat at the dose of 0.32 mg/kg i.v.,,BAO_0000218,5983,
,,A,,Intermediate,1,,50597,CHEMBL622665,,8096,Rattus norvegicus,,10116.0,N,,1,,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,,BAO_0000218,6295,
,,A,,Intermediate,1,,50597,CHEMBL622666,,8097,Rattus norvegicus,,10116.0,N,,1,,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,,BAO_0000218,6296,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621615,,8098,Rattus norvegicus,,10116.0,N,,1,,Cl in rat i.v. at 2 mg/kg concentration,,BAO_0000218,17686,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621616,,8099,Rattus norvegicus,,10116.0,N,,1,,Clearance of compound after intravenous administration in rats at 24 uM/kg,,BAO_0000218,17764,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621617,,8100,Rattus norvegicus,,10116.0,N,,1,,Clearance was determined,,BAO_0000218,5503,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621618,,8101,Rattus norvegicus,,10116.0,N,,1,,Clearance by intravenous administration of 3.4 mg/kg in rat,,BAO_0000218,4368,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621619,,8102,Rattus norvegicus,,10116.0,N,,1,,Clearance was evaluated after i.v. administration in rat at a dose of 1 mg/kg,,BAO_0000218,6005,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621620,,8103,Rattus norvegicus,,10116.0,N,,1,,Clearance rate after i.v. administration in rats,,BAO_0000218,5031,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621786,,8104,Rattus norvegicus,,10116.0,N,,1,,Clearance was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,,BAO_0000218,4890,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621787,,8105,Rattus norvegicus,,10116.0,N,,1,,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,,BAO_0000218,5182,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621788,,8106,Rattus norvegicus,,10116.0,N,,1,,Clearance (Cl) of compound after 2 h iv infusion of 8.4 mg/kg in three rat,,BAO_0000218,5979,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621789,,8107,Rattus norvegicus,,10116.0,N,,1,,Clearance (Cl) after oral administration in rat,,BAO_0000218,5656,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621790,,8108,Rattus norvegicus,,10116.0,N,,1,,Compound clearance in rats was measured after intravenous administration at 3 mg/kg,,BAO_0000218,17804,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621791,1969.0,8109,Rattus norvegicus,,10116.0,N,Plasma,1,,Compound was tested for plasma clearance in rat,,BAO_0000218,4839,
In vitro,,A,,Intermediate,1,,50597,CHEMBL621792,,8110,Rattus norvegicus,,10116.0,N,,1,,In vitro microsome metabolism clearance in rat was determined,Microsomes,BAO_0000218,5041,
In vitro,,A,,Intermediate,1,,50597,CHEMBL621793,,8111,Rattus norvegicus,,10116.0,N,,1,,In vitro microsome metabolism clearance in rat was determined; ND denotes no data,Microsomes,BAO_0000218,5041,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621794,,8112,Rattus norvegicus,,10116.0,N,,1,,In vivo Clearance (Cl) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,BAO_0000218,5974,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621795,1969.0,8113,Rattus norvegicus,,10116.0,N,Plasma,1,,In vivo plasma clearance was determined,,BAO_0000218,5496,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621796,,8114,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic property (Clearance) for the compound (5 mg/kg iv) was determined in rats,,BAO_0000218,5739,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621797,2107.0,8115,Rattus norvegicus,Hepatocyte,10116.0,N,Liver,1,401.0,Pharmacokinetic property (Clearance) in rat hepatocyte i.v.,,BAO_0000218,5676,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621798,,8116,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic property (Plasma clearance) was measured in rat,,BAO_0000218,4239,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621799,,8117,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic property (clearance) in rat i.v.,,BAO_0000218,5676,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621800,,8118,Rattus norvegicus,,10116.0,N,,1,,"Plasma Clearance was evaluated in rats, iv",,BAO_0000218,1918,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621801,,8119,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance (in vivo) in rats was determined,,BAO_0000218,17800,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621802,,8120,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance for the compound was calculated at a single intravenous administration of 20 mg/kg in rat,,BAO_0000218,6056,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618596,,8121,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance was determined,,BAO_0000218,5496,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618597,,8122,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance in rat after peroral administration at 10 mg/kg concentration,,BAO_0000218,5939,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618598,,8123,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance in rat after peroral administration at 5 mg/kg concentration,,BAO_0000218,5939,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618599,,8124,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance in rats,,BAO_0000218,17752,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618600,,8125,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance rate determined in rat,,BAO_0000218,4576,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618601,,8126,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance was determined in rat,,BAO_0000218,6011,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618602,,8127,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance was determined,,BAO_0000218,5510,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618603,,8128,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance value in rat,,BAO_0000218,5948,
Ex vivo,,A,,Intermediate,1,,50597,CHEMBL618604,2107.0,8129,Rattus norvegicus,,10116.0,N,Liver,1,,Clearance rate constant using isolated perfused rat liver (IPRL) assay,,BAO_0000218,6125,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618605,,8130,Rattus norvegicus,,10116.0,N,,1,,Clearance in rat,,BAO_0000218,4839,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618606,,8131,Rattus norvegicus,,10116.0,N,,1,,Total body clearance in rat i.v. at 2 mg/kg concentration,,BAO_0000218,17686,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618607,,8132,Rattus norvegicus,,10116.0,N,,1,,Clearance of compound in rats after intravenous administration,,BAO_0000218,6571,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618608,,8133,Rattus norvegicus,,10116.0,N,,1,,Clearance after iv administration to rats,,BAO_0000218,3364,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618609,,8134,Rattus norvegicus,,10116.0,N,,1,,Clearance at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,,BAO_0000218,13569,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618610,,8135,Rattus norvegicus,,10116.0,N,,1,,Clearance at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,,BAO_0000218,13569,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618611,,8136,Rattus norvegicus,,10116.0,N,,1,,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,,BAO_0000218,13569,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618612,,8137,Rattus norvegicus,,10116.0,N,,1,,Clearance at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,,BAO_0000218,13569,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618613,,8138,Rattus norvegicus,,10116.0,N,,1,,Clearance at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,,BAO_0000218,13569,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621076,,8139,Rattus norvegicus,,10116.0,N,,1,,Clearance at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,,BAO_0000218,13569,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621077,,8140,Rattus norvegicus,,10116.0,N,,1,,Clearance at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,,BAO_0000218,13569,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621078,,8141,Rattus norvegicus,,10116.0,N,,1,,"Clearance in fischer rats at 5 mg/kg dose, administered intravenously",,BAO_0000218,17670,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621251,,8142,Rattus norvegicus,,10116.0,N,,1,,Clearance in rat,,BAO_0000218,5970,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621252,,8143,Rattus norvegicus,,10116.0,N,,1,,Clearance in rat after oral administration at 10 mg/kg,,BAO_0000218,6495,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621253,,8144,Rattus norvegicus,,10116.0,N,,1,,Clearance in rat.,,BAO_0000218,4590,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621254,,8145,Rattus norvegicus,,10116.0,N,,1,,Clearance rate following an oral dose of 20 mg/kg in rats,,BAO_0000218,6193,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621255,,8146,Rattus norvegicus,,10116.0,N,,1,,Compound was evaluated for the rate of clearance in rat upon intravenous administration.,,BAO_0000218,2832,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621256,1969.0,8147,Rattus norvegicus,,10116.0,N,Plasma,1,,Compound was tested for plasma clearance in rats after 5 mg/kg of intravenous dosing,,BAO_0000218,1052,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621257,2107.0,8148,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution in rat liver in the presence of GdDTPA-BDP at 1 hr,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621258,2107.0,8149,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution in rat liver in the presence of GdDTPA-BDP at 30 min,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621259,2107.0,8150,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution in rat liver in the presence of GdDTPA-BDP at 4 hr,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621260,2107.0,8151,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 15 min,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL876494,2107.0,8152,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 1 hr,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621261,2107.0,8153,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 30 min,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621262,2107.0,8154,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 4 hr,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621263,2107.0,8155,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution in rat liver in the presence of NAC Gd/0.01 M GdDTPA-HPDP,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621264,2107.0,8156,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution in rat liver in the presence of NCA Gd/0.01 M lip,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621265,2385.0,8157,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Biodistribution in rat muscle in the presence of 0.01 M GdDTPA-BDP,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621266,2385.0,8158,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Biodistribution in rat muscle in the presence of 0.05 M Gd/0.15 M lig,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621267,2385.0,8159,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Biodistribution in rat muscle in the presence of 0.05 M GdDTPA-BDP,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621268,2385.0,8160,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Biodistribution in rat muscle in the presence of 0.10 M GdDTPA-BDP,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621269,2385.0,8161,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 1 hr,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621270,2385.0,8162,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 4 hr,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621271,2385.0,8163,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 15 min,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621272,2385.0,8164,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 30 min,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621273,2385.0,8165,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 1 hr,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621274,2385.0,8166,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 4 hr,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL876495,2385.0,8167,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 15 min,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621275,2385.0,8168,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 30 min,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621276,2385.0,8169,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Biodistribution in rat muscle in the presence of NCA Gd/0.01 M lip,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621277,2385.0,8170,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Biodistribution in rat muscle in the presence of NCAGd/0.01 M lig,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621278,160.0,8171,Rattus norvegicus,,10116.0,N,Intestine,1,,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 2 hr,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621279,160.0,8172,Rattus norvegicus,,10116.0,N,Intestine,1,,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 6 hr,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621280,160.0,8173,Rattus norvegicus,,10116.0,N,Intestine,1,,Biodistribution in rat s. intestine in the presence of NCA (No carrier added),,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621281,2106.0,8174,Rattus norvegicus,,10116.0,N,Spleen,1,,Biodistribution in rat spleen in the presence of 0.01 M GdDTPA-BDP,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621282,2106.0,8175,Rattus norvegicus,,10116.0,N,Spleen,1,,Biodistribution in rat spleen in the presence of 0.05 M Gd/0.15 M lig; ND=No data,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621283,2106.0,8176,Rattus norvegicus,,10116.0,N,Spleen,1,,Biodistribution in rat spleen in the presence of 0.05 M GdDTPA-BDP; ND=No data,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621284,2106.0,8177,Rattus norvegicus,,10116.0,N,Spleen,1,,Biodistribution in rat spleen in the presence of 0.10 M GdDTPA-BDP,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621285,2106.0,8178,Rattus norvegicus,,10116.0,N,Spleen,1,,Biodistribution in rat spleen in the presence of 50 Gd/kg at 15 min,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621286,2106.0,8179,Rattus norvegicus,,10116.0,N,Spleen,1,,Biodistribution in rat spleen in the presence of 50 Gd/kg at 2 hr,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623220,2106.0,8180,Rattus norvegicus,,10116.0,N,Spleen,1,,Biodistribution in rat spleen in the presence of 50 Gd/kg at 6 hr,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623221,2106.0,8181,Rattus norvegicus,,10116.0,N,Spleen,1,,Biodistribution in rat spleen in the presence of NCA Gd/0.01 M lip,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL876029,2106.0,8182,Rattus norvegicus,,10116.0,N,Spleen,1,,Biodistribution in rat spleen in the presence of NCAGd/0.01 M lig,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623222,945.0,8183,Rattus norvegicus,,10116.0,N,Stomach,1,,Biodistribution in rat stomach in the presence of 50 Gd/kg at 15 min,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623223,945.0,8184,Rattus norvegicus,,10116.0,N,Stomach,1,,Biodistribution in rat stomach in the presence of 50 Gd/kg at 2 hr,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621445,945.0,8185,Rattus norvegicus,,10116.0,N,Stomach,1,,Biodistribution in rat stomach in the presence of 50 Gd/kg at 6 h; ND=No data,,BAO_0000218,9866,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621446,178.0,8186,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution of [123I]-label in rat blood was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,13950,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621447,178.0,8187,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution of [123I]-label in rat blood was reported at 1 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,13950,
In vivo,,A,,Intermediate,1,,50597,CHEMBL619681,178.0,8188,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution of [123I]-label in rat blood was reported at 2 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,13950,
In vivo,,A,,Intermediate,1,,50597,CHEMBL619682,178.0,8189,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution of [123I]-label in rat blood was reported at 24 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,13950,
In vivo,,A,,Intermediate,1,,50597,CHEMBL619683,178.0,8190,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution of [123I]-label in rat blood was reported at 4 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,13950,
In vivo,,A,,Intermediate,1,,50597,CHEMBL619684,955.0,8191,Rattus norvegicus,,10116.0,N,Brain,1,,Biodistribution of [123I]-label in rat brain was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,13950,
In vivo,,A,,Intermediate,1,,50597,CHEMBL619685,955.0,8192,Rattus norvegicus,,10116.0,N,Brain,1,,Biodistribution of [123I]-label in rat brain was reported at 1 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,13950,
In vivo,,A,,Intermediate,1,,50597,CHEMBL619686,955.0,8193,Rattus norvegicus,,10116.0,N,Brain,1,,Biodistribution of [123I]-label in rat brain was reported at 2 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,13950,
In vivo,,A,,Intermediate,1,,50597,CHEMBL619687,955.0,8194,Rattus norvegicus,,10116.0,N,Brain,1,,Biodistribution of [123I]-label in rat brain was reported at 24 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,13950,
In vivo,,A,,Intermediate,1,,50597,CHEMBL619688,955.0,8195,Rattus norvegicus,,10116.0,N,Brain,1,,Biodistribution of [123I]-label in rat brain was reported at 4 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,13950,
In vivo,,A,,Intermediate,1,,50597,CHEMBL619689,948.0,8196,Rattus norvegicus,,10116.0,N,Heart,1,,Biodistribution of [123I]-label in rat heart was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,13950,
In vivo,,A,,Intermediate,1,,50597,CHEMBL619690,948.0,8197,Rattus norvegicus,,10116.0,N,Heart,1,,Biodistribution of [123I]-label in rat heart was reported at 1 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,13950,
In vivo,,A,,Intermediate,1,,50597,CHEMBL619691,948.0,8198,Rattus norvegicus,,10116.0,N,Heart,1,,Biodistribution of [123I]-label in rat heart was reported at 2 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,13950,
In vivo,,A,,Intermediate,1,,50597,CHEMBL619692,,8199,Rattus norvegicus,,10116.0,N,,1,,Terminal phase volume of distribution was measured in rat after an iv dose of 1 mg/kg,,BAO_0000218,6062,
,,A,,Expert,1,,50597,CHEMBL619693,,8200,Rattus norvegicus,,10116.0,N,,1,,Apparent volume of the central plasma compartment (Vc) of compound determined in rat after iv administration at a dose of 10 mg/kg,,BAO_0000218,3598,
In vivo,,A,,Intermediate,1,,50597,CHEMBL619694,,8201,Rattus norvegicus,,10116.0,N,,1,,Vc value after IV dose at a dose of 5 mg/kg in rats.,,BAO_0000218,1908,
In vivo,,A,,Intermediate,1,,50597,CHEMBL619695,,8202,Rattus norvegicus,,10116.0,N,,1,,Apparent volume of distribution at 10 mg/kg in rat upon intravenous administration,,BAO_0000218,17596,
In vivo,,A,,Intermediate,1,,50597,CHEMBL619696,,8203,Rattus norvegicus,,10116.0,N,,1,,Compound was evaluated for pharmacokinetic parameter volume of distribution,,BAO_0000218,4891,
In vivo,,A,,Intermediate,1,,50597,CHEMBL619697,,8204,Rattus norvegicus,,10116.0,N,,1,,Compound was evaluated for volume of distribution in rat,,BAO_0000218,740,
In vivo,,A,,Intermediate,1,,50597,CHEMBL619698,,8205,Rattus norvegicus,,10116.0,N,,1,,Steady state volume distribution was determined; steady state(ss),,BAO_0000218,16366,
In vivo,,A,,Intermediate,1,,50597,CHEMBL619699,,8206,Rattus norvegicus,,10116.0,N,,1,,Steady state volume of distribution after iv administration to rats,,BAO_0000218,3364,
In vivo,,A,,Intermediate,1,,50597,CHEMBL619700,,8207,Rattus norvegicus,,10116.0,N,,1,,Steady state volume of distribution dosing at 3 mg/kg iv,,BAO_0000218,2552,
In vivo,,A,,Intermediate,1,,50597,CHEMBL619701,,8208,Rattus norvegicus,,10116.0,N,,1,,The compound was evaluated for volume of distribution in rat,,BAO_0000218,406,
In vivo,,A,,Intermediate,1,,50597,CHEMBL619702,,8209,Rattus norvegicus,,10116.0,N,,1,,The compound was tested for volume of distribution in rat,,BAO_0000218,12500,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620335,,8210,Rattus norvegicus,,10116.0,N,,1,,The compound was tested for volume of distribution in rat at dose of 3-10 mgkg,,BAO_0000218,12500,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620336,,8211,Rattus norvegicus,,10116.0,N,,1,,Volume distribution (VD) after oral administration in rat,,BAO_0000218,5656,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620337,,8212,Rattus norvegicus,,10116.0,N,,1,,Volume distribution of compound in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,BAO_0000218,17671,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620520,,8213,Rattus norvegicus,,10116.0,N,,1,,Volume distribution in rat,,BAO_0000218,1094,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620521,,8214,Rattus norvegicus,,10116.0,N,,1,,Volume distribution in rat,,BAO_0000218,5833,
In vivo,,A,,Intermediate,1,,50597,CHEMBL875825,,8215,Rattus norvegicus,,10116.0,N,,1,,Volume distribution in rat after peroral administration at 10 mg/kg,,BAO_0000218,5939,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620522,,8216,Rattus norvegicus,,10116.0,N,,1,,Volume distribution in rat after peroral administration at 5 mg/kg,,BAO_0000218,5939,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620523,,8217,Rattus norvegicus,,10116.0,N,,1,,Volume distribution was evaluated after i.v. administration in rat at a dose of 1 mg/kg,,BAO_0000218,6005,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620524,,8218,Rattus norvegicus,,10116.0,N,,1,,Volume of distribution in rat.,,BAO_0000218,1696,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620525,,8219,Rattus norvegicus,,10116.0,N,,1,,Volume of distribution in rat,,BAO_0000218,6672,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620526,,8220,Rattus norvegicus,,10116.0,N,,1,,Volume of distribution in rat,,BAO_0000218,6673,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620527,,8221,Rattus norvegicus,,10116.0,N,,1,,Volume of distribution in rat by iv administration,,BAO_0000218,5871,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620528,,8222,Rattus norvegicus,,10116.0,N,,1,,Volume of distribution in rats,,BAO_0000218,6803,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620529,,8223,Rattus norvegicus,,10116.0,N,,1,,Volume of distribution was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,,BAO_0000218,5199,
,,A,,Intermediate,1,,50597,CHEMBL620530,,8224,Rattus norvegicus,,10116.0,N,,1,,Volume distribution at the dose of 2 mg/kg in rat,,BAO_0000218,4727,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620531,,8225,Rattus norvegicus,,10116.0,N,,1,,Steady state volume of distribution was determined,,BAO_0000218,16367,
In vivo,,A,,Intermediate,0,,22224,CHEMBL620532,,8226,Macaca mulatta,,9544.0,U,,1,,Compound was tested for its plasma volume distribution in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,,BAO_0000218,5005,
In vivo,,A,,Intermediate,0,,22224,CHEMBL620533,,8227,Rattus norvegicus,,10116.0,U,,1,,Compound was tested for its plasma volume distribution in Sprague Dawley rats,,BAO_0000218,5005,
In vivo,,A,,Intermediate,0,,22224,CHEMBL620534,,8228,Rattus norvegicus,,10116.0,U,,1,,Compound was tested for its plasma volume distribution in Sprague Dawley rats; ND is not determined,,BAO_0000218,5005,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620535,,8229,Rattus norvegicus,,10116.0,N,,1,,Mean (%CV) PK parameters for Vdss(mL/kg).,,BAO_0000218,15765,
In vivo,,A,,Intermediate,1,,50597,CHEMBL875826,,8230,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic parameter Vdss was determined at 2 mg/kg i.v. dose in rats,,BAO_0000218,2792,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620536,,8231,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic parameter Vdss was determined at 5 mg/kg i.v. dose in rats,,BAO_0000218,2792,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620537,,8232,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic parameter volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,,BAO_0000218,5334,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618526,,8233,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic parameter volume of distribution was reported in Sprague-Dawley rat; ND=Not determined,,BAO_0000218,5334,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618527,,8234,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic property (Vdss) for the compound (5 mg/kg iv) was determined in rats,,BAO_0000218,5739,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618528,,8235,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic property (Vdss) in rat,,BAO_0000218,5789,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618529,,8236,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic property (vdss) was measured in rat,,BAO_0000218,4239,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618530,,8237,Rattus norvegicus,,10116.0,N,,1,,Steady state volume of distribution for the compound after intravenous administration of 1 mg/kg in rat,,BAO_0000218,4709,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618531,,8238,Rattus norvegicus,,10116.0,N,,1,,Volume of distribution in rat,,BAO_0000218,6642,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618532,,8239,Rattus norvegicus,,10116.0,N,,1,,The pharmacokinetic parameter volume of distribution in vivo in rats,,BAO_0000218,5247,
In vivo,,F,,Intermediate,1,,50597,CHEMBL618533,,8240,Rattus norvegicus,,10116.0,N,,1,,Vdss at a dose of 4 mg/kg in Rat Plasma after iv administration,,BAO_0000218,17720,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618534,,8241,Rattus norvegicus,,10116.0,N,,1,,Vdss in rat i.v. at 2 mg/kg concentration,,BAO_0000218,17686,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618535,,8242,Rattus norvegicus,,10116.0,N,,1,,Volume distribution after intravenous administration (1 mg/kg) in rat,,BAO_0000218,4689,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618536,,8243,Rattus norvegicus,,10116.0,N,,1,,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,,BAO_0000218,5654,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618537,,8244,Rattus norvegicus,,10116.0,N,,1,,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,,BAO_0000218,5654,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618538,,8245,Rattus norvegicus,,10116.0,N,,1,,Volume distribution at a dose of 10 uM/kg in rat was determined,,BAO_0000218,4527,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618539,,8246,Rattus norvegicus,,10116.0,N,,1,,Volume distribution in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,,BAO_0000218,4521,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618540,,8247,Rattus norvegicus,,10116.0,N,,1,,Volume distribution was calculated in rat,,BAO_0000218,6057,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618541,,8248,Rattus norvegicus,,10116.0,N,,1,,Volume distribution was determined,,BAO_0000218,5510,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618542,,8249,Rattus norvegicus,,10116.0,N,,1,,Volume of distribution after intravenous administration was evaluated in rat,,BAO_0000218,2938,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622544,,8250,Rattus norvegicus,,10116.0,N,,1,,Volume of distribution at steady state was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,,BAO_0000218,6679,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622545,,8251,Rattus norvegicus,,10116.0,N,,1,,"Volume of distribution at steady state was determined in rats at 10 mg/kg, p.o. dose; n/a: not applicable",,BAO_0000218,6685,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622546,,8252,Rattus norvegicus,,10116.0,N,,1,,"Volume of distribution at steady state was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",,BAO_0000218,6685,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622547,,8253,Rattus norvegicus,,10116.0,N,,1,,"Volume of distribution at steady state was determined in rats at 2 mg/kg, i.v. dose",,BAO_0000218,6685,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622548,,8254,Rattus norvegicus,,10116.0,N,,1,,Volume of distribution in steady state was determined in rat,,BAO_0000218,5145,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622549,,8255,Rattus norvegicus,,10116.0,N,,1,,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration,,BAO_0000218,6467,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622550,,8256,Rattus norvegicus,,10116.0,N,,1,,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,,BAO_0000218,6467,
,,A,,Intermediate,1,,50594,CHEMBL622551,,8257,Mus musculus,,10090.0,N,,1,,Compound was evaluated for area under curve when administered through oral route to mouse,,BAO_0000218,15115,
,,A,,Intermediate,1,,50597,CHEMBL622552,,8258,Rattus norvegicus,,10116.0,N,,1,,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,,BAO_0000218,8758,
,,A,,Intermediate,1,,50597,CHEMBL622553,,8259,Rattus norvegicus,,10116.0,N,,1,,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,,BAO_0000218,8758,
In vivo,,F,,Autocuration,0,,22224,CHEMBL622554,,8260,,,,U,,1,,Compound was evaluated for its bioavailability after oral administration (100 mg) to Beagle dogs,,BAO_0000218,8267,
,,A,,Intermediate,1,,50588,CHEMBL622555,,8261,Canis lupus familiaris,,9615.0,N,,1,,Compound was evaluated for its bioavailability after oral administration (200 mg) to Beagle dogs,,BAO_0000218,8267,
,,A,,Intermediate,1,,50594,CHEMBL622556,,8262,Mus musculus,,10090.0,N,,1,,Compound was evaluated for the area under the concentration - time curve by administering intravenously at 25 mg/kg in mice,,BAO_0000218,14239,
,,A,,Intermediate,1,,50594,CHEMBL622557,,8263,Mus musculus,,10090.0,N,,1,,Compound was evaluated for the area under the concentration - time curve by administering orally at 25 mg/kg in mice,,BAO_0000218,14239,
,,A,,Intermediate,1,,50594,CHEMBL622558,178.0,8264,Mus musculus,,10090.0,N,Blood,1,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg intramuscular administration to mice,,BAO_0000218,10754,
,,A,,Intermediate,1,,50594,CHEMBL622559,178.0,8265,Mus musculus,,10090.0,N,Blood,1,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to mice,,BAO_0000218,10754,
,,A,,Intermediate,1,,50588,CHEMBL622560,,8266,Canis lupus familiaris,,9615.0,N,,1,,Compound was evaluated in vivo in for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to dogs.,,BAO_0000218,10754,
,,A,,Intermediate,1,,50597,CHEMBL622561,,8267,Rattus norvegicus,,10116.0,N,,1,,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose,,BAO_0000218,14681,
,,A,,Intermediate,1,,50597,CHEMBL622562,,8268,Rattus norvegicus,,10116.0,N,,1,,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose. ,,BAO_0000218,14681,
,,A,,Intermediate,1,,50597,CHEMBL622563,,8269,Rattus norvegicus,,10116.0,N,,1,,Compound was tested for area under concentration -time curve from time 0 to time of last detectable concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,,BAO_0000218,14681,
,,A,,Autocuration,0,,22224,CHEMBL622564,,8270,,,,U,,1,,Concentration of compound in Central nervous system,,BAO_0000019,13118,
,,A,,Autocuration,0,,22224,CHEMBL622565,,8271,,,,U,,1,,Concentration of compound in Central nervous system; Not detectable,,BAO_0000019,13118,
,,A,,Intermediate,1,,50594,CHEMBL622566,,8272,Mus musculus,,10090.0,N,,1,,"Concentration of diester in the blood, following oral administration in mice",,BAO_0000218,13318,
,,A,,Intermediate,1,,50594,CHEMBL624515,,8273,Mus musculus,,10090.0,N,,1,,"Concentration of monoester in the blood, following oral administration in mice",,BAO_0000218,13318,
,,A,,Intermediate,1,,50594,CHEMBL624516,,8274,Mus musculus,,10090.0,N,,1,,Concentration of the 9-[2-(Phosphonomethoxy)ethoxy]adenine in the blood following oral administration in mice,,BAO_0000218,13318,
,,A,,Autocuration,0,,22224,CHEMBL624517,,8275,,,,U,,1,,Evaluated for Pharmacokinetic property: Area under the curve,,BAO_0000019,15692,
,,A,,Intermediate,1,,50594,CHEMBL624518,,8276,Mus musculus,,10090.0,N,,1,,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after a peroral dose of 25 mg/kg in nude mice,,BAO_0000218,14839,
,,A,,Intermediate,1,,100710,CHEMBL624519,,8277,Macaca fascicularis,,9541.0,N,,1,,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after iv dose of 25 mg/kg in nude mice,,BAO_0000218,14839,
,,A,,Intermediate,1,,100710,CHEMBL624520,,8278,Macaca fascicularis,,9541.0,N,,1,,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after iv dose of 5 mg/kg expressed as Area under the curve,,BAO_0000218,14839,
,,A,,Intermediate,1,,100710,CHEMBL624521,,8279,Macaca fascicularis,,9541.0,N,,1,,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 10 mg/kg expressed as Area under the curve,,BAO_0000218,14839,
,,A,,Intermediate,1,,100710,CHEMBL624522,,8280,Macaca fascicularis,,9541.0,N,,1,,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 5 mg/kg expressed as Area under the curve,,BAO_0000218,14839,
,,A,,Intermediate,1,,100710,CHEMBL624523,,8281,Macaca fascicularis,,9541.0,N,,1,,In vivo antitumor efficacy in cynomolgus monkeys 0-8 hours after peroral dose of 25 mg/kg expressed as Area under the curve,,BAO_0000218,14839,
,,A,,Intermediate,1,,100710,CHEMBL624409,,8282,Macaca fascicularis,,9541.0,N,,1,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",,BAO_0000218,14839,
,,A,,Intermediate,1,,100710,CHEMBL624410,,8283,Macaca fascicularis,,9541.0,N,,1,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-8 hr)",,BAO_0000218,14839,
,,A,,Intermediate,1,,100710,CHEMBL624411,,8284,Macaca fascicularis,,9541.0,N,,1,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",,BAO_0000218,14839,
,,A,,Intermediate,1,,100710,CHEMBL623531,,8285,Macaca fascicularis,,9541.0,N,,1,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, iv and the total drug exposure was determined. (0-8 hr)",,BAO_0000218,14839,
,,A,,Intermediate,1,,100710,CHEMBL623532,,8286,Macaca fascicularis,,9541.0,N,,1,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, perorally and the total drug exposure was determined (0-8 hr)",,BAO_0000218,14839,
,,A,,Intermediate,1,,100710,CHEMBL623533,,8287,Macaca fascicularis,,9541.0,N,,1,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, intravenously and the total drug exposure was determined (0-8 hr)",,BAO_0000218,14839,
,,A,,Intermediate,1,,100710,CHEMBL623534,,8288,Macaca fascicularis,,9541.0,N,,1,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",,BAO_0000218,14839,
,,A,,Intermediate,1,,50594,CHEMBL623535,,8289,Mus musculus,,10090.0,N,,1,,In vivo antitumor efficacy in nude mice 0-24 hr after intravenous dose of 25 mg/kg expressed as Area under the curve,,BAO_0000218,14839,
,,A,,Intermediate,1,,50594,CHEMBL623536,,8290,Mus musculus,,10090.0,N,,1,,In vivo antitumor efficacy in nude mice 0-24 hr after iperoral dose of 25 mg/kg expressed as Area under the curve,,BAO_0000218,14839,
,,A,,Intermediate,1,,50594,CHEMBL623537,,8291,Mus musculus,,10090.0,N,,1,,In vivo antitumor efficacy in nude mice 0-24 hr after iv dose of 25 mg/kg expressed as Area under the curve,,BAO_0000218,14839,
,,A,,Intermediate,1,,50594,CHEMBL623538,,8292,Mus musculus,,10090.0,N,,1,,In vivo antitumor efficacy in nude mice 0-24 hr after peroral dose of 25 mg/kg expressed as Area under the curve,,BAO_0000218,14839,
,,A,,Intermediate,1,,50594,CHEMBL623539,,8293,Mus musculus,,10090.0,N,,1,,In vivo antitumor efficacy in nude mice after peroral dose of 10 mg/kg expressed as Area under the curve,,BAO_0000218,14839,
,,A,,Intermediate,1,,50594,CHEMBL623540,,8294,Mus musculus,,10090.0,N,,1,,In vivo antitumor efficacy in nude mice after peroral dose of 25 mg/kg expressed as Area under the curve,,BAO_0000218,14839,
,,A,,Intermediate,1,,50594,CHEMBL623541,,8295,Mus musculus,,10090.0,N,,1,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined.",,BAO_0000218,14839,
,,A,,Intermediate,1,,50594,CHEMBL623542,,8296,Mus musculus,,10090.0,N,,1,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-24hr)",,BAO_0000218,14839,
,,A,,Intermediate,1,,50594,CHEMBL623543,,8297,Mus musculus,,10090.0,N,,1,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-4 hr)",,BAO_0000218,14839,
,,A,,Intermediate,1,,50594,CHEMBL623544,,8298,Mus musculus,,10090.0,N,,1,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined",,BAO_0000218,14839,
,,A,,Intermediate,1,,50594,CHEMBL623545,,8299,Mus musculus,,10090.0,N,,1,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-24hr)",,BAO_0000218,14839,
,,A,,Intermediate,1,,50594,CHEMBL623546,,8300,Mus musculus,,10090.0,N,,1,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-4 hr)",,BAO_0000218,14839,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623547,1969.0,8301,Rattus norvegicus,,10116.0,N,Plasma,1,,Evaluated for plasma clearance after iv administration of 5 mg/kg to male Sprague-Dawley rats,,BAO_0000218,5408,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623548,,8302,Rattus norvegicus,,10116.0,N,,1,,High i.v. clearance in Dawley rats,,BAO_0000218,6827,
In vitro,,A,,Intermediate,1,,50597,CHEMBL623549,2107.0,8303,Rattus norvegicus,,10116.0,N,Liver,1,,In vitro clearance in rat liver microsomes,Microsomes,BAO_0000218,17538,
In vitro,,A,,Intermediate,1,,50597,CHEMBL623550,2107.0,8304,Rattus norvegicus,,10116.0,N,Liver,1,,Intrinsic clearance in rat liver microsomes was determined,Microsomes,BAO_0000218,6331,
In vitro,,A,,Intermediate,1,,50597,CHEMBL875276,2107.0,8305,Rattus norvegicus,Hepatocyte,10116.0,N,Liver,1,401.0,Intrinsic clearance in rat hepatocytes was determined,,BAO_0000218,5948,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621872,,8306,Rattus norvegicus,,10116.0,N,,1,,Plasma Clearance was determined,,BAO_0000218,4026,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621873,,8307,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance after intravenous administration of 0.4 mg/kg of dose in rats was determined,,BAO_0000218,6647,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621874,,8308,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance in rat.,,BAO_0000218,1696,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621875,,8309,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance in rats,,BAO_0000218,6597,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621876,,8310,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance was estimated from the AUC after 5 mg/kg intravenous dosing in rats,,BAO_0000218,347,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621877,,8311,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance was evaluated after 10 uM/kg of intra arterial administration,,BAO_0000218,16423,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621878,,8312,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance was measured in rat,,BAO_0000218,2879,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621879,,8313,Rattus norvegicus,,10116.0,N,,1,,Clearance after iv administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,,BAO_0000218,4883,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621880,1969.0,8314,Rattus norvegicus,,10116.0,N,Plasma,1,,"Tested for the plasma clearance in Dawley rat at a dose of 1 mg/kg intravenous, 2 mg/kg orally",,BAO_0000218,5328,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621881,,8315,Rattus norvegicus,,10116.0,N,,1,,The clearance rate in mature male rat at a intravenous dose of 3 mg/kg,,BAO_0000218,5160,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621882,,8316,Rattus norvegicus,,10116.0,N,,1,,Total body clearance was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,,BAO_0000218,17582,
In vivo,,A,,Intermediate,1,,50597,CHEMBL875283,,8317,Rattus norvegicus,,10116.0,N,,1,,Total clearance at 1 mg/kg was determined in rat,,BAO_0000218,17651,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621883,,8318,Rattus norvegicus,,10116.0,N,,1,,Total clearance at 10 mg/kg was determined in rat,,BAO_0000218,17651,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621884,,8319,Rattus norvegicus,,10116.0,N,,1,,Clearance in rat,,BAO_0000218,6596,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621885,,8320,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance rate determined in rats,,BAO_0000218,4796,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621886,,8321,Rattus norvegicus,,10116.0,N,,1,,Clearance of compound in rat was evaluated,,BAO_0000218,6850,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621887,1969.0,8322,Rattus norvegicus,,10116.0,N,Plasma,1,,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,,BAO_0000218,5932,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621888,,8323,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic property (blood clearance) in rat,,BAO_0000218,3371,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621889,,8324,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance in rat,,BAO_0000218,2083,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621890,,8325,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance in rats,,BAO_0000218,4942,
In vitro,,A,,Intermediate,1,,50597,CHEMBL621891,2107.0,8326,Rattus norvegicus,,10116.0,N,Liver,1,,Intrinsic clearance of compound against NADPH-fortified rat liver microsomes,Microsomes,BAO_0000218,6838,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621892,,8327,Rattus norvegicus,,10116.0,N,,1,,Clearance in Dawley rat,,BAO_0000218,5353,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621893,,8328,Rattus norvegicus,,10116.0,N,,1,,Clearance rat,,BAO_0000218,6641,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621894,,8329,Rattus norvegicus,,10116.0,N,,1,,Clearance rat (dosed at 0.5 mpk IV and 2.0 mpk po.),,BAO_0000218,6641,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621895,,8330,Rattus norvegicus,,10116.0,N,,1,,Clearance rat; Not determined,,BAO_0000218,6641,
In vivo,,A,,Intermediate,1,,50597,CHEMBL875284,,8331,Rattus norvegicus,,10116.0,N,,1,,Clearance rate was determined in rat at a dose of 1 mpk i.v.,,BAO_0000218,6444,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618699,,8332,Rattus norvegicus,,10116.0,N,,1,,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND means not determined,,BAO_0000218,6444,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618700,,8333,Rattus norvegicus,,10116.0,N,,1,,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND=not determined,,BAO_0000218,6444,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618701,,8334,Rattus norvegicus,,10116.0,N,,1,,Clearance was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,,BAO_0000218,6211,
In vivo,,A,,Intermediate,1,,50597,CHEMBL876600,1969.0,8335,Rattus norvegicus,,10116.0,N,Plasma,1,,"Clearance in plasma calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",,BAO_0000218,12873,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618702,,8336,Rattus norvegicus,,10116.0,N,,1,,Clearance of compound in rat after 1 mg/kg i.v. administration,,BAO_0000218,6570,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618703,,8337,Rattus norvegicus,,10116.0,N,,1,,Compound was evaluated for Hepatic clearance in rat,,BAO_0000218,3341,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618704,,8338,Rattus norvegicus,,10116.0,N,,1,,In vivo clearance after 5 mg/kg dose,,BAO_0000218,4891,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618705,1969.0,8339,Rattus norvegicus,,10116.0,N,Plasma,1,,Compound was tested for plasma clearance in rats,,BAO_0000218,1094,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618706,,8340,Rattus norvegicus,,10116.0,N,,1,,Hepatic clearance after intravenous administration was evaluated in rat,,BAO_0000218,2938,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618707,,8341,Rattus norvegicus,,10116.0,N,,1,,Lower clearance in rat (i.v.) at 0.5 mpk,,BAO_0000218,17853,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618708,1969.0,8342,Rattus norvegicus,,10116.0,N,Plasma,1,,Pharmacokinetic parameter expressed as plasma clearance in rat,,BAO_0000218,6049,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618709,,8343,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic property (Clp) in rat,,BAO_0000218,5789,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618710,,8344,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance in Sprague-Dawley rats,,BAO_0000218,4514,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618711,,8345,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance (Clp) in rat,,BAO_0000218,6448,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618712,,8346,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance for the compound was measured in rat after an iv dose of 1 mg/kg,,BAO_0000218,6062,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618713,,8347,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance in fasted male Sprague dawely rats on administration of 0.5 mg/Kg i.v. of the compound,,BAO_0000218,5710,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618714,,8348,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance after intravenous administration of 1 mg/kg in rat,,BAO_0000218,4709,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618715,,8349,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,,BAO_0000218,4521,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618716,,8350,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance in rat was determined,,BAO_0000218,1742,
In vivo,,A,,Intermediate,1,,50597,CHEMBL876601,,8351,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance measured in rat,,BAO_0000218,6057,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618717,,8352,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance was calculated in rat,,BAO_0000218,6057,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618718,,8353,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance in rat,,BAO_0000218,5145,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618719,,8354,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance in rat,,BAO_0000218,5833,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618720,,8355,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance in rat,,BAO_0000218,6453,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618721,,8356,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance in rat,,BAO_0000218,6640,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621477,,8357,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance in rats,,BAO_0000218,6305,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621478,,8358,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance in rat,,BAO_0000218,6642,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621479,,8359,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance was evaluated in rat,,BAO_0000218,5472,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621480,,8360,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance was evaluated in rat; Not tested,,BAO_0000218,5472,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621481,,8361,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance rate was determined for the compound in rat,,BAO_0000218,5144,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621482,,8362,Rattus norvegicus,,10116.0,N,,1,,"Plasma clearance rate was determined in rats at 10mg/kg, p.o. dose; n/a: not applicable",,BAO_0000218,6685,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621483,,8363,Rattus norvegicus,,10116.0,N,,1,,"Plasma clearance rate was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",,BAO_0000218,6685,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621484,,8364,Rattus norvegicus,,10116.0,N,,1,,"Plasma clearance rate was determined in rats at 2 mg/kg, i.v. dose",,BAO_0000218,6685,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621485,948.0,8365,Rattus norvegicus,,10116.0,N,Heart,1,,Biodistribution of [123I]-label in rat heart was reported at 24 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,13950,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621486,948.0,8366,Rattus norvegicus,,10116.0,N,Heart,1,,Biodistribution of [123I]-label in rat heart was reported at 4 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,13950,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621487,160.0,8367,Rattus norvegicus,,10116.0,N,Intestine,1,,Biodistribution of [123I]-label in rat intestine was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,13950,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621488,160.0,8368,Rattus norvegicus,,10116.0,N,Intestine,1,,Biodistribution of [123I]-label in rat intestine was reported at 1 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,13950,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621489,160.0,8369,Rattus norvegicus,,10116.0,N,Intestine,1,,Biodistribution of [123I]-label in rat intestine was reported at 2 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,13950,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621490,160.0,8370,Rattus norvegicus,,10116.0,N,Intestine,1,,Biodistribution of [123I]-label in rat intestine was reported at 24 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,13950,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621491,160.0,8371,Rattus norvegicus,,10116.0,N,Intestine,1,,Biodistribution of [123I]-label in rat intestine was reported at 4 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,13950,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621492,2113.0,8372,Rattus norvegicus,,10116.0,N,Kidney,1,,Biodistribution of [123I]-label in rat kidneys was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,13950,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621493,2113.0,8373,Rattus norvegicus,,10116.0,N,Kidney,1,,Biodistribution of [123I]-label in rat kidneys was reported at 1 h post injection. Value shown is %ID/g of tissue,,BAO_0000218,13950,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621494,2113.0,8374,Rattus norvegicus,,10116.0,N,Kidney,1,,Biodistribution of [123I]-label in rat kidneys was reported at 2 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,13950,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621495,2113.0,8375,Rattus norvegicus,,10116.0,N,Kidney,1,,Biodistribution of [123I]-label in rat kidneys was reported at 24 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,13950,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621496,2113.0,8376,Rattus norvegicus,,10116.0,N,Kidney,1,,Biodistribution of [123I]-label in rat kidneys was reported at 4 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,13950,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621497,2107.0,8377,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution of [123I]-label in rat liver was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,13950,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621498,2107.0,8378,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution of [123I]-label in rat liver was reported at 1 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,13950,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621499,2107.0,8379,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution of [123I]-label in rat liver was reported at 2 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,13950,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618634,2107.0,8380,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution of [123I]-label in rat liver was reported at 24 h post injection. Value shown is %ID/g of tissue,,BAO_0000218,13950,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618635,2107.0,8381,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution of [123I]-label in rat liver was reported at 4 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,13950,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618636,2048.0,8382,Rattus norvegicus,,10116.0,N,Lung,1,,Biodistribution of [123I]-label in rat lung was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,13950,
In vivo,,A,,Intermediate,1,,50597,CHEMBL619737,2048.0,8383,Rattus norvegicus,,10116.0,N,Lung,1,,Biodistribution of [123I]-label in rat lung was reported at 1 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,13950,
In vivo,,A,,Intermediate,1,,50597,CHEMBL619738,2048.0,8384,Rattus norvegicus,,10116.0,N,Lung,1,,Biodistribution of [123I]-label in rat lung was reported at 2 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,13950,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624329,2048.0,8385,Rattus norvegicus,,10116.0,N,Lung,1,,Biodistribution of [123I]-label in rat lung was reported at 24 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,13950,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624330,2048.0,8386,Rattus norvegicus,,10116.0,N,Lung,1,,Biodistribution of [123I]-label in rat lung was reported at 4 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,13950,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624331,2385.0,8387,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Biodistribution of [123I]-label in rat muscle was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,13950,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624332,2385.0,8388,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Biodistribution of [123I]-label in rat muscle was reported at 1 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,13950,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624333,2385.0,8389,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Biodistribution of [123I]-label in rat muscle was reported at 2 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,13950,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624334,2385.0,8390,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Biodistribution of [123I]-label in rat muscle was reported at 24 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,13950,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624335,2385.0,8391,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Biodistribution of [123I]-label in rat muscle was reported at 4 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,13950,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620016,2106.0,8392,Rattus norvegicus,,10116.0,N,Spleen,1,,Biodistribution of [123I]-label in rat spleen was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,13950,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620169,2106.0,8393,Rattus norvegicus,,10116.0,N,Spleen,1,,Biodistribution of [123I]-label in rat spleen was reported at 1 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,13950,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620170,2106.0,8394,Rattus norvegicus,,10116.0,N,Spleen,1,,Biodistribution of [123I]-label in rat spleen was reported at 2 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,13950,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620171,2106.0,8395,Rattus norvegicus,,10116.0,N,Spleen,1,,Biodistribution of [123I]-label in rat spleen was reported at 24 h post injection. Value shown is %ID/g of tissue,,BAO_0000218,13950,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620172,2106.0,8396,Rattus norvegicus,,10116.0,N,Spleen,1,,Biodistribution of [123I]-label in rat spleen was reported at 4 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,13950,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620173,945.0,8397,Rattus norvegicus,,10116.0,N,Stomach,1,,Biodistribution of [123I]-label in rat stomach was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,13950,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620174,945.0,8398,Rattus norvegicus,,10116.0,N,Stomach,1,,Biodistribution of [123I]-label in rat stomach was reported at 1 h post injection. Value shown is %ID/g of tissue,,BAO_0000218,13950,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620175,945.0,8399,Rattus norvegicus,,10116.0,N,Stomach,1,,Biodistribution of [123I]-label in rat stomach was reported at 2 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,13950,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620176,945.0,8400,Rattus norvegicus,,10116.0,N,Stomach,1,,Biodistribution of [123I]-label in rat stomach was reported at 24 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,13950,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620177,945.0,8401,Rattus norvegicus,,10116.0,N,Stomach,1,,Biodistribution of [123I]-label in rat stomach was reported at 4 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,13950,
,,A,,Intermediate,1,,50597,CHEMBL620178,2037.0,8402,Rattus norvegicus,,10116.0,N,Cerebellum,1,,Distribution of [123I]-label in rat brain (cerebellum) was reported at 20 min post injection. Value shown is %ID/g of tissue,,BAO_0000218,13950,
,,A,,Intermediate,1,,50597,CHEMBL620179,2037.0,8403,Rattus norvegicus,,10116.0,N,Cerebellum,1,,Distribution of [123I]-label in rat brain (cerebellum) was reported at 60 min post injection. Value shown is %ID/g of tissue,,BAO_0000218,13950,
,,A,,Intermediate,1,,50597,CHEMBL620180,,8404,Rattus norvegicus,,10116.0,N,,1,,Distribution of [123I]-label in rat brain (diencephalon) was reported at 20 min post injection. Value shown is %ID/g of tissue,,BAO_0000218,13950,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620181,,8405,Rattus norvegicus,,10116.0,N,,1,,Volume of distribution of compound in rat after 1 mg/kg i.v. administration,,BAO_0000218,6570,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620182,,8406,Rattus norvegicus,,10116.0,N,,1,,Volume of distribution of compound in rats after intravenous administration,,BAO_0000218,6571,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620183,,8407,Rattus norvegicus,,10116.0,N,,1,,Volume of distribution in rat,,BAO_0000218,6453,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620184,,8408,Rattus norvegicus,,10116.0,N,,1,,Volume of distribution was determined in rat at a dose of 1 mpk i.v.,,BAO_0000218,6444,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620185,,8409,Rattus norvegicus,,10116.0,N,,1,,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND means not determined,,BAO_0000218,6444,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620186,,8410,Rattus norvegicus,,10116.0,N,,1,,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND=not determined,,BAO_0000218,6444,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620187,,8411,Rattus norvegicus,,10116.0,N,,1,,Volume of distribution was determined in Dawley rat,,BAO_0000218,5353,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620188,,8412,Rattus norvegicus,,10116.0,N,,1,,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,,BAO_0000218,5334,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620189,,8413,Rattus norvegicus,,10116.0,N,,1,,Volume of distribution was reported in Sprague-Dawley rat,,BAO_0000218,5334,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620190,,8414,Rattus norvegicus,,10116.0,N,,1,,Volumes of distribution in rat after peroral administration,,BAO_0000218,6641,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620191,,8415,Rattus norvegicus,,10116.0,N,,1,,Volumes of distribution in rat after po administration,,BAO_0000218,6641,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620192,,8416,Rattus norvegicus,,10116.0,N,,1,,Volumes of distribution in rat after po administration; Not determined,,BAO_0000218,6641,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620193,,8417,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic property (Volume) in rat i.v.,,BAO_0000218,5676,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620194,,8418,Rattus norvegicus,,10116.0,N,,1,,Apparent volume of distribution when 3 mg/Kg dose was administered intravenously,,BAO_0000218,6410,
In vivo,,A,,Intermediate,1,,50597,CHEMBL876730,,8419,Rattus norvegicus,,10116.0,N,,1,,"Volume distribution in fischer rats at 5 mg/kg dose, administered intravenously",,BAO_0000218,17670,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620195,,8420,Rattus norvegicus,,10116.0,N,,1,,Volume distribution in rat after oral administration at 10 mg/kg,,BAO_0000218,6495,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620196,,8421,Rattus norvegicus,,10116.0,N,,1,,Evaluated for Volume of distribution after iv administration of 5 mg/kg to male Sprague-Dawley rats,,BAO_0000218,5408,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620197,,8422,Rattus norvegicus,,10116.0,N,,1,,Tested for volume of distribution after intravenous administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,,BAO_0000218,4883,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620198,,8423,Rattus norvegicus,,10116.0,N,,1,,Volume of distribution after oral administration of 6 mg/kg of dose in rats was determined,,BAO_0000218,6647,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620199,,8424,Rattus norvegicus,,10116.0,N,,1,,Volume of distribution in rats,,BAO_0000218,6495,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620200,,8425,Rattus norvegicus,,10116.0,N,,1,,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to female wistar rats,,BAO_0000218,2661,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620201,,8426,Rattus norvegicus,,10116.0,N,,1,,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to male wistar rats,,BAO_0000218,2661,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620202,,8427,Rattus norvegicus,,10116.0,N,,1,,In vivo Volume distribution (Vss) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,BAO_0000218,5974,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620203,,8428,Rattus norvegicus,,10116.0,N,,1,,In vivo Volume distribution (Vss) was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,BAO_0000218,5974,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620204,,8429,Rattus norvegicus,,10116.0,N,,1,,In vivo Volume distribution (Vss) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat;no value,,BAO_0000218,5974,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620205,,8430,Rattus norvegicus,,10116.0,N,,1,,In vivo Volume distribution (Vss) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,BAO_0000218,5974,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624664,,8431,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic parameter (Vss) in rat,,BAO_0000218,5960,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624665,,8432,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic property (Volume) in rat i.v.,,BAO_0000218,5676,
,,A,,Intermediate,1,,50597,CHEMBL624666,,8433,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic property (Vss) in rat,,BAO_0000218,5948,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624667,,8434,Rattus norvegicus,,10116.0,N,,1,,Steady state volume distribution (Vss) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,,BAO_0000218,5979,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624668,,8435,Rattus norvegicus,,10116.0,N,,1,,Steady state volume distribution (Vss) of compound after iv administration was determined in Sprague-Dawley rat,,BAO_0000218,5978,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624669,,8436,Rattus norvegicus,,10116.0,N,,1,,Steady state volume distribution (Vss) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,,BAO_0000218,5978,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624670,,8437,Rattus norvegicus,,10116.0,N,,1,,Steady state volume distribution (Vss) of compound(9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,,BAO_0000218,5978,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624671,,8438,Rattus norvegicus,,10116.0,N,,1,,Steady state volume distribution (Vss) of compound(9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,,BAO_0000218,5978,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624672,,8439,Rattus norvegicus,,10116.0,N,,1,,Steady state volume distribution in rat,,BAO_0000218,6448,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624673,1969.0,8440,Rattus norvegicus,,10116.0,N,Plasma,1,,"Steady state volume of distribution calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv.",,BAO_0000218,12873,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624674,,8441,Rattus norvegicus,,10116.0,N,,1,,Steady state volume of distribution determined in rat,,BAO_0000218,4576,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624675,,8442,Rattus norvegicus,,10116.0,N,,1,,Steady-state volume of distribution was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,,BAO_0000218,17582,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621728,,8443,Rattus norvegicus,,10116.0,N,,1,,Tested for volume of distribution at steady state upon intravenous administration of 5.0 mg/Kg dose in rat,,BAO_0000218,1466,
,,A,,Intermediate,1,,50597,CHEMBL621729,,8444,Rattus norvegicus,,10116.0,N,,1,,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined,,BAO_0000218,5182,
,,A,,Intermediate,1,,50597,CHEMBL621730,,8445,Rattus norvegicus,,10116.0,N,,1,,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined; NC means not calculated,,BAO_0000218,5182,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621731,,8446,Rattus norvegicus,,10116.0,N,,1,,Volume distribution in rat after administration of 2 mg/kg iv,,BAO_0000218,6535,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621732,,8447,Rattus norvegicus,,10116.0,N,,1,,Volume distribution in rat after administration of 2 mg/kg iv,,BAO_0000218,6535,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621908,,8448,Rattus norvegicus,,10116.0,N,,1,,Volume in steady state distribution value was determined,,BAO_0000218,5041,
In vivo,,A,,Intermediate,1,,50597,CHEMBL875347,,8449,Rattus norvegicus,,10116.0,N,,1,,Volume in steady state distribution value was determined; ND denotes no data,,BAO_0000218,5041,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621909,,8450,Rattus norvegicus,,10116.0,N,,1,,Volume in steady state distribution value was determined; ND denotes not determined,,BAO_0000218,5041,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621910,,8451,Rattus norvegicus,,10116.0,N,,1,,Volume of distribution at a steady state measured after intravenous bolus administration of 50 mg/kg of compound to rats,,BAO_0000218,17065,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621911,,8452,Rattus norvegicus,,10116.0,N,,1,,Volume of distribution at steady state was evaluated in rats,,BAO_0000218,6597,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621912,,8453,Rattus norvegicus,,10116.0,N,,1,,Volume of distribution at steady state was observed after intravenous administration in rat,,BAO_0000218,15662,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621913,,8454,Rattus norvegicus,,10116.0,N,,1,,Volume of distribution in steady state was determined in rat,,BAO_0000218,6485,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621914,,8455,Rattus norvegicus,,10116.0,N,,1,,Volume of distribution in steady state was determined in rat,,BAO_0000218,17655,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621915,,8456,Rattus norvegicus,,10116.0,N,,1,,Volume of distribution after i.v. administration,,BAO_0000218,6616,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621916,,8457,Rattus norvegicus,,10116.0,N,,1,,Volume of distribution was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,,BAO_0000218,1916,
In vivo,,A,,Intermediate,1,,50594,CHEMBL621917,2107.0,8458,Mus musculus,,10090.0,N,Liver,1,,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",,BAO_0000218,16438,
In vivo,,A,,Intermediate,1,,50594,CHEMBL621918,2107.0,8459,Mus musculus,,10090.0,N,Liver,1,,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",,BAO_0000218,16438,
In vivo,,A,,Intermediate,1,,50594,CHEMBL621919,2106.0,8460,Mus musculus,,10090.0,N,Spleen,1,,Biodistribution of compound (oxidized form) in spleen tissue,,BAO_0000218,16438,
In vivo,,A,,Intermediate,1,,50594,CHEMBL621920,2106.0,8461,Mus musculus,,10090.0,N,Spleen,1,,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO sol.",,BAO_0000218,16438,
In vivo,,A,,Intermediate,1,,50594,CHEMBL621921,2106.0,8462,Mus musculus,,10090.0,N,Spleen,1,,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO solution",,BAO_0000218,16438,
In vivo,,A,,Intermediate,1,,50594,CHEMBL622401,2106.0,8463,Mus musculus,,10090.0,N,Spleen,1,,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,BAO_0000218,16438,
In vivo,,A,,Intermediate,1,,50594,CHEMBL875348,2106.0,8464,Mus musculus,,10090.0,N,Spleen,1,,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",,BAO_0000218,16438,
In vivo,,A,,Intermediate,1,,50594,CHEMBL622402,2106.0,8465,Mus musculus,,10090.0,N,Spleen,1,,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",,BAO_0000218,16438,
In vivo,,A,,Intermediate,1,,50594,CHEMBL622403,178.0,8466,Mus musculus,,10090.0,N,Blood,1,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood,,BAO_0000218,16438,
In vivo,,A,,Intermediate,1,,50594,CHEMBL622404,178.0,8467,Mus musculus,,10090.0,N,Blood,1,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,BAO_0000218,16438,
In vivo,,A,,Intermediate,1,,50594,CHEMBL622405,955.0,8468,Mus musculus,,10090.0,N,Brain,1,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues,,BAO_0000218,16438,
In vivo,,A,,Intermediate,1,,50594,CHEMBL622406,955.0,8469,Mus musculus,,10090.0,N,Brain,1,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 10 minutes after dosing, in DMSO",,BAO_0000218,16438,
In vivo,,A,,Intermediate,1,,50594,CHEMBL622407,955.0,8470,Mus musculus,,10090.0,N,Brain,1,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,BAO_0000218,16438,
In vivo,,A,,Intermediate,1,,50594,CHEMBL622408,948.0,8471,Mus musculus,,10090.0,N,Heart,1,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues,,BAO_0000218,16438,
In vivo,,A,,Intermediate,1,,50594,CHEMBL622409,948.0,8472,Mus musculus,,10090.0,N,Heart,1,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 10 minutes after dosing, in DMSO",,BAO_0000218,16438,
In vivo,,A,,Intermediate,1,,50594,CHEMBL622410,948.0,8473,Mus musculus,,10090.0,N,Heart,1,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,BAO_0000218,16438,
In vivo,,A,,Intermediate,1,,50594,CHEMBL622411,2113.0,8474,Mus musculus,,10090.0,N,Kidney,1,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney,,BAO_0000218,16438,
In vivo,,A,,Intermediate,1,,50594,CHEMBL627864,2113.0,8475,Mus musculus,,10090.0,N,Kidney,1,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing in DMSO",,BAO_0000218,16438,
In vivo,,A,,Intermediate,1,,50594,CHEMBL627865,2113.0,8476,Mus musculus,,10090.0,N,Kidney,1,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,BAO_0000218,16438,
In vivo,,A,,Intermediate,1,,50594,CHEMBL627866,2107.0,8477,Mus musculus,,10090.0,N,Liver,1,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver,,BAO_0000218,16438,
In vivo,,A,,Intermediate,1,,50594,CHEMBL627751,2107.0,8478,Mus musculus,,10090.0,N,Liver,1,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,BAO_0000218,16438,
In vivo,,A,,Intermediate,1,,50594,CHEMBL627752,2106.0,8479,Mus musculus,,10090.0,N,Spleen,1,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen,,BAO_0000218,16438,
In vivo,,A,,Intermediate,1,,50594,CHEMBL627753,2106.0,8480,Mus musculus,,10090.0,N,Spleen,1,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing in DMSO",,BAO_0000218,16438,
In vivo,,A,,Intermediate,1,,50594,CHEMBL627754,2106.0,8481,Mus musculus,,10090.0,N,Spleen,1,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,BAO_0000218,16438,
,,A,,Intermediate,1,,50594,CHEMBL627755,,8482,Mus musculus,,10090.0,N,,1,,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK2 murine fibrosarcoma cells,,BAO_0000218,12467,
In vivo,,A,,Intermediate,1,,50594,CHEMBL627756,955.0,8483,Mus musculus,,10090.0,N,Brain,1,,Biodistribution of radioactivity in normal mice (ICR) brain after 1 hour of intravenous injection of [125I]-16(IMPY),,BAO_0000218,17208,
In vivo,,A,,Intermediate,1,,50594,CHEMBL627757,955.0,8484,Mus musculus,,10090.0,N,Brain,1,,Biodistribution of radioactivity in normal mice (ICR) brain after 2 hours of intravenous injection of [125I]-16(IMPY),,BAO_0000218,17208,
In vivo,,A,,Intermediate,1,,50594,CHEMBL627758,955.0,8485,Mus musculus,,10090.0,N,Brain,1,,Biodistribution of radioactivity in normal mice (ICR) brain after 2 minutes of intravenous injection of [125I]-16(IMPY),,BAO_0000218,17208,
In vivo,,A,,Intermediate,1,,50594,CHEMBL627759,955.0,8486,Mus musculus,,10090.0,N,Brain,1,,Biodistribution of radioactivity in normal mice (ICR) brain after 24 hours of intravenous injection of [125I]-16(IMPY),,BAO_0000218,17208,
In vivo,,A,,Intermediate,1,,50594,CHEMBL627760,955.0,8487,Mus musculus,,10090.0,N,Brain,1,,Biodistribution of radioactivity in normal mice (ICR) brain after 30 minutes of intravenous injection of [125I]-16(IMPY),,BAO_0000218,17208,
In vivo,,A,,Intermediate,1,,50594,CHEMBL627761,955.0,8488,Mus musculus,,10090.0,N,Brain,1,,Biodistribution of radioactivity in normal mice (ICR) brain after 6 hours of intravenous injection of [125I]-16(IMPY),,BAO_0000218,17208,
In vivo,,A,,Intermediate,1,,50594,CHEMBL876811,948.0,8489,Mus musculus,,10090.0,N,Heart,1,,Biodistribution of radioactivity in normal mice (ICR) heart after 1 hour of intravenous injection of [125I]-16(IMPY),,BAO_0000218,17208,
In vivo,,A,,Intermediate,1,,50594,CHEMBL627762,948.0,8490,Mus musculus,,10090.0,N,Heart,1,,Biodistribution of radioactivity in normal mice (ICR) heart after 2 hours of intravenous injection of [125I]-16(IMPY),,BAO_0000218,17208,
In vivo,,A,,Intermediate,1,,50594,CHEMBL627763,948.0,8491,Mus musculus,,10090.0,N,Heart,1,,Biodistribution of radioactivity in normal mice (ICR) heart after 2 minutes of intravenous injection of [125I]-16(IMPY),,BAO_0000218,17208,
In vivo,,A,,Intermediate,1,,50594,CHEMBL627764,948.0,8492,Mus musculus,,10090.0,N,Heart,1,,Biodistribution of radioactivity in normal mice (ICR) heart after 24 hours of intravenous injection of [125I]-16(IMPY),,BAO_0000218,17208,
In vivo,,A,,Intermediate,1,,50594,CHEMBL627765,948.0,8493,Mus musculus,,10090.0,N,Heart,1,,Biodistribution of radioactivity in normal mice (ICR) heart after 30 minutes of intravenous injection of [125I]-16(IMPY),,BAO_0000218,17208,
In vivo,,A,,Intermediate,1,,50594,CHEMBL627766,948.0,8494,Mus musculus,,10090.0,N,Heart,1,,Biodistribution of radioactivity in normal mice (ICR) heart after 6 hours of intravenous injection of [125I]-16(IMPY),,BAO_0000218,17208,
In vivo,,A,,Intermediate,1,,50594,CHEMBL627767,2113.0,8495,Mus musculus,,10090.0,N,Kidney,1,,Biodistribution of radioactivity in normal mice (ICR) kidney after 1 hour of intravenous injection of [125I]-16(IMPY),,BAO_0000218,17208,
In vivo,,A,,Intermediate,1,,50594,CHEMBL627768,2113.0,8496,Mus musculus,,10090.0,N,Kidney,1,,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 hours of intravenous injection of [125I]-16(IMPY),,BAO_0000218,17208,
In vivo,,A,,Intermediate,1,,50594,CHEMBL628422,2113.0,8497,Mus musculus,,10090.0,N,Kidney,1,,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 minutes of intravenous injection of [125I]-16(IMPY),,BAO_0000218,17208,
In vivo,,A,,Intermediate,1,,50594,CHEMBL628423,2113.0,8498,Mus musculus,,10090.0,N,Kidney,1,,Biodistribution of radioactivity in normal mice (ICR) kidney after 24 hours of intravenous injection of [125I]-16(IMPY),,BAO_0000218,17208,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628424,,8499,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing) in Dawley rat,,BAO_0000218,5089,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628425,,8500,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing)) in Dawley rat,,BAO_0000218,5089,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628426,,8501,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance value was determined in rat after a 3 mg/kg of iv dose,,BAO_0000218,4257,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628427,,8502,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,,BAO_0000218,6679,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626938,,8503,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,,BAO_0000218,5546,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626939,,8504,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,,BAO_0000218,6141,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626940,,8505,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,,BAO_0000218,5334,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626941,,8506,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,,BAO_0000218,5334,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626942,,8507,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance was reported in Sprague-Dawley rat,,BAO_0000218,5334,
In vivo,,A,,Intermediate,1,,50597,CHEMBL876812,,8508,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance after intravenous administration (1 mg/kg) in rat,,BAO_0000218,4689,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626943,,8509,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance of compound in rats was evaluated,,BAO_0000218,6848,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626944,,8510,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance of compound in rats was evaluated; ND indicates not determined,,BAO_0000218,6848,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626945,,8511,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration,,BAO_0000218,6467,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626946,,8512,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,,BAO_0000218,6467,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626856,,8513,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance rate in Sprague-Dawley rats,,BAO_0000218,4956,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626857,,8514,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance was determined in rat after intravenous administration (0.5 mg/kg),,BAO_0000218,5529,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626858,1969.0,8515,Rattus norvegicus,,10116.0,N,Plasma,1,,The compound was evaluated for plasma clearance in rat,,BAO_0000218,406,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627018,1969.0,8516,Rattus norvegicus,,10116.0,N,Plasma,1,,Total plasma clearance in rat,,BAO_0000218,17655,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625331,178.0,8517,Rattus norvegicus,,10116.0,N,Blood,1,,Absorption behavior was judged by the peak blood concentration determined after oral dose of 30 mg/kg in rats.,,BAO_0000218,3293,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625332,178.0,8518,Rattus norvegicus,,10116.0,N,Blood,1,,Blood level after a 10 mg/kg oral dose in rat expressed as Cmax was determined,,BAO_0000218,4075,
In vivo,,A,,Intermediate,1,,50597,CHEMBL877590,,8519,Rattus norvegicus,,10116.0,N,,1,,C max was determined at 10 mg/kg po dose in rats,,BAO_0000218,2792,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625333,,8520,Rattus norvegicus,,10116.0,N,,1,,C max was determined at 3 mg/kg po dose in rats,,BAO_0000218,2792,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625334,,8521,Rattus norvegicus,,10116.0,N,,1,,Cmax after repeated oral dose of compound at 1 mg/kg in rats,,BAO_0000218,17594,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625335,,8522,Rattus norvegicus,,10116.0,N,,1,,Cmax after single intravenous bolus of 1 mg/kg in rats,,BAO_0000218,17594,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625336,,8523,Rattus norvegicus,,10116.0,N,,1,,Cmax of compound at 5 mg/kg after po administration was determined in rat,,BAO_0000218,4762,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625337,,8524,Rattus norvegicus,,10116.0,N,,1,,Cmax 24 hr after 10 mg/kg oral administration in rats,,BAO_0000218,17509,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625338,,8525,Rattus norvegicus,,10116.0,N,,1,,Cmax 24 hr after 2 mg/kg oral administration in rats,,BAO_0000218,17509,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625339,1969.0,8526,Rattus norvegicus,,10116.0,N,Plasma,1,,Cmax in plasma was determined upon peroral administration of 10.0 mg/Kg dose in rat,,BAO_0000218,1466,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625340,,8527,Rattus norvegicus,,10116.0,N,,1,,Cmax in rat after administration of 2 mg/kg iv,,BAO_0000218,6535,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625341,,8528,Rattus norvegicus,,10116.0,N,,1,,Cmax in rat after administration of 2 mg/kg iv,,BAO_0000218,6535,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622687,,8529,Rattus norvegicus,,10116.0,N,,1,,Cmax in rats determined 6 hours after oral dosing of 20 mg/kg,,BAO_0000218,3169,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622688,1969.0,8530,Rattus norvegicus,,10116.0,N,Plasma,1,,Cmax wa determined in rat plasma at 30 mg/kg after po administration,,BAO_0000218,6515,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622689,178.0,8531,Rattus norvegicus,,10116.0,N,Blood,1,,Cmax was calculated as maximum concentration reached in the blood after oral administration to male F344 rats,,BAO_0000218,11149,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620295,178.0,8532,Rattus norvegicus,,10116.0,N,Blood,1,,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate after oral administration to male F344 rats,,BAO_0000218,11149,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620296,,8533,Rattus norvegicus,,10116.0,N,,1,,Cmax after 10 mg/kg oral administration in rat,,BAO_0000218,17858,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620297,,8534,Rattus norvegicus,,10116.0,N,,1,,Cmax after IV dosing at 0.5 mg/kg in rat; no data,,BAO_0000218,6518,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620298,,8535,Rattus norvegicus,,10116.0,N,,1,,Cmax after IV dosing at 1 mg/kg in rat; no data,,BAO_0000218,6518,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620299,,8536,Rattus norvegicus,,10116.0,N,,1,,Cmax after oral administration at 20 mpk in rats,,BAO_0000218,4426,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620300,,8537,Rattus norvegicus,,10116.0,N,,1,,Cmax after oral administration at 20 mpk in rats; Not performed.,,BAO_0000218,4426,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620301,,8538,Rattus norvegicus,,10116.0,N,,1,,Cmax after oral administration at 20 mpk in rats d; Not performed.,,BAO_0000218,4426,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620302,,8539,Rattus norvegicus,,10116.0,N,,1,,Cmax after oral administration in rat,,BAO_0000218,5656,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620303,,8540,Rattus norvegicus,,10116.0,N,,1,,Cmax after oral administration at a dose of 2 mg/kg in rat,,BAO_0000218,6518,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620304,,8541,Rattus norvegicus,,10116.0,N,,1,,Cmax after oral administration at a dose of 4 mg/kg in rat,,BAO_0000218,6518,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620305,,8542,Rattus norvegicus,,10116.0,N,,1,,Cmax in rats after 20 mg/kg oral dose,,BAO_0000218,6113,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620306,,8543,Rattus norvegicus,,10116.0,N,,1,,Cmax after peroral administration in rats at 2.4 uM/kg,,BAO_0000218,17764,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620307,,8544,Rattus norvegicus,,10116.0,N,,1,,Cmax at the dose of 2 mg/Kg administered perorally in rats,,BAO_0000218,4756,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620308,,8545,Rattus norvegicus,,10116.0,N,,1,,Cmax at the dose of 5 mg/Kg administered perorally in rats,,BAO_0000218,4756,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620309,,8546,Rattus norvegicus,,10116.0,N,,1,,Cmax by administering at 20 mg/kg p.o. in rats,,BAO_0000218,6402,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620310,,8547,Rattus norvegicus,,10116.0,N,,1,,Cmax in male rat,,BAO_0000218,5610,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620311,,8548,Rattus norvegicus,,10116.0,N,,1,,Cmax in rat,,BAO_0000218,5207,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620312,,8549,Rattus norvegicus,,10116.0,N,,1,,Cmax in rat,,BAO_0000218,6011,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620313,,8550,Rattus norvegicus,,10116.0,N,,1,,Cmax in rat,,BAO_0000218,6504,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620314,,8551,Rattus norvegicus,,10116.0,N,,1,,Cmax in rat at 10 mg/kg,,BAO_0000218,6046,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620315,,8552,Rattus norvegicus,,10116.0,N,,1,,Cmax in rat at the dose of 1 mg/kg i.v.,,BAO_0000218,6504,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620316,,8553,Rattus norvegicus,,10116.0,N,,1,,Cmax in rat by po administration at a dose of 40 mg/kg,,BAO_0000218,5874,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620317,,8554,Rattus norvegicus,,10116.0,N,,1,,Cmax in rat p.o. at 20 mg/kg concentration,,BAO_0000218,17686,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620318,,8555,Rattus norvegicus,,10116.0,N,,1,,Cmax in rats,,BAO_0000218,5836,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620319,,8556,Rattus norvegicus,,10116.0,N,,1,,Cmax in rats,,BAO_0000218,17596,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620320,,8557,Rattus norvegicus,,10116.0,N,,1,,Cmax was evaluated after 20 uM/kg of peroral administration,,BAO_0000218,16423,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620321,,8558,Rattus norvegicus,,10116.0,N,,1,,Cmax was measured in rats after peroral administration at 3 mg/kg,,BAO_0000218,17804,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620322,,8559,Rattus norvegicus,,10116.0,N,,1,,Cmax value after oral dose at a dose of 10 mg/kg in rats.,,BAO_0000218,1908,
,,A,,Intermediate,1,,50597,CHEMBL620323,,8560,Rattus norvegicus,,10116.0,N,,1,,Distribution of [123I]-label in rat brain (diencephalon) was reported at 60 min post injection. Value shown is %ID/g of tissue,,BAO_0000218,13950,
,,A,,Intermediate,1,,50597,CHEMBL620324,1870.0,8561,Rattus norvegicus,,10116.0,N,Frontal cortex,1,,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,,BAO_0000218,13950,
,,A,,Intermediate,1,,50597,CHEMBL620325,1870.0,8562,Rattus norvegicus,,10116.0,N,Frontal cortex,1,,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,,BAO_0000218,13950,
,,A,,Intermediate,1,,50597,CHEMBL620326,10000000.0,8563,Rattus norvegicus,,10116.0,N,Hippocampus,1,,Distribution of [123I]-label in rat brain (hippocampus) was reported at 20 min post injection. Value shown is %ID/g of tissue,,BAO_0000218,13950,
,,A,,Intermediate,1,,50597,CHEMBL620327,10000000.0,8564,Rattus norvegicus,,10116.0,N,Hippocampus,1,,Distribution of [123I]-label in rat brain (hippocampus) was reported at 60 min post injection. Value shown is %ID/g of tissue,,BAO_0000218,13950,
,,A,,Intermediate,1,,50597,CHEMBL620328,,8565,Rattus norvegicus,,10116.0,N,,1,,Distribution of [123I]-label in rat brain (medulla pons) was reported at 20 min post injection. Value shown is %ID/g of tissue,,BAO_0000218,13950,
,,A,,Intermediate,1,,50597,CHEMBL620329,,8566,Rattus norvegicus,,10116.0,N,,1,,Distribution of [123I]-label in rat brain (medulla pons) was reported at 60 min post injection. Value shown is %ID/g of tissue,,BAO_0000218,13950,
,,A,,Intermediate,1,,50597,CHEMBL620330,1891.0,8567,Rattus norvegicus,,10116.0,N,Midbrain,1,,Distribution of [123I]-label in rat brain (midbrain) was reported at 20 min post injection. Value shown is %ID/g of tissue,,BAO_0000218,13950,
,,A,,Intermediate,1,,50597,CHEMBL875286,1891.0,8568,Rattus norvegicus,,10116.0,N,Midbrain,1,,Distribution of [123I]-label in rat brain (midbrain) was reported at 60 min post injection. Value shown is %ID/g of tissue,,BAO_0000218,13950,
,,A,,Intermediate,1,,50597,CHEMBL620331,,8569,Rattus norvegicus,,10116.0,N,,1,,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,,BAO_0000218,13950,
,,A,,Intermediate,1,,50597,CHEMBL620332,,8570,Rattus norvegicus,,10116.0,N,,1,,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,,BAO_0000218,13950,
,,A,,Intermediate,1,,50597,CHEMBL620333,2435.0,8571,Rattus norvegicus,,10116.0,N,Striatum,1,,Distribution of [123I]-label in rat brain (striatum) was reported at 20 min post injection. Value shown is %ID/g of tissue,,BAO_0000218,13950,
,,A,,Intermediate,1,,50597,CHEMBL620334,2435.0,8572,Rattus norvegicus,,10116.0,N,Striatum,1,,Distribution of [123I]-label in rat brain (striatum) was reported at 60 min post injection. Value shown is %ID/g of tissue,,BAO_0000218,13950,
,,A,,Intermediate,1,,50597,CHEMBL621015,178.0,8573,Rattus norvegicus,,10116.0,N,Blood,1,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL621016,178.0,8574,Rattus norvegicus,,10116.0,N,Blood,1,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL621191,178.0,8575,Rattus norvegicus,,10116.0,N,Blood,1,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL621192,178.0,8576,Rattus norvegicus,,10116.0,N,Blood,1,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL621193,178.0,8577,Rattus norvegicus,,10116.0,N,Blood,1,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL621194,178.0,8578,Rattus norvegicus,,10116.0,N,Blood,1,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL624204,178.0,8579,Rattus norvegicus,,10116.0,N,Blood,1,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL624205,178.0,8580,Rattus norvegicus,,10116.0,N,Blood,1,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL624206,178.0,8581,Rattus norvegicus,,10116.0,N,Blood,1,,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL624207,178.0,8582,Rattus norvegicus,,10116.0,N,Blood,1,,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL624208,178.0,8583,Rattus norvegicus,,10116.0,N,Blood,1,,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL624209,178.0,8584,Rattus norvegicus,,10116.0,N,Blood,1,,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL624210,178.0,8585,Rattus norvegicus,,10116.0,N,Blood,1,,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL624211,178.0,8586,Rattus norvegicus,,10116.0,N,Blood,1,,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL624212,178.0,8587,Rattus norvegicus,,10116.0,N,Blood,1,,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL624213,178.0,8588,Rattus norvegicus,,10116.0,N,Blood,1,,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL876611,178.0,8589,Rattus norvegicus,,10116.0,N,Blood,1,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL624214,178.0,8590,Rattus norvegicus,,10116.0,N,Blood,1,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL624215,178.0,8591,Rattus norvegicus,,10116.0,N,Blood,1,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL624216,178.0,8592,Rattus norvegicus,,10116.0,N,Blood,1,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL624217,178.0,8593,Rattus norvegicus,,10116.0,N,Blood,1,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL624218,178.0,8594,Rattus norvegicus,,10116.0,N,Blood,1,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL624219,178.0,8595,Rattus norvegicus,,10116.0,N,Blood,1,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL624220,178.0,8596,Rattus norvegicus,,10116.0,N,Blood,1,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL624221,178.0,8597,Rattus norvegicus,,10116.0,N,Blood,1,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL624222,,8598,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL624223,,8599,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL624224,,8600,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL624225,,8601,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,BAO_0000218,16434,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622420,,8602,Rattus norvegicus,,10116.0,N,,1,,Volume of solubility in solution after intravenous administration in rats at 24 uM/kg,,BAO_0000218,17764,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622421,,8603,Rattus norvegicus,,10116.0,N,,1,,Volume of steady state distribution after i.v. administration in rats,,BAO_0000218,5031,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622422,,8604,Rattus norvegicus,,10116.0,N,,1,,Vss after intravenous administration (5.0 mg/kg) was determined in rat,,BAO_0000218,6215,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622423,,8605,Rattus norvegicus,,10116.0,N,,1,,Vss in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,BAO_0000218,17671,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622424,,8606,Rattus norvegicus,,10116.0,N,,1,,Vss was determined,,BAO_0000218,17752,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622425,,8607,Rattus norvegicus,,10116.0,N,,1,,Vss in rat,,BAO_0000218,6596,
In vivo,,A,,Intermediate,1,,50597,CHEMBL876612,,8608,Rattus norvegicus,,10116.0,N,,1,,Vss was evaluated after 10 uM/kg of intra arterial administration,,BAO_0000218,16423,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622426,,8609,Rattus norvegicus,,10116.0,N,,1,,volume of distribution at steady state was observed after intravenous administration in rat,,BAO_0000218,15662,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622427,,8610,Rattus norvegicus,,10116.0,N,,1,,Volume of distribution was measured in rat after an iv dose of 1 mg/kg,,BAO_0000218,6062,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622428,,8611,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic (PK) parameter Vz in rat,,BAO_0000218,5874,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622429,,8612,Rattus norvegicus,,10116.0,N,,1,,Volume distribution in rats,,BAO_0000218,4942,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622430,,8613,Rattus norvegicus,,10116.0,N,,1,,Volume of distribution in rat; No data,,BAO_0000218,17796,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622431,,8614,Rattus norvegicus,,10116.0,N,,1,,Volume of distribution was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,,BAO_0000218,4890,
,,A,,Intermediate,1,,50597,CHEMBL622432,2116.0,8615,Rattus norvegicus,,10116.0,N,Ileum,1,,% absorption predicted from in vitro rat ileum transport studies,,BAO_0000218,15765,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622433,,8616,Rattus norvegicus,,10116.0,N,,1,,Bioavailability at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,,BAO_0000218,13569,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622434,,8617,Rattus norvegicus,,10116.0,N,,1,,Bioavailability at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,,BAO_0000218,13569,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622435,,8618,Rattus norvegicus,,10116.0,N,,1,,Bioavailability at an iv dose of 14 mg/Kg and po dose of 28 mg/Kg,,BAO_0000218,13569,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618748,,8619,Rattus norvegicus,,10116.0,N,,1,,Bioavailability (dose 15 mg/kg i.v. and 30 mg/kg p.o.),,BAO_0000218,13569,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618749,,8620,Rattus norvegicus,,10116.0,N,,1,,Bioavailability at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,,BAO_0000218,13569,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618750,,8621,Rattus norvegicus,,10116.0,N,,1,,Bioavailability at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,,BAO_0000218,13569,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618751,,8622,Rattus norvegicus,,10116.0,N,,1,,Bioavailability at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,,BAO_0000218,13569,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618752,,8623,Rattus norvegicus,,10116.0,N,,1,,Bioavailability at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,,BAO_0000218,13569,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618753,,8624,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat,,BAO_0000218,4576,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618754,1969.0,8625,Rattus norvegicus,,10116.0,N,Plasma,1,,Oral bioavailability estimated by measurement of the circulating plasma levels of BMS-183920 after intravenous and oral dosing to rats for 4 determinations,,BAO_0000218,750,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618755,,8626,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat,,BAO_0000218,750,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618756,,8627,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat,,BAO_0000218,4590,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618757,,8628,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat,,BAO_0000218,1716,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618758,,8629,Rattus norvegicus,,10116.0,N,,1,,Bioavailability in rat,,BAO_0000218,1974,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621088,,8630,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat (dose 30 mg/kg),,BAO_0000218,4502,
,,A,,Intermediate,1,,50597,CHEMBL621089,,8631,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic property (cLogP) in rat,,BAO_0000218,3371,
,,F,,Intermediate,1,,50597,CHEMBL621090,178.0,8632,Rattus norvegicus,,10116.0,N,Blood,1,,Hyperglycemic activity and change in blood glucose concentration was reported 2 hours after administration of 100 mg/Kg perorally,,BAO_0000218,9099,
,,F,,Intermediate,1,,50597,CHEMBL621091,178.0,8633,Rattus norvegicus,,10116.0,N,Blood,1,,Hyperglycemic activity and change in blood glucose concentration was reported 4 hours after administration of 100 mg/Kg perorally,,BAO_0000218,9099,
In vivo,,A,,Intermediate,1,,50597,CHEMBL876731,,8634,Rattus norvegicus,,10116.0,N,,1,,Clearance in rat.,,BAO_0000218,4590,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621092,,8635,Rattus norvegicus,,10116.0,N,,1,,Compound was evaluated for its clearance when administered intravenously in rat,,BAO_0000218,3184,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621093,,8636,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,,BAO_0000218,16456,
,,A,,Intermediate,1,,50597,CHEMBL621094,,8637,Rattus norvegicus,,10116.0,N,,1,,Blood: Brain distribution ratio is determined in rat,,BAO_0000218,4199,
,,A,,Intermediate,1,,50597,CHEMBL621095,,8638,Rattus norvegicus,,10116.0,N,,1,,Blood: Brain distribution ratio is determined in rat; NQ: non quantifable,,BAO_0000218,4199,
,,A,,Intermediate,1,,50597,CHEMBL621096,,8639,Rattus norvegicus,,10116.0,N,,1,,Blood: Brain distribution ratio is determined in rat; NQ:non quantifable,,BAO_0000218,4199,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621097,2113.0,8640,Rattus norvegicus,,10116.0,N,Kidney,1,,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,BAO_0000218,8677,
,,F,,Intermediate,1,,50597,CHEMBL621098,,8641,Rattus norvegicus,,10116.0,N,,1,,Percent dose excreted in 0-48 hours administered ip to male rat,,BAO_0000218,7449,
,,A,,Intermediate,1,,50597,CHEMBL621099,2037.0,8642,Rattus norvegicus,,10116.0,N,Cerebellum,1,,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,11977,
,,A,,Intermediate,1,,50597,CHEMBL621100,2037.0,8643,Rattus norvegicus,,10116.0,N,Cerebellum,1,,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,11977,
,,A,,Intermediate,1,,50597,CHEMBL621101,2037.0,8644,Rattus norvegicus,,10116.0,N,Cerebellum,1,,Uptake of radioligand [125I]-FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),,BAO_0000218,11977,
,,A,,Intermediate,1,,50597,CHEMBL621102,2037.0,8645,Rattus norvegicus,,10116.0,N,Cerebellum,1,,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,11977,
,,A,,Intermediate,1,,50597,CHEMBL876732,2037.0,8646,Rattus norvegicus,,10116.0,N,Cerebellum,1,,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,11977,
,,A,,Intermediate,1,,50597,CHEMBL621103,,8647,Rattus norvegicus,,10116.0,N,,1,,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,11977,
,,A,,Intermediate,1,,50597,CHEMBL621104,,8648,Rattus norvegicus,,10116.0,N,,1,,Uptake of radioligand [125I]FIDA1 by cortex in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,11977,
,,A,,Intermediate,1,,50597,CHEMBL621105,,8649,Rattus norvegicus,,10116.0,N,,1,,Uptake of radioligand [125I]FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 2 rats),,BAO_0000218,11977,
,,A,,Intermediate,1,,50597,CHEMBL621106,,8650,Rattus norvegicus,,10116.0,N,,1,,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,11977,
,,A,,Intermediate,1,,50597,CHEMBL621107,,8651,Rattus norvegicus,,10116.0,N,,1,,Uptake of radioligand [125I]FIDA1 by cortex in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,11977,
,,A,,Intermediate,1,,50597,CHEMBL621108,,8652,Rattus norvegicus,,10116.0,N,,1,,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,11977,
,,A,,Intermediate,1,,50597,CHEMBL621109,,8653,Rattus norvegicus,,10116.0,N,,1,,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,11977,
In vivo,,A,,Intermediate,1,,50594,CHEMBL621110,2113.0,8654,Mus musculus,,10090.0,N,Kidney,1,,Biodistribution of radioactivity in normal mice (ICR) kidney after 30 minutes of intravenous injection of [125I]-16(IMPY),,BAO_0000218,17208,
In vivo,,A,,Intermediate,1,,50594,CHEMBL621111,2113.0,8655,Mus musculus,,10090.0,N,Kidney,1,,Biodistribution of radioactivity in normal mice (ICR) kidney after 6 hours of intravenous injection of [125I]-16(IMPY),,BAO_0000218,17208,
In vivo,,A,,Intermediate,1,,50594,CHEMBL622541,2107.0,8656,Mus musculus,,10090.0,N,Liver,1,,Biodistribution of radioactivity in normal mice (ICR) liver after 1 hour of intravenous injection of [125I]-16(IMPY),,BAO_0000218,17208,
In vivo,,A,,Intermediate,1,,50594,CHEMBL622542,2107.0,8657,Mus musculus,,10090.0,N,Liver,1,,Biodistribution of radioactivity in normal mice (ICR) liver after 2 hours of intravenous injection of [125I]-16(IMPY),,BAO_0000218,17208,
In vivo,,A,,Intermediate,1,,50594,CHEMBL622543,2107.0,8658,Mus musculus,,10090.0,N,Liver,1,,Biodistribution of radioactivity in normal mice (ICR) liver after 2 minutes of intravenous injection of [125I]-16(IMPY),,BAO_0000218,17208,
In vivo,,A,,Intermediate,1,,50594,CHEMBL624412,2107.0,8659,Mus musculus,,10090.0,N,Liver,1,,Biodistribution of radioactivity in normal mice (ICR) liver after 24 hours of intravenous injection of [125I]-16(IMPY),,BAO_0000218,17208,
In vivo,,A,,Intermediate,1,,50594,CHEMBL624413,2107.0,8660,Mus musculus,,10090.0,N,Liver,1,,Biodistribution of radioactivity in normal mice (ICR) liver after 30 minutes of intravenous injection of [125I]-16(IMPY),,BAO_0000218,17208,
In vivo,,A,,Intermediate,1,,50594,CHEMBL624414,2107.0,8661,Mus musculus,,10090.0,N,Liver,1,,Biodistribution of radioactivity in normal mice (ICR) liver after 6 hours of intravenous injection of [125I]-16(IMPY),,BAO_0000218,17208,
In vivo,,A,,Intermediate,1,,50594,CHEMBL624415,2048.0,8662,Mus musculus,,10090.0,N,Lung,1,,Biodistribution of radioactivity in normal mice (ICR) lung after 1 hour of intravenous injection of [125I]-16(IMPY),,BAO_0000218,17208,
In vivo,,A,,Intermediate,1,,50594,CHEMBL624416,2048.0,8663,Mus musculus,,10090.0,N,Lung,1,,Biodistribution of radioactivity in normal mice (ICR) lung after 2 hours of intravenous injection of [125I]-16(IMPY),,BAO_0000218,17208,
In vivo,,A,,Intermediate,1,,50594,CHEMBL624417,2048.0,8664,Mus musculus,,10090.0,N,Lung,1,,Biodistribution of radioactivity in normal mice (ICR) lung after 2 minutes of intravenous injection of [125I]-16(IMPY),,BAO_0000218,17208,
In vivo,,A,,Intermediate,1,,50594,CHEMBL624418,2048.0,8665,Mus musculus,,10090.0,N,Lung,1,,Biodistribution of radioactivity in normal mice (ICR) lung after 24 hours of intravenous injection of [125I]-16(IMPY),,BAO_0000218,17208,
In vivo,,A,,Intermediate,1,,50594,CHEMBL624419,2048.0,8666,Mus musculus,,10090.0,N,Lung,1,,Biodistribution of radioactivity in normal mice (ICR) lung after 30 minutes of intravenous injection of [125I]-16(IMPY),,BAO_0000218,17208,
In vivo,,A,,Intermediate,1,,50594,CHEMBL624420,2048.0,8667,Mus musculus,,10090.0,N,Lung,1,,Biodistribution of radioactivity in normal mice (ICR) lung after 6 hours of intravenous injection of [125I]-16(IMPY),,BAO_0000218,17208,
In vivo,,A,,Intermediate,1,,50594,CHEMBL624421,2385.0,8668,Mus musculus,,10090.0,N,Muscle tissue,1,,Biodistribution of radioactivity in normal mice (ICR) muscle after 1 hr of intravenous injection of [125I]-16(IMPY),,BAO_0000218,17208,
In vivo,,A,,Intermediate,1,,50594,CHEMBL624422,2385.0,8669,Mus musculus,,10090.0,N,Muscle tissue,1,,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 hours of intravenous injection of [125I]-16(IMPY),,BAO_0000218,17208,
In vivo,,A,,Intermediate,1,,50594,CHEMBL624423,2385.0,8670,Mus musculus,,10090.0,N,Muscle tissue,1,,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 minutes of intravenous injection of [125I]-16(IMPY),,BAO_0000218,17208,
In vivo,,A,,Intermediate,1,,50594,CHEMBL625123,2385.0,8671,Mus musculus,,10090.0,N,Muscle tissue,1,,Biodistribution of radioactivity in normal mice (ICR) muscle after 24 hours of intravenous injection of [125I]-16(IMPY),,BAO_0000218,17208,
In vivo,,A,,Intermediate,1,,50594,CHEMBL625124,2385.0,8672,Mus musculus,,10090.0,N,Muscle tissue,1,,Biodistribution of radioactivity in normal mice (ICR) muscle after 30 minutes of intravenous injection of [125I]-16(IMPY),,BAO_0000218,17208,
In vivo,,A,,Intermediate,1,,50594,CHEMBL625125,2385.0,8673,Mus musculus,,10090.0,N,Muscle tissue,1,,Biodistribution of radioactivity in normal mice (ICR) muscle after 6 hours of intravenous injection of [125I]-16(IMPY),,BAO_0000218,17208,
In vivo,,A,,Intermediate,1,,50594,CHEMBL625126,14.0,8674,Mus musculus,,10090.0,N,Zone of skin,1,,Biodistribution of radioactivity in normal mice (ICR) skin after 1 hour of intravenous injection of [125I]-16(IMPY),,BAO_0000218,17208,
In vivo,,A,,Intermediate,1,,50594,CHEMBL626947,14.0,8675,Mus musculus,,10090.0,N,Zone of skin,1,,Biodistribution of radioactivity in normal mice (ICR) skin after 2 hours of intravenous injection of [125I]-16(IMPY),,BAO_0000218,17208,
In vivo,,A,,Intermediate,1,,50594,CHEMBL626948,14.0,8676,Mus musculus,,10090.0,N,Zone of skin,1,,Biodistribution of radioactivity in normal mice (ICR) skin after 2 minutes of intravenous injection of [125I]-16(IMPY),,BAO_0000218,17208,
In vivo,,A,,Intermediate,1,,50594,CHEMBL626949,14.0,8677,Mus musculus,,10090.0,N,Zone of skin,1,,Biodistribution of radioactivity in normal mice (ICR) skin after 24 hours of intravenous injection of [125I]-16(IMPY),,BAO_0000218,17208,
In vivo,,A,,Intermediate,1,,50594,CHEMBL626950,14.0,8678,Mus musculus,,10090.0,N,Zone of skin,1,,Biodistribution of radioactivity in normal mice (ICR) skin after 30 minutes of intravenous injection of [125I]-16(IMPY),,BAO_0000218,17208,
In vivo,,A,,Intermediate,1,,50594,CHEMBL626951,14.0,8679,Mus musculus,,10090.0,N,Zone of skin,1,,Biodistribution of radioactivity in normal mice (ICR) skin after 6 hours of intravenous injection of [125I]-16(IMPY),,BAO_0000218,17208,
In vivo,,A,,Intermediate,1,,50594,CHEMBL626952,2106.0,8680,Mus musculus,,10090.0,N,Spleen,1,,Biodistribution of radioactivity in normal mice (ICR) spleen after 1 hour of intravenous injection of [125I]-16(IMPY),,BAO_0000218,17208,
In vivo,,A,,Intermediate,1,,50594,CHEMBL626953,2106.0,8681,Mus musculus,,10090.0,N,Spleen,1,,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 hours of intravenous injection of [125I]-16(IMPY),,BAO_0000218,17208,
In vivo,,A,,Intermediate,1,,50594,CHEMBL626954,2106.0,8682,Mus musculus,,10090.0,N,Spleen,1,,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 minutes of intravenous injection of [125I]-16(IMPY),,BAO_0000218,17208,
In vivo,,A,,Intermediate,1,,50594,CHEMBL626955,2106.0,8683,Mus musculus,,10090.0,N,Spleen,1,,Biodistribution of radioactivity in normal mice (ICR) spleen after 24 hours of intravenous injection of [125I]-16(IMPY),,BAO_0000218,17208,
In vivo,,A,,Intermediate,1,,50594,CHEMBL626956,2106.0,8684,Mus musculus,,10090.0,N,Spleen,1,,Biodistribution of radioactivity in normal mice (ICR) spleen after 30 minutes of intravenous injection of [125I]-16(IMPY),,BAO_0000218,17208,
In vivo,,A,,Intermediate,1,,50594,CHEMBL626957,2106.0,8685,Mus musculus,,10090.0,N,Spleen,1,,Biodistribution of radioactivity in normal mice (ICR) spleen after 6 hours of intravenous injection of [125I]-16(IMPY),,BAO_0000218,17208,
In vivo,,A,,Intermediate,1,,50594,CHEMBL626958,178.0,8686,Mus musculus,,10090.0,N,Blood,1,,Biodistribution of radioactivity in normal mice blood after 1 hour of intravenous injection of [125I]-16(IMPY),,BAO_0000218,17208,
In vivo,,A,,Intermediate,1,,50594,CHEMBL626959,178.0,8687,Mus musculus,,10090.0,N,Blood,1,,Biodistribution of radioactivity in normal mice blood after 2 hours of intravenous injection of [125I]-16(IMPY),,BAO_0000218,17208,
In vivo,,A,,Intermediate,1,,50594,CHEMBL626960,178.0,8688,Mus musculus,,10090.0,N,Blood,1,,Biodistribution of radioactivity in normal mice blood after 2 minutes of intravenous injection of [125I]-16(IMPY),,BAO_0000218,17208,
In vivo,,A,,Intermediate,1,,50594,CHEMBL626961,178.0,8689,Mus musculus,,10090.0,N,Blood,1,,Biodistribution of radioactivity in normal mice blood after 24 hours of intravenous injection of [125I]-16(IMPY),,BAO_0000218,17208,
In vivo,,A,,Intermediate,1,,50594,CHEMBL627589,178.0,8690,Mus musculus,,10090.0,N,Blood,1,,Biodistribution of radioactivity in normal mice blood after 30 minutes of intravenous injection of [125I]-16(IMPY),,BAO_0000218,17208,
In vivo,,A,,Intermediate,1,,50594,CHEMBL627590,178.0,8691,Mus musculus,,10090.0,N,Blood,1,,Biodistribution of radioactivity in normal mice blood after 6 hours of intravenous injection of [125I]-16(IMPY),,BAO_0000218,17208,
,,A,,Intermediate,1,,50594,CHEMBL627591,,8692,Mus musculus,,10090.0,N,,1,,Time taken for EC90 was determined when tested in mouse,,BAO_0000218,3132,
,,A,,Intermediate,1,,50594,CHEMBL627592,,8693,Mus musculus,,10090.0,N,,1,,Time taken for EC90 was determined when tested in mouse at dose 25 mg/kg,,BAO_0000218,3132,
In vivo,,A,,Intermediate,1,,50594,CHEMBL627593,,8694,Mus musculus,,10090.0,N,,1,,At a dose 50 mg/kg (114 umol/kg) was administered intraperitoneally to mice and was evaluated for half life (T1/2),,BAO_0000218,16597,
,,A,,Intermediate,1,,50594,CHEMBL627594,,8695,Mus musculus,,10090.0,N,,1,,Half life in mice,,BAO_0000218,5727,
In vivo,,A,,Intermediate,1,,50594,CHEMBL876813,,8696,Mus musculus,,10090.0,N,,1,,Half life period in mouse after 10 mg/Kg dose,,BAO_0000218,5302,
In vivo,,A,,Intermediate,1,,50594,CHEMBL627595,,8697,Mus musculus,,10090.0,N,,1,,Half life period in mouse after 10 mg/kg dose,,BAO_0000218,5302,
In vivo,,A,,Intermediate,1,,50594,CHEMBL627596,,8698,Mus musculus,,10090.0,N,,1,,Half life was determined in mouse after 5 mg/kg (i.v.) and 6 mg/kg (p.o.) administration,,BAO_0000218,6348,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627597,,8699,Rattus norvegicus,,10116.0,N,,1,,Cmax value at 5 mg/kg po was determined in rat,,BAO_0000218,5964,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627598,,8700,Rattus norvegicus,,10116.0,N,,1,,Cmax value evaluated in rat,,BAO_0000218,6078,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627599,955.0,8701,Rattus norvegicus,,10116.0,N,Brain,1,,Cmax value was calculated by applying at a dose of 10 mg/Kg ip in rat brain,,BAO_0000218,5206,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627600,,8702,Rattus norvegicus,,10116.0,N,,1,,Cmax value after administration of 20 mg/Kg oral dose in rat,,BAO_0000218,2959,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627601,,8703,Rattus norvegicus,,10116.0,N,,1,,Cmax value at 1 mg/kg po in rat,,BAO_0000218,5964,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627776,,8704,Rattus norvegicus,,10116.0,N,,1,,Cmax value at 5 mg/kg po in rat,,BAO_0000218,5964,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627777,,8705,Rattus norvegicus,,10116.0,N,,1,,Cmax value at a dose of 10 mg/kg in male SD rats,,BAO_0000218,6757,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627778,,8706,Rattus norvegicus,,10116.0,N,,1,,Cmax value at a dose of 100 mg/kg in male SD rats,,BAO_0000218,6757,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627779,,8707,Rattus norvegicus,,10116.0,N,,1,,Cmax value at a dose of 50 mg/kg in male SD rats,,BAO_0000218,6757,
In vivo,,A,,Intermediate,1,,50597,CHEMBL876814,,8708,Rattus norvegicus,,10116.0,N,,1,,Cmax value in rats at 10 mg/kg,,BAO_0000218,17617,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627780,,8709,Rattus norvegicus,,10116.0,N,,1,,Cmax value was evaluated in rats at a dose of 20 mg/kg,,BAO_0000218,1445,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627781,,8710,Rattus norvegicus,,10116.0,N,,1,,Cmax value was determined after peroral administration of 20 mg/kg in rat,,BAO_0000218,6082,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627782,,8711,Rattus norvegicus,,10116.0,N,,1,,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,,BAO_0000218,1446,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627783,1969.0,8712,Rattus norvegicus,,10116.0,N,Plasma,1,,Compound was evaluated for its pharmacokinetic parameter maximum plasma concentration (Cmax) after oral administration to rats,,BAO_0000218,5407,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627784,1969.0,8713,Rattus norvegicus,,10116.0,N,Plasma,1,,Compound was evaluated for maximal plasma concentration in rat upon 5 mg/kg upon oral administration,,BAO_0000218,2690,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627785,,8714,Rattus norvegicus,,10116.0,N,,1,,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to female wistar rats,,BAO_0000218,2661,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627786,,8715,Rattus norvegicus,,10116.0,N,,1,,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to male wistar rats,,BAO_0000218,2661,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627787,1969.0,8716,Rattus norvegicus,,10116.0,N,Plasma,1,,Compound was evaluated for pharmacokinetic parameter maximum plasma concentration,,BAO_0000218,4891,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627788,1969.0,8717,Rattus norvegicus,,10116.0,N,Plasma,1,,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 0.5 hr,,BAO_0000218,2807,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626579,1969.0,8718,Rattus norvegicus,,10116.0,N,Plasma,1,,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 1 hr,,BAO_0000218,2807,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626580,1969.0,8719,Rattus norvegicus,,10116.0,N,Plasma,1,,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 2 hr,,BAO_0000218,2807,
In vivo,,A,,Intermediate,1,,50597,CHEMBL876815,,8720,Rattus norvegicus,,10116.0,N,,1,,Compound was evaluated for the pharmacokinetic property in rats after an oral dose of 10 mg/kg,,BAO_0000218,3634,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626581,1969.0,8721,Rattus norvegicus,,10116.0,N,Plasma,1,,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 1 hr,,BAO_0000218,1881,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626582,1969.0,8722,Rattus norvegicus,,10116.0,N,Plasma,1,,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 2 hr,,BAO_0000218,1881,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626583,,8723,Rattus norvegicus,,10116.0,N,,1,,Evaluated for pharmacokinetic parameter Cmax in rat at the dose 50 mg/kg,,BAO_0000218,429,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626205,,8724,Rattus norvegicus,,10116.0,N,,1,,In vivo Cmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,BAO_0000218,5974,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626206,,8725,Rattus norvegicus,,10116.0,N,,1,,In vivo Cmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,BAO_0000218,5974,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626207,,8726,Rattus norvegicus,,10116.0,N,,1,,In vivo Cmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,BAO_0000218,5974,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623882,,8727,Rattus norvegicus,,10116.0,N,,1,,In vivo Cmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,BAO_0000218,5974,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623883,,8728,Rattus norvegicus,,10116.0,N,,1,,Maximal concentration in male Sprague-Dawley rats after 5 mg/kg intravenous dose,,BAO_0000218,17582,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623884,,8729,Rattus norvegicus,,10116.0,N,,1,,Maximal concentration in male Sprague-Dawley rats after 10 mg/kg oral dose,,BAO_0000218,17582,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623885,1969.0,8730,Rattus norvegicus,,10116.0,N,Plasma,1,,"In vivo maximum concentration of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",,BAO_0000218,3032,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623886,1969.0,8731,Rattus norvegicus,,10116.0,N,Plasma,1,,In vivo maximum concentration in rat plasma exposure after oral administration 50 mg/kg,,BAO_0000218,6295,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623887,,8732,Rattus norvegicus,,10116.0,N,,1,,Maximal concentration in rat was determined,,BAO_0000218,6619,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623888,,8733,Rattus norvegicus,,10116.0,N,,1,,Maximal concentration after i.v. administration,,BAO_0000218,6616,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623889,1969.0,8734,Rattus norvegicus,,10116.0,N,Plasma,1,,Maximal concentration (Cmax) in the rat plasma at a dose of 10 mg/kg,,BAO_0000218,3249,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623890,1969.0,8735,Rattus norvegicus,,10116.0,N,Plasma,1,,Maximal plasma concentration in rat after oral administration at 50 mg/kg,,BAO_0000218,17791,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623891,1969.0,8736,Rattus norvegicus,,10116.0,N,Plasma,1,,Cmax in rat plasma after oral dose (50 mg/Kg),,BAO_0000218,17791,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623892,1969.0,8737,Rattus norvegicus,,10116.0,N,Plasma,1,,Maximal plasma concentration was determined.,,BAO_0000218,1360,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623893,1969.0,8738,Rattus norvegicus,,10116.0,N,Plasma,1,,Maximal plasma drug concentration was determined,,BAO_0000218,2552,
In vivo,,A,,Intermediate,1,,50597,CHEMBL877616,,8739,Rattus norvegicus,,10116.0,N,,1,,Maximal concentration in rats after peroral administration,,BAO_0000218,6571,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623894,,8740,Rattus norvegicus,,10116.0,N,,1,,Maximum concentration in rat after 2 mg/kg peroral administration,,BAO_0000218,6570,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623895,1969.0,8741,Rattus norvegicus,,10116.0,N,Plasma,1,,Maximum concentration in rat plasma after 5 mg/kg oral gavage,,BAO_0000218,6567,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623896,,8742,Rattus norvegicus,,10116.0,N,,1,,Maximum concentration of compound in rat was evaluated.,,BAO_0000218,3031,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623897,,8743,Rattus norvegicus,,10116.0,N,,1,,Maximum concentration at 0.5 hr by peroral administration at a dose of 20 mg/kg in rats,,BAO_0000218,3436,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623898,,8744,Rattus norvegicus,,10116.0,N,,1,,Maximum concentration at 2 hr by peroral administration at a dose of 20 mg/kg in rats,,BAO_0000218,3436,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623899,,8745,Rattus norvegicus,,10116.0,N,,1,,Maximum concentration at 4 hr after administration of 5 mg/kg dose peroral in rat,,BAO_0000218,2083,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623900,,8746,Rattus norvegicus,,10116.0,N,,1,,Maximum concentration at 4 hr by peroral administration at a dose of 20 mg/kg in rats,,BAO_0000218,3436,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623901,,8747,Rattus norvegicus,,10116.0,N,,1,,Maximum concentration by oral administration at a dose of 100 uM/kg in rat was determined,,BAO_0000218,4527,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623902,,8748,Rattus norvegicus,,10116.0,N,,1,,Maximum concentration was evaluated in rats,,BAO_0000218,1974,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623903,1359.0,8749,Rattus norvegicus,,10116.0,N,Cerebrospinal fluid,1,,Maximum concentration in CSF at 30 min following 24 mg/kg subcutaneous dose in rats,,BAO_0000218,3307,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623904,1969.0,8750,Rattus norvegicus,,10116.0,N,Plasma,1,,Maximum concentration in plasma at 30 min following 24 mg/kg subcutaneous dose in rats,,BAO_0000218,3307,
In vivo,,A,,Intermediate,1,,50597,CHEMBL877617,1969.0,8751,Rattus norvegicus,,10116.0,N,Plasma,1,,Maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,,BAO_0000218,1916,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623905,,8752,Rattus norvegicus,,10116.0,N,,1,,Maximum concentration in portal vein was determined at a concentration of 10 mg/kg in rats,,BAO_0000218,1500,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623906,,8753,Rattus norvegicus,,10116.0,N,,1,,Maximum concentration in portal vein was determined at a concentration of 20 mg/kg in rats,,BAO_0000218,1500,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623907,1969.0,8754,Rattus norvegicus,,10116.0,N,Plasma,1,,Maximum concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,,BAO_0000218,4186,
,,A,,Intermediate,1,,50597,CHEMBL623908,,8755,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL623909,,8756,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 30 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL623910,,8757,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL623911,,8758,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL623912,,8759,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL624616,,8760,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL624617,,8761,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL624618,,8762,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL624619,,8763,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL624794,,8764,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL624795,,8765,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL623921,,8766,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL623922,,8767,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL623923,,8768,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL623924,,8769,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL623925,,8770,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL623926,,8771,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL623927,,8772,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL623928,,8773,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL623929,,8774,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL623930,,8775,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL623931,955.0,8776,Rattus norvegicus,,10116.0,N,Brain,1,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL622165,955.0,8777,Rattus norvegicus,,10116.0,N,Brain,1,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL621249,955.0,8778,Rattus norvegicus,,10116.0,N,Brain,1,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL621250,955.0,8779,Rattus norvegicus,,10116.0,N,Brain,1,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL621448,955.0,8780,Rattus norvegicus,,10116.0,N,Brain,1,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL621449,955.0,8781,Rattus norvegicus,,10116.0,N,Brain,1,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL621450,955.0,8782,Rattus norvegicus,,10116.0,N,Brain,1,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL621451,955.0,8783,Rattus norvegicus,,10116.0,N,Brain,1,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL621452,955.0,8784,Rattus norvegicus,,10116.0,N,Brain,1,,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL621453,955.0,8785,Rattus norvegicus,,10116.0,N,Brain,1,,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL621454,955.0,8786,Rattus norvegicus,,10116.0,N,Brain,1,,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL621455,955.0,8787,Rattus norvegicus,,10116.0,N,Brain,1,,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL621456,955.0,8788,Rattus norvegicus,,10116.0,N,Brain,1,,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL625145,955.0,8789,Rattus norvegicus,,10116.0,N,Brain,1,,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL875847,955.0,8790,Rattus norvegicus,,10116.0,N,Brain,1,,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL625146,955.0,8791,Rattus norvegicus,,10116.0,N,Brain,1,,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL625147,955.0,8792,Rattus norvegicus,,10116.0,N,Brain,1,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL625148,955.0,8793,Rattus norvegicus,,10116.0,N,Brain,1,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL625149,955.0,8794,Rattus norvegicus,,10116.0,N,Brain,1,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL625150,955.0,8795,Rattus norvegicus,,10116.0,N,Brain,1,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL625151,955.0,8796,Rattus norvegicus,,10116.0,N,Brain,1,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL625152,955.0,8797,Rattus norvegicus,,10116.0,N,Brain,1,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL625153,955.0,8798,Rattus norvegicus,,10116.0,N,Brain,1,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL625154,955.0,8799,Rattus norvegicus,,10116.0,N,Brain,1,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL625155,955.0,8800,Rattus norvegicus,,10116.0,N,Brain,1,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL625156,,8801,Rattus norvegicus,,10116.0,N,,1,,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 30 minutes after an intravenous injection is given (average of 2 rats),,BAO_0000218,11977,
,,A,,Intermediate,1,,50597,CHEMBL624354,,8802,Rattus norvegicus,,10116.0,N,,1,,Uptake of radioligand [125I]-FIDA1 by hippo-campus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,11977,
,,A,,Intermediate,1,,50597,CHEMBL624355,10000000.0,8803,Rattus norvegicus,,10116.0,N,Hippocampus,1,,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,11977,
,,A,,Intermediate,1,,50597,CHEMBL624356,10000000.0,8804,Rattus norvegicus,,10116.0,N,Hippocampus,1,,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,11977,
,,A,,Intermediate,1,,50597,CHEMBL624357,10000000.0,8805,Rattus norvegicus,,10116.0,N,Hippocampus,1,,Uptake of radioligand [125I]-FIDA1 by hippocampus in rat after 30 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,11977,
,,A,,Intermediate,1,,50597,CHEMBL624358,10000000.0,8806,Rattus norvegicus,,10116.0,N,Hippocampus,1,,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,11977,
,,A,,Intermediate,1,,50597,CHEMBL624359,2435.0,8807,Rattus norvegicus,,10116.0,N,Striatum,1,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,11977,
,,A,,Intermediate,1,,50597,CHEMBL624360,2435.0,8808,Rattus norvegicus,,10116.0,N,Striatum,1,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,11977,
,,A,,Intermediate,1,,50597,CHEMBL624361,2435.0,8809,Rattus norvegicus,,10116.0,N,Striatum,1,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),,BAO_0000218,11977,
,,A,,Intermediate,1,,50597,CHEMBL624362,2435.0,8810,Rattus norvegicus,,10116.0,N,Striatum,1,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,11977,
,,A,,Intermediate,1,,50597,CHEMBL624363,2435.0,8811,Rattus norvegicus,,10116.0,N,Striatum,1,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,11977,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624364,178.0,8812,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,11977,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624365,178.0,8813,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,11977,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624366,178.0,8814,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,11977,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624367,178.0,8815,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,11977,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624368,955.0,8816,Rattus norvegicus,,10116.0,N,Brain,1,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,11977,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624369,955.0,8817,Rattus norvegicus,,10116.0,N,Brain,1,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,11977,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624370,955.0,8818,Rattus norvegicus,,10116.0,N,Brain,1,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,BAO_0000218,11977,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625069,955.0,8819,Rattus norvegicus,,10116.0,N,Brain,1,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,11977,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625070,955.0,8820,Rattus norvegicus,,10116.0,N,Brain,1,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,11977,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626051,948.0,8821,Rattus norvegicus,,10116.0,N,Heart,1,,Biodistribution of radioligand [125I]-FIDA1 in heart of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,11977,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626052,948.0,8822,Rattus norvegicus,,10116.0,N,Heart,1,,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,11977,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626053,948.0,8823,Rattus norvegicus,,10116.0,N,Heart,1,,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,BAO_0000218,11977,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626054,948.0,8824,Rattus norvegicus,,10116.0,N,Heart,1,,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,11977,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626055,948.0,8825,Rattus norvegicus,,10116.0,N,Heart,1,,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,11977,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626056,2113.0,8826,Rattus norvegicus,,10116.0,N,Kidney,1,,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,11977,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626057,2113.0,8827,Rattus norvegicus,,10116.0,N,Kidney,1,,Biodistribution of radioligand [125I]-FIDA1 in kidney of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,11977,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625193,2113.0,8828,Rattus norvegicus,,10116.0,N,Kidney,1,,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,11977,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625194,2113.0,8829,Rattus norvegicus,,10116.0,N,Kidney,1,,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,11977,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625195,2107.0,8830,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,11977,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625196,2107.0,8831,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,11977,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625197,2107.0,8832,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,BAO_0000218,11977,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625198,2107.0,8833,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,11977,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627929,2107.0,8834,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,11977,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627074,2048.0,8835,Rattus norvegicus,,10116.0,N,Lung,1,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,11977,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627075,2048.0,8836,Rattus norvegicus,,10116.0,N,Lung,1,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,11977,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627076,2048.0,8837,Rattus norvegicus,,10116.0,N,Lung,1,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,BAO_0000218,11977,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627077,2048.0,8838,Rattus norvegicus,,10116.0,N,Lung,1,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,11977,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627078,2048.0,8839,Rattus norvegicus,,10116.0,N,Lung,1,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,11977,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627079,2385.0,8840,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 2 rats),,BAO_0000218,11977,
In vivo,,A,,Intermediate,1,,50594,CHEMBL873824,,8841,Mus musculus,,10090.0,N,,1,,Half life (t1/2) determined at a dose 10 mg/kg administered intraperitoneally to mice,,BAO_0000218,4573,
In vivo,,A,,Intermediate,1,,50594,CHEMBL627080,1969.0,8842,Mus musculus,,10090.0,N,Plasma,1,,Half life in mouse plasma was determined at dose 25 mg/kg,,BAO_0000218,3132,
,,A,,Intermediate,1,,50594,CHEMBL627081,,8843,Mus musculus,,10090.0,N,,1,,Half life was determined,,BAO_0000218,17718,
In vivo,,A,,Intermediate,1,,50594,CHEMBL627082,,8844,Mus musculus,,10090.0,N,,1,,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,,BAO_0000218,17728,
In vivo,,A,,Intermediate,1,,50594,CHEMBL627083,,8845,Mus musculus,,10090.0,N,,1,,Half-life in male mice after 1 mg/kg intravenous dose,,BAO_0000218,5961,
,,A,,Intermediate,1,,50594,CHEMBL627085,1969.0,8847,Mus musculus,,10090.0,N,Plasma,1,,Half life in mice plasma,,BAO_0000218,17731,
,,A,,Intermediate,1,,50594,CHEMBL627086,,8848,Mus musculus,,10090.0,N,,1,,Half life in mouse,,BAO_0000218,17592,
In vivo,,A,,Intermediate,1,,50594,CHEMBL627087,1969.0,8849,Mus musculus,,10090.0,N,Plasma,1,,Half life in mouse plasma at dose 25 mg/kg,,BAO_0000218,3132,
In vivo,,A,,Intermediate,1,,50594,CHEMBL627088,,8850,Mus musculus,,10090.0,N,,1,,Half life when injected i.p. in mice at a dose of 50 mg/kg was determined,,BAO_0000218,17729,
In vivo,,A,,Intermediate,1,,50594,CHEMBL627089,,8851,Mus musculus,,10090.0,N,,1,,Half life when injected intravenously in mice at a dose of 20 mg/kg was determined,,BAO_0000218,17729,
In vivo,,A,,Intermediate,1,,50594,CHEMBL627090,,8852,Mus musculus,,10090.0,N,,1,,Half life when injected perorally in mice at a dose of 50 mg/kg was determined,,BAO_0000218,17729,
In vivo,,A,,Intermediate,1,,50594,CHEMBL627091,,8853,Mus musculus,,10090.0,N,,1,,Half life was determined in mice at a single subcutaneous administration of 40 mg/kg (n=4),,BAO_0000218,3277,
In vivo,,A,,Intermediate,1,,50594,CHEMBL627092,,8854,Mus musculus,,10090.0,N,,1,,"Half life was evaluated at 5 mg/kg of compound dose, administered perorally in mice",,BAO_0000218,3760,
In vivo,,A,,Intermediate,1,,50594,CHEMBL876785,,8855,Mus musculus,,10090.0,N,,1,,"Half life was evaluated at 50 mg/kg of compound dose, administered perorally in mice",,BAO_0000218,3760,
In vivo,,A,,Intermediate,1,,50594,CHEMBL627093,,8856,Mus musculus,,10090.0,N,,1,,Half-life by iv administration in mouse,,BAO_0000218,2862,
In vivo,,A,,Intermediate,1,,50594,CHEMBL627094,,8857,Mus musculus,,10090.0,N,,1,,Half-life by oral administration in mouse,,BAO_0000218,2862,
,,A,,Intermediate,1,,50594,CHEMBL627095,,8858,Mus musculus,,10090.0,N,,1,,Half-life in mice,,BAO_0000218,5980,
,,A,,Intermediate,1,,50594,CHEMBL627096,955.0,8859,Mus musculus,,10090.0,N,Brain,1,,Half-life using mouse brain homogenate,,BAO_0000218,6159,
,,A,,Intermediate,1,,50594,CHEMBL627097,,8860,Mus musculus,,10090.0,N,,1,,Half-life was measured in mice,,BAO_0000218,6254,
In vivo,,A,,Intermediate,1,,50594,CHEMBL627098,,8861,Mus musculus,,10090.0,N,,1,,Half-life was measured in mouse after an iv dose of 1 mg/kg,,BAO_0000218,6062,
,,A,,Intermediate,1,,50594,CHEMBL627099,178.0,8862,Mus musculus,,10090.0,N,Blood,1,,Half-life period was determined in mouse blood,,BAO_0000218,1574,
,,A,,Intermediate,1,,50594,CHEMBL627100,955.0,8863,Mus musculus,,10090.0,N,Brain,1,,"Half-times of inhibition of PEP in in an ex vivo enzyme studies, using mice brain",,BAO_0000218,56,
,,A,,Intermediate,1,,50594,CHEMBL627101,1969.0,8864,Mus musculus,,10090.0,N,Plasma,1,,Plasma half life in mouse,,BAO_0000218,993,
,,A,,Intermediate,1,,50594,CHEMBL627102,,8865,Mus musculus,,10090.0,N,,1,,Stability of the peptide in the presence of mouse serum,,BAO_0000218,6652,
,,A,,Intermediate,1,,50594,CHEMBL627103,,8866,Mus musculus,,10090.0,N,,1,,Terminal half life of compound was determined in mouse,,BAO_0000218,17852,
In vivo,,A,,Intermediate,1,,50594,CHEMBL627104,,8867,Mus musculus,,10090.0,N,,1,,Terminal half life was evaluated in mice after intravenous administration,,BAO_0000218,2675,
In vivo,,A,,Intermediate,1,,50594,CHEMBL627105,,8868,Mus musculus,,10090.0,N,,1,,Terminal half life was evaluated in mice after oral administration,,BAO_0000218,2675,
,,A,,Intermediate,1,,50594,CHEMBL876786,,8869,Mus musculus,,10090.0,N,,1,,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 5.,,BAO_0000218,499,
,,A,,Intermediate,1,,50594,CHEMBL873825,,8870,Mus musculus,,10090.0,N,,1,,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7.,,BAO_0000218,499,
,,A,,Intermediate,1,,50594,CHEMBL627106,,8871,Mus musculus,,10090.0,N,,1,,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7; ND means no data,,BAO_0000218,499,
In vivo,,A,,Intermediate,1,,50594,CHEMBL626336,,8872,Mus musculus,,10090.0,N,,1,,half life period is evaluated by administering intravenously at 25 mg/kg in mice,,BAO_0000218,14239,
In vivo,,A,,Intermediate,1,,50594,CHEMBL877462,,8873,Mus musculus,,10090.0,N,,1,,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice",,BAO_0000218,5506,
In vivo,,A,,Intermediate,1,,50594,CHEMBL626337,,8874,Mus musculus,,10090.0,N,,1,,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice; NC: not calculable",,BAO_0000218,5506,
,,A,,Intermediate,1,,50594,CHEMBL626338,,8875,Mus musculus,,10090.0,N,,1,,Half life after intraperitoneal administration of 100 mg/kg in mice,,BAO_0000218,17734,
In vivo,,A,,Intermediate,1,,50594,CHEMBL626339,,8876,Mus musculus,,10090.0,N,,1,,Half life in BALB/C mice at the dose of 20 mg/kg by i.p. administration,,BAO_0000218,17728,
In vivo,,A,,Intermediate,1,,50594,CHEMBL626340,,8877,Mus musculus,,10090.0,N,,1,,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,,BAO_0000218,17728,
In vivo,,A,,Intermediate,1,,50594,CHEMBL625377,,8878,Mus musculus,,10090.0,N,,1,,Half life in BALB/C mice at the dose of 20 mg/kg by p.o. administration,,BAO_0000218,17728,
In vivo,,A,,Intermediate,1,,50594,CHEMBL625378,,8879,Mus musculus,,10090.0,N,,1,,Half life in BALB/C mice at the dose of 50 mg/kg by i.p. administration,,BAO_0000218,17728,
In vivo,,A,,Intermediate,1,,50594,CHEMBL625379,,8880,Mus musculus,,10090.0,N,,1,,Half life in BALB/C mice at the dose of 50 mg/kg by p.o. administration,,BAO_0000218,17728,
,,A,,Autocuration,0,,22224,CHEMBL625380,,8881,Sus scrofa,,9823.0,U,,1,,Metabolism of compound in mini pig S9 microsomes ('+''indicates <20% largest observed peak),Microsomes,BAO_0000251,14294,
,,A,,Autocuration,0,,22224,CHEMBL625381,,8882,Sus scrofa,,9823.0,U,,1,,Metabolism of compound in mini pig S9 microsomes ('++++' indicates largest observed peak),Microsomes,BAO_0000251,14294,
,,A,,Autocuration,0,,22224,CHEMBL625382,,8883,Sus scrofa,,9823.0,U,,1,,Stability to porcine renal DHP-I,,BAO_0000019,6056,
In vivo,,A,,Autocuration,0,,22224,CHEMBL873828,,8884,Sus scrofa,,9823.0,U,,1,,Compound was tested for its half-life period at an intravenous dose of 30 ug/kg,,BAO_0000218,1317,
In vivo,,A,,Autocuration,0,,22224,CHEMBL625383,,8885,Sus scrofa,,9823.0,U,,1,,Compound was tested for its half-life period at an intravenous dose of 3 ug/kg,,BAO_0000218,1317,
,,A,,Autocuration,0,,22224,CHEMBL625384,,8886,Sus scrofa,,9823.0,U,,1,,Half-life of the parent prodrug in porcine esterase solution,,BAO_0000019,5229,
,,A,,Autocuration,0,,22224,CHEMBL625385,,8887,Sus scrofa,,9823.0,U,,1,,"First order rate constant, k was determined in in pig liver Esterase",,BAO_0000019,4231,
,,A,,Autocuration,0,,22224,CHEMBL625386,2107.0,8888,Sus scrofa,,9823.0,U,Liver,1,,Half life of the in pig liver Esterase,,BAO_0000221,4231,
,,A,,Autocuration,0,,22224,CHEMBL623571,2107.0,8889,Sus scrofa,,9823.0,U,Liver,1,,Tested for half life period at 37 degree Celsius in PBS buffer at 11.8 pH containing porcine liver esterase,,BAO_0000221,5318,
,,A,,Autocuration,0,,22224,CHEMBL623572,2107.0,8890,Sus scrofa,,9823.0,U,Liver,1,,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH containing porcine liver esterase,,BAO_0000221,5318,
,,A,,Autocuration,0,,22224,CHEMBL623573,2107.0,8891,Sus scrofa,,9823.0,U,Liver,1,,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH in containing porcine liver esterase,,BAO_0000221,5318,
,,A,,Autocuration,0,,22224,CHEMBL623574,2107.0,8892,Sus scrofa,,9823.0,U,Liver,1,,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay,,BAO_0000221,3305,
,,A,,Autocuration,0,,22224,CHEMBL623575,2107.0,8893,Sus scrofa,,9823.0,U,Liver,1,,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay; ND is not determined,,BAO_0000221,3305,
,,A,,Autocuration,0,,22224,CHEMBL623749,2107.0,8894,Sus scrofa,,9823.0,U,Liver,1,,Half-life in the presence of pig liver esterase(PLE) was evaluated.,,BAO_0000221,2842,
,,A,,Autocuration,0,,22224,CHEMBL623750,2107.0,8895,Sus scrofa,,9823.0,U,Liver,1,,Half-life in the presence of pig liver esterase(PLE) was evaluated; Stable,,BAO_0000221,2842,
In vitro,,A,,Autocuration,0,,22224,CHEMBL623751,2107.0,8896,Sus scrofa,,9823.0,U,Liver,1,,Half-life in vitro in pig liver,,BAO_0000221,889,
,,A,,Autocuration,0,,22224,CHEMBL623752,2107.0,8897,Sus scrofa,,9823.0,U,Liver,1,,Half-life time was determined for esterase-catalyzed hydrolysis of the phenol ester bond in porcine liver esterase,,BAO_0000221,1904,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623753,1969.0,8898,Rattus norvegicus,,10116.0,N,Plasma,1,,Maximum concentration in rat plasma after administration of 50 mg/kg dose through subcutaneous route,,BAO_0000218,4186,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623754,1969.0,8899,Rattus norvegicus,,10116.0,N,Plasma,1,,Maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,,BAO_0000218,2774,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623755,1969.0,8900,Rattus norvegicus,,10116.0,N,Plasma,1,,Maximum concentration in rat plasma was determined,,BAO_0000218,1742,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623756,,8901,Rattus norvegicus,,10116.0,N,,1,,Maximum concentration in rats,,BAO_0000218,3169,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623757,,8902,Rattus norvegicus,,10116.0,N,,1,,Maximum concentration in rats at 1-2 hours,,BAO_0000218,3169,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623758,,8903,Rattus norvegicus,,10116.0,N,,1,,Maximum concentration in rats at 1 hr was determined when dosed at 20 mg/Kg perorally,,BAO_0000218,2081,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623759,955.0,8904,Rattus norvegicus,,10116.0,N,Brain,1,,Maximum concentration in whole brain at 30 min following 24 mg/kg subcutaneous dose in rats,,BAO_0000218,3307,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623760,,8905,Rattus norvegicus,,10116.0,N,,1,,Maximum concentration at the dose of 2 mg/kg in rat,,BAO_0000218,4727,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623761,,8906,Rattus norvegicus,,10116.0,N,,1,,Maximum concentration was evaluated in rats,,BAO_0000218,6597,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623762,1969.0,8907,Rattus norvegicus,,10116.0,N,Plasma,1,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 10 mg/kg to a fasting rat,,BAO_0000218,16365,
In vivo,,A,,Intermediate,1,,50597,CHEMBL877594,1969.0,8908,Rattus norvegicus,,10116.0,N,Plasma,1,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 1 mg/kg to a fasting rat,,BAO_0000218,16365,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623763,1969.0,8909,Rattus norvegicus,,10116.0,N,Plasma,1,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 30 mg/kg,,BAO_0000218,16365,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623764,1969.0,8910,Rattus norvegicus,,10116.0,N,Plasma,1,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg,,BAO_0000218,16365,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623765,1969.0,8911,Rattus norvegicus,,10116.0,N,Plasma,1,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg to a fasting rat,,BAO_0000218,16365,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623766,178.0,8912,Rattus norvegicus,,10116.0,N,Blood,1,,Maximum concentration value was evaluated for high sustained blood levels in rat after 1 hr of administration,,BAO_0000218,2591,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623767,178.0,8913,Rattus norvegicus,,10116.0,N,Blood,1,,Maximum concentration value was evaluated for high sustained blood levels in rat after 2 hr of administration,,BAO_0000218,2591,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623768,178.0,8914,Rattus norvegicus,,10116.0,N,Blood,1,,Maximum concentration value was evaluated for high sustained blood levels in rat after 30 min of administration,,BAO_0000218,2591,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623769,1969.0,8915,Rattus norvegicus,,10116.0,N,Plasma,1,,Maximum plasma concentration (Cmax) of compound (19.2 mg/kg) after po administration was determined Sprague-Dawley rat,,BAO_0000218,5978,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623770,1969.0,8916,Rattus norvegicus,,10116.0,N,Plasma,1,,Maximum plasma concentration (Cmax) of compound (19.76 mg/kg) after po administration was determined Sprague-Dawley rat,,BAO_0000218,5978,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623771,1969.0,8917,Rattus norvegicus,,10116.0,N,Plasma,1,,Maximum plasma concentration (Cmax) of compound (20.73 mg/kg) after po administration was determined Sprague-Dawley rat,,BAO_0000218,5978,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623772,1969.0,8918,Rattus norvegicus,,10116.0,N,Plasma,1,,Maximum plasma concentration (Cmax) of compound (25 mg/kg) after po administration was determined Sprague-Dawley rat,,BAO_0000218,5978,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623773,1969.0,8919,Rattus norvegicus,,10116.0,N,Plasma,1,,Maximum plasma concentration (Cmax) of compound (9.83 mg/kg) after iv administration was determined Sprague-Dawley rat,,BAO_0000218,5978,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623774,1969.0,8920,Rattus norvegicus,,10116.0,N,Plasma,1,,Maximum plasma concentration (Cmax) of compound (9.84 mg/kg) after iv administration was determined Sprague-Dawley rat,,BAO_0000218,5978,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623775,1969.0,8921,Rattus norvegicus,,10116.0,N,Plasma,1,,Maximum plasma concentration (Cmax) of compound (9.92 mg/kg) after iv administration was determined Sprague-Dawley rat,,BAO_0000218,5978,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623776,,8922,Rattus norvegicus,,10116.0,N,,1,,Cmax in rat (PO dose),,BAO_0000218,14465,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622191,1969.0,8923,Rattus norvegicus,,10116.0,N,Plasma,1,,Maximum plasma concentration determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,BAO_0000218,4723,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622192,1969.0,8924,Rattus norvegicus,,10116.0,N,Plasma,1,,Maximum plasma concentration determined after 3 mg/kg oral administration in potassium oxonate treated rats,,BAO_0000218,4723,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622193,1969.0,8925,Rattus norvegicus,,10116.0,N,Plasma,1,,Maximum plasma concentration determined in rat,,BAO_0000218,4576,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622194,1969.0,8926,Rattus norvegicus,,10116.0,N,Plasma,1,,Maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,,BAO_0000218,12873,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622195,1969.0,8927,Rattus norvegicus,,10116.0,N,Plasma,1,,Maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,,BAO_0000218,12873,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622196,1969.0,8928,Rattus norvegicus,,10116.0,N,Plasma,1,,Maximum plasma concentration in rat,,BAO_0000218,6824,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622197,1969.0,8929,Rattus norvegicus,,10116.0,N,Plasma,1,,Maximum plasma concentration measured after intravenous bolus administration of 50 mg/kg of compound to rats,,BAO_0000218,17065,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622198,1969.0,8930,Rattus norvegicus,,10116.0,N,Plasma,1,,Maximum plasma concentration of compound present in rats at the dose of 37 mg/kg in 15 min,,BAO_0000218,2932,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622199,1969.0,8931,Rattus norvegicus,,10116.0,N,Plasma,1,,Maximum plasma concentration of compound present in rats at the dose of 38 mg/kg in 15 min,,BAO_0000218,2932,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622200,1969.0,8932,Rattus norvegicus,,10116.0,N,Plasma,1,,Maximum plasma concentration of compound was measured in rat,,BAO_0000218,2879,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622201,1969.0,8933,Rattus norvegicus,,10116.0,N,Plasma,1,,Maximum plasma concentration after 20 mg/kg oral administration in rat,,BAO_0000218,2864,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623990,1969.0,8934,Rattus norvegicus,,10116.0,N,Plasma,1,,Maximum plasma concentration after oral administration to rats,,BAO_0000218,16367,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623991,1969.0,8935,Rattus norvegicus,,10116.0,N,Plasma,1,,Maximum plasma concentration at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,,BAO_0000218,17717,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623992,1969.0,8936,Rattus norvegicus,,10116.0,N,Plasma,1,,"Maximum plasma concentration at a concentration of 3 mg/kg in rats, intravenously",,BAO_0000218,17717,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623993,1969.0,8937,Rattus norvegicus,,10116.0,N,Plasma,1,,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,,BAO_0000218,17717,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623994,1969.0,8938,Rattus norvegicus,,10116.0,N,Plasma,1,,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with control,,BAO_0000218,17717,
In vivo,,F,,Intermediate,1,,50597,CHEMBL623995,1969.0,8939,Rattus norvegicus,,10116.0,N,Plasma,1,,Maximum plasma concentration at a dose of 100 mg/kg in Rat Plasma after iv administration,,BAO_0000218,17720,
In vivo,,F,,Intermediate,1,,50597,CHEMBL623996,1969.0,8940,Rattus norvegicus,,10116.0,N,Plasma,1,,Maximum plasma concentration at a dose of 4 mg/kg in Rat Plasma after iv administration,,BAO_0000218,17720,
In vivo,,F,,Intermediate,1,,50597,CHEMBL623997,1969.0,8941,Rattus norvegicus,,10116.0,N,Plasma,1,,Maximum plasma concentration at a dose of 50 mg/kg in Rat Plasma after iv administration,,BAO_0000218,17720,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623998,1969.0,8942,Rattus norvegicus,,10116.0,N,Plasma,1,,Maximum plasma concentration dosed orally in rats,,BAO_0000218,4516,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623999,1969.0,8943,Rattus norvegicus,,10116.0,N,Plasma,1,,Maximum plasma concentration dosed orally in rats after 6 hours,,BAO_0000218,4516,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624000,1969.0,8944,Rattus norvegicus,,10116.0,N,Plasma,1,,Maximum plasma concentration dosed orally in rats after 6 hours; ND is not detected,,BAO_0000218,4516,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624001,1969.0,8945,Rattus norvegicus,,10116.0,N,Plasma,1,,Maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,,BAO_0000218,5199,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624002,1969.0,8946,Rattus norvegicus,,10116.0,N,Plasma,1,,Maximum plasma concentration in rat after po administration,,BAO_0000218,17538,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624003,1969.0,8947,Rattus norvegicus,,10116.0,N,Plasma,1,,"Maximum plasma concentration in rats at 10 mg/kg, p.o. dose",,BAO_0000218,6685,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624004,1969.0,8948,Rattus norvegicus,,10116.0,N,Plasma,1,,"Maximum plasma concentration in rats at 20mg/kg, i.p. dose",,BAO_0000218,6685,
,,A,,Intermediate,1,,50597,CHEMBL624005,948.0,8949,Rattus norvegicus,,10116.0,N,Heart,1,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL624006,948.0,8950,Rattus norvegicus,,10116.0,N,Heart,1,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL624007,948.0,8951,Rattus norvegicus,,10116.0,N,Heart,1,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL624008,948.0,8952,Rattus norvegicus,,10116.0,N,Heart,1,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL624009,948.0,8953,Rattus norvegicus,,10116.0,N,Heart,1,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL874387,948.0,8954,Rattus norvegicus,,10116.0,N,Heart,1,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL624010,948.0,8955,Rattus norvegicus,,10116.0,N,Heart,1,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL624011,948.0,8956,Rattus norvegicus,,10116.0,N,Heart,1,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL624012,948.0,8957,Rattus norvegicus,,10116.0,N,Heart,1,,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL624013,948.0,8958,Rattus norvegicus,,10116.0,N,Heart,1,,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL624736,948.0,8959,Rattus norvegicus,,10116.0,N,Heart,1,,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL624737,948.0,8960,Rattus norvegicus,,10116.0,N,Heart,1,,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL624738,948.0,8961,Rattus norvegicus,,10116.0,N,Heart,1,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL624739,948.0,8962,Rattus norvegicus,,10116.0,N,Heart,1,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL624740,948.0,8963,Rattus norvegicus,,10116.0,N,Heart,1,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL624896,948.0,8964,Rattus norvegicus,,10116.0,N,Heart,1,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL624897,948.0,8965,Rattus norvegicus,,10116.0,N,Heart,1,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL624108,948.0,8966,Rattus norvegicus,,10116.0,N,Heart,1,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL624109,948.0,8967,Rattus norvegicus,,10116.0,N,Heart,1,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL624110,948.0,8968,Rattus norvegicus,,10116.0,N,Heart,1,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL624111,948.0,8969,Rattus norvegicus,,10116.0,N,Heart,1,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL624112,948.0,8970,Rattus norvegicus,,10116.0,N,Heart,1,,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL624113,948.0,8971,Rattus norvegicus,,10116.0,N,Heart,1,,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL619709,948.0,8972,Rattus norvegicus,,10116.0,N,Heart,1,,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL619710,948.0,8973,Rattus norvegicus,,10116.0,N,Heart,1,,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL619711,2113.0,8974,Rattus norvegicus,,10116.0,N,Kidney,1,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL619712,2113.0,8975,Rattus norvegicus,,10116.0,N,Kidney,1,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL619713,2113.0,8976,Rattus norvegicus,,10116.0,N,Kidney,1,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL619714,2113.0,8977,Rattus norvegicus,,10116.0,N,Kidney,1,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL619715,2113.0,8978,Rattus norvegicus,,10116.0,N,Kidney,1,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL619716,2113.0,8979,Rattus norvegicus,,10116.0,N,Kidney,1,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL619717,2113.0,8980,Rattus norvegicus,,10116.0,N,Kidney,1,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL619718,2113.0,8981,Rattus norvegicus,,10116.0,N,Kidney,1,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL619719,2113.0,8982,Rattus norvegicus,,10116.0,N,Kidney,1,,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL875329,2113.0,8983,Rattus norvegicus,,10116.0,N,Kidney,1,,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL619720,2113.0,8984,Rattus norvegicus,,10116.0,N,Kidney,1,,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL619721,2113.0,8985,Rattus norvegicus,,10116.0,N,Kidney,1,,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL619722,2113.0,8986,Rattus norvegicus,,10116.0,N,Kidney,1,,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL619723,2113.0,8987,Rattus norvegicus,,10116.0,N,Kidney,1,,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL619724,2113.0,8988,Rattus norvegicus,,10116.0,N,Kidney,1,,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL619725,2113.0,8989,Rattus norvegicus,,10116.0,N,Kidney,1,,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL619726,2113.0,8990,Rattus norvegicus,,10116.0,N,Kidney,1,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL619727,2113.0,8991,Rattus norvegicus,,10116.0,N,Kidney,1,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL619728,2113.0,8992,Rattus norvegicus,,10116.0,N,Kidney,1,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL619729,2113.0,8993,Rattus norvegicus,,10116.0,N,Kidney,1,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,BAO_0000218,16435,
In vivo,,A,,Intermediate,1,,50597,CHEMBL619730,2385.0,8994,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,11977,
In vivo,,A,,Intermediate,1,,50597,CHEMBL619731,2385.0,8995,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,11977,
In vivo,,A,,Intermediate,1,,50597,CHEMBL619732,2385.0,8996,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,BAO_0000218,11977,
In vivo,,A,,Intermediate,1,,50597,CHEMBL619733,2385.0,8997,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,11977,
In vivo,,A,,Intermediate,1,,50597,CHEMBL619734,2385.0,8998,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,11977,
In vivo,,A,,Intermediate,1,,50597,CHEMBL619735,14.0,8999,Rattus norvegicus,,10116.0,N,Zone of skin,1,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,11977,
In vivo,,A,,Intermediate,1,,50597,CHEMBL875330,14.0,9000,Rattus norvegicus,,10116.0,N,Zone of skin,1,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,11977,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628465,14.0,9001,Rattus norvegicus,,10116.0,N,Zone of skin,1,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,BAO_0000218,11977,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628466,14.0,9002,Rattus norvegicus,,10116.0,N,Zone of skin,1,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,11977,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628467,14.0,9003,Rattus norvegicus,,10116.0,N,Zone of skin,1,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,11977,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628468,2106.0,9004,Rattus norvegicus,,10116.0,N,Spleen,1,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,11977,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628469,2106.0,9005,Rattus norvegicus,,10116.0,N,Spleen,1,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,11977,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628470,2106.0,9006,Rattus norvegicus,,10116.0,N,Spleen,1,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,BAO_0000218,11977,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628471,2106.0,9007,Rattus norvegicus,,10116.0,N,Spleen,1,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,11977,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628472,2106.0,9008,Rattus norvegicus,,10116.0,N,Spleen,1,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,11977,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625191,2046.0,9009,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,11977,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625192,2046.0,9010,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,11977,
In vivo,,A,,Intermediate,1,,50597,CHEMBL875337,2046.0,9011,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,BAO_0000218,11977,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626341,2046.0,9012,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,11977,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626342,2046.0,9013,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,11977,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621943,2107.0,9014,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,11977,
,,A,,Intermediate,1,,50597,CHEMBL621944,,9015,Rattus norvegicus,,10116.0,N,,1,,Half life in rats,,BAO_0000218,3748,
,,A,,Intermediate,1,,50597,CHEMBL621945,,9016,Rattus norvegicus,,10116.0,N,,1,,Mean percent inhibition of joint damage reduction in fasted rats at 35 mg/kg administered orally twice daily,,BAO_0000218,15765,
,,A,,Intermediate,1,,50597,CHEMBL621946,,9017,Rattus norvegicus,,10116.0,N,,1,,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver),,BAO_0000218,4871,
,,A,,Intermediate,1,,50597,CHEMBL621947,,9018,Rattus norvegicus,,10116.0,N,,1,,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver); ND=Not determined,,BAO_0000218,4871,
,,A,,Intermediate,1,,50597,CHEMBL621948,,9019,Rattus norvegicus,,10116.0,N,,1,,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver),,BAO_0000218,4872,
,,A,,Intermediate,1,,50597,CHEMBL621949,,9020,Rattus norvegicus,,10116.0,N,,1,,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver); ND=Not determined,,BAO_0000218,4872,
,,A,,Intermediate,1,,50597,CHEMBL621950,,9021,Rattus norvegicus,,10116.0,N,,1,,Rate constant (k) of clearance from isolated perfused rat liver (IPRL),,BAO_0000218,5413,
,,A,,Intermediate,1,,50597,CHEMBL621951,,9022,Rattus norvegicus,,10116.0,N,,1,,Tested for rate of clearance from isolated perfused rat liver (IPRL) and expressed in terms of rate constant (k); not determined,,BAO_0000218,5413,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621952,178.0,9023,Rattus norvegicus,,10116.0,N,Blood,1,,Maximal blood concentration after oral administration of a 30 uM/kg dose of compound,,BAO_0000218,15272,
,,A,,Intermediate,1,,50597,CHEMBL621953,2107.0,9024,Rattus norvegicus,,10116.0,N,Liver,1,,Stability (%) in rat liver microsomes,,BAO_0000218,4689,
,,A,,Intermediate,1,,50597,CHEMBL621954,,9025,Rattus norvegicus,,10116.0,N,,1,,Area under curve was calculated after intravenous administration,,BAO_0000218,6057,
,,A,,Intermediate,1,,50597,CHEMBL621955,,9026,Rattus norvegicus,,10116.0,N,,1,,Area under the curve was calculated after iv administration in rat,,BAO_0000218,6057,
,,A,,Intermediate,1,,50597,CHEMBL621956,,9027,Rattus norvegicus,,10116.0,N,,1,,Area under the curve was calculated in rat after peroral administration,,BAO_0000218,6057,
,,A,,Intermediate,1,,50597,CHEMBL621957,,9028,Rattus norvegicus,,10116.0,N,,1,,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,,BAO_0000218,6211,
,,A,,Intermediate,1,,50597,CHEMBL621958,,9029,Rattus norvegicus,,10116.0,N,,1,,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral dose of 2 mg/Kg,,BAO_0000218,5710,
,,A,,Intermediate,1,,50597,CHEMBL621959,,9030,Rattus norvegicus,,10116.0,N,,1,,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral of 2 mg/Kg,,BAO_0000218,5710,
,,A,,Intermediate,1,,50597,CHEMBL621960,,9031,Rattus norvegicus,,10116.0,N,,1,,Dose-normalized area under curve in rat (i.v.) at 0.5 mpk,,BAO_0000218,17853,
,,A,,Intermediate,1,,50597,CHEMBL621961,,9032,Rattus norvegicus,,10116.0,N,,1,,Dose-normalized area under curve in rat (p.o.) at 2.0 mpk,,BAO_0000218,17853,
,,A,,Intermediate,1,,50597,CHEMBL621962,,9033,Rattus norvegicus,,10116.0,N,,1,,p value of the compound,,BAO_0000218,15765,
,,F,,Intermediate,1,,50597,CHEMBL876787,,9034,Rattus norvegicus,,10116.0,N,,1,,p value of the compound,,BAO_0000218,15765,
,,A,,Intermediate,1,,50597,CHEMBL621963,,9035,Rattus norvegicus,,10116.0,N,,1,,p value of the compound,,BAO_0000218,15765,
,,A,,Intermediate,1,,50597,CHEMBL622637,945.0,9036,Rattus norvegicus,,10116.0,N,Stomach,1,,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,BAO_0000218,6175,
,,A,,Intermediate,1,,50597,CHEMBL622638,945.0,9037,Rattus norvegicus,,10116.0,N,Stomach,1,,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (20 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,BAO_0000218,6175,
,,A,,Intermediate,1,,50597,CHEMBL626561,945.0,9038,Rattus norvegicus,,10116.0,N,Stomach,1,,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,BAO_0000218,6175,
,,F,,Autocuration,0,,22224,CHEMBL626562,,9039,Oryctolagus cuniculus,,9986.0,U,,1,,Negative log of minimum effective dose (moles per kilogram) in rabbits (hypnotic),,BAO_0000019,7991,
,,A,,Autocuration,0,,22224,CHEMBL626563,,9040,Oryctolagus cuniculus,,9986.0,U,,1,,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg ( 0-4 hr ),,BAO_0000218,429,
,,A,,Autocuration,0,,22224,CHEMBL626564,,9041,Oryctolagus cuniculus,,9986.0,U,,1,,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg (0-4 hr ),,BAO_0000218,429,
In vivo,,A,,Autocuration,0,,22224,CHEMBL626565,,9042,Oryctolagus cuniculus,,9986.0,U,,1,,Clearance was measured at the concentration of 1.11 mg/kg in rabbit blood sample,,BAO_0000218,6253,
In vivo,,A,,Autocuration,0,,22224,CHEMBL626566,,9043,Oryctolagus cuniculus,,9986.0,U,,1,,Clearance was measured at the concentration of 2.0 mg/kg in rabbit blood sample,,BAO_0000218,6253,
In vivo,,A,,Autocuration,0,,22224,CHEMBL626567,,9044,Oryctolagus cuniculus,,9986.0,U,,1,,Clearance rate in rabbits,,BAO_0000218,3615,
In vivo,,A,,Autocuration,0,,22224,CHEMBL626568,,9045,Oryctolagus cuniculus,,9986.0,U,,1,,Plasma clearance was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,,BAO_0000218,4059,
In vivo,,A,,Autocuration,0,,22224,CHEMBL626569,,9046,Oryctolagus cuniculus,,9986.0,U,,1,,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,,BAO_0000218,5124,
In vivo,,A,,Autocuration,0,,22224,CHEMBL626570,,9047,Oryctolagus cuniculus,,9986.0,U,,1,,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,,BAO_0000218,5124,
In vivo,,A,,Autocuration,0,,22224,CHEMBL626571,,9048,Oryctolagus cuniculus,,9986.0,U,,1,,Clearance in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,,BAO_0000218,5124,
In vivo,,A,,Autocuration,0,,22224,CHEMBL626572,,9049,Oryctolagus cuniculus,,9986.0,U,,1,,Evaluated for pharmacokinetic parameter Cmax in rabbit at the dose 20 mg/kg,,BAO_0000218,429,
In vivo,,A,,Autocuration,0,,22224,CHEMBL626573,1969.0,9050,Oryctolagus cuniculus,,9986.0,U,Plasma,1,,Maximum plasma concentration was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,,BAO_0000218,4059,
,,A,,Autocuration,0,,22224,CHEMBL626574,2107.0,9051,Oryctolagus cuniculus,,9986.0,U,Liver,1,,Oxidation by dutch rabbit liver microsomes in presence of NADPH/O2,Microsomes,BAO_0000251,9659,
,,A,,Autocuration,0,,22224,CHEMBL626575,2107.0,9052,Oryctolagus cuniculus,,9986.0,U,Liver,1,,Oxidation by dutch rabbit liver microsomes in presence of cumene hydroperoxide,Microsomes,BAO_0000251,9659,
,,A,,Autocuration,0,,22224,CHEMBL626576,,9053,Oryctolagus cuniculus,,9986.0,U,,1,,Dose at which bioavailability of intravenously administered compound was tested in rabbit,,BAO_0000218,3639,
,,A,,Autocuration,0,,22224,CHEMBL626577,,9054,Oryctolagus cuniculus,,9986.0,U,,1,,Dose at which bioavailability of perorally administered compound was tested in rabbit,,BAO_0000218,3639,
In vivo,,A,,Autocuration,0,,22224,CHEMBL626578,,9055,Oryctolagus cuniculus,,9986.0,U,,1,,The compound was tested for its bioavailability in rabbit (by oral dosage).,,BAO_0000218,3639,
In vivo,,A,,Autocuration,0,,22224,CHEMBL625263,,9056,Oryctolagus cuniculus,,9986.0,U,,1,,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,,BAO_0000218,5124,
In vivo,,A,,Autocuration,0,,22224,CHEMBL625264,,9057,Oryctolagus cuniculus,,9986.0,U,,1,,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,,BAO_0000218,5124,
In vivo,,A,,Autocuration,0,,22224,CHEMBL625265,,9058,Oryctolagus cuniculus,,9986.0,U,,1,,Mean retention time in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,,BAO_0000218,5124,
,,A,,Autocuration,0,,22224,CHEMBL625266,,9059,Oryctolagus cuniculus,,9986.0,U,,1,,Metabolism of compound in rabbit S9 microsomes ('+''indicates <20% largest observed peak),Microsomes,BAO_0000251,14294,
,,A,,Autocuration,0,,22224,CHEMBL876796,,9060,Oryctolagus cuniculus,,9986.0,U,,1,,Metabolism of compound in rabbit S9 microsomes ('++++' indicates largest observed peak),Microsomes,BAO_0000251,14294,
In vivo,,A,,Autocuration,0,,22224,CHEMBL625267,,9061,Oryctolagus cuniculus,,9986.0,U,,1,,Evaluated for pharmacokinetic parameter half-life in rabbit at the dose 20 mg/kg,,BAO_0000218,429,
In vivo,,A,,Autocuration,0,,22224,CHEMBL625268,1969.0,9062,Oryctolagus cuniculus,,9986.0,U,Plasma,1,,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,,BAO_0000218,5124,
In vivo,,A,,Autocuration,0,,22224,CHEMBL625269,1969.0,9063,Oryctolagus cuniculus,,9986.0,U,Plasma,1,,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,,BAO_0000218,5124,
In vivo,,A,,Autocuration,0,,22224,CHEMBL624689,1969.0,9064,Oryctolagus cuniculus,,9986.0,U,Plasma,1,,Plasma half-life in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,,BAO_0000218,5124,
In vivo,,A,,Autocuration,0,,22224,CHEMBL624690,,9065,Oryctolagus cuniculus,,9986.0,U,,1,,Evaluated for pharmacokinetic parameter tmax in rabbit at the dose 20 mg/kg,,BAO_0000218,429,
,,A,,Autocuration,0,,22224,CHEMBL624691,1088.0,9066,Oryctolagus cuniculus,,9986.0,U,Urine,1,,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg ( 0-24 hr ),,BAO_0000218,429,
,,A,,Autocuration,0,,22224,CHEMBL624692,1088.0,9067,Oryctolagus cuniculus,,9986.0,U,Urine,1,,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg (0-24 hr),,BAO_0000218,429,
In vivo,,A,,Autocuration,0,,22224,CHEMBL624693,,9068,Oryctolagus cuniculus,,9986.0,U,,1,,The compound was evaluated for volume of distribution in rabbit at a dose of 5 mg/kg/h administered i.v.,,BAO_0000218,4059,
In vivo,,A,,Autocuration,0,,22224,CHEMBL624694,,9069,Oryctolagus cuniculus,,9986.0,U,,1,,Volume of distribution after intravenous administration of 1 mg/kg/h in dog,,BAO_0000218,4137,
In vitro,,A,,Autocuration,0,,22224,CHEMBL877596,,9070,Oryctolagus cuniculus,,9986.0,U,,1,,In vitro Biological half-life in crude homogenate of rabbit renal cortex,,BAO_0000221,11672,
,,A,,Autocuration,0,,22224,CHEMBL624695,,9071,Oryctolagus cuniculus,,9986.0,U,,1,,Time within which only 10% of the drug was degraded,,BAO_0000019,12886,
,,A,,Autocuration,0,,22224,CHEMBL624696,2107.0,9072,Oryctolagus cuniculus,,9986.0,U,Liver,1,,Half life period in rabbit liver homogenate,,BAO_0000221,3853,
,,A,,Autocuration,0,,22224,CHEMBL624697,,9073,Oryctolagus cuniculus,,9986.0,U,,1,,Half life value in rabbits,,BAO_0000019,3615,
In vivo,,A,,Autocuration,0,,22224,CHEMBL624698,178.0,9074,Oryctolagus cuniculus,,9986.0,U,Blood,1,,Half-life was measured at the concentration of 1.11 mg/kg in rabbit blood sample,,BAO_0000218,6253,
In vivo,,A,,Autocuration,0,,22224,CHEMBL624699,178.0,9075,Oryctolagus cuniculus,,9986.0,U,Blood,1,,Half-life was measured at the concentration of 2.0 mg/kg in rabbit blood sample,,BAO_0000218,6253,
In vivo,,A,,Autocuration,0,,22224,CHEMBL624700,,9076,Oryctolagus cuniculus,,9986.0,U,,1,,Half-life period in rabbits following intravenous administration at 2 mg/kg,,BAO_0000218,6077,
,,A,,Intermediate,1,,50597,CHEMBL622903,1969.0,9077,Rattus norvegicus,,10116.0,N,Plasma,1,,AUC 0-8 hr value in rats at 10 mg/kg,,BAO_0000218,17617,
,,A,,Intermediate,1,,50597,CHEMBL622904,1969.0,9078,Rattus norvegicus,,10116.0,N,Plasma,1,,AUC after administration at 2000 mg/kg/day in rats,,BAO_0000218,17594,
,,A,,Intermediate,1,,50597,CHEMBL622905,1969.0,9079,Rattus norvegicus,,10116.0,N,Plasma,1,,AUC of compound for a 2 mpk po dose of the sodium salt in rats.,,BAO_0000218,6149,
,,A,,Intermediate,1,,50597,CHEMBL622906,1969.0,9080,Rattus norvegicus,,10116.0,N,Plasma,1,,AUC at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,BAO_0000218,17260,
,,A,,Intermediate,1,,50597,CHEMBL622907,1969.0,9081,Rattus norvegicus,,10116.0,N,Plasma,1,,AUC at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,BAO_0000218,17260,
,,A,,Intermediate,1,,50597,CHEMBL622908,1969.0,9082,Rattus norvegicus,,10116.0,N,Plasma,1,,AUC in rat after oral administration at 10.5 mg/kg dose,,BAO_0000218,6644,
,,A,,Intermediate,1,,50597,CHEMBL622909,1969.0,9083,Rattus norvegicus,,10116.0,N,Plasma,1,,AUC in rat after oral administration at 11.2 mg/kg dose,,BAO_0000218,6644,
,,A,,Intermediate,1,,50597,CHEMBL622910,1969.0,9084,Rattus norvegicus,,10116.0,N,Plasma,1,,AUC in rat after oral administration at 9.7 mg/kg dose,,BAO_0000218,6644,
,,A,,Intermediate,1,,50597,CHEMBL622911,955.0,9085,Rattus norvegicus,,10116.0,N,Brain,1,,AUC in rat brain after oral administration at 10 mg/kg,,BAO_0000218,6495,
,,A,,Intermediate,1,,50597,CHEMBL622912,1969.0,9086,Rattus norvegicus,,10116.0,N,Plasma,1,,AUC in rat p.o.,,BAO_0000218,6504,
,,A,,Intermediate,1,,50597,CHEMBL622913,1969.0,9087,Rattus norvegicus,,10116.0,N,Plasma,1,,AUC in rat p.o. at 20 mg/kg concentration,,BAO_0000218,17686,
,,A,,Intermediate,1,,50597,CHEMBL622914,1969.0,9088,Rattus norvegicus,,10116.0,N,Plasma,1,,AUC in rat plasma after oral administration at 10 mg/kg,,BAO_0000218,6495,
,,A,,Intermediate,1,,50597,CHEMBL622915,1969.0,9089,Rattus norvegicus,,10116.0,N,Plasma,1,,AUC in rats,,BAO_0000218,216,
,,A,,Intermediate,1,,50597,CHEMBL622916,1969.0,9090,Rattus norvegicus,,10116.0,N,Plasma,1,,AUC value after IV dose at a dose of 5 mg/kg in rats.,,BAO_0000218,1908,
,,A,,Intermediate,1,,50597,CHEMBL622917,1969.0,9091,Rattus norvegicus,,10116.0,N,Plasma,1,,AUC value after oral dose at a dose of 10 mg/kg in rats.,,BAO_0000218,1908,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622918,1969.0,9092,Rattus norvegicus,,10116.0,N,Plasma,1,,"Maximum plasma concentration in rats at 2 mg/kg, i.v. dose; n/a: not applicable",,BAO_0000218,6685,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622919,1969.0,9093,Rattus norvegicus,,10116.0,N,Plasma,1,,Maximum plasma concentration in rats when a oral dose of 200 mg/kg was given,,BAO_0000218,216,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622920,1969.0,9094,Rattus norvegicus,,10116.0,N,Plasma,1,,Maximum plasma concentration was evaluated in rat,,BAO_0000218,6049,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622921,1969.0,9095,Rattus norvegicus,,10116.0,N,Plasma,1,,Maximum plasma concentration was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,,BAO_0000218,2463,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622922,1969.0,9096,Rattus norvegicus,,10116.0,N,Plasma,1,,Maximum plasma concentration reached by compound was determined after 2 mg/kg (p.o.) administration,,BAO_0000218,6679,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622923,1969.0,9097,Rattus norvegicus,,10116.0,N,Plasma,1,,Maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,,BAO_0000218,6681,
In vivo,,A,,Intermediate,1,,50597,CHEMBL877604,1969.0,9098,Rattus norvegicus,,10116.0,N,Plasma,1,,Maximum plasma concentration was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,,BAO_0000218,4890,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622924,1969.0,9099,Rattus norvegicus,,10116.0,N,Plasma,1,,Maximum plasma concentration was evaluated in rats at an intravenous dose of 3 mg/kg,,BAO_0000218,6410,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622925,1969.0,9100,Rattus norvegicus,,10116.0,N,Plasma,1,,Maximum plasma concentration was evaluated in rats at an oral dose of 30 mg/kg,,BAO_0000218,6410,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622926,1969.0,9101,Rattus norvegicus,,10116.0,N,Plasma,1,,Maximum plasma concentration was measured when a dose of 1 mg/kg is administered orally,,BAO_0000218,16366,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623625,1969.0,9102,Rattus norvegicus,,10116.0,N,Plasma,1,,Maximum plasma concentration (Cmax) in rat (in vivo) at a dose of 10 mg/kg,,BAO_0000218,6227,
In vivo,,A,,Expert,1,,50597,CHEMBL623626,1969.0,9103,Rattus norvegicus,,10116.0,N,Plasma,1,,Maximum plasma drug concentration of compound determined in rat after iv administration at a dose of 10 mg/kg,,BAO_0000218,3598,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623627,1969.0,9104,Rattus norvegicus,,10116.0,N,Plasma,1,,Maximum plasma drug concentration was determined,,BAO_0000218,1465,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623628,,9105,Rattus norvegicus,,10116.0,N,,1,,Maximum concentration by intravenous administration of 3.4 mg/kg in rat,,BAO_0000218,4368,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623629,1969.0,9106,Rattus norvegicus,,10116.0,N,Plasma,1,,Mean peak plasma concentration was observed after intravenous administration in rat,,BAO_0000218,15662,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623630,1969.0,9107,Rattus norvegicus,,10116.0,N,Plasma,1,,Mean peak plasma concentration was observed after oral administration in rat,,BAO_0000218,15662,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623804,,9108,Rattus norvegicus,,10116.0,N,,1,,Peak concentration (Cmax) at a dose of 10 mg/kg in rats,,BAO_0000218,5355,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623805,,9109,Rattus norvegicus,,10116.0,N,,1,,Peak concentration (Cmax) at a dose of 20 mg/kg in rats,,BAO_0000218,5355,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623806,1969.0,9110,Rattus norvegicus,,10116.0,N,Plasma,1,,Peak oral plasma concentration was determined in rats by oral administration,,BAO_0000218,1567,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623807,1969.0,9111,Rattus norvegicus,,10116.0,N,Plasma,1,,Peak plasma concentration (Cmax) was determined,,BAO_0000218,4026,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623808,1969.0,9112,Rattus norvegicus,,10116.0,N,Plasma,1,,Peak plasma concentration (Cmax) following an oral dose of 20 mg/kg in rats,,BAO_0000218,6193,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623809,1969.0,9113,Rattus norvegicus,,10116.0,N,Plasma,1,,Peak plasma concentration (Cmax) in rats,,BAO_0000218,4026,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623810,1969.0,9114,Rattus norvegicus,,10116.0,N,Plasma,1,,Peak plasma concentration at 1 mg/kg peroral administration,,BAO_0000218,6485,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623811,1969.0,9115,Rattus norvegicus,,10116.0,N,Plasma,1,,Peak plasma concentration in rat,,BAO_0000218,17655,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623812,1969.0,9116,Rattus norvegicus,,10116.0,N,Plasma,1,,"Pharmacokinetic Parameter, Cmax is observed maximum plasma concentration in Female Wistar Rats at 100 mg/kg by po administration",,BAO_0000218,14941,
In vivo,,A,,Intermediate,1,,50597,CHEMBL877605,,9117,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic parameter Cmax was measured after administration into rat at 10 mg/kg,,BAO_0000218,5394,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623813,,9118,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic property (Cmax) in rat,,BAO_0000218,4408,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623814,,9119,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic property (Cmax) was measured in rat at the dose of 0.32 mg/kg p.o.,,BAO_0000218,5983,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623815,,9120,Rattus norvegicus,,10116.0,N,,1,,Cmax in rat after 3mg/kg oral dose,,BAO_0000218,4878,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623816,,9121,Rattus norvegicus,,10116.0,N,,1,,Clearance in Sprague-Dawley rats after 2mg/kg oral dose,,BAO_0000218,5862,Sprague-Dawley
In vivo,,A,,Intermediate,1,,50597,CHEMBL623145,,9122,Rattus norvegicus,,10116.0,N,,1,,Cmax in rats after 20 mg/kg oral dose,,BAO_0000218,4517,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623146,1969.0,9123,Rattus norvegicus,,10116.0,N,Plasma,1,,Cmax in rat plasma after 30mg/kg oral dose,,BAO_0000218,5932,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623147,1969.0,9124,Rattus norvegicus,,10116.0,N,Plasma,1,,Plasma concentration after oral administration of 100 mg/kg to rats,,BAO_0000218,5436,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623042,955.0,9125,Rattus norvegicus,,10116.0,N,Brain,1,,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,,BAO_0000218,4910,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623043,,9126,Rattus norvegicus,,10116.0,N,,1,,Tested for the Cmax in rat at 10 mg/kg per orally,,BAO_0000218,4950,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623044,,9127,Rattus norvegicus,,10116.0,N,,1,,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",,BAO_0000218,15078,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623045,,9128,Rattus norvegicus,,10116.0,N,,1,,"The Cmax value in male wistar rat at 100 mg/kg, p.o. dose",,BAO_0000218,15078,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623046,,9129,Rattus norvegicus,,10116.0,N,,1,,Bioavailability as oral Cmax in rats at 30 mins,,BAO_0000218,3360,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623226,,9130,Rattus norvegicus,,10116.0,N,,1,,Bioavailability as oral Cmax in rats at 6hr,,BAO_0000218,3360,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623227,,9131,Rattus norvegicus,,10116.0,N,,1,,The maximum concentration of compound was measured at the dose of 100 umol/kg,,BAO_0000218,15022,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623228,,9132,Rattus norvegicus,,10116.0,N,,1,,The maximum concentration of compound was measured at the dose of 300 umol/kg,,BAO_0000218,15022,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623229,,9133,Rattus norvegicus,,10116.0,N,,1,,The maximum concentration of compound was measured at the dose of 30 umol/kg,,BAO_0000218,15022,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623230,1969.0,9134,Rattus norvegicus,,10116.0,N,Plasma,1,,The maximum plasma levels for the compounds were determined by LC-MS.,,BAO_0000218,5160,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623231,1969.0,9135,Rattus norvegicus,,10116.0,N,Plasma,1,,mean peak plasma concentration was observed after intravenous administration in rat,,BAO_0000218,15662,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623232,1969.0,9136,Rattus norvegicus,,10116.0,N,Plasma,1,,mean peak plasma concentration was observed after oral administration in rat,,BAO_0000218,15662,
,,A,,Intermediate,1,,50597,CHEMBL623233,,9137,Rattus norvegicus,,10116.0,N,,1,,Concentration in the plasma after intravenous administration of 1 mg/kg in rat,,BAO_0000218,4709,
,,A,,Intermediate,1,,50597,CHEMBL623234,,9138,Rattus norvegicus,,10116.0,N,,1,,Concentration in plasma (portal) following oral dose in rats at 0.25 hr,,BAO_0000218,3535,
,,A,,Intermediate,1,,50597,CHEMBL623235,,9139,Rattus norvegicus,,10116.0,N,,1,,Concentration in plasma (portal) following oral dose in rats at 1 hr,,BAO_0000218,3535,
,,A,,Intermediate,1,,50597,CHEMBL623236,,9140,Rattus norvegicus,,10116.0,N,,1,,Concentration in plasma (portal) following oral dose in rats at 2 hr,,BAO_0000218,3535,
,,A,,Intermediate,1,,50597,CHEMBL623237,,9141,Rattus norvegicus,,10116.0,N,,1,,Concentration in plasma (systemic) following oral dose in rats at 0.25 hr,,BAO_0000218,3535,
,,A,,Intermediate,1,,50597,CHEMBL623238,,9142,Rattus norvegicus,,10116.0,N,,1,,Concentration in plasma (systemic) following oral dose in rats at 1 hr,,BAO_0000218,3535,
,,A,,Intermediate,1,,50597,CHEMBL623239,,9143,Rattus norvegicus,,10116.0,N,,1,,Concentration in plasma (systemic) following oral dose in rats at 2 hr,,BAO_0000218,3535,
In vivo,,A,,Intermediate,0,,22224,CHEMBL623240,1969.0,9144,Rattus norvegicus,,10116.0,U,Plasma,1,,Compound was evaluated for the plasma concentration in rats versus time curves (AUC) in vivo,,BAO_0000218,5005,
,,A,,Intermediate,1,,50597,CHEMBL623241,1898.0,9145,Rattus norvegicus,,10116.0,N,Hypothalamus,1,,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 2 hours",,BAO_0000218,6326,
,,A,,Intermediate,1,,50597,CHEMBL623242,1898.0,9146,Rattus norvegicus,,10116.0,N,Hypothalamus,1,,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 6 hours",,BAO_0000218,6326,
,,A,,Intermediate,1,,50597,CHEMBL874394,,9147,Rattus norvegicus,,10116.0,N,,1,,"Concentration (30 mg/kg, p.o.) in rat plasma after 2 hours",,BAO_0000218,6326,
,,A,,Intermediate,1,,50597,CHEMBL623243,,9148,Rattus norvegicus,,10116.0,N,,1,,"Concentration (30 mg/kg, p.o.) in rat plasma after 6 hours",,BAO_0000218,6326,
,,A,,Intermediate,1,,50597,CHEMBL623244,,9149,Rattus norvegicus,,10116.0,N,,1,,Kidney concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,BAO_0000218,17411,
,,A,,Intermediate,1,,50597,CHEMBL623245,2113.0,9150,Rattus norvegicus,,10116.0,N,Kidney,1,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL623246,2113.0,9151,Rattus norvegicus,,10116.0,N,Kidney,1,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL623247,2113.0,9152,Rattus norvegicus,,10116.0,N,Kidney,1,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL623248,2113.0,9153,Rattus norvegicus,,10116.0,N,Kidney,1,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL623249,2113.0,9154,Rattus norvegicus,,10116.0,N,Kidney,1,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL625072,2107.0,9155,Rattus norvegicus,,10116.0,N,Liver,1,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL625073,2107.0,9156,Rattus norvegicus,,10116.0,N,Liver,1,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL625074,2107.0,9157,Rattus norvegicus,,10116.0,N,Liver,1,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL625075,2107.0,9158,Rattus norvegicus,,10116.0,N,Liver,1,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL625076,2107.0,9159,Rattus norvegicus,,10116.0,N,Liver,1,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL625077,2107.0,9160,Rattus norvegicus,,10116.0,N,Liver,1,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL625078,2107.0,9161,Rattus norvegicus,,10116.0,N,Liver,1,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL874395,2107.0,9162,Rattus norvegicus,,10116.0,N,Liver,1,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL625079,2107.0,9163,Rattus norvegicus,,10116.0,N,Liver,1,,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL625080,2107.0,9164,Rattus norvegicus,,10116.0,N,Liver,1,,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL625081,2107.0,9165,Rattus norvegicus,,10116.0,N,Liver,1,,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL625082,2107.0,9166,Rattus norvegicus,,10116.0,N,Liver,1,,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL625083,2107.0,9167,Rattus norvegicus,,10116.0,N,Liver,1,,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL625084,2107.0,9168,Rattus norvegicus,,10116.0,N,Liver,1,,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL625085,2107.0,9169,Rattus norvegicus,,10116.0,N,Liver,1,,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL625086,2107.0,9170,Rattus norvegicus,,10116.0,N,Liver,1,,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL625087,2107.0,9171,Rattus norvegicus,,10116.0,N,Liver,1,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL625088,2107.0,9172,Rattus norvegicus,,10116.0,N,Liver,1,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL622205,2107.0,9173,Rattus norvegicus,,10116.0,N,Liver,1,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL622206,2107.0,9174,Rattus norvegicus,,10116.0,N,Liver,1,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL622207,2107.0,9175,Rattus norvegicus,,10116.0,N,Liver,1,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL622366,2107.0,9176,Rattus norvegicus,,10116.0,N,Liver,1,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL622367,2107.0,9177,Rattus norvegicus,,10116.0,N,Liver,1,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL875331,2107.0,9178,Rattus norvegicus,,10116.0,N,Liver,1,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL622368,2107.0,9179,Rattus norvegicus,,10116.0,N,Liver,1,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL622369,2048.0,9180,Rattus norvegicus,,10116.0,N,Lung,1,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL622370,2048.0,9181,Rattus norvegicus,,10116.0,N,Lung,1,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL622371,2048.0,9182,Rattus norvegicus,,10116.0,N,Lung,1,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL622372,2048.0,9183,Rattus norvegicus,,10116.0,N,Lung,1,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL622373,2048.0,9184,Rattus norvegicus,,10116.0,N,Lung,1,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL622374,2048.0,9185,Rattus norvegicus,,10116.0,N,Lung,1,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL622375,2048.0,9186,Rattus norvegicus,,10116.0,N,Lung,1,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL622376,2048.0,9187,Rattus norvegicus,,10116.0,N,Lung,1,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL622377,2048.0,9188,Rattus norvegicus,,10116.0,N,Lung,1,,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL622378,2048.0,9189,Rattus norvegicus,,10116.0,N,Lung,1,,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL622379,2048.0,9190,Rattus norvegicus,,10116.0,N,Lung,1,,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL622380,2048.0,9191,Rattus norvegicus,,10116.0,N,Lung,1,,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL622381,2048.0,9192,Rattus norvegicus,,10116.0,N,Lung,1,,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL622382,2048.0,9193,Rattus norvegicus,,10116.0,N,Lung,1,,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL622383,2048.0,9194,Rattus norvegicus,,10116.0,N,Lung,1,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL875332,945.0,9195,Rattus norvegicus,,10116.0,N,Stomach,1,,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured ( 5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,BAO_0000218,6175,
,,A,,Intermediate,1,,50597,CHEMBL622384,945.0,9196,Rattus norvegicus,,10116.0,N,Stomach,1,,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,BAO_0000218,6175,
,,A,,Intermediate,1,,50597,CHEMBL622385,945.0,9197,Rattus norvegicus,,10116.0,N,Stomach,1,,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (2.5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,BAO_0000218,6175,
,,A,,Intermediate,1,,50597,CHEMBL622386,945.0,9198,Rattus norvegicus,,10116.0,N,Stomach,1,,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,BAO_0000218,6175,
,,A,,Intermediate,1,,50597,CHEMBL622387,,9199,Rattus norvegicus,,10116.0,N,,1,,The compound was tested for the plasma binding in rat,,BAO_0000218,10839,
,,A,,Intermediate,1,,50597,CHEMBL622388,,9200,Rattus norvegicus,,10116.0,N,,1,,"Plasma concentration after intravenous aministration at 1hr, (1 mg/kg, n=3)",,BAO_0000218,16459,
,,A,,Intermediate,1,,50597,CHEMBL622389,,9201,Rattus norvegicus,,10116.0,N,,1,,"Plasma concentration after intravenous aministration at 30 min. (1 mg/kg, n=3)",,BAO_0000218,16459,
,,A,,Intermediate,1,,50597,CHEMBL622390,,9202,Rattus norvegicus,,10116.0,N,,1,,"Plasma concentration after intravenous aministration at 60 min. (1 mg/kg, n=3)",,BAO_0000218,16459,
,,A,,Intermediate,1,,50597,CHEMBL622391,,9203,Rattus norvegicus,,10116.0,N,,1,,Plasma concentration after oral aministration at 1 hr. (10 mg/kg),,BAO_0000218,16459,
,,A,,Intermediate,1,,50597,CHEMBL622392,,9204,Rattus norvegicus,,10116.0,N,,1,,Plasma concentration after oral aministration at 2 hr. (10 mg/kg),,BAO_0000218,16459,
,,A,,Intermediate,1,,50597,CHEMBL622393,,9205,Rattus norvegicus,,10116.0,N,,1,,Plasma concentration after oral aministration at 4 hr. (10 mg/kg),,BAO_0000218,16459,
,,A,,Intermediate,1,,50597,CHEMBL622394,,9206,Rattus norvegicus,,10116.0,N,,1,,Plasma level at 2 hr after administration of the compound,,BAO_0000218,3278,
,,A,,Intermediate,1,,50597,CHEMBL622395,,9207,Rattus norvegicus,,10116.0,N,,1,,plasma level at 2 hr after administration of the compound,,BAO_0000218,3278,
,,A,,Intermediate,1,,50597,CHEMBL622396,1977.0,9208,Rattus norvegicus,,10116.0,N,Serum,1,,Stability in rat serum measured as % recovery at 1 min,,BAO_0000218,4684,
,,A,,Intermediate,1,,50597,CHEMBL624894,1977.0,9209,Rattus norvegicus,,10116.0,N,Serum,1,,Stability in rat serum measured as % recovery at 10 min,,BAO_0000218,4684,
,,A,,Intermediate,1,,50597,CHEMBL624895,1977.0,9210,Rattus norvegicus,,10116.0,N,Serum,1,,Stability in rat serum measured as % recovery at 10 mins,,BAO_0000218,4684,
,,A,,Intermediate,1,,50597,CHEMBL624058,1977.0,9211,Rattus norvegicus,,10116.0,N,Serum,1,,Stability in rat serum measured as % recovery at 2 hr,,BAO_0000218,4684,
,,A,,Intermediate,1,,50597,CHEMBL624059,1977.0,9212,Rattus norvegicus,,10116.0,N,Serum,1,,Stability in rat serum measured as % recovery at 3 min,,BAO_0000218,4684,
,,A,,Intermediate,1,,50597,CHEMBL624060,1977.0,9213,Rattus norvegicus,,10116.0,N,Serum,1,,Stability in rat serum measured as % recovery at 3 mins,,BAO_0000218,4684,
,,A,,Intermediate,1,,50597,CHEMBL624061,1977.0,9214,Rattus norvegicus,,10116.0,N,Serum,1,,Stability in rat serum measured as % recovery at 5 min,,BAO_0000218,4684,
,,A,,Intermediate,1,,50597,CHEMBL624062,1977.0,9215,Rattus norvegicus,,10116.0,N,Serum,1,,Stability in rat serum measured as % recovery at 5 mins,,BAO_0000218,4684,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624063,,9216,Rattus norvegicus,,10116.0,N,,1,,Alpha-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,,BAO_0000218,16456,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624064,,9217,Rattus norvegicus,,10116.0,N,,1,,Beta-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,,BAO_0000218,16456,
,,A,,Intermediate,1,,50597,CHEMBL624065,1969.0,9218,Rattus norvegicus,,10116.0,N,Plasma,1,,Half life in plasma was determined against ovariectomized rats; t 1/2 (h) is short in plasma,,BAO_0000218,723,
,,A,,Intermediate,1,,50597,CHEMBL624066,1969.0,9219,Rattus norvegicus,,10116.0,N,Plasma,1,,Half life in plasma was determined against ovariectomized rats; t1/2 is longer in plasma.,,BAO_0000218,723,
In vivo,,A,,Intermediate,1,,50597,CHEMBL877490,,9220,Rattus norvegicus,,10116.0,N,,1,,Half life tested in mature male rat at a dose of 30 mg/kg,,BAO_0000218,5160,
In vivo,,A,,Intermediate,1,,50597,CHEMBL874442,,9221,Rattus norvegicus,,10116.0,N,,1,,Half life after intravenous administration of 1 mg/kg in rat,,BAO_0000218,4709,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626890,,9222,Rattus norvegicus,,10116.0,N,,1,,Half life period after administration (30 mg/kg) in rat,,BAO_0000218,5633,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626891,,9223,Rattus norvegicus,,10116.0,N,,1,,Half life period in rat after 5 mg/Kg dose,,BAO_0000218,5302,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626892,,9224,Rattus norvegicus,,10116.0,N,,1,,Half life period in rat after 5 mg/kg dose,,BAO_0000218,5302,
,,A,,Intermediate,1,,50597,CHEMBL626893,,9225,Rattus norvegicus,,10116.0,N,,1,,Half life period was determined,,BAO_0000218,17791,
,,A,,Intermediate,1,,50597,CHEMBL626894,,9226,Rattus norvegicus,,10116.0,N,,1,,Half life period was evaluated in rat,,BAO_0000218,17791,
,,A,,Intermediate,1,,50597,CHEMBL626895,,9227,Rattus norvegicus,,10116.0,N,,1,,Half life period was evaluated in rat; 0.5-1.0,,BAO_0000218,17791,
,,A,,Intermediate,1,,50597,CHEMBL626896,,9228,Rattus norvegicus,,10116.0,N,,1,,Half life period was evaluated in rat; 5.9-7.5,,BAO_0000218,17791,
,,A,,Intermediate,1,,50597,CHEMBL626897,1969.0,9229,Rattus norvegicus,,10116.0,N,Plasma,1,,Half-life in rat plasma,,BAO_0000218,14512,
,,A,,Intermediate,1,,50597,CHEMBL626898,,9230,Rattus norvegicus,,10116.0,N,,1,,Half-life time in rat was determined,,BAO_0000218,6230,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626899,,9231,Rattus norvegicus,,10116.0,N,,1,,Terminal half-life after iv administration to rats,,BAO_0000218,3364,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626900,,9232,Rattus norvegicus,,10116.0,N,,1,,Tested for iv terminal half-life dosed as a solution in male Han Wistar rats,,BAO_0000218,6874,
,,A,,Intermediate,1,,50597,CHEMBL626901,,9233,Rattus norvegicus,,10116.0,N,,1,,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg,,BAO_0000218,857,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626902,,9234,Rattus norvegicus,,10116.0,N,,1,,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg (iv),,BAO_0000218,858,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626903,,9235,Rattus norvegicus,,10116.0,N,,1,,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 5 umol/kg (iv),,BAO_0000218,858,
In vivo,,A,,Intermediate,1,,50597,CHEMBL874443,,9236,Rattus norvegicus,,10116.0,N,,1,,Time for peak concentration (tmax) at a dose of 10 mg/kg in rats,,BAO_0000218,5355,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626904,,9237,Rattus norvegicus,,10116.0,N,,1,,Time for peak concentration (tmax) at a dose of 20 mg/kg in rats,,BAO_0000218,5355,
,,A,,Intermediate,1,,50597,CHEMBL626905,,9238,Rattus norvegicus,,10116.0,N,,1,,Half life in rats,,BAO_0000218,6305,
In vivo,,A,,Intermediate,1,,50597,CHEMBL873830,1969.0,9239,Rattus norvegicus,,10116.0,N,Plasma,1,,Apparent Half life was determined from the linear portion of the log plasma concentration-time profile after oral administration of compound 18 at a dose of 4 mg/kg to rat,,BAO_0000218,13501,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626906,,9240,Rattus norvegicus,,10116.0,N,,1,,Apparent half-life after single intravenous bolus of 1 mg/kg in rats,,BAO_0000218,17594,
In vivo,,A,,Intermediate,1,,50597,CHEMBL631076,1969.0,9241,Rattus norvegicus,,10116.0,N,Plasma,1,,Apparent terminal elimination half-life in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,,BAO_0000218,4186,
,,A,,Intermediate,1,,50597,CHEMBL631077,1969.0,9242,Rattus norvegicus,,10116.0,N,Plasma,1,,Biological half-life was measured in plasma of rats,,BAO_0000218,2932,
In vivo,,A,,Intermediate,1,,50597,CHEMBL631078,,9243,Rattus norvegicus,,10116.0,N,,1,,Circulatory half life measured after intravenous bolus administration of 50 mg/kg of compound to rats,,BAO_0000218,17065,
In vivo,,A,,Intermediate,1,,50597,CHEMBL631079,,9244,Rattus norvegicus,,10116.0,N,,1,,Compound demonstarted an oral bioavailability of 6% with the half-life time as given in rats.,,BAO_0000218,15765,
In vivo,,A,,Intermediate,1,,50597,CHEMBL631080,,9245,Rattus norvegicus,,10116.0,N,,1,,Compound was evaluated for half life (t1/2) upon intravenous administration of 1 mg/Kg in rats,,BAO_0000218,2713,
In vivo,,A,,Intermediate,1,,50597,CHEMBL631081,,9246,Rattus norvegicus,,10116.0,N,,1,,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to female wistar rats,,BAO_0000218,2661,
In vivo,,A,,Intermediate,1,,50597,CHEMBL631239,,9247,Rattus norvegicus,,10116.0,N,,1,,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to male wistar rats,,BAO_0000218,2661,
,,A,,Intermediate,1,,50597,CHEMBL631240,1969.0,9248,Rattus norvegicus,,10116.0,N,Plasma,1,,Compound was evaluated for plasma half life in rat,,BAO_0000218,740,
,,A,,Intermediate,1,,50597,CHEMBL631241,1969.0,9249,Rattus norvegicus,,10116.0,N,Plasma,1,,AUC value at a dose of 5 mg/kg (p.o.) in rats,,BAO_0000218,6597,
,,A,,Intermediate,1,,50597,CHEMBL631242,1969.0,9250,Rattus norvegicus,,10116.0,N,Plasma,1,,AUC value after administration of 20 mg/Kg oral dose in rat,,BAO_0000218,2959,
,,A,,Intermediate,1,,50597,CHEMBL631243,1969.0,9251,Rattus norvegicus,,10116.0,N,Plasma,1,,AUC0-24 after repeated oral dose of compound at 1 mg/kg in rats,,BAO_0000218,17594,
,,A,,Intermediate,1,,50597,CHEMBL874444,1969.0,9252,Rattus norvegicus,,10116.0,N,Plasma,1,,AUC0-96 after administration at 50 mg/kg,,BAO_0000218,17596,
,,A,,Intermediate,1,,50597,CHEMBL631244,1969.0,9253,Rattus norvegicus,,10116.0,N,Plasma,1,,AUC0-infinity after single intravenous bolus of 1 mg/kg in rats,,BAO_0000218,17594,
,,A,,Intermediate,1,,50597,CHEMBL631245,,9254,Rattus norvegicus,,10116.0,N,,1,,"Absorption behavior was judged by the area under the curve, determined after oral dose of 30 mg/kg in rats.",,BAO_0000218,3293,
,,A,,Intermediate,1,,50597,CHEMBL627162,,9255,Rattus norvegicus,,10116.0,N,,1,,Area under curve (0-24 hr) at a dose of 10 mg/kg in male SD rats,,BAO_0000218,6757,
,,A,,Intermediate,1,,50597,CHEMBL627163,,9256,Rattus norvegicus,,10116.0,N,,1,,Area under curve (0-24 hr) at a dose of 100 mg/kg in male SD rats,,BAO_0000218,6757,
,,A,,Intermediate,1,,50597,CHEMBL627164,,9257,Rattus norvegicus,,10116.0,N,,1,,Area under curve (0-24 hr) at a dose of 50 mg/kg in male SD rats,,BAO_0000218,6757,
,,A,,Intermediate,1,,50597,CHEMBL627165,2113.0,9258,Rattus norvegicus,,10116.0,N,Kidney,1,,Area under curve (AUC) at a dose 1 mg/kg was determined in rat kidney,,BAO_0000218,5979,
,,A,,Intermediate,1,,50597,CHEMBL627166,,9259,Rattus norvegicus,,10116.0,N,,1,,Area under curve (AUC) at a dose 1 mg/kg was determined in rat liver,,BAO_0000218,5979,
,,A,,Intermediate,1,,50597,CHEMBL627167,,9260,Rattus norvegicus,,10116.0,N,,1,,Area under curve (AUC) at a dose 1 mg/kg was determined in rat lung,,BAO_0000218,5979,
,,A,,Intermediate,1,,50597,CHEMBL627822,,9261,Rattus norvegicus,,10116.0,N,,1,,Area under curve (AUC) at a dose of 30 mg/kg in rats,,BAO_0000218,4026,
,,A,,Intermediate,1,,50597,CHEMBL627823,,9262,Rattus norvegicus,,10116.0,N,,1,,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,,BAO_0000218,5355,
,,A,,Intermediate,1,,50597,CHEMBL627824,,9263,Rattus norvegicus,,10116.0,N,,1,,Area under curve (AUC) was calculated using trapezoidal rule. at a dose of 10 mg/kg in rats,,BAO_0000218,5355,
,,A,,Intermediate,1,,50597,CHEMBL627825,,9264,Rattus norvegicus,,10116.0,N,,1,,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,,BAO_0000218,5355,
,,A,,Intermediate,1,,50597,CHEMBL627826,,9265,Rattus norvegicus,,10116.0,N,,1,,Area under curve (AUC0-24 h) after administration (30 mg/kg) in rat,,BAO_0000218,5633,
,,A,,Intermediate,1,,50597,CHEMBL627827,,9266,Rattus norvegicus,,10116.0,N,,1,,Area under curve (Pharmacokinetic property) was determined,,BAO_0000218,1716,
,,A,,Intermediate,1,,50597,CHEMBL627828,,9267,Rattus norvegicus,,10116.0,N,,1,,Area under curve (Pharmacokinetic property) of the compound; Not determined,,BAO_0000218,1716,
,,A,,Intermediate,1,,50597,CHEMBL627829,,9268,Rattus norvegicus,,10116.0,N,,1,,Area under curve after intravenous administration (1 mg/kg) in rat,,BAO_0000218,4689,
,,A,,Intermediate,1,,50597,CHEMBL627830,,9269,Rattus norvegicus,,10116.0,N,,1,,Area under curve by intravenous administration at a dose of 10 uM/kg in rat was determined,,BAO_0000218,4527,
,,A,,Intermediate,1,,50597,CHEMBL627831,,9270,Rattus norvegicus,,10116.0,N,,1,,Area under curve by oral administration at a dose of 100 uM/kg in rat was determined,,BAO_0000218,4527,
,,A,,Intermediate,1,,50597,CHEMBL627832,,9271,Rattus norvegicus,,10116.0,N,,1,,Area under curve in male SD rats was observed after oral administration in rat,,BAO_0000218,15662,
,,A,,Intermediate,1,,50597,CHEMBL627833,,9272,Rattus norvegicus,,10116.0,N,,1,,Area under curve of compound after iv administration of 20 mg/kg dose in rat,,BAO_0000218,4413,
,,A,,Expert,1,,50597,CHEMBL627834,,9273,Rattus norvegicus,,10116.0,N,,1,,Area under curve of compound determined in rat after iv administration at a dose of 10 mg/kg,,BAO_0000218,3598,
,,A,,Expert,1,,50597,CHEMBL628004,,9274,Rattus norvegicus,,10116.0,N,,1,,Area under curve of compound from zero time to infinity determined in rat after iv administration at a dose of 10 mg/kg,,BAO_0000218,3598,
,,A,,Intermediate,1,,50597,CHEMBL628005,,9275,Rattus norvegicus,,10116.0,N,,1,,Area under curve at 5 mg/kg po was determined in rat,,BAO_0000218,5964,
,,A,,Intermediate,1,,50597,CHEMBL628006,,9276,Rattus norvegicus,,10116.0,N,,1,,Area under curve in Rat at a oral dose of 5 mg/kg,,BAO_0000218,4689,
,,A,,Intermediate,1,,50597,CHEMBL628007,,9277,Rattus norvegicus,,10116.0,N,,1,,Area under curve in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,,BAO_0000218,4186,
,,A,,Intermediate,1,,50597,CHEMBL625676,,9278,Rattus norvegicus,,10116.0,N,,1,,Area under curve was determined,,BAO_0000218,5510,
,,A,,Intermediate,1,,50597,CHEMBL631309,,9279,Rattus norvegicus,,10116.0,N,,1,,Area under curve after 10 mg/kg oral administration in rat at 0-24 hr,,BAO_0000218,17858,
,,A,,Intermediate,1,,50597,CHEMBL631310,,9280,Rattus norvegicus,,10116.0,N,,1,,Area under curve after intravenous administration at 3 mg/kg,,BAO_0000218,17804,
,,A,,Intermediate,1,,50597,CHEMBL631311,,9281,Rattus norvegicus,,10116.0,N,,1,,Area under curve after peroral administration at 10 mg/kg in rat for 0-6 h,,BAO_0000218,6106,
,,A,,Intermediate,1,,50597,CHEMBL631312,,9282,Rattus norvegicus,,10116.0,N,,1,,Area under curve at 4 hr in rat,,BAO_0000218,5964,
,,A,,Intermediate,1,,50597,CHEMBL631313,,9283,Rattus norvegicus,,10116.0,N,,1,,Area under curve at a dose of 30 mg/kg,,BAO_0000218,4026,
,,A,,Intermediate,1,,50597,CHEMBL631314,,9284,Rattus norvegicus,,10116.0,N,,1,,Area under curve at the dose of 2 mg/Kg administered perorally in rats,,BAO_0000218,4756,
,,A,,Intermediate,1,,50597,CHEMBL631315,,9285,Rattus norvegicus,,10116.0,N,,1,,Area under curve at the dose of 5 mg/Kg administered perorally in rats,,BAO_0000218,4756,
,,A,,Intermediate,1,,50597,CHEMBL631316,,9286,Rattus norvegicus,,10116.0,N,,1,,Area under curve for a 2-mpk po dose in SD rats,,BAO_0000218,5862,
,,A,,Intermediate,1,,50597,CHEMBL631317,,9287,Rattus norvegicus,,10116.0,N,,1,,Area under curve in SD rats,,BAO_0000218,5862,
,,A,,Intermediate,1,,50597,CHEMBL874471,,9288,Rattus norvegicus,,10116.0,N,,1,,Area under curve in rat after oral administration at 13 mg/kg dose,,BAO_0000218,6644,
,,A,,Intermediate,1,,50597,CHEMBL631318,,9289,Rattus norvegicus,,10116.0,N,,1,,Area under curve in rat by po administration at 0-24 hr,,BAO_0000218,5871,
,,A,,Intermediate,1,,50597,CHEMBL631319,1969.0,9290,Rattus norvegicus,,10116.0,N,Plasma,1,,Area under curve in rat plasma,,BAO_0000218,5919,
,,A,,Intermediate,1,,50597,CHEMBL631320,,9291,Rattus norvegicus,,10116.0,N,,1,,Area under curve in rat plasma for 0-4 hr after peroral administration at 10 mg/kg,,BAO_0000218,5939,
,,A,,Intermediate,1,,50597,CHEMBL631321,,9292,Rattus norvegicus,,10116.0,N,,1,,Area under curve in rat plasma for 0-4 hr after peroral administration at 5 mg/kg,,BAO_0000218,5939,
,,A,,Intermediate,1,,50597,CHEMBL631322,,9293,Rattus norvegicus,,10116.0,N,,1,,Area under curve was evaluated in rat at 3 mg/kg dose administered intravenously,,BAO_0000218,10,
,,A,,Intermediate,1,,50597,CHEMBL631323,,9294,Rattus norvegicus,,10116.0,N,,1,,Area under curve was measured from the graph obtained from concentration Vs time after oral administration to male F344 rats,,BAO_0000218,11149,
,,A,,Intermediate,1,,50597,CHEMBL631324,,9295,Rattus norvegicus,,10116.0,N,,1,,Area under curve value in rat at a dose of 5 mg/kg,,BAO_0000218,5302,
,,A,,Intermediate,1,,50597,CHEMBL631325,,9296,Rattus norvegicus,,10116.0,N,,1,,Area under curve was determined after oral administration in rats,,BAO_0000218,17796,
,,A,,Intermediate,1,,50597,CHEMBL631326,,9297,Rattus norvegicus,,10116.0,N,,1,,Area under curve was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,,BAO_0000218,4890,
,,A,,Intermediate,1,,50597,CHEMBL631327,,9298,Rattus norvegicus,,10116.0,N,,1,,Area under curve was determined after peroral administration in rat,,BAO_0000218,6011,
,,A,,Intermediate,1,,50597,CHEMBL631328,,9299,Rattus norvegicus,,10116.0,N,,1,,Area under curve was determined at a dose 30 mpk administered orally.,,BAO_0000218,5375,
,,A,,Intermediate,1,,50597,CHEMBL631329,,9300,Rattus norvegicus,,10116.0,N,,1,,Area under curve was determined for compound after intravenous administration in rats at 24 uM/kg,,BAO_0000218,17764,
,,A,,Intermediate,1,,50597,CHEMBL627217,,9301,Rattus norvegicus,,10116.0,N,,1,,Area under curve was determined for the compound by intravenous administration of 3.4 mg/kg in rat,,BAO_0000218,4368,
,,A,,Intermediate,1,,50597,CHEMBL626352,,9302,Rattus norvegicus,,10116.0,N,,1,,Area under curve was determined in male rat,,BAO_0000218,5610,
,,A,,Intermediate,1,,50597,CHEMBL626353,,9303,Rattus norvegicus,,10116.0,N,,1,,Area under curve was determined in rat after PO administration,,BAO_0000218,5833,
,,A,,Intermediate,1,,50597,CHEMBL626354,,9304,Rattus norvegicus,,10116.0,N,,1,,Area under curve was determined in rat after a 3 mg/kg of oral dose,,BAO_0000218,4257,
,,A,,Intermediate,1,,50597,CHEMBL626355,,9305,Rattus norvegicus,,10116.0,N,,1,,Area under curve was determined in rat after oral administration at a concentration 1 mg/kg,,BAO_0000218,5937,
,,A,,Intermediate,1,,50597,CHEMBL626356,,9306,Rattus norvegicus,,10116.0,N,,1,,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg,,BAO_0000218,5932,
,,A,,Intermediate,1,,50597,CHEMBL626357,,9307,Rattus norvegicus,,10116.0,N,,1,,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg; NA= Not active,,BAO_0000218,5932,
,,A,,Intermediate,1,,50597,CHEMBL626358,,9308,Rattus norvegicus,,10116.0,N,,1,,Liver concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,BAO_0000218,17411,
,,A,,Intermediate,1,,50597,CHEMBL626359,,9309,Rattus norvegicus,,10116.0,N,,1,,Lung concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,BAO_0000218,17411,
,,A,,Intermediate,1,,50597,CHEMBL626360,1969.0,9310,Rattus norvegicus,,10116.0,N,Plasma,1,,Peak plasma concentration in rat at a dose of 3 mg/kg,,BAO_0000218,17771,
,,A,,Intermediate,1,,50597,CHEMBL626361,,9311,Rattus norvegicus,,10116.0,N,,1,,Plasma concentration at 2 hr in rats was evaluated.,,BAO_0000218,1628,
,,A,,Intermediate,1,,50597,CHEMBL626362,,9312,Rattus norvegicus,,10116.0,N,,1,,Plasma concentration at 2 hr in rats was evaluated; Not available,,BAO_0000218,1628,
,,A,,Intermediate,1,,50597,CHEMBL626363,,9313,Rattus norvegicus,,10116.0,N,,1,,Serum concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,BAO_0000218,17411,
,,A,,Intermediate,1,,50597,CHEMBL626970,,9314,Rattus norvegicus,,10116.0,N,,1,,Tested for concentration in brain after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,,BAO_0000218,4910,
,,A,,Intermediate,1,,50597,CHEMBL626971,,9315,Rattus norvegicus,,10116.0,N,,1,,Tested for concentration in brain after 2 hrs of intravenous administration (5 mg/kg) to male rats,,BAO_0000218,4910,
,,A,,Intermediate,1,,50597,CHEMBL626972,1969.0,9316,Rattus norvegicus,,10116.0,N,Plasma,1,,Tested for plasma concentration after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,,BAO_0000218,4910,
,,A,,Intermediate,1,,50597,CHEMBL626973,1969.0,9317,Rattus norvegicus,,10116.0,N,Plasma,1,,Tested for plasma concentration after 2 hrs of intravenous administration (5 mg/kg) to male rats,,BAO_0000218,4910,
,,A,,Intermediate,1,,50597,CHEMBL626974,1969.0,9318,Rattus norvegicus,,10116.0,N,Plasma,1,,Tested for plasma concentration in the after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,,BAO_0000218,4910,
,,A,,Intermediate,1,,50597,CHEMBL874592,1969.0,9319,Rattus norvegicus,,10116.0,N,Plasma,1,,Tested for plasma concentration in the after 2 hrs of intravenous administration (5 mg/kg) to male rats,,BAO_0000218,4910,
,,A,,Intermediate,1,,50597,CHEMBL626975,,9320,Rattus norvegicus,,10116.0,N,,1,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C,,BAO_0000218,5510,
,,A,,Intermediate,1,,50597,CHEMBL626976,,9321,Rattus norvegicus,,10116.0,N,,1,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Converted to an unknown compound,,BAO_0000218,5510,
,,A,,Intermediate,1,,50597,CHEMBL626977,,9322,Rattus norvegicus,,10116.0,N,,1,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not determined,,BAO_0000218,5510,
,,A,,Intermediate,1,,50597,CHEMBL626978,,9323,Rattus norvegicus,,10116.0,N,,1,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not tested,,BAO_0000218,5510,
,,A,,Intermediate,1,,50597,CHEMBL626979,,9324,Rattus norvegicus,,10116.0,N,,1,,PK study was carried to determine the relative absorption ranking in rat.,,BAO_0000218,16427,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626980,1969.0,9325,Rattus norvegicus,,10116.0,N,Plasma,1,,Maximum plasma concentration in Rat at a oral dose of 5 mg/kg,,BAO_0000218,4689,
,,A,,Intermediate,1,,50597,CHEMBL626981,178.0,9326,Rattus norvegicus,,10116.0,N,Blood,1,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.57-0.75 % dose/g",,BAO_0000218,11450,
,,A,,Intermediate,1,,50597,CHEMBL626982,178.0,9327,Rattus norvegicus,,10116.0,N,Blood,1,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.63 % dose/g",,BAO_0000218,11450,
,,A,,Intermediate,1,,50597,CHEMBL626983,178.0,9328,Rattus norvegicus,,10116.0,N,Blood,1,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.40-0.55 % dose/g",,BAO_0000218,11450,
,,A,,Intermediate,1,,50597,CHEMBL622522,178.0,9329,Rattus norvegicus,,10116.0,N,Blood,1,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.28-0.37% dose/g",,BAO_0000218,11450,
,,A,,Intermediate,1,,50597,CHEMBL622523,178.0,9330,Rattus norvegicus,,10116.0,N,Blood,1,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.56-0.74 % dose/g",,BAO_0000218,11450,
,,A,,Intermediate,1,,50597,CHEMBL622524,178.0,9331,Rattus norvegicus,,10116.0,N,Blood,1,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from % dose/g",,BAO_0000218,11450,
,,A,,Intermediate,1,,50597,CHEMBL622525,955.0,9332,Rattus norvegicus,,10116.0,N,Brain,1,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.20-2.85 % dose/g",,BAO_0000218,11450,
,,A,,Intermediate,1,,50597,CHEMBL622526,955.0,9333,Rattus norvegicus,,10116.0,N,Brain,1,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.16-1.76 % dose/g",,BAO_0000218,11450,
,,A,,Intermediate,1,,50597,CHEMBL619849,955.0,9334,Rattus norvegicus,,10116.0,N,Brain,1,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.96-3.72 % dose/g",,BAO_0000218,11450,
,,A,,Intermediate,1,,50597,CHEMBL619850,955.0,9335,Rattus norvegicus,,10116.0,N,Brain,1,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.57-3.59 % dose/g",,BAO_0000218,11450,
,,A,,Intermediate,1,,50597,CHEMBL623864,955.0,9336,Rattus norvegicus,,10116.0,N,Brain,1,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.36-1.53 % dose/g",,BAO_0000218,11450,
,,A,,Intermediate,1,,50597,CHEMBL623865,955.0,9337,Rattus norvegicus,,10116.0,N,Brain,1,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.81-1.08 % dose/g",,BAO_0000218,11450,
,,A,,Intermediate,1,,50597,CHEMBL623866,948.0,9338,Rattus norvegicus,,10116.0,N,Heart,1,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.84-0.98 % dose/g",,BAO_0000218,11450,
,,A,,Intermediate,1,,50597,CHEMBL623867,948.0,9339,Rattus norvegicus,,10116.0,N,Heart,1,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.53 % dose/g",,BAO_0000218,11450,
,,A,,Intermediate,1,,50597,CHEMBL877615,948.0,9340,Rattus norvegicus,,10116.0,N,Heart,1,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.22-1.48 % dose/g",,BAO_0000218,11450,
,,A,,Intermediate,1,,50597,CHEMBL623868,948.0,9341,Rattus norvegicus,,10116.0,N,Heart,1,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.85-1.13 % dose/g",,BAO_0000218,11450,
,,A,,Intermediate,1,,50597,CHEMBL623869,948.0,9342,Rattus norvegicus,,10116.0,N,Heart,1,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.55-0.63 % dose/g",,BAO_0000218,11450,
,,A,,Intermediate,1,,50597,CHEMBL623870,948.0,9343,Rattus norvegicus,,10116.0,N,Heart,1,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.33-0.42 % dose/g",,BAO_0000218,11450,
,,A,,Intermediate,1,,50597,CHEMBL623871,2048.0,9344,Rattus norvegicus,,10116.0,N,Lung,1,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL623872,2048.0,9345,Rattus norvegicus,,10116.0,N,Lung,1,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL622129,2048.0,9346,Rattus norvegicus,,10116.0,N,Lung,1,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL622130,2048.0,9347,Rattus norvegicus,,10116.0,N,Lung,1,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL622131,2048.0,9348,Rattus norvegicus,,10116.0,N,Lung,1,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL622132,2048.0,9349,Rattus norvegicus,,10116.0,N,Lung,1,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL622133,2048.0,9350,Rattus norvegicus,,10116.0,N,Lung,1,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL622134,2048.0,9351,Rattus norvegicus,,10116.0,N,Lung,1,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL622135,2048.0,9352,Rattus norvegicus,,10116.0,N,Lung,1,,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL622136,2048.0,9353,Rattus norvegicus,,10116.0,N,Lung,1,,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL622137,2385.0,9354,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL622138,2385.0,9355,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL623017,2385.0,9356,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL623018,2385.0,9357,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL623019,2385.0,9358,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL623020,2385.0,9359,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL623021,2385.0,9360,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL623022,2385.0,9361,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL623023,2385.0,9362,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL623024,2385.0,9363,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL623025,2385.0,9364,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL620545,2385.0,9365,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL620546,2385.0,9366,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL620547,2385.0,9367,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL620548,2385.0,9368,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL620549,2385.0,9369,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL620550,2385.0,9370,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL620551,2385.0,9371,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL620552,2385.0,9372,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL620553,2385.0,9373,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL620554,2385.0,9374,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL875845,2385.0,9375,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL620555,2385.0,9376,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL620556,2385.0,9377,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL620557,2385.0,9378,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL620558,,9379,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL620559,,9380,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL622939,,9381,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL622940,,9382,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL622941,,9383,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL622942,,9384,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL622943,,9385,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL622944,,9386,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL622945,,9387,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL622946,,9388,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL622947,,9389,Rattus norvegicus,,10116.0,N,,1,,Compound was evaluated for terminal half life in rat,,BAO_0000218,3341,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622948,1969.0,9390,Rattus norvegicus,,10116.0,N,Plasma,1,,Compound was evaluated in vivo in rat for the plasma half-life at a iv dose of 3 mg/kg and oral dose of 10 mg/kg and experiment by using concentration vs time curve,,BAO_0000218,3634,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622949,1969.0,9391,Rattus norvegicus,,10116.0,N,Plasma,1,,Compound was evaluated in vivo in rat for the plasma half-life at a oral dose of 20 mg/kg experiment by using concentration vs time curve,,BAO_0000218,3634,
,,A,,Intermediate,1,,50597,CHEMBL622950,,9392,Rattus norvegicus,,10116.0,N,,1,,Compound was tested for its half life in rat,,BAO_0000218,4839,
In vivo,,A,,Intermediate,0,,22224,CHEMBL622951,1969.0,9393,Macaca mulatta,,9544.0,U,Plasma,1,,Compound was tested for its plasma half life in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po; ND is not determined.,,BAO_0000218,5005,
,,A,,Intermediate,0,,22224,CHEMBL622952,1969.0,9394,Rattus norvegicus,,10116.0,U,Plasma,1,,Compound was tested for its plasma half life in Sprague Dawley rats,,BAO_0000366,5005,
,,A,,Intermediate,0,,22224,CHEMBL622953,1969.0,9395,Rattus norvegicus,,10116.0,U,Plasma,1,,Compound was tested for its plasma half life in Sprague Dawley rats; ND is not determined,,BAO_0000366,5005,
,,A,,Intermediate,1,,50597,CHEMBL873818,1969.0,9396,Rattus norvegicus,,10116.0,N,Plasma,1,,Compound was tested for plasma half-life period in rat,,BAO_0000218,1094,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622954,,9397,Rattus norvegicus,,10116.0,N,,1,,Elimination half life after i.v. administration of compound in rats,,BAO_0000218,5031,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622955,,9398,Rattus norvegicus,,10116.0,N,,1,,Elimination half-life after IV dosing at 0.5 mg/kg in rat,,BAO_0000218,6518,
In vivo,,A,,Intermediate,1,,50597,CHEMBL875229,,9399,Rattus norvegicus,,10116.0,N,,1,,Elimination half-life after IV dosing at 1 mg/kg in rat,,BAO_0000218,6518,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622956,,9400,Rattus norvegicus,,10116.0,N,,1,,Elimination half-life after oral administration at a dose of 2 mg/kg in rat,,BAO_0000218,6518,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622957,,9401,Rattus norvegicus,,10116.0,N,,1,,Elimination half-life after oral administration at a dose of 4 mg/kg in rat,,BAO_0000218,6518,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622958,955.0,9402,Rattus norvegicus,,10116.0,N,Brain,1,,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,,BAO_0000218,5408,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622959,1969.0,9403,Rattus norvegicus,,10116.0,N,Plasma,1,,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,,BAO_0000218,5408,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622960,955.0,9404,Rattus norvegicus,,10116.0,N,Brain,1,,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,,BAO_0000218,5408,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622961,1969.0,9405,Rattus norvegicus,,10116.0,N,Plasma,1,,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,,BAO_0000218,5408,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622962,,9406,Rattus norvegicus,,10116.0,N,,1,,Evaluated for the half life in rat (in vivo),,BAO_0000218,4687,
,,A,,Intermediate,1,,50597,CHEMBL622963,,9407,Rattus norvegicus,,10116.0,N,,1,,Hafl life in rat,,BAO_0000218,6640,
,,A,,Intermediate,1,,50597,CHEMBL622964,,9408,Rattus norvegicus,,10116.0,N,,1,,Hafl life rat,,BAO_0000218,6640,
,,A,,Intermediate,1,,50597,CHEMBL622965,,9409,Rattus norvegicus,,10116.0,N,,1,,Hafl life rat,,BAO_0000218,6641,
,,A,,Intermediate,1,,50597,CHEMBL622966,,9410,Rattus norvegicus,,10116.0,N,,1,,Hafl life rat; Not determined,,BAO_0000218,6640,
,,A,,Intermediate,1,,50597,CHEMBL622967,,9411,Rattus norvegicus,,10116.0,N,,1,,Hafl life rat; Not determined,,BAO_0000218,6641,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622968,2113.0,9412,Rattus norvegicus,,10116.0,N,Kidney,1,,Half life in kidney was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,,BAO_0000218,17411,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622969,2107.0,9413,Rattus norvegicus,,10116.0,N,Liver,1,,Half life in liver was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,,BAO_0000218,17411,
In vivo,,A,,Intermediate,1,,50597,CHEMBL875327,2048.0,9414,Rattus norvegicus,,10116.0,N,Lung,1,,Half life in lung was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,,BAO_0000218,17411,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628638,,9415,Rattus norvegicus,,10116.0,N,,1,,Half life in rat after 1 mg/kg i.v. administration,,BAO_0000218,6570,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628639,,9416,Rattus norvegicus,,10116.0,N,,1,,Half life in rat after 2 mg/kg peroral administration,,BAO_0000218,6570,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625840,,9417,Rattus norvegicus,,10116.0,N,,1,,Half life in serum was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,,BAO_0000218,17411,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625841,,9418,Rattus norvegicus,,10116.0,N,,1,,Half life of 10 mg/kg oral dose determined in rats,,BAO_0000218,4722,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625842,,9419,Rattus norvegicus,,10116.0,N,,1,,Half life of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,,BAO_0000218,5978,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625843,,9420,Rattus norvegicus,,10116.0,N,,1,,Half life of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,,BAO_0000218,5978,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625844,,9421,Rattus norvegicus,,10116.0,N,,1,,Half life of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,,BAO_0000218,5978,
In vivo,,A,,Intermediate,1,,50597,CHEMBL873822,,9422,Rattus norvegicus,,10116.0,N,,1,,Half life of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,,BAO_0000218,5978,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625845,,9423,Rattus norvegicus,,10116.0,N,,1,,Half life of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,,BAO_0000218,5978,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627059,,9424,Rattus norvegicus,,10116.0,N,,1,,Half life of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,,BAO_0000218,5978,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627060,,9425,Rattus norvegicus,,10116.0,N,,1,,Half life of compound (9.84 mg/kg) after po administration was determined in Sprague-Dawley rat,,BAO_0000218,5978,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627061,,9426,Rattus norvegicus,,10116.0,N,,1,,Half life of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,,BAO_0000218,5978,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627709,,9427,Rattus norvegicus,,10116.0,N,,1,,Half life of compound at 5 mg/kg after po administration was determined in rat,,BAO_0000218,4762,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627710,,9428,Rattus norvegicus,,10116.0,N,,1,,Half life of compound determined after intravenous administration to rat,,BAO_0000218,5327,
,,A,,Intermediate,1,,50597,CHEMBL627711,,9429,Rattus norvegicus,,10116.0,N,,1,,Half life of compound was determined in rat,,BAO_0000218,4847,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627712,1969.0,9430,Rattus norvegicus,,10116.0,N,Plasma,1,,Half life at a dose of 4 mg/kg in Rat Plasma after iv administration,,BAO_0000218,17720,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627713,,9431,Rattus norvegicus,,10116.0,N,,1,,Half life determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,BAO_0000218,4723,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627714,,9432,Rattus norvegicus,,10116.0,N,,1,,Half life determined after 3 mg/kg oral administration in potassium oxonate treated rats,,BAO_0000218,4723,
In vivo,,A,,Intermediate,0,,22224,CHEMBL627889,,9433,Macaca fascicularis,,9541.0,U,,1,,Half life determined after intravenous administration at a dose of 3 mg/kg in cynomolgus monkey,,BAO_0000218,4256,
In vivo,,A,,Intermediate,0,,22224,CHEMBL627890,,9434,Rattus norvegicus,,10116.0,U,,1,,Half life determined in rat by intravenous administration,,BAO_0000218,4256,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627891,,9435,Rattus norvegicus,,10116.0,N,,1,,Half life determined in rats after iv administration,,BAO_0000218,4722,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627892,1969.0,9436,Rattus norvegicus,,10116.0,N,Plasma,1,,Half life in rat plasma after administration of 2 mg/kg iv,,BAO_0000218,6535,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627893,1969.0,9437,Rattus norvegicus,,10116.0,N,Plasma,1,,Half life in rat plasma after administration of 2 mg/kg iv,,BAO_0000218,6535,
,,A,,Intermediate,1,,50597,CHEMBL627894,1969.0,9438,Rattus norvegicus,,10116.0,N,Plasma,1,,Half life in rat plasma was determined,,BAO_0000218,1435,
,,A,,Intermediate,1,,50597,CHEMBL627895,1969.0,9439,Rattus norvegicus,,10116.0,N,Plasma,1,,Half life in rat plasma was determined; NA means not applicable,,BAO_0000218,1435,
,,A,,Intermediate,1,,50597,CHEMBL627896,,9440,Rattus norvegicus,,10116.0,N,,1,,Half life in rat was tested,,BAO_0000218,5206,
,,A,,Intermediate,1,,50597,CHEMBL627897,1969.0,9441,Rattus norvegicus,,10116.0,N,Plasma,1,,Half life measured in rat plasma,,BAO_0000218,6080,
,,A,,Intermediate,1,,50597,CHEMBL627898,,9442,Rattus norvegicus,,10116.0,N,,1,,Half life recorded in rats,,BAO_0000218,4449,
,,A,,Intermediate,1,,50597,CHEMBL627899,,9443,Rattus norvegicus,,10116.0,N,,1,,Half life was calculated,,BAO_0000218,6057,
,,A,,Intermediate,1,,50597,CHEMBL873823,,9444,Rattus norvegicus,,10116.0,N,,1,,Half life was calculated in rat,,BAO_0000218,6057,
,,A,,Intermediate,1,,50597,CHEMBL627900,,9445,Rattus norvegicus,,10116.0,N,,1,,Half life was determined,,BAO_0000218,3747,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627901,,9446,Rattus norvegicus,,10116.0,N,,1,,Half life after 10 mg/kg oral administration in rat,,BAO_0000218,17858,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627902,,9447,Rattus norvegicus,,10116.0,N,,1,,Half life after administering orally a dose of 10 mg/kg to a fasting rat,,BAO_0000218,16365,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627903,,9448,Rattus norvegicus,,10116.0,N,,1,,Half life after administering orally a dose of 30 mg/kg,,BAO_0000218,16365,
,,A,,Intermediate,1,,50597,CHEMBL627904,,9449,Rattus norvegicus,,10116.0,N,,1,,Area under the curve (Concentration) was determined for the compound as AUC with limits 0-8 after i.v. administration in rats,,BAO_0000218,5031,
,,A,,Intermediate,1,,50597,CHEMBL627905,,9450,Rattus norvegicus,,10116.0,N,,1,,Area under the curve determined under pharmacokinetic behavior of the 10 mg/kg oral dose of compound for 0-6 hours,,BAO_0000218,4722,
,,A,,Intermediate,1,,50597,CHEMBL627906,,9451,Rattus norvegicus,,10116.0,N,,1,,Area under the curve for the compound calculated from 0-24 hr after intravenous administration at a dose of 10 mg/kg in rat,,BAO_0000218,6078,
,,A,,Intermediate,1,,50597,CHEMBL627907,,9452,Rattus norvegicus,,10116.0,N,,1,,Area under the curve for the compound calculated from 0-24 hr after oral administration at a dose of 10 mg/kg in rat,,BAO_0000218,6078,
,,A,,Intermediate,1,,50597,CHEMBL876783,,9453,Rattus norvegicus,,10116.0,N,,1,,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg,,BAO_0000218,6078,
,,A,,Intermediate,1,,50597,CHEMBL627908,,9454,Rattus norvegicus,,10116.0,N,,1,,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg; activity was not determined,,BAO_0000218,6078,
,,A,,Intermediate,1,,50597,CHEMBL627909,,9455,Rattus norvegicus,,10116.0,N,,1,,Area under the curve measured after intravenous bolus administration of 50 mg/kg of compound to rats,,BAO_0000218,17065,
,,A,,Intermediate,1,,50597,CHEMBL627910,,9456,Rattus norvegicus,,10116.0,N,,1,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats,,BAO_0000218,1353,
,,A,,Intermediate,1,,50597,CHEMBL627911,,9457,Rattus norvegicus,,10116.0,N,,1,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-1),,BAO_0000218,1353,
,,A,,Intermediate,1,,50597,CHEMBL627912,,9458,Rattus norvegicus,,10116.0,N,,1,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-2),,BAO_0000218,1353,
,,A,,Intermediate,1,,50597,CHEMBL627913,,9459,Rattus norvegicus,,10116.0,N,,1,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-5),,BAO_0000218,1353,
,,A,,Intermediate,1,,50597,CHEMBL627914,,9460,Rattus norvegicus,,10116.0,N,,1,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(5-10),,BAO_0000218,1353,
,,A,,Intermediate,1,,50597,CHEMBL627915,,9461,Rattus norvegicus,,10116.0,N,,1,,Area under the curve was evaluated after 10 uM/kg of intra arterial administration,,BAO_0000218,16423,
,,A,,Intermediate,1,,50597,CHEMBL627916,,9462,Rattus norvegicus,,10116.0,N,,1,,Area under the curve was evaluated after 20 uM/kg of peroral administration,,BAO_0000218,16423,
,,A,,Intermediate,1,,50597,CHEMBL627917,,9463,Rattus norvegicus,,10116.0,N,,1,,Area under the curve was measured in rat after an iv dose of 1 mg/kg,,BAO_0000218,6062,
,,A,,Intermediate,1,,50597,CHEMBL627918,,9464,Rattus norvegicus,,10116.0,N,,1,,Area under the curve was calculated for the compound at a single intravenous administration of 20 mg/kg in rat,,BAO_0000218,6056,
,,A,,Intermediate,1,,50597,CHEMBL627919,,9465,Rattus norvegicus,,10116.0,N,,1,,Area under the curve was determined by administering the compound at a dose of 1 mg/kg intravenously in male wistar rat,,BAO_0000218,5182,
,,A,,Intermediate,1,,50597,CHEMBL627920,,9466,Rattus norvegicus,,10116.0,N,,1,,Area under the curve was evaluated at an intravenous dose of 3 mg/kg,,BAO_0000218,6410,
,,A,,Intermediate,1,,50597,CHEMBL627921,,9467,Rattus norvegicus,,10116.0,N,,1,,Area under the curve was evaluated at an oral dose of 30 mg/kg,,BAO_0000218,6410,
,,A,,Intermediate,1,,50597,CHEMBL627922,,9468,Rattus norvegicus,,10116.0,N,,1,,Area under the effect time curves from time 0-24 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,BAO_0000218,4723,
,,A,,Intermediate,1,,50597,CHEMBL876784,,9469,Rattus norvegicus,,10116.0,N,,1,,Area under the effect time curves from time 0-24 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,,BAO_0000218,4723,
,,A,,Intermediate,1,,50597,CHEMBL627923,,9470,Rattus norvegicus,,10116.0,N,,1,,Area under the effect time curves from time 0-6 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,BAO_0000218,4723,
,,A,,Intermediate,1,,50597,CHEMBL626208,,9471,Rattus norvegicus,,10116.0,N,,1,,Area under the effect time curves from time 0-6 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,,BAO_0000218,4723,
,,A,,Intermediate,1,,50597,CHEMBL626209,,9472,Rattus norvegicus,,10116.0,N,,1,,Area under the effect time curves from time 0-infinity hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,BAO_0000218,4723,
,,A,,Intermediate,1,,50597,CHEMBL626210,,9473,Rattus norvegicus,,10116.0,N,,1,,Area under the effect time curves from time 0-infinity hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,,BAO_0000218,4723,
,,A,,Intermediate,1,,50597,CHEMBL627994,1969.0,9474,Rattus norvegicus,,10116.0,N,Plasma,1,,Area under the plasma concentration curve was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,,BAO_0000218,2463,
,,A,,Intermediate,1,,50597,CHEMBL627995,,9475,Rattus norvegicus,,10116.0,N,,1,,Bioavailability from area under the curve at time 0 to infinity after intravenous administration of 1 mg/kg in rat,,BAO_0000218,4709,
,,A,,Intermediate,1,,50597,CHEMBL627996,,9476,Rattus norvegicus,,10116.0,N,,1,,Blood level after a 10 mg/kg oral dose in rat expressed as AUC was determined,,BAO_0000218,4075,
,,A,,Intermediate,1,,50597,CHEMBL627997,,9477,Rattus norvegicus,,10116.0,N,,1,,Compound at a dose 10 mg/kg was administered orally to rat and the pharmacokinetic parameter area under curve (AUC) was measured,,BAO_0000218,5394,
,,A,,Intermediate,1,,50597,CHEMBL627998,,9478,Rattus norvegicus,,10116.0,N,,1,,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to female wistar rats,,BAO_0000218,2661,
,,A,,Intermediate,1,,50597,CHEMBL628640,,9479,Rattus norvegicus,,10116.0,N,,1,,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to male wistar rats,,BAO_0000218,2661,
,,A,,Intermediate,1,,50597,CHEMBL628641,,9480,Rattus norvegicus,,10116.0,N,,1,,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to female wistar rats,,BAO_0000218,2661,
,,A,,Intermediate,1,,50597,CHEMBL628642,,9481,Rattus norvegicus,,10116.0,N,,1,,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to male wistar rats,,BAO_0000218,2661,
,,A,,Intermediate,1,,50597,CHEMBL628643,,9482,Rattus norvegicus,,10116.0,N,,1,,Compound was evaluated for area under the curve expressed as (h*ug/ml),,BAO_0000218,17791,
,,A,,Intermediate,1,,50597,CHEMBL628644,,9483,Rattus norvegicus,,10116.0,N,,1,,Compound was tested for area under curve in rat,,BAO_0000218,2591,
,,A,,Intermediate,1,,50597,CHEMBL628645,,9484,Rattus norvegicus,,10116.0,N,,1,,Concentration in rat plasma after 5 mg/kg oral gavage for 8 hours,,BAO_0000218,6567,
,,A,,Intermediate,1,,50597,CHEMBL628646,,9485,Rattus norvegicus,,10116.0,N,,1,,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,,BAO_0000218,6211,
,,A,,Intermediate,1,,50597,CHEMBL628647,,9486,Rattus norvegicus,,10116.0,N,,1,,Dose-normalized AUC was determined in rat after peroral administration (2 mg/kg),,BAO_0000218,5529,
,,A,,Intermediate,1,,50597,CHEMBL628648,,9487,Rattus norvegicus,,10116.0,N,,1,,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,,BAO_0000218,5408,
,,A,,Intermediate,1,,50597,CHEMBL625358,,9488,Rattus norvegicus,,10116.0,N,,1,,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,,BAO_0000218,5408,
,,A,,Intermediate,1,,50597,CHEMBL625359,,9489,Rattus norvegicus,,10116.0,N,,1,,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,,BAO_0000218,5408,
,,A,,Intermediate,1,,50597,CHEMBL625360,,9490,Rattus norvegicus,,10116.0,N,,1,,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,,BAO_0000218,5408,
,,A,,Intermediate,1,,50597,CHEMBL625361,,9491,Rattus norvegicus,,10116.0,N,,1,,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg ( 0-8 hr ),,BAO_0000218,429,
,,A,,Intermediate,1,,50597,CHEMBL625362,,9492,Rattus norvegicus,,10116.0,N,,1,,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr ),,BAO_0000218,429,
,,A,,Intermediate,1,,50597,CHEMBL625363,,9493,Rattus norvegicus,,10116.0,N,,1,,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr),,BAO_0000218,429,
,,A,,Intermediate,1,,50597,CHEMBL625364,,9494,Rattus norvegicus,,10116.0,N,,1,,Hepatic portal AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,,BAO_0000218,4796,
,,A,,Intermediate,1,,50597,CHEMBL625365,,9495,Rattus norvegicus,,10116.0,N,,1,,In vivo Area under curve (AUC) was determined after intravenous administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,BAO_0000218,5974,
,,A,,Intermediate,1,,50597,CHEMBL625366,,9496,Rattus norvegicus,,10116.0,N,,1,,In vivo Area under curve (AUC) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,BAO_0000218,5974,
,,A,,Intermediate,1,,50597,CHEMBL625367,,9497,Rattus norvegicus,,10116.0,N,,1,,In vivo Area under curve (AUC) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,BAO_0000218,5974,
,,A,,Intermediate,1,,50597,CHEMBL625368,2113.0,9498,Rattus norvegicus,,10116.0,N,Kidney,1,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.98-2.56 % dose/g",,BAO_0000218,11450,
,,A,,Intermediate,1,,50597,CHEMBL625369,2113.0,9499,Rattus norvegicus,,10116.0,N,Kidney,1,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.15-1.43 % dose/g",,BAO_0000218,11450,
,,A,,Intermediate,1,,50597,CHEMBL625370,2113.0,9500,Rattus norvegicus,,10116.0,N,Kidney,1,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.43-4.52 % dose/g",,BAO_0000218,11450,
,,A,,Intermediate,1,,50597,CHEMBL625371,2113.0,9501,Rattus norvegicus,,10116.0,N,Kidney,1,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.12-3.14 % dose/g",,BAO_0000218,11450,
,,A,,Intermediate,1,,50597,CHEMBL625372,2113.0,9502,Rattus norvegicus,,10116.0,N,Kidney,1,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.40-1.60 % dose/g",,BAO_0000218,11450,
,,A,,Intermediate,1,,50597,CHEMBL625373,2113.0,9503,Rattus norvegicus,,10116.0,N,Kidney,1,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.74-0.85 % dose/g",,BAO_0000218,11450,
,,A,,Intermediate,1,,50597,CHEMBL625374,2107.0,9504,Rattus norvegicus,,10116.0,N,Liver,1,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.31-1.45 % dose/g",,BAO_0000218,11450,
,,A,,Intermediate,1,,50597,CHEMBL877593,2107.0,9505,Rattus norvegicus,,10116.0,N,Liver,1,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.90 % dose/g",,BAO_0000218,11450,
,,A,,Intermediate,1,,50597,CHEMBL625375,2107.0,9506,Rattus norvegicus,,10116.0,N,Liver,1,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.02-2.78 % dose/g",,BAO_0000218,11450,
,,A,,Intermediate,1,,50597,CHEMBL625376,2107.0,9507,Rattus norvegicus,,10116.0,N,Liver,1,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.64-2.38 % dose/g",,BAO_0000218,11450,
,,A,,Intermediate,1,,50597,CHEMBL621973,2107.0,9508,Rattus norvegicus,,10116.0,N,Liver,1,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.95-1.07 % dose/g",,BAO_0000218,11450,
,,A,,Intermediate,1,,50597,CHEMBL621974,2107.0,9509,Rattus norvegicus,,10116.0,N,Liver,1,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.61-0.81 % dose/g",,BAO_0000218,11450,
,,A,,Intermediate,1,,50597,CHEMBL621975,2048.0,9510,Rattus norvegicus,,10116.0,N,Lung,1,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 5.01-7.13 % dose/g",,BAO_0000218,11450,
,,A,,Intermediate,1,,50597,CHEMBL622166,2048.0,9511,Rattus norvegicus,,10116.0,N,Lung,1,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.51-3.71 % dose/g",,BAO_0000218,11450,
,,A,,Intermediate,1,,50597,CHEMBL622167,2048.0,9512,Rattus norvegicus,,10116.0,N,Lung,1,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 10.84-13.77 % dose/g",,BAO_0000218,11450,
,,A,,Intermediate,1,,50597,CHEMBL622168,2048.0,9513,Rattus norvegicus,,10116.0,N,Lung,1,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.92-8.51% dose/g",,BAO_0000218,11450,
,,A,,Intermediate,1,,50597,CHEMBL622169,2048.0,9514,Rattus norvegicus,,10116.0,N,Lung,1,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.37-3.94 % dose/g",,BAO_0000218,11450,
,,A,,Intermediate,1,,50597,CHEMBL622170,2048.0,9515,Rattus norvegicus,,10116.0,N,Lung,1,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.87-2.12 % dose/g",,BAO_0000218,11450,
,,A,,Intermediate,1,,50597,CHEMBL622171,2046.0,9516,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 37.97-75.23 % dose/g",,BAO_0000218,11450,
,,A,,Intermediate,1,,50597,CHEMBL622172,2046.0,9517,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.03-36.88 % dose/g",,BAO_0000218,11450,
,,A,,Intermediate,1,,50597,CHEMBL622173,2046.0,9518,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 13.20-17.31 % dose/g",,BAO_0000218,11450,
,,A,,Intermediate,1,,50597,CHEMBL622174,2046.0,9519,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 7.87-16.51 % dose/g",,BAO_0000218,11450,
,,A,,Intermediate,1,,50597,CHEMBL622175,2046.0,9520,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 81.37-166.09 % dose/g",,BAO_0000218,11450,
,,A,,Intermediate,1,,50597,CHEMBL622176,2046.0,9521,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 31.90-39.98 % dose/g",,BAO_0000218,11450,
,,A,,Intermediate,1,,50597,CHEMBL622177,2046.0,9522,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.41-0.83 % dose/g",,BAO_0000218,11450,
,,A,,Intermediate,1,,50597,CHEMBL622178,2046.0,9523,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.05-0.38 % dose/g",,BAO_0000218,11450,
,,A,,Intermediate,1,,50597,CHEMBL622179,2046.0,9524,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.16-0.20 % dose/g",,BAO_0000218,11450,
,,A,,Intermediate,1,,50597,CHEMBL622180,2046.0,9525,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.17 % dose/g",,BAO_0000218,11450,
,,A,,Intermediate,1,,50597,CHEMBL622181,,9526,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL622182,,9527,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL622183,,9528,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL622184,,9529,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL622185,,9530,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL622186,,9531,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL622187,,9532,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL625002,,9533,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL622090,,9534,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL622091,,9535,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL622092,,9536,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL622093,,9537,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL622094,,9538,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL622095,,9539,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL622264,,9540,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL622265,2106.0,9541,Rattus norvegicus,,10116.0,N,Spleen,1,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL622266,2106.0,9542,Rattus norvegicus,,10116.0,N,Spleen,1,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL622267,2106.0,9543,Rattus norvegicus,,10116.0,N,Spleen,1,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL622268,2106.0,9544,Rattus norvegicus,,10116.0,N,Spleen,1,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL622269,2106.0,9545,Rattus norvegicus,,10116.0,N,Spleen,1,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL625071,2106.0,9546,Rattus norvegicus,,10116.0,N,Spleen,1,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL621621,2106.0,9547,Rattus norvegicus,,10116.0,N,Spleen,1,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL621622,2106.0,9548,Rattus norvegicus,,10116.0,N,Spleen,1,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL621623,2106.0,9549,Rattus norvegicus,,10116.0,N,Spleen,1,,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL621624,2106.0,9550,Rattus norvegicus,,10116.0,N,Spleen,1,,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL621625,2106.0,9551,Rattus norvegicus,,10116.0,N,Spleen,1,,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL621626,2106.0,9552,Rattus norvegicus,,10116.0,N,Spleen,1,,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL621627,2106.0,9553,Rattus norvegicus,,10116.0,N,Spleen,1,,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL621628,2106.0,9554,Rattus norvegicus,,10116.0,N,Spleen,1,,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL875328,2106.0,9555,Rattus norvegicus,,10116.0,N,Spleen,1,,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL621629,2106.0,9556,Rattus norvegicus,,10116.0,N,Spleen,1,,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL621630,2106.0,9557,Rattus norvegicus,,10116.0,N,Spleen,1,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL621631,2106.0,9558,Rattus norvegicus,,10116.0,N,Spleen,1,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL621632,2106.0,9559,Rattus norvegicus,,10116.0,N,Spleen,1,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL621633,2106.0,9560,Rattus norvegicus,,10116.0,N,Spleen,1,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL621634,2106.0,9561,Rattus norvegicus,,10116.0,N,Spleen,1,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL621635,2106.0,9562,Rattus norvegicus,,10116.0,N,Spleen,1,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL621636,2106.0,9563,Rattus norvegicus,,10116.0,N,Spleen,1,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL621637,2106.0,9564,Rattus norvegicus,,10116.0,N,Spleen,1,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL621638,2106.0,9565,Rattus norvegicus,,10116.0,N,Spleen,1,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL618883,,9566,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL618884,,9567,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL628627,,9568,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL628628,,9569,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL628629,,9570,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,BAO_0000218,16434,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628630,,9571,Rattus norvegicus,,10116.0,N,,1,,Half life after administering orally a dose of 3 mg/kg,,BAO_0000218,16365,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628631,,9572,Rattus norvegicus,,10116.0,N,,1,,Half life after administering orally a dose of 3 mg/kg to a fasting rat,,BAO_0000218,16365,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628632,,9573,Rattus norvegicus,,10116.0,N,,1,,Half life after administering intravenously a dose of 1 mg/kg,,BAO_0000218,16365,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628633,,9574,Rattus norvegicus,,10116.0,N,,1,,Half life after oral dosing in rats,,BAO_0000218,526,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628634,,9575,Rattus norvegicus,,10116.0,N,,1,,Half life after the administered orally a dose of 1 mg/kg to a fasting rat,,BAO_0000218,16365,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627789,,9576,Rattus norvegicus,,10116.0,N,,1,,Half life by intravenous administration of 3.4 mg/kg in rat,,BAO_0000218,4368,
,,A,,Intermediate,1,,50597,CHEMBL627790,,9577,Rattus norvegicus,,10116.0,N,,1,,Half life in rat,,BAO_0000218,3371,
,,A,,Intermediate,1,,50597,CHEMBL627791,,9578,Rattus norvegicus,,10116.0,N,,1,,Half life in rat,,BAO_0000218,6448,
,,A,,Intermediate,1,,50597,CHEMBL627792,,9579,Rattus norvegicus,,10116.0,N,,1,,Half life in rat,,BAO_0000218,6453,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627793,,9580,Rattus norvegicus,,10116.0,N,,1,,Half life in rat after intravenous administration of the compound,,BAO_0000218,4353,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627794,1969.0,9581,Rattus norvegicus,,10116.0,N,Plasma,1,,Half life in rat after intravenous administration of the compound; nf:unable to estimate plasma elimination half life,,BAO_0000218,4353,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627795,,9582,Rattus norvegicus,,10116.0,N,,1,,Half life in rat after po administration of the compound,,BAO_0000218,4353,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627796,,9583,Rattus norvegicus,,10116.0,N,,1,,Half life in rat after po administration of the compound; ND means Not determined,,BAO_0000218,4353,
In vivo,,A,,Intermediate,1,,50597,CHEMBL875335,1969.0,9584,Rattus norvegicus,,10116.0,N,Plasma,1,,Half life in rat after po administration of the compound; nf: unable to estimate plasma elimination half life,,BAO_0000218,4353,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627797,1969.0,9585,Rattus norvegicus,,10116.0,N,Plasma,1,,Half life in rat after po administration of the compound; nf:unable to estimate plasma elimination half life,,BAO_0000218,4353,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627798,,9586,Rattus norvegicus,,10116.0,N,,1,,Half life in rat i.v.,,BAO_0000218,5789,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627799,,9587,Rattus norvegicus,,10116.0,N,,1,,Half life in rat i.v. at 2 mg/kg concentration,,BAO_0000218,17686,
,,A,,Intermediate,1,,50597,CHEMBL627800,,9588,Rattus norvegicus,,10116.0,N,,1,,Half life in rats,,BAO_0000218,6495,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627801,,9589,Rattus norvegicus,,10116.0,N,,1,,Half life in rats after intravenous administration,,BAO_0000218,484,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627802,,9590,Rattus norvegicus,,10116.0,N,,1,,Half life in rats at the dose of 1.0 mpk by i.v. administration,,BAO_0000218,6467,
,,A,,Expert,1,,50597,CHEMBL627803,,9591,Rattus norvegicus,,10116.0,N,,1,,Half life in rat,,BAO_0000218,6642,
In vivo,,A,,Intermediate,1,,50597,CHEMBL873820,,9592,Rattus norvegicus,,10116.0,N,,1,,Half life was evaluated after intravenous administration to rats,,BAO_0000218,16367,
,,A,,Intermediate,1,,50597,CHEMBL627804,,9593,Rattus norvegicus,,10116.0,N,,1,,Half life was evaluated by addition of 2 mM of 2-mercaptoethanol for inactivation of semicarbazide-sensitive amine oxidase (SSAO),,BAO_0000218,1369,
,,A,,Intermediate,1,,50597,CHEMBL627805,,9594,Rattus norvegicus,,10116.0,N,,1,,Half life was evaluated in rat,,BAO_0000218,5472,
,,A,,Intermediate,1,,50597,CHEMBL627806,,9595,Rattus norvegicus,,10116.0,N,,1,,Half life was evaluated in rat,,BAO_0000218,6049,
,,A,,Intermediate,1,,50597,CHEMBL627107,,9596,Rattus norvegicus,,10116.0,N,,1,,Half life was evaluated in rat; Not tested,,BAO_0000218,5472,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627108,,9597,Rattus norvegicus,,10116.0,N,,1,,Half life was evaluated when a dose of 1 mg/kg was administered intravenously to rats,,BAO_0000218,16366,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627109,,9598,Rattus norvegicus,,10116.0,N,,1,,Half life was measured as time taken to reach the half of the initial dose in air pouch exudate after oral administration to male F344 rats,,BAO_0000218,11149,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627110,178.0,9599,Rattus norvegicus,,10116.0,N,Blood,1,,Half life was measured as time taken to reach the half of the initial dose in the blood after oral administration to male F344 rats,,BAO_0000218,11149,
In vivo,,A,,Intermediate,0,,22224,CHEMBL627111,,9600,Primates,,9443.0,U,,1,,Half life was measured in monkey at dose of 10 mg/kg by po administration,,BAO_0000218,2891,
In vivo,,A,,Intermediate,0,,22224,CHEMBL627112,,9601,Primates,,9443.0,U,,1,,Half life was measured in monkey at dose of 10 mg/kg by po administration,,BAO_0000218,2891,
In vivo,,A,,Intermediate,0,,22224,CHEMBL627113,,9602,Rattus norvegicus,,10116.0,U,,1,,Half life was measured in rat at dose of 30 mg/kg by iv administration,,BAO_0000218,2891,
In vivo,,A,,Intermediate,0,,22224,CHEMBL627114,,9603,Rattus norvegicus,,10116.0,U,,1,,Half life was measured in rat at dose of 30 mg/kg by po administration,,BAO_0000218,2891,
,,A,,Intermediate,1,,50597,CHEMBL627115,,9604,Rattus norvegicus,,10116.0,N,,1,,Half life (t1/2) was determined,,BAO_0000218,4026,
,,A,,Intermediate,1,,50597,CHEMBL627116,,9605,Rattus norvegicus,,10116.0,N,,1,,Half life period at a dose of 10 uM/kg in rat was determined,,BAO_0000218,4527,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627117,,9606,Rattus norvegicus,,10116.0,N,,1,,Half life period by oral administration at a dose of 100 uM/kg in rat was determined; ND is not determined,,BAO_0000218,4527,
,,A,,Intermediate,1,,50597,CHEMBL627118,,9607,Rattus norvegicus,,10116.0,N,,1,,Half life period was determined,,BAO_0000218,5503,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627119,,9608,Rattus norvegicus,,10116.0,N,,1,,Half life period after intravenous administration at 20 mpk in rats,,BAO_0000218,4426,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627120,,9609,Rattus norvegicus,,10116.0,N,,1,,Half life period after intravenous administration at 20 mpk in rats; Not performed.,,BAO_0000218,4426,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626922,,9610,Rattus norvegicus,,10116.0,N,,1,,Half life period after intravenous administration in rat,,BAO_0000218,6109,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626923,,9611,Rattus norvegicus,,10116.0,N,,1,,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,,BAO_0000218,5654,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626924,,9612,Rattus norvegicus,,10116.0,N,,1,,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,,BAO_0000218,5654,
,,A,,Intermediate,1,,50597,CHEMBL626925,1969.0,9613,Rattus norvegicus,,10116.0,N,Plasma,1,,Half life period in 80% rat plasma at 37 degree Centigrade,,BAO_0000218,4755,
,,A,,Intermediate,1,,50597,CHEMBL626926,,9614,Rattus norvegicus,,10116.0,N,,1,,Half life period in SD rats,,BAO_0000218,5862,
,,A,,Intermediate,1,,50597,CHEMBL626927,1969.0,9615,Rattus norvegicus,,10116.0,N,Plasma,1,,Half life period in human plasma at 25 degree Celsius temperature (pH 7.4),,BAO_0000218,1515,
,,A,,Intermediate,1,,50597,CHEMBL626928,1969.0,9616,Rattus norvegicus,,10116.0,N,Plasma,1,,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4),,BAO_0000218,1515,
,,A,,Intermediate,1,,50597,CHEMBL626929,1969.0,9617,Rattus norvegicus,,10116.0,N,Plasma,1,,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,,BAO_0000218,1515,
,,A,,Intermediate,1,,50597,CHEMBL626930,1969.0,9618,Rattus norvegicus,,10116.0,N,Plasma,1,,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,,BAO_0000218,1515,
,,A,,Intermediate,1,,50597,CHEMBL626931,,9619,Rattus norvegicus,,10116.0,N,,1,,Half life period in rat,,BAO_0000218,5960,
,,A,,Intermediate,1,,50597,CHEMBL626932,,9620,Rattus norvegicus,,10116.0,N,,1,,Half life period in rat,,BAO_0000218,6103,
,,A,,Intermediate,1,,50597,CHEMBL626933,,9621,Rattus norvegicus,,10116.0,N,,1,,Half life period in rat,,BAO_0000218,6317,
In vivo,,A,,Intermediate,1,,50597,CHEMBL873826,,9622,Rattus norvegicus,,10116.0,N,,1,,Half life period in rat after oral administration at 10.5 mg/kg dose,,BAO_0000218,6644,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626934,,9623,Rattus norvegicus,,10116.0,N,,1,,Half life period in rat after oral administration at 11.2 mg/kg dose,,BAO_0000218,6644,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626935,,9624,Rattus norvegicus,,10116.0,N,,1,,Half life period in rat after oral administration at 13 mg/kg dose,,BAO_0000218,6644,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626936,,9625,Rattus norvegicus,,10116.0,N,,1,,Half life period in rat after oral administration at 9.7 mg/kg dose,,BAO_0000218,6644,
,,A,,Intermediate,1,,50597,CHEMBL626937,,9626,Rattus norvegicus,,10116.0,N,,1,,In vivo Area under curve (AUC) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,BAO_0000218,5974,
,,A,,Intermediate,1,,50597,CHEMBL625906,,9627,Rattus norvegicus,,10116.0,N,,1,,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,,BAO_0000218,6295,
,,A,,Intermediate,1,,50597,CHEMBL625907,,9628,Rattus norvegicus,,10116.0,N,,1,,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,,BAO_0000218,6296,
,,A,,Intermediate,1,,50597,CHEMBL625908,,9629,Rattus norvegicus,,10116.0,N,,1,,PK study was carried to determine AUC (area under curve) value in rat,,BAO_0000218,16427,
,,A,,Intermediate,1,,50597,CHEMBL625909,,9630,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic parameter AUC after intravenous administration to rats,,BAO_0000218,16367,
,,A,,Intermediate,1,,50597,CHEMBL625910,,9631,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic parameter AUC after oral administration to rats,,BAO_0000218,16367,
,,A,,Intermediate,1,,50597,CHEMBL625911,,9632,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic parameter AUC was evaluated intravenous administration of 3 mg/kg,,BAO_0000218,16365,
,,A,,Intermediate,1,,50597,CHEMBL625912,,9633,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic parameter AUC was evaluated when a dose of 10 mg/kg is administered orally to a fasting rat,,BAO_0000218,16365,
,,A,,Intermediate,1,,50597,CHEMBL626538,,9634,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic parameter AUC was evaluated when a dose of 1 mg/kg is administered orally to a fasting rat,,BAO_0000218,16365,
,,A,,Intermediate,1,,50597,CHEMBL876794,,9635,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic parameter AUC was evaluated when a dose of 30 mg/kg is administered orally,,BAO_0000218,16365,
,,A,,Intermediate,1,,50597,CHEMBL626539,,9636,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally,,BAO_0000218,16365,
,,A,,Intermediate,1,,50597,CHEMBL626540,,9637,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally to a fasting rat,,BAO_0000218,16365,
,,A,,Intermediate,1,,50597,CHEMBL626541,,9638,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic parameter area under curve (AUC) was measured after administration into monkey at 3 mg/kg,,BAO_0000218,5394,
,,A,,Intermediate,1,,50597,CHEMBL626542,,9639,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic parameter area under curve (AUC) was measured after administration into rat at 10 mg/kg,,BAO_0000218,5394,
,,A,,Intermediate,1,,50597,CHEMBL626543,,9640,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic parameter area under curve was determined at 10 mg/kg po dose in rats,,BAO_0000218,2792,
,,A,,Intermediate,1,,50597,CHEMBL626544,,9641,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic parameter area under curve was determined at 2 mg/kg i.v. dose in rats,,BAO_0000218,2792,
,,A,,Intermediate,1,,50597,CHEMBL626545,,9642,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic parameter area under curve was determined at 3 mg/kg po dose in rats,,BAO_0000218,2792,
,,A,,Intermediate,1,,50597,CHEMBL626546,,9643,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic parameter area under curve was determined at 5 mg/kg i.v. dose in rats,,BAO_0000218,2792,
,,A,,Intermediate,1,,50597,CHEMBL626547,,9644,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic parameter area under curve was reported,,BAO_0000218,5334,
,,A,,Intermediate,1,,50597,CHEMBL626548,,9645,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic property (AUC) in rat,,BAO_0000218,4408,
,,A,,Intermediate,1,,50597,CHEMBL626549,,9646,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic property (AUC) was measured in rat at the dose of 0.32 mg/kg p.o.,,BAO_0000218,5983,
,,A,,Intermediate,1,,50597,CHEMBL626550,,9647,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.,,BAO_0000218,4397,
,,A,,Intermediate,1,,50597,CHEMBL626551,,9648,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.; Not tested,,BAO_0000218,4397,
,,A,,Intermediate,1,,50597,CHEMBL623777,,9649,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic property was determined,,BAO_0000218,5491,
,,A,,Intermediate,1,,50597,CHEMBL623778,,9650,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg,,BAO_0000218,5491,
,,A,,Intermediate,1,,50597,CHEMBL623779,,9651,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg; Not tested,,BAO_0000218,5491,
,,A,,Intermediate,1,,50597,CHEMBL623780,1969.0,9652,Rattus norvegicus,,10116.0,N,Plasma,1,,Pharmacokinetic property( plasma concentration) was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,,BAO_0000218,4199,
,,A,,Intermediate,1,,50597,CHEMBL622015,1969.0,9653,Rattus norvegicus,,10116.0,N,Plasma,1,,Pharmacokinetic property( plasma concentration) was determined upon 2 mg/kg in 1% methylcellulose peroral administration in rats,,BAO_0000218,4199,
,,A,,Intermediate,1,,50597,CHEMBL622016,1969.0,9654,Rattus norvegicus,,10116.0,N,Plasma,1,,Pharmacokinetic property( plasma concentration) was determined upon 3 mg/kg in 1% methylcellulose peroral administration in rats,,BAO_0000218,4199,
,,A,,Intermediate,1,,50597,CHEMBL622017,,9655,Rattus norvegicus,,10116.0,N,,1,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.25 h",,BAO_0000218,5173,
,,A,,Intermediate,1,,50597,CHEMBL622018,,9656,Rattus norvegicus,,10116.0,N,,1,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.5 h",,BAO_0000218,5173,
,,A,,Intermediate,1,,50597,CHEMBL622019,,9657,Rattus norvegicus,,10116.0,N,,1,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 1 h",,BAO_0000218,5173,
,,A,,Intermediate,1,,50597,CHEMBL622020,,9658,Rattus norvegicus,,10116.0,N,,1,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 2 h",,BAO_0000218,5173,
,,A,,Intermediate,1,,50597,CHEMBL622021,,9659,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered intravenously,,BAO_0000218,16366,
,,A,,Intermediate,1,,50597,CHEMBL622022,,9660,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered orally,,BAO_0000218,16366,
,,A,,Intermediate,1,,50597,CHEMBL622023,,9661,Rattus norvegicus,,10116.0,N,,1,,Plasma concentration expressed as area under curve after intravenous administration was determined in rat,,BAO_0000218,5327,
,,A,,Intermediate,1,,50597,CHEMBL622024,,9662,Rattus norvegicus,,10116.0,N,,1,,Plasma concentration for the compound was determined in rats at 50 mg/kg dose,,BAO_0000218,6681,
,,A,,Intermediate,1,,50597,CHEMBL622693,,9663,Rattus norvegicus,,10116.0,N,,1,,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of solution (formulation of compound),,BAO_0000218,12873,
,,A,,Intermediate,1,,50597,CHEMBL622694,,9664,Rattus norvegicus,,10116.0,N,,1,,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of suspension (formulation of compound),,BAO_0000218,12873,
,,A,,Intermediate,1,,50597,CHEMBL622695,,9665,Rattus norvegicus,,10116.0,N,,1,,"Plasma concentration was determined in rats at 10 mg/kg, p.o. dose",,BAO_0000218,6685,
,,A,,Intermediate,1,,50597,CHEMBL622696,,9666,Rattus norvegicus,,10116.0,N,,1,,"Plasma concentration was determined in rats at 20 mg/kg, i.p. dose",,BAO_0000218,6685,
,,A,,Intermediate,1,,50597,CHEMBL622697,,9667,Rattus norvegicus,,10116.0,N,,1,,"Plasma concentration was determined in rats at 2 mg/kg, i.v. dose",,BAO_0000218,6685,
,,A,,Intermediate,1,,50597,CHEMBL622874,,9668,Rattus norvegicus,,10116.0,N,,1,,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (20 mg/kg, 30 min pre-treatment)",,BAO_0000218,6619,
,,A,,Intermediate,1,,50597,CHEMBL622875,,9669,Rattus norvegicus,,10116.0,N,,1,,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (30 mg/kg, 30 min pre-treatment)",,BAO_0000218,6619,
,,A,,Intermediate,1,,50597,CHEMBL622876,,9670,Rattus norvegicus,,10116.0,N,,1,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,,BAO_0000218,10363,
,,A,,Intermediate,1,,50597,CHEMBL622877,,9671,Rattus norvegicus,,10116.0,N,,1,,Systemic AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,,BAO_0000218,4796,
,,A,,Intermediate,1,,50597,CHEMBL622878,,9672,Rattus norvegicus,,10116.0,N,,1,,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,,BAO_0000218,4910,
,,A,,Intermediate,1,,50597,CHEMBL622879,1969.0,9673,Rattus norvegicus,,10116.0,N,Plasma,1,,Tested for plasma concentration after intravenous administration (4.7 mg/kg) to male rats,,BAO_0000218,4910,
,,A,,Intermediate,1,,50597,CHEMBL877602,,9674,Rattus norvegicus,,10116.0,N,,1,,Tested for the pharmacokinetic parameter in rat and expressed as area under curve,,BAO_0000218,4839,
,,A,,Intermediate,1,,50597,CHEMBL622880,,9675,Rattus norvegicus,,10116.0,N,,1,,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",,BAO_0000218,15078,
,,A,,Intermediate,1,,50597,CHEMBL622881,,9676,Rattus norvegicus,,10116.0,N,,1,,"The AUC(0-infinitive) value in male wistar rat at 100 mg/kg, p.o. dose",,BAO_0000218,15078,
,,A,,Intermediate,1,,50597,CHEMBL622882,,9677,Rattus norvegicus,,10116.0,N,,1,,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",,BAO_0000218,15078,
,,A,,Intermediate,1,,50597,CHEMBL622883,,9678,Rattus norvegicus,,10116.0,N,,1,,"The AUC(0-t)value in male wistar rat at 100 mg/kg, p.o. dose",,BAO_0000218,15078,
,,A,,Intermediate,1,,50597,CHEMBL622884,2046.0,9679,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.16-2.39% dose/g",,BAO_0000218,11450,
,,A,,Intermediate,1,,50597,CHEMBL622885,2046.0,9680,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.99-1.40 % dose/g",,BAO_0000218,11450,
,,A,,Intermediate,1,,50597,CHEMBL622886,,9681,Rattus norvegicus,,10116.0,N,,1,,Antidiuretic activity expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,,BAO_0000218,8151,
,,A,,Intermediate,1,,50597,CHEMBL622887,,9682,Rattus norvegicus,,10116.0,N,,1,,Antidiuretic activity expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,BAO_0000218,8151,
,,A,,Intermediate,1,,50597,CHEMBL622888,1088.0,9683,Rattus norvegicus,,10116.0,N,Urine,1,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,,BAO_0000218,8151,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622889,178.0,9684,Rattus norvegicus,,10116.0,N,Blood,1,,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,BAO_0000218,8677,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622890,178.0,9685,Rattus norvegicus,,10116.0,N,Blood,1,,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,BAO_0000218,8677,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622891,178.0,9686,Rattus norvegicus,,10116.0,N,Blood,1,,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,BAO_0000218,8677,
In vivo,,A,,Intermediate,1,,50597,CHEMBL877603,178.0,9687,Rattus norvegicus,,10116.0,N,Blood,1,,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,BAO_0000218,8677,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622892,955.0,9688,Rattus norvegicus,,10116.0,N,Brain,1,,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,BAO_0000218,8677,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622893,955.0,9689,Rattus norvegicus,,10116.0,N,Brain,1,,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,BAO_0000218,8677,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622894,955.0,9690,Rattus norvegicus,,10116.0,N,Brain,1,,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,BAO_0000218,8677,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622895,955.0,9691,Rattus norvegicus,,10116.0,N,Brain,1,,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,BAO_0000218,8677,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622896,955.0,9692,Rattus norvegicus,,10116.0,N,Brain,1,,Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration.,,BAO_0000218,8677,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622897,948.0,9693,Rattus norvegicus,,10116.0,N,Heart,1,,"Biodistribution in Sprague-Dawley rat heart 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,BAO_0000218,8677,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622898,948.0,9694,Rattus norvegicus,,10116.0,N,Heart,1,,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,BAO_0000218,8677,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622899,948.0,9695,Rattus norvegicus,,10116.0,N,Heart,1,,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,BAO_0000218,8677,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622900,2113.0,9696,Rattus norvegicus,,10116.0,N,Kidney,1,,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,BAO_0000218,8677,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624114,2113.0,9697,Rattus norvegicus,,10116.0,N,Kidney,1,,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,BAO_0000218,8677,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624115,2113.0,9698,Rattus norvegicus,,10116.0,N,Kidney,1,,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,BAO_0000218,8677,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624116,2113.0,9699,Rattus norvegicus,,10116.0,N,Kidney,1,,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,BAO_0000218,8677,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624117,2107.0,9700,Rattus norvegicus,,10116.0,N,Liver,1,,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,BAO_0000218,8677,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624118,2107.0,9701,Rattus norvegicus,,10116.0,N,Liver,1,,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,BAO_0000218,8677,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624119,2107.0,9702,Rattus norvegicus,,10116.0,N,Liver,1,,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,BAO_0000218,8677,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624120,2107.0,9703,Rattus norvegicus,,10116.0,N,Liver,1,,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,BAO_0000218,8677,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624121,2048.0,9704,Rattus norvegicus,,10116.0,N,Lung,1,,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,BAO_0000218,8677,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624122,2048.0,9705,Rattus norvegicus,,10116.0,N,Lung,1,,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,BAO_0000218,8677,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624123,2048.0,9706,Rattus norvegicus,,10116.0,N,Lung,1,,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,BAO_0000218,8677,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624124,2048.0,9707,Rattus norvegicus,,10116.0,N,Lung,1,,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,BAO_0000218,8677,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624125,2385.0,9708,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,BAO_0000218,8677,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624126,2385.0,9709,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,BAO_0000218,8677,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624127,2385.0,9710,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,BAO_0000218,8677,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624128,2385.0,9711,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,BAO_0000218,8677,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624129,14.0,9712,Rattus norvegicus,,10116.0,N,Zone of skin,1,,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,BAO_0000218,8677,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624130,14.0,9713,Rattus norvegicus,,10116.0,N,Zone of skin,1,,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,BAO_0000218,8677,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622340,14.0,9714,Rattus norvegicus,,10116.0,N,Zone of skin,1,,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,BAO_0000218,8677,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622341,14.0,9715,Rattus norvegicus,,10116.0,N,Zone of skin,1,,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,BAO_0000218,8677,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622342,160.0,9716,Rattus norvegicus,,10116.0,N,Intestine,1,,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,BAO_0000218,8677,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622343,160.0,9717,Rattus norvegicus,,10116.0,N,Intestine,1,,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,BAO_0000218,8677,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622344,160.0,9718,Rattus norvegicus,,10116.0,N,Intestine,1,,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,BAO_0000218,8677,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622345,160.0,9719,Rattus norvegicus,,10116.0,N,Intestine,1,,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,BAO_0000218,8677,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622346,2106.0,9720,Rattus norvegicus,,10116.0,N,Spleen,1,,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,BAO_0000218,8677,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622347,2106.0,9721,Rattus norvegicus,,10116.0,N,Spleen,1,,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,BAO_0000218,8677,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622348,2106.0,9722,Rattus norvegicus,,10116.0,N,Spleen,1,,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,BAO_0000218,8677,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622349,2106.0,9723,Rattus norvegicus,,10116.0,N,Spleen,1,,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,BAO_0000218,8677,
,,A,,Intermediate,1,,50597,CHEMBL622350,,9724,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL622351,,9725,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL622352,,9726,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL622353,,9727,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL622354,,9728,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL622355,,9729,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL622356,,9730,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL622357,,9731,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL622358,,9732,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL622359,,9733,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL874393,,9734,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL622872,,9735,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL622873,,9736,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL623047,,9737,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL623048,,9738,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL623049,,9739,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL623050,,9740,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL623051,,9741,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL623052,,9742,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL626343,,9743,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL626344,,9744,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL626345,,9745,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL626346,,9746,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL626347,,9747,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL626348,,9748,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,BAO_0000218,16434,
,,A,,Intermediate,1,,50597,CHEMBL626349,,9749,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,BAO_0000218,16434,
,,F,,Intermediate,1,,50597,CHEMBL626350,,9750,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL626351,,9751,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL627650,,9752,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,BAO_0000218,16435,
,,F,,Intermediate,1,,50597,CHEMBL627651,,9753,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL627652,,9754,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL627653,,9755,Rattus norvegicus,,10116.0,N,,1,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,BAO_0000218,16435,
,,A,,Intermediate,1,,50597,CHEMBL627654,,9756,Rattus norvegicus,,10116.0,N,,1,,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr blocked time interval,,BAO_0000218,13091,
,,A,,Intermediate,1,,50597,CHEMBL627835,,9757,Rattus norvegicus,,10116.0,N,,1,,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr low time interval,,BAO_0000218,13091,
,,A,,Intermediate,1,,50597,CHEMBL627836,,9758,Rattus norvegicus,,10116.0,N,,1,,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr time interval,,BAO_0000218,13091,
,,A,,Intermediate,1,,50597,CHEMBL627837,,9759,Rattus norvegicus,,10116.0,N,,1,,Tissue biodistribution into estrogen-primed immature female rat blood at 3 hr time interval,,BAO_0000218,13091,
,,A,,Intermediate,1,,50597,CHEMBL627838,,9760,Rattus norvegicus,,10116.0,N,,1,,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr blocked time interval,,BAO_0000218,13091,
,,A,,Intermediate,1,,50597,CHEMBL875338,,9761,Rattus norvegicus,,10116.0,N,,1,,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr low time interval,,BAO_0000218,13091,
,,A,,Intermediate,1,,50597,CHEMBL627839,,9762,Rattus norvegicus,,10116.0,N,,1,,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr time interval,,BAO_0000218,13091,
,,A,,Intermediate,1,,50597,CHEMBL627840,,9763,Rattus norvegicus,,10116.0,N,,1,,Tissue biodistribution into estrogen-primed immature female rat bone at 3 hr time interval,,BAO_0000218,13091,
,,A,,Intermediate,1,,50597,CHEMBL627841,,9764,Rattus norvegicus,,10116.0,N,,1,,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr blocked time interval,,BAO_0000218,13091,
,,A,,Intermediate,1,,50597,CHEMBL627842,,9765,Rattus norvegicus,,10116.0,N,,1,,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr low time interval,,BAO_0000218,13091,
,,A,,Intermediate,1,,50597,CHEMBL627843,,9766,Rattus norvegicus,,10116.0,N,,1,,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr time interval,,BAO_0000218,13091,
,,A,,Intermediate,1,,50597,CHEMBL627844,,9767,Rattus norvegicus,,10116.0,N,,1,,Tissue biodistribution into estrogen-primed immature female rat brain at 3 hr time interval,,BAO_0000218,13091,
,,A,,Intermediate,1,,50597,CHEMBL627845,,9768,Rattus norvegicus,,10116.0,N,,1,,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr blocked time interval,,BAO_0000218,13091,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627846,,9769,Rattus norvegicus,,10116.0,N,,1,,Half life period in rat by iv administration at a dose of 3 mg/kg,,BAO_0000218,5874,
,,A,,Intermediate,1,,50597,CHEMBL627847,1969.0,9770,Rattus norvegicus,,10116.0,N,Plasma,1,,Half life period in rat plasma at 25 degree Centigrade temperature (pH 7.4),,BAO_0000218,1515,
,,A,,Intermediate,1,,50597,CHEMBL873821,1969.0,9771,Rattus norvegicus,,10116.0,N,Plasma,1,,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4),,BAO_0000218,1515,
,,A,,Intermediate,1,,50597,CHEMBL626079,1969.0,9772,Rattus norvegicus,,10116.0,N,Plasma,1,,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,,BAO_0000218,1515,
,,A,,Intermediate,1,,50597,CHEMBL626080,1969.0,9773,Rattus norvegicus,,10116.0,N,Plasma,1,,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,,BAO_0000218,1515,
,,A,,Intermediate,1,,50597,CHEMBL626081,1969.0,9774,Rattus norvegicus,,10116.0,N,Plasma,1,,Half life period was evaluated in rat plasma,,BAO_0000218,5491,
,,A,,Intermediate,1,,50597,CHEMBL875344,1969.0,9775,Rattus norvegicus,,10116.0,N,Plasma,1,,Half life period was evaluated in rat plasma; Not tested,,BAO_0000218,5491,
,,A,,Intermediate,1,,50597,CHEMBL626082,,9776,Rattus norvegicus,,10116.0,N,,1,,Half life period was evaluated in rats,,BAO_0000218,1918,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626250,,9777,Rattus norvegicus,,10116.0,N,,1,,"Half life period was evaluated in rats, iv",,BAO_0000218,1918,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626251,,9778,Rattus norvegicus,,10116.0,N,,1,,Half life period after intravenous administration at 5 mg/kg in rat,,BAO_0000218,6113,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626252,,9779,Rattus norvegicus,,10116.0,N,,1,,Half life period was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,,BAO_0000218,5546,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626253,,9780,Rattus norvegicus,,10116.0,N,,1,,Half life period was determined in rat after iv administration at a dose of 5 mg/kg,,BAO_0000218,5553,
,,A,,Intermediate,1,,50597,CHEMBL626254,1969.0,9781,Rattus norvegicus,,10116.0,N,Plasma,1,,Half life stability of compound was evaluated in rat plasma,,BAO_0000218,4188,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626255,,9782,Rattus norvegicus,,10116.0,N,,1,,Half life time after intravenous administration (5.0 mg/kg) was determined in rat,,BAO_0000218,6215,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626256,,9783,Rattus norvegicus,,10116.0,N,,1,,Half life time was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,,BAO_0000218,6141,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626257,,9784,Rattus norvegicus,,10116.0,N,,1,,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,,BAO_0000218,5182,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626258,,9785,Rattus norvegicus,,10116.0,N,,1,,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat; NC means not calculated,,BAO_0000218,5182,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626259,,9786,Rattus norvegicus,,10116.0,N,,1,,Half life was measured in fasted male administration of compound 0.5 mg/Kg i.v.,,BAO_0000218,5710,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626260,,9787,Rattus norvegicus,,10116.0,N,,1,,Half in rat i.v.,,BAO_0000218,5789,
In vivo,,A,,Intermediate,1,,50597,CHEMBL875345,,9788,Rattus norvegicus,,10116.0,N,,1,,Half period in rat after intravenous administration,,BAO_0000218,6011,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626261,,9789,Rattus norvegicus,,10116.0,N,,1,,Half-life after repeated oral dose of compound at 1 mg/kg in rats,,BAO_0000218,17594,
In vitro,,A,,Intermediate,1,,50597,CHEMBL626262,2107.0,9790,Rattus norvegicus,,10116.0,N,Liver,1,,Half-life measured in in vitro Cathepsin B assay in rat liver,,BAO_0000218,12357,
,,A,,Intermediate,1,,50597,CHEMBL626263,,9791,Rattus norvegicus,,10116.0,N,,1,,Half-life of compound was determined in rats,,BAO_0000218,5210,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625270,,9792,Rattus norvegicus,,10116.0,N,,1,,Half-life at 10 mg/kg in rat upon intravenous administration,,BAO_0000218,17596,
,,A,,Intermediate,1,,50597,CHEMBL625271,,9793,Rattus norvegicus,,10116.0,N,,1,,Half-life determined in rat,,BAO_0000218,6672,
,,A,,Intermediate,1,,50597,CHEMBL625272,,9794,Rattus norvegicus,,10116.0,N,,1,,Half-life determined in rat,,BAO_0000218,6673,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625273,955.0,9795,Rattus norvegicus,,10116.0,N,Brain,1,,Half-life in brain after intravenous administration (4.7 mg/kg) to male rats,,BAO_0000218,4910,
,,A,,Intermediate,1,,50597,CHEMBL625274,1969.0,9796,Rattus norvegicus,,10116.0,N,Plasma,1,,"Half-life in chemical and enzymatic hydrolysis, in 80% rat plasma",,BAO_0000218,3741,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625275,,9797,Rattus norvegicus,,10116.0,N,,1,,Half-life in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,BAO_0000218,17671,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625276,1969.0,9798,Rattus norvegicus,,10116.0,N,Plasma,1,,Half-life in plasma after intravenous administration (4.7 mg/kg) to male rats,,BAO_0000218,4910,
,,A,,Intermediate,1,,50597,CHEMBL625277,1969.0,9799,Rattus norvegicus,,10116.0,N,Plasma,1,,Half-life in rat plasma,,BAO_0000218,17537,
,,A,,Intermediate,1,,50597,CHEMBL625278,1969.0,9800,Rattus norvegicus,,10116.0,N,Plasma,1,,Half-life in rat plasma was determined,,BAO_0000218,4965,
,,A,,Intermediate,1,,50597,CHEMBL625279,1969.0,9801,Rattus norvegicus,,10116.0,N,Plasma,1,,Half-life in rat plasma; Not tested,,BAO_0000218,17537,
,,A,,Intermediate,1,,50597,CHEMBL625280,1977.0,9802,Rattus norvegicus,,10116.0,N,Serum,1,,Half-life in rat serum,,BAO_0000218,6124,
,,A,,Intermediate,1,,50597,CHEMBL876797,1977.0,9803,Rattus norvegicus,,10116.0,N,Serum,1,,Half-life in rat serum; na is not available,,BAO_0000218,6124,
,,A,,Intermediate,1,,50597,CHEMBL625281,,9804,Rattus norvegicus,,10116.0,N,,1,,Half-life was calculated in rat,,BAO_0000218,6078,
,,A,,Intermediate,1,,50597,CHEMBL873827,1969.0,9805,Rattus norvegicus,,10116.0,N,Plasma,1,,Half-life was calculated in rat plasma,,BAO_0000218,17668,
,,A,,Intermediate,1,,50597,CHEMBL625282,,9806,Rattus norvegicus,,10116.0,N,,1,,Half-life was determined,,BAO_0000218,3185,
,,A,,Intermediate,1,,50597,CHEMBL625283,,9807,Rattus norvegicus,,10116.0,N,,1,,Half-life was determined,,BAO_0000218,4883,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625284,,9808,Rattus norvegicus,,10116.0,N,,1,,Half-life after administration of 20 mg/Kg oral dose in rat,,BAO_0000218,2959,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625285,,9809,Rattus norvegicus,,10116.0,N,,1,,Half-life after administration of 3.2 mg/kg intravenously in male rat,,BAO_0000218,4029,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625286,,9810,Rattus norvegicus,,10116.0,N,,1,,Half-life after intravenous administration in female rat,,BAO_0000218,4029,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625287,,9811,Rattus norvegicus,,10116.0,N,,1,,Half-life after intravenous administration in male rat,,BAO_0000218,4029,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625288,,9812,Rattus norvegicus,,10116.0,N,,1,,Half-life after intravenous dose in rat,,BAO_0000218,6180,
,,A,,Intermediate,1,,50597,CHEMBL625289,2107.0,9813,Rattus norvegicus,,10116.0,N,Liver,1,,Half-life in a rat liver homogenate preparation,,BAO_0000218,1557,
,,A,,Intermediate,1,,50597,CHEMBL625290,1969.0,9814,Rattus norvegicus,,10116.0,N,Plasma,1,,Half-life in plasma of rat,,BAO_0000218,12500,
,,A,,Intermediate,1,,50597,CHEMBL876798,1969.0,9815,Rattus norvegicus,,10116.0,N,Plasma,1,,Half-life in plasma of rat at dose of 3-10 mgkg,,BAO_0000218,12500,
,,A,,Intermediate,1,,50597,CHEMBL625291,,9816,Rattus norvegicus,,10116.0,N,,1,,Half-life in rat,,BAO_0000218,5064,
,,A,,Intermediate,1,,50597,CHEMBL625292,,9817,Rattus norvegicus,,10116.0,N,,1,,Half-life in rat,,BAO_0000218,5145,
,,A,,Intermediate,1,,50597,CHEMBL625293,,9818,Rattus norvegicus,,10116.0,N,,1,,Half-life in rat,,BAO_0000218,5147,
,,A,,Intermediate,1,,50597,CHEMBL622832,,9819,Rattus norvegicus,,10116.0,N,,1,,Half-life in rat,,BAO_0000218,5833,
,,A,,Intermediate,1,,50597,CHEMBL622833,,9820,Rattus norvegicus,,10116.0,N,,1,,Half-life in rat,,BAO_0000218,6596,
,,A,,Intermediate,1,,50597,CHEMBL622834,,9821,Rattus norvegicus,,10116.0,N,,1,,Half-life in rat,,BAO_0000218,17655,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622835,,9822,Rattus norvegicus,,10116.0,N,,1,,Half-life in rat after oral administration at 10 mg/kg,,BAO_0000218,6495,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622836,,9823,Rattus norvegicus,,10116.0,N,,1,,Half-life in rat after po administration at a dose of 10 mg/kg,,BAO_0000218,17538,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622837,,9824,Rattus norvegicus,,10116.0,N,,1,,Half-life in rat after po administration at a dose of 10 mg/kg; nd is not determined,,BAO_0000218,17538,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622838,,9825,Rattus norvegicus,,10116.0,N,,1,,Half-life in rat at 3 mg/kg dose administered intravenously,,BAO_0000218,10,
,,A,,Intermediate,1,,50597,CHEMBL622839,955.0,9826,Rattus norvegicus,,10116.0,N,Brain,1,,Half-life in rat brain homogenate,,BAO_0000218,17669,
,,A,,Intermediate,1,,50597,CHEMBL622840,1969.0,9827,Rattus norvegicus,,10116.0,N,Plasma,1,,Half-life in rat plasma,,BAO_0000218,17065,
,,A,,Intermediate,1,,50597,CHEMBL622841,,9828,Rattus norvegicus,,10116.0,N,,1,,Half-life in rats,,BAO_0000218,4333,
,,A,,Intermediate,1,,50597,CHEMBL622842,,9829,Rattus norvegicus,,10116.0,N,,1,,Half-life in Dawley rats,,BAO_0000218,6827,
In vitro,,A,,Intermediate,1,,50597,CHEMBL622843,1969.0,9830,Rattus norvegicus,,10116.0,N,Plasma,1,,Half-life in vitro in rat plasma,,BAO_0000218,889,
In vitro,,A,,Intermediate,1,,50597,CHEMBL622844,1969.0,9831,Rattus norvegicus,,10116.0,N,Plasma,1,,Half-life in vitro in rat plasma; No detectable degradation over 2 hr; no detectable degradation over 2 hours,,BAO_0000218,889,
,,A,,Intermediate,1,,50597,CHEMBL622845,,9832,Rattus norvegicus,,10116.0,N,,1,,"The area under concentration-time curve(AUC) was determined at 20 mg/kg of compound dose, administered intravenously in rat",,BAO_0000218,3747,
,,A,,Intermediate,1,,50597,CHEMBL622846,,9833,Rattus norvegicus,,10116.0,N,,1,,The area under the curve of compound was measured at the dose of 100 umol/kg,,BAO_0000218,15022,
,,A,,Intermediate,1,,50597,CHEMBL622847,,9834,Rattus norvegicus,,10116.0,N,,1,,The area under the curve of compound was measured at the dose of 300 umol/kg,,BAO_0000218,15022,
,,A,,Intermediate,1,,50597,CHEMBL622848,,9835,Rattus norvegicus,,10116.0,N,,1,,The area under the curve of compound was measured at the dose of 30 umol/kg,,BAO_0000218,15022,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622849,,9836,Rattus norvegicus,,10116.0,N,,1,,Bioavailability as oral AUC in rats,,BAO_0000218,3360,
,,A,,Intermediate,1,,50597,CHEMBL622850,1969.0,9837,Rattus norvegicus,,10116.0,N,Plasma,1,,The plasma concentration versus time curve (AUC) was determined,,BAO_0000218,5334,
,,A,,Intermediate,1,,50597,CHEMBL876807,,9838,Rattus norvegicus,,10116.0,N,,1,,Total concentration in kidney was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,BAO_0000218,17411,
,,A,,Intermediate,1,,50597,CHEMBL622851,,9839,Rattus norvegicus,,10116.0,N,,1,,Total concentration in liver was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,BAO_0000218,17411,
,,A,,Intermediate,1,,50597,CHEMBL622852,,9840,Rattus norvegicus,,10116.0,N,,1,,Total concentration in lung was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,BAO_0000218,17411,
,,A,,Intermediate,1,,50597,CHEMBL622853,,9841,Rattus norvegicus,,10116.0,N,,1,,Total concentration in rat after 1 mg/kg i.v. administration in 24 hours,,BAO_0000218,6570,
,,A,,Intermediate,1,,50597,CHEMBL622854,,9842,Rattus norvegicus,,10116.0,N,,1,,Total concentration in rat after 2 mg/kg peroral administration in 24 hours,,BAO_0000218,6570,
,,A,,Intermediate,1,,50597,CHEMBL622855,,9843,Rattus norvegicus,,10116.0,N,,1,,Total concentration in serum was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,BAO_0000218,17411,
,,A,,Intermediate,1,,50597,CHEMBL622856,1969.0,9844,Rattus norvegicus,,10116.0,N,Plasma,1,,"Pharmacokinetic Parameter, AUC (0-infinity) is the area under the plasma concentration versus time curve extrapolated to infinity in Female Wistar Rats at 100 mg/kg by po administration",,BAO_0000218,14941,
,,A,,Intermediate,1,,50597,CHEMBL622857,1969.0,9845,Rattus norvegicus,,10116.0,N,Plasma,1,,"Pharmacokinetic Parameter, AUC (0-t) is the area under the plasma concentration versus time curve in Female Wistar Rats at 100 mg/kg by po administration",,BAO_0000218,14941,
,,A,,Intermediate,1,,50597,CHEMBL622858,1969.0,9846,Rattus norvegicus,,10116.0,N,Plasma,1,,AUC in rat after po administration at a dose of 10 mg/kg,,BAO_0000218,17538,
,,A,,Intermediate,1,,50597,CHEMBL622859,1969.0,9847,Rattus norvegicus,,10116.0,N,Plasma,1,,Area under the plasma concentration-time curve in rats after oral administration at 25 mg/kg,,BAO_0000218,17752,
,,A,,Intermediate,1,,50597,CHEMBL622860,,9848,Rattus norvegicus,,10116.0,N,,1,,Area under curve value 24 hr after 10 mg/kg iv administration in rats,,BAO_0000218,17509,
,,A,,Intermediate,1,,50597,CHEMBL622861,,9849,Rattus norvegicus,,10116.0,N,,1,,Area under curve value 24 hr after 10 mg/kg oral administration in rats,,BAO_0000218,17509,
,,A,,Intermediate,1,,50597,CHEMBL622862,,9850,Rattus norvegicus,,10116.0,N,,1,,Area under curve value 24 hr after 2 mg/kg iv administration in rats,,BAO_0000218,17509,
,,A,,Intermediate,1,,50597,CHEMBL622863,,9851,Rattus norvegicus,,10116.0,N,,1,,Area under curve value 24 hr after 2 mg/kg oral administration in rats,,BAO_0000218,17509,
,,A,,Intermediate,1,,50597,CHEMBL623817,,9852,Rattus norvegicus,,10116.0,N,,1,,Area under curve value 6 hr after po administration in rat,,BAO_0000218,17509,
,,A,,Intermediate,1,,50597,CHEMBL623818,,9853,Rattus norvegicus,,10116.0,N,,1,,Area under the curve at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,,BAO_0000218,17717,
,,A,,Intermediate,1,,50597,CHEMBL623819,,9854,Rattus norvegicus,,10116.0,N,,1,,"Area under the curve at a concentration of 3 mg/kg in rats, intravenously",,BAO_0000218,17717,
,,A,,Intermediate,1,,50597,CHEMBL623820,,9855,Rattus norvegicus,,10116.0,N,,1,,Area under the curve at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,,BAO_0000218,17717,
,,A,,Intermediate,1,,50597,CHEMBL623821,,9856,Rattus norvegicus,,10116.0,N,,1,,Area under the curve at a concentration of 60 mg/kg perorally in rats along with control,,BAO_0000218,17717,
,,A,,Intermediate,1,,50597,CHEMBL623822,1969.0,9857,Rattus norvegicus,,10116.0,N,Plasma,1,,AUC normalized for dose (AUCN) in rat,,BAO_0000218,6642,
,,A,,Intermediate,1,,50597,CHEMBL623823,,9858,Rattus norvegicus,,10116.0,N,,1,,Area under curve in rat after p.o. administration,,BAO_0000218,6640,
,,A,,Intermediate,1,,50597,CHEMBL623824,,9859,Rattus norvegicus,,10116.0,N,,1,,Area under curve in rat after p.o. administration,,BAO_0000218,6641,
,,A,,Intermediate,1,,50597,CHEMBL623825,,9860,Rattus norvegicus,,10116.0,N,,1,,Area under curve in rat after p.o. administration; Not determined,,BAO_0000218,6641,
,,A,,Intermediate,1,,50597,CHEMBL622070,,9861,Rattus norvegicus,,10116.0,N,,1,,Area under curve in rat after peroral administration,,BAO_0000218,6641,
,,A,,Intermediate,1,,50597,CHEMBL622071,,9862,Rattus norvegicus,,10116.0,N,,1,,Area under curve (carotid artery) value of the compound,,BAO_0000218,3603,
,,A,,Intermediate,1,,50597,CHEMBL622072,,9863,Rattus norvegicus,,10116.0,N,,1,,Bioavailability expressed as the area under curve of rat carotid artery,,BAO_0000218,3550,
,,A,,Intermediate,1,,50597,CHEMBL622073,,9864,Rattus norvegicus,,10116.0,N,,1,,Area under curve in male SD rats was observed after intravenous administration in rat,,BAO_0000218,15662,
,,A,,Intermediate,1,,50597,CHEMBL622074,,9865,Rattus norvegicus,,10116.0,N,,1,,Area under curve of the compound was determined,,BAO_0000218,17720,
,,A,,Intermediate,1,,50597,CHEMBL622075,,9866,Rattus norvegicus,,10116.0,N,,1,,Compound was evaluated for its pharmacokinetic parameter maximum area under curve AUCmax,,BAO_0000218,5407,
,,A,,Intermediate,1,,50597,CHEMBL622076,1969.0,9867,Rattus norvegicus,,10116.0,N,Plasma,1,,Area under the plasma concentration-time curve in rats after oral administration at 20 mg/kg,,BAO_0000218,17752,
,,A,,Intermediate,1,,50597,CHEMBL622077,1969.0,9868,Rattus norvegicus,,10116.0,N,Plasma,1,,Area under the plasma concentration-time curve in rats following oral administration at 20 mg/kg,,BAO_0000218,17752,
,,A,,Intermediate,1,,50597,CHEMBL622078,,9869,Rattus norvegicus,,10116.0,N,,1,,Area under curve (portal vein) value of the compound,,BAO_0000218,3603,
,,A,,Intermediate,1,,50597,CHEMBL622079,,9870,Rattus norvegicus,,10116.0,N,,1,,Bioavailability expressed as the area under curve of rat portal vein,,BAO_0000218,3550,
,,A,,Intermediate,1,,50597,CHEMBL622080,1969.0,9871,Rattus norvegicus,,10116.0,N,Plasma,1,,Area Under plasma concentration time curve in rat upon peroral administration,,BAO_0000218,17655,
,,A,,Intermediate,1,,50597,CHEMBL877612,,9872,Rattus norvegicus,,10116.0,N,,1,,In vivo area under curve was determined for the compound after i.v. administration at a dose of 5 mg/kg in rats,,BAO_0000218,17582,
,,A,,Intermediate,1,,50597,CHEMBL622081,,9873,Rattus norvegicus,,10116.0,N,,1,,In vivo area under curve was determined for the compound after oral (po) administration at a dose of 10 mg/kg in rats,,BAO_0000218,17582,
,,A,,Intermediate,1,,50597,CHEMBL622082,,9874,Rattus norvegicus,,10116.0,N,,1,,Compound was evaluated for oral bioavailability in rats,,BAO_0000218,17791,
,,A,,Intermediate,1,,50597,CHEMBL622083,,9875,Rattus norvegicus,,10116.0,N,,1,,Compound was evaluated for oral bioavailability in rats after iv administration,,BAO_0000218,17791,
,,A,,Intermediate,1,,50597,CHEMBL622084,,9876,Rattus norvegicus,,10116.0,N,,1,,Compound was evaluated for oral bioavailability in rats; 30-80,,BAO_0000218,17791,
,,A,,Intermediate,1,,50597,CHEMBL622085,,9877,Rattus norvegicus,,10116.0,N,,1,,Compound was evaluated for oral bioavailability in rats; 50-60,,BAO_0000218,17791,
,,A,,Intermediate,1,,50597,CHEMBL622086,,9878,Rattus norvegicus,,10116.0,N,,1,,Compound was evaluated for oral bioavailability in rats; no data,,BAO_0000218,17791,
,,A,,Intermediate,1,,50597,CHEMBL622087,,9879,Rattus norvegicus,,10116.0,N,,1,,Compound was evaluated for oral bioavailability in rats; peptide,,BAO_0000218,17791,
,,A,,Intermediate,1,,50597,CHEMBL622088,178.0,9880,Rattus norvegicus,,10116.0,N,Blood,1,,"Distribution of radioactivity in blood of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.03",,BAO_0000218,7768,
,,A,,Intermediate,1,,50597,CHEMBL622089,178.0,9881,Rattus norvegicus,,10116.0,N,Blood,1,,"Distribution of radioactivity in blood of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range-0.9-1.03",,BAO_0000218,7768,
,,A,,Intermediate,1,,50597,CHEMBL623685,178.0,9882,Rattus norvegicus,,10116.0,N,Blood,1,,"Distribution of radioactivity in blood of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.88-1.15",,BAO_0000218,7768,
,,A,,Intermediate,1,,50597,CHEMBL623686,178.0,9883,Rattus norvegicus,,10116.0,N,Blood,1,,"Distribution of radioactivity in blood of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range = 0.71-0.87",,BAO_0000218,7768,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623687,945.0,9884,Rattus norvegicus,,10116.0,N,Stomach,1,,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,BAO_0000218,8677,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623688,945.0,9885,Rattus norvegicus,,10116.0,N,Stomach,1,,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,BAO_0000218,8677,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623689,945.0,9886,Rattus norvegicus,,10116.0,N,Stomach,1,,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,BAO_0000218,8677,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622485,945.0,9887,Rattus norvegicus,,10116.0,N,Stomach,1,,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,BAO_0000218,8677,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622486,2046.0,9888,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,BAO_0000218,8677,
In vivo,,A,,Intermediate,1,,50597,CHEMBL877613,2046.0,9889,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,BAO_0000218,8677,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622487,2046.0,9890,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,BAO_0000218,8677,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622488,2046.0,9891,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,BAO_0000218,8677,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622489,948.0,9892,Rattus norvegicus,,10116.0,N,Heart,1,,"Biodistribution in Sprague-Dawley rats heart 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,BAO_0000218,8677,
,,A,,Intermediate,1,,50597,CHEMBL622490,1088.0,9893,Rattus norvegicus,,10116.0,N,Urine,1,,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,,BAO_0000218,6899,
,,A,,Intermediate,1,,50597,CHEMBL622491,1088.0,9894,Rattus norvegicus,,10116.0,N,Urine,1,,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,,BAO_0000218,6899,
,,A,,Intermediate,1,,50597,CHEMBL622492,2107.0,9895,Rattus norvegicus,,10116.0,N,Liver,1,,Compound was evaluated for percent dose tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in liver,,BAO_0000218,6899,
,,A,,Intermediate,1,,50597,CHEMBL622493,1088.0,9896,Rattus norvegicus,,10116.0,N,Urine,1,,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,,BAO_0000218,6899,
,,A,,Intermediate,1,,50597,CHEMBL622494,1088.0,9897,Rattus norvegicus,,10116.0,N,Urine,1,,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,,BAO_0000218,6899,
,,A,,Intermediate,1,,50597,CHEMBL622495,2385.0,9898,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,"Compound was evaluated for the biodistribution in Sprague-Dawley rats in muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,BAO_0000218,8677,
,,A,,Intermediate,1,,50597,CHEMBL622496,,9899,Rattus norvegicus,,10116.0,N,,1,,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in rat kidney,,BAO_0000218,6899,
,,A,,Intermediate,1,,50597,CHEMBL622497,1088.0,9900,Rattus norvegicus,,10116.0,N,Urine,1,,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,,BAO_0000218,6899,
,,A,,Intermediate,1,,50597,CHEMBL622498,,9901,Rattus norvegicus,,10116.0,N,,1,,Percent of radioactive dose in urine and faeces excreted in 0-24 hr by rats,,BAO_0000218,2189,
,,A,,Intermediate,1,,50597,CHEMBL624918,1088.0,9902,Rattus norvegicus,,10116.0,N,Urine,1,,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats,,BAO_0000218,2189,
,,A,,Intermediate,1,,50597,CHEMBL624919,1088.0,9903,Rattus norvegicus,,10116.0,N,Urine,1,,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats; NA is <10% inhibition at 1 uM for binding data,,BAO_0000218,2189,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624920,178.0,9904,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution of compound in rat blood after 5 min of administration,,BAO_0000218,10839,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624921,178.0,9905,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution of compound in rat blood after 5 min of administration.,,BAO_0000218,10839,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624922,955.0,9906,Rattus norvegicus,,10116.0,N,Brain,1,,Biodistribution of compound in rat brain after 5 min of administration,,BAO_0000218,10839,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624923,948.0,9907,Rattus norvegicus,,10116.0,N,Heart,1,,Biodistribution of compound in rat heart after 5 min of administration,,BAO_0000218,10839,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624924,948.0,9908,Rattus norvegicus,,10116.0,N,Heart,1,,Biodistribution of compound in rat heart after 5 min of administration.,,BAO_0000218,10839,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624925,2113.0,9909,Rattus norvegicus,,10116.0,N,Kidney,1,,Biodistribution of compound in rat kidney after 5 min of administration,,BAO_0000218,10839,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624926,2113.0,9910,Rattus norvegicus,,10116.0,N,Kidney,1,,Biodistribution of compound in rat kidney after 5 min of administration.,,BAO_0000218,10839,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624927,2107.0,9911,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution of compound in rat liver after 5 min of administration,,BAO_0000218,10839,
In vivo,,A,,Intermediate,1,,50597,CHEMBL874402,2107.0,9912,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution of compound in rat liver after 5 min of administration.,,BAO_0000218,10839,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624928,2048.0,9913,Rattus norvegicus,,10116.0,N,Lung,1,,Biodistribution of compound in rat lung after 5 min of administration,,BAO_0000218,10839,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624929,2048.0,9914,Rattus norvegicus,,10116.0,N,Lung,1,,Biodistribution of compound in rat lung after 5 min of administration.,,BAO_0000218,10839,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624930,2385.0,9915,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Biodistribution of compound in rat muscle after 5 min of administration,,BAO_0000218,10839,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624931,2385.0,9916,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Biodistribution of compound in rat muscle after 5 min of administration.,,BAO_0000218,10839,
,,A,,Intermediate,1,,50597,CHEMBL624932,948.0,9917,Rattus norvegicus,,10116.0,N,Heart,1,,In vivo heart distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,BAO_0000218,4043,
,,A,,Intermediate,1,,50597,CHEMBL624933,948.0,9918,Rattus norvegicus,,10116.0,N,Heart,1,,In vivo heart distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,BAO_0000218,4043,
,,A,,Intermediate,1,,50597,CHEMBL624934,2107.0,9919,Rattus norvegicus,,10116.0,N,Liver,1,,In vivo liver distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,BAO_0000218,4043,
,,A,,Intermediate,1,,50597,CHEMBL624935,2107.0,9920,Rattus norvegicus,,10116.0,N,Liver,1,,In vivo liver distribution of total doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,BAO_0000218,4043,
,,A,,Intermediate,1,,50597,CHEMBL624936,,9921,Rattus norvegicus,,10116.0,N,,1,,In vivo plasma distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,BAO_0000218,4043,
,,A,,Intermediate,1,,50597,CHEMBL624937,,9922,Rattus norvegicus,,10116.0,N,,1,,In vivo plasma distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,BAO_0000218,4043,
,,A,,Intermediate,1,,50597,CHEMBL624938,2106.0,9923,Rattus norvegicus,,10116.0,N,Spleen,1,,In vivo spleen distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,BAO_0000218,4043,
,,A,,Intermediate,1,,50597,CHEMBL624939,2106.0,9924,Rattus norvegicus,,10116.0,N,Spleen,1,,In vivo spleen distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,BAO_0000218,4043,
,,A,,Intermediate,1,,50597,CHEMBL624940,,9925,Rattus norvegicus,,10116.0,N,,1,,In vivo tumor distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,BAO_0000218,4043,
,,A,,Intermediate,1,,50597,CHEMBL874403,,9926,Rattus norvegicus,,10116.0,N,,1,,In vivo tumor distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,BAO_0000218,4043,
,,A,,Intermediate,1,,50597,CHEMBL624941,,9927,Rattus norvegicus,,10116.0,N,,1,,Compound was tested for the duration that the plasma drug concentrations remained above the IC95,,BAO_0000218,1446,
,,A,,Intermediate,1,,50597,CHEMBL624942,1088.0,9928,Rattus norvegicus,,10116.0,N,Urine,1,,Dose required to lower urine osmolality to 300 mOsm/kg in rat,,BAO_0000218,9971,
,,A,,Intermediate,1,,50597,CHEMBL624943,1088.0,9929,Rattus norvegicus,,10116.0,N,Urine,1,,Dose required to lower urine osmolality to 300 mOsm/kg in rat; NT=Not tested,,BAO_0000218,9971,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624944,,9930,Rattus norvegicus,,10116.0,N,,1,,% Bioavailability after 1 day of the drug administration in rats,,BAO_0000218,5765,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624945,,9931,Rattus norvegicus,,10116.0,N,,1,,% Bioavailability after 4 day of the drug administration in rats,,BAO_0000218,5765,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624946,,9932,Rattus norvegicus,,10116.0,N,,1,,Absolute bioavailability was evaluated in rat,,BAO_0000218,4257,
,,A,,Intermediate,1,,50597,CHEMBL624947,,9933,Rattus norvegicus,,10116.0,N,,1,,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr low time interval,,BAO_0000218,13091,
,,A,,Intermediate,1,,50597,CHEMBL624948,,9934,Rattus norvegicus,,10116.0,N,,1,,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr time interval,,BAO_0000218,13091,
,,A,,Intermediate,1,,50597,CHEMBL624949,,9935,Rattus norvegicus,,10116.0,N,,1,,Tissue biodistribution into estrogen-primed immature female rat fat at 3 hr time interval,,BAO_0000218,13091,
,,A,,Intermediate,1,,50597,CHEMBL622025,2113.0,9936,Rattus norvegicus,,10116.0,N,Kidney,1,,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr blocked time interval,,BAO_0000218,13091,
,,A,,Intermediate,1,,50597,CHEMBL622026,2113.0,9937,Rattus norvegicus,,10116.0,N,Kidney,1,,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr low time interval,,BAO_0000218,13091,
,,A,,Intermediate,1,,50597,CHEMBL622027,2113.0,9938,Rattus norvegicus,,10116.0,N,Kidney,1,,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr time interval,,BAO_0000218,13091,
,,A,,Intermediate,1,,50597,CHEMBL622028,2113.0,9939,Rattus norvegicus,,10116.0,N,Kidney,1,,Tissue biodistribution into estrogen-primed immature female rat kidney at 3 hr time interval,,BAO_0000218,13091,
,,A,,Intermediate,1,,50597,CHEMBL622029,2107.0,9940,Rattus norvegicus,,10116.0,N,Liver,1,,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr blocked time interval,,BAO_0000218,13091,
,,A,,Intermediate,1,,50597,CHEMBL622208,2107.0,9941,Rattus norvegicus,,10116.0,N,Liver,1,,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr low time interval,,BAO_0000218,13091,
,,A,,Intermediate,1,,50597,CHEMBL622209,2107.0,9942,Rattus norvegicus,,10116.0,N,Liver,1,,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr time interval,,BAO_0000218,13091,
,,A,,Intermediate,1,,50597,CHEMBL622210,2107.0,9943,Rattus norvegicus,,10116.0,N,Liver,1,,Tissue biodistribution into estrogen-primed immature female rat liver at 3 hr time interval,,BAO_0000218,13091,
,,A,,Intermediate,1,,50597,CHEMBL622211,,9944,Rattus norvegicus,,10116.0,N,,1,,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr blocked time interval,,BAO_0000218,13091,
,,A,,Intermediate,1,,50597,CHEMBL622212,,9945,Rattus norvegicus,,10116.0,N,,1,,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr low time interval,,BAO_0000218,13091,
,,A,,Intermediate,1,,50597,CHEMBL622213,,9946,Rattus norvegicus,,10116.0,N,,1,,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr time interval,,BAO_0000218,13091,
,,A,,Intermediate,1,,50597,CHEMBL874404,,9947,Rattus norvegicus,,10116.0,N,,1,,Tissue biodistribution into estrogen-primed immature female rat lung at 3 hr time interval,,BAO_0000218,13091,
,,A,,Intermediate,1,,50597,CHEMBL620452,2385.0,9948,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr blocked time interval,,BAO_0000218,13091,
,,A,,Intermediate,1,,50597,CHEMBL620453,2385.0,9949,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr low time interval,,BAO_0000218,13091,
,,A,,Intermediate,1,,50597,CHEMBL620454,2385.0,9950,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr time interval,,BAO_0000218,13091,
,,A,,Intermediate,1,,50597,CHEMBL624067,2385.0,9951,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Tissue biodistribution into estrogen-primed immature female rat muscle at 3 hr time interval,,BAO_0000218,13091,
,,A,,Intermediate,1,,50597,CHEMBL624068,,9952,Rattus norvegicus,,10116.0,N,,1,,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr blocked time interval,,BAO_0000218,13091,
,,A,,Intermediate,1,,50597,CHEMBL624069,992.0,9953,Rattus norvegicus,,10116.0,N,Female gonad,1,,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr low time interval,,BAO_0000218,13091,
,,A,,Intermediate,1,,50597,CHEMBL624070,992.0,9954,Rattus norvegicus,,10116.0,N,Female gonad,1,,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr time interval,,BAO_0000218,13091,
,,A,,Intermediate,1,,50597,CHEMBL624071,992.0,9955,Rattus norvegicus,,10116.0,N,Female gonad,1,,Tissue biodistribution into estrogen-primed immature female rat ovaries at 3 hr time interval,,BAO_0000218,13091,
,,A,,Intermediate,1,,50597,CHEMBL624072,995.0,9956,Rattus norvegicus,,10116.0,N,Uterus,1,,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr blocked time interval,,BAO_0000218,13091,
,,A,,Intermediate,1,,50597,CHEMBL624073,995.0,9957,Rattus norvegicus,,10116.0,N,Uterus,1,,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr low time interval,,BAO_0000218,13091,
,,A,,Intermediate,1,,50597,CHEMBL624788,995.0,9958,Rattus norvegicus,,10116.0,N,Uterus,1,,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr time interval,,BAO_0000218,13091,
,,A,,Intermediate,1,,50597,CHEMBL624789,995.0,9959,Rattus norvegicus,,10116.0,N,Uterus,1,,Tissue biodistribution into estrogen-primed immature female rat uterus at 3 hr time interval,,BAO_0000218,13091,
,,A,,Intermediate,1,,50597,CHEMBL624790,,9960,Rattus norvegicus,,10116.0,N,,1,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr blocked time interval,,BAO_0000218,13091,
,,A,,Intermediate,1,,50597,CHEMBL624791,,9961,Rattus norvegicus,,10116.0,N,,1,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr low time interval,,BAO_0000218,13091,
,,A,,Intermediate,1,,50597,CHEMBL624792,,9962,Rattus norvegicus,,10116.0,N,,1,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr time interval,,BAO_0000218,13091,
,,A,,Intermediate,1,,50597,CHEMBL624793,,9963,Rattus norvegicus,,10116.0,N,,1,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 3 hr time interval,,BAO_0000218,13091,
,,A,,Intermediate,1,,50597,CHEMBL877491,2385.0,9964,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr blocked time interval,,BAO_0000218,13091,
,,A,,Intermediate,1,,50597,CHEMBL624957,2385.0,9965,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr low time interval,,BAO_0000218,13091,
,,A,,Intermediate,1,,50597,CHEMBL624958,2385.0,9966,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr time interval,,BAO_0000218,13091,
,,A,,Intermediate,1,,50597,CHEMBL624959,2385.0,9967,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 3 hr time interval,,BAO_0000218,13091,
,,A,,Intermediate,1,,50597,CHEMBL624960,,9968,Rattus norvegicus,,10116.0,N,,1,,Dissociation constant was determined,,BAO_0000218,11977,
,,A,,Intermediate,1,,50597,CHEMBL624961,,9969,Rattus norvegicus,,10116.0,N,,1,,"Pharmacokinetic Parameter, Kel is elimination rate constant in Female Wistar Rats at 100 mg/kg by po administration",,BAO_0000218,14941,
,,A,,Intermediate,1,,50597,CHEMBL624962,,9970,Rattus norvegicus,,10116.0,N,,1,,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",,BAO_0000218,15078,
,,A,,Intermediate,1,,50597,CHEMBL624963,,9971,Rattus norvegicus,,10116.0,N,,1,,"The Kel value in male wistar rat at 100 mg/kg, p.o. dose",,BAO_0000218,15078,
,,A,,Intermediate,1,,50597,CHEMBL624964,,9972,Rattus norvegicus,,10116.0,N,,1,,Observed rate constant in 80% rat plasma at 37 degree Centigrade,,BAO_0000218,4755,
,,A,,Intermediate,1,,50597,CHEMBL624965,,9973,Rattus norvegicus,,10116.0,N,,1,,LogP value was evaluated in the in situ rat gut perfusion assay,,BAO_0000218,589,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624966,,9974,Rattus norvegicus,,10116.0,N,,1,,In vivo retention time was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,,BAO_0000218,17582,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624967,,9975,Rattus norvegicus,,10116.0,N,,1,,Mean residence time (Pharmacokinetic property) after i.v. administration in rats,,BAO_0000218,5031,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624968,,9976,Rattus norvegicus,,10116.0,N,,1,,Mean-residence time of compound after intravenous administration in rats at 24 uM/kg,,BAO_0000218,17764,
,,A,,Intermediate,1,,50597,CHEMBL624969,,9977,Rattus norvegicus,,10116.0,N,,1,,Mean residence time at a dose of 4 mg/kg in Rat Plasma after iv administration,,BAO_0000218,17720,
,,F,,Expert,1,,50597,CHEMBL624970,,9978,Rattus norvegicus,,10116.0,N,,1,,Streptococcal cell wall-washed arthritis model in rats at 10.0 mg/kg peroral dose,,BAO_0000218,2862,
,,A,,Intermediate,1,,50597,CHEMBL624971,,9979,Rattus norvegicus,,10116.0,N,,1,,Half-life was evaluated after 10 uM/kg of intra arterial administration,,BAO_0000218,16423,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624972,,9980,Rattus norvegicus,,10116.0,N,,1,,Half-life was evaluated after 20 uM/kg of peroral administration,,BAO_0000218,16423,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624973,,9981,Rattus norvegicus,,10116.0,N,,1,,Half-life was evaluated after i.v. administration in rat at a dose of 1 mg/kg,,BAO_0000218,6005,
,,A,,Intermediate,1,,50597,CHEMBL624974,1969.0,9982,Rattus norvegicus,,10116.0,N,Plasma,1,,Half-life was evaluated in plasma of rat,,BAO_0000218,2938,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624975,,9983,Rattus norvegicus,,10116.0,N,,1,,Half-life was evaluated in rats at an intravenous dose of 3 mg/kg,,BAO_0000218,6410,
In vivo,,A,,Intermediate,1,,50597,CHEMBL877492,,9984,Rattus norvegicus,,10116.0,N,,1,,Half-life was evaluated in rats at an oral dose of 30 mg/kg,,BAO_0000218,6410,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624976,,9985,Rattus norvegicus,,10116.0,N,,1,,Half-life was measured in rat after an iv dose of 1 mg/kg,,BAO_0000218,6062,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624977,,9986,Rattus norvegicus,,10116.0,N,,1,,Half-life period of compound in rats after peroral administration,,BAO_0000218,6571,
,,A,,Intermediate,1,,50597,CHEMBL626848,1969.0,9987,Rattus norvegicus,,10116.0,N,Plasma,1,,Half-life period of compound was measured in rat plasma.,,BAO_0000218,3136,
,,A,,Intermediate,1,,50597,CHEMBL626849,1969.0,9988,Rattus norvegicus,,10116.0,N,Plasma,1,,Half-life period of compound was measured in rat plasma; ND is not determined,,BAO_0000218,3136,
,,A,,Intermediate,1,,50597,CHEMBL626850,1969.0,9989,Rattus norvegicus,,10116.0,N,Plasma,1,,Half-life period of compound was measured in rat plasma; not determined,,BAO_0000218,3136,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626851,,9990,Rattus norvegicus,,10116.0,N,,1,,Half-life period in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,,BAO_0000218,4521,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626852,,9991,Rattus norvegicus,,10116.0,N,,1,,Half-life period in rat by iv administration,,BAO_0000218,5871,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626853,,9992,Rattus norvegicus,,10116.0,N,,1,,Half-life period in rats following intravenous administration at 2 mg/kg,,BAO_0000218,6077,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626854,,9993,Rattus norvegicus,,10116.0,N,,1,,Half-life period was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,,BAO_0000218,6679,
,,A,,Intermediate,1,,50597,CHEMBL627486,,9994,Rattus norvegicus,,10116.0,N,,1,,Half-life period was determined for the compound in rat,,BAO_0000218,5144,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627487,,9995,Rattus norvegicus,,10116.0,N,,1,,"Half-life period was evaluated in rat, after administering 1 mg/kg intravenously",,BAO_0000218,4498,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627488,,9996,Rattus norvegicus,,10116.0,N,,1,,"Half-life period was evaluated in rat, after administering 10 mg/kg orally",,BAO_0000218,4498,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627489,,9997,Rattus norvegicus,,10116.0,N,,1,,Half-life value after IV dose at a dose of 5 mg/kg in rats.,,BAO_0000218,1908,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627490,,9998,Rattus norvegicus,,10116.0,N,,1,,Half-life was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,,BAO_0000218,6211,
In vivo,,A,,Intermediate,1,,50597,CHEMBL873829,,9999,Rattus norvegicus,,10116.0,N,,1,,Half-life was determined in rat after intravenous administration (0.5 mg/kg),,BAO_0000218,5529,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627655,,10000,Rattus norvegicus,,10116.0,N,,1,,Half-life was determined in rat at a dose of 1 mpk i.v.,,BAO_0000218,6444,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625994,,10001,Rattus norvegicus,,10116.0,N,,1,,Half-life was determined in rat at a dose of 1 mpk i.v.; ND means not determined,,BAO_0000218,6444,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625995,,10002,Rattus norvegicus,,10116.0,N,,1,,Half-life was determined in rat at a dose of 1 mpk i.v.; ND=not determined,,BAO_0000218,6444,
,,A,,Intermediate,1,,50597,CHEMBL625996,,10003,Rattus norvegicus,,10116.0,N,,1,,Half-life in rat,,BAO_0000218,5207,
In vitro,,A,,Intermediate,1,,50597,CHEMBL625850,1969.0,10004,Rattus norvegicus,,10116.0,N,Plasma,1,,In vitro half life in rat plasma,,BAO_0000218,530,
In vitro,,A,,Intermediate,1,,50597,CHEMBL625851,1969.0,10005,Rattus norvegicus,,10116.0,N,Plasma,1,,"In vitro half life at 1.5 -5.6ug/mL, 37 degree C in rat plasma",,BAO_0000218,1116,
In vitro,,A,,Intermediate,1,,50597,CHEMBL625852,,10006,Rattus norvegicus,,10116.0,N,,1,,In vitro half life in rat,,BAO_0000218,3219,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625853,,10007,Rattus norvegicus,,10116.0,N,,1,,In vivo half life period after intravenous administration in rat,,BAO_0000218,6109,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625854,,10008,Rattus norvegicus,,10116.0,N,,1,,In vivo half-life period for compound after i.v. administration at a dose of 5 mg/kg was measured in rats,,BAO_0000218,17582,
In vivo,,A,,Intermediate,1,,50597,CHEMBL874450,,10009,Rattus norvegicus,,10116.0,N,,1,,In vivo half-life period for compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,,BAO_0000218,17582,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625855,,10010,Rattus norvegicus,,10116.0,N,,1,,In vivo t1/2 was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,BAO_0000218,5974,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625856,,10011,Rattus norvegicus,,10116.0,N,,1,,In vivo t1/2 was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,BAO_0000218,5974,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625857,,10012,Rattus norvegicus,,10116.0,N,,1,,In vivo t1/2 was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,BAO_0000218,5974,
In vivo,,A,,Intermediate,1,,50597,CHEMBL873831,,10013,Rattus norvegicus,,10116.0,N,,1,,In vivo t1/2 was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,BAO_0000218,5974,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625858,,10014,Rattus norvegicus,,10116.0,N,,1,,Longer half-life in rat (i.v.) at 0.5 mpk,,BAO_0000218,17853,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625859,,10015,Rattus norvegicus,,10116.0,N,,1,,Longer half-life in rat (p.o.) at 2.0 mpk,,BAO_0000218,17853,
,,A,,Intermediate,1,,50597,CHEMBL625860,,10016,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic property (half life) in rat,,BAO_0000218,3457,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625861,,10017,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic parameter half-life was determined at 10 mg/kg po dose in rats,,BAO_0000218,2792,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625862,,10018,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic parameter half-life was determined at 2 mg/kg i.v. dose in rats,,BAO_0000218,2792,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625863,,10019,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic parameter half-life was determined at 3 mg/kg po dose in rats,,BAO_0000218,2792,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625864,,10020,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic parameter half-life was determined at 5 mg/kg i.v. dose in rats,,BAO_0000218,2792,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625865,,10021,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic property (t1/2) for the compound (5 mg/kg iv) was determined in rats,,BAO_0000218,5739,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625866,,10022,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic half time was determined intravenously in rats.,,BAO_0000218,15765,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625867,1969.0,10023,Rattus norvegicus,,10116.0,N,Plasma,1,,Plasma half life in rat after 5 mg/kg oral gavage; 6-8 hours,,BAO_0000218,6567,
,,A,,Intermediate,1,,50597,CHEMBL625868,1969.0,10024,Rattus norvegicus,,10116.0,N,Plasma,1,,Plasma half life of hydrolysis of the compound,,BAO_0000218,2448,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625869,1969.0,10025,Rattus norvegicus,,10116.0,N,Plasma,1,,Plasma half life was reported after a intravenous dose of 1 mg/kg in Dawley rat,,BAO_0000218,5423,
,,A,,Intermediate,1,,50597,CHEMBL874451,1969.0,10026,Rattus norvegicus,,10116.0,N,Plasma,1,,Plasma half life period was calculated in rat,,BAO_0000218,4853,
,,A,,Intermediate,1,,50597,CHEMBL625870,1969.0,10027,Rattus norvegicus,,10116.0,N,Plasma,1,,Plasma half-life in Sprague-Dawley rats,,BAO_0000218,4514,
,,A,,Intermediate,1,,50597,CHEMBL625871,1969.0,10028,Rattus norvegicus,,10116.0,N,Plasma,1,,Plasma half-life in Sprague-Dawley rats; Not determined,,BAO_0000218,4514,
,,A,,Intermediate,1,,50597,CHEMBL625872,1969.0,10029,Rattus norvegicus,,10116.0,N,Plasma,1,,Plasma half-life in rats,,BAO_0000218,1500,
,,A,,Intermediate,1,,50597,CHEMBL625873,1969.0,10030,Rattus norvegicus,,10116.0,N,Plasma,1,,Plasma half-life in rats; <MQL,,BAO_0000218,1500,
,,A,,Intermediate,1,,50597,CHEMBL625874,1969.0,10031,Rattus norvegicus,,10116.0,N,Plasma,1,,Plasma half-life period (0-8 h) was determined,,BAO_0000218,5334,
,,A,,Intermediate,1,,50597,CHEMBL625875,1969.0,10032,Rattus norvegicus,,10116.0,N,Plasma,1,,Plasma half-life period (0-8 h) was determined in Sprague-Dawley rat,,BAO_0000218,5334,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625876,1969.0,10033,Rattus norvegicus,,10116.0,N,Plasma,1,,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,,BAO_0000218,5334,
In vivo,,A,,Intermediate,1,,50597,CHEMBL631258,1969.0,10034,Rattus norvegicus,,10116.0,N,Plasma,1,,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,,BAO_0000218,5334,
,,A,,Intermediate,1,,50597,CHEMBL631259,1969.0,10035,Rattus norvegicus,,10116.0,N,Plasma,1,,Plasma half-life was determined in Sprague-Dawley rats after 0-8 h administration of the compound,,BAO_0000218,4956,
,,A,,Intermediate,1,,50597,CHEMBL631260,1969.0,10036,Rattus norvegicus,,10116.0,N,Plasma,1,,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr administration of the compound; Not determined,,BAO_0000218,4956,
,,A,,Intermediate,1,,50597,CHEMBL631261,178.0,10037,Rattus norvegicus,,10116.0,N,Blood,1,,"Distribution of radioactivity in blood of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.68-1.03",,BAO_0000218,7768,
,,A,,Intermediate,1,,50597,CHEMBL631262,178.0,10038,Rattus norvegicus,,10116.0,N,Blood,1,,"Distribution of radioactivity in blood of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.45-0.48",,BAO_0000218,7768,
,,A,,Intermediate,1,,50597,CHEMBL631263,178.0,10039,Rattus norvegicus,,10116.0,N,Blood,1,,"Distribution of radioactivity in blood of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range-0.81-1",,BAO_0000218,7768,
,,A,,Intermediate,1,,50597,CHEMBL631264,,10040,Rattus norvegicus,,10116.0,N,,1,,"Distribution of radioactivity in brain tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.007-0.008",,BAO_0000218,7768,
,,A,,Intermediate,1,,50597,CHEMBL631265,,10041,Rattus norvegicus,,10116.0,N,,1,,"Distribution of radioactivity in brain tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.18-0.22",,BAO_0000218,7768,
,,A,,Intermediate,1,,50597,CHEMBL631266,,10042,Rattus norvegicus,,10116.0,N,,1,,"Distribution of radioactivity in brain tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.77-0.97",,BAO_0000218,7768,
,,A,,Intermediate,1,,50597,CHEMBL631267,,10043,Rattus norvegicus,,10116.0,N,,1,,"Distribution of radioactivity in brain tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.08-0.13",,BAO_0000218,7768,
,,A,,Intermediate,1,,50597,CHEMBL631268,,10044,Rattus norvegicus,,10116.0,N,,1,,"Distribution of radioactivity in brain tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.25-0.37",,BAO_0000218,7768,
,,A,,Intermediate,1,,50597,CHEMBL631269,,10045,Rattus norvegicus,,10116.0,N,,1,,"Distribution of radioactivity in brain tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.04",,BAO_0000218,7768,
,,A,,Intermediate,1,,50597,CHEMBL631270,,10046,Rattus norvegicus,,10116.0,N,,1,,"Distribution of radioactivity in brain tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.74-0.94",,BAO_0000218,7768,
,,A,,Intermediate,1,,50597,CHEMBL631271,948.0,10047,Rattus norvegicus,,10116.0,N,Heart,1,,"Distribution of radioactivity in heart tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",,BAO_0000218,7768,
,,A,,Intermediate,1,,50597,CHEMBL631272,948.0,10048,Rattus norvegicus,,10116.0,N,Heart,1,,"Distribution of radioactivity in heart tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.5-0.63",,BAO_0000218,7768,
,,A,,Intermediate,1,,50597,CHEMBL631273,948.0,10049,Rattus norvegicus,,10116.0,N,Heart,1,,"Distribution of radioactivity in heart tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.35-1.55",,BAO_0000218,7768,
,,A,,Intermediate,1,,50597,CHEMBL631274,948.0,10050,Rattus norvegicus,,10116.0,N,Heart,1,,"Distribution of radioactivity in heart tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.24-0.38",,BAO_0000218,7768,
,,A,,Intermediate,1,,50597,CHEMBL631275,948.0,10051,Rattus norvegicus,,10116.0,N,Heart,1,,"Distribution of radioactivity in heart tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.55-0.82",,BAO_0000218,7768,
,,A,,Intermediate,1,,50597,CHEMBL626984,948.0,10052,Rattus norvegicus,,10116.0,N,Heart,1,,"Distribution of radioactivity in heart tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.16-0.2",,BAO_0000218,7768,
,,A,,Intermediate,1,,50597,CHEMBL626985,948.0,10053,Rattus norvegicus,,10116.0,N,Heart,1,,"Distribution of radioactivity in heart tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.13-1.29",,BAO_0000218,7768,
,,A,,Intermediate,1,,50597,CHEMBL626986,2107.0,10054,Rattus norvegicus,,10116.0,N,Liver,1,,"Distribution of radioactivity in liver tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",,BAO_0000218,7768,
,,A,,Intermediate,1,,50597,CHEMBL626987,2107.0,10055,Rattus norvegicus,,10116.0,N,Liver,1,,"Distribution of radioactivity in liver tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.71-0.93",,BAO_0000218,7768,
,,A,,Intermediate,1,,50597,CHEMBL626988,2107.0,10056,Rattus norvegicus,,10116.0,N,Liver,1,,"Distribution of radioactivity in liver tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.91-3.53",,BAO_0000218,7768,
,,A,,Intermediate,1,,50597,CHEMBL626989,2107.0,10057,Rattus norvegicus,,10116.0,N,Liver,1,,"Distribution of radioactivity in liver tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.42-0.62",,BAO_0000218,7768,
,,A,,Intermediate,1,,50597,CHEMBL626990,2107.0,10058,Rattus norvegicus,,10116.0,N,Liver,1,,"Distribution of radioactivity in liver tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.97-1.41",,BAO_0000218,7768,
,,A,,Intermediate,1,,50597,CHEMBL626991,2107.0,10059,Rattus norvegicus,,10116.0,N,Liver,1,,"Distribution of radioactivity in liver tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.19-0.23",,BAO_0000218,7768,
,,A,,Intermediate,1,,50597,CHEMBL626992,2107.0,10060,Rattus norvegicus,,10116.0,N,Liver,1,,"Distribution of radioactivity in liver tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.49-2.82",,BAO_0000218,7768,
,,A,,Intermediate,1,,50597,CHEMBL626993,2048.0,10061,Rattus norvegicus,,10116.0,N,Lung,1,,"Distribution of radioactivity in lung tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.03",,BAO_0000218,7768,
,,A,,Intermediate,1,,50597,CHEMBL874593,2048.0,10062,Rattus norvegicus,,10116.0,N,Lung,1,,"Distribution of radioactivity in lung tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.66-0.77",,BAO_0000218,7768,
,,A,,Intermediate,1,,50597,CHEMBL626994,2048.0,10063,Rattus norvegicus,,10116.0,N,Lung,1,,"Distribution of radioactivity in lung tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.17-1.42",,BAO_0000218,7768,
,,A,,Intermediate,1,,50597,CHEMBL626995,2048.0,10064,Rattus norvegicus,,10116.0,N,Lung,1,,"Distribution of radioactivity in lung tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.47-0.58",,BAO_0000218,7768,
,,A,,Intermediate,1,,50597,CHEMBL626190,2048.0,10065,Rattus norvegicus,,10116.0,N,Lung,1,,"Distribution of radioactivity in lung tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.65-0.87",,BAO_0000218,7768,
,,A,,Intermediate,1,,50597,CHEMBL626191,2048.0,10066,Rattus norvegicus,,10116.0,N,Lung,1,,"Distribution of radioactivity in lung tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.28-0.31",,BAO_0000218,7768,
,,A,,Intermediate,1,,50597,CHEMBL626364,2048.0,10067,Rattus norvegicus,,10116.0,N,Lung,1,,"Distribution of radioactivity in lung tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.98-1.22",,BAO_0000218,7768,
,,A,,Intermediate,1,,50597,CHEMBL626365,2046.0,10068,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,"Distribution of radioactivity in thyroid tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 406-499",,BAO_0000218,7768,
,,A,,Intermediate,1,,50597,CHEMBL626366,2046.0,10069,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,"Distribution of radioactivity in thyroid tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 53.0-96",,BAO_0000218,7768,
,,A,,Intermediate,1,,50597,CHEMBL626367,2046.0,10070,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,"Distribution of radioactivity in thyroid tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.65-8.0.8",,BAO_0000218,7768,
,,A,,Intermediate,1,,50597,CHEMBL626368,2046.0,10071,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,"Distribution of radioactivity in thyroid tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 92-159",,BAO_0000218,7768,
,,A,,Intermediate,1,,50597,CHEMBL626369,2046.0,10072,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,"Distribution of radioactivity in thyroid tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 18.74-30.84",,BAO_0000218,7768,
,,A,,Intermediate,1,,50597,CHEMBL626370,2046.0,10073,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,"Distribution of radioactivity in thyroid tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 156-207",,BAO_0000218,7768,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626371,,10074,Rattus norvegicus,,10116.0,N,,1,,"Bioavailability (F) was evaluated in rat, after administering 1 mg/kg intravenously",,BAO_0000218,4498,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626372,,10075,Rattus norvegicus,,10116.0,N,,1,,"Bioavailability (F) was evaluated in rat, after administering 10 mg/kg orally",,BAO_0000218,4498,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626373,,10076,Rattus norvegicus,,10116.0,N,,1,,Bioavailability after a dose of 10 mg/kg p.o.,,BAO_0000218,3603,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626374,,10077,Rattus norvegicus,,10116.0,N,,1,,Bioavailability after peroral administration (10 mg/kg) was determined in rat,,BAO_0000218,6215,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626375,,10078,Rattus norvegicus,,10116.0,N,,1,,Bioavailability in fasted male administration of 2 mg/Kg of compound p.o.,,BAO_0000218,5710,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626376,,10079,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 2 mg/kg),,BAO_0000218,5710,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626377,,10080,Rattus norvegicus,,10116.0,N,,1,,Bioavailability in rat po was determined,,BAO_0000218,5676,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626378,,10081,Rattus norvegicus,,10116.0,N,,1,,Bioavailability of compound at 10 mg/kg in rat after oral administration,,BAO_0000218,17667,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626379,,10082,Rattus norvegicus,,10116.0,N,,1,,Bioavailability of compound at 3 mg/kg in rat after i.v. administration,,BAO_0000218,17667,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626380,,10083,Rattus norvegicus,,10116.0,N,,1,,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),,BAO_0000218,6848,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626381,,10084,Rattus norvegicus,,10116.0,N,,1,,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),,BAO_0000218,6848,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626382,,10085,Rattus norvegicus,,10116.0,N,,1,,Bioavailability in rat,,BAO_0000218,17267,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626383,,10086,Rattus norvegicus,,10116.0,N,,1,,Bioavailability in rat (Sprague-Dawley) (female),,BAO_0000218,6362,
In vivo,,A,,Intermediate,1,,50597,CHEMBL874652,,10087,Rattus norvegicus,,10116.0,N,,1,,Bioavailability in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,BAO_0000218,17671,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626384,,10088,Rattus norvegicus,,10116.0,N,,1,,Bioavailability in rat (Sprague-Dawley) (male) (dose 10-20 mg/kg),,BAO_0000218,17671,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626385,,10089,Rattus norvegicus,,10116.0,N,,1,,Bioavailability in rat (Sprague-Dawley) (male) (dose 1 mg/kg i.v. and 3 mg/kg p.o.) measured from 0.3 to 6 hr,,BAO_0000218,4333,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626386,,10090,Rattus norvegicus,,10116.0,N,,1,,Bioavailability in rat at an oral dose of 2 mg/kg,,BAO_0000218,6077,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626387,,10091,Rattus norvegicus,,10116.0,N,,1,,Bioavailability in rat,,BAO_0000218,3278,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626388,,10092,Rattus norvegicus,,10116.0,N,,1,,Bioavailability in rat,,BAO_0000218,5964,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626389,,10093,Rattus norvegicus,,10116.0,N,,1,,Bioavailability in rat,,BAO_0000218,4884,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626390,,10094,Rattus norvegicus,,10116.0,N,,1,,Bioavailability in rat,,BAO_0000218,4905,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626391,,10095,Rattus norvegicus,,10116.0,N,,1,,Bioavailability in rat was reported at the dose of 6 mg/kg in 25% PEG-300,,BAO_0000218,4884,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626392,,10096,Rattus norvegicus,,10116.0,N,,1,,Bioavailability in rat,,BAO_0000218,6850,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626393,,10097,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat,,BAO_0000218,2864,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623026,,10098,Rattus norvegicus,,10116.0,N,,1,,Bioavailability was determined in rat,,BAO_0000218,5780,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623027,,10099,Rattus norvegicus,,10116.0,N,,1,,Bioavailability,,BAO_0000218,1465,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623028,,10100,Rattus norvegicus,,10116.0,N,,1,,Bioavailability,,BAO_0000218,5199,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623029,,10101,Rattus norvegicus,,10116.0,N,,1,,Bioavailability in rat after 1 day dosing,,BAO_0000218,5765,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623030,,10102,Rattus norvegicus,,10116.0,N,,1,,Bioavailability in rat after 4 day dosing,,BAO_0000218,5765,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623031,,10103,Rattus norvegicus,,10116.0,N,,1,,Bioavailability after IV dosing at 0.5 mg/kg in rat; no data,,BAO_0000218,6518,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623032,,10104,Rattus norvegicus,,10116.0,N,,1,,Bioavailability after IV dosing at 1 mg/kg in rat; no data,,BAO_0000218,6518,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623033,,10105,Rattus norvegicus,,10116.0,N,,1,,Bioavailability after oral administration at a dose of 2 mg/kg in rat,,BAO_0000218,6518,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623034,,10106,Rattus norvegicus,,10116.0,N,,1,,Bioavailability after oral administration at a dose of 4 mg/kg in rat,,BAO_0000218,6518,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623035,,10107,Rattus norvegicus,,10116.0,N,,1,,Bioavailability at 4 hr after administration of 5 mg/kg dose peroral in rat,,BAO_0000218,2083,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623036,,10108,Rattus norvegicus,,10116.0,N,,1,,Bioavailability at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,BAO_0000218,17260,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623037,,10109,Rattus norvegicus,,10116.0,N,,1,,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),,BAO_0000218,4956,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623038,,10110,Rattus norvegicus,,10116.0,N,,1,,Bioavailability by intravenous administration of 3.4 mg/kg in rat,,BAO_0000218,4368,
In vivo,,A,,Intermediate,1,,50597,CHEMBL874385,1969.0,10111,Rattus norvegicus,,10116.0,N,Plasma,1,,Bioavailability from rat plasma at a single oral dose of 25 mg/kg,,BAO_0000218,17752,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623039,,10112,Rattus norvegicus,,10116.0,N,,1,,Bioavailability in rat (Fisher) (fasted),,BAO_0000218,1446,
In vivo,,A,,Intermediate,0,,22224,CHEMBL623040,,10113,Primates,,9443.0,U,,1,,Bioavailability in monkey after po administration of 10 mg/kg dose,,BAO_0000218,2891,
In vivo,,A,,Intermediate,0,,22224,CHEMBL623041,,10114,Primates,,9443.0,U,,1,,Oral bioavailability in monkey (dose 10 mg/kg),,BAO_0000218,2891,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623741,,10115,Rattus norvegicus,,10116.0,N,,1,,Bioavailability in rat,,BAO_0000218,6672,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623742,,10116,Rattus norvegicus,,10116.0,N,,1,,Bioavailability in rat,,BAO_0000218,6673,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623743,,10117,Rattus norvegicus,,10116.0,N,,1,,Bioavailability in rat,,BAO_0000218,17655,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623744,,10118,Rattus norvegicus,,10116.0,N,,1,,Bioavailability in rat,,BAO_0000218,17796,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623745,,10119,Rattus norvegicus,,10116.0,N,,1,,Bioavailability in rat (dose 2.0 mg/kg p.o.),,BAO_0000218,17853,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623746,,10120,Rattus norvegicus,,10116.0,N,,1,,Bioavailability in rat (dose 5 mg/kg p.o. and 1 mg/kg i.v.),,BAO_0000218,4521,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623747,,10121,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat (dose 5 mg/kg p.o.),,BAO_0000218,4940,
In vivo,,A,,Intermediate,0,,22224,CHEMBL623748,,10122,Rattus norvegicus,,10116.0,U,,1,,Bioavailability in rat after po administration of 30 mg/kg dose,,BAO_0000218,2891,
In vivo,,A,,Intermediate,0,,22224,CHEMBL623916,,10123,Rattus norvegicus,,10116.0,U,,1,,Bioavailability in rat after po administration of 30 mg/kg dose,,BAO_0000218,2891,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623917,,10124,Rattus norvegicus,,10116.0,N,,1,,Bioavailability in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,,BAO_0000218,4521,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623918,,10125,Rattus norvegicus,,10116.0,N,,1,,Bioavailability in rat (dose 2 mg/kg i.v.),,BAO_0000218,17686,
In vivo,,A,,Intermediate,1,,50597,CHEMBL874386,,10126,Rattus norvegicus,,10116.0,N,,1,,Bioavailability in rat,,BAO_0000218,17796,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623919,1969.0,10127,Rattus norvegicus,,10116.0,N,Plasma,1,,Bioavailability in rat; Only traces detected in rat plasma,,BAO_0000218,17796,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623920,,10128,Rattus norvegicus,,10116.0,N,,1,,Bioavailability in rat,,BAO_0000218,5064,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623148,,10129,Rattus norvegicus,,10116.0,N,,1,,Bioavailability upon oral administration of compound,,BAO_0000218,5147,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623149,,10130,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat (Sprague-Dawley) (dose 15 mg/kg),,BAO_0000218,1916,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623150,,10131,Rattus norvegicus,,10116.0,N,,1,,Bioavailability in rat,,BAO_0000218,6049,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623151,,10132,Rattus norvegicus,,10116.0,N,,1,,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fasting state",,BAO_0000218,1445,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623152,,10133,Rattus norvegicus,,10116.0,N,,1,,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fed state",,BAO_0000218,1445,
,,F,,Expert,1,,50597,CHEMBL623153,,10134,Rattus norvegicus,,10116.0,N,,1,,Streptococcal cell wall-washed arthritis model in rats at 3.0 mg/kg peroral dose,,BAO_0000218,2862,
,,F,,Expert,1,,50597,CHEMBL623154,,10135,Rattus norvegicus,,10116.0,N,,1,,Streptococcal cell wall-washed arthritis model in rats at 30.0 mg/kg peroral dose,,BAO_0000218,2862,
,,A,,Intermediate,1,,50597,CHEMBL623155,,10136,Rattus norvegicus,,10116.0,N,,1,,In vitro and metabolic stability was determined,,BAO_0000218,4194,
,,A,,Intermediate,1,,50597,CHEMBL623156,,10137,Rattus norvegicus,,10116.0,N,,1,,In vitro metabolic stability in rat hepatocytes,,BAO_0000218,4194,
,,A,,Intermediate,1,,50597,CHEMBL623157,,10138,Rattus norvegicus,,10116.0,N,,1,,In vitro metabolic stability in rat was measured as pmol/min/mg/protein,,BAO_0000218,5486,
In vitro,,A,,Intermediate,1,,50597,CHEMBL623158,2107.0,10139,Rattus norvegicus,Hepatocyte,10116.0,N,Liver,1,401.0,Metabolic rate for compound was observed in rat hepatocytes,,BAO_0000218,17582,
,,A,,Intermediate,1,,50597,CHEMBL623159,,10140,Rattus norvegicus,,10116.0,N,,1,,In vitro metabolic stability determined after 30 min of incubation in rat hepatic microsomes,,BAO_0000218,5600,
,,A,,Intermediate,1,,50597,CHEMBL874390,,10141,Rattus norvegicus,,10116.0,N,,1,,Metabolism of compound in rat S9 microsomes ('+''indicates <20% largest observed peak),,BAO_0000218,14294,
,,A,,Intermediate,1,,50597,CHEMBL623160,,10142,Rattus norvegicus,,10116.0,N,,1,,Metabolism of compound in rat S9 microsomes ('++++' indicates largest observed peak),,BAO_0000218,14294,
,,A,,Intermediate,1,,50597,CHEMBL623161,,10143,Rattus norvegicus,,10116.0,N,,1,,Metabolism of compound in rat S9 microsomes; Trace,,BAO_0000218,14294,
,,A,,Intermediate,1,,50597,CHEMBL623162,,10144,Rattus norvegicus,,10116.0,N,,1,,Metabolism was measured as percent loss at 4 hr in rat hepatocytes,,BAO_0000218,17847,
,,A,,Intermediate,1,,50597,CHEMBL623163,,10145,Rattus norvegicus,,10116.0,N,,1,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HIAA,,BAO_0000218,11020,
,,A,,Intermediate,1,,50597,CHEMBL623164,,10146,Rattus norvegicus,,10116.0,N,,1,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HT,,BAO_0000218,11020,
,,A,,Intermediate,1,,50597,CHEMBL623165,,10147,Rattus norvegicus,,10116.0,N,,1,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DA,,BAO_0000218,11020,
,,A,,Intermediate,1,,50597,CHEMBL623166,,10148,Rattus norvegicus,,10116.0,N,,1,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DOPAC,,BAO_0000218,11020,
,,A,,Intermediate,1,,50597,CHEMBL624983,,10149,Rattus norvegicus,,10116.0,N,,1,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex HVA,,BAO_0000218,11020,
,,A,,Intermediate,1,,50597,CHEMBL624984,,10150,Rattus norvegicus,,10116.0,N,,1,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex NE,,BAO_0000218,11020,
,,A,,Intermediate,1,,50597,CHEMBL624985,,10151,Rattus norvegicus,,10116.0,N,,1,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Hippocampus 5-HIAA,,BAO_0000218,11020,
,,A,,Intermediate,1,,50597,CHEMBL622970,,10152,Rattus norvegicus,,10116.0,N,,1,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus 5-HT,,BAO_0000218,11020,
,,A,,Intermediate,1,,50597,CHEMBL622971,,10153,Rattus norvegicus,,10116.0,N,,1,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below level of detection,,BAO_0000218,11020,
,,A,,Intermediate,1,,50597,CHEMBL622972,,10154,Rattus norvegicus,,10116.0,N,,1,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below the levels of detection,,BAO_0000218,11020,
,,A,,Intermediate,1,,50597,CHEMBL622973,,10155,Rattus norvegicus,,10116.0,N,,1,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below level of detection,,BAO_0000218,11020,
,,A,,Intermediate,1,,50597,CHEMBL622974,,10156,Rattus norvegicus,,10116.0,N,,1,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below the levels of detection,,BAO_0000218,11020,
,,A,,Intermediate,1,,50597,CHEMBL622975,,10157,Rattus norvegicus,,10116.0,N,,1,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below level of detection,,BAO_0000218,11020,
,,A,,Intermediate,1,,50597,CHEMBL622976,,10158,Rattus norvegicus,,10116.0,N,,1,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below the levels of detection,,BAO_0000218,11020,
,,A,,Intermediate,1,,50597,CHEMBL622977,,10159,Rattus norvegicus,,10116.0,N,,1,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus NE,,BAO_0000218,11020,
,,A,,Intermediate,1,,50597,CHEMBL624351,,10160,Rattus norvegicus,,10116.0,N,,1,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HIAA,,BAO_0000218,11020,
,,A,,Intermediate,1,,50597,CHEMBL624352,,10161,Rattus norvegicus,,10116.0,N,,1,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HT,,BAO_0000218,11020,
,,A,,Intermediate,1,,50597,CHEMBL624353,,10162,Rattus norvegicus,,10116.0,N,,1,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,,BAO_0000218,11020,
,,A,,Intermediate,1,,50597,CHEMBL622397,,10163,Rattus norvegicus,,10116.0,N,,1,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DOPAC,,BAO_0000218,11020,
,,A,,Intermediate,1,,50597,CHEMBL622398,,10164,Rattus norvegicus,,10116.0,N,,1,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex HVA,,BAO_0000218,11020,
,,A,,Intermediate,1,,50597,CHEMBL622399,,10165,Rattus norvegicus,,10116.0,N,,1,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex NE,,BAO_0000218,11020,
,,A,,Intermediate,1,,50597,CHEMBL622400,,10166,Rattus norvegicus,,10116.0,N,,1,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,,BAO_0000218,11020,
,,A,,Intermediate,1,,50597,CHEMBL628428,,10167,Rattus norvegicus,,10116.0,N,,1,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HIAA,,BAO_0000218,11020,
,,A,,Intermediate,1,,50597,CHEMBL628590,,10168,Rattus norvegicus,,10116.0,N,,1,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HT,,BAO_0000218,11020,
,,A,,Intermediate,1,,50597,CHEMBL628591,,10169,Rattus norvegicus,,10116.0,N,,1,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below level of detection,,BAO_0000218,11020,
,,A,,Intermediate,1,,50597,CHEMBL628592,,10170,Rattus norvegicus,,10116.0,N,,1,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below the levels of detection,,BAO_0000218,11020,
,,A,,Intermediate,1,,50597,CHEMBL628593,,10171,Rattus norvegicus,,10116.0,N,,1,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,,BAO_0000218,11020,
,,A,,Intermediate,1,,50597,CHEMBL875333,,10172,Rattus norvegicus,,10116.0,N,,1,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection,,BAO_0000218,11020,
,,A,,Intermediate,1,,50597,CHEMBL628594,,10173,Rattus norvegicus,,10116.0,N,,1,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,,BAO_0000218,11020,
,,A,,Intermediate,1,,50597,CHEMBL628595,1969.0,10174,Rattus norvegicus,,10116.0,N,Plasma,1,,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr of administration,,BAO_0000218,4969,
,,A,,Intermediate,1,,50597,CHEMBL628596,1969.0,10175,Rattus norvegicus,,10116.0,N,Plasma,1,,Stability in rat plasma was determined,,BAO_0000218,6737,
,,A,,Intermediate,1,,50597,CHEMBL628597,1969.0,10176,Rattus norvegicus,,10116.0,N,Plasma,1,,Stability in rat plasma was determined; ND= no data,,BAO_0000218,6737,
,,A,,Intermediate,1,,50597,CHEMBL628598,1969.0,10177,Rattus norvegicus,,10116.0,N,Plasma,1,,Tested for plasma half life period in rat (0-8 hr),,BAO_0000218,5089,
,,A,,Intermediate,1,,50597,CHEMBL628599,1969.0,10178,Rattus norvegicus,,10116.0,N,Plasma,1,,Tested for plasma half life period in rat (0-8 hr); Not determined,,BAO_0000218,5089,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628600,,10179,Rattus norvegicus,,10116.0,N,,1,,Tested for t1/2 upon intravenous administration of 5.0 mg/Kg dose in rat,,BAO_0000218,1466,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628601,,10180,Rattus norvegicus,,10116.0,N,,1,,Tested for t1/2 upon peroral administration of 10.0 mg/Kg dose in rat,,BAO_0000218,1466,
,,A,,Intermediate,1,,50597,CHEMBL628602,,10181,Rattus norvegicus,,10116.0,N,,1,,Tested for the half life in rat,,BAO_0000218,4950,
In vitro,,A,,Intermediate,1,,50597,CHEMBL628603,,10182,Rattus norvegicus,,10116.0,N,,1,,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase,,BAO_0000218,2412,
In vitro,,A,,Intermediate,1,,50597,CHEMBL628604,,10183,Rattus norvegicus,,10116.0,N,,1,,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase; ND=Not determined,,BAO_0000218,2412,
In vitro,,A,,Intermediate,1,,50597,CHEMBL628605,,10184,Rattus norvegicus,,10116.0,N,,1,,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase,,BAO_0000218,2412,
In vitro,,A,,Intermediate,1,,50597,CHEMBL628606,,10185,Rattus norvegicus,,10116.0,N,,1,,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase; ND=Not determined,,BAO_0000218,2412,
In vitro,,A,,Intermediate,1,,50597,CHEMBL628607,,10186,Rattus norvegicus,,10116.0,N,,1,,Tested in vitro for the time for half reactivation against rat small intestinal sucrase,,BAO_0000218,2412,
,,A,,Intermediate,1,,50597,CHEMBL628608,,10187,Rattus norvegicus,,10116.0,N,,1,,The biological half life the compound was measured at the dose of 100 umol/kg,,BAO_0000218,15022,
,,A,,Intermediate,1,,50597,CHEMBL628609,,10188,Rattus norvegicus,,10116.0,N,,1,,The biological half life the compound was measured at the dose of 30 umol/kg,,BAO_0000218,15022,
,,A,,Intermediate,1,,50597,CHEMBL628610,1969.0,10189,Rattus norvegicus,,10116.0,N,Plasma,1,,The compound was evaluated for plasma half life period in rat,,BAO_0000218,406,
In vivo,,A,,Intermediate,1,,50597,CHEMBL873819,,10190,Rattus norvegicus,,10116.0,N,,1,,"The half life value in female wistar rat at 100 mg/kg, p.o. dose",,BAO_0000218,15078,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628611,,10191,Rattus norvegicus,,10116.0,N,,1,,"The half life value in male wistar rat at 100 mg/kg, p.o. dose",,BAO_0000218,15078,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628612,,10192,Rattus norvegicus,,10116.0,N,,1,,The pharmacokinetic parameter half-life period in vivo in rats,,BAO_0000218,5247,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628613,,10193,Rattus norvegicus,,10116.0,N,,1,,"The pharmacokinetic property, Half-life was determined",,BAO_0000218,5041,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628614,,10194,Rattus norvegicus,,10116.0,N,,1,,"The pharmacokinetic property, Half-life in rat in vivo",,BAO_0000218,5041,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628615,,10195,Rattus norvegicus,,10116.0,N,,1,,"The pharmacokinetic property, Half-life was determined; ND denotes no data",,BAO_0000218,5041,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628616,,10196,Rattus norvegicus,,10116.0,N,,1,,"The pharmacokinetic property, Half-life was determined; ND denotes not determined",,BAO_0000218,5041,
,,A,,Intermediate,1,,50597,CHEMBL627924,1969.0,10197,Rattus norvegicus,,10116.0,N,Plasma,1,,The plasma half life period in rats,,BAO_0000218,3918,
,,A,,Intermediate,1,,50597,CHEMBL627925,2107.0,10198,Rattus norvegicus,,10116.0,N,Liver,1,,The release rate of the free drug from the substrate in rat liver lysosomal preparation by rat liver lysosomal assay,,BAO_0000218,2906,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627926,,10199,Rattus norvegicus,,10116.0,N,,1,,half life in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,,BAO_0000218,6467,
,,A,,Intermediate,1,,50597,CHEMBL627927,,10200,Rattus norvegicus,,10116.0,N,,1,,t1/2 (apparent elimination)of the compound was determined,,BAO_0000218,5510,
,,A,,Intermediate,1,,50597,CHEMBL627928,,10201,Rattus norvegicus,,10116.0,N,,1,,t1/2 value in rat,,BAO_0000218,3788,
,,A,,Intermediate,1,,50597,CHEMBL627539,,10202,Rattus norvegicus,,10116.0,N,,1,,Half life in rat,,BAO_0000218,17796,
In vivo,,A,,Intermediate,1,,50597,CHEMBL876790,1969.0,10203,Rattus norvegicus,,10116.0,N,Plasma,1,,"Half life period calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",,BAO_0000218,12873,
In vivo,,A,,Intermediate,1,,50597,CHEMBL858186,,10204,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic property (t1/2beta) was measured in rat at the dose of 0.32 mg/kg i.v.,,BAO_0000218,5983,
,,A,,Intermediate,1,,50597,CHEMBL627540,,10205,Rattus norvegicus,,10116.0,N,,1,,Half-life period in fasted rats,,BAO_0000218,15765,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627541,,10206,Rattus norvegicus,,10116.0,N,,1,,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to female wistar rats,,BAO_0000218,2661,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627715,,10207,Rattus norvegicus,,10116.0,N,,1,,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to male wistar rats,,BAO_0000218,2661,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627716,,10208,Rattus norvegicus,,10116.0,N,,1,,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,,BAO_0000218,429,
,,A,,Intermediate,1,,50597,CHEMBL627717,,10209,Rattus norvegicus,,10116.0,N,,1,,Maximum time required to achieve Cmax was determined in rat,,BAO_0000218,17655,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627718,,10210,Rattus norvegicus,,10116.0,N,,1,,Time calculated to reach Cmax at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,,BAO_0000218,17717,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627719,,10211,Rattus norvegicus,,10116.0,N,,1,,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,,BAO_0000218,17717,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627720,,10212,Rattus norvegicus,,10116.0,N,,1,,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with control,,BAO_0000218,17717,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627721,,10213,Rattus norvegicus,,10116.0,N,,1,,Time to reach maximum concentration in rat after 2 mg/kg peroral administration,,BAO_0000218,6570,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627722,,10214,Rattus norvegicus,,10116.0,N,,1,,Time to reach maximum concentration in rat after 2 mg/kg peroral administration; 4-6,,BAO_0000218,6570,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627723,,10215,Rattus norvegicus,,10116.0,N,,1,,Tmax of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,,BAO_0000218,5978,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626058,,10216,Rattus norvegicus,,10116.0,N,,1,,Tmax of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,,BAO_0000218,5978,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626059,,10217,Rattus norvegicus,,10116.0,N,,1,,Tmax of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,,BAO_0000218,5978,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626060,,10218,Rattus norvegicus,,10116.0,N,,1,,Tmax of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,,BAO_0000218,5978,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626061,1969.0,10219,Rattus norvegicus,,10116.0,N,Plasma,1,,Tmax at a dose of 4 mg/kg in Rat Plasma after iv administration,,BAO_0000218,17720,
In vivo,,A,,Intermediate,1,,50597,CHEMBL876791,,10220,Rattus norvegicus,,10116.0,N,,1,,Tmax determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,BAO_0000218,4723,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626062,,10221,Rattus norvegicus,,10116.0,N,,1,,Tmax determined after 3 mg/kg oral administration in potassium oxonate treated rats,,BAO_0000218,4723,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626063,,10222,Rattus norvegicus,,10116.0,N,,1,,Tmax at the dose of 2 mg/Kg administered perorally in rats,,BAO_0000218,4756,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626064,,10223,Rattus norvegicus,,10116.0,N,,1,,Tmax at the dose of 5 mg/Kg administered perorally in rats,,BAO_0000218,4756,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626065,1969.0,10224,Rattus norvegicus,,10116.0,N,Plasma,1,,tmax at a dose of 100 mg/kg in Rat Plasma after iv administration,,BAO_0000218,17720,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626066,1969.0,10225,Rattus norvegicus,,10116.0,N,Plasma,1,,tmax at a dose of 50 mg/kg in Rat Plasma after iv administration,,BAO_0000218,17720,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626067,,10226,Rattus norvegicus,,10116.0,N,,1,,tmax upon peroral administration of 10.0 mg/Kg dose in rat,,BAO_0000218,1466,
,,F,,Intermediate,1,,50597,CHEMBL626068,,10227,Rattus norvegicus,,10116.0,N,,1,,Percent total excretion of 3-(thiomethyl)acetaminophen glucuronide,,BAO_0000218,7449,
,,F,,Intermediate,1,,50597,CHEMBL626069,,10228,Rattus norvegicus,,10116.0,N,,1,,Percent total excretion of 3-(thiomethyl)acetaminophen sulfate,,BAO_0000218,7449,
,,F,,Intermediate,1,,50597,CHEMBL626070,,10229,Rattus norvegicus,,10116.0,N,,1,,Percent total excretion of 3-methoxyacetaminophen glucuronide,,BAO_0000218,7449,
,,F,,Intermediate,1,,50597,CHEMBL626071,,10230,Rattus norvegicus,,10116.0,N,,1,,Percent total excretion of N-methoxyacetaminophen glucuronide,,BAO_0000218,7449,
,,F,,Intermediate,1,,50597,CHEMBL626072,,10231,Rattus norvegicus,,10116.0,N,,1,,Percent total excretion of N-methoxyacetaminophen sulfate,,BAO_0000218,7449,
,,F,,Intermediate,1,,50597,CHEMBL626073,,10232,Rattus norvegicus,,10116.0,N,,1,,Percent total excretion of acetaminophen,,BAO_0000218,7449,
,,A,,Intermediate,1,,50597,CHEMBL626741,2046.0,10233,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,"Distribution of radioactivity in thyroid tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.19-7.22",,BAO_0000218,7768,
,,A,,Intermediate,1,,50597,CHEMBL626742,,10234,Rattus norvegicus,,10116.0,N,,1,,"Percent instability was measured by Rat S9 liver slice metabolism assay, in vitro",,BAO_0000218,17655,
,,A,,Intermediate,1,,50597,CHEMBL626743,,10235,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats,,BAO_0000218,17735,
,,A,,Intermediate,1,,50597,CHEMBL876792,,10236,Rattus norvegicus,,10116.0,N,,1,,Plasma concentration at 4 hr after 30 mg/kg post dosing in rat using HPLC/MS,,BAO_0000218,5960,
,,A,,Intermediate,1,,50597,CHEMBL626744,,10237,Rattus norvegicus,,10116.0,N,,1,,Volume of distribution following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,,BAO_0000218,17735,
,,A,,Intermediate,1,,50597,CHEMBL626745,,10238,Rattus norvegicus,,10116.0,N,,1,,Compound was tested for antidiuretic activity in rats,,BAO_0000218,7116,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626746,1969.0,10239,Rattus norvegicus,,10116.0,N,Plasma,1,,AUC in rat after 3mg/kg oral dose,,BAO_0000218,4878,
,,A,,Intermediate,1,,50597,CHEMBL626747,,10240,Rattus norvegicus,,10116.0,N,,1,,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 10 mg/kg,,BAO_0000218,5939,
,,A,,Intermediate,1,,50597,CHEMBL626748,,10241,Rattus norvegicus,,10116.0,N,,1,,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 5 mg/kg,,BAO_0000218,5939,
,,A,,Intermediate,1,,50597,CHEMBL626749,,10242,Rattus norvegicus,,10116.0,N,,1,,Bioavailability administered orally at a dose of 10 mg/kg to rats,,BAO_0000218,16367,
,,A,,Intermediate,1,,50597,CHEMBL626750,,10243,Rattus norvegicus,,10116.0,N,,1,,Oral Bioavailability was determined,,BAO_0000218,16366,
,,A,,Intermediate,1,,50597,CHEMBL626751,,10244,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat,,BAO_0000218,4426,
,,A,,Intermediate,1,,50597,CHEMBL626913,,10245,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat; Not performed.,,BAO_0000218,4426,
,,A,,Intermediate,1,,50597,CHEMBL626914,,10246,Rattus norvegicus,,10116.0,N,,1,,Bioavailability,,BAO_0000218,5041,
,,A,,Intermediate,1,,50597,CHEMBL626915,,10247,Rattus norvegicus,,10116.0,N,,1,,Bioavailability was determined; ND denotes no data,,BAO_0000218,5041,
,,A,,Intermediate,1,,50597,CHEMBL626916,,10248,Rattus norvegicus,,10116.0,N,,1,,Biliary excretion when administered intravenously at a dose of 2.5 mg/kg in rats,,BAO_0000218,1500,
,,A,,Intermediate,1,,50597,CHEMBL626917,,10249,Rattus norvegicus,,10116.0,N,,1,,Biliary excretion when administered intravenously at a dose of 5 mg/kg in rats,,BAO_0000218,1500,
,,A,,Intermediate,1,,50597,CHEMBL626918,,10250,Rattus norvegicus,,10116.0,N,,1,,Binding towards rat plasma protein at 10 uM,,BAO_0000218,17409,
,,A,,Intermediate,1,,50597,CHEMBL626919,,10251,Rattus norvegicus,,10116.0,N,,1,,Binding towards rat plasma protein at 100 uM,,BAO_0000218,17409,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626920,,10252,Rattus norvegicus,,10116.0,N,,1,,Bioavailability in rat (dose 20 mg/kg p.o.),,BAO_0000218,2959,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621976,,10253,Rattus norvegicus,,10116.0,N,,1,,Bioavailability was determined after oral administration of compound 18 at a dose of 4 mg/kg to rat,,BAO_0000218,13501,
In vivo,,A,,Intermediate,1,,50597,CHEMBL877599,,10254,Rattus norvegicus,,10116.0,N,,1,,Bioavailability in rat after 5 mg/kg oral gavage,,BAO_0000218,6567,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621977,,10255,Rattus norvegicus,,10116.0,N,,1,,Bioavailability in rat,,BAO_0000218,6571,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621978,,10256,Rattus norvegicus,,10116.0,N,,1,,Bioavailability in rat (dose 1 mg/kg i.v.),,BAO_0000218,6715,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621979,,10257,Rattus norvegicus,,10116.0,N,,1,,Bioavailability in rat (dose 3 mg/kg p.o.),,BAO_0000218,6715,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621980,,10258,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat,,BAO_0000218,2932,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621981,,10259,Rattus norvegicus,,10116.0,N,,1,,Bioavailability of the compound in rats after administration of 30 mg/kg,,BAO_0000218,4171,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621982,,10260,Rattus norvegicus,,10116.0,N,,1,,Bioavailability after administration of 10 mg/kg in rats,,BAO_0000218,17509,
In vivo,,A,,Intermediate,1,,50597,CHEMBL882953,,10261,Rattus norvegicus,,10116.0,N,,1,,Bioavailability after administration of 2 mg/kg in rats,,BAO_0000218,17509,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621983,,10262,Rattus norvegicus,,10116.0,N,,1,,Bioavailability by oral administration at a dose of 100 uM/kg in rat was determined,,BAO_0000218,4527,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621984,,10263,Rattus norvegicus,,10116.0,N,,1,,Bioavailability in dogs was determined; high,,BAO_0000218,4026,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621985,,10264,Rattus norvegicus,,10116.0,N,,1,,Bioavailability in monkey after intravenous administration at 1 mpk,,BAO_0000218,6659,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621986,,10265,Rattus norvegicus,,10116.0,N,,1,,Bioavailability in monkey after peroral administration at 10 mpk,,BAO_0000218,6659,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621987,,10266,Rattus norvegicus,,10116.0,N,,1,,Bioavailability in rat after intravenous administration at 1 mpk,,BAO_0000218,6659,
In vivo,,F,,Intermediate,1,,50597,CHEMBL877600,,10267,Rattus norvegicus,,10116.0,N,,1,,Bioavailability in rat after intravenous administration at 2 mpk,,BAO_0000218,6659,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621988,,10268,Rattus norvegicus,,10116.0,N,,1,,Bioavailability in rat after peroral administration at 30 mpk,,BAO_0000218,6659,
In vivo,,F,,Intermediate,1,,50597,CHEMBL621989,,10269,Rattus norvegicus,,10116.0,N,,1,,Bioavailability in rat after peroral administration at at 100 mpk,,BAO_0000218,6659,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621990,,10270,Rattus norvegicus,,10116.0,N,,1,,Bioavailability in rats was evaluated,,BAO_0000218,6597,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621991,,10271,Rattus norvegicus,,10116.0,N,,1,,Bioavailability was calculated after an intravenous dose of 0.3 mg/Kg in rats after 6 hr,,BAO_0000218,1202,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621992,,10272,Rattus norvegicus,,10116.0,N,,1,,Bioavailability was calculated after an intravenous dose of 1 mg/Kg in rats after 6 hr,,BAO_0000218,1202,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621993,,10273,Rattus norvegicus,,10116.0,N,,1,,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 4 hr,,BAO_0000218,1202,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621994,,10274,Rattus norvegicus,,10116.0,N,,1,,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 6 hr,,BAO_0000218,1202,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621995,,10275,Rattus norvegicus,,10116.0,N,,1,,Bioavailability in rat,,BAO_0000218,5207,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621996,,10276,Rattus norvegicus,,10116.0,N,,1,,Bioavailability in rat,,BAO_0000218,5970,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621997,,10277,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat (dose 10 mg/kg),,BAO_0000218,17538,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621998,,10278,Rattus norvegicus,,10116.0,N,,1,,Bioavailability in rat after po administration at a dose of 10 mg/kg; nd is not determined,,BAO_0000218,17538,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621999,,10279,Rattus norvegicus,,10116.0,N,,1,,Bioavailability upon peroral administration of 10.0 mg/Kg dose in rat,,BAO_0000218,1466,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622000,,10280,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat,,BAO_0000218,2879,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622001,,10281,Rattus norvegicus,,10116.0,N,,1,,Bioavailability was measured in rat after oral administration; 2-4,,BAO_0000218,2879,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622002,,10282,Rattus norvegicus,,10116.0,N,,1,,Bioavailability was measured in rat after oral administration; 3-7,,BAO_0000218,2879,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622003,,10283,Rattus norvegicus,,10116.0,N,,1,,Bioavailability in rat (intraduodenal administration),,BAO_0000218,3777,
In vivo,,A,,Intermediate,1,,50597,CHEMBL877601,,10284,Rattus norvegicus,,10116.0,N,,1,,Bioavailability in rat (intraduodenal administration),,BAO_0000218,3777,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624871,,10285,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat,,BAO_0000218,3777,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622004,,10286,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat,,BAO_0000218,3777,
In vivo,,A,,Intermediate,1,,50597,CHEMBL882954,,10287,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg p.o.),,BAO_0000218,5423,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622005,,10288,Rattus norvegicus,,10116.0,N,,1,,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally,,BAO_0000218,16365,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622006,,10289,Rattus norvegicus,,10116.0,N,,1,,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally to a fasting rat,,BAO_0000218,16365,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622007,,10290,Rattus norvegicus,,10116.0,N,,1,,Bioavailability was measured in rat,,BAO_0000218,4239,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622008,,10291,Rattus norvegicus,,10116.0,N,,1,,Bioavailability was reported,,BAO_0000218,5438,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622009,,10292,Rattus norvegicus,,10116.0,N,,1,,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,BAO_0000218,5334,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622010,,10293,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),,BAO_0000218,5334,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622011,,10294,Rattus norvegicus,,10116.0,N,,1,,Bioavailability was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,,BAO_0000218,4199,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622012,,10295,Rattus norvegicus,,10116.0,N,,1,,Bioavailability in rat (dose 2 mg/kg in 1% methylcellulose p.o.),,BAO_0000218,4199,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622013,,10296,Rattus norvegicus,,10116.0,N,,1,,Bioavailability in rat (dose 3 mg/kg in 1% methylcellulose ),,BAO_0000218,4199,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622014,,10297,Rattus norvegicus,,10116.0,N,,1,,Bioavailability was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,,BAO_0000218,4890,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624749,,10298,Rattus norvegicus,,10116.0,N,,1,,Bioavailability was determined at 3 mg/kg po dose in rats,,BAO_0000218,2792,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624750,,10299,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat (dose 2 mg/kg),,BAO_0000218,5529,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624751,,10300,Rattus norvegicus,,10116.0,N,,1,,"Bioavailability was determined in rats at 10 mg/kg, p.o. dose",,BAO_0000218,6685,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624752,,10301,Rattus norvegicus,,10116.0,N,,1,,"Bioavailability was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",,BAO_0000218,6685,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624753,,10302,Rattus norvegicus,,10116.0,N,,1,,"Bioavailability was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",,BAO_0000218,6685,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624754,,10303,Rattus norvegicus,,10116.0,N,,1,,Bioavailability was evaluated in rat after peroral administration at a dose of 1 mg/kg,,BAO_0000218,6005,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624755,,10304,Rattus norvegicus,,10116.0,N,,1,,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,,BAO_0000218,6410,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624756,,10305,Rattus norvegicus,,10116.0,N,,1,,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,,BAO_0000218,6410,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624757,,10306,Rattus norvegicus,,10116.0,N,,1,,Bioavailability in rat,,BAO_0000218,6103,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624758,,10307,Rattus norvegicus,,10116.0,N,,1,,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,,BAO_0000218,6410,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622270,,10308,Rattus norvegicus,,10116.0,N,,1,,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,,BAO_0000218,6410,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622271,,10309,Rattus norvegicus,,10116.0,N,,1,,Bioavailability in rat (Sprague-Dawley),,BAO_0000218,5353,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622272,,10310,Rattus norvegicus,,10116.0,N,,1,,Bioavailability in rat at the dose of 2 mg/kg,,BAO_0000218,4727,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622273,,10311,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat,,BAO_0000218,17804,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622274,,10312,Rattus norvegicus,,10116.0,N,,1,,Bioavailability in rat (cannulated) (dose 2 mg/kg),,BAO_0000218,5809,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622275,,10313,Rattus norvegicus,,10116.0,N,,1,,Bioavailability value of compound in rats was determined after peroral administration,,BAO_0000218,17804,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622276,,10314,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat (dose 20 mg/kg),,BAO_0000218,3634,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622277,,10315,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat,,BAO_0000218,3341,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622278,,10316,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat (dose 5 mg/kg),,BAO_0000218,2690,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622279,,10317,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat,,BAO_0000218,3184,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622280,,10318,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat,,BAO_0000218,740,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624083,,10319,Rattus norvegicus,,10116.0,N,,1,,Compound was evaluated for oral bioavailability in rats; 15-27 %,,BAO_0000218,1806,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624084,,10320,Rattus norvegicus,,10116.0,N,,1,,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 18 h,,BAO_0000218,4891,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624085,,10321,Rattus norvegicus,,10116.0,N,,1,,Compound was evaluated for pharmacokinetic property in rats after an oral dose of 10 mg/kg and the value was reported as oral bioavailability (F),,BAO_0000218,3634,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624086,,10322,Rattus norvegicus,,10116.0,N,,1,,Compound was tested for bioavailability in rats,,BAO_0000218,64,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624087,,10323,Rattus norvegicus,,10116.0,N,,1,,Bioavailability in rat,,BAO_0000218,4839,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624088,,10324,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat,,BAO_0000218,1094,
In vivo,,A,,Intermediate,0,,22224,CHEMBL624089,,10325,Macaca mulatta,,9544.0,U,,1,,Compound was tested for oral bioavailability in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po.,,BAO_0000218,5005,
In vivo,,A,,Intermediate,0,,22224,CHEMBL624090,,10326,Rattus norvegicus,,10116.0,U,,1,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),,BAO_0000218,5005,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624091,,10327,Rattus norvegicus,,10116.0,N,,1,,Evaluated for the bioavailability in rat (in vivo),,BAO_0000218,4687,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624092,,10328,Rattus norvegicus,,10116.0,N,,1,,F value of compound in rats was determined after peroral administration,,BAO_0000218,17804,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624093,,10329,Rattus norvegicus,,10116.0,N,,1,,In vivo Oral bioavailability (F)was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,BAO_0000218,5974,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624094,,10330,Rattus norvegicus,,10116.0,N,,1,,In vivo Oral bioavailability (F)was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,BAO_0000218,5974,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624095,,10331,Rattus norvegicus,,10116.0,N,,1,,In vivo Oral bioavailability (F)was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,BAO_0000218,5974,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624096,,10332,Rattus norvegicus,,10116.0,N,,1,,In vivo Oral bioavailability (F)was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,BAO_0000218,5974,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624097,,10333,Rattus norvegicus,,10116.0,N,,1,,"In vivo percent of absolute bioavailability obtained from blood plasma levels analyzed by means of GC/MS (dose 5 uM/kg i.v. and 40 uM/kg, p.o.)",,BAO_0000218,1088,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624098,,10334,Rattus norvegicus,,10116.0,N,,1,,Maximum fall in carotid flow in rat,,BAO_0000218,1742,
In vivo,,A,,Intermediate,1,,50597,CHEMBL874392,,10335,Rattus norvegicus,,10116.0,N,,1,,Oral Bioavailability after intravenous administration (1 mg/kg) in rat,,BAO_0000218,4689,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624099,,10336,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat (dose 5 mg/kg),,BAO_0000218,2463,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624100,,10337,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,,BAO_0000218,5654,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624101,,10338,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,,BAO_0000218,5654,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624102,,10339,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat (male Wistar),,BAO_0000218,6874,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624103,,10340,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability after administration (30 mg/kg) in rat; good,,BAO_0000218,5633,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624104,,10341,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability at the dose of 2 mg/kg in rat,,BAO_0000218,5496,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624105,,10342,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability determined in rats,,BAO_0000218,2358,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624106,,10343,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat (Sprague-Dawley) (male) (dose 50 mg/kg p.o.),,BAO_0000218,16456,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624107,,10344,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat (dose single 10 mg/kg),,BAO_0000218,5302,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623943,,10345,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat (dose single 10 mg/kg),,BAO_0000218,5302,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623944,,10346,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat (dose 5 mg/kg,,BAO_0000218,5302,
,,A,,Intermediate,1,,50597,CHEMBL623945,,10347,Rattus norvegicus,,10116.0,N,,1,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection,,BAO_0000218,11020,
,,A,,Intermediate,1,,50597,CHEMBL623946,,10348,Rattus norvegicus,,10116.0,N,,1,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus NE,,BAO_0000218,11020,
,,A,,Intermediate,1,,50597,CHEMBL623947,,10349,Rattus norvegicus,,10116.0,N,,1,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HIAA,,BAO_0000218,11020,
,,A,,Intermediate,1,,50597,CHEMBL623948,,10350,Rattus norvegicus,,10116.0,N,,1,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HT,,BAO_0000218,11020,
,,A,,Intermediate,1,,50597,CHEMBL623949,,10351,Rattus norvegicus,,10116.0,N,,1,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DA,,BAO_0000218,11020,
,,A,,Intermediate,1,,50597,CHEMBL623950,,10352,Rattus norvegicus,,10116.0,N,,1,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DOPAC,,BAO_0000218,11020,
,,A,,Intermediate,1,,50597,CHEMBL874398,,10353,Rattus norvegicus,,10116.0,N,,1,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex HVA,,BAO_0000218,11020,
,,A,,Intermediate,1,,50597,CHEMBL623951,,10354,Rattus norvegicus,,10116.0,N,,1,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex NE,,BAO_0000218,11020,
,,A,,Intermediate,1,,50597,CHEMBL623952,,10355,Rattus norvegicus,,10116.0,N,,1,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HIAA,,BAO_0000218,11020,
,,A,,Intermediate,1,,50597,CHEMBL623953,,10356,Rattus norvegicus,,10116.0,N,,1,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HT,,BAO_0000218,11020,
,,A,,Intermediate,1,,50597,CHEMBL623954,,10357,Rattus norvegicus,,10116.0,N,,1,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below level of detection,,BAO_0000218,11020,
,,A,,Intermediate,1,,50597,CHEMBL623955,,10358,Rattus norvegicus,,10116.0,N,,1,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below the levels of detection,,BAO_0000218,11020,
,,A,,Intermediate,1,,50597,CHEMBL623956,,10359,Rattus norvegicus,,10116.0,N,,1,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below level of detection,,BAO_0000218,11020,
,,A,,Intermediate,1,,50597,CHEMBL627807,,10360,Rattus norvegicus,,10116.0,N,,1,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below the levels of detection,,BAO_0000218,11020,
,,A,,Intermediate,1,,50597,CHEMBL627808,,10361,Rattus norvegicus,,10116.0,N,,1,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below level of detection,,BAO_0000218,11020,
,,A,,Intermediate,1,,50597,CHEMBL627809,,10362,Rattus norvegicus,,10116.0,N,,1,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below the levels of detection,,BAO_0000218,11020,
,,A,,Intermediate,1,,50597,CHEMBL627810,,10363,Rattus norvegicus,,10116.0,N,,1,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus NE,,BAO_0000218,11020,
,,A,,Intermediate,1,,50597,CHEMBL627811,,10364,Rattus norvegicus,,10116.0,N,,1,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HIAA",,BAO_0000218,11020,
,,A,,Intermediate,1,,50597,CHEMBL627812,,10365,Rattus norvegicus,,10116.0,N,,1,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HT",,BAO_0000218,11020,
,,A,,Intermediate,1,,50597,CHEMBL627813,,10366,Rattus norvegicus,,10116.0,N,,1,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DA",,BAO_0000218,11020,
,,A,,Intermediate,1,,50597,CHEMBL627814,,10367,Rattus norvegicus,,10116.0,N,,1,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DOPAC",,BAO_0000218,11020,
,,A,,Intermediate,1,,50597,CHEMBL875336,,10368,Rattus norvegicus,,10116.0,N,,1,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex HVA",,BAO_0000218,11020,
,,A,,Intermediate,1,,50597,CHEMBL627815,,10369,Rattus norvegicus,,10116.0,N,,1,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex NE",,BAO_0000218,11020,
,,A,,Intermediate,1,,50597,CHEMBL627816,,10370,Rattus norvegicus,,10116.0,N,,1,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus 5-HIAA",,BAO_0000218,11020,
,,A,,Intermediate,1,,50597,CHEMBL627817,,10371,Rattus norvegicus,,10116.0,N,,1,,"Momoamine and metabolic levels observed at 3 h postdrug against, at a dose of 20 mg/kg Hippocampus 5-HT",,BAO_0000218,11020,
,,A,,Intermediate,1,,50597,CHEMBL627818,,10372,Rattus norvegicus,,10116.0,N,,1,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DA; below the levels of detection",,BAO_0000218,11020,
,,A,,Intermediate,1,,50597,CHEMBL627819,,10373,Rattus norvegicus,,10116.0,N,,1,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection",,BAO_0000218,11020,
,,A,,Intermediate,1,,50597,CHEMBL627820,,10374,Rattus norvegicus,,10116.0,N,,1,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection",,BAO_0000218,11020,
,,A,,Intermediate,1,,50597,CHEMBL627821,,10375,Rattus norvegicus,,10116.0,N,,1,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus NE",,BAO_0000218,11020,
,,A,,Intermediate,1,,50597,CHEMBL628464,,10376,Rattus norvegicus,,10116.0,N,,1,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HIAA,,BAO_0000218,11020,
,,A,,Intermediate,1,,50597,CHEMBL626239,,10377,Rattus norvegicus,,10116.0,N,,1,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HT,,BAO_0000218,11020,
,,A,,Intermediate,1,,50597,CHEMBL626240,,10378,Rattus norvegicus,,10116.0,N,,1,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex DA,,BAO_0000218,11020,
,,A,,Intermediate,1,,50597,CHEMBL626241,,10379,Rattus norvegicus,,10116.0,N,,1,,Momoamine and metabolic levels observed at 3 h postdrug against at a dose of 20 mg/kg Frontal cortex DOPAC,,BAO_0000218,11020,
,,A,,Intermediate,1,,50597,CHEMBL626242,,10380,Rattus norvegicus,,10116.0,N,,1,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex HVA,,BAO_0000218,11020,
,,A,,Intermediate,1,,50597,CHEMBL626243,,10381,Rattus norvegicus,,10116.0,N,,1,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex NE,,BAO_0000218,11020,
,,A,,Intermediate,1,,50597,CHEMBL626244,,10382,Rattus norvegicus,,10116.0,N,,1,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HIAA,,BAO_0000218,11020,
,,A,,Intermediate,1,,50597,CHEMBL626907,,10383,Rattus norvegicus,,10116.0,N,,1,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HT; below level of detection,,BAO_0000218,11020,
,,A,,Intermediate,1,,50597,CHEMBL626908,,10384,Rattus norvegicus,,10116.0,N,,1,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DA; below level of detection,,BAO_0000218,11020,
,,A,,Intermediate,1,,50597,CHEMBL626909,,10385,Rattus norvegicus,,10116.0,N,,1,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,,BAO_0000218,11020,
,,A,,Intermediate,1,,50597,CHEMBL626910,,10386,Rattus norvegicus,,10116.0,N,,1,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,,BAO_0000218,11020,
,,F,,Intermediate,1,,50597,CHEMBL875342,,10387,Rattus norvegicus,,10116.0,N,,1,,Percent total excretion of acetaminophen cysteine conjugate,,BAO_0000218,7449,
,,F,,Intermediate,1,,50597,CHEMBL626911,,10388,Rattus norvegicus,,10116.0,N,,1,,Percent total excretion of acetaminophen glucuronide,,BAO_0000218,7449,
,,F,,Intermediate,1,,50597,CHEMBL626912,,10389,Rattus norvegicus,,10116.0,N,,1,,Percent total excretion of acetaminophen sulfate,,BAO_0000218,7449,
,,F,,Intermediate,1,,50597,CHEMBL627065,,10390,Rattus norvegicus,,10116.0,N,,1,,Percent total excretion of acetaminophen-mercapturic acid,,BAO_0000218,7449,
,,A,,Intermediate,1,,50597,CHEMBL627066,1088.0,10391,Rattus norvegicus,,10116.0,N,Urine,1,,Amount of urine output was measured in rat at a dose of 10 mg/kg administered orally,,BAO_0000218,3172,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627067,,10392,Rattus norvegicus,,10116.0,N,,1,,Volume of distribution in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,,BAO_0000218,16456,
In vivo,,A,,Autocuration,0,,22224,CHEMBL627068,2385.0,10393,ratrat,,8656.0,U,Muscle tissue,1,,Biodistribution of compound in rat muscle after 5 min of administration,,BAO_0000218,10839,
In vivo,,A,,Autocuration,0,,22224,CHEMBL627069,2385.0,10394,ratrat,,8656.0,U,Muscle tissue,1,,Biodistribution of compound in rat muscle after 5 min of administration.,,BAO_0000218,10839,
In vivo,,A,,Autocuration,0,,22224,CHEMBL627070,,10395,Ovis aries,,9940.0,U,,1,,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),,BAO_0000218,5334,
In vivo,,A,,Autocuration,0,,22224,CHEMBL627071,,10396,Ovis aries,,9940.0,U,,1,,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),,BAO_0000218,5334,
In vivo,,A,,Autocuration,0,,22224,CHEMBL627072,,10397,Ovis aries,,9940.0,U,,1,,Bioavailability was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),,BAO_0000218,5334,
In vivo,,A,,Autocuration,0,,22224,CHEMBL627073,,10398,Ovis aries,,9940.0,U,,1,,Bioavailability was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),,BAO_0000218,5334,
In vivo,,A,,Autocuration,0,,22224,CHEMBL625387,,10399,Ovis aries,,9940.0,U,,1,,Volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),,BAO_0000218,5334,
In vivo,,A,,Autocuration,0,,22224,CHEMBL625388,,10400,Ovis aries,,9940.0,U,,1,,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),,BAO_0000218,5334,
In vivo,,A,,Autocuration,0,,22224,CHEMBL625389,1969.0,10401,Ovis aries,,9940.0,U,Plasma,1,,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),,BAO_0000218,5334,
In vivo,,A,,Autocuration,0,,22224,CHEMBL875343,1969.0,10402,Ovis aries,,9940.0,U,Plasma,1,,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),,BAO_0000218,5334,
,,A,,Intermediate,1,,50497,CHEMBL876795,,10403,Serpentes,,8570.0,N,,1,,Biological half life period of compound was measured against snake venom phosphodiesterase (SVPDE),,BAO_0000218,1735,
,,A,,Intermediate,1,,50497,CHEMBL626552,,10404,Serpentes,,8570.0,N,,1,,Half life (t) of enzymatic phosphodiester hydrolysis of compound towards snake venom (SV-PDE) at a concentration of 4 microg,,BAO_0000218,1469,
,,A,,Intermediate,1,,50497,CHEMBL626553,,10405,Serpentes,,8570.0,N,,1,,Enzymatic stability was assessed with snake venom phosphodiesterase (SV PDE) exonuclase,,BAO_0000218,1336,
,,A,,Autocuration,0,,22224,CHEMBL626554,1969.0,10406,Homo sapiens,,9606.0,U,Plasma,1,,The human biological plasma half life of the compound,,BAO_0000366,12403,
,,A,,Intermediate,1,,50597,CHEMBL626555,1088.0,10407,Rattus norvegicus,,10116.0,N,Urine,1,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,,BAO_0000218,8151,
,,A,,Intermediate,1,,50597,CHEMBL626556,,10408,Rattus norvegicus,,10116.0,N,,1,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 120 min after iv administration compound,,BAO_0000218,8004,
,,A,,Intermediate,1,,50597,CHEMBL626557,,10409,Rattus norvegicus,,10116.0,N,,1,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 15 after iv administration of compound,,BAO_0000218,8004,
,,A,,Intermediate,1,,50597,CHEMBL626558,,10410,Rattus norvegicus,,10116.0,N,,1,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 240 min after iv administration compound,,BAO_0000218,8004,
,,A,,Intermediate,1,,50597,CHEMBL626559,,10411,Rattus norvegicus,,10116.0,N,,1,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 30 min after iv administration of compound,,BAO_0000218,8004,
,,A,,Intermediate,1,,50597,CHEMBL626560,,10412,Rattus norvegicus,,10116.0,N,,1,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 5 min after iv administration of compound,,BAO_0000218,8004,
,,A,,Intermediate,1,,50597,CHEMBL876803,,10413,Rattus norvegicus,,10116.0,N,,1,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 60 min after iv administration of compound,,BAO_0000218,8004,
,,A,,Intermediate,1,,50597,CHEMBL627964,,10414,Rattus norvegicus,,10116.0,N,,1,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 120 min after iv administration compound,,BAO_0000218,8004,
,,A,,Intermediate,1,,50597,CHEMBL627965,,10415,Rattus norvegicus,,10116.0,N,,1,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 15 min after iv administration of compound,,BAO_0000218,8004,
,,A,,Intermediate,1,,50597,CHEMBL627966,,10416,Rattus norvegicus,,10116.0,N,,1,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 240 min after iv administration compound,,BAO_0000218,8004,
,,A,,Intermediate,1,,50597,CHEMBL627967,,10417,Rattus norvegicus,,10116.0,N,,1,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 30 min after iv administration of compound,,BAO_0000218,8004,
,,A,,Intermediate,1,,50597,CHEMBL627968,,10418,Rattus norvegicus,,10116.0,N,,1,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 5 min after iv administration of compound,,BAO_0000218,8004,
,,A,,Intermediate,1,,50597,CHEMBL627969,,10419,Rattus norvegicus,,10116.0,N,,1,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 60 min after iv administration of compound,,BAO_0000218,8004,
,,A,,Intermediate,1,,50597,CHEMBL627970,,10420,Rattus norvegicus,,10116.0,N,,1,,Distribution of Se-75 activity in Liver of female Sprague-Dawley Rat 5 min after iv administration of compound,,BAO_0000218,8004,
,,A,,Intermediate,1,,50597,CHEMBL627971,178.0,10421,Rattus norvegicus,,10116.0,N,Blood,1,,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 120 min after iv administration of compound,,BAO_0000218,8004,
,,A,,Intermediate,1,,50597,CHEMBL627972,178.0,10422,Rattus norvegicus,,10116.0,N,Blood,1,,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 240 min after iv administration of compound,,BAO_0000218,8004,
,,B,,Expert,9,,180,CHEMBL856029,,10423,Homo sapiens,,9606.0,D,,1,,Dissociation constant against binding to human cyclophilin A,,BAO_0000357,15917,
,,B,,Expert,8,,11591,CHEMBL627973,,10424,Bos taurus,,9913.0,H,,1,,Michaelis-Menten constant for inhibitory activity against bovine liver glyoxalase II,,BAO_0000019,12396,
,,A,,Autocuration,0,,22224,CHEMBL627974,,10425,,,,U,,1,,-Log C was determined by performing the electroshock minimum test,,BAO_0000019,7065,
,,A,,Autocuration,0,,22224,CHEMBL627975,,10426,,,,U,,1,,-Log C was determined by performing the foot shock test,,BAO_0000019,7065,
,,A,,Autocuration,0,,22224,CHEMBL627976,,10427,,,,U,,1,,-Log C was determined by performing the incl screen test,,BAO_0000019,7065,
,,A,,Autocuration,0,,22224,CHEMBL627977,,10428,,,,U,,1,,-Log C was determined by performing the maximum electroshock test,,BAO_0000019,7065,
,,A,,Autocuration,0,,22224,CHEMBL627978,,10429,,,,U,,1,,-Log C was determined by performing the pentylenetetrazole test,,BAO_0000019,7065,
,,A,,Autocuration,0,,22224,CHEMBL627979,,10430,,,,U,,1,,Tested for experimental arotinoid inhibitory dose,,BAO_0000019,12415,
,,A,,Autocuration,0,,22224,CHEMBL876804,,10431,,,,U,,1,,Negative log transformed activity,,BAO_0000019,10256,
,,A,,Autocuration,0,,22224,CHEMBL627980,,10432,,,,U,,1,,"Negative log of Langmuir's alpha constant (-log alpha), which is inversely proportional to the effective binding constant (protein binding)",,BAO_0000019,7991,
,,A,,Intermediate,1,,50512,CHEMBL627981,,10433,Cavia porcellus,,10141.0,N,,1,,Dissociation constant was evaluated on guinea pig bladder at M3 muscarinic receptor,,BAO_0000218,14342,
,,A,,Intermediate,1,,50512,CHEMBL627982,,10434,Cavia porcellus,,10141.0,N,,1,,Dissociation constant was evaluated on guinea pig heart (force) at M2 muscarinic receptor,,BAO_0000218,14342,
,,A,,Intermediate,1,,50512,CHEMBL627983,,10435,Cavia porcellus,,10141.0,N,,1,,Dissociation constant was evaluated on guinea pig heart (rate) at M2 muscarinic receptor,,BAO_0000218,14342,
,,A,,Intermediate,1,,50512,CHEMBL627984,2116.0,10436,Cavia porcellus,,10141.0,N,Ileum,1,,Dissociation constant was evaluated on guinea pig ileum at M3 muscarinic receptor,,BAO_0000218,14342,
,,P,,Autocuration,0,,22229,CHEMBL627985,,10437,,,,U,,1,,Solubility in water was determined; values expressed as -log,,BAO_0000100,6047,
,,A,,Autocuration,0,,22224,CHEMBL627986,,10438,,,,U,,1,,Ratio of Kcat to that of Km was determined,,BAO_0000019,17269,
,,A,,Autocuration,0,,22224,CHEMBL627987,,10439,,,,U,,1,,Observed first order rate constant,,BAO_0000019,10026,
,,A,,Autocuration,0,,22224,CHEMBL627988,,10440,,,,U,,1,,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours,,BAO_0000019,14583,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627989,,10441,Rattus norvegicus,,10116.0,N,,1,,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to female wistar rats,,BAO_0000218,2661,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627990,,10442,Rattus norvegicus,,10116.0,N,,1,,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to male wistar rats,,BAO_0000218,2661,
In vivo,,A,,Intermediate,1,,50597,CHEMBL876805,,10443,Rattus norvegicus,,10116.0,N,,1,,Oral Bioavailability after administration of 10 mg/kg in male rat,,BAO_0000218,4029,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627991,,10444,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat (dose 10 mg/kg i.v. and 50 mg/kg p.o.),,BAO_0000218,17735,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627992,,10445,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat,,BAO_0000218,4576,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627993,,10446,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability after oral (po) administration at a dose of 10 mg/kg was measured in rats,,BAO_0000218,17582,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622817,,10447,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability at 1 mg/kg was determined in rat,,BAO_0000218,17651,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622818,,10448,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability at 10 mg/kg was determined in rat,,BAO_0000218,17651,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622819,,10449,Rattus norvegicus,,10116.0,N,,1,,"Oral bioavailability in fischer rats at 30 mg/kg dose, administered perorally",,BAO_0000218,17670,
In vivo,,A,,Intermediate,1,,50597,CHEMBL872267,,10450,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat,,BAO_0000218,5045,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622820,,10451,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat,,BAO_0000218,1696,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622821,,10452,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability after intravenous administration in rats at 24 uM/kg,,BAO_0000218,17764,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622822,,10453,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat,,BAO_0000218,6448,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622823,,10454,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat,,BAO_0000218,6596,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622824,,10455,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat,,BAO_0000218,17547,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622825,,10456,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat at a dose of 3 mg/kg,,BAO_0000218,17771,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622901,,10457,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat after oral administration at 10 mg/kg,,BAO_0000218,6495,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622902,,10458,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat,,BAO_0000218,4558,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621844,,10459,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat,,BAO_0000218,17596,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621845,,10460,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in Dawley rats,,BAO_0000218,6827,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621846,,10461,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability,,BAO_0000218,4026,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621847,,10462,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat (dose 30 mg/kg),,BAO_0000218,10,
In vivo,,A,,Intermediate,1,,50597,CHEMBL877609,,10463,Rattus norvegicus,,10116.0,N,,1,,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,,BAO_0000218,17717,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621848,,10464,Rattus norvegicus,,10116.0,N,,1,,Bioavailability in rat (dose 3 mg/kg i.v.),,BAO_0000218,17717,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621849,,10465,Rattus norvegicus,,10116.0,N,,1,,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,,BAO_0000218,17717,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622030,,10466,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat (dose 60 mg/kg p.o.),,BAO_0000218,17717,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622031,,10467,Rattus norvegicus,,10116.0,N,,1,,Percent oral bioavailability determined in rats,,BAO_0000218,4796,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622032,,10468,Rattus norvegicus,,10116.0,N,,1,,Tested for percent bioavailability after oral administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,,BAO_0000218,4883,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622033,,10469,Rattus norvegicus,,10116.0,N,,1,,The compound was evaluated for bioavailability in rats; 32-51,,BAO_0000218,2137,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622034,,10470,Rattus norvegicus,,10116.0,N,,1,,Bioavailability in rat (dose 20 mg/kg p.o.),,BAO_0000218,2959,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622035,,10471,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat,,BAO_0000218,1361,
In vivo,,A,,Intermediate,1,,50597,CHEMBL882966,,10472,Rattus norvegicus,,10116.0,N,,1,,Bioavailability percent in rat at the dose of 2 mg/kg,,BAO_0000218,4727,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622036,,10473,Rattus norvegicus,,10116.0,N,,1,,Bioavailability was evaluated after 20 uM/kg of peroral administration,,BAO_0000218,16423,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622037,,10474,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat,,BAO_0000218,5206,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622038,,10475,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat,,BAO_0000218,6448,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622039,,10476,Rattus norvegicus,,10116.0,N,,1,,Bioavailability in rats,,BAO_0000218,17723,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622040,178.0,10477,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution of radiolabeled compound in rat blood after 24 hr postinjection activity expressed as %ID/Organ,,BAO_0000218,17738,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622041,178.0,10478,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution of radiolabeled compound in rat blood after 24 hr activity expressed as %ID/Organ,,BAO_0000218,17738,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622042,178.0,10479,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution of radiolabeled compound in rat blood after 2 hr activity expressed as %ID/Organ,,BAO_0000218,17738,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622043,178.0,10480,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution of radiolabeled compound in rat blood after 30 min activity expressed as %ID/Organ,,BAO_0000218,17738,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622044,178.0,10481,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution of radiolabeled compound in rat blood after 5 min activity expressed as %ID/Organ,,BAO_0000218,17738,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622045,10000001.0,10482,Rattus norvegicus,,10116.0,N,Bone,1,,Biodistribution of radiolabeled compound in rat bone after 24 hr activity expressed as %ID/Organ,,BAO_0000218,17738,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622046,10000001.0,10483,Rattus norvegicus,,10116.0,N,Bone,1,,Biodistribution of radiolabeled compound in rat bone after 2 hr activity expressed as %ID/Organ,,BAO_0000218,17738,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622047,10000001.0,10484,Rattus norvegicus,,10116.0,N,Bone,1,,Biodistribution of radiolabeled compound in rat bone after 30 min activity expressed as %ID/Organ,,BAO_0000218,17738,
In vivo,,A,,Intermediate,1,,50597,CHEMBL877610,10000001.0,10485,Rattus norvegicus,,10116.0,N,Bone,1,,Biodistribution of radiolabeled compound in rat bone after 5 min activity expressed as %ID/Organ,,BAO_0000218,17738,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622048,955.0,10486,Rattus norvegicus,,10116.0,N,Brain,1,,Biodistribution of radiolabeled compound in rat brain after 24 hr activity expressed as %ID/Organ,,BAO_0000218,17738,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622049,955.0,10487,Rattus norvegicus,,10116.0,N,Brain,1,,Biodistribution of radiolabeled compound in rat brain after 2 hr activity expressed as %ID/Organ,,BAO_0000218,17738,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622050,955.0,10488,Rattus norvegicus,,10116.0,N,Brain,1,,Biodistribution of radiolabeled compound in rat brain after 30 min activity expressed as %ID/Organ,,BAO_0000218,17738,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622051,955.0,10489,Rattus norvegicus,,10116.0,N,Brain,1,,Biodistribution of radiolabeled compound in rat brain after 5 min activity expressed as %ID/Organ,,BAO_0000218,17738,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622052,,10490,Rattus norvegicus,,10116.0,N,,1,,Biodistribution of radiolabeled compound in rat fat after 24 hr activity expressed as %ID/Organ,,BAO_0000218,17738,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622053,,10491,Rattus norvegicus,,10116.0,N,,1,,Biodistribution of radiolabeled compound in rat fat after 2 hr activity expressed as %ID/Organ,,BAO_0000218,17738,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622054,,10492,Rattus norvegicus,,10116.0,N,,1,,Biodistribution of radiolabeled compound in rat fat after 30 min activity expressed as %ID/Organ,,BAO_0000218,17738,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622055,,10493,Rattus norvegicus,,10116.0,N,,1,,Biodistribution of radiolabeled compound in rat fat after 5 min activity expressed as %ID/Organ,,BAO_0000218,17738,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622056,,10494,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rats was determined; High,,BAO_0000218,5237,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622057,,10495,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in the rat was determined,,BAO_0000218,5503,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628008,,10496,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability measured by the ratio of intravenous to oral area under concentration.,,BAO_0000218,15765,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622058,,10497,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat (dose 10 mg/kg p.o. and 3 mg/kg i.v.),,BAO_0000218,15660,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622059,,10498,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,,BAO_0000218,5978,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622060,,10499,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,,BAO_0000218,5978,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622061,,10500,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,,BAO_0000218,5978,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622062,,10501,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,,BAO_0000218,5978,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622063,,10502,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability of compound at a dose of 20 mg/kg was determined after oral administration in rat,,BAO_0000218,5656,
In vivo,,A,,Expert,1,,50597,CHEMBL877611,,10503,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability of compound determined in rat after iv administration at a dose of 10 mg/kg,,BAO_0000218,3598,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622064,,10504,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability of compound in Sprague Dawley rats,,BAO_0000218,4216,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622065,,10505,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability of compound in rat,,BAO_0000218,17839,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622066,,10506,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat (dose 2 mg/kg),,BAO_0000218,6570,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622067,,10507,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability of compound in rat was determined,,BAO_0000218,5334,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622068,,10508,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability of compound in rats,,BAO_0000218,6886,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622069,,10509,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability of compound was determined in rats,,BAO_0000218,5210,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624796,,10510,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability at a dose of 30 mg/kg in rats,,BAO_0000218,4170,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624797,,10511,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat (dose 10 mg/kg),,BAO_0000218,6028,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623053,,10512,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat (dose 10 mg/kg),,BAO_0000218,6028,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623054,,10513,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability evaluated in rat,,BAO_0000218,6078,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623055,,10514,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in fasted rat,,BAO_0000218,6168,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623056,,10515,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in fed rat,,BAO_0000218,6168,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623057,,10516,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat (mature male) (dose 30 mg/kg),,BAO_0000218,5160,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623058,,10517,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat,,BAO_0000218,6057,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623059,,10518,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat (dose 10 mg/kg p.o.),,BAO_0000218,6535,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623060,,10519,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat after administration of 10 mg/kg po,,BAO_0000218,6535,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623061,,10520,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat,,BAO_0000218,4194,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623062,,10521,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat,,BAO_0000218,6230,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623063,,10522,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat,,BAO_0000218,6619,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623064,,10523,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat,,BAO_0000218,17607,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623065,,10524,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in ratrs,,BAO_0000218,4942,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623066,,10525,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat,,BAO_0000218,4942,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623067,,10526,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat,,BAO_0000218,6646,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623068,,10527,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rats was determined; High,,BAO_0000218,5237,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623069,,10528,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat,,BAO_0000218,6646,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623070,,10529,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat,,BAO_0000218,4449,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623071,,10530,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability was calculated in rat,,BAO_0000218,6057,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623072,,10531,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability,,BAO_0000218,2552,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623073,,10532,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability,,BAO_0000218,5496,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623074,,10533,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability,,BAO_0000218,6484,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623075,,10534,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability,,BAO_0000218,6485,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623076,,10535,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability after i.v. administration,,BAO_0000218,6616,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623077,,10536,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,BAO_0000218,4969,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623078,,10537,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat (Sprague-Dawley),,BAO_0000218,5862,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623079,,10538,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in Sprague-Dawley rats,,BAO_0000218,4514,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623080,,10539,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,BAO_0000218,4514,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623081,,10540,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),,BAO_0000218,4514,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623082,,10541,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in Sprague-Dawley rats at a dose of 2 mg/kg by po administration,,BAO_0000218,5546,
In vivo,,A,,Intermediate,1,,50597,CHEMBL874400,,10542,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in fasted rat,,BAO_0000218,6168,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623083,,10543,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in fed rat,,BAO_0000218,6168,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623084,,10544,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat,,BAO_0000218,3624,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623085,,10545,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat,,BAO_0000218,5213,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623086,,10546,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat,,BAO_0000218,5496,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623087,,10547,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat,,BAO_0000218,5553,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623088,,10548,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat,,BAO_0000218,5833,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623089,,10549,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat,,BAO_0000218,5836,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623090,,10550,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat,,BAO_0000218,5865,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623091,,10551,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat,,BAO_0000218,5960,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623092,,10552,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat,,BAO_0000218,6249,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623093,,10553,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat,,BAO_0000218,6448,
In vivo,,A,,Intermediate,1,,50597,CHEMBL874401,,10554,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat,,BAO_0000218,6453,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623094,,10555,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat,,BAO_0000218,6640,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623095,,10556,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat,,BAO_0000218,17607,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623096,,10557,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat after peroral administration at 10 mg/kg,,BAO_0000218,5939,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624913,,10558,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat after peroral administration at 5 mg/kg,,BAO_0000218,5939,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624914,,10559,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat (dose 2.8 mg/kg p.o.),,BAO_0000218,6281,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624915,,10560,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat by po administration at a dose of 40 mg/kg,,BAO_0000218,5874,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624916,,10561,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat; Not measured,,BAO_0000218,5213,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624917,,10562,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat,,BAO_0000218,4964,
,,A,,Intermediate,1,,50597,CHEMBL625157,,10563,Rattus norvegicus,,10116.0,N,,1,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus NE,,BAO_0000218,11020,
,,A,,Intermediate,1,,50597,CHEMBL625158,2107.0,10564,Rattus norvegicus,,10116.0,N,Liver,1,,In vitro metabolic potential in rat liver microsomes,,BAO_0000218,6251,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625159,,10565,Rattus norvegicus,,10116.0,N,,1,,"Oral availability was tested for plasma levels at a dose of 40 mg/kg, after 6 hr of in fed fisher rats.",,BAO_0000218,1568,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625160,,10566,Rattus norvegicus,,10116.0,N,,1,,"In vivo percentage mean absolute bioavailability of compound in rat after an oral dose of 10 mg/kg (in water, N=4)",,BAO_0000218,3032,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625161,,10567,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability of intravenously administered compound (3 mg/kg) was tested in rats,,BAO_0000218,3748,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625162,,10568,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat,,BAO_0000218,401,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625163,,10569,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat,,BAO_0000218,6512,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625164,,10570,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rats at 10 mg/kg,,BAO_0000218,17617,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625165,,10571,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,,BAO_0000218,6679,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625166,,10572,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat,,BAO_0000218,6742,
,,A,,Intermediate,1,,50597,CHEMBL625167,,10573,Rattus norvegicus,,10116.0,N,,1,,Tested for effective permeability across the rat intestinal membrane using mass balance analysis,,BAO_0000218,589,
,,A,,Intermediate,1,,50597,CHEMBL625168,,10574,Rattus norvegicus,,10116.0,N,,1,,Tested for effective permeability across the rat intestinal membrane using mass balance analysis at 0.01 mM concentration,,BAO_0000218,589,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625169,,10575,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance of the compound,,BAO_0000218,3185,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626264,,10576,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance at 10 mg/kg in rat upon intravenous administration,,BAO_0000218,17596,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626265,,10577,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance upon intravenous administration of 1 mg/Kg in rats,,BAO_0000218,2713,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626266,1969.0,10578,Rattus norvegicus,,10116.0,N,Plasma,1,,The compound was tested for plasma clearance in rat,,BAO_0000218,12500,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626267,1969.0,10579,Rattus norvegicus,,10116.0,N,Plasma,1,,The compound was tested for plasma clearance in rat at dose of 3-10 mgkg,,BAO_0000218,12500,
,,A,,Intermediate,1,,50597,CHEMBL626268,,10580,Rattus norvegicus,,10116.0,N,,1,,Plasma concentration upon oral administration of 1 mg/Kg in rats,,BAO_0000218,2713,
,,A,,Intermediate,1,,50597,CHEMBL626269,,10581,Rattus norvegicus,,10116.0,N,,1,,Peak plasma level between 0.5 and 1.0 hour in Dawley rats; value ranges from 1021-2551,,BAO_0000218,1446,
,,A,,Intermediate,1,,50597,CHEMBL626270,,10582,Rattus norvegicus,,10116.0,N,,1,,Plasma level after intravenous administration in rat model of FeCl3-induced carotid thrombosis,,BAO_0000218,6227,
,,A,,Intermediate,1,,50597,CHEMBL626271,,10583,Rattus norvegicus,,10116.0,N,,1,,Plasma protein binding was determined after intravenous administration of 1 mg/kg in rat,,BAO_0000218,4709,
,,A,,Intermediate,1,,50597,CHEMBL626272,,10584,Rattus norvegicus,,10116.0,N,,1,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1",,BAO_0000218,5510,
,,A,,Intermediate,1,,50597,CHEMBL626273,,10585,Rattus norvegicus,,10116.0,N,,1,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",,BAO_0000218,5510,
,,A,,Intermediate,1,,50597,CHEMBL875346,,10586,Rattus norvegicus,,10116.0,N,,1,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",,BAO_0000218,5510,
,,A,,Intermediate,1,,50597,CHEMBL626274,,10587,Rattus norvegicus,,10116.0,N,,1,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not stable",,BAO_0000218,5510,
,,A,,Intermediate,1,,50597,CHEMBL626275,,10588,Rattus norvegicus,,10116.0,N,,1,,Compound was tested for protein binding in rat plasma,,BAO_0000218,4514,
,,A,,Intermediate,1,,50597,CHEMBL624646,,10589,Rattus norvegicus,,10116.0,N,,1,,Compound was evaluated for absorption of radioligand following oral administration to bile duct cannulated rat. ,,BAO_0000218,2713,
,,A,,Intermediate,1,,50597,CHEMBL624647,,10590,Rattus norvegicus,,10116.0,N,,1,,Compound was evaluated for absorption of radioligand upon oral administration to bile duct cannulated rats,,BAO_0000218,2713,
,,A,,Intermediate,1,,50597,CHEMBL624648,2107.0,10591,Rattus norvegicus,,10116.0,N,Liver,1,,In vitro metabolism in rat liver microsomes was evaluated to determine diminishing of glucuronidation rate,,BAO_0000218,5340,
,,A,,Intermediate,1,,50597,CHEMBL624649,,10592,Rattus norvegicus,,10116.0,N,,1,,Area under curve ratio was determined (po/iv) in rat,,BAO_0000218,12058,
,,A,,Intermediate,1,,50597,CHEMBL624650,,10593,Rattus norvegicus,,10116.0,N,,1,,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 15 mins after i.v. administration,,BAO_0000218,11195,
,,A,,Intermediate,1,,50597,CHEMBL624651,,10594,Rattus norvegicus,,10116.0,N,,1,,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 2 mins after i.v. administration,,BAO_0000218,11195,
,,A,,Intermediate,1,,50597,CHEMBL624652,,10595,Rattus norvegicus,,10116.0,N,,1,,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 65 mins after i.v. administration,,BAO_0000218,11195,
,,A,,Intermediate,1,,50597,CHEMBL624653,,10596,Rattus norvegicus,,10116.0,N,,1,,Compound was tested for brain/plasma ratio after oral administration at 10 mg/kg,,BAO_0000218,6495,
,,A,,Intermediate,1,,50597,CHEMBL624654,,10597,Rattus norvegicus,,10116.0,N,,1,,Ratio of AUCbrain to AUCplasma,,BAO_0000218,6078,
,,A,,Intermediate,1,,50597,CHEMBL624655,,10598,Rattus norvegicus,,10116.0,N,,1,,Ratio of brain to plasma,,BAO_0000218,5656,
,,A,,Intermediate,1,,50597,CHEMBL624656,,10599,Rattus norvegicus,,10116.0,N,,1,,Ratio of the AUC values of brain and plasma after intravenous administration (4.7 mg/kg) to male rats was evaluated,,BAO_0000218,4910,
,,A,,Intermediate,1,,50597,CHEMBL624657,,10600,Rattus norvegicus,,10116.0,N,,1,,Ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,,BAO_0000218,4910,
,,A,,Intermediate,1,,50597,CHEMBL624658,,10601,Rattus norvegicus,,10116.0,N,,1,,Ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,,BAO_0000218,4910,
,,A,,Intermediate,1,,50597,CHEMBL624659,,10602,Rattus norvegicus,,10116.0,N,,1,,Selectivity ratio for biodistribution in brain and blood of rats after 15 minutes; Expressed as percent dose/gram ratio,,BAO_0000218,10130,
,,A,,Intermediate,1,,50597,CHEMBL624660,,10603,Rattus norvegicus,,10116.0,N,,1,,Selectivity ratio for biodistribution in brain and blood of rats after 2 minutes; Expressed as percent dose/gram ratio,,BAO_0000218,10130,
,,A,,Intermediate,1,,50597,CHEMBL624661,,10604,Rattus norvegicus,,10116.0,N,,1,,Selectivity ratio for biodistribution in brain and blood of rats after 60 minutes; Expressed as percent dose/gram ratio,,BAO_0000218,10130,
,,A,,Intermediate,1,,50597,CHEMBL624662,,10605,Rattus norvegicus,,10116.0,N,,1,,Steady state brain :blood ratio was determined,,BAO_0000218,5213,
,,A,,Intermediate,1,,50597,CHEMBL625199,,10606,Rattus norvegicus,,10116.0,N,,1,,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,,BAO_0000218,4910,
,,A,,Intermediate,1,,50597,CHEMBL625200,,10607,Rattus norvegicus,,10116.0,N,,1,,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,,BAO_0000218,4910,
,,A,,Intermediate,1,,50597,CHEMBL625201,,10608,Rattus norvegicus,,10116.0,N,,1,,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats,,BAO_0000218,4910,
,,A,,Intermediate,1,,50597,CHEMBL625202,,10609,Rattus norvegicus,,10116.0,N,,1,,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,,BAO_0000218,4910,
,,A,,Intermediate,1,,50597,CHEMBL625203,,10610,Rattus norvegicus,,10116.0,N,,1,,Percentage recovery after 3h incubation with rat hapatocytes was determined,,BAO_0000218,2083,
,,A,,Intermediate,1,,50597,CHEMBL625204,,10611,Rattus norvegicus,,10116.0,N,,1,,Percentage recovery in rat hepatic microsomal fractions under oxidative conditions after 1 hour,,BAO_0000218,2082,
,,A,,Intermediate,1,,50597,CHEMBL625205,,10612,Rattus norvegicus,,10116.0,N,,1,,Percentage recovery in rhesus monkey hepatic microsomal fractions under oxidative conditions after 1 hour,,BAO_0000218,2082,
,,A,,Intermediate,1,,50597,CHEMBL625206,,10613,Rattus norvegicus,,10116.0,N,,1,,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats,,BAO_0000218,6351,
,,A,,Autocuration,0,,22224,CHEMBL625207,,10614,,,,U,,1,,"Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured, No site available for protein conjugation.",,BAO_0000019,14583,
,,A,,Autocuration,0,,22224,CHEMBL625208,,10615,,,,U,,1,,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured.,,BAO_0000019,14583,
,,A,,Intermediate,1,,50587,CHEMBL625209,,10616,Homo sapiens,Caco-2,9606.0,N,,1,495.0,In vivo absorption in Caco-2 cell line monolayers was determined,,BAO_0000218,4608,
,,P,,Autocuration,0,,22229,CHEMBL625210,,10617,,,,U,,1,,Calculated partition coefficient (clogP),,BAO_0000100,13668,
,,A,,Intermediate,1,,50597,CHEMBL625211,,10618,Rattus norvegicus,,10116.0,N,,1,,Area under curve was determine after peroral administration at 10 mpk in Rat,,BAO_0000218,5669,
,,A,,Intermediate,1,,50797,CHEMBL625212,,10619,Macaca mulatta,,9544.0,N,,1,,Area under curve was determine after peroral administration at 10 mpk in Rhesus,,BAO_0000218,5669,
,,A,,Intermediate,1,,50597,CHEMBL625213,,10620,Rattus norvegicus,,10116.0,N,,1,,Area under curve was determine after peroral administration at 160 mpk in Rat,,BAO_0000218,5669,
,,A,,Intermediate,1,,50597,CHEMBL625214,,10621,Rattus norvegicus,,10116.0,N,,1,,Area under curve was determine after peroral administration at 20 mpk in Rat,,BAO_0000218,5669,
,,A,,Intermediate,1,,50597,CHEMBL874542,,10622,Rattus norvegicus,,10116.0,N,,1,,Area under curve was determine after peroral administration at 50 mpk in Rat,,BAO_0000218,5669,
,,P,,Autocuration,0,,22229,CHEMBL625215,,10623,,,,U,,1,,Calculated partition coefficient (clogP) (AlogP),,BAO_0000100,6472,
,,A,,Autocuration,0,,22224,CHEMBL625216,,10624,,,,U,,1,,Activated partial thromboplastin time measured,,BAO_0000019,15106,
,,P,,Autocuration,0,,22224,CHEMBL625217,,10625,,,,U,,1,,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4),,BAO_0000100,15207,
,,P,,Autocuration,0,,22224,CHEMBL625218,,10626,,,,U,,1,,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4); ND=Not determined (AS mg/mL),,BAO_0000100,15207,
,,A,,Intermediate,1,,50588,CHEMBL622864,1969.0,10627,Canis lupus familiaris,,9615.0,N,Plasma,1,,AUC (Area under curve) was determined after intravenous administration at a dose 1 mg/kg in dog,,BAO_0000218,13941,
,,A,,Intermediate,1,,50597,CHEMBL622865,1969.0,10628,Rattus norvegicus,,10116.0,N,Plasma,1,,AUC (Area under curve) was determined after intravenous administration at a dose 2 mg/kg in rat.,,BAO_0000218,13941,
,,A,,Intermediate,1,,50597,CHEMBL622866,1969.0,10629,Rattus norvegicus,,10116.0,N,Plasma,1,,AUC (Area under curve) was determined after peroral administration at a dose 10 mg/kg in rat.,,BAO_0000218,13941,
,,A,,Intermediate,1,,50588,CHEMBL622867,1969.0,10630,Canis lupus familiaris,,9615.0,N,Plasma,1,,AUC (Area under curve) was determined after peroral administration at a dose 5 mg/kg in dog,,BAO_0000218,13941,
,,A,,Intermediate,1,,50512,CHEMBL876808,1969.0,10631,Cavia porcellus,,10141.0,N,Plasma,1,,AUC (ng h/mL) value after oral administration of 10 mg/kg in guinea pig.,,BAO_0000218,15240,
,,A,,Autocuration,0,,22224,CHEMBL627725,955.0,10632,,,,U,Brain,1,,AUC in brain,,BAO_0000019,10655,
,,A,,Autocuration,0,,22224,CHEMBL627726,1977.0,10633,,,,U,Serum,1,,AUC in serum,,BAO_0000019,10655,
,,A,,Autocuration,0,,22224,CHEMBL627727,1969.0,10634,,,,U,Plasma,1,,AUC was determined,,BAO_0000019,6504,
,,A,,Autocuration,0,,22224,CHEMBL627728,1969.0,10635,,,,U,Plasma,1,,AUC of the compound.,,BAO_0000019,10615,
,,A,,Autocuration,0,,22224,CHEMBL627729,1969.0,10636,,,,U,Plasma,1,,AUC value (0-4 hr),,BAO_0000019,10353,
,,A,,Autocuration,0,,22224,CHEMBL627730,1969.0,10637,,,,U,Plasma,1,,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 150 uMol/kg,",,BAO_0000019,14907,
,,A,,Autocuration,0,,22224,CHEMBL627731,1969.0,10638,,,,U,Plasma,1,,AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,,BAO_0000019,14907,
,,A,,Autocuration,0,,22224,CHEMBL627732,1969.0,10639,,,,U,Plasma,1,,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,",,BAO_0000019,14907,
,,A,,Autocuration,0,,22224,CHEMBL627733,1969.0,10640,,,,U,Plasma,1,,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 700 uMol/kg,",,BAO_0000019,14907,
,,A,,Intermediate,1,,50597,CHEMBL627734,1969.0,10641,Rattus norvegicus,,10116.0,N,Plasma,1,,AUC(area under curve) was determined after intravenous administration in rats,,BAO_0000218,16359,
,,A,,Intermediate,1,,50597,CHEMBL627735,1969.0,10642,Rattus norvegicus,,10116.0,N,Plasma,1,,AUC(area under curve) was determined after oral administration in rats,,BAO_0000218,16359,
,,A,,Intermediate,1,,50512,CHEMBL627736,1969.0,10643,Cavia porcellus,,10141.0,N,Plasma,1,,AUC(ng h/mL)values after oral administration of 10 mg/kg in guinea pig.,,BAO_0000218,15240,
,,A,,Intermediate,1,,50597,CHEMBL876809,1969.0,10644,Rattus norvegicus,,10116.0,N,Plasma,1,,AUC(ng h/mL)values after oral administration of 10 mg/kg in rat.,,BAO_0000218,15240,
,,A,,Autocuration,0,,22224,CHEMBL627737,,10645,,,,U,,1,,Area Under Curve after oral dosing of 100 uM/Kg,,BAO_0000019,15469,
,,A,,Autocuration,0,,22224,CHEMBL627738,,10646,,,,U,,1,,Area Under Curve after oral dosing of 30 uM/Kg,,BAO_0000019,15469,
,,A,,Autocuration,0,,22224,CHEMBL627739,,10647,,,,U,,1,,Area Under Curve was measured by ploting the graph between concentration verses time,,BAO_0000019,13520,
,,A,,Intermediate,1,,50588,CHEMBL626143,,10648,Canis lupus familiaris,,9615.0,N,,1,,Area under concentration-time curve of compound was determined in dog at 25 mg/kg orally,,BAO_0000218,17025,
,,A,,Autocuration,0,,22224,CHEMBL626144,,10649,Simiiformes,,314293.0,U,,1,,Area under concentration-time curve of compound was determined in monkey at 25 mg/kg orally,,BAO_0000218,17025,
,,A,,Intermediate,1,,50592,CHEMBL626145,,10650,Oryctolagus cuniculus,,9986.0,N,,1,,Area under concentration-time curve of compound was determined in rabbit at 25 mg/kg orally,,BAO_0000218,17025,
,,A,,Intermediate,1,,50597,CHEMBL626146,,10651,Rattus norvegicus,,10116.0,N,,1,,Area under concentration-time curve of compound was determined in rat at 25 mg/kg orally,,BAO_0000218,17025,
,,A,,Intermediate,1,,50597,CHEMBL626147,178.0,10652,Rattus norvegicus,,10116.0,N,Blood,1,,Area under curve (AUC) is the drug concentrations in blood samples of rats with arterial catheters at 5 min and 12 hr plotted against time,,BAO_0000218,12032,
,,A,,Autocuration,0,,22224,CHEMBL626148,,10653,,,,U,,1,,Area under curve (AUC) was determined,,BAO_0000019,10291,
,,A,,Autocuration,0,,22224,CHEMBL626149,,10654,,,,U,,1,,Area under curve (AUC) following ip administration at 1 mg/kg,,BAO_0000218,5767,
,,A,,Autocuration,0,,22224,CHEMBL626150,,10655,,,,U,,1,,Area under curve (AUC) was determined; ND is Not determined,,BAO_0000019,1434,
,,A,,Intermediate,1,,50588,CHEMBL626151,,10656,Canis lupus familiaris,,9615.0,N,,1,,Area under curve (AUC) was determined in dogs fed after intravenous administration of 25 mg/kg of the compound,,BAO_0000218,14925,
,,A,,Intermediate,1,,50588,CHEMBL626152,,10657,Canis lupus familiaris,,9615.0,N,,1,,Area under curve (AUC) was determined in dogs fed after oral administration of 25 mg/kg of the compound,,BAO_0000218,14925,
,,A,,Intermediate,1,,50588,CHEMBL626153,,10658,Canis lupus familiaris,,9615.0,N,,1,,Area under curve (AUC) was determined in fasted dogs after oral administration of 25 mg/kg of the compound,,BAO_0000218,14925,
,,A,,Autocuration,0,,22224,CHEMBL626154,,10659,,,,U,,1,,Area under curve (AUR) was determined,,BAO_0000019,1434,
,,A,,Autocuration,0,,22224,CHEMBL626155,,10660,,,,U,,1,,Area under curve at 1 uM/dg administered intravenously,,BAO_0000019,11883,
,,A,,Autocuration,0,,22224,CHEMBL626156,,10661,,,,U,,1,,Area under curve at 10 uM/dg administered perorally,,BAO_0000019,11883,
,,A,,Autocuration,0,,22224,CHEMBL626157,,10662,,,,U,,1,,Area under curve at 2 uM/dg administered intravenously,,BAO_0000019,11883,
,,A,,Autocuration,0,,22224,CHEMBL626158,,10663,,,,U,,1,,Area under curve at 20 uM/dg administered perorally,,BAO_0000019,11883,
,,A,,Intermediate,1,,50588,CHEMBL626159,,10664,Canis lupus familiaris,,9615.0,N,,1,,Area under curve at a peroral dose of 3 mg/kg in dog,,BAO_0000218,15233,
,,A,,Intermediate,1,,50597,CHEMBL626160,,10665,Rattus norvegicus,,10116.0,N,,1,,Area under curve at a peroral dose of 3 mg/kg in rat,,BAO_0000218,15233,
,,A,,Intermediate,1,,50588,CHEMBL626161,,10666,Canis lupus familiaris,,9615.0,N,,1,,Area under curve at an iv dose of 1 mg/kg in dog,,BAO_0000218,15233,
,,A,,Intermediate,1,,50597,CHEMBL626162,,10667,Rattus norvegicus,,10116.0,N,,1,,Area under curve at an iv dose of 1 mg/kg in rat,,BAO_0000218,15233,
,,A,,Autocuration,0,,22224,CHEMBL626163,,10668,,,,U,,1,,Area under curve gives the effective duration for the angiotensin II antagonist effect of the compound.,,BAO_0000019,12978,
,,A,,Autocuration,0,,22224,CHEMBL626164,,10669,,,,U,,1,,Area under curve gives the effective duration for the angiotensin II antagonist effect.,,BAO_0000019,12978,
,,A,,Intermediate,1,,50594,CHEMBL626165,,10670,Mus musculus,,10090.0,N,,1,,Area under curve measured as conc vs time after intravenous administration to mice.,,BAO_0000218,11355,
,,A,,Intermediate,1,,50594,CHEMBL626166,,10671,Mus musculus,,10090.0,N,,1,,Area under curve measured as conc vs time after peroral administration to mice.,,BAO_0000218,11355,
,,A,,Intermediate,1,,50588,CHEMBL626167,,10672,Canis lupus familiaris,,9615.0,N,,1,,Area under curve of acid 2a was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,,BAO_0000218,12923,
,,A,,Intermediate,1,,50588,CHEMBL626168,,10673,Canis lupus familiaris,,9615.0,N,,1,,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by capsule method in dog,,BAO_0000218,12923,
,,A,,Intermediate,1,,50588,CHEMBL877463,,10674,Canis lupus familiaris,,9615.0,N,,1,,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by gavage method in dog,,BAO_0000218,12923,
,,A,,Intermediate,1,,50588,CHEMBL626169,,10675,Canis lupus familiaris,,9615.0,N,,1,,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by capsule method in dog,,BAO_0000218,12923,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626170,948.0,10676,Rattus norvegicus,,10116.0,N,Heart,1,,Biodistribution of radiolabeled compound in rat heart after 24 hr activity expressed as %ID/Organ,,BAO_0000218,17738,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626171,948.0,10677,Rattus norvegicus,,10116.0,N,Heart,1,,Biodistribution of radiolabeled compound in rat heart after 2 hr activity expressed as %ID/Organ,,BAO_0000218,17738,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626172,948.0,10678,Rattus norvegicus,,10116.0,N,Heart,1,,Biodistribution of radiolabeled compound in rat heart after 30 min activity expressed as %ID/Organ,,BAO_0000218,17738,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626173,948.0,10679,Rattus norvegicus,,10116.0,N,Heart,1,,Biodistribution of radiolabeled compound in rat heart after 5 min activity expressed as %ID/Organ,,BAO_0000218,17738,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626174,2113.0,10680,Rattus norvegicus,,10116.0,N,Kidney,1,,Biodistribution of radiolabeled compound in rat kidney after 24 hr postinjection activity expressed as %ID/Organ,,BAO_0000218,17738,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626175,2113.0,10681,Rattus norvegicus,,10116.0,N,Kidney,1,,Biodistribution of radiolabeled compound in rat kidney after 24 hr activity expressed as %ID/Organ,,BAO_0000218,17738,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626176,2113.0,10682,Rattus norvegicus,,10116.0,N,Kidney,1,,Biodistribution of radiolabeled compound in rat kidney after 2 hr activity expressed as %ID/Organ,,BAO_0000218,17738,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626177,2113.0,10683,Rattus norvegicus,,10116.0,N,Kidney,1,,Biodistribution of radiolabeled compound in rat kidney after 30 min activity expressed as %ID/Organ,,BAO_0000218,17738,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622499,2113.0,10684,Rattus norvegicus,,10116.0,N,Kidney,1,,Biodistribution of radiolabeled compound in rat kidney after 5 min activity expressed as %ID/Organ,,BAO_0000218,17738,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622500,2107.0,10685,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution of radiolabeled compound in rat liver after 24 hr postinjection activity expressed as %ID/Organ,,BAO_0000218,17738,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622501,2107.0,10686,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution of radiolabeled compound in rat liver after 24 hr activity expressed as %ID/Organ,,BAO_0000218,17738,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622502,2107.0,10687,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution of radiolabeled compound in rat liver after 2 hr activity expressed as %ID/Organ,,BAO_0000218,17738,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622503,2107.0,10688,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution of radiolabeled compound in rat liver after 30 min activity expressed as %ID/Organ,,BAO_0000218,17738,
In vivo,,A,,Intermediate,1,,50597,CHEMBL877614,2107.0,10689,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution of radiolabeled compound in rat liver after 5 min activity expressed as %ID/Organ,,BAO_0000218,17738,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624839,2048.0,10690,Rattus norvegicus,,10116.0,N,Lung,1,,Biodistribution of radiolabeled compound in rat lung after 24 hr activity expressed as %ID/Organ,,BAO_0000218,17738,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624840,2048.0,10691,Rattus norvegicus,,10116.0,N,Lung,1,,Biodistribution of radiolabeled compound in rat lung after 2 hr activity expressed as %ID/Organ,,BAO_0000218,17738,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624841,2048.0,10692,Rattus norvegicus,,10116.0,N,Lung,1,,Biodistribution of radiolabeled compound in rat lung after 30 min activity expressed as %ID/Organ,,BAO_0000218,17738,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624842,2048.0,10693,Rattus norvegicus,,10116.0,N,Lung,1,,Biodistribution of radiolabeled compound in rat lung after 5 min activity expressed as %ID/Organ,,BAO_0000218,17738,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624843,2385.0,10694,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Biodistribution of radiolabeled compound in rat muscle after 24 hr activity expressed as %ID/Organ,,BAO_0000218,17738,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624844,2385.0,10695,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Biodistribution of radiolabeled compound in rat muscle after 2 hr activity expressed as %ID/Organ,,BAO_0000218,17738,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624845,2385.0,10696,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Biodistribution of radiolabeled compound in rat muscle after 30 min activity expressed as %ID/Organ,,BAO_0000218,17738,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621904,2385.0,10697,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Biodistribution of radiolabeled compound in rat muscle after 5 min activity expressed as %ID/Organ,,BAO_0000218,17738,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621905,178.0,10698,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 15 mins after i.v. administration,,BAO_0000218,11195,
In vivo,,A,,Intermediate,1,,50597,CHEMBL874382,178.0,10699,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 2 mins after i.v. administration,,BAO_0000218,11195,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621906,178.0,10700,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 65 mins after i.v. administration,,BAO_0000218,11195,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621907,955.0,10701,Rattus norvegicus,,10116.0,N,Brain,1,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 15 mins after i.v. administration,,BAO_0000218,11195,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622096,955.0,10702,Rattus norvegicus,,10116.0,N,Brain,1,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 2 mins after i.v. administration,,BAO_0000218,11195,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622097,955.0,10703,Rattus norvegicus,,10116.0,N,Brain,1,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 65 mins after i.v. administration,,BAO_0000218,11195,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622098,948.0,10704,Rattus norvegicus,,10116.0,N,Heart,1,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 15 mins after i.v. administration,,BAO_0000218,11195,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622099,948.0,10705,Rattus norvegicus,,10116.0,N,Heart,1,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 2 mins after i.v. administration,,BAO_0000218,11195,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622100,948.0,10706,Rattus norvegicus,,10116.0,N,Heart,1,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 65 mins after i.v. administration,,BAO_0000218,11195,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622101,2113.0,10707,Rattus norvegicus,,10116.0,N,Kidney,1,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 15 mins after i.v. administration,,BAO_0000218,11195,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622102,2113.0,10708,Rattus norvegicus,,10116.0,N,Kidney,1,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 2 mins after i.v. administration,,BAO_0000218,11195,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622103,2113.0,10709,Rattus norvegicus,,10116.0,N,Kidney,1,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 65 mins after i.v. administration,,BAO_0000218,11195,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622104,2107.0,10710,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 15 mins after i.v. administration,,BAO_0000218,11195,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622105,2107.0,10711,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 2 mins after i.v. administration,,BAO_0000218,11195,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622106,2107.0,10712,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 65 mins after i.v. administration,,BAO_0000218,11195,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622107,2048.0,10713,Rattus norvegicus,,10116.0,N,Lung,1,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 15 mins after i.v. administration,,BAO_0000218,11195,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622108,2048.0,10714,Rattus norvegicus,,10116.0,N,Lung,1,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 2 mins after i.v. administration,,BAO_0000218,11195,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622109,2048.0,10715,Rattus norvegicus,,10116.0,N,Lung,1,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 65 mins after i.v. administration,,BAO_0000218,11195,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622110,2385.0,10716,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 15 mins after i.v. administration,,BAO_0000218,11195,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622111,2385.0,10717,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 2 mins after i.v. administration,,BAO_0000218,11195,
In vivo,,A,,Intermediate,1,,50597,CHEMBL874383,2385.0,10718,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 65 mins after i.v. administration,,BAO_0000218,11195,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622112,14.0,10719,Rattus norvegicus,,10116.0,N,Zone of skin,1,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 15 mins after i.v. administration,,BAO_0000218,11195,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622113,14.0,10720,Rattus norvegicus,,10116.0,N,Zone of skin,1,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 2 mins after i.v. administration,,BAO_0000218,11195,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622114,14.0,10721,Rattus norvegicus,,10116.0,N,Zone of skin,1,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 65 mins after i.v. administration,,BAO_0000218,11195,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622115,2106.0,10722,Rattus norvegicus,,10116.0,N,Spleen,1,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 15 mins after i.v. administration,,BAO_0000218,11195,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622116,2106.0,10723,Rattus norvegicus,,10116.0,N,Spleen,1,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 2 mins after i.v. administration,,BAO_0000218,11195,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622117,,10724,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat,,BAO_0000218,6193,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622118,,10725,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat,,BAO_0000218,6803,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622119,,10726,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rats at 6 mg/kg,,BAO_0000218,6647,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622120,,10727,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat (dose 6 mg/kg),,BAO_0000218,6647,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622121,,10728,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rats at 6 mg/kg dose; Not tested,,BAO_0000218,6647,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622122,,10729,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat,,BAO_0000218,6640,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622123,,10730,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat,,BAO_0000218,6641,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622124,,10731,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat,,BAO_0000218,6641,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622125,,10732,Rattus norvegicus,,10116.0,N,,1,,Bioavailability in rat,,BAO_0000218,6642,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622126,,10733,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability,,BAO_0000218,5472,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620455,,10734,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),,BAO_0000218,6141,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620456,,10735,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat,,BAO_0000218,4390,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620457,,10736,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat,,BAO_0000218,5472,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620458,,10737,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability was evaluated; Not tested,,BAO_0000218,5472,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620459,,10738,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability,,BAO_0000218,5438,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620460,,10739,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat by oral dosing,,BAO_0000218,4883,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620461,,10740,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat (dose 10 mg/kg p.o.),,BAO_0000218,1908,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620462,,10741,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat (Sprague-Dawley),,BAO_0000218,4853,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620463,,10742,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,BAO_0000218,4853,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620464,,10743,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,BAO_0000218,4853,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620465,,10744,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),,BAO_0000218,4853,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620466,,10745,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg p.o.),,BAO_0000218,4853,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620467,,10746,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 1 mg/kg,,BAO_0000218,4853,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620468,,10747,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 2 mg/kg,,BAO_0000218,4853,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620469,,10748,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in solution form,,BAO_0000218,12873,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620470,,10749,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in suspension form,,BAO_0000218,12873,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620471,,10750,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat,,BAO_0000218,3169,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620472,,10751,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat,,BAO_0000218,6305,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620473,,10752,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability of compound at 5 mg/kg after po administration was determined in rat,,BAO_0000218,4762,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620474,,10753,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat,,BAO_0000218,17847,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620475,,10754,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 10 mg/kg),,BAO_0000218,6211,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620476,,10755,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat,,BAO_0000218,6011,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620477,,10756,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat,,BAO_0000218,6317,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620478,,10757,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat after oral administration at 10.5 mg/kg dose,,BAO_0000218,6644,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618768,,10758,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat after oral administration at 11.2 mg/kg dose,,BAO_0000218,6644,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618769,,10759,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat after oral administration at 13 mg/kg dose,,BAO_0000218,6644,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618770,,10760,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat after oral administration at 9.7 mg/kg dose,,BAO_0000218,6644,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618771,,10761,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability (dose 20 mg/kg p.o.),,BAO_0000218,6113,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618772,,10762,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability was determined in rat after oral administration at a concentration 1 mg/kg,,BAO_0000218,5937,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618773,,10763,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat at 10 mg/kg of the compound,,BAO_0000218,5711,
In vivo,,A,,Intermediate,1,,50597,CHEMBL875842,,10764,Rattus norvegicus,,10116.0,N,,1,,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,,BAO_0000218,17717,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618774,,10765,Rattus norvegicus,,10116.0,N,,1,,Bioavailability in rat (dose 3 mg/kg i.v.),,BAO_0000218,17717,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618775,,10766,Rattus norvegicus,,10116.0,N,,1,,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,,BAO_0000218,17717,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618776,,10767,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat (dose 60 mg/kg p.o.),,BAO_0000218,17717,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618777,,10768,Rattus norvegicus,,10116.0,N,,1,,Percent bioavailability (F) in rats after iv administration,,BAO_0000218,4722,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618778,,10769,Rattus norvegicus,,10116.0,N,,1,,Percent bioavailability (F) in rats after oral dose of 10 mg/kg,,BAO_0000218,4722,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618779,,10770,Rattus norvegicus,,10116.0,N,,1,,Bioavailability in rat (dose 5 uM/kg p.o.),,BAO_0000218,4353,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618780,,10771,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability,,BAO_0000218,15662,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618781,,10772,Rattus norvegicus,,10116.0,N,,1,,Bioavailability in rat (dose 2 mg/kg p.o.),,BAO_0000218,4756,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618782,,10773,Rattus norvegicus,,10116.0,N,,1,,Percent bioavailability at the dose of 5 mg/Kg administered perorally in rats,,BAO_0000218,4756,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618783,,10774,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat (dose 20 mg/kg),,BAO_0000218,3436,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618784,,10775,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat,,BAO_0000218,17800,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618785,,10776,Rattus norvegicus,,10116.0,N,,1,,Percent oral bioavailability evaluated in rat,,BAO_0000218,15762,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618786,,10777,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat,,BAO_0000218,5089,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618787,,10778,Rattus norvegicus,,10116.0,N,,1,,Percent oral bioavailability in rat; Not determined,,BAO_0000218,5089,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618788,,10779,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat,,BAO_0000218,3185,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618789,,10780,Rattus norvegicus,,10116.0,N,,1,,Bioavailability in rat,,BAO_0000218,5145,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618790,,10781,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic property (oral bioavailability) in rat (dose given as a solution),,BAO_0000218,3457,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618791,,10782,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic property (oral bioavailability) in rat (dose given as a suspension),,BAO_0000218,3457,
In vivo,,A,,Intermediate,1,,50597,CHEMBL875843,,10783,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic property (F) was measured in rat at the dose of 0.32 mg/kg,,BAO_0000218,5983,
In vivo,,A,,Intermediate,1,,50597,CHEMBL618792,,10784,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat (dose 20 mg/kg p.o.),,BAO_0000218,5739,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623395,,10785,Rattus norvegicus,,10116.0,N,,1,,Cmax at a dose of 30 mg/kg in rat,,BAO_0000218,3579,
In vivo,,A,,Autocuration,0,,22224,CHEMBL623396,,10786,Simiiformes,,314293.0,U,,1,,Cmax in monkeys at a dose of 1 mg/kg,,BAO_0000218,17788,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623397,,10787,Rattus norvegicus,,10116.0,N,,1,,Cmax in rat,,BAO_0000218,14956,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623398,,10788,Rattus norvegicus,,10116.0,N,,1,,Cmax in rats at a dose of 1 mg/kg,,BAO_0000218,17788,
In vivo,,A,,Intermediate,1,,50594,CHEMBL623399,,10789,Mus musculus,,10090.0,N,,1,,Cmax was measured in mice after an oral dose of 50 mg/kg.,,BAO_0000218,9750,
In vivo,,A,,Autocuration,0,,22224,CHEMBL623400,,10790,,,,U,,1,,"Cmax value at a dose of 12.7 uM/kg, po",,BAO_0000218,12767,
In vivo,,A,,Autocuration,0,,22224,CHEMBL623401,,10791,,,,U,,1,,"Cmax value at a dose of 6.3 uM/kg, iv",,BAO_0000218,12767,
In vivo,,A,,Autocuration,0,,22224,CHEMBL623402,,10792,,,,U,,1,,"Cmax value at a dose of 7.1 uM/kg, iv",,BAO_0000218,12767,
In vivo,,A,,Autocuration,0,,22224,CHEMBL623403,,10793,,,,U,,1,,Cmax value of compound was determined after 1 hr,,BAO_0000218,12703,
In vivo,,A,,Autocuration,0,,22224,CHEMBL623404,,10794,,,,U,,1,,Cmax value of the compound,,BAO_0000218,15778,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625997,,10795,Rattus norvegicus,,10116.0,N,,1,,Cmax value administered intraintestinal in rats.,,BAO_0000218,12818,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625998,,10796,Rattus norvegicus,,10116.0,N,,1,,Cmax value administered perorally was determined in rat; Not determined,,BAO_0000218,14964,
In vivo,,A,,Autocuration,0,,22224,CHEMBL625999,,10797,,,,U,,1,,Cmax value at the dose of 2.3 mg/kg,,BAO_0000218,15808,
In vivo,,A,,Autocuration,0,,22224,CHEMBL626000,,10798,,,,U,,1,,Cmax value at the dose of 5 mg/kg,,BAO_0000218,15808,
In vivo,,A,,Autocuration,0,,22224,CHEMBL626001,,10799,,,,U,,1,,Cmax value in the period of 8 hr after dosing. ,,BAO_0000218,15778,
In vivo,,A,,Autocuration,0,,22224,CHEMBL626002,,10800,,,,U,,1,,Cmax value at a oral dose of 20 mg/kg; Not tested,,BAO_0000218,3715,
In vivo,,A,,Autocuration,0,,22224,CHEMBL626003,,10801,,,,U,,1,,Cmax value at a oral dose of 20 mg/kg,,BAO_0000218,3715,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626004,,10802,Rattus norvegicus,,10116.0,N,,1,,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,,BAO_0000218,1446,
In vivo,,A,,Intermediate,1,,50512,CHEMBL626005,,10803,Cavia porcellus,,10141.0,N,,1,,Cmax(ng /mL)values after oral administration of 10 mg/kg in guinea pig.,,BAO_0000218,15240,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626006,,10804,Rattus norvegicus,,10116.0,N,,1,,Cmax(ng /mL)values after oral administration of 10 mg/kg in rat.,,BAO_0000218,15240,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626007,1969.0,10805,Rattus norvegicus,,10116.0,N,Plasma,1,,Compound at a dose of 10 mg/kg was orally administered to rats and maximum plasma concentration was reported,,BAO_0000218,14810,
In vivo,,A,,Intermediate,1,,50594,CHEMBL626008,1969.0,10806,Mus musculus,,10090.0,N,Plasma,1,,Compound was evaluated for maximum plasma concentration by administering orally at 25 mg/kg in mice,,BAO_0000218,14239,
In vivo,,A,,Intermediate,1,,50588,CHEMBL626009,2107.0,10807,Canis lupus familiaris,,9615.0,N,Liver,1,,Compound was evaluated for maximum plasma concentration levels in dogs for the orally delivered compound in 0.05 M citric acid,,BAO_0000218,12555,
In vivo,,A,,Intermediate,1,,50588,CHEMBL626010,,10808,Canis lupus familiaris,,9615.0,N,,1,,Compound was evaluated in vivo for its concentration after a peroral administration 40 mg/kg in dogs.,,BAO_0000218,10754,
In vivo,,A,,Intermediate,1,,50594,CHEMBL626011,178.0,10809,Mus musculus,,10090.0,N,Blood,1,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a intramuscular administration 40 mg/kg in mice,,BAO_0000218,10754,
In vivo,,A,,Intermediate,1,,50594,CHEMBL626012,178.0,10810,Mus musculus,,10090.0,N,Blood,1,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration 40 mg/kg in mice,,BAO_0000218,10754,
In vivo,,A,,Intermediate,1,,50594,CHEMBL626013,178.0,10811,Mus musculus,,10090.0,N,Blood,1,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration of 40 mg/kg in mice,,BAO_0000218,10754,
In vivo,,A,,Intermediate,1,,50594,CHEMBL626014,178.0,10812,Mus musculus,,10090.0,N,Blood,1,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice,,BAO_0000218,10754,
In vivo,,A,,Intermediate,1,,50594,CHEMBL877496,178.0,10813,Mus musculus,,10090.0,N,Blood,1,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice.,,BAO_0000218,10754,
In vivo,,F,,Intermediate,1,,50588,CHEMBL626015,,10814,Canis lupus familiaris,,9615.0,N,,1,,Compound was tested Growth Hormone(GH) release after 0.5 mg/kg administration (Po) in Beagle dogs,,BAO_0000218,14600,
In vivo,,F,,Intermediate,1,,50588,CHEMBL626016,,10815,Canis lupus familiaris,,9615.0,N,,1,,Compound was tested Growth Hormone(GH) release after 10 mg/kg administration (Po) in Beagle dogs,,BAO_0000218,14600,
In vivo,,F,,Intermediate,1,,50588,CHEMBL626017,,10816,Canis lupus familiaris,,9615.0,N,,1,,Compound was tested Growth Hormone(GH) release after 2.5 mg/kg administration (Po) in Beagle dogs,,BAO_0000218,14600,
In vivo,,A,,Intermediate,1,,50588,CHEMBL626018,1969.0,10817,Canis lupus familiaris,,9615.0,N,Plasma,1,,Bioavailability as maximal plasma concentration in dogs,,BAO_0000218,13543,
In vivo,,A,,Intermediate,1,,50588,CHEMBL626692,1969.0,10818,Canis lupus familiaris,,9615.0,N,Plasma,1,,Bioavailability as maximal plasma concentration in dogs,,BAO_0000218,13543,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626693,1969.0,10819,Rattus norvegicus,,10116.0,N,Plasma,1,,Bioavailability as maximal plasma concentration in rats,,BAO_0000218,13543,
In vivo,,A,,Autocuration,0,,22224,CHEMBL626694,1969.0,10820,Rattus norvegicus,,10116.0,U,Plasma,1,,Bioavailability as maximal plasma concentration in rats,,BAO_0000218,13543,
In vivo,,A,,Intermediate,1,,50588,CHEMBL626695,178.0,10821,Canis lupus familiaris,,9615.0,N,Blood,1,,Compound was tested for maximum blood concentration after 0.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,,BAO_0000218,14600,
In vivo,,A,,Intermediate,1,,50588,CHEMBL626696,178.0,10822,Canis lupus familiaris,,9615.0,N,Blood,1,,Compound was tested for maximum blood concentration after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,,BAO_0000218,14600,
In vivo,,A,,Intermediate,1,,50588,CHEMBL626697,178.0,10823,Canis lupus familiaris,,9615.0,N,Blood,1,,Compound was tested for maximum blood concentration after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,,BAO_0000218,14600,
In vivo,,A,,Intermediate,1,,50588,CHEMBL626859,178.0,10824,Canis lupus familiaris,,9615.0,N,Blood,1,,Compound was tested for maximum concentration in blood after 0.5 mg/kg administration (Po) in Beagle dogs; nd = Not Detectable,,BAO_0000218,14600,
In vivo,,A,,Intermediate,1,,50588,CHEMBL626860,178.0,10825,Canis lupus familiaris,,9615.0,N,Blood,1,,Compound was tested for maximum concentration in blood after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,,BAO_0000218,14600,
In vivo,,A,,Intermediate,1,,50588,CHEMBL626861,178.0,10826,Canis lupus familiaris,,9615.0,N,Blood,1,,Compound was tested for maximum concentration in blood after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,,BAO_0000218,14600,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626296,,10827,Rattus norvegicus,,10116.0,N,,1,,Compound was tested for maximum observed concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,,BAO_0000218,14681,
In vivo,,A,,Autocuration,0,,22224,CHEMBL626297,,10828,,,,U,,1,,Compound was tested for the max. conc. when administered perorally(po) 30 mg/kg,,BAO_0000218,15905,
In vivo,,A,,Autocuration,0,,22224,CHEMBL626298,1969.0,10829,,,,U,Plasma,1,,Compound was tested for the max. plasma conc. when administered intraperitoneally (ip) 30 mg/kg.,,BAO_0000218,15905,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626299,1969.0,10830,Rattus norvegicus,,10116.0,N,Plasma,1,,"Drug plasma level in rat was determined on the last day of dosing at 1,2,4.8 and 24 hr and ED50 was evaluated",,BAO_0000218,13304,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626300,1969.0,10831,Rattus norvegicus,,10116.0,N,Plasma,1,,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats after 30 min.,,BAO_0000218,15137,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626301,1969.0,10832,Rattus norvegicus,,10116.0,N,Plasma,1,,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats after 30 min.,,BAO_0000218,15137,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626962,1969.0,10833,Rattus norvegicus,,10116.0,N,Plasma,1,,Effect of ip administration of compound on plasma concentration of corticosterone (CTS) in rats after 30 min.,,BAO_0000218,15137,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626963,1969.0,10834,Rattus norvegicus,,10116.0,N,Plasma,1,,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats after 30 min.,,BAO_0000218,15137,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626964,1969.0,10835,Rattus norvegicus,,10116.0,N,Plasma,1,,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats after 30 min.,,BAO_0000218,15137,
In vivo,,A,,Intermediate,1,,100710,CHEMBL626965,1969.0,10836,Macaca fascicularis,,9541.0,N,Plasma,1,,In vivo antitumor efficacy expressed as maximum plasma concentration 0.4 hr after a peroral dose of 25 mg/kg in cynomolgus monkeys,,BAO_0000218,14839,
In vivo,,A,,Intermediate,1,,50594,CHEMBL626966,1969.0,10837,Mus musculus,,10090.0,N,Plasma,1,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,BAO_0000218,14839,
In vivo,,A,,Intermediate,1,,50594,CHEMBL626967,1969.0,10838,Mus musculus,,10090.0,N,Plasma,1,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,BAO_0000218,14839,
In vivo,,A,,Intermediate,1,,100710,CHEMBL626968,1969.0,10839,Macaca fascicularis,,9541.0,N,Plasma,1,,In vivo antitumor efficacy expressed as maximum plasma concentration after a peroral dose of 10 mg/kg in cynomolgus monkeys,,BAO_0000218,14839,
,,A,,Intermediate,1,,50597,CHEMBL626969,948.0,10840,Rattus norvegicus,,10116.0,N,Heart,1,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.89-1.24,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL627126,948.0,10841,Rattus norvegicus,,10116.0,N,Heart,1,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-2.58,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL631276,948.0,10842,Rattus norvegicus,,10116.0,N,Heart,1,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.24-0.28,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL631277,948.0,10843,Rattus norvegicus,,10116.0,N,Heart,1,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.52-0.62,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL631278,948.0,10844,Rattus norvegicus,,10116.0,N,Heart,1,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.68-0.84,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL874457,948.0,10845,Rattus norvegicus,,10116.0,N,Heart,1,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.75-1.03,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL631279,948.0,10846,Rattus norvegicus,,10116.0,N,Heart,1,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.96-2.46,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL631280,948.0,10847,Rattus norvegicus,,10116.0,N,Heart,1,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.36-0.42,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL631281,948.0,10848,Rattus norvegicus,,10116.0,N,Heart,1,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.82,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL631968,948.0,10849,Rattus norvegicus,,10116.0,N,Heart,1,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.24-1.46,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL631969,948.0,10850,Rattus norvegicus,,10116.0,N,Heart,1,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.36-3.96,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL631970,948.0,10851,Rattus norvegicus,,10116.0,N,Heart,1,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.24-0.29,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL631971,948.0,10852,Rattus norvegicus,,10116.0,N,Heart,1,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.39-0.74,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL631972,948.0,10853,Rattus norvegicus,,10116.0,N,Heart,1,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.79-0.85,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL630435,948.0,10854,Rattus norvegicus,,10116.0,N,Heart,1,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.64-0.86,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL630436,948.0,10855,Rattus norvegicus,,10116.0,N,Heart,1,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.68-2.23,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL630437,948.0,10856,Rattus norvegicus,,10116.0,N,Heart,1,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.19-0.23,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL630438,948.0,10857,Rattus norvegicus,,10116.0,N,Heart,1,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.22-0.29,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL630439,948.0,10858,Rattus norvegicus,,10116.0,N,Heart,1,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.75,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL630440,2113.0,10859,Rattus norvegicus,,10116.0,N,Kidney,1,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.42-1.82,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL630441,2113.0,10860,Rattus norvegicus,,10116.0,N,Kidney,1,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-3.12,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL630442,2113.0,10861,Rattus norvegicus,,10116.0,N,Kidney,1,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.62-0.92,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL625234,2113.0,10862,Rattus norvegicus,,10116.0,N,Kidney,1,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.12-2.04,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL625235,2113.0,10863,Rattus norvegicus,,10116.0,N,Kidney,1,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.59-2.03,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL625236,2113.0,10864,Rattus norvegicus,,10116.0,N,Kidney,1,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.14-1.4,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL625237,2113.0,10865,Rattus norvegicus,,10116.0,N,Kidney,1,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.56-1.83,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL626125,2113.0,10866,Rattus norvegicus,,10116.0,N,Kidney,1,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.73,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL626126,2113.0,10867,Rattus norvegicus,,10116.0,N,Kidney,1,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.67-2.11,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL626127,2113.0,10868,Rattus norvegicus,,10116.0,N,Kidney,1,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.64-3.43,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL626128,2113.0,10869,Rattus norvegicus,,10116.0,N,Kidney,1,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.18-4.74,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL626129,2113.0,10870,Rattus norvegicus,,10116.0,N,Kidney,1,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.62-1.13,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL626130,2113.0,10871,Rattus norvegicus,,10116.0,N,Kidney,1,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.73-2.64,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL626131,2113.0,10872,Rattus norvegicus,,10116.0,N,Kidney,1,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 13.02-19.07,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL626132,2113.0,10873,Rattus norvegicus,,10116.0,N,Kidney,1,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.89-1.19,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL626752,2113.0,10874,Rattus norvegicus,,10116.0,N,Kidney,1,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.17-1.48,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL626753,2113.0,10875,Rattus norvegicus,,10116.0,N,Kidney,1,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.48-0.72,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL626754,2113.0,10876,Rattus norvegicus,,10116.0,N,Kidney,1,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.57,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL626755,2113.0,10877,Rattus norvegicus,,10116.0,N,Kidney,1,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.99-1.24,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL626756,2107.0,10878,Rattus norvegicus,,10116.0,N,Liver,1,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.23-1.78,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL626757,2107.0,10879,Rattus norvegicus,,10116.0,N,Liver,1,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.43-2.92,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL626758,2107.0,10880,Rattus norvegicus,,10116.0,N,Liver,1,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.81-1.18,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL626759,2107.0,10881,Rattus norvegicus,,10116.0,N,Liver,1,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.37-1.74,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL626760,2107.0,10882,Rattus norvegicus,,10116.0,N,Liver,1,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 4.01-4.81,,BAO_0000218,8418,
,,A,,Intermediate,1,,50588,CHEMBL626394,,10883,Canis lupus familiaris,,9615.0,N,,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50588,CHEMBL626395,,10884,Canis lupus familiaris,,9615.0,N,,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration,,BAO_0000218,6996,
,,A,,Intermediate,1,,50588,CHEMBL626396,,10885,Canis lupus familiaris,,9615.0,N,,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration (0-6 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50588,CHEMBL626397,,10886,Canis lupus familiaris,,9615.0,N,,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50588,CHEMBL626398,,10887,Canis lupus familiaris,,9615.0,N,,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),,BAO_0000218,6996,
,,A,,Intermediate,1,,50588,CHEMBL626399,,10888,Canis lupus familiaris,,9615.0,N,,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50597,CHEMBL874653,,10889,Rattus norvegicus,,10116.0,N,,1,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration,,BAO_0000218,6996,
,,A,,Intermediate,1,,50597,CHEMBL626400,,10890,Rattus norvegicus,,10116.0,N,,1,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50597,CHEMBL626401,,10891,Rattus norvegicus,,10116.0,N,,1,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50597,CHEMBL626402,,10892,Rattus norvegicus,,10116.0,N,,1,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50597,CHEMBL626403,,10893,Rattus norvegicus,,10116.0,N,,1,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),,BAO_0000218,6996,
,,A,,Intermediate,1,,50597,CHEMBL626404,,10894,Rattus norvegicus,,10116.0,N,,1,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50597,CHEMBL626405,,10895,Rattus norvegicus,,10116.0,N,,1,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration,,BAO_0000218,6996,
,,A,,Intermediate,1,,50597,CHEMBL625529,,10896,Rattus norvegicus,,10116.0,N,,1,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50597,CHEMBL625530,,10897,Rattus norvegicus,,10116.0,N,,1,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50597,CHEMBL625531,,10898,Rattus norvegicus,,10116.0,N,,1,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50597,CHEMBL625532,,10899,Rattus norvegicus,,10116.0,N,,1,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),,BAO_0000218,6996,
,,A,,Intermediate,1,,50597,CHEMBL625533,,10900,Rattus norvegicus,,10116.0,N,,1,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50597,CHEMBL875474,,10901,Rattus norvegicus,,10116.0,N,,1,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration,,BAO_0000218,6996,
,,A,,Intermediate,1,,50597,CHEMBL625534,,10902,Rattus norvegicus,,10116.0,N,,1,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50597,CHEMBL625535,,10903,Rattus norvegicus,,10116.0,N,,1,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50597,CHEMBL625536,,10904,Rattus norvegicus,,10116.0,N,,1,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50597,CHEMBL625537,,10905,Rattus norvegicus,,10116.0,N,,1,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),,BAO_0000218,6996,
,,A,,Intermediate,1,,50597,CHEMBL625538,,10906,Rattus norvegicus,,10116.0,N,,1,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50597,CHEMBL625539,,10907,Rattus norvegicus,,10116.0,N,,1,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration,,BAO_0000218,6996,
,,A,,Intermediate,1,,50597,CHEMBL625540,,10908,Rattus norvegicus,,10116.0,N,,1,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50597,CHEMBL625541,,10909,Rattus norvegicus,,10116.0,N,,1,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50597,CHEMBL625542,,10910,Rattus norvegicus,,10116.0,N,,1,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50597,CHEMBL625543,,10911,Rattus norvegicus,,10116.0,N,,1,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),,BAO_0000218,6996,
,,A,,Intermediate,1,,50597,CHEMBL625544,,10912,Rattus norvegicus,,10116.0,N,,1,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50588,CHEMBL625545,,10913,Canis lupus familiaris,,9615.0,N,,1,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.312 mg/kg after ip administration,,BAO_0000218,6996,
,,A,,Intermediate,1,,50588,CHEMBL625546,,10914,Canis lupus familiaris,,9615.0,N,,1,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50588,CHEMBL625547,,10915,Canis lupus familiaris,,9615.0,N,,1,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.625 mg/kg after ip administration,,BAO_0000218,6996,
,,A,,Intermediate,1,,50588,CHEMBL625548,,10916,Canis lupus familiaris,,9615.0,N,,1,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50588,CHEMBL625549,,10917,Canis lupus familiaris,,9615.0,N,,1,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50588,CHEMBL625550,,10918,Canis lupus familiaris,,9615.0,N,,1,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50588,CHEMBL625551,,10919,Canis lupus familiaris,,9615.0,N,,1,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50588,CHEMBL875475,,10920,Canis lupus familiaris,,9615.0,N,,1,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50588,CHEMBL625552,,10921,Canis lupus familiaris,,9615.0,N,,1,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50588,CHEMBL625553,,10922,Canis lupus familiaris,,9615.0,N,,1,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50588,CHEMBL625554,,10923,Canis lupus familiaris,,9615.0,N,,1,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50588,CHEMBL625555,,10924,Canis lupus familiaris,,9615.0,N,,1,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),,BAO_0000218,6996,
,,A,,Intermediate,1,,50588,CHEMBL625556,,10925,Canis lupus familiaris,,9615.0,N,,1,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50588,CHEMBL624986,,10926,Canis lupus familiaris,,9615.0,N,,1,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration,,BAO_0000218,6996,
,,A,,Intermediate,1,,50588,CHEMBL624987,,10927,Canis lupus familiaris,,9615.0,N,,1,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50588,CHEMBL624988,,10928,Canis lupus familiaris,,9615.0,N,,1,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),,BAO_0000218,6996,
In vivo,,A,,Intermediate,1,,50588,CHEMBL624989,1637.0,10929,Canis lupus familiaris,,9615.0,N,Artery,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -2/-14,,BAO_0000218,9025,
In vivo,,A,,Intermediate,1,,50588,CHEMBL624990,1637.0,10930,Canis lupus familiaris,,9615.0,N,Artery,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -4/-4,,BAO_0000218,9025,
In vivo,,A,,Intermediate,1,,50588,CHEMBL874391,1637.0,10931,Canis lupus familiaris,,9615.0,N,Artery,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; 4/7,,BAO_0000218,9025,
In vivo,,A,,Intermediate,1,,50588,CHEMBL624991,1637.0,10932,Canis lupus familiaris,,9615.0,N,Artery,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3/10 range; -3/0/4,,BAO_0000218,9025,
In vivo,,A,,Intermediate,1,,50588,CHEMBL624992,1637.0,10933,Canis lupus familiaris,,9615.0,N,Artery,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; -6/0,,BAO_0000218,9025,
In vivo,,A,,Intermediate,1,,50588,CHEMBL624993,1637.0,10934,Canis lupus familiaris,,9615.0,N,Artery,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 10/31,,BAO_0000218,9025,
In vivo,,A,,Intermediate,1,,50588,CHEMBL624994,1637.0,10935,Canis lupus familiaris,,9615.0,N,Artery,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 11/-19,,BAO_0000218,9025,
In vivo,,A,,Intermediate,1,,50588,CHEMBL624995,1637.0,10936,Canis lupus familiaris,,9615.0,N,Artery,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 14/6,,BAO_0000218,9025,
In vivo,,A,,Intermediate,1,,50588,CHEMBL624996,1637.0,10937,Canis lupus familiaris,,9615.0,N,Artery,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/25,,BAO_0000218,9025,
In vivo,,A,,Intermediate,1,,50588,CHEMBL624997,1637.0,10938,Canis lupus familiaris,,9615.0,N,Artery,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/3,,BAO_0000218,9025,
In vivo,,A,,Intermediate,1,,50588,CHEMBL624998,1637.0,10939,Canis lupus familiaris,,9615.0,N,Artery,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 2/16,,BAO_0000218,9025,
In vivo,,A,,Intermediate,1,,50588,CHEMBL624999,1637.0,10940,Canis lupus familiaris,,9615.0,N,Artery,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 6/2,,BAO_0000218,9025,
In vivo,,A,,Intermediate,1,,50588,CHEMBL882955,1637.0,10941,Canis lupus familiaris,,9615.0,N,Artery,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 7/26,,BAO_0000218,9025,
In vivo,,A,,Intermediate,1,,50588,CHEMBL625000,1637.0,10942,Canis lupus familiaris,,9615.0,N,Artery,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/49,,BAO_0000218,9025,
In vivo,,A,,Intermediate,1,,50588,CHEMBL625001,1637.0,10943,Canis lupus familiaris,,9615.0,N,Artery,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/8,,BAO_0000218,9025,
In vivo,,A,,Intermediate,1,,50588,CHEMBL625089,1637.0,10944,Canis lupus familiaris,,9615.0,N,Artery,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 9/-18,,BAO_0000218,9025,
In vivo,,A,,Intermediate,1,,50588,CHEMBL625090,1637.0,10945,Canis lupus familiaris,,9615.0,N,Artery,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/60 range; 13/23,,BAO_0000218,9025,
In vivo,,A,,Intermediate,1,,50588,CHEMBL625091,1637.0,10946,Canis lupus familiaris,,9615.0,N,Artery,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3 range,,BAO_0000218,9025,
In vivo,,A,,Intermediate,1,,50588,CHEMBL625092,1637.0,10947,Canis lupus familiaris,,9615.0,N,Artery,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3/10 range; -7/-11,,BAO_0000218,9025,
In vivo,,A,,Intermediate,1,,50588,CHEMBL625093,1637.0,10948,Canis lupus familiaris,,9615.0,N,Artery,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 1/3 dose range; 6/-7,,BAO_0000218,9025,
In vivo,,A,,Intermediate,1,,50588,CHEMBL625094,1637.0,10949,Canis lupus familiaris,,9615.0,N,Artery,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 10/30 dose range; -13/19,,BAO_0000218,9025,
In vivo,,A,,Intermediate,1,,50588,CHEMBL625095,1637.0,10950,Canis lupus familiaris,,9615.0,N,Artery,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 3/10 dose range; 30/47,,BAO_0000218,9025,
In vivo,,A,,Intermediate,1,,50588,CHEMBL625096,,10951,Canis lupus familiaris,,9615.0,N,,1,,Compound was evaluated for its bioavailability in the dogs,,BAO_0000218,2249,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625097,,10952,Rattus norvegicus,,10116.0,N,,1,,Compound was evaluated for its bioavailability in the rats,,BAO_0000218,2249,
In vivo,,A,,Autocuration,0,,22224,CHEMBL882956,,10953,,,,U,,1,,Compound was evaluated for oral bioavailability,,BAO_0000218,17515,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625098,,10954,Rattus norvegicus,,10116.0,N,,1,,Compound was evaluated for percentage of Oral bioavailability in rats,,BAO_0000218,14541,
In vivo,,A,,Autocuration,0,,22224,CHEMBL625099,,10955,Cavia porcellus,,10141.0,U,,1,,Bioavailability in guinea pig,,BAO_0000218,12797,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625100,,10956,Rattus norvegicus,,10116.0,N,,1,,Compound was evaluated for the oral bioavailability in rat,,BAO_0000218,12797,
In vivo,,A,,Intermediate,1,,50588,CHEMBL625101,,10957,Canis lupus familiaris,,9615.0,N,,1,,Compound was evaluated for the oral bioavailability in dog,,BAO_0000218,12797,
In vivo,,A,,Intermediate,1,,50597,CHEMBL874396,,10958,Rattus norvegicus,,10116.0,N,,1,,Compound was evaluated for the oral bioavailability in rat,,BAO_0000218,12797,
In vivo,,F,,Autocuration,0,,22224,CHEMBL625102,,10959,Canis lupus familiaris,,9615.0,U,,1,,Bioavailability in dog (dosed i.v.),,BAO_0000218,11727,
In vivo,,A,,Intermediate,1,,50588,CHEMBL625103,,10960,Canis lupus familiaris,,9615.0,N,,1,,Compound was tested for in vivo bioavailability in dog,,BAO_0000218,13249,
In vivo,,A,,Intermediate,1,,100712,CHEMBL625104,,10961,Cricetinae,,10026.0,N,,1,,Compound was tested for in vivo bioavailability in hamsters,,BAO_0000218,13249,
In vivo,,A,,Autocuration,0,,22224,CHEMBL625105,,10962,Simiiformes,,314293.0,U,,1,,Compound was tested for in vivo bioavailability in monkey,,BAO_0000218,13249,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625106,,10963,Rattus norvegicus,,10116.0,N,,1,,Compound was tested for in vivo bioavailability in rat,,BAO_0000218,13249,
In vivo,,A,,Autocuration,0,,22224,CHEMBL625107,,10964,Mus musculus,,10090.0,U,,1,,Oral bioavailability in mouse,,BAO_0000218,9552,
In vivo,,A,,Intermediate,1,,50594,CHEMBL625108,,10965,Mus musculus,,10090.0,N,,1,,Compound was tested for percent of oral bioavailability in mice; 56-74,,BAO_0000218,9552,
In vivo,,A,,Autocuration,0,,22224,CHEMBL625109,,10966,Mus musculus,,10090.0,U,,1,,Oral bioavailability in mouse (nude) (dose of 25 mg/kg),,BAO_0000218,14839,
In vivo,,A,,Autocuration,0,,22224,CHEMBL625110,,10967,Macaca fascicularis,,9541.0,U,,1,,Bioavailability in cynomolgus monkey (dose 25 mg/kg i.v.),,BAO_0000218,14839,
In vivo,,A,,Autocuration,0,,22224,CHEMBL625111,,10968,Macaca fascicularis,,9541.0,U,,1,,Bioavailability in cynomolgus monkey (dose 5 mg/kg i.v.),,BAO_0000218,14839,
In vivo,,A,,Intermediate,1,,50594,CHEMBL625112,,10969,Mus musculus,,10090.0,N,,1,,Oral bioavailability in mouse (nude) (dose 25 mg/kg i.v.),,BAO_0000218,14839,
In vivo,,A,,Intermediate,1,,50594,CHEMBL875334,,10970,Mus musculus,,10090.0,N,,1,,Oral bioavailability in nude mice,,BAO_0000218,14839,
In vivo,,A,,Autocuration,0,,22224,CHEMBL628617,,10971,Primates,,9443.0,U,,1,,Bioavailability in monkey (i.d. dosing),,BAO_0000218,11219,
In vivo,,A,,Autocuration,0,,22224,CHEMBL628618,,10972,Rattus norvegicus,,10116.0,U,,1,,Bioavailability in rat,,BAO_0000218,9552,
In vivo,,A,,Autocuration,0,,22224,CHEMBL628619,,10973,,,,U,,1,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 10%,,BAO_0000218,11732,
In vivo,,A,,Autocuration,0,,22224,CHEMBL628620,,10974,,,,U,,1,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 20%,,BAO_0000218,11732,
In vivo,,A,,Intermediate,1,,100710,CHEMBL628621,,10975,Macaca fascicularis,,9541.0,N,,1,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",,BAO_0000218,14839,
In vivo,,A,,Intermediate,1,,100710,CHEMBL628622,,10976,Macaca fascicularis,,9541.0,N,,1,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",,BAO_0000218,14839,
In vivo,,A,,Intermediate,1,,100710,CHEMBL628623,,10977,Macaca fascicularis,,9541.0,N,,1,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",,BAO_0000218,14839,
In vivo,,A,,Intermediate,1,,100710,CHEMBL628624,1969.0,10978,Macaca fascicularis,,9541.0,N,Plasma,1,,Maximal plasma concentration in cynomolgus monkeys after 10 mg/kg oral dose,,BAO_0000218,14839,
In vivo,,A,,Intermediate,1,,50594,CHEMBL628625,1969.0,10979,Mus musculus,,10090.0,N,Plasma,1,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,BAO_0000218,14839,
In vivo,,A,,Intermediate,1,,100710,CHEMBL628626,1969.0,10980,Macaca fascicularis,,9541.0,N,Plasma,1,,Maximal plasma concentration in cynomolgus monkeys after 5 mg/kg oral dose,,BAO_0000218,14839,
In vivo,,A,,Intermediate,1,,50594,CHEMBL627041,1969.0,10981,Mus musculus,,10090.0,N,Plasma,1,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,BAO_0000218,14839,
In vivo,,A,,Intermediate,1,,50594,CHEMBL627042,1969.0,10982,Mus musculus,,10090.0,N,Plasma,1,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,BAO_0000218,14839,
In vivo,,A,,Intermediate,1,,50594,CHEMBL627043,1969.0,10983,Mus musculus,,10090.0,N,Plasma,1,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,BAO_0000218,14839,
In vivo,,A,,Autocuration,0,,22224,CHEMBL627044,1969.0,10984,,,,U,Plasma,1,,In vivo evaluation of maximum plasma concentration at a dose of 10 mg/kg,,BAO_0000218,13932,
In vivo,,A,,Intermediate,1,,50594,CHEMBL627045,1969.0,10985,Mus musculus,,10090.0,N,Plasma,1,,Cmax in mouse plasma,,BAO_0000218,11637,
In vivo,,A,,Autocuration,0,,22224,CHEMBL627046,1969.0,10986,,,,U,Plasma,1,,Max plasma concentration was measured by 40 mg/kg dose of peroral administration.,,BAO_0000218,11637,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627047,1969.0,10987,Rattus norvegicus,,10116.0,N,Plasma,1,,Maximal plasma concentration in rat,,BAO_0000218,13960,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627048,1969.0,10988,Rattus norvegicus,,10116.0,N,Plasma,1,,Maximal plasma level when administered 1 mg/kg perorally (po) in rat,,BAO_0000218,15905,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627049,,10989,Rattus norvegicus,,10116.0,N,,1,,Maximum concentration at an intraduodenal dose of 5.2 mg/kg in rat,,BAO_0000218,14062,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627050,,10990,Rattus norvegicus,,10116.0,N,,1,,Maximum concentration at an intraduodenal dose of 6.6 mg/kg in rat,,BAO_0000218,14062,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627051,,10991,Rattus norvegicus,,10116.0,N,,1,,Maximum concentration at an intravenous dose of 5.5 mg/kg in rat,,BAO_0000218,14062,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627052,,10992,Rattus norvegicus,,10116.0,N,,1,,Maximum concentration at an intravenous dose of 6.5 mg/kg in rat,,BAO_0000218,14062,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627053,,10993,Rattus norvegicus,,10116.0,N,,1,,Maximum concentration at an peroral dose of 6.2 mg/kg in rat,,BAO_0000218,14062,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627054,,10994,Rattus norvegicus,,10116.0,N,,1,,Maximum concentration at an peroral dose of 6.3 mg/kg in rat,,BAO_0000218,14062,
In vivo,,A,,Intermediate,1,,50594,CHEMBL627055,,10995,Mus musculus,,10090.0,N,,1,,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,,BAO_0000218,15011,
In vivo,,A,,Intermediate,1,,50594,CHEMBL627056,,10996,Mus musculus,,10090.0,N,,1,,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,,BAO_0000218,15011,
In vivo,,A,,Intermediate,1,,50594,CHEMBL627057,,10997,Mus musculus,,10090.0,N,,1,,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),,BAO_0000218,15011,
In vivo,,A,,Intermediate,1,,50594,CHEMBL627058,,10998,Mus musculus,,10090.0,N,,1,,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,,BAO_0000218,15011,
In vivo,,A,,Intermediate,1,,50594,CHEMBL626211,,10999,Mus musculus,,10090.0,N,,1,,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,,BAO_0000218,15011,
In vivo,,A,,Autocuration,0,,22224,CHEMBL626212,,11000,,,,U,,1,,Maximum Concentration of the compound.,,BAO_0000218,10291,
In vivo,,A,,Intermediate,1,,50588,CHEMBL626213,,11001,Canis lupus familiaris,,9615.0,N,,1,,Maximum Concentration was measured after iv administration into Beagle dog,,BAO_0000218,14599,
In vivo,,A,,Intermediate,1,,50588,CHEMBL626214,,11002,Canis lupus familiaris,,9615.0,N,,1,,Maximum Concentration was measured after iv administration into Beagle dog.,,BAO_0000218,14599,
In vivo,,A,,Intermediate,1,,50588,CHEMBL626215,,11003,Canis lupus familiaris,,9615.0,N,,1,,Maximum Concentration was measured after po administration into Beagle dog,,BAO_0000218,14599,
In vivo,,A,,Intermediate,1,,50588,CHEMBL626216,,11004,Canis lupus familiaris,,9615.0,N,,1,,Maximum Concentration was measured after po administration into Beagle dog.,,BAO_0000218,14599,
In vivo,,A,,Autocuration,0,,22224,CHEMBL626217,178.0,11005,,,,U,Blood,1,,Maximum blood level reached after an dose of 10.6 uM/kg intravenously,,BAO_0000218,12767,
In vivo,,A,,Autocuration,0,,22224,CHEMBL626218,178.0,11006,,,,U,Blood,1,,Maximum blood level reached after an iv dose of 12.2 uM/kg,,BAO_0000218,12767,
In vivo,,A,,Autocuration,0,,22224,CHEMBL626219,178.0,11007,,,,U,Blood,1,,Maximum blood level reached after an oral dose 14.7 uM/kg oral route,,BAO_0000218,12767,
In vivo,,A,,Autocuration,0,,22224,CHEMBL626220,178.0,11008,,,,U,Blood,1,,Maximum blood level reached after an oral dose of 14.7 uM/kg intravenous route,,BAO_0000218,12767,
In vivo,,A,,Autocuration,0,,22224,CHEMBL626221,178.0,11009,,,,U,Blood,1,,Maximum blood level reached after an oral dose of 5.0 mg/kg,,BAO_0000218,12767,
In vivo,,A,,Autocuration,0,,22224,CHEMBL626222,178.0,11010,,,,U,Blood,1,,Maximum blood level reached at dose of 10.6 uM/kg orally,,BAO_0000218,12767,
In vivo,,A,,Intermediate,1,,50512,CHEMBL626223,,11011,Cavia porcellus,,10141.0,N,,1,,Maximum concentration (Cmax) in guinea pigs at 2 mg/kg after oral administration,,BAO_0000218,14706,
In vivo,,A,,Intermediate,1,,50512,CHEMBL626224,,11012,Cavia porcellus,,10141.0,N,,1,,Maximum concentration (Cmax) in guinea pigs at 3 mg/kg after oral administration,,BAO_0000218,14706,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626225,955.0,11013,Rattus norvegicus,,10116.0,N,Brain,1,,Maximum concentration achieved in rat brain when administered intraperitoneally at a dose of 10 mg/kg,,BAO_0000218,14793,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626226,955.0,11014,Rattus norvegicus,,10116.0,N,Brain,1,,Maximum concentration achieved in rat brain when administered intravenously at a dose of 10 mg/kg,,BAO_0000218,14793,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626227,955.0,11015,Rattus norvegicus,,10116.0,N,Brain,1,,Maximum concentration achieved in rat brain when administered perorally at a dose of 100 mg/kg,,BAO_0000218,14793,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626228,955.0,11016,Rattus norvegicus,,10116.0,N,Brain,1,,Maximum concentration achieved in rat brain when administered perorally at a dose of 10 mg/kg,,BAO_0000218,14793,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626229,,11017,Rattus norvegicus,,10116.0,N,,1,,Maximum concentration achieved in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,,BAO_0000218,14793,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626921,,11018,Rattus norvegicus,,10116.0,N,,1,,Maximum concentration achieved in rat plasma when administered intravenously at a dose of 10 mg/kg,,BAO_0000218,14793,
In vivo,,A,,Intermediate,1,,50597,CHEMBL876793,,11019,Rattus norvegicus,,10116.0,N,,1,,Maximum concentration achieved in rat plasma when administered perorally at a dose of 100 mg/kg,,BAO_0000218,14793,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625309,,11020,Rattus norvegicus,,10116.0,N,,1,,Maximum concentration achieved in rat plasma when administered perorally at a dose of 10 mg/kg,,BAO_0000218,14793,
In vivo,,A,,Intermediate,1,,50278,CHEMBL625310,,11021,Bacillus subtilis,,1423.0,N,,1,,Maximum concentration determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),,BAO_0000218,10524,
In vivo,,A,,Autocuration,0,,22224,CHEMBL625311,,11022,Simiiformes,,314293.0,U,,1,,Maximum concentration determined in monkeys dosed intravenously with 30 mg/kg,,BAO_0000218,11871,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625312,,11023,Rattus norvegicus,,10116.0,N,,1,,Maximum concentration determined in rats dosed intravenously with 20 mg/kg,,BAO_0000218,11871,
In vivo,,A,,Autocuration,0,,22224,CHEMBL625313,,11024,,,,U,,1,,Maximum concentration for the bioavailability at a dose of 20 mg/kg administered orally,,BAO_0000218,3437,
In vivo,,A,,Intermediate,1,,50594,CHEMBL625314,,11025,Mus musculus,,10090.0,N,,1,,Maximum concentration in male CD-1 mice after sc administration of 20 mg/kg,,BAO_0000218,12038,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625315,,11026,Rattus norvegicus,,10116.0,N,,1,,Maximum concentration in male rats after iv administration of 20 mg/kg,,BAO_0000218,12038,
,,A,,Intermediate,1,,50597,CHEMBL625316,2107.0,11027,Rattus norvegicus,,10116.0,N,Liver,1,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.06-1.29,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL625317,2107.0,11028,Rattus norvegicus,,10116.0,N,Liver,1,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.77-2.08,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL625318,2107.0,11029,Rattus norvegicus,,10116.0,N,Liver,1,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.89,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL625319,2107.0,11030,Rattus norvegicus,,10116.0,N,Liver,1,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.57-1.66,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL625320,2107.0,11031,Rattus norvegicus,,10116.0,N,Liver,1,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.06-2.71,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL625321,2107.0,11032,Rattus norvegicus,,10116.0,N,Liver,1,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.98-3.22,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL625322,2107.0,11033,Rattus norvegicus,,10116.0,N,Liver,1,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.73-1.45,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL876801,2107.0,11034,Rattus norvegicus,,10116.0,N,Liver,1,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.03-1.31,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL625323,2107.0,11035,Rattus norvegicus,,10116.0,N,Liver,1,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 6.76-10.44,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL625324,2107.0,11036,Rattus norvegicus,,10116.0,N,Liver,1,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.47-1.17,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL625325,2107.0,11037,Rattus norvegicus,,10116.0,N,Liver,1,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.12-1.44,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL625326,2107.0,11038,Rattus norvegicus,,10116.0,N,Liver,1,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.38-0.57,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL625327,2107.0,11039,Rattus norvegicus,,10116.0,N,Liver,1,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.75-1.14,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL625328,2107.0,11040,Rattus norvegicus,,10116.0,N,Liver,1,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 1.36-1.74,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL625329,2048.0,11041,Rattus norvegicus,,10116.0,N,Lung,1,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.5,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL625330,2048.0,11042,Rattus norvegicus,,10116.0,N,Lung,1,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 3.10-3.77,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL627774,2048.0,11043,Rattus norvegicus,,10116.0,N,Lung,1,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.4-0.54,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL627775,2048.0,11044,Rattus norvegicus,,10116.0,N,Lung,1,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.58-0.86,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL627949,2048.0,11045,Rattus norvegicus,,10116.0,N,Lung,1,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.77-0.86,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL627950,2048.0,11046,Rattus norvegicus,,10116.0,N,Lung,1,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.86-1.13,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL627951,2048.0,11047,Rattus norvegicus,,10116.0,N,Lung,1,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 2.26-2.89,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL627952,2048.0,11048,Rattus norvegicus,,10116.0,N,Lung,1,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.7,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL627953,2048.0,11049,Rattus norvegicus,,10116.0,N,Lung,1,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.6-0.66,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL627954,2048.0,11050,Rattus norvegicus,,10116.0,N,Lung,1,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.35-1.74,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL627955,2048.0,11051,Rattus norvegicus,,10116.0,N,Lung,1,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.62-7.08,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL627956,2048.0,11052,Rattus norvegicus,,10116.0,N,Lung,1,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.47-0.56,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL876802,2048.0,11053,Rattus norvegicus,,10116.0,N,Lung,1,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.54-1.07,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL627957,2048.0,11054,Rattus norvegicus,,10116.0,N,Lung,1,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.76-0.91,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL627958,2048.0,11055,Rattus norvegicus,,10116.0,N,Lung,1,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.61-0.86,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL627959,2048.0,11056,Rattus norvegicus,,10116.0,N,Lung,1,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 2.11-3.79,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL627960,2048.0,11057,Rattus norvegicus,,10116.0,N,Lung,1,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.3-0.36,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL627961,2048.0,11058,Rattus norvegicus,,10116.0,N,Lung,1,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.36-0.44,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL627962,2048.0,11059,Rattus norvegicus,,10116.0,N,Lung,1,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.5-0.65,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL627963,,11060,Rattus norvegicus,,10116.0,N,,1,,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,,BAO_0000218,9796,
,,A,,Intermediate,1,,50597,CHEMBL624759,,11061,Rattus norvegicus,,10116.0,N,,1,,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,,BAO_0000218,9796,
,,A,,Intermediate,1,,50597,CHEMBL624760,,11062,Rattus norvegicus,,10116.0,N,,1,,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,,BAO_0000218,9796,
,,A,,Intermediate,1,,50597,CHEMBL624761,,11063,Rattus norvegicus,,10116.0,N,,1,,Distribution of radiolabeled compound in intestinal contents of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,,BAO_0000218,9796,
,,A,,Intermediate,1,,50597,CHEMBL877607,,11064,Rattus norvegicus,,10116.0,N,,1,,Distribution of radiolabeled compound in intestinal contents of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,,BAO_0000218,9796,
,,A,,Intermediate,1,,50597,CHEMBL624762,2107.0,11065,Rattus norvegicus,,10116.0,N,Liver,1,,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,,BAO_0000218,9796,
,,A,,Intermediate,1,,50597,CHEMBL624763,2107.0,11066,Rattus norvegicus,,10116.0,N,Liver,1,,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,,BAO_0000218,9796,
,,A,,Intermediate,1,,50597,CHEMBL624764,2107.0,11067,Rattus norvegicus,,10116.0,N,Liver,1,,Distribution of radiolabeled compound in liver of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,,BAO_0000218,9796,
,,A,,Intermediate,1,,50597,CHEMBL624765,2107.0,11068,Rattus norvegicus,,10116.0,N,Liver,1,,Distribution of radiolabeled compound in liver of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,,BAO_0000218,9796,
,,A,,Intermediate,1,,50597,CHEMBL624766,2107.0,11069,Rattus norvegicus,,10116.0,N,Liver,1,,Distribution of radiolabeled compound in liver of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,,BAO_0000218,9796,
,,A,,Intermediate,1,,50588,CHEMBL624767,,11070,Canis lupus familiaris,,9615.0,N,,1,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50588,CHEMBL624768,,11071,Canis lupus familiaris,,9615.0,N,,1,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration,,BAO_0000218,6996,
,,A,,Intermediate,1,,50588,CHEMBL624769,,11072,Canis lupus familiaris,,9615.0,N,,1,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50588,CHEMBL624770,,11073,Canis lupus familiaris,,9615.0,N,,1,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50588,CHEMBL624771,,11074,Canis lupus familiaris,,9615.0,N,,1,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),,BAO_0000218,6996,
,,A,,Intermediate,1,,50588,CHEMBL624772,,11075,Canis lupus familiaris,,9615.0,N,,1,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50597,CHEMBL624773,,11076,Rattus norvegicus,,10116.0,N,,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration,,BAO_0000218,6996,
,,A,,Intermediate,1,,50597,CHEMBL624774,,11077,Rattus norvegicus,,10116.0,N,,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50597,CHEMBL624775,,11078,Rattus norvegicus,,10116.0,N,,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50597,CHEMBL624776,,11079,Rattus norvegicus,,10116.0,N,,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50597,CHEMBL624777,,11080,Rattus norvegicus,,10116.0,N,,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),,BAO_0000218,6996,
,,A,,Intermediate,1,,50597,CHEMBL624778,,11081,Rattus norvegicus,,10116.0,N,,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50597,CHEMBL624779,,11082,Rattus norvegicus,,10116.0,N,,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration,,BAO_0000218,6996,
,,A,,Intermediate,1,,50597,CHEMBL624780,,11083,Rattus norvegicus,,10116.0,N,,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50597,CHEMBL624781,,11084,Rattus norvegicus,,10116.0,N,,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),,BAO_0000218,6996,
,,A,,Intermediate,1,,50597,CHEMBL877608,,11085,Rattus norvegicus,,10116.0,N,,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50597,CHEMBL624782,,11086,Rattus norvegicus,,10116.0,N,,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50597,CHEMBL624783,,11087,Rattus norvegicus,,10116.0,N,,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50597,CHEMBL624784,,11088,Rattus norvegicus,,10116.0,N,,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration,,BAO_0000218,6996,
,,A,,Intermediate,1,,50597,CHEMBL624785,,11089,Rattus norvegicus,,10116.0,N,,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50597,CHEMBL624786,,11090,Rattus norvegicus,,10116.0,N,,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50597,CHEMBL624787,,11091,Rattus norvegicus,,10116.0,N,,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),,BAO_0000218,6996,
,,A,,Intermediate,1,,50597,CHEMBL628676,,11092,Rattus norvegicus,,10116.0,N,,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50597,CHEMBL621842,,11093,Rattus norvegicus,,10116.0,N,,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration,,BAO_0000218,6996,
,,A,,Intermediate,1,,50597,CHEMBL621843,,11094,Rattus norvegicus,,10116.0,N,,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50597,CHEMBL623873,,11095,Rattus norvegicus,,10116.0,N,,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50597,CHEMBL623874,,11096,Rattus norvegicus,,10116.0,N,,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50597,CHEMBL623875,,11097,Rattus norvegicus,,10116.0,N,,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),,BAO_0000218,6996,
,,A,,Intermediate,1,,50597,CHEMBL623876,,11098,Rattus norvegicus,,10116.0,N,,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50588,CHEMBL623877,,11099,Canis lupus familiaris,,9615.0,N,,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.312 mg/kg after ip administration,,BAO_0000218,6996,
,,A,,Intermediate,1,,50588,CHEMBL623878,,11100,Canis lupus familiaris,,9615.0,N,,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50588,CHEMBL623879,,11101,Canis lupus familiaris,,9615.0,N,,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.625 mg/kg after ip administration,,BAO_0000218,6996,
,,A,,Intermediate,1,,50588,CHEMBL623880,,11102,Canis lupus familiaris,,9615.0,N,,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50588,CHEMBL623881,,11103,Canis lupus familiaris,,9615.0,N,,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50588,CHEMBL623957,,11104,Canis lupus familiaris,,9615.0,N,,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50588,CHEMBL623958,,11105,Canis lupus familiaris,,9615.0,N,,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50588,CHEMBL623959,,11106,Canis lupus familiaris,,9615.0,N,,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50588,CHEMBL623960,,11107,Canis lupus familiaris,,9615.0,N,,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50588,CHEMBL623961,,11108,Canis lupus familiaris,,9615.0,N,,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50588,CHEMBL623962,,11109,Canis lupus familiaris,,9615.0,N,,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50588,CHEMBL624676,,11110,Canis lupus familiaris,,9615.0,N,,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),,BAO_0000218,6996,
,,A,,Intermediate,1,,50588,CHEMBL624677,,11111,Canis lupus familiaris,,9615.0,N,,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50588,CHEMBL624678,,11112,Canis lupus familiaris,,9615.0,N,,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration,,BAO_0000218,6996,
,,A,,Intermediate,1,,50588,CHEMBL624679,,11113,Canis lupus familiaris,,9615.0,N,,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50588,CHEMBL624680,,11114,Canis lupus familiaris,,9615.0,N,,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),,BAO_0000218,6996,
In vivo,,A,,Autocuration,0,,22224,CHEMBL624849,,11115,,,,U,,1,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 27%,,BAO_0000218,11732,
In vivo,,A,,Autocuration,0,,22224,CHEMBL624850,,11116,,,,U,,1,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 4%,,BAO_0000218,11732,
In vivo,,A,,Autocuration,0,,22224,CHEMBL874399,,11117,,,,U,,1,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 54%,,BAO_0000218,11732,
In vivo,,A,,Autocuration,0,,22224,CHEMBL624851,,11118,,,,U,,1,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 72%,,BAO_0000218,11732,
In vivo,,A,,Autocuration,0,,22224,CHEMBL624852,,11119,,,,U,,1,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 76%,,BAO_0000218,11732,
In vivo,,A,,Autocuration,0,,22224,CHEMBL624853,,11120,Rattus norvegicus,,10116.0,U,,1,,Oral bioavailability in rat (dose 10 mg/kg),,BAO_0000218,13359,
In vivo,,A,,Autocuration,0,,22224,CHEMBL624854,,11121,Rattus norvegicus,,10116.0,U,,1,,Oral bioavailability in rat (Sprague-Dawley),,BAO_0000218,16618,
In vivo,,A,,Autocuration,0,,22224,CHEMBL624855,,11122,Rattus norvegicus,,10116.0,U,,1,,Oral bioavailability in rat,,BAO_0000218,13960,
In vivo,,A,,Autocuration,0,,22224,CHEMBL624856,,11123,Rattus norvegicus,,10116.0,U,,1,,Oral bioavailability in rats was determined in vivo,,BAO_0000218,13917,
In vivo,,A,,Autocuration,0,,22224,CHEMBL882957,,11124,Canis lupus familiaris,,9615.0,U,,1,,Oral bioavailability in dog,,BAO_0000218,14266,
In vivo,,A,,Autocuration,0,,22224,CHEMBL624857,,11125,Simiiformes,,314293.0,U,,1,,Oral bioavailability of compound in monkey,,BAO_0000218,12359,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622202,,11126,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability of compound in rat,,BAO_0000218,12359,
In vivo,,A,,Autocuration,0,,22224,CHEMBL622203,,11127,Rattus norvegicus,,10116.0,U,,1,,Bioavailability in rat of PMEA prodrug,,BAO_0000218,12359,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625522,,11128,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability of compound was evaluated relative to that of PMEA in rat; Not determined due to lack of solubility,,BAO_0000218,12359,
In vivo,,A,,Autocuration,0,,22224,CHEMBL622868,,11129,Macaca mulatta,,9544.0,U,,1,,Serum conc at 3 hours following 25 mg/kg dose,,BAO_0000218,10791,
In vivo,,A,,Autocuration,0,,22224,CHEMBL622869,1088.0,11130,Macaca mulatta,,9544.0,U,Urine,1,,Urine conc 0-5 hours following 25 mg/kg dose,,BAO_0000218,10791,
In vivo,,A,,Autocuration,0,,22224,CHEMBL622870,1088.0,11131,Macaca mulatta,,9544.0,U,Urine,1,,Urine conc 0-24 hours following 25 mg/kg dose,,BAO_0000218,10791,
In vivo,,A,,Autocuration,0,,22224,CHEMBL622871,,11132,Chlorocebus aethiops,,9534.0,U,,1,,Oral bioavailability in African green monkeys; 20-25,,BAO_0000218,138,
In vivo,,A,,Intermediate,1,,100710,CHEMBL620560,,11133,Macaca fascicularis,,9541.0,N,,1,,Oral bioavailability in cynomolgus monkey.,,BAO_0000218,14521,
In vivo,,A,,Autocuration,0,,22224,CHEMBL620561,,11134,Canis lupus familiaris,,9615.0,U,,1,,Oral bioavailability in dog,,BAO_0000218,13953,
In vivo,,A,,Intermediate,1,,50588,CHEMBL620562,,11135,Canis lupus familiaris,,9615.0,N,,1,,Oral bioavailability in dog at 10 mg/kg oral dose,,BAO_0000218,12836,
In vivo,,A,,Intermediate,1,,100712,CHEMBL620563,,11136,Cricetinae,,10026.0,N,,1,,Oral bioavailability in hamster at 10 mg/kg oral dose,,BAO_0000218,12836,
In vivo,,A,,Intermediate,1,,50597,CHEMBL620564,,11137,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability in rat at 10 mg/kg oral dose,,BAO_0000218,12836,
In vivo,,A,,Autocuration,0,,22224,CHEMBL872265,,11138,Rattus norvegicus,,10116.0,U,,1,,Oral bioavailability in rat,,BAO_0000218,14521,
In vivo,,A,,Autocuration,0,,22224,CHEMBL620565,,11139,Rattus norvegicus,,10116.0,U,,1,,Oral bioavailability in rat,,BAO_0000218,13953,
In vivo,,A,,Autocuration,0,,22224,CHEMBL620566,,11140,Eutheria,,9347.0,U,,1,,Oral bioavailability,,BAO_0000218,6799,
In vivo,,A,,Autocuration,0,,22224,CHEMBL620567,,11141,,,,U,,1,,Oral bioavailability was determined; range 49-102%,,BAO_0000218,11311,
In vivo,,A,,Intermediate,1,,50588,CHEMBL620568,,11142,Canis lupus familiaris,,9615.0,N,,1,,Oral bioavailability was determined in dogs,,BAO_0000218,4013,
In vivo,,A,,Autocuration,0,,22224,CHEMBL620569,,11143,Rattus norvegicus,,10116.0,U,,1,,Oral bioavailability in rat,,BAO_0000218,4013,
In vivo,,A,,Autocuration,0,,22224,CHEMBL620570,,11144,Eutheria,,9347.0,U,,1,,Oral bioavailability,,BAO_0000218,17591,
In vivo,,A,,Autocuration,0,,22224,CHEMBL620571,,11145,,,,U,,1,,Oral bioavailability was determined; Not orally available,,BAO_0000218,17591,
In vivo,,A,,Intermediate,1,,50594,CHEMBL620572,,11146,Mus musculus,,10090.0,N,,1,,Percent bioavailability was administered by using 0.4% Methyl cellulose (MC) as vehicle to nude mice at a dose of 25 mg/kg (micronized sample),,BAO_0000218,15011,
In vivo,,A,,Autocuration,0,,22224,CHEMBL620573,,11147,Mus musculus,,10090.0,U,,1,,Bioavailability in mouse (nude) (dose 0.4% Methylcellulose (MC) as vehicle 25 mg/kg),,BAO_0000218,15011,
In vivo,,A,,Autocuration,0,,22224,CHEMBL620574,,11148,Mus musculus,,10090.0,U,,1,,Bioavailability in mouse (nude) using 20% aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle 25 mg/kg,,BAO_0000218,15011,
In vivo,,A,,Autocuration,0,,22224,CHEMBL620575,,11149,Macaca mulatta,,9544.0,U,,1,,Oral bioavailability in Rhesus monkey,,BAO_0000218,9552,
In vivo,,A,,Autocuration,0,,22224,CHEMBL620576,,11150,Canis lupus familiaris,,9615.0,U,,1,,Oral bioavailability in dog (female mongrel),,BAO_0000218,9552,
In vivo,,A,,Autocuration,0,,22224,CHEMBL875846,,11151,,,,U,,1,,Percent oral bioavailability of perorally administered compound (30 mg/kg) was tested,,BAO_0000218,3639,
In vivo,,A,,Autocuration,0,,22224,CHEMBL620577,,11152,Canis lupus familiaris,,9615.0,U,,1,,Oral bioavailability in dog,,BAO_0000218,13397,
In vivo,,A,,Autocuration,0,,22224,CHEMBL620578,,11153,,,,U,,1,,Percentage Bioavailability was evaluated.,,BAO_0000218,3031,
In vivo,,A,,Autocuration,0,,22224,CHEMBL620579,,11154,Rattus norvegicus,,10116.0,U,,1,,Bioavailability in rat administered i.d.,,BAO_0000218,12818,
In vivo,,A,,Autocuration,0,,22224,CHEMBL621248,,11155,Eutheria,,9347.0,U,,1,,Bioavailability,,BAO_0000218,4847,
In vivo,,A,,Autocuration,0,,22224,CHEMBL625390,,11156,Canis lupus familiaris,,9615.0,U,,1,,Bioavailability in dog (male Beagle) i.v. administration,,BAO_0000218,12421,
In vivo,,A,,Autocuration,0,,22224,CHEMBL625391,,11157,Rattus norvegicus,,10116.0,U,,1,,"Bioavailability in rat (dose 20 mg/kg p.o. in 1% methocel, and 5 mg/kg i.v. in PEG400)",,BAO_0000218,11966,
In vivo,,A,,Autocuration,0,,22224,CHEMBL872266,,11158,Primates,,9443.0,U,,1,,Bioavailability in monkey (dose 10 mg/kg i.d. or 0.3 mg/kg i.v.),,BAO_0000218,11218,
In vivo,,A,,Autocuration,0,,22224,CHEMBL625392,,11159,Rattus norvegicus,,10116.0,U,,1,,Oral bioavailability in rat (Sprague-Dawley) (male),,BAO_0000218,13129,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625393,,11160,Rattus norvegicus,,10116.0,N,,1,,The oral bioavailability was measured on rats after oral administration,,BAO_0000218,12350,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625394,,11161,Rattus norvegicus,,10116.0,N,,1,,Bioavailability was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,,BAO_0000218,2231,
In vivo,,A,,Intermediate,1,,50797,CHEMBL625395,,11162,Macaca mulatta,,9544.0,N,,1,,Bioavailability was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,,BAO_0000218,2231,
In vivo,,A,,Autocuration,0,,22224,CHEMBL625396,,11163,Rattus norvegicus,,10116.0,U,,1,,Bioavailability in rat (dose 10 mg/kg i.d.),,BAO_0000218,12187,
In vivo,,A,,Autocuration,0,,22224,CHEMBL625397,,11164,Canis lupus familiaris,,9615.0,U,,1,,Bioavailability in dog (male Beagle) i.v. administration,,BAO_0000218,12421,
In vivo,,A,,Intermediate,1,,50594,CHEMBL625398,,11165,Mus musculus,,10090.0,N,,1,,Biodistribution in CD-1 mice was determined after 1 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),,BAO_0000218,13256,
In vivo,,A,,Intermediate,1,,50594,CHEMBL625399,178.0,11166,Mus musculus,,10090.0,N,Blood,1,,Biodistribution in CD-1 mice was determined after 1 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),,BAO_0000218,13256,
In vivo,,A,,Intermediate,1,,50594,CHEMBL626074,2037.0,11167,Mus musculus,,10090.0,N,Cerebellum,1,,Biodistribution in CD-1 mice was determined after 1 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),,BAO_0000218,13256,
In vivo,,A,,Intermediate,1,,50594,CHEMBL626075,,11168,Mus musculus,,10090.0,N,,1,,Biodistribution in CD-1 mice was determined after 1 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),,BAO_0000218,13256,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626076,1969.0,11169,Rattus norvegicus,,10116.0,N,Plasma,1,,Maximum concentration in plasma (Cmax) was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,,BAO_0000218,2231,
In vivo,,A,,Intermediate,1,,50797,CHEMBL626077,1969.0,11170,Macaca mulatta,,9544.0,N,Plasma,1,,Maximum concentration in plasma (Cmax) was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,,BAO_0000218,2231,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626078,178.0,11171,Rattus norvegicus,,10116.0,N,Blood,1,,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 1 mg/kg in rat (normalized to a 1 mg/kg dose),,BAO_0000218,12178,
In vivo,,A,,Autocuration,0,,22224,CHEMBL625846,178.0,11172,,,,U,Blood,1,,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 2.5 mg/kg in rat (normalized to a 1 mg/kg dose),,BAO_0000218,12178,
In vivo,,A,,Autocuration,0,,22224,CHEMBL625847,178.0,11173,,,,U,Blood,1,,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 5.0 mg/kg GP (normalized to a 1 mg/kg dose),,BAO_0000218,12178,
In vivo,,A,,Expert,1,,50597,CHEMBL625848,,11174,Rattus norvegicus,,10116.0,N,,1,,Maximum concentration observed in rats at an oral dose of 50 mg/kg,,BAO_0000218,15633,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625849,1969.0,11175,Rattus norvegicus,,10116.0,N,Plasma,1,,Maximum concentration of compound in plasma administered orally to rats,,BAO_0000218,14258,
In vivo,,A,,Intermediate,1,,50588,CHEMBL626023,1969.0,11176,Canis lupus familiaris,,9615.0,N,Plasma,1,,"Maximum concentration (10 mg/kg, orally) in plasma of dogs",,BAO_0000218,14224,
In vivo,,A,,Intermediate,1,,50588,CHEMBL626024,1969.0,11177,Canis lupus familiaris,,9615.0,N,Plasma,1,,"Maximum concentration (10 mg/kg, perorally) in plasma of dogs",,BAO_0000218,14224,
In vivo,,A,,Intermediate,1,,50588,CHEMBL626025,1969.0,11178,Canis lupus familiaris,,9615.0,N,Plasma,1,,"Maximum concentration (5 mg/kg, intravenously) in plasma of dogs",,BAO_0000218,14224,
In vivo,,A,,Autocuration,0,,22224,CHEMBL626026,,11179,,,,U,,1,,Maximum concentration after 10 mg/kg by oral administration,,BAO_0000218,5566,
In vivo,,A,,Autocuration,0,,22224,CHEMBL626027,,11180,,,,U,,1,,Maximum concentration at a dose of 1.5 mg/kg,,BAO_0000218,16935,
In vivo,,A,,Autocuration,0,,22224,CHEMBL626028,,11181,,,,U,,1,,Maximum concentration at a dose of 2.0 mg/kg,,BAO_0000218,16935,
In vivo,,A,,Intermediate,1,,50588,CHEMBL626029,1969.0,11182,Canis lupus familiaris,,9615.0,N,Plasma,1,,Maximum concentration in dog plasma,,BAO_0000218,14224,
In vivo,,A,,Autocuration,0,,22224,CHEMBL626030,1969.0,11183,,,,U,Plasma,1,,Maximum concentration in plasma after administration of 10 umol/kg dose perorally,,BAO_0000218,12536,
In vivo,,A,,Autocuration,0,,22224,CHEMBL626031,1969.0,11184,,,,U,Plasma,1,,Maximum concentration in plasma after administration of 2 umol/kg dose intravenously,,BAO_0000218,12536,
In vivo,,A,,Autocuration,0,,22224,CHEMBL626032,1969.0,11185,,,,U,Plasma,1,,Maximum concentration in plasma after administration of 4 umol/kg dose intravenously,,BAO_0000218,12536,
In vivo,,A,,Autocuration,0,,22224,CHEMBL626033,1969.0,11186,,,,U,Plasma,1,,Maximum concentration in plasma after administration of 40 umol/kg dose perorally,,BAO_0000218,12536,
In vivo,,A,,Autocuration,0,,22224,CHEMBL626034,1969.0,11187,,,,U,Plasma,1,,Maximum concentration in plasma after administration of 5 umol/kg dose intravenously,,BAO_0000218,12536,
In vivo,,A,,Intermediate,1,,50588,CHEMBL626035,1969.0,11188,Canis lupus familiaris,,9615.0,N,Plasma,1,,Maximum concentration in plasma after oral administration in dog (25 mg/kg),,BAO_0000218,9994,
In vivo,,A,,Autocuration,0,,22224,CHEMBL626036,1969.0,11189,,,,U,Plasma,1,,Maximum concentration in plasma at Tmax,,BAO_0000218,1434,
In vivo,,A,,Expert,1,,50588,CHEMBL626037,1969.0,11190,Canis lupus familiaris,,9615.0,N,Plasma,1,,Maximum concentration in plasma recorded 0-6 hr post dose in dog at 10 mg/kg oral dose,,BAO_0000218,12836,
In vivo,,A,,Intermediate,1,,100712,CHEMBL626038,1969.0,11191,Cricetinae,,10026.0,N,Plasma,1,,Maximum concentration in plasma recorded in the period 0-6 hr post dose in hamster at 10 mg/kg oral dose,,BAO_0000218,12836,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626039,1969.0,11192,Rattus norvegicus,,10116.0,N,Plasma,1,,Maximum concentration in plasma recorded in the period 0-6 hr post dose in rat at 10 mg/kg oral dose,,BAO_0000218,12836,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626040,1969.0,11193,Rattus norvegicus,,10116.0,N,Plasma,1,,Maximum concentration in plasma was determined by oral administration to rats at 20 mg/kg,,BAO_0000218,12545,
In vivo,,A,,Intermediate,1,,50592,CHEMBL626041,1969.0,11194,Oryctolagus cuniculus,,9986.0,N,Plasma,1,,Maximum concentration present in the rabbit plasma following peroral administration of 10 mg/kg,,BAO_0000218,13856,
In vivo,,A,,Autocuration,0,,22224,CHEMBL626042,,11195,,,,U,,1,,Maximum concentration was calculated,,BAO_0000218,3550,
In vivo,,A,,Autocuration,0,,22224,CHEMBL626043,,11196,,,,U,,1,,Maximum concentration was calculated.,,BAO_0000218,2632,
In vivo,,A,,Autocuration,0,,22224,CHEMBL626044,,11197,,,,U,,1,,Maximum concentration at a peroral dose of 10 mg/kg,,BAO_0000218,5566,
In vivo,,A,,Autocuration,0,,22224,CHEMBL626045,,11198,,,,U,,1,,Maximum concentration of the drug at 10 uM/dg administered perorally,,BAO_0000218,11883,
In vivo,,A,,Autocuration,0,,22224,CHEMBL626046,,11199,,,,U,,1,,Maximum concentration of the drug at 2 uM/dg administered intravenously,,BAO_0000218,11883,
In vivo,,A,,Intermediate,1,,50588,CHEMBL626047,1969.0,11200,Canis lupus familiaris,,9615.0,N,Plasma,1,,"Maximum concentration of the unchanged compound in dog plasma, recorded in the period 0-6 hr post dose.",,BAO_0000218,14122,
In vivo,,A,,Intermediate,1,,100712,CHEMBL626048,1969.0,11201,Cricetinae,,10026.0,N,Plasma,1,,"Maximum concentration of the unchanged compound in hamster plasma, recorded in the period 0-6 hr post dose.",,BAO_0000218,14122,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626049,1969.0,11202,Rattus norvegicus,,10116.0,N,Plasma,1,,"Maximum concentration of the unchanged compound in rat plasma, recorded in the period 0-6 hr post dose.",,BAO_0000218,14122,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626050,1969.0,11203,Rattus norvegicus,,10116.0,N,Plasma,1,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 60 mg/kg oral dose,,BAO_0000218,12542,
In vivo,,A,,Intermediate,1,,50588,CHEMBL874541,1969.0,11204,Canis lupus familiaris,,9615.0,N,Plasma,1,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in dog at 5 mg/kg oral dose,,BAO_0000218,12542,
In vivo,,A,,Intermediate,1,,100712,CHEMBL622826,1969.0,11205,Cricetinae,,10026.0,N,Plasma,1,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in hamster at 40 mg/kg oral dose,,BAO_0000218,12542,
In vivo,,A,,Intermediate,1,,100712,CHEMBL622827,1969.0,11206,Cricetinae,,10026.0,N,Plasma,1,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose to hamster at 40 mg/kg oral dose,,BAO_0000218,12542,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622828,1969.0,11207,Rattus norvegicus,,10116.0,N,Plasma,1,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 25 mg/kg oral dose,,BAO_0000218,12542,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622829,1969.0,11208,Rattus norvegicus,,10116.0,N,Plasma,1,,Maximum concentration of unchanged drug in rat plasma in the period 0-24 hr after dosing,,BAO_0000218,14080,
In vivo,,A,,Intermediate,1,,50597,CHEMBL876806,,11209,Rattus norvegicus,,10116.0,N,,1,,Maximum concentration reached following intravenous administration in male rat,,BAO_0000218,11911,
In vivo,,A,,Intermediate,1,,50588,CHEMBL622830,,11210,Canis lupus familiaris,,9615.0,N,,1,,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 10 mg/kg dosage administered perorally in dog,,BAO_0000218,13204,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622831,,11211,Rattus norvegicus,,10116.0,N,,1,,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 5 mg/kg dosage administered perorally in rats,,BAO_0000218,13204,
In vivo,,A,,Intermediate,1,,50588,CHEMBL626794,,11212,Canis lupus familiaris,,9615.0,N,,1,,Maximum concentration was measured after peroral administration of 10 mg/kg of drug in male Beagle dogs,,BAO_0000218,14346,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626795,,11213,Rattus norvegicus,,10116.0,N,,1,,Maximum concentration was measured after peroral administration of 5.0 mg/kg of drug in male Dawley rats,,BAO_0000218,14346,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626796,,11214,Rattus norvegicus,,10116.0,N,,1,,Maximum concentration was measured after peroral administration of 5.1 mg/kg of drug in male Dawley rats,,BAO_0000218,14346,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626797,,11215,Rattus norvegicus,,10116.0,N,,1,,Maximum concentration was measured after peroral administration of 5.2 mg/kg of drug in male Dawley rats,,BAO_0000218,14346,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626798,,11216,Rattus norvegicus,,10116.0,N,,1,,Maximum drug concentration is determined after oral dosing in rats.,,BAO_0000218,14127,
In vivo,,A,,Intermediate,1,,50588,CHEMBL626799,,11217,Canis lupus familiaris,,9615.0,N,,1,,Maximum observed concentration in oral (5 mg/kg) fasted dogs,,BAO_0000218,14339,
In vivo,,A,,Intermediate,1,,50588,CHEMBL626800,,11218,Canis lupus familiaris,,9615.0,N,,1,,Maximum observed concentration in oral (5 mg/kg) fed dogs,,BAO_0000218,14339,
In vivo,,A,,Autocuration,0,,22224,CHEMBL626801,1969.0,11219,,,,U,Plasma,1,,Maximum plasma concentration,,BAO_0000218,13494,
In vivo,,A,,Intermediate,1,,50597,CHEMBL876816,1969.0,11220,Rattus norvegicus,,10116.0,N,Plasma,1,,Maximum plasma concentration (Cmax) was determined in rats after intraduodenal administration of the drug,,BAO_0000218,14925,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626802,1969.0,11221,Rattus norvegicus,,10116.0,N,Plasma,1,,Maximum plasma concentration following oral administration of 26.3 mg/kg in rats,,BAO_0000218,14474,
In vivo,,A,,Intermediate,1,,50588,CHEMBL626803,1969.0,11222,Canis lupus familiaris,,9615.0,N,Plasma,1,,Maximum plasma concentration following oral administration of 3.8 mg/kg in Beagle dog,,BAO_0000218,14474,
In vivo,,A,,Autocuration,0,,22224,CHEMBL626804,1969.0,11223,,,,U,Plasma,1,,Maximum plasma concentration following oral administration of 30 umol/kg,,BAO_0000218,13917,
,,A,,Intermediate,1,,50597,CHEMBL626805,1969.0,11224,Rattus norvegicus,,10116.0,N,Plasma,1,,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose,,BAO_0000218,9796,
,,A,,Intermediate,1,,50597,CHEMBL626309,1969.0,11225,Rattus norvegicus,,10116.0,N,Plasma,1,,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,,BAO_0000218,9796,
,,A,,Intermediate,1,,50597,CHEMBL626310,1969.0,11226,Rattus norvegicus,,10116.0,N,Plasma,1,,Distribution of radiolabeled compound in plasma of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,,BAO_0000218,9796,
,,A,,Intermediate,1,,50597,CHEMBL626311,1969.0,11227,Rattus norvegicus,,10116.0,N,Plasma,1,,Distribution of radiolabeled compound in plasma of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,,BAO_0000218,9796,
,,A,,Intermediate,1,,50597,CHEMBL626312,1969.0,11228,Rattus norvegicus,,10116.0,N,Plasma,1,,Distribution of radiolabeled compound in plasma of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,,BAO_0000218,9796,
,,A,,Intermediate,1,,50597,CHEMBL626313,995.0,11229,Rattus norvegicus,,10116.0,N,Uterus,1,,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,,BAO_0000218,9796,
,,A,,Intermediate,1,,50597,CHEMBL626314,995.0,11230,Rattus norvegicus,,10116.0,N,Uterus,1,,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,,BAO_0000218,9796,
,,A,,Intermediate,1,,50597,CHEMBL626315,995.0,11231,Rattus norvegicus,,10116.0,N,Uterus,1,,Distribution of radiolabeled compound in uterus of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,,BAO_0000218,9796,
,,A,,Intermediate,1,,50597,CHEMBL626316,995.0,11232,Rattus norvegicus,,10116.0,N,Uterus,1,,Distribution of radiolabeled compound in uterus of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,,BAO_0000218,9796,
,,A,,Intermediate,1,,50597,CHEMBL626317,995.0,11233,Rattus norvegicus,,10116.0,N,Uterus,1,,Distribution of radiolabeled compound in uterus of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,,BAO_0000218,9796,
,,A,,Intermediate,1,,50597,CHEMBL626318,,11234,Rattus norvegicus,,10116.0,N,,1,,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Minus (-),,BAO_0000218,8363,
,,A,,Intermediate,1,,50597,CHEMBL626319,,11235,Rattus norvegicus,,10116.0,N,,1,,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Plus (+),,BAO_0000218,8363,
,,A,,Intermediate,1,,50597,CHEMBL626320,,11236,Rattus norvegicus,,10116.0,N,,1,,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Minus (-),,BAO_0000218,8363,
,,A,,Intermediate,1,,50597,CHEMBL875053,,11237,Rattus norvegicus,,10116.0,N,,1,,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Plus (+),,BAO_0000218,8363,
,,A,,Intermediate,1,,50597,CHEMBL626321,,11238,Rattus norvegicus,,10116.0,N,,1,,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Minus (-),,BAO_0000218,8363,
,,A,,Intermediate,1,,50597,CHEMBL626322,,11239,Rattus norvegicus,,10116.0,N,,1,,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Plus (+),,BAO_0000218,8363,
,,A,,Intermediate,1,,50597,CHEMBL626323,,11240,Rattus norvegicus,,10116.0,N,,1,,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Minus (-),,BAO_0000218,8363,
,,A,,Intermediate,1,,50597,CHEMBL626324,,11241,Rattus norvegicus,,10116.0,N,,1,,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Plus (+),,BAO_0000218,8363,
,,A,,Intermediate,1,,50597,CHEMBL626325,,11242,Rattus norvegicus,,10116.0,N,,1,,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Minus (-),,BAO_0000218,8363,
,,A,,Intermediate,1,,50597,CHEMBL626326,,11243,Rattus norvegicus,,10116.0,N,,1,,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Plus (+),,BAO_0000218,8363,
,,A,,Intermediate,1,,50597,CHEMBL626327,,11244,Rattus norvegicus,,10116.0,N,,1,,Distribution of rat erythrocytes for tube 7 on rate of aging in 2 mL of cell suspension; Plus (+),,BAO_0000218,8363,
,,A,,Intermediate,1,,50597,CHEMBL626328,,11245,Rattus norvegicus,,10116.0,N,,1,,Distribution of rat erythrocytes for tube 1 on rate of aging in 2 mL of cell suspension; Minus (-),,BAO_0000218,8363,
,,A,,Intermediate,1,,50597,CHEMBL626329,178.0,11246,Rattus norvegicus,,10116.0,N,Blood,1,,"Distribution in blood of rat 5 min after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL626330,178.0,11247,Rattus norvegicus,,10116.0,N,Blood,1,,"Distribution in blood of rat, 15 min after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL626331,178.0,11248,Rattus norvegicus,,10116.0,N,Blood,1,,"Distribution in blood of rat, 1 hr after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL626332,178.0,11249,Rattus norvegicus,,10116.0,N,Blood,1,,"Distribution in blood of rat, 2 hr after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL626333,178.0,11250,Rattus norvegicus,,10116.0,N,Blood,1,,"Distribution in blood of rat, 30 min after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL626334,178.0,11251,Rattus norvegicus,,10116.0,N,Blood,1,,"Distribution in blood of rat, 4 hr after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL626335,178.0,11252,Rattus norvegicus,,10116.0,N,Blood,1,,"Distribution in blood of rat, 6 hr after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL624798,178.0,11253,Rattus norvegicus,,10116.0,N,Blood,1,,"Distribution in blood of rat, 8 hr after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL624799,955.0,11254,Rattus norvegicus,,10116.0,N,Brain,1,,"Distribution in brain of rat, 15 min after intravenous administered, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL624800,955.0,11255,Rattus norvegicus,,10116.0,N,Brain,1,,"Distribution in brain of rat, 1 hr after intravenous administered, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL624801,955.0,11256,Rattus norvegicus,,10116.0,N,Brain,1,,"Distribution in brain of rat, 2 hr after intravenous administered, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL624802,955.0,11257,Rattus norvegicus,,10116.0,N,Brain,1,,"Distribution in brain of rat, 30 min after intravenous administered, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL624803,955.0,11258,Rattus norvegicus,,10116.0,N,Brain,1,,"Distribution in brain of rat, 4 hr after intravenous administered, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL624804,955.0,11259,Rattus norvegicus,,10116.0,N,Brain,1,,"Distribution in brain of rat, 5 min after intravenous administered, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL624805,955.0,11260,Rattus norvegicus,,10116.0,N,Brain,1,,"Distribution in brain of rat, 6 hr after intravenous administered, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL624806,955.0,11261,Rattus norvegicus,,10116.0,N,Brain,1,,"Distribution in brain of rat, 8 hr after intravenous administered, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL624807,,11262,Rattus norvegicus,,10116.0,N,,1,,"Distribution in rat fat 15 min after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL624808,,11263,Rattus norvegicus,,10116.0,N,,1,,"Distribution in rat fat 1 hr after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL624809,,11264,Rattus norvegicus,,10116.0,N,,1,,"Distribution in rat fat 2 hr after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL624810,,11265,Rattus norvegicus,,10116.0,N,,1,,"Distribution in rat fat 30 min after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL877618,,11266,Rattus norvegicus,,10116.0,N,,1,,"Distribution in rat fat 4 hr after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL624811,,11267,Rattus norvegicus,,10116.0,N,,1,,"Distribution in rat fat 5 min after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL624812,,11268,Rattus norvegicus,,10116.0,N,,1,,"Distribution in rat fat 6 hr after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL624813,,11269,Rattus norvegicus,,10116.0,N,,1,,"Distribution in rat fat 8 hr after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL624814,,11270,Rattus norvegicus,,10116.0,N,,1,,"Distribution in rat heart 15 min after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL624815,,11271,Rattus norvegicus,,10116.0,N,,1,,"Distribution in rat heart 1 hr after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL624816,,11272,Rattus norvegicus,,10116.0,N,,1,,"Distribution in rat heart 2 hr after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL624817,,11273,Rattus norvegicus,,10116.0,N,,1,,"Distribution in rat heart 30 min after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50588,CHEMBL624818,,11274,Canis lupus familiaris,,9615.0,N,,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50588,CHEMBL624819,,11275,Canis lupus familiaris,,9615.0,N,,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration,,BAO_0000218,6996,
,,A,,Intermediate,1,,50588,CHEMBL624820,,11276,Canis lupus familiaris,,9615.0,N,,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50588,CHEMBL624821,,11277,Canis lupus familiaris,,9615.0,N,,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50588,CHEMBL624822,,11278,Canis lupus familiaris,,9615.0,N,,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),,BAO_0000218,6996,
,,A,,Intermediate,1,,50588,CHEMBL624823,,11279,Canis lupus familiaris,,9615.0,N,,1,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50212,CHEMBL624824,,11280,Escherichia coli,,562.0,N,,1,,Observed diffusion coefficient in organic solvent for Escherichia coli,,BAO_0000218,15599,
,,A,,Intermediate,1,,50597,CHEMBL624825,178.0,11281,Rattus norvegicus,,10116.0,N,Blood,1,,"Concentration of compound in blood of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,BAO_0000218,9614,
,,A,,Intermediate,1,,50597,CHEMBL624826,178.0,11282,Rattus norvegicus,,10116.0,N,Blood,1,,"Concentration of compound in blood of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,BAO_0000218,9614,
,,A,,Intermediate,1,,50597,CHEMBL876817,2081.0,11283,Rattus norvegicus,,10116.0,N,Cardiac atrium,1,,"Concentration of compound in left atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,BAO_0000218,9614,
,,A,,Intermediate,1,,50597,CHEMBL624827,2081.0,11284,Rattus norvegicus,,10116.0,N,Cardiac atrium,1,,"Concentration of compound in left atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,BAO_0000218,9614,
,,A,,Intermediate,1,,50597,CHEMBL624828,,11285,Rattus norvegicus,,10116.0,N,,1,,"Concentration of compound in left ventricle of of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,BAO_0000218,9614,
,,A,,Intermediate,1,,50597,CHEMBL624829,,11286,Rattus norvegicus,,10116.0,N,,1,,"Concentration of compound in left ventricle of of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,BAO_0000218,9614,
,,A,,Intermediate,1,,50597,CHEMBL624830,2107.0,11287,Rattus norvegicus,,10116.0,N,Liver,1,,"Concentration of compound in liver of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,BAO_0000218,9614,
,,A,,Intermediate,1,,50597,CHEMBL624831,2107.0,11288,Rattus norvegicus,,10116.0,N,Liver,1,,"Concentration of compound in liver of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,BAO_0000218,9614,
,,A,,Intermediate,1,,50597,CHEMBL624832,2081.0,11289,Rattus norvegicus,,10116.0,N,Cardiac atrium,1,,"Concentration of compound in right atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,BAO_0000218,9614,
,,A,,Intermediate,1,,50597,CHEMBL624833,2081.0,11290,Rattus norvegicus,,10116.0,N,Cardiac atrium,1,,"Concentration of compound in right atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,BAO_0000218,9614,
,,A,,Intermediate,1,,50597,CHEMBL624834,,11291,Rattus norvegicus,,10116.0,N,,1,,"Concentration of compound in right ventricle of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,BAO_0000218,9614,
,,A,,Intermediate,1,,50597,CHEMBL624835,,11292,Rattus norvegicus,,10116.0,N,,1,,"Concentration of compound in right ventricle of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,BAO_0000218,9614,
,,A,,Intermediate,1,,50597,CHEMBL624836,2106.0,11293,Rattus norvegicus,,10116.0,N,Spleen,1,,"Concentration of compound in spleen of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,BAO_0000218,9614,
,,A,,Intermediate,1,,50597,CHEMBL624837,2106.0,11294,Rattus norvegicus,,10116.0,N,Spleen,1,,"Concentration of compound in spleen of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,BAO_0000218,9614,
,,A,,Intermediate,1,,50597,CHEMBL624838,178.0,11295,Rattus norvegicus,,10116.0,N,Blood,1,,Distribution of radioactivity of radiolabeled compound in blood of female rats 30 minutes after intravenous administration,,BAO_0000218,9071,
,,A,,Intermediate,1,,50597,CHEMBL622188,178.0,11296,Rattus norvegicus,,10116.0,N,Blood,1,,Distribution of radioactivity of radiolabeled compound in blood of female rats 5 minutes after intravenous administration,,BAO_0000218,9071,
,,A,,Intermediate,1,,50597,CHEMBL622189,948.0,11297,Rattus norvegicus,,10116.0,N,Heart,1,,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration,,BAO_0000218,9071,
,,A,,Intermediate,1,,50597,CHEMBL622190,948.0,11298,Rattus norvegicus,,10116.0,N,Heart,1,,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration at,,BAO_0000218,9071,
,,A,,Intermediate,1,,50597,CHEMBL625170,948.0,11299,Rattus norvegicus,,10116.0,N,Heart,1,,Distribution of radioactivity of radiolabeled compound in heart of female rats 5 minutes after intravenous administration,,BAO_0000218,9071,
,,A,,Intermediate,1,,50597,CHEMBL625171,2113.0,11300,Rattus norvegicus,,10116.0,N,Kidney,1,,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,,BAO_0000218,9071,
,,A,,Intermediate,1,,50597,CHEMBL625172,2113.0,11301,Rattus norvegicus,,10116.0,N,Kidney,1,,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,,BAO_0000218,9071,
,,A,,Intermediate,1,,50597,CHEMBL625173,2113.0,11302,Rattus norvegicus,,10116.0,N,Kidney,1,,Distribution of radioactivity of radiolabeled compound in kidney of female rats 5 minutes after intravenous administration,,BAO_0000218,9071,
,,A,,Intermediate,1,,50597,CHEMBL625174,2107.0,11303,Rattus norvegicus,,10116.0,N,Liver,1,,Distribution of radioactivity of radiolabeled compound in liver of female rats 30 minutes after intravenous administration,,BAO_0000218,9071,
,,A,,Intermediate,1,,50597,CHEMBL625175,2107.0,11304,Rattus norvegicus,,10116.0,N,Liver,1,,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration,,BAO_0000218,9071,
,,A,,Intermediate,1,,50597,CHEMBL625176,2107.0,11305,Rattus norvegicus,,10116.0,N,Liver,1,,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration at,,BAO_0000218,9071,
,,A,,Intermediate,1,,50597,CHEMBL625177,2048.0,11306,Rattus norvegicus,,10116.0,N,Lung,1,,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,,BAO_0000218,9071,
,,A,,Intermediate,1,,50597,CHEMBL625178,2048.0,11307,Rattus norvegicus,,10116.0,N,Lung,1,,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration,,BAO_0000218,9071,
,,A,,Intermediate,1,,50597,CHEMBL625179,2048.0,11308,Rattus norvegicus,,10116.0,N,Lung,1,,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration at,,BAO_0000218,9071,
,,A,,Intermediate,1,,50597,CHEMBL625180,2048.0,11309,Rattus norvegicus,,10116.0,N,Lung,1,,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,,BAO_0000218,9071,
,,A,,Autocuration,0,,22224,CHEMBL625181,,11310,,,,U,,1,,"Original dose appeared in the bile as unchanged compound, which was eliminated at a fairly constant rate over the first 4 hr following the iv administration",,BAO_0000218,10677,
,,A,,Intermediate,1,,50594,CHEMBL625182,1088.0,11311,Mus musculus,,10090.0,N,Urine,1,,Percentage of dose recovered after 0-6 hr in the urine of mice was measured.,,BAO_0000218,9750,
,,A,,Intermediate,1,,50597,CHEMBL625183,,11312,Rattus norvegicus,,10116.0,N,,1,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,BAO_0000218,8319,
,,A,,Intermediate,1,,50597,CHEMBL875848,,11313,Rattus norvegicus,,10116.0,N,,1,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,,BAO_0000218,8319,
,,A,,Intermediate,1,,50597,CHEMBL622260,,11314,Rattus norvegicus,,10116.0,N,,1,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,BAO_0000218,8319,
,,A,,Intermediate,1,,50597,CHEMBL622261,,11315,Rattus norvegicus,,10116.0,N,,1,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,,BAO_0000218,8319,
,,A,,Intermediate,1,,50597,CHEMBL622262,,11316,Rattus norvegicus,,10116.0,N,,1,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,BAO_0000218,8319,
,,A,,Intermediate,1,,50597,CHEMBL622263,2113.0,11317,Rattus norvegicus,,10116.0,N,Kidney,1,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,,BAO_0000218,8319,
,,A,,Intermediate,1,,50597,CHEMBL622418,2113.0,11318,Rattus norvegicus,,10116.0,N,Kidney,1,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,,BAO_0000218,8319,
,,A,,Intermediate,1,,50597,CHEMBL622419,2107.0,11319,Rattus norvegicus,,10116.0,N,Liver,1,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,,BAO_0000218,8319,
In vivo,,A,,Intermediate,1,,50594,CHEMBL623388,,11320,Mus musculus,,10090.0,N,,1,,Biodistribution in CD-1 mice was determined after 1 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),,BAO_0000218,13256,
In vivo,,A,,Intermediate,1,,50594,CHEMBL623389,2107.0,11321,Mus musculus,,10090.0,N,Liver,1,,Biodistribution in CD-1 mice was determined after 1 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),,BAO_0000218,13256,
In vivo,,A,,Intermediate,1,,50594,CHEMBL623390,,11322,Mus musculus,,10090.0,N,,1,,Biodistribution in CD-1 mice was determined after 1 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),,BAO_0000218,13256,
In vivo,,A,,Intermediate,1,,50594,CHEMBL623391,,11323,Mus musculus,,10090.0,N,,1,,Biodistribution in CD-1 mice was determined after 120 minutes in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),,BAO_0000218,13256,
In vivo,,A,,Intermediate,1,,50594,CHEMBL623392,178.0,11324,Mus musculus,,10090.0,N,Blood,1,,Biodistribution in CD-1 mice was determined after 120 minutes in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),,BAO_0000218,13256,
In vivo,,A,,Intermediate,1,,50594,CHEMBL623393,2037.0,11325,Mus musculus,,10090.0,N,Cerebellum,1,,Biodistribution in CD-1 mice was determined after 120 minutes in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),,BAO_0000218,13256,
In vivo,,A,,Intermediate,1,,50594,CHEMBL623394,,11326,Mus musculus,,10090.0,N,,1,,Biodistribution in CD-1 mice was determined after 120 minutes in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),,BAO_0000218,13256,
In vivo,,A,,Intermediate,1,,50594,CHEMBL618885,,11327,Mus musculus,,10090.0,N,,1,,Biodistribution in CD-1 mice was determined after 120 minutes in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),,BAO_0000218,13256,
In vivo,,A,,Intermediate,1,,50594,CHEMBL618886,2107.0,11328,Mus musculus,,10090.0,N,Liver,1,,Biodistribution in CD-1 mice was determined after 120 minutes in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),,BAO_0000218,13256,
In vivo,,A,,Intermediate,1,,50594,CHEMBL618887,,11329,Mus musculus,,10090.0,N,,1,,Biodistribution in CD-1 mice was determined after 120 minutes in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),,BAO_0000218,13256,
In vivo,,A,,Intermediate,1,,50594,CHEMBL619535,,11330,Mus musculus,,10090.0,N,,1,,Biodistribution in CD-1 mice was determined after 30 minutes in Striatum (expressed as percent injected dose per gram normalized to a 25 g mouse),,BAO_0000218,13256,
In vivo,,A,,Intermediate,1,,50594,CHEMBL619536,178.0,11331,Mus musculus,,10090.0,N,Blood,1,,Biodistribution in CD-1 mice was determined after 30 minutes in blood (expressed as percent injected dose per gram normalized to a 25 g mouse),,BAO_0000218,13256,
In vivo,,A,,Intermediate,1,,50594,CHEMBL619537,2037.0,11332,Mus musculus,,10090.0,N,Cerebellum,1,,Biodistribution in CD-1 mice was determined after 30 minutes in cerebellum (expressed as percent injected dose per gram normalized to a 25 g mouse),,BAO_0000218,13256,
In vivo,,A,,Intermediate,1,,50594,CHEMBL619705,,11333,Mus musculus,,10090.0,N,,1,,Biodistribution in CD-1 mice was determined after 30 minutes in cortex (expressed as percent injected dose per gram normalized to a 25 g mouse),,BAO_0000218,13256,
In vivo,,A,,Intermediate,1,,50594,CHEMBL619706,,11334,Mus musculus,,10090.0,N,,1,,Biodistribution in CD-1 mice was determined after 30 minutes in femur (expressed as percent injected dose per gram normalized to a 25 g mouse),,BAO_0000218,13256,
In vivo,,A,,Intermediate,1,,50594,CHEMBL619707,2107.0,11335,Mus musculus,,10090.0,N,Liver,1,,Biodistribution in CD-1 mice was determined after 30 minutes in liver (expressed as percent injected dose per gram normalized to a 25 g mouse),,BAO_0000218,13256,
In vivo,,A,,Intermediate,1,,50594,CHEMBL619708,,11336,Mus musculus,,10090.0,N,,1,,Biodistribution in CD-1 mice was determined after 30 minutes in lung (expressed as percent injected dose per gram normalized to a 25 g mouse),,BAO_0000218,13256,
In vivo,,A,,Intermediate,1,,50594,CHEMBL625219,,11337,Mus musculus,,10090.0,N,,1,,Biodistribution in CD-1 mice was determined after 5 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),,BAO_0000218,13256,
In vivo,,A,,Intermediate,1,,50594,CHEMBL625220,178.0,11338,Mus musculus,,10090.0,N,Blood,1,,Biodistribution in CD-1 mice was determined after 5 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),,BAO_0000218,13256,
In vivo,,A,,Intermediate,1,,50594,CHEMBL625221,2037.0,11339,Mus musculus,,10090.0,N,Cerebellum,1,,Biodistribution in CD-1 mice was determined after 5 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),,BAO_0000218,13256,
In vivo,,A,,Intermediate,1,,50594,CHEMBL625222,,11340,Mus musculus,,10090.0,N,,1,,Biodistribution in CD-1 mice was determined after 5 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),,BAO_0000218,13256,
In vivo,,A,,Intermediate,1,,50594,CHEMBL625223,,11341,Mus musculus,,10090.0,N,,1,,Biodistribution in CD-1 mice was determined after 5 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),,BAO_0000218,13256,
In vivo,,A,,Intermediate,1,,50594,CHEMBL625224,2107.0,11342,Mus musculus,,10090.0,N,Liver,1,,Biodistribution in CD-1 mice was determined after 5 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),,BAO_0000218,13256,
In vivo,,A,,Intermediate,1,,50594,CHEMBL625225,,11343,Mus musculus,,10090.0,N,,1,,Biodistribution in CD-1 mice was determined after 5 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),,BAO_0000218,13256,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625226,178.0,11344,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution in Rat blood after 24 hours of iv administration,,BAO_0000218,8829,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625227,178.0,11345,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution in Rat blood after 24 hours of iv administration; per g of tissue,,BAO_0000218,8829,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625228,178.0,11346,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution in Rat blood after 30 minutes of iv administration,,BAO_0000218,8829,
In vivo,,A,,Intermediate,1,,50597,CHEMBL875354,178.0,11347,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution in Rat blood after 30 minutes of iv administration; per g of tissue,,BAO_0000218,8829,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625229,178.0,11348,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution in Rat blood after 5 minutes of iv administration,,BAO_0000218,8829,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625230,178.0,11349,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution in Rat blood after 5 minutes of iv administration; per g of tissue,,BAO_0000218,8829,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625231,948.0,11350,Rattus norvegicus,,10116.0,N,Heart,1,,Biodistribution in Rat heart after 24 hours of iv administration,,BAO_0000218,8829,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625900,948.0,11351,Rattus norvegicus,,10116.0,N,Heart,1,,Biodistribution in Rat heart after 24 hours of iv administration; per g of tissue,,BAO_0000218,8829,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625901,948.0,11352,Rattus norvegicus,,10116.0,N,Heart,1,,Biodistribution in Rat heart after 30 minutes of iv administration,,BAO_0000218,8829,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625902,948.0,11353,Rattus norvegicus,,10116.0,N,Heart,1,,Biodistribution in Rat heart after 30 minutes of iv administration; per g of tissue,,BAO_0000218,8829,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625903,948.0,11354,Rattus norvegicus,,10116.0,N,Heart,1,,Biodistribution in Rat heart after 5 minutes of iv administration,,BAO_0000218,8829,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625904,948.0,11355,Rattus norvegicus,,10116.0,N,Heart,1,,Biodistribution in Rat heart after 5 minutes of iv administration; per g of tissue,,BAO_0000218,8829,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625905,2107.0,11356,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution in Rat liver after 24 hours of iv administration,,BAO_0000218,8829,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627861,2107.0,11357,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution in Rat liver after 24 hours of iv administration; per g of tissue,,BAO_0000218,8829,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627862,2107.0,11358,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution in Rat liver after 30 minutes of iv administration,,BAO_0000218,8829,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627863,2107.0,11359,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,,BAO_0000218,8829,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627769,2107.0,11360,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution in Rat liver after 30 minutes of iv administration,,BAO_0000218,8829,
In vivo,,A,,Intermediate,1,,50588,CHEMBL627770,1969.0,11361,Canis lupus familiaris,,9615.0,N,Plasma,1,,Maximum plasma concentration in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,,BAO_0000218,13249,
In vivo,,A,,Intermediate,1,,100710,CHEMBL627771,,11362,Macaca fascicularis,,9541.0,N,,1,,Cmax in cynomolgus monkey (PO dose),,BAO_0000218,13622,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627772,,11363,Rattus norvegicus,,10116.0,N,,1,,Cmax in rat (PO dose),,BAO_0000218,13622,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627773,,11364,Rattus norvegicus,,10116.0,N,,1,,Cmax in rat (PO dose),,BAO_0000218,13622,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621922,1969.0,11365,Rattus norvegicus,,10116.0,N,Plasma,1,,Maximum plasma concentration in rats after an oral dose of 5 mg/kg,,BAO_0000218,13494,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621923,1969.0,11366,Rattus norvegicus,,10116.0,N,Plasma,1,,Cmax in rat plasma after oral dose (10 mg/kg),,BAO_0000218,12170,
In vivo,,A,,Autocuration,0,,22224,CHEMBL621924,1969.0,11367,,,,U,Plasma,1,,Cmax in plasma after oral dose (10 mg/kg),,BAO_0000218,12170,
In vivo,,A,,Intermediate,1,,50588,CHEMBL621925,1969.0,11368,Canis lupus familiaris,,9615.0,N,Plasma,1,,Maximum plasma concentration of compound was determined in dog at 25 mg/kg orally,,BAO_0000218,17025,
In vivo,,A,,Autocuration,0,,22224,CHEMBL621926,1969.0,11369,Simiiformes,,314293.0,U,Plasma,1,,Maximum plasma concentration of compound was determined in monkey at 25 mg/kg orally,,BAO_0000218,17025,
In vivo,,A,,Intermediate,1,,50592,CHEMBL621927,1969.0,11370,Oryctolagus cuniculus,,9986.0,N,Plasma,1,,Maximum plasma concentration of compound was determined in rabbit at 25 mg/kg orally,,BAO_0000218,17025,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621928,1969.0,11371,Rattus norvegicus,,10116.0,N,Plasma,1,,Maximum plasma concentration of compound was determined in rat at 25 mg/kg orally,,BAO_0000218,17025,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621929,1969.0,11372,Rattus norvegicus,,10116.0,N,Plasma,1,,Maximum plasma concentration after p.o. (10 mpk) administration in rats.,,BAO_0000218,14187,
In vivo,,A,,Intermediate,1,,50594,CHEMBL621930,1969.0,11373,Mus musculus,,10090.0,N,Plasma,1,,Maximum plasma concentration (Cmax) after p.o. administration of 200 mg/kg in mice,,BAO_0000218,14816,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621931,1969.0,11374,Rattus norvegicus,,10116.0,N,Plasma,1,,Maximum plasma concentration after oral dosing in rat,,BAO_0000218,17820,
In vivo,,A,,Autocuration,0,,22224,CHEMBL621932,1969.0,11375,,,,U,Plasma,1,,Maximum plasma concentration evaluated in 100% PEG solution at a dose of 20 mg/kg orally,,BAO_0000218,14380,
In vivo,,A,,Autocuration,0,,22224,CHEMBL621933,1969.0,11376,,,,U,Plasma,1,,Maximum plasma concentration evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,,BAO_0000218,14380,
In vivo,,A,,Intermediate,1,,50588,CHEMBL621934,1969.0,11377,Canis lupus familiaris,,9615.0,N,Plasma,1,,Maximum plasma concentration in dogs at 0.5 mg/kg dose upon oral administration,,BAO_0000218,14691,
In vivo,,A,,Intermediate,1,,50588,CHEMBL621935,1969.0,11378,Canis lupus familiaris,,9615.0,N,Plasma,1,,Maximum plasma concentration in dogs at 1 mg/kg dose upon oral administration,,BAO_0000218,14691,
In vivo,,A,,Intermediate,1,,50597,CHEMBL621936,1969.0,11379,Rattus norvegicus,,10116.0,N,Plasma,1,,Maximum plasma concentration in rat upon oral administration of 40 mg/kg,,BAO_0000218,13375,
In vivo,,A,,Autocuration,0,,22224,CHEMBL621937,1969.0,11380,,,,U,Plasma,1,,Maximum plasma concentration was determined,,BAO_0000218,6236,
In vivo,,A,,Autocuration,0,,22224,CHEMBL621938,1969.0,11381,,,,U,Plasma,1,,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,BAO_0000218,14380,
In vivo,,A,,Autocuration,0,,22224,CHEMBL621939,1969.0,11382,,,,U,Plasma,1,,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,BAO_0000218,14380,
In vivo,,A,,Autocuration,0,,22224,CHEMBL621940,1969.0,11383,,,,U,Plasma,1,,Maximum plasma concentration was evaluated in 10% of PEG suspension at a dose of 20 mg/kg orally,,BAO_0000218,14380,
In vivo,,A,,Autocuration,0,,22224,CHEMBL621941,1969.0,11384,,,,U,Plasma,1,,Maximum plasma concentration was evaluated in 100% of PEG solution at a dose of 20 mg/kg orally,,BAO_0000218,14380,
In vivo,,A,,Autocuration,0,,22224,CHEMBL621942,1969.0,11385,,,,U,Plasma,1,,Maximum plasma concentration was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,,BAO_0000218,14380,
In vivo,,A,,Autocuration,0,,22224,CHEMBL626178,1969.0,11386,,,,U,Plasma,1,,Maximum plasma concentration was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,,BAO_0000218,14380,
In vivo,,A,,Autocuration,0,,22224,CHEMBL626179,1969.0,11387,,,,U,Plasma,1,,Maximum plasma concentration was evaluated in Hp-beta-CD solution at a dose of 20 mg/kg orally,,BAO_0000218,14380,
In vivo,,A,,Autocuration,0,,22224,CHEMBL626180,1969.0,11388,,,,U,Plasma,1,,Maximum plasma concentration was evaluated in saline solution at a dose of 20 mg/kg orally,,BAO_0000218,14380,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626181,1969.0,11389,Rattus norvegicus,,10116.0,N,Plasma,1,,Plasma Cmax in rat (PO dose),,BAO_0000218,13622,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626182,,11390,Rattus norvegicus,,10116.0,N,,1,,Maximum serum concentration after po dose of 5.22 mg/kg in rats,,BAO_0000218,15372,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626183,,11391,Rattus norvegicus,,10116.0,N,,1,,Maximum serum concentration after po dose of 5.46 mg/kg in rats,,BAO_0000218,15372,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626184,,11392,Rattus norvegicus,,10116.0,N,,1,,Maximum serum concentration was determined for the compound after po dose of 5.01 mg/kg in rats,,BAO_0000218,15372,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626185,,11393,Rattus norvegicus,,10116.0,N,,1,,Maximum serum concentration was determined for the compound after po dose of 5.03 mg/kg in rats,,BAO_0000218,15372,
In vivo,,A,,Intermediate,1,,50588,CHEMBL626186,1969.0,11394,Canis lupus familiaris,,9615.0,N,Plasma,1,,Maximum plasma concentration (Cmax) was determined in dogs fed after oral administration of 25 mg/kg of the compound.,,BAO_0000218,14925,
In vivo,,A,,Intermediate,1,,50588,CHEMBL877589,1969.0,11395,Canis lupus familiaris,,9615.0,N,Plasma,1,,Maximum plasma concentration (Cmax) was determined in fasted dogs after oral administration of 25 mg/kg of the compound.,,BAO_0000218,14925,
In vivo,,A,,Autocuration,0,,22224,CHEMBL626187,,11396,,,,U,,1,,Maximum concentration of the drug at 1 uM/dg administered intravenously,,BAO_0000218,11883,
In vivo,,A,,Autocuration,0,,22224,CHEMBL626188,,11397,,,,U,,1,,Maximum concentration of the drug at 20 uM/dg administered perorally,,BAO_0000218,11883,
In vivo,,A,,Autocuration,0,,22224,CHEMBL626189,,11398,,,,U,,1,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg,,BAO_0000218,13391,
In vivo,,A,,Autocuration,0,,22224,CHEMBL626855,178.0,11399,,,,U,Blood,1,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,,BAO_0000218,13391,
In vivo,,A,,Autocuration,0,,22224,CHEMBL623781,178.0,11400,,,,U,Blood,1,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,,BAO_0000218,13391,
In vivo,,A,,Autocuration,0,,22224,CHEMBL623782,178.0,11401,,,,U,Blood,1,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,,BAO_0000218,13391,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623783,1969.0,11402,Rattus norvegicus,,10116.0,N,Plasma,1,,Oral absorption expressed as peak plasma conc (Cmax) after oral dosing of 50 mg/kg in rat,,BAO_0000218,16360,
In vivo,,A,,Intermediate,1,,50588,CHEMBL623784,1969.0,11403,Canis lupus familiaris,,9615.0,N,Plasma,1,,Cmax in dog plasma after 1mg/kg oral dose,,BAO_0000218,3673,
In vivo,,A,,Intermediate,1,,50588,CHEMBL623785,1969.0,11404,Canis lupus familiaris,,9615.0,N,Plasma,1,,Bioavailability as maximal plasma concentration in dogs after 2.5 mg/kg oral dose,,BAO_0000218,14431,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623786,1969.0,11405,Rattus norvegicus,,10116.0,N,Plasma,1,,Bioavailability as maximal plasma concentration in rats after 10 mg/kg oral dose,,BAO_0000218,14431,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623787,,11406,Rattus norvegicus,,10116.0,N,,1,,Oral maximum concentration in rat,,BAO_0000218,14964,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623788,,11407,Rattus norvegicus,,10116.0,N,,1,,Oral maximum concentration in rat,,BAO_0000218,14964,
In vivo,,A,,Intermediate,1,,50594,CHEMBL623789,1969.0,11408,Mus musculus,,10090.0,N,Plasma,1,,Oral plasma concentration in mice at 100 mg/kg dosage within 4-hr time frame.,,BAO_0000218,14209,
In vivo,,A,,Intermediate,1,,50594,CHEMBL623790,178.0,11409,Mus musculus,,10090.0,N,Blood,1,,Peak concentration in blood after intravenous administration to mice,,BAO_0000218,11355,
In vivo,,A,,Intermediate,1,,50594,CHEMBL623791,178.0,11410,Mus musculus,,10090.0,N,Blood,1,,Peak concentration in blood after peroral administration to mice,,BAO_0000218,11355,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623792,1969.0,11411,Rattus norvegicus,,10116.0,N,Plasma,1,,Peak concentration in rat plasma was determined,,BAO_0000218,11966,
In vivo,,A,,Autocuration,0,,22224,CHEMBL623793,1969.0,11412,Simiiformes,,314293.0,U,Plasma,1,,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of monkey after oral administration of 0.05 mmol/kg,,BAO_0000218,8918,
In vivo,,A,,Intermediate,1,,50594,CHEMBL623794,1969.0,11413,Mus musculus,,10090.0,N,Plasma,1,,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of mouse after oral administration of 0.05 mmol/kg,,BAO_0000218,8918,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623795,1969.0,11414,Rattus norvegicus,,10116.0,N,Plasma,1,,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of rat after oral administration of 0.05 mmol/kg,,BAO_0000218,8918,
,,A,,Intermediate,1,,50597,CHEMBL623796,,11415,Rattus norvegicus,,10116.0,N,,1,,"Distribution in rat heart 4 hr after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL623797,,11416,Rattus norvegicus,,10116.0,N,,1,,"Distribution in rat heart 5 min after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL623798,,11417,Rattus norvegicus,,10116.0,N,,1,,"Distribution in rat heart 6 hr after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL623799,,11418,Rattus norvegicus,,10116.0,N,,1,,"Distribution in rat heart 8 hr after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL624490,160.0,11419,Rattus norvegicus,,10116.0,N,Intestine,1,,"Distribution in rat intestine 15 min after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL624491,160.0,11420,Rattus norvegicus,,10116.0,N,Intestine,1,,"Distribution in rat intestine 1 hr after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL624492,160.0,11421,Rattus norvegicus,,10116.0,N,Intestine,1,,"Distribution in rat intestine 2 hr after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL624493,160.0,11422,Rattus norvegicus,,10116.0,N,Intestine,1,,"Distribution in rat intestine 30 min after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL877595,160.0,11423,Rattus norvegicus,,10116.0,N,Intestine,1,,"Distribution in rat intestine 4 hr after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL624494,160.0,11424,Rattus norvegicus,,10116.0,N,Intestine,1,,"Distribution in rat intestine 5 min after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL624495,160.0,11425,Rattus norvegicus,,10116.0,N,Intestine,1,,"Distribution in rat intestine 6 hr after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL624681,160.0,11426,Rattus norvegicus,,10116.0,N,Intestine,1,,"Distribution in rat intestine 8 hr after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL624682,,11427,Rattus norvegicus,,10116.0,N,,1,,"Distribution in rat kidney, 15 min after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL624683,,11428,Rattus norvegicus,,10116.0,N,,1,,"Distribution in rat kidney, 1 hr after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL624684,,11429,Rattus norvegicus,,10116.0,N,,1,,"Distribution in rat kidney, 2 hr after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL624685,,11430,Rattus norvegicus,,10116.0,N,,1,,"Distribution in rat kidney, 30 min after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL624686,,11431,Rattus norvegicus,,10116.0,N,,1,,"Distribution in rat kidney, 4 hr after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL624687,,11432,Rattus norvegicus,,10116.0,N,,1,,"Distribution in rat kidney, 5 min after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL624688,,11433,Rattus norvegicus,,10116.0,N,,1,,"Distribution in rat kidney, 6 hr after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL627161,,11434,Rattus norvegicus,,10116.0,N,,1,,"Distribution in rat kidney, 8 hr after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL622127,,11435,Rattus norvegicus,,10116.0,N,,1,,"Distribution in rat liver 15 min after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL622128,,11436,Rattus norvegicus,,10116.0,N,,1,,"Distribution in rat liver 1 hr after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL874384,,11437,Rattus norvegicus,,10116.0,N,,1,,"Distribution in rat liver 2 hr after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL624898,,11438,Rattus norvegicus,,10116.0,N,,1,,"Distribution in rat liver 30 min after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL624899,,11439,Rattus norvegicus,,10116.0,N,,1,,"Distribution in rat liver 4 hr after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL624900,,11440,Rattus norvegicus,,10116.0,N,,1,,"Distribution in rat liver 5 min after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL624901,,11441,Rattus norvegicus,,10116.0,N,,1,,"Distribution in rat liver 6 hr after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL624902,,11442,Rattus norvegicus,,10116.0,N,,1,,"Distribution in rat liver 8 hr after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL624903,,11443,Rattus norvegicus,,10116.0,N,,1,,"Distribution in rat lungs 15 min after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL624904,,11444,Rattus norvegicus,,10116.0,N,,1,,"Distribution in rat lungs 1 hr after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL624905,,11445,Rattus norvegicus,,10116.0,N,,1,,"Distribution in rat lungs 2 hr after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL624906,,11446,Rattus norvegicus,,10116.0,N,,1,,"Distribution in rat lungs 30 min after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL624907,,11447,Rattus norvegicus,,10116.0,N,,1,,"Distribution in rat lungs 4 hr after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL624908,,11448,Rattus norvegicus,,10116.0,N,,1,,"Distribution in rat lungs 5 min after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL624909,,11449,Rattus norvegicus,,10116.0,N,,1,,"Distribution in rat lungs 6 hr after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL624910,,11450,Rattus norvegicus,,10116.0,N,,1,,"Distribution in rat lungs 8 hr after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL624911,2385.0,11451,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,"Distribution in rat muscle 15 min after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL874388,2385.0,11452,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,"Distribution in rat muscle 1 hr after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL624912,2385.0,11453,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,"Distribution in rat muscle 2 hr after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL622930,2385.0,11454,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,"Distribution in rat muscle 30 min after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL623121,2385.0,11455,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,"Distribution in rat muscle 4 hr after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL623122,2385.0,11456,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,"Distribution in rat muscle 5 min after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL623123,2385.0,11457,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,"Distribution in rat muscle 6 hr after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL623124,2385.0,11458,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,"Distribution in rat muscle 8 hr after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL623125,,11459,Rattus norvegicus,,10116.0,N,,1,,"Distribution in rat pancreas 15 min after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL623126,,11460,Rattus norvegicus,,10116.0,N,,1,,"Distribution in rat pancreas 1 hr after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL623127,,11461,Rattus norvegicus,,10116.0,N,,1,,"Distribution in rat pancreas 2 hr after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL623128,,11462,Rattus norvegicus,,10116.0,N,,1,,"Distribution in rat pancreas 30 min after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL623129,,11463,Rattus norvegicus,,10116.0,N,,1,,"Distribution in rat pancreas 4 hr after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL623130,,11464,Rattus norvegicus,,10116.0,N,,1,,"Distribution in rat pancreas 5 min after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL623131,,11465,Rattus norvegicus,,10116.0,N,,1,,"Distribution in rat pancreas 6 hr after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL623132,,11466,Rattus norvegicus,,10116.0,N,,1,,"Distribution in rat pancreas 8 hr after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL623133,2107.0,11467,Rattus norvegicus,,10116.0,N,Liver,1,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,,BAO_0000218,8319,
,,A,,Intermediate,1,,50597,CHEMBL623134,,11468,Rattus norvegicus,,10116.0,N,,1,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,BAO_0000218,8319,
,,A,,Intermediate,1,,50597,CHEMBL874389,,11469,Rattus norvegicus,,10116.0,N,,1,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,BAO_0000218,8319,
,,A,,Intermediate,1,,50597,CHEMBL623135,,11470,Rattus norvegicus,,10116.0,N,,1,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,,BAO_0000218,8319,
,,A,,Intermediate,1,,50597,CHEMBL623136,,11471,Rattus norvegicus,,10116.0,N,,1,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,BAO_0000218,8319,
,,A,,Intermediate,1,,50597,CHEMBL623137,,11472,Rattus norvegicus,,10116.0,N,,1,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,,BAO_0000218,8319,
,,A,,Intermediate,1,,50597,CHEMBL623138,,11473,Rattus norvegicus,,10116.0,N,,1,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,BAO_0000218,8319,
,,A,,Intermediate,1,,50597,CHEMBL623139,2113.0,11474,Rattus norvegicus,,10116.0,N,Kidney,1,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,,BAO_0000218,8319,
,,A,,Intermediate,1,,50597,CHEMBL623140,2113.0,11475,Rattus norvegicus,,10116.0,N,Kidney,1,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,,BAO_0000218,8319,
,,A,,Intermediate,1,,50597,CHEMBL623141,2107.0,11476,Rattus norvegicus,,10116.0,N,Liver,1,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,,BAO_0000218,8319,
,,A,,Intermediate,1,,50597,CHEMBL623142,2107.0,11477,Rattus norvegicus,,10116.0,N,Liver,1,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,,BAO_0000218,8319,
,,A,,Intermediate,1,,50597,CHEMBL623143,,11478,Rattus norvegicus,,10116.0,N,,1,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,BAO_0000218,8319,
,,A,,Intermediate,1,,50594,CHEMBL623144,1088.0,11479,Mus musculus,,10090.0,N,Urine,1,,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in mouse.,,BAO_0000218,14571,
,,A,,Intermediate,1,,50597,CHEMBL623405,1088.0,11480,Rattus norvegicus,,10116.0,N,Urine,1,,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in rat.,,BAO_0000218,14571,
,,A,,Intermediate,1,,50597,CHEMBL624074,,11481,Rattus norvegicus,,10116.0,N,,1,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,BAO_0000218,8319,
,,A,,Intermediate,1,,50597,CHEMBL624075,,11482,Rattus norvegicus,,10116.0,N,,1,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,,BAO_0000218,8319,
,,A,,Intermediate,1,,50597,CHEMBL624076,,11483,Rattus norvegicus,,10116.0,N,,1,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,BAO_0000218,8319,
,,A,,Intermediate,1,,50597,CHEMBL624077,,11484,Rattus norvegicus,,10116.0,N,,1,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,,BAO_0000218,8319,
,,A,,Intermediate,1,,50597,CHEMBL624078,,11485,Rattus norvegicus,,10116.0,N,,1,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,BAO_0000218,8319,
,,A,,Intermediate,1,,50597,CHEMBL624079,2113.0,11486,Rattus norvegicus,,10116.0,N,Kidney,1,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,,BAO_0000218,8319,
,,A,,Intermediate,1,,50597,CHEMBL624261,2113.0,11487,Rattus norvegicus,,10116.0,N,Kidney,1,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,,BAO_0000218,8319,
,,A,,Intermediate,1,,50597,CHEMBL624262,,11488,Rattus norvegicus,,10116.0,N,,1,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,,BAO_0000218,8319,
,,A,,Intermediate,1,,50597,CHEMBL624263,,11489,Rattus norvegicus,,10116.0,N,,1,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,,BAO_0000218,8319,
,,A,,Intermediate,1,,50597,CHEMBL624264,,11490,Rattus norvegicus,,10116.0,N,,1,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,BAO_0000218,8319,
,,A,,Intermediate,1,,50597,CHEMBL624265,,11491,Rattus norvegicus,,10116.0,N,,1,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,BAO_0000218,8319,
,,A,,Intermediate,1,,50597,CHEMBL624266,,11492,Rattus norvegicus,,10116.0,N,,1,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,,BAO_0000218,8319,
,,A,,Intermediate,1,,50597,CHEMBL624267,,11493,Rattus norvegicus,,10116.0,N,,1,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,BAO_0000218,8319,
,,A,,Intermediate,1,,50597,CHEMBL624268,,11494,Rattus norvegicus,,10116.0,N,,1,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,,BAO_0000218,8319,
,,A,,Intermediate,1,,50597,CHEMBL875227,,11495,Rattus norvegicus,,10116.0,N,,1,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,BAO_0000218,8319,
,,A,,Intermediate,1,,50597,CHEMBL624269,2113.0,11496,Rattus norvegicus,,10116.0,N,Kidney,1,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,,BAO_0000218,8319,
,,A,,Intermediate,1,,50597,CHEMBL624270,2113.0,11497,Rattus norvegicus,,10116.0,N,Kidney,1,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,,BAO_0000218,8319,
,,A,,Intermediate,1,,50597,CHEMBL624271,,11498,Rattus norvegicus,,10116.0,N,,1,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,,BAO_0000218,8319,
,,A,,Intermediate,1,,50597,CHEMBL624272,,11499,Rattus norvegicus,,10116.0,N,,1,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,,BAO_0000218,8319,
,,A,,Intermediate,1,,50597,CHEMBL624273,,11500,Rattus norvegicus,,10116.0,N,,1,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,BAO_0000218,8319,
,,A,,Intermediate,1,,50597,CHEMBL624274,1088.0,11501,Rattus norvegicus,,10116.0,N,Urine,1,,Urinary excretion in rat after 0-4 hours of oral administration at 50 mg/kg,,BAO_0000218,12064,
,,A,,Intermediate,1,,50597,CHEMBL624275,1088.0,11502,Rattus norvegicus,,10116.0,N,Urine,1,,Urinary excretion in rat after 4-8 hours of oral administration at 50 mg/kg,,BAO_0000218,12064,
,,A,,Intermediate,1,,50597,CHEMBL624276,1088.0,11503,Rattus norvegicus,,10116.0,N,Urine,1,,Urinary excretion in rat after 8-24 hours of oral administration at 50 mg/kg,,BAO_0000218,12064,
,,A,,Intermediate,1,,50597,CHEMBL624277,1088.0,11504,Rattus norvegicus,,10116.0,N,Urine,1,,Urinary recovery expressed as percentage dose in male rats after iv administration of 20 mg/kg,,BAO_0000218,12038,
,,A,,Autocuration,0,,22224,CHEMBL624278,,11505,,,,U,,1,,% dose converted to 2-amino-5-chlorophenyl sulfate,,BAO_0000019,14314,
,,A,,Autocuration,0,,22224,CHEMBL624279,,11506,,,,U,,1,,% dose converted to 4-(S-amino-N-{[(4-chlorophenyl)amino]carbonyl}sulfonimidoyl)benzoic acid (compound 41),,BAO_0000019,14314,
,,A,,Intermediate,1,,50597,CHEMBL624280,1988.0,11507,Rattus norvegicus,,10116.0,N,Feces,1,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",,BAO_0000218,11488,
,,A,,Intermediate,1,,50597,CHEMBL624281,1988.0,11508,Rattus norvegicus,,10116.0,N,Feces,1,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",,BAO_0000218,11488,
,,A,,Intermediate,1,,50597,CHEMBL622933,1988.0,11509,Rattus norvegicus,,10116.0,N,Feces,1,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",,BAO_0000218,11488,
,,A,,Intermediate,1,,50597,CHEMBL622934,1988.0,11510,Rattus norvegicus,,10116.0,N,Feces,1,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",,BAO_0000218,11488,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622935,2107.0,11511,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,,BAO_0000218,8829,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622936,2107.0,11512,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution in Rat liver after 5 minutes of iv administration,,BAO_0000218,8829,
In vivo,,A,,Intermediate,1,,50597,CHEMBL875228,2107.0,11513,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution in Rat liver after 5 minutes of iv administration; per g of tissue,,BAO_0000218,8829,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622937,2048.0,11514,Rattus norvegicus,,10116.0,N,Lung,1,,Biodistribution in Rat lung after 24 hours of iv administration,,BAO_0000218,8829,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622938,2048.0,11515,Rattus norvegicus,,10116.0,N,Lung,1,,Biodistribution in Rat lung after 24 hours of iv administration; per g of tissue,,BAO_0000218,8829,
In vivo,,A,,Intermediate,1,,50597,CHEMBL619736,2048.0,11516,Rattus norvegicus,,10116.0,N,Lung,1,,Biodistribution in Rat lung after 30 minutes of iv administration,,BAO_0000218,8829,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625117,2048.0,11517,Rattus norvegicus,,10116.0,N,Lung,1,,Biodistribution in Rat lung after 30 minutes of iv administration; per g of tissue,,BAO_0000218,8829,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625118,2048.0,11518,Rattus norvegicus,,10116.0,N,Lung,1,,Biodistribution in Rat lung after 5 minutes of iv administration,,BAO_0000218,8829,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625119,2048.0,11519,Rattus norvegicus,,10116.0,N,Lung,1,,Biodistribution in Rat lung after 5 minutes of iv administration; per g of tissue,,BAO_0000218,8829,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625120,2037.0,11520,Rattus norvegicus,,10116.0,N,Cerebellum,1,,"Biodistribution in rat cerebellum, expressed as percent I.D./g tissue",,BAO_0000218,14972,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625121,,11521,Rattus norvegicus,,10116.0,N,,1,,"Biodistribution in rat superior coliculus, expressed as percent I.D./g tissue",,BAO_0000218,14972,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625122,10000006.0,11522,Rattus norvegicus,,10116.0,N,Thalamus,1,,"Biodistribution in rat thalamus, expressed as percent I.D./g tissue",,BAO_0000218,14972,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622204,178.0,11523,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 2 min,,BAO_0000218,14608,
In vivo,,A,,Intermediate,1,,50597,CHEMBL877503,178.0,11524,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 30 min,,BAO_0000218,14608,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627127,178.0,11525,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 60 min,,BAO_0000218,14608,
In vivo,,A,,Autocuration,0,,22224,CHEMBL627128,10000000.0,11526,,,,U,Hippocampus,1,,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 2 min,,BAO_0000218,14608,
In vivo,,A,,Autocuration,0,,22224,CHEMBL627129,10000000.0,11527,,,,U,Hippocampus,1,,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 30 min,,BAO_0000218,14608,
In vivo,,A,,Autocuration,0,,22224,CHEMBL627130,10000000.0,11528,,,,U,Hippocampus,1,,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 60 min,,BAO_0000218,14608,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627131,955.0,11529,Rattus norvegicus,,10116.0,N,Brain,1,,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 2 min,,BAO_0000218,14608,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627132,955.0,11530,Rattus norvegicus,,10116.0,N,Brain,1,,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 30 min,,BAO_0000218,14608,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627133,955.0,11531,Rattus norvegicus,,10116.0,N,Brain,1,,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 60 min,,BAO_0000218,14608,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627134,2037.0,11532,Rattus norvegicus,,10116.0,N,Cerebellum,1,,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 2 min,,BAO_0000218,14608,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627135,2037.0,11533,Rattus norvegicus,,10116.0,N,Cerebellum,1,,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 30 min,,BAO_0000218,14608,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627136,2037.0,11534,Rattus norvegicus,,10116.0,N,Cerebellum,1,,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 60 min,,BAO_0000218,14608,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628435,,11535,Rattus norvegicus,,10116.0,N,,1,,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 2 min,,BAO_0000218,14608,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628436,,11536,Rattus norvegicus,,10116.0,N,,1,,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 30 min,,BAO_0000218,14608,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628437,,11537,Rattus norvegicus,,10116.0,N,,1,,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 60 min,,BAO_0000218,14608,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628438,948.0,11538,Rattus norvegicus,,10116.0,N,Heart,1,,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 2 min,,BAO_0000218,14608,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628439,948.0,11539,Rattus norvegicus,,10116.0,N,Heart,1,,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 30 min,,BAO_0000218,14608,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628440,948.0,11540,Rattus norvegicus,,10116.0,N,Heart,1,,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 60 min,,BAO_0000218,14608,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628441,10000000.0,11541,Rattus norvegicus,,10116.0,N,Hippocampus,1,,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 2 min,,BAO_0000218,14608,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628442,10000000.0,11542,Rattus norvegicus,,10116.0,N,Hippocampus,1,,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 30 min,,BAO_0000218,14608,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628443,10000000.0,11543,Rattus norvegicus,,10116.0,N,Hippocampus,1,,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 60 min,,BAO_0000218,14608,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628444,2113.0,11544,Rattus norvegicus,,10116.0,N,Kidney,1,,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 2 min,,BAO_0000218,14608,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628445,2113.0,11545,Rattus norvegicus,,10116.0,N,Kidney,1,,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 30 min,,BAO_0000218,14608,
In vivo,,A,,Intermediate,1,,50597,CHEMBL877504,2113.0,11546,Rattus norvegicus,,10116.0,N,Kidney,1,,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 60 min,,BAO_0000218,14608,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628446,2107.0,11547,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 2 min,,BAO_0000218,14608,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626874,2107.0,11548,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 30 min,,BAO_0000218,14608,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626875,2107.0,11549,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 60 min,,BAO_0000218,14608,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626876,2048.0,11550,Rattus norvegicus,,10116.0,N,Lung,1,,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 2 min,,BAO_0000218,14608,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626877,2048.0,11551,Rattus norvegicus,,10116.0,N,Lung,1,,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 30 min,,BAO_0000218,14608,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626878,2048.0,11552,Rattus norvegicus,,10116.0,N,Lung,1,,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 60 min,,BAO_0000218,14608,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626879,2385.0,11553,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 2 min,,BAO_0000218,14608,
In vivo,,A,,Autocuration,0,,22224,CHEMBL626880,1969.0,11554,Simiiformes,,314293.0,U,Plasma,1,,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of monkey after oral administration of 0.05 mmol/kg,,BAO_0000218,8918,
In vivo,,A,,Intermediate,1,,50594,CHEMBL626881,1969.0,11555,Mus musculus,,10090.0,N,Plasma,1,,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of mouse after oral administration of 0.05 mmol/kg,,BAO_0000218,8918,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626882,1969.0,11556,Rattus norvegicus,,10116.0,N,Plasma,1,,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of rat after oral administration of 0.05 mmol/kg,,BAO_0000218,8918,
In vivo,,A,,Intermediate,1,,50588,CHEMBL626883,1969.0,11557,Canis lupus familiaris,,9615.0,N,Plasma,1,,Peak plasma concentration was measured in dogs,,BAO_0000218,14470,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626884,,11558,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic Parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,,BAO_0000218,14393,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626885,,11559,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,,BAO_0000218,14886,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626886,,11560,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,,BAO_0000218,14886,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626887,,11561,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,,BAO_0000218,14886,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626888,,11562,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,,BAO_0000218,14393,
In vivo,,A,,Intermediate,1,,50588,CHEMBL626889,,11563,Canis lupus familiaris,,9615.0,N,,1,,Pharmacokinetic parameter Cmax determined after intravenous administration of 15 mg/kg to dog,,BAO_0000218,13465,
In vivo,,A,,Autocuration,0,,22224,CHEMBL626761,,11564,Simiiformes,,314293.0,U,,1,,Pharmacokinetic parameter Cmax determined after intravenous administration of 25 mg/kg to monkey,,BAO_0000218,13465,
In vivo,,A,,Intermediate,1,,50588,CHEMBL626762,,11565,Canis lupus familiaris,,9615.0,N,,1,,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg abd antacid (CaCO3 dosed orally 10 min prior to and 60 min postdosing) to dog,,BAO_0000218,13465,
In vivo,,A,,Intermediate,1,,50588,CHEMBL626763,,11566,Canis lupus familiaris,,9615.0,N,,1,,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg to dog,,BAO_0000218,13465,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626764,,11567,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic parameter Cmax determined after intravenous administration of 50 mg/kg to rat,,BAO_0000218,13465,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626765,,11568,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic parameter Cmax determined after intravenous administration of 60 mg/kg to rat,,BAO_0000218,13465,
In vivo,,A,,Intermediate,1,,50588,CHEMBL626766,,11569,Canis lupus familiaris,,9615.0,N,,1,,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to dog,,BAO_0000218,13465,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626767,,11570,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat,,BAO_0000218,13465,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626768,,11571,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat; No levels,,BAO_0000218,13465,
In vivo,,A,,Intermediate,1,,50588,CHEMBL626769,,11572,Canis lupus familiaris,,9615.0,N,,1,,Pharmacokinetic parameter Cmax determined after peroral administration of 15 mg/kg to dog,,BAO_0000218,13465,
In vivo,,A,,Intermediate,1,,50588,CHEMBL874463,,11573,Canis lupus familiaris,,9615.0,N,,1,,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to dog,,BAO_0000218,13465,
In vivo,,A,,Autocuration,0,,22224,CHEMBL626770,,11574,Simiiformes,,314293.0,U,,1,,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey,,BAO_0000218,13465,
In vivo,,A,,Autocuration,0,,22224,CHEMBL626771,,11575,Simiiformes,,314293.0,U,,1,,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey; No levels,,BAO_0000218,13465,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626772,,11576,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic parameter Cmax determined after peroral administration of 50 mg/kg to rat,,BAO_0000218,13465,
In vivo,,A,,Intermediate,1,,100710,CHEMBL626773,,11577,Macaca fascicularis,,9541.0,N,,1,,Pharmacokinetic parameter Cmax for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,,BAO_0000218,14731,
In vivo,,A,,Intermediate,1,,50594,CHEMBL626774,,11578,Mus musculus,,10090.0,N,,1,,Pharmacokinetic parameter Cmax for the compound was evaluated in nude mice after oral administration. ,,BAO_0000218,14731,
In vivo,,A,,Intermediate,1,,50588,CHEMBL626775,,11579,Canis lupus familiaris,,9615.0,N,,1,,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 375 mg/kg,,BAO_0000218,13376,
In vivo,,A,,Intermediate,1,,50588,CHEMBL626776,,11580,Canis lupus familiaris,,9615.0,N,,1,,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 500 mg/kg,,BAO_0000218,13376,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626777,,11581,Rattus norvegicus,,10116.0,N,,1,,Maximum concentration (Cmax) in rat when administered orally,,BAO_0000218,14443,
In vivo,,A,,Autocuration,0,,22224,CHEMBL626778,1969.0,11582,Simiiformes,,314293.0,U,Plasma,1,,Maximal concentration in monkey plasma after 25 mg/kg oral dose,,BAO_0000218,13465,
In vivo,,A,,Autocuration,0,,22224,CHEMBL626779,,11583,Rattus norvegicus,,10116.0,U,,1,,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.17-0.20)",,BAO_0000218,16359,
In vivo,,A,,Autocuration,0,,22224,CHEMBL626780,,11584,Rattus norvegicus,,10116.0,U,,1,,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.4-0.8)",,BAO_0000218,16359,
In vivo,,A,,Autocuration,0,,22224,CHEMBL626781,1969.0,11585,,,,U,Plasma,1,,Cmax in rat plasma after single 5 mg/kg oral cassette gavage dose,,BAO_0000218,15618,
In vivo,,A,,Intermediate,1,,50597,CHEMBL632164,,11586,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic profile Cmax was evaluated in rats,,BAO_0000218,14554,
In vivo,,A,,Intermediate,1,,50588,CHEMBL632165,,11587,Canis lupus familiaris,,9615.0,N,,1,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in dog (25 mg/kg),,BAO_0000218,11537,
In vivo,,A,,Intermediate,1,,50594,CHEMBL632166,,11588,Mus musculus,,10090.0,N,,1,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in mice (50 mg/kg),,BAO_0000218,11537,
In vivo,,A,,Intermediate,1,,50588,CHEMBL632167,,11589,Canis lupus familiaris,,9615.0,N,,1,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to dog (25 mg/kg),,BAO_0000218,11537,
In vivo,,A,,Intermediate,1,,50594,CHEMBL632168,,11590,Mus musculus,,10090.0,N,,1,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to mice (50 mg/kg),,BAO_0000218,11537,
In vivo,,A,,Autocuration,0,,22224,CHEMBL632169,1969.0,11591,Rattus norvegicus,,10116.0,U,Plasma,1,,Cmax in rat plasma,,BAO_0000218,2021,
In vivo,,A,,Intermediate,1,,50588,CHEMBL632170,1969.0,11592,Canis lupus familiaris,,9615.0,N,Plasma,1,,Cmax in dog plasma after 30mg/kg oral dose,,BAO_0000218,5932,
In vivo,,A,,Intermediate,1,,50597,CHEMBL632171,1969.0,11593,Rattus norvegicus,,10116.0,N,Plasma,1,,Cmax in rat plasma after 30mg/kg oral dose,,BAO_0000218,5932,
In vivo,,A,,Intermediate,1,,50597,CHEMBL632172,1969.0,11594,Rattus norvegicus,,10116.0,N,Plasma,1,,Plasma level in rats at 30 mg/kg,,BAO_0000218,17320,
In vivo,,A,,Intermediate,1,,50594,CHEMBL632173,1969.0,11595,Mus musculus,,10090.0,N,Plasma,1,,Tested for maximum plasma concentration in mice,,BAO_0000218,15831,
In vivo,,A,,Intermediate,1,,50597,CHEMBL632174,,11596,Rattus norvegicus,,10116.0,N,,1,,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",,BAO_0000218,15078,
In vivo,,A,,Intermediate,1,,50597,CHEMBL632175,,11597,Rattus norvegicus,,10116.0,N,,1,,The Cmax values in female wistar rats.,,BAO_0000218,14941,
In vivo,,A,,Intermediate,1,,50588,CHEMBL632176,1969.0,11598,Canis lupus familiaris,,9615.0,N,Plasma,1,,The Peak plasma concentration was measured in dogs after oral administration of 1 mg/kg dose,,BAO_0000218,15343,
In vivo,,A,,Intermediate,1,,50597,CHEMBL632177,1969.0,11599,Rattus norvegicus,,10116.0,N,Plasma,1,,The Peak plasma concentration was measured in rats after oral administration of 1 mg/kg dose,,BAO_0000218,15343,
In vivo,,A,,Intermediate,1,,50597,CHEMBL632178,1969.0,11600,Rattus norvegicus,,10116.0,N,Plasma,1,,The compound tested for maximum observed plasma concentration in rats and is expressed in microgram/mL.,,BAO_0000218,14856,
In vivo,,A,,Intermediate,1,,50597,CHEMBL632179,,11601,Rattus norvegicus,,10116.0,N,,1,,The compound was tested for Cmax value pharmacokinetic parameter in the male Sprague-Dawley rat.,,BAO_0000218,13129,
In vivo,,A,,Intermediate,1,,50597,CHEMBL632180,178.0,11602,Rattus norvegicus,,10116.0,N,Blood,1,,The compound was tested for maximum blood level reached in rats at 15.9 uM/kg after peroral administration.,,BAO_0000218,13098,
In vivo,,A,,Intermediate,1,,50597,CHEMBL632181,178.0,11603,Rattus norvegicus,,10116.0,N,Blood,1,,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after intravenous administration.,,BAO_0000218,13098,
In vivo,,A,,Intermediate,1,,50597,CHEMBL632182,178.0,11604,Rattus norvegicus,,10116.0,N,Blood,1,,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after peroral administration.,,BAO_0000218,13098,
In vivo,,A,,Autocuration,0,,22224,CHEMBL632183,178.0,11605,Mus musculus,,10090.0,U,Blood,1,,The maximum concentration observed (Cmax) in the blood sample at indicated time point (tmax) at a dose 50 mg/Kg administered orally in mice.,,BAO_0000218,15478,
In vivo,,A,,Intermediate,1,,50588,CHEMBL632184,,11606,Canis lupus familiaris,,9615.0,N,,1,,The maximum concentration of the compound was measured in dog at dose 5 mg/kg after peroral administration.,,BAO_0000218,15341,
In vivo,,A,,Intermediate,1,,50597,CHEMBL874470,,11607,Rattus norvegicus,,10116.0,N,,1,,The maximum concentration of the compound was measured in rat at dose 1 mg/kg after peroral administration.,,BAO_0000218,15341,
,,A,,Intermediate,1,,50597,CHEMBL631302,,11608,Rattus norvegicus,,10116.0,N,,1,,"Distribution in rat skin 15 min after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL631303,,11609,Rattus norvegicus,,10116.0,N,,1,,"Distribution in rat skin 1 hr after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL631304,,11610,Rattus norvegicus,,10116.0,N,,1,,"Distribution in rat skin 2 hr after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL631305,,11611,Rattus norvegicus,,10116.0,N,,1,,"Distribution in rat skin 30 min after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL631306,,11612,Rattus norvegicus,,10116.0,N,,1,,"Distribution in rat skin 4 hr after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL631307,,11613,Rattus norvegicus,,10116.0,N,,1,,"Distribution in rat skin 5 min after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL631308,,11614,Rattus norvegicus,,10116.0,N,,1,,"Distribution in rat skin 6 hr after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL625557,,11615,Rattus norvegicus,,10116.0,N,,1,,"Distribution in rat skin 8 hr after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL625558,2106.0,11616,Rattus norvegicus,,10116.0,N,Spleen,1,,"Distribution in rat spleen 15 min after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL625559,2106.0,11617,Rattus norvegicus,,10116.0,N,Spleen,1,,"Distribution in rat spleen 1 hr after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL625560,2106.0,11618,Rattus norvegicus,,10116.0,N,Spleen,1,,"Distribution in rat spleen 2 hr after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL625561,2106.0,11619,Rattus norvegicus,,10116.0,N,Spleen,1,,"Distribution in rat spleen 30 min after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL625562,2106.0,11620,Rattus norvegicus,,10116.0,N,Spleen,1,,"Distribution in rat spleen 4 hr after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL875320,2106.0,11621,Rattus norvegicus,,10116.0,N,Spleen,1,,"Distribution in rat spleen 5 min after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL625563,2106.0,11622,Rattus norvegicus,,10116.0,N,Spleen,1,,"Distribution in rat spleen 6 hr after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL625564,2106.0,11623,Rattus norvegicus,,10116.0,N,Spleen,1,,"Distribution in rat spleen 8 hr after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL625565,995.0,11624,Rattus norvegicus,,10116.0,N,Uterus,1,,"Distribution in rat uterus 15 min after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL625566,995.0,11625,Rattus norvegicus,,10116.0,N,Uterus,1,,"Distribution in rat uterus 1 hr after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL625567,995.0,11626,Rattus norvegicus,,10116.0,N,Uterus,1,,"Distribution in rat uterus 2 hr after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL625568,995.0,11627,Rattus norvegicus,,10116.0,N,Uterus,1,,"Distribution in rat uterus 30 min after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL628217,995.0,11628,Rattus norvegicus,,10116.0,N,Uterus,1,,"Distribution in rat uterus 4 hr after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL628218,995.0,11629,Rattus norvegicus,,10116.0,N,Uterus,1,,"Distribution in rat uterus 5 min after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL628219,995.0,11630,Rattus norvegicus,,10116.0,N,Uterus,1,,"Distribution in rat uterus 6 hr after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Intermediate,1,,50597,CHEMBL628220,995.0,11631,Rattus norvegicus,,10116.0,N,Uterus,1,,"Distribution in rat uterus 8 hr after intravenous administration, injected dose/gm",,BAO_0000218,8684,
,,A,,Autocuration,0,,22224,CHEMBL628221,,11632,,,,U,,1,,Distribution in the blood after 120 min of intravenous administration,,BAO_0000019,8926,
,,A,,Autocuration,0,,22224,CHEMBL628222,,11633,,,,U,,1,,Distribution in the blood after 15 min of intravenous administration,,BAO_0000019,8926,
,,A,,Autocuration,0,,22224,CHEMBL628223,,11634,,,,U,,1,,Distribution in the blood after 30 min of intravenous administration,,BAO_0000019,8926,
,,A,,Autocuration,0,,22224,CHEMBL628224,,11635,,,,U,,1,,Distribution in the blood after 5 min of intravenous administration,,BAO_0000019,8926,
,,A,,Autocuration,0,,22224,CHEMBL628225,,11636,,,,U,,1,,Distribution in the blood after 60 min of intravenous administration,,BAO_0000019,8926,
,,A,,Autocuration,0,,22224,CHEMBL628226,,11637,,,,U,,1,,Distribution in the blood after 90 min of intravenous administration,,BAO_0000019,8926,
,,A,,Autocuration,0,,22224,CHEMBL628227,,11638,,,,U,,1,,Distribution in the bone after 120 min of intravenous administration,,BAO_0000019,8926,
,,A,,Autocuration,0,,22224,CHEMBL875481,,11639,,,,U,,1,,Distribution in the bone after 15 min of intravenous administration,,BAO_0000019,8926,
,,A,,Autocuration,0,,22224,CHEMBL628228,,11640,,,,U,,1,,Distribution in the bone after 30 min of intravenous administration,,BAO_0000019,8926,
,,A,,Autocuration,0,,22224,CHEMBL628229,,11641,,,,U,,1,,Distribution in the bone after 5 min of intravenous administration,,BAO_0000019,8926,
,,A,,Autocuration,0,,22224,CHEMBL628230,,11642,,,,U,,1,,Distribution in the bone after 60 min of intravenous administration,,BAO_0000019,8926,
,,A,,Autocuration,0,,22224,CHEMBL628231,,11643,,,,U,,1,,Distribution in the bone after 90 min of intravenous administration,,BAO_0000019,8926,
,,A,,Autocuration,0,,22224,CHEMBL628232,,11644,,,,U,,1,,Distribution in the heart after 120 min of intravenous administration,,BAO_0000019,8926,
,,A,,Autocuration,0,,22224,CHEMBL628233,,11645,,,,U,,1,,Distribution in the heart after 15 min of intravenous administration,,BAO_0000019,8926,
,,A,,Autocuration,0,,22224,CHEMBL628234,,11646,,,,U,,1,,Distribution in the heart after 30 min of intravenous administration,,BAO_0000019,8926,
,,A,,Autocuration,0,,22224,CHEMBL628235,,11647,,,,U,,1,,Distribution in the heart after 5 min of intravenous administration,,BAO_0000019,8926,
,,A,,Autocuration,0,,22224,CHEMBL628236,,11648,,,,U,,1,,Distribution in the heart after 60 min of intravenous administration,,BAO_0000019,8926,
,,A,,Autocuration,0,,22224,CHEMBL628237,,11649,,,,U,,1,,Distribution in the heart after 90 min of intravenous administration,,BAO_0000019,8926,
,,A,,Autocuration,0,,22224,CHEMBL628238,,11650,,,,U,,1,,Distribution in the kidneys after 120 min of intravenous administration,,BAO_0000019,8926,
,,A,,Autocuration,0,,22224,CHEMBL628239,,11651,,,,U,,1,,Distribution in the kidneys after 15 min of intravenous administration,,BAO_0000019,8926,
,,A,,Autocuration,0,,22224,CHEMBL628240,,11652,,,,U,,1,,Distribution in the kidneys after 30 min of intravenous administration,,BAO_0000019,8926,
,,A,,Autocuration,0,,22224,CHEMBL628241,,11653,,,,U,,1,,Distribution in the kidneys after 5 min of intravenous administration,,BAO_0000019,8926,
,,A,,Autocuration,0,,22224,CHEMBL628242,,11654,,,,U,,1,,Distribution in the kidneys after 60 min of intravenous administration,,BAO_0000019,8926,
,,A,,Autocuration,0,,22224,CHEMBL875482,,11655,,,,U,,1,,Distribution in the kidneys after 90 min of intravenous administration,,BAO_0000019,8926,
,,A,,Autocuration,0,,22224,CHEMBL628243,,11656,,,,U,,1,,Distribution in the liver after 120 min of intravenous administration,,BAO_0000019,8926,
,,A,,Autocuration,0,,22224,CHEMBL628244,,11657,,,,U,,1,,Distribution in the liver after 15 min of intravenous administration,,BAO_0000019,8926,
,,A,,Autocuration,0,,22224,CHEMBL628245,,11658,,,,U,,1,,Distribution in the liver after 30 min of intravenous administration,,BAO_0000019,8926,
,,A,,Autocuration,0,,22224,CHEMBL628246,,11659,,,,U,,1,,Distribution in the liver after 5 min of intravenous administration,,BAO_0000019,8926,
,,A,,Autocuration,0,,22224,CHEMBL628247,,11660,,,,U,,1,,Distribution in the liver after 60 min of intravenous administration,,BAO_0000019,8926,
,,A,,Autocuration,0,,22224,CHEMBL628248,,11661,,,,U,,1,,Distribution in the liver after 90 min of intravenous administration,,BAO_0000019,8926,
,,A,,Autocuration,0,,22224,CHEMBL628249,,11662,,,,U,,1,,Distribution in the lung after 120 min of intravenous administration,,BAO_0000019,8926,
,,A,,Intermediate,1,,50594,CHEMBL625452,,11663,Mus musculus,,10090.0,N,,1,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, iv and the total drug exposure was determined. (0-24hr)",,BAO_0000218,14839,
,,A,,Intermediate,1,,50594,CHEMBL625453,,11664,Mus musculus,,10090.0,N,,1,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, perorally and the total drug exposure was determined (0-24hr)",,BAO_0000218,14839,
,,A,,Intermediate,1,,50594,CHEMBL625454,,11665,Mus musculus,,10090.0,N,,1,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, iv and the total drug exposure was determined. (0-24hr)",,BAO_0000218,14839,
,,A,,Intermediate,1,,50594,CHEMBL623844,,11666,Mus musculus,,10090.0,N,,1,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, perorally and the total drug exposure was determined (0-24hr)",,BAO_0000218,14839,
,,A,,Intermediate,1,,50597,CHEMBL623845,,11667,Rattus norvegicus,,10116.0,N,,1,,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 1 mg/kg (normalized to a 1 mg/kg dose) in rat,,BAO_0000218,12178,
,,A,,Intermediate,1,,50597,CHEMBL623846,,11668,Rattus norvegicus,,10116.0,N,,1,,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 2.5 mg/kg (normalized to a 1 mg/kg dose) in rat,,BAO_0000218,12178,
,,A,,Autocuration,0,,22224,CHEMBL623847,,11669,,,,U,,1,,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 5.0 mg/kg (normalized to a 1 mg/kg dose) GP,,BAO_0000218,12178,
,,A,,Intermediate,1,,100710,CHEMBL623848,,11670,Macaca fascicularis,,9541.0,N,,1,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,,BAO_0000218,12186,
,,A,,Intermediate,1,,100710,CHEMBL623849,,11671,Macaca fascicularis,,9541.0,N,,1,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,,BAO_0000218,12186,
,,A,,Intermediate,1,,100710,CHEMBL623850,,11672,Macaca fascicularis,,9541.0,N,,1,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,,BAO_0000218,12186,
,,A,,Intermediate,1,,100710,CHEMBL623851,,11673,Macaca fascicularis,,9541.0,N,,1,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,,BAO_0000218,12186,
,,A,,Autocuration,0,,22224,CHEMBL623852,,11674,Simiiformes,,314293.0,U,,1,,Integrated area under the plasma drug level-time curve was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,,BAO_0000218,12187,
,,A,,Intermediate,1,,50506,CHEMBL624551,,11675,Mustela putorius furo,,9669.0,N,,1,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,,BAO_0000218,12187,
,,A,,Intermediate,1,,50506,CHEMBL624552,,11676,Mustela putorius furo,,9669.0,N,,1,,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",,BAO_0000218,12187,
,,A,,Autocuration,0,,22224,CHEMBL624553,,11677,Simiiformes,,314293.0,U,,1,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,,BAO_0000218,12187,
,,A,,Autocuration,0,,22224,CHEMBL624554,,11678,Simiiformes,,314293.0,U,,1,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey determined by renin inhibition assay,,BAO_0000218,12187,
,,A,,Intermediate,1,,50597,CHEMBL624555,,11679,Rattus norvegicus,,10116.0,N,,1,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,,BAO_0000218,12187,
,,A,,Intermediate,1,,50597,CHEMBL624741,,11680,Rattus norvegicus,,10116.0,N,,1,,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",,BAO_0000218,12187,
,,A,,Intermediate,1,,50588,CHEMBL624742,,11681,Canis lupus familiaris,,9615.0,N,,1,,"Intravenous integrated area under the concentration vs time curve, for compound in dog plasma",,BAO_0000218,14122,
,,A,,Intermediate,1,,100712,CHEMBL624743,,11682,Cricetinae,,10026.0,N,,1,,"Intravenous integrated area under the concentration vs time curve, for compound in hamster plasma",,BAO_0000218,14122,
,,A,,Intermediate,1,,50597,CHEMBL877606,,11683,Rattus norvegicus,,10116.0,N,,1,,"Intravenous integrated area under the concentration vs time curve, for compound in rat plasma",,BAO_0000218,14122,
,,A,,Autocuration,0,,22224,CHEMBL624744,,11684,,,,U,,1,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg,,BAO_0000218,13391,
,,A,,Autocuration,0,,22224,CHEMBL624745,178.0,11685,,,,U,Blood,1,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,,BAO_0000218,13391,
,,A,,Autocuration,0,,22224,CHEMBL624746,178.0,11686,,,,U,Blood,1,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,,BAO_0000218,13391,
,,A,,Autocuration,0,,22224,CHEMBL624747,178.0,11687,,,,U,Blood,1,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,,BAO_0000218,13391,
,,A,,Autocuration,0,,22224,CHEMBL624748,,11688,,,,U,,1,,Oral absorption expressed as Area under curve was determined,,BAO_0000019,16360,
,,A,,Intermediate,1,,50588,CHEMBL622504,,11689,Canis lupus familiaris,,9615.0,N,,1,,Oral absorption kinetics (AUC) was determined after administration of compound orally at 1 mg/kg in dogs,,BAO_0000218,3673,
,,A,,Intermediate,1,,50588,CHEMBL622505,,11690,Canis lupus familiaris,,9615.0,N,,1,,"Oral integrated area under the concentration vs time curve, for compound in dog plasma",,BAO_0000218,14122,
,,A,,Intermediate,1,,100712,CHEMBL622506,,11691,Cricetinae,,10026.0,N,,1,,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",,BAO_0000218,14122,
,,A,,Intermediate,1,,100712,CHEMBL622507,,11692,Cricetinae,,10026.0,N,,1,,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",,BAO_0000218,14122,
,,A,,Intermediate,1,,50597,CHEMBL622508,,11693,Rattus norvegicus,,10116.0,N,,1,,"Oral integrated area under the concentration vs time curve, for compound in rat plasma",,BAO_0000218,14122,
,,A,,Autocuration,0,,22224,CHEMBL622509,,11694,,,,U,,1,,Pharmacokinetic parameter AUC in mice following a single dose intravenous administration of the compound,,BAO_0000019,13889,
,,A,,Intermediate,1,,50597,CHEMBL622510,,11695,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic Parameter [Area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,BAO_0000218,14393,
,,A,,Intermediate,1,,50597,CHEMBL622511,,11696,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic parameter (AUC) was determined after administering 1 mg/kg of compound intravenously in rat no.3 belonging to phenotype EM (extensive metabolizer),,BAO_0000218,17279,
,,A,,Intermediate,1,,100710,CHEMBL622512,,11697,Macaca fascicularis,,9541.0,N,,1,,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,,BAO_0000218,14548,
,,A,,Intermediate,1,,100710,CHEMBL622513,,11698,Macaca fascicularis,,9541.0,N,,1,,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,,BAO_0000218,14548,
,,A,,Intermediate,1,,100710,CHEMBL622514,,11699,Macaca fascicularis,,9541.0,N,,1,,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered po at 5 mg/kg concentration,,BAO_0000218,14548,
,,A,,Intermediate,1,,50588,CHEMBL622515,,11700,Canis lupus familiaris,,9615.0,N,,1,,Pharmacokinetic parameter AUC calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,,BAO_0000218,14548,
,,A,,Intermediate,1,,50588,CHEMBL622516,,11701,Canis lupus familiaris,,9615.0,N,,1,,Pharmacokinetic parameter AUC calculated in dog when the compound was administered po at 5 mg/kg concentration,,BAO_0000218,14548,
,,A,,Intermediate,1,,50597,CHEMBL622517,,11702,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic parameter AUC calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,,BAO_0000218,14548,
,,A,,Intermediate,1,,50597,CHEMBL622518,,11703,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 12 mg/kg concentration,,BAO_0000218,14548,
,,A,,Intermediate,1,,50597,CHEMBL622519,,11704,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 20 mg/kg concentration,,BAO_0000218,14548,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622520,2385.0,11705,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 30 min,,BAO_0000218,14608,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622521,2385.0,11706,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 60 min,,BAO_0000218,14608,
In vivo,,A,,Intermediate,1,,50594,CHEMBL625113,14.0,11707,Mus musculus,,10090.0,N,Zone of skin,1,,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 2 min,,BAO_0000218,14608,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625114,14.0,11708,Rattus norvegicus,,10116.0,N,Zone of skin,1,,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 30 min,,BAO_0000218,14608,
In vivo,,A,,Intermediate,1,,50597,CHEMBL874397,14.0,11709,Rattus norvegicus,,10116.0,N,Zone of skin,1,,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 60 min,,BAO_0000218,14608,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625115,2106.0,11710,Rattus norvegicus,,10116.0,N,Spleen,1,,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 2 min,,BAO_0000218,14608,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625116,2106.0,11711,Rattus norvegicus,,10116.0,N,Spleen,1,,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 30 min,,BAO_0000218,14608,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623932,2106.0,11712,Rattus norvegicus,,10116.0,N,Spleen,1,,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 60 min,,BAO_0000218,14608,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623933,2435.0,11713,Rattus norvegicus,,10116.0,N,Striatum,1,,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 2 min,,BAO_0000218,14608,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623934,2435.0,11714,Rattus norvegicus,,10116.0,N,Striatum,1,,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 30 min,,BAO_0000218,14608,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623935,2435.0,11715,Rattus norvegicus,,10116.0,N,Striatum,1,,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 60 min,,BAO_0000218,14608,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623936,2046.0,11716,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 2 min,,BAO_0000218,14608,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623937,2046.0,11717,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 30 min,,BAO_0000218,14608,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623938,2046.0,11718,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 60 min,,BAO_0000218,14608,
,,A,,Intermediate,1,,50594,CHEMBL623939,,11719,Mus musculus,,10090.0,N,,1,,In vivo biodistribution in mice blood bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,BAO_0000218,15383,
,,A,,Intermediate,1,,50594,CHEMBL623940,,11720,Mus musculus,,10090.0,N,,1,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 10 ug/g,,BAO_0000218,15383,
,,A,,Intermediate,1,,50594,CHEMBL623941,,11721,Mus musculus,,10090.0,N,,1,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,BAO_0000218,15383,
,,A,,Intermediate,1,,50594,CHEMBL627216,,11722,Mus musculus,,10090.0,N,,1,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,BAO_0000218,15383,
,,A,,Intermediate,1,,50594,CHEMBL623942,,11723,Mus musculus,,10090.0,N,,1,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,BAO_0000218,15383,
,,A,,Intermediate,1,,50594,CHEMBL618793,955.0,11724,Mus musculus,,10090.0,N,Brain,1,,In vivo biodistribution in mice brain bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,BAO_0000218,15383,
,,A,,Intermediate,1,,50594,CHEMBL618794,955.0,11725,Mus musculus,,10090.0,N,Brain,1,,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,BAO_0000218,15383,
,,A,,Intermediate,1,,50594,CHEMBL618795,955.0,11726,Mus musculus,,10090.0,N,Brain,1,,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,BAO_0000218,15383,
,,A,,Intermediate,1,,50594,CHEMBL618796,,11727,Mus musculus,,10090.0,N,,1,,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,BAO_0000218,15383,
,,A,,Intermediate,1,,50594,CHEMBL618797,,11728,Mus musculus,,10090.0,N,,1,,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,BAO_0000218,15383,
,,A,,Intermediate,1,,50594,CHEMBL618798,2113.0,11729,Mus musculus,,10090.0,N,Kidney,1,,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,,BAO_0000218,15383,
,,A,,Intermediate,1,,50594,CHEMBL618799,2113.0,11730,Mus musculus,,10090.0,N,Kidney,1,,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,BAO_0000218,15383,
,,A,,Intermediate,1,,50594,CHEMBL618800,2113.0,11731,Mus musculus,,10090.0,N,Kidney,1,,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 10 ug/g,,BAO_0000218,15383,
,,A,,Intermediate,1,,50594,CHEMBL618801,2113.0,11732,Mus musculus,,10090.0,N,Kidney,1,,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,BAO_0000218,15383,
,,A,,Intermediate,1,,50594,CHEMBL618802,2113.0,11733,Mus musculus,,10090.0,N,Kidney,1,,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,BAO_0000218,15383,
,,A,,Intermediate,1,,50594,CHEMBL618803,2113.0,11734,Mus musculus,,10090.0,N,Kidney,1,,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,BAO_0000218,15383,
,,A,,Intermediate,1,,50594,CHEMBL618804,2107.0,11735,Mus musculus,,10090.0,N,Liver,1,,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,,BAO_0000218,15383,
,,A,,Intermediate,1,,50594,CHEMBL618805,2107.0,11736,Mus musculus,,10090.0,N,Liver,1,,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,BAO_0000218,15383,
,,A,,Intermediate,1,,50594,CHEMBL618806,2107.0,11737,Mus musculus,,10090.0,N,Liver,1,,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 10 ug/g,,BAO_0000218,15383,
,,A,,Intermediate,1,,50594,CHEMBL618807,2107.0,11738,Mus musculus,,10090.0,N,Liver,1,,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,BAO_0000218,15383,
,,A,,Intermediate,1,,50594,CHEMBL618808,2107.0,11739,Mus musculus,,10090.0,N,Liver,1,,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,BAO_0000218,15383,
,,A,,Intermediate,1,,50594,CHEMBL618809,2107.0,11740,Mus musculus,,10090.0,N,Liver,1,,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,BAO_0000218,15383,
,,A,,Intermediate,1,,50594,CHEMBL618810,2385.0,11741,Mus musculus,,10090.0,N,Muscle tissue,1,,In vivo biodistribution in mice muscle bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,BAO_0000218,15383,
,,A,,Intermediate,1,,50594,CHEMBL618811,2385.0,11742,Mus musculus,,10090.0,N,Muscle tissue,1,,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 10 ug/g,,BAO_0000218,15383,
,,A,,Intermediate,1,,50594,CHEMBL875844,2385.0,11743,Mus musculus,,10090.0,N,Muscle tissue,1,,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,BAO_0000218,15383,
,,A,,Intermediate,1,,50594,CHEMBL618812,2385.0,11744,Mus musculus,,10090.0,N,Muscle tissue,1,,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,BAO_0000218,15383,
,,A,,Intermediate,1,,50594,CHEMBL618813,2385.0,11745,Mus musculus,,10090.0,N,Muscle tissue,1,,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,BAO_0000218,15383,
,,A,,Intermediate,1,,50594,CHEMBL618814,,11746,Mus musculus,,10090.0,N,,1,,In vivo biodistribution in mice skin bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,BAO_0000218,15383,
,,A,,Intermediate,1,,50594,CHEMBL618815,,11747,Mus musculus,,10090.0,N,,1,,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,BAO_0000218,15383,
,,A,,Intermediate,1,,50594,CHEMBL618816,,11748,Mus musculus,,10090.0,N,,1,,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,BAO_0000218,15383,
,,A,,Intermediate,1,,50594,CHEMBL618817,,11749,Mus musculus,,10090.0,N,,1,,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,BAO_0000218,15383,
,,A,,Intermediate,1,,50594,CHEMBL620544,,11750,Mus musculus,,10090.0,N,,1,,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,BAO_0000218,15383,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626230,,11751,Rattus norvegicus,,10116.0,N,,1,,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intraperitoneal administration.,,BAO_0000218,15341,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626231,,11752,Rattus norvegicus,,10116.0,N,,1,,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intravenous administration.,,BAO_0000218,15341,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626232,,11753,Rattus norvegicus,,10116.0,N,,1,,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after peroral administration.,,BAO_0000218,15341,
In vivo,,A,,Intermediate,1,,50588,CHEMBL626233,1969.0,11754,Canis lupus familiaris,,9615.0,N,Plasma,1,,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on dog.,,BAO_0000218,14906,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626234,1969.0,11755,Rattus norvegicus,,10116.0,N,Plasma,1,,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat,,BAO_0000218,14906,
In vivo,,A,,Intermediate,1,,50597,CHEMBL875341,1969.0,11756,Rattus norvegicus,,10116.0,N,Plasma,1,,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat.,,BAO_0000218,14906,
In vivo,,A,,Intermediate,1,,50587,CHEMBL626235,1969.0,11757,Homo sapiens,,9606.0,N,Plasma,1,,The maximum plasma concentration (100 mg/kg) administered orally in human,,BAO_0000218,14215,
In vivo,,A,,Autocuration,0,,22224,CHEMBL626236,1969.0,11758,Callithrix,,9481.0,U,Plasma,1,,The maximum plasma concentration (12.5 mg/kg) administered intravenously in marmoset,,BAO_0000218,14215,
In vivo,,A,,Autocuration,0,,22224,CHEMBL626237,1969.0,11759,Simiiformes,,314293.0,U,Plasma,1,,The maximum plasma concentration (12.5 mg/kg) administered intravenously in monkey,,BAO_0000218,14215,
In vivo,,A,,Intermediate,1,,50588,CHEMBL626238,1969.0,11760,Canis lupus familiaris,,9615.0,N,Plasma,1,,The maximum plasma concentration (15 mg/kg) administered intravenously in dog,,BAO_0000218,14215,
In vivo,,A,,Intermediate,1,,50587,CHEMBL622412,1969.0,11761,Homo sapiens,,9606.0,N,Plasma,1,,The maximum plasma concentration (200 mg/kg) administered orally in human,,BAO_0000218,14215,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623114,1969.0,11762,Rattus norvegicus,,10116.0,N,Plasma,1,,The maximum plasma concentration (25 mg/kg) administered intravenously in rat,,BAO_0000218,14215,
In vivo,,A,,Autocuration,0,,22224,CHEMBL623115,1969.0,11763,Callithrix,,9481.0,U,Plasma,1,,The maximum plasma concentration (25 mg/kg) administered orally in marmoset,,BAO_0000218,14215,
In vivo,,A,,Autocuration,0,,22224,CHEMBL623116,1969.0,11764,Simiiformes,,314293.0,U,Plasma,1,,The maximum plasma concentration (25 mg/kg) administered orally in monkey,,BAO_0000218,14215,
In vivo,,A,,Autocuration,0,,22224,CHEMBL623117,1969.0,11765,Canis lupus familiaris,,9615.0,U,Plasma,1,,The maximum plasma concentration (30 mg/kg) administered orally in dog,,BAO_0000218,14215,
In vivo,,A,,Intermediate,1,,50587,CHEMBL623118,1969.0,11766,Homo sapiens,,9606.0,N,Plasma,1,,The maximum plasma concentration (400 mg/kg) administered orally in human,,BAO_0000218,14215,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623119,1969.0,11767,Rattus norvegicus,,10116.0,N,Plasma,1,,The maximum plasma concentration (50 mg/kg) administered orally in fasted rat,,BAO_0000218,14215,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623120,1969.0,11768,Rattus norvegicus,,10116.0,N,Plasma,1,,The maximum plasma concentration (50 mg/kg) administered orally in rat,,BAO_0000218,14215,
In vivo,,A,,Intermediate,1,,50587,CHEMBL623286,1969.0,11769,Homo sapiens,,9606.0,N,Plasma,1,,The maximum plasma concentration (800 mg/kg) administered orally in human,,BAO_0000218,14215,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623287,1969.0,11770,Rattus norvegicus,,10116.0,N,Plasma,1,,The maximum plasma concentration was measured on rats,,BAO_0000218,14067,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623288,1969.0,11771,Rattus norvegicus,,10116.0,N,Plasma,1,,The maximum plasma concentration was measured on rats after oral administration,,BAO_0000218,12350,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623289,1969.0,11772,Rattus norvegicus,,10116.0,N,Plasma,1,,Plasma drug Cmax in rat (PO dose),,BAO_0000218,14813,
In vivo,,A,,Autocuration,0,,22224,CHEMBL623290,,11773,,,,U,,1,,Time taken to reach maximum concentration after administration of 2 umol/kg dose intravenously,,BAO_0000218,12536,
In vivo,,A,,Intermediate,1,,50588,CHEMBL623291,1969.0,11774,Canis lupus familiaris,,9615.0,N,Plasma,1,,maximum Plasma concentration in Dog was determined after Peroral administration,,BAO_0000218,14169,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623292,1969.0,11775,Rattus norvegicus,,10116.0,N,Plasma,1,,maximum Plasma concentration in Rats was determined after Peroral administration,,BAO_0000218,14169,
In vivo,,A,,Intermediate,1,,50588,CHEMBL623293,1969.0,11776,Canis lupus familiaris,,9615.0,N,Plasma,1,,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,,BAO_0000218,15604,
In vivo,,A,,Autocuration,0,,22224,CHEMBL623294,1969.0,11777,Simiiformes,,314293.0,U,Plasma,1,,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,,BAO_0000218,15604,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623295,1969.0,11778,Rattus norvegicus,,10116.0,N,Plasma,1,,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,,BAO_0000218,15604,
In vivo,,A,,Intermediate,1,,50594,CHEMBL623296,,11779,Mus musculus,,10090.0,N,,1,,maximum concentration was measured when administered through oral route in mice,,BAO_0000218,14387,
,,A,,Intermediate,1,,50594,CHEMBL875349,,11780,Mus musculus,,10090.0,N,,1,,Compound was evaluated for Cmax/Tmax when administered through oral route in mouse; Value is 0.93/1,,BAO_0000218,15115,
,,A,,Autocuration,0,,22224,CHEMBL623297,,11781,Simiiformes,,314293.0,U,,1,,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.34/1,,BAO_0000019,15115,
,,A,,Autocuration,0,,22224,CHEMBL623298,,11782,Simiiformes,,314293.0,U,,1,,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.81/1.6,,BAO_0000019,15115,
,,A,,Autocuration,0,,22224,CHEMBL623299,,11783,Simiiformes,,314293.0,U,,1,,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 1.1/1.3,,BAO_0000019,15115,
,,A,,Intermediate,1,,50597,CHEMBL623300,,11784,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic parameter was evaluated in rats,,BAO_0000218,16359,
,,A,,Intermediate,1,,50594,CHEMBL623301,,11785,Mus musculus,,10090.0,N,,1,,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,,BAO_0000218,12829,
,,A,,Intermediate,1,,50594,CHEMBL623302,,11786,Mus musculus,,10090.0,N,,1,,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with saline(pH=11.4) as vehicle,,BAO_0000218,12829,
,,A,,Intermediate,1,,50594,CHEMBL623303,,11787,Mus musculus,,10090.0,N,,1,,Plasma concentration at time-0 was measured in mice at 120 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,,BAO_0000218,12829,
,,A,,Intermediate,1,,50594,CHEMBL623304,,11788,Mus musculus,,10090.0,N,,1,,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with saline(pH=11.4) as vehicle,,BAO_0000218,12829,
,,A,,Intermediate,1,,50594,CHEMBL623305,,11789,Mus musculus,,10090.0,N,,1,,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with 90% DMSO as vehicle,,BAO_0000218,12829,
,,A,,Intermediate,1,,50597,CHEMBL623306,1969.0,11790,Rattus norvegicus,,10116.0,N,Plasma,1,,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats(Cerebral Cortex) after 30 min.,,BAO_0000218,15137,
,,A,,Intermediate,1,,50597,CHEMBL623307,1969.0,11791,Rattus norvegicus,,10116.0,N,Plasma,1,,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats(Cerebral Cortex) after 30 min.,,BAO_0000218,15137,
,,A,,Intermediate,1,,50597,CHEMBL623308,1969.0,11792,Rattus norvegicus,,10116.0,N,Plasma,1,,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats(Cerebral Cortex) after 30 min.,,BAO_0000218,15137,
,,A,,Intermediate,1,,50594,CHEMBL623309,1969.0,11793,Mus musculus,,10090.0,N,Plasma,1,,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats(Cerebral Cortex) after 30 min.,,BAO_0000218,15137,
,,A,,Intermediate,1,,50594,CHEMBL623310,,11794,Mus musculus,,10090.0,N,,1,,Plasma Concentration after 120 min of oral administration to mice,,BAO_0000218,13509,
,,A,,Intermediate,1,,50594,CHEMBL623311,,11795,Mus musculus,,10090.0,N,,1,,Plasma Concentration after 30 min of oral administration to mice,,BAO_0000218,13509,
,,A,,Intermediate,1,,100710,CHEMBL623312,,11796,Macaca fascicularis,,9541.0,N,,1,,Plasma Concentration after 60 min of oral administration to mice,,BAO_0000218,13509,
,,A,,Intermediate,1,,50594,CHEMBL875350,,11797,Mus musculus,,10090.0,N,,1,,Plasma Concentration after 60 min of oral administration to mice; Not determined,,BAO_0000218,13509,
,,A,,Intermediate,1,,50594,CHEMBL628635,,11798,Mus musculus,,10090.0,N,,1,,Plasma Concentration after 90 min of oral administration to mice,,BAO_0000218,13509,
,,A,,Intermediate,1,,50597,CHEMBL628636,,11799,Rattus norvegicus,,10116.0,N,,1,,Plasma concentration level in rat after 1 hour of oral administration at 50 mg/kg,,BAO_0000218,12064,
,,A,,Intermediate,1,,50597,CHEMBL628637,,11800,Rattus norvegicus,,10116.0,N,,1,,Plasma concentration level in rat after 15 hours of oral administration at 50 mg/kg,,BAO_0000218,12064,
,,A,,Intermediate,1,,50597,CHEMBL628058,,11801,Rattus norvegicus,,10116.0,N,,1,,Plasma concentration level in rat after 4 hours of oral administration at 50 mg/kg,,BAO_0000218,12064,
,,A,,Intermediate,1,,50597,CHEMBL628059,,11802,Rattus norvegicus,,10116.0,N,,1,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 0-1 hr time,,BAO_0000218,10677,
,,A,,Intermediate,1,,50597,CHEMBL628060,,11803,Rattus norvegicus,,10116.0,N,,1,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 1-2 hr time,,BAO_0000218,10677,
,,A,,Autocuration,0,,22224,CHEMBL628061,,11804,,,,U,,1,,Distribution in the lung after 15 min of intravenous administration,,BAO_0000019,8926,
,,A,,Autocuration,0,,22224,CHEMBL628062,,11805,,,,U,,1,,Distribution in the lung after 30 min of intravenous administration,,BAO_0000019,8926,
,,A,,Autocuration,0,,22224,CHEMBL628063,,11806,,,,U,,1,,Distribution in the lung after 5 min of intravenous administration,,BAO_0000019,8926,
,,A,,Autocuration,0,,22224,CHEMBL628064,,11807,,,,U,,1,,Distribution in the lung after 60 min of intravenous administration,,BAO_0000019,8926,
,,A,,Autocuration,0,,22224,CHEMBL628065,,11808,,,,U,,1,,Distribution in the lung after 90 min of intravenous administration,,BAO_0000019,8926,
,,A,,Autocuration,0,,22224,CHEMBL628066,2385.0,11809,,,,U,Muscle tissue,1,,Distribution in the muscle after 120 min of intravenous administration,,BAO_0000019,8926,
,,A,,Autocuration,0,,22224,CHEMBL628067,2385.0,11810,,,,U,Muscle tissue,1,,Distribution in the muscle after 15 min of intravenous administration,,BAO_0000019,8926,
,,A,,Intermediate,1,,50594,CHEMBL874646,2385.0,11811,Mus musculus,,10090.0,N,Muscle tissue,1,,Distribution in the muscle after 30 min of intravenous administration,,BAO_0000218,8926,
,,A,,Autocuration,0,,22224,CHEMBL628068,2385.0,11812,,,,U,Muscle tissue,1,,Distribution in the muscle after 5 min of intravenous administration,,BAO_0000019,8926,
,,A,,Autocuration,0,,22224,CHEMBL628069,2385.0,11813,,,,U,Muscle tissue,1,,Distribution in the muscle after 60 min of intravenous administration,,BAO_0000019,8926,
,,A,,Autocuration,0,,22224,CHEMBL628070,2385.0,11814,,,,U,Muscle tissue,1,,Distribution in the muscle after 90 min of intravenous administration,,BAO_0000019,8926,
,,A,,Autocuration,0,,22224,CHEMBL628071,2106.0,11815,,,,U,Spleen,1,,Distribution in the spleen after 120 min of intravenous administration,,BAO_0000019,8926,
,,A,,Autocuration,0,,22224,CHEMBL628072,2106.0,11816,,,,U,Spleen,1,,Distribution in the spleen after 15 min of intravenous administration,,BAO_0000019,8926,
,,A,,Autocuration,0,,22224,CHEMBL628073,2106.0,11817,,,,U,Spleen,1,,Distribution in the spleen after 30 min of intravenous administration,,BAO_0000019,8926,
,,A,,Autocuration,0,,22224,CHEMBL628074,2106.0,11818,,,,U,Spleen,1,,Distribution in the spleen after 5 min of intravenous administration,,BAO_0000019,8926,
,,A,,Autocuration,0,,22224,CHEMBL628075,2106.0,11819,,,,U,Spleen,1,,Distribution in the spleen after 60 min of intravenous administration,,BAO_0000019,8926,
,,A,,Autocuration,0,,22224,CHEMBL628076,2106.0,11820,,,,U,Spleen,1,,Distribution in the spleen after 90 min of intravenous administration,,BAO_0000019,8926,
,,A,,Intermediate,1,,50597,CHEMBL628077,1235.0,11821,Rattus norvegicus,,10116.0,N,Adrenal cortex,1,,Evaluated for distribution at 0.5 hr after intravenous administration in adrenal cortex of female Sprague Dawley rats,,BAO_0000218,7570,
,,A,,Intermediate,1,,50597,CHEMBL628078,178.0,11822,Rattus norvegicus,,10116.0,N,Blood,1,,Evaluated for distribution at 0.5 hr after intravenous administration in blood of female Sprague Dawley rats,,BAO_0000218,7570,
,,A,,Intermediate,1,,50597,CHEMBL628079,2107.0,11823,Rattus norvegicus,,10116.0,N,Liver,1,,Evaluated for distribution at 0.5 hr after intravenous administration in liver of female Sprague Dawley rats,,BAO_0000218,7570,
,,A,,Intermediate,1,,50597,CHEMBL628080,992.0,11824,Rattus norvegicus,,10116.0,N,Female gonad,1,,Evaluated for distribution at 0.5 hr after intravenous administration in ovary of female Sprague Dawley rats,,BAO_0000218,7570,
,,A,,Intermediate,1,,50597,CHEMBL628081,2046.0,11825,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,Evaluated for distribution at 0.5 hr after intravenous administration in thyroid of female Sprague Dawley rats,,BAO_0000218,7570,
,,A,,Intermediate,1,,50597,CHEMBL628082,1235.0,11826,Rattus norvegicus,,10116.0,N,Adrenal cortex,1,,Evaluated for distribution at 24 hours after intravenous administration in adrenal cortex of female Sprague Dawley rats,,BAO_0000218,7570,
,,A,,Intermediate,1,,50597,CHEMBL874647,178.0,11827,Rattus norvegicus,,10116.0,N,Blood,1,,Evaluated for distribution at 24 hours after intravenous administration in blood of female Sprague Dawley rats,,BAO_0000218,7570,
,,A,,Intermediate,1,,50597,CHEMBL626406,2107.0,11828,Rattus norvegicus,,10116.0,N,Liver,1,,Evaluated for distribution at 24 hours after intravenous administration in liver of female Sprague Dawley rats,,BAO_0000218,7570,
,,A,,Intermediate,1,,50597,CHEMBL626407,992.0,11829,Rattus norvegicus,,10116.0,N,Female gonad,1,,Evaluated for distribution at 24 hours after intravenous administration in ovary of female Sprague Dawley rats,,BAO_0000218,7570,
,,A,,Intermediate,1,,50597,CHEMBL626408,2046.0,11830,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,Evaluated for distribution at 24 hours after intravenous administration in thyroid of female Sprague Dawley rats,,BAO_0000218,7570,
,,A,,Intermediate,1,,50597,CHEMBL626409,178.0,11831,Rattus norvegicus,,10116.0,N,Blood,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.07-0.09",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL626410,178.0,11832,Rattus norvegicus,,10116.0,N,Blood,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.10-0.13",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL626411,178.0,11833,Rattus norvegicus,,10116.0,N,Blood,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.18-0.24",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL626412,178.0,11834,Rattus norvegicus,,10116.0,N,Blood,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.19-0.24",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL626413,178.0,11835,Rattus norvegicus,,10116.0,N,Blood,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.22-0.32",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL626414,178.0,11836,Rattus norvegicus,,10116.0,N,Blood,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.25-0.32",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL626415,178.0,11837,Rattus norvegicus,,10116.0,N,Blood,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.10-0.14",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL626416,178.0,11838,Rattus norvegicus,,10116.0,N,Blood,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.25-0.34",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL627062,178.0,11839,Rattus norvegicus,,10116.0,N,Blood,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.27-0.33",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL627063,178.0,11840,Rattus norvegicus,,10116.0,N,Blood,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.32-0.46",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL627064,178.0,11841,Rattus norvegicus,,10116.0,N,Blood,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.40-0.45",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL627227,178.0,11842,Rattus norvegicus,,10116.0,N,Blood,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.44-0.52",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL627228,178.0,11843,Rattus norvegicus,,10116.0,N,Blood,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.08-0.09",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL627229,178.0,11844,Rattus norvegicus,,10116.0,N,Blood,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.12-0.14",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL625792,178.0,11845,Rattus norvegicus,,10116.0,N,Blood,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.13-0.15",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL625793,178.0,11846,Rattus norvegicus,,10116.0,N,Blood,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.20",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL625794,178.0,11847,Rattus norvegicus,,10116.0,N,Blood,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.23",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL625795,178.0,11848,Rattus norvegicus,,10116.0,N,Blood,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.16-0.21",,BAO_0000218,8608,
,,A,,Intermediate,1,,50594,CHEMBL625796,,11849,Mus musculus,,10090.0,N,,1,,Pharmacokinetic parameter AUC for the compound after intravenous administration into BALB/c Mice in plasma samples.,,BAO_0000218,13792,
,,A,,Intermediate,1,,50588,CHEMBL625797,,11850,Canis lupus familiaris,,9615.0,N,,1,,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 375 mg/kg,,BAO_0000218,13376,
,,A,,Intermediate,1,,50588,CHEMBL625798,,11851,Canis lupus familiaris,,9615.0,N,,1,,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 500 mg/kg,,BAO_0000218,13376,
,,A,,Autocuration,0,,22224,CHEMBL875613,,11852,,,,U,,1,,Pharmacokinetic parameter AUC evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,BAO_0000218,14380,
,,A,,Autocuration,0,,22224,CHEMBL625799,,11853,,,,U,,1,,Pharmacokinetic parameter AUC was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,BAO_0000218,14380,
,,A,,Autocuration,0,,22224,CHEMBL625800,,11854,,,,U,,1,,Pharmacokinetic parameter AUC was evaluated in 10% PEG suspension at a dose of 20 mg/kg orally,,BAO_0000218,14380,
,,A,,Autocuration,0,,22224,CHEMBL625801,,11855,,,,U,,1,,Pharmacokinetic parameter AUC was evaluated in 100% PEG solution at a dose of 20 mg/kg orally,,BAO_0000218,14380,
,,A,,Autocuration,0,,22224,CHEMBL625802,,11856,,,,U,,1,,Pharmacokinetic parameter AUC was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,,BAO_0000218,14380,
,,A,,Autocuration,0,,22224,CHEMBL625803,,11857,,,,U,,1,,Pharmacokinetic parameter AUC was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,,BAO_0000218,14380,
,,A,,Autocuration,0,,22224,CHEMBL625804,,11858,,,,U,,1,,Pharmacokinetic parameter AUC was evaluated in Hp-beta-CD solution,,BAO_0000019,14380,
,,A,,Autocuration,0,,22224,CHEMBL622530,,11859,,,,U,,1,,Pharmacokinetic parameter AUC was evaluated in saline solution at a dose of 20 mg/kg orally,,BAO_0000218,14380,
,,A,,Intermediate,1,,50594,CHEMBL622531,,11860,Mus musculus,,10090.0,N,,1,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h); not detected,,BAO_0000218,13701,
,,A,,Intermediate,1,,50594,CHEMBL622532,,11861,Mus musculus,,10090.0,N,,1,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),,BAO_0000218,13701,
,,A,,Intermediate,1,,50594,CHEMBL623176,,11862,Mus musculus,,10090.0,N,,1,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),,BAO_0000218,13701,
,,A,,Intermediate,1,,50594,CHEMBL623177,,11863,Mus musculus,,10090.0,N,,1,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),,BAO_0000218,13701,
,,A,,Intermediate,1,,50594,CHEMBL623178,,11864,Mus musculus,,10090.0,N,,1,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),,BAO_0000218,13701,
,,A,,Intermediate,1,,50594,CHEMBL623179,,11865,Mus musculus,,10090.0,N,,1,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration using FMAddA as substrate in mice brain; AUC 0-r (mM.h); not detected,,BAO_0000218,13701,
,,A,,Intermediate,1,,50594,CHEMBL623180,,11866,Mus musculus,,10090.0,N,,1,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),,BAO_0000218,13701,
,,A,,Intermediate,1,,50594,CHEMBL623181,,11867,Mus musculus,,10090.0,N,,1,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),,BAO_0000218,13701,
,,A,,Intermediate,1,,50594,CHEMBL624131,,11868,Mus musculus,,10090.0,N,,1,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),,BAO_0000218,13701,
,,A,,Intermediate,1,,50594,CHEMBL624132,,11869,Mus musculus,,10090.0,N,,1,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration using 2`-F-ara-ddI as substrate in mice serum; AUC (mM.h),,BAO_0000218,13701,
,,A,,Intermediate,1,,50594,CHEMBL624133,,11870,Mus musculus,,10090.0,N,,1,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),,BAO_0000218,13701,
,,A,,Intermediate,1,,50594,CHEMBL624846,,11871,Mus musculus,,10090.0,N,,1,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h).,,BAO_0000218,13701,
,,A,,Intermediate,1,,50594,CHEMBL624847,,11872,Mus musculus,,10090.0,N,,1,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),,BAO_0000218,13701,
,,A,,Intermediate,1,,50594,CHEMBL624848,,11873,Mus musculus,,10090.0,N,,1,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),,BAO_0000218,13701,
,,A,,Intermediate,1,,50594,CHEMBL625012,,11874,Mus musculus,,10090.0,N,,1,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),,BAO_0000218,13701,
,,A,,Intermediate,1,,50594,CHEMBL625013,,11875,Mus musculus,,10090.0,N,,1,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),,BAO_0000218,13701,
,,A,,Intermediate,1,,50594,CHEMBL625014,,11876,Mus musculus,,10090.0,N,,1,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain; AUC 0-r (mM.h); not detected,,BAO_0000218,13701,
,,A,,Intermediate,1,,50594,CHEMBL625015,,11877,Mus musculus,,10090.0,N,,1,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC (mM.h),,BAO_0000218,13701,
,,A,,Intermediate,1,,50594,CHEMBL625016,,11878,Mus musculus,,10090.0,N,,1,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),,BAO_0000218,13701,
,,A,,Intermediate,1,,50594,CHEMBL625017,,11879,Mus musculus,,10090.0,N,,1,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral in mice brain; AUC (mM.h); not detected,,BAO_0000218,13701,
,,A,,Intermediate,1,,50594,CHEMBL625018,,11880,Mus musculus,,10090.0,N,,1,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),,BAO_0000218,13701,
,,A,,Intermediate,1,,50594,CHEMBL625019,,11881,Mus musculus,,10090.0,N,,1,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration mice serum.; AUC 0-r (mM.h),,BAO_0000218,13701,
,,A,,Intermediate,1,,50594,CHEMBL625020,,11882,Mus musculus,,10090.0,N,,1,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain.; AUC 0-r (mM.h),,BAO_0000218,13701,
,,A,,Intermediate,1,,50594,CHEMBL625021,,11883,Mus musculus,,10090.0,N,,1,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum.,,BAO_0000218,13701,
,,A,,Intermediate,1,,50597,CHEMBL625022,,11884,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic parameter [area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,BAO_0000218,14393,
,,A,,Intermediate,1,,50594,CHEMBL625023,,11885,Mus musculus,,10090.0,N,,1,,Pharmacokinetic parameter area under the curve (0-24 hr) for the compound was evaluated in nude mice after oral administration. ,,BAO_0000218,14731,
,,A,,Intermediate,1,,100710,CHEMBL625024,,11886,Macaca fascicularis,,9541.0,N,,1,,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration,,BAO_0000218,14731,
,,A,,Intermediate,1,,100710,CHEMBL627626,,11887,Macaca fascicularis,,9541.0,N,,1,,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,,BAO_0000218,14731,
,,A,,Autocuration,0,,22224,CHEMBL627627,955.0,11888,,,,U,Brain,1,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,,BAO_0000218,13758,
,,A,,Autocuration,0,,22224,CHEMBL627628,1977.0,11889,,,,U,Serum,1,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in serum,,BAO_0000218,13758,
,,A,,Autocuration,0,,22224,CHEMBL627629,955.0,11890,,,,U,Brain,1,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,,BAO_0000218,13758,
,,A,,Autocuration,0,,22224,CHEMBL627630,1977.0,11891,,,,U,Serum,1,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in serum,,BAO_0000218,13758,
,,A,,Autocuration,0,,22224,CHEMBL627631,,11892,,,,U,,1,,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/Kg orally; range (0.19-0.35),,BAO_0000019,16359,
,,A,,Autocuration,0,,22224,CHEMBL629515,,11893,,,,U,,1,,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/kg intravenously; range (2.1-2.3),,BAO_0000218,16359,
,,A,,Intermediate,1,,50594,CHEMBL629516,2106.0,11894,Mus musculus,,10090.0,N,Spleen,1,,In vivo biodistribution in mice spleen bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,BAO_0000218,15383,
,,A,,Intermediate,1,,50594,CHEMBL629517,2106.0,11895,Mus musculus,,10090.0,N,Spleen,1,,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,BAO_0000218,15383,
,,A,,Intermediate,1,,50594,CHEMBL629518,2106.0,11896,Mus musculus,,10090.0,N,Spleen,1,,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,BAO_0000218,15383,
,,A,,Intermediate,1,,50594,CHEMBL877499,,11897,Mus musculus,,10090.0,N,,1,,In vivo biodistribution in mice tumor bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,BAO_0000218,15383,
,,A,,Intermediate,1,,50594,CHEMBL629519,,11898,Mus musculus,,10090.0,N,,1,,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,BAO_0000218,15383,
,,A,,Intermediate,1,,50594,CHEMBL629520,,11899,Mus musculus,,10090.0,N,,1,,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,BAO_0000218,15383,
,,A,,Intermediate,1,,50594,CHEMBL629521,,11900,Mus musculus,,10090.0,N,,1,,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,BAO_0000218,15383,
,,A,,Intermediate,1,,50594,CHEMBL629522,,11901,Mus musculus,,10090.0,N,,1,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Blood (B),,BAO_0000218,14439,
,,A,,Intermediate,1,,50594,CHEMBL629523,,11902,Mus musculus,,10090.0,N,,1,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Lung (L),,BAO_0000218,14439,
,,A,,Intermediate,1,,50594,CHEMBL629524,,11903,Mus musculus,,10090.0,N,,1,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and Muscle (M),,BAO_0000218,14439,
,,A,,Intermediate,1,,50594,CHEMBL629525,,11904,Mus musculus,,10090.0,N,,1,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and blood (B),,BAO_0000218,14439,
,,A,,Intermediate,1,,50594,CHEMBL629526,,11905,Mus musculus,,10090.0,N,,1,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Blood (B),,BAO_0000218,14439,
,,A,,Intermediate,1,,50594,CHEMBL629527,,11906,Mus musculus,,10090.0,N,,1,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Lung (L),,BAO_0000218,14439,
,,A,,Intermediate,1,,50594,CHEMBL629528,,11907,Mus musculus,,10090.0,N,,1,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and Muscle (M),,BAO_0000218,14439,
,,A,,Intermediate,1,,50594,CHEMBL629529,,11908,Mus musculus,,10090.0,N,,1,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and blood (B),,BAO_0000218,14439,
,,A,,Intermediate,1,,50594,CHEMBL629530,,11909,Mus musculus,,10090.0,N,,1,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Blood (B),,BAO_0000218,14439,
,,A,,Intermediate,1,,50594,CHEMBL629531,,11910,Mus musculus,,10090.0,N,,1,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Lung (L),,BAO_0000218,14439,
,,A,,Intermediate,1,,50594,CHEMBL628656,,11911,Mus musculus,,10090.0,N,,1,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and Muscle (M),,BAO_0000218,14439,
,,A,,Intermediate,1,,50594,CHEMBL628657,,11912,Mus musculus,,10090.0,N,,1,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and blood (B),,BAO_0000218,14439,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628658,,11913,Rattus norvegicus,,10116.0,N,,1,,"Biodistribution in abdominal Dawley rat after 30min, expressed as percent injected dose/g",,BAO_0000218,13751,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628659,,11914,Rattus norvegicus,,10116.0,N,,1,,"Biodistribution in abdominal of mature female Dawley rat after 10min, expressed as percent injected dose/g",,BAO_0000218,13751,
In vivo,,A,,Intermediate,1,,50597,CHEMBL877500,,11915,Rattus norvegicus,,10116.0,N,,1,,"Biodistribution in abdominal of mature female Dawley rat after 15min, expressed as percent injected dose/g",,BAO_0000218,13751,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628660,,11916,Rattus norvegicus,,10116.0,N,,1,,"Biodistribution in abdominal of mature female Dawley rat after 1h, expressed as percent injected dose/g",,BAO_0000218,13751,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628661,,11917,Rattus norvegicus,,10116.0,N,,1,,"Biodistribution in abdominal of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,BAO_0000218,13751,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628662,,11918,Rattus norvegicus,,10116.0,N,,1,,"Biodistribution in abdominal of mature female Dawley rat after 30min, expressed as percent injected dose/g",,BAO_0000218,13751,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628663,,11919,Rattus norvegicus,,10116.0,N,,1,,"Biodistribution in abdominal of mature female Dawley rat after 45min, expressed as percent injected dose/g",,BAO_0000218,13751,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628664,,11920,Rattus norvegicus,,10116.0,N,,1,,"Biodistribution in abdominal of mature female Dawley rat after 5min, expressed as percent injected dose/g",,BAO_0000218,13751,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628665,178.0,11921,Rattus norvegicus,,10116.0,N,Blood,1,,"Biodistribution in blood of mature female Dawley rat after 10min, expressed as percent injected dose/g",,BAO_0000218,13751,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628666,178.0,11922,Rattus norvegicus,,10116.0,N,Blood,1,,"Biodistribution in blood of mature female Dawley rat after 15min, expressed as percent injected dose/g",,BAO_0000218,13751,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628667,178.0,11923,Rattus norvegicus,,10116.0,N,Blood,1,,"Biodistribution in blood of mature female Dawley rat after 1h, expressed as percent injected dose/g",,BAO_0000218,13751,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628668,178.0,11924,Rattus norvegicus,,10116.0,N,Blood,1,,"Biodistribution in blood of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,BAO_0000218,13751,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628669,178.0,11925,Rattus norvegicus,,10116.0,N,Blood,1,,"Biodistribution in blood of mature female Dawley rat after 30min, expressed as percent injected dose/g",,BAO_0000218,13751,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628670,178.0,11926,Rattus norvegicus,,10116.0,N,Blood,1,,"Biodistribution in blood of mature female Dawley rat after 45min, expressed as percent injected dose/g",,BAO_0000218,13751,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628671,178.0,11927,Rattus norvegicus,,10116.0,N,Blood,1,,"Biodistribution in blood of mature female Dawley rat after 5min, expressed as percent injected dose/g",,BAO_0000218,13751,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628672,10000001.0,11928,Rattus norvegicus,,10116.0,N,Bone,1,,"Biodistribution in bone of mature female Dawley rat after 10min, expressed as percent injected dose/g",,BAO_0000218,13751,
In vivo,,A,,Intermediate,1,,50597,CHEMBL630300,10000001.0,11929,Rattus norvegicus,,10116.0,N,Bone,1,,"Biodistribution in bone of mature female Dawley rat after 1h, expressed as percent injected dose/g",,BAO_0000218,13751,
In vivo,,A,,Intermediate,1,,50597,CHEMBL629787,10000001.0,11930,Rattus norvegicus,,10116.0,N,Bone,1,,"Biodistribution in bone of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,BAO_0000218,13751,
In vivo,,A,,Intermediate,1,,50597,CHEMBL629788,10000001.0,11931,Rattus norvegicus,,10116.0,N,Bone,1,,"Biodistribution in bone of mature female Dawley rat after 30min, expressed as percent injected dose/g",,BAO_0000218,13751,
In vivo,,A,,Intermediate,1,,50597,CHEMBL629789,955.0,11932,Rattus norvegicus,,10116.0,N,Brain,1,,"Biodistribution in brain of mature female Dawley rat after 10min, expressed as percent injected dose/g",,BAO_0000218,13751,
In vivo,,A,,Intermediate,1,,50597,CHEMBL629790,955.0,11933,Rattus norvegicus,,10116.0,N,Brain,1,,"Biodistribution in brain of mature female Dawley rat after 15min, expressed as percent injected dose/g",,BAO_0000218,13751,
In vivo,,A,,Intermediate,1,,50597,CHEMBL629791,955.0,11934,Rattus norvegicus,,10116.0,N,Brain,1,,"Biodistribution in brain of mature female Dawley rat after 1h, expressed as percent injected dose/g",,BAO_0000218,13751,
In vivo,,A,,Intermediate,1,,50597,CHEMBL629792,955.0,11935,Rattus norvegicus,,10116.0,N,Brain,1,,"Biodistribution in brain of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,BAO_0000218,13751,
In vivo,,A,,Intermediate,1,,50597,CHEMBL629793,955.0,11936,Rattus norvegicus,,10116.0,N,Brain,1,,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",,BAO_0000218,13751,
In vivo,,A,,Intermediate,1,,50597,CHEMBL629794,955.0,11937,Rattus norvegicus,,10116.0,N,Brain,1,,"Biodistribution in brain of mature female Dawley rat after 45min, expressed as percent injected dose/g",,BAO_0000218,13751,
,,A,,Intermediate,1,,50597,CHEMBL874459,,11938,Rattus norvegicus,,10116.0,N,,1,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 2-3 hr time,,BAO_0000218,10677,
,,A,,Intermediate,1,,50597,CHEMBL629795,,11939,Rattus norvegicus,,10116.0,N,,1,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 3-4 hr time,,BAO_0000218,10677,
,,A,,Intermediate,1,,50597,CHEMBL629796,,11940,Rattus norvegicus,,10116.0,N,,1,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 4-5 hr time,,BAO_0000218,10677,
,,A,,Intermediate,1,,50597,CHEMBL629797,,11941,Rattus norvegicus,,10116.0,N,,1,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 5-6 hr time,,BAO_0000218,10677,
,,A,,Intermediate,1,,50597,CHEMBL629798,,11942,Rattus norvegicus,,10116.0,N,,1,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 6-24 h time,,BAO_0000218,10677,
In vivo,,A,,Intermediate,1,,50597,CHEMBL629799,2369.0,11943,Rattus norvegicus,,10116.0,N,Adrenal gland,1,,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,BAO_0000218,10911,
In vivo,,A,,Intermediate,1,,50597,CHEMBL629800,2369.0,11944,Rattus norvegicus,,10116.0,N,Adrenal gland,1,,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,BAO_0000218,10911,
In vivo,,A,,Intermediate,1,,50597,CHEMBL629801,2369.0,11945,Rattus norvegicus,,10116.0,N,Adrenal gland,1,,Biodistribution studied in the adrenals of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,BAO_0000218,10911,
In vivo,,A,,Intermediate,1,,50597,CHEMBL629802,2369.0,11946,Rattus norvegicus,,10116.0,N,Adrenal gland,1,,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour,,BAO_0000218,10911,
In vivo,,A,,Intermediate,1,,50597,CHEMBL629803,2369.0,11947,Rattus norvegicus,,10116.0,N,Adrenal gland,1,,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,BAO_0000218,10911,
In vivo,,A,,Intermediate,1,,50597,CHEMBL629804,178.0,11948,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution studied in the blood of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,BAO_0000218,10911,
In vivo,,A,,Intermediate,1,,50597,CHEMBL629805,178.0,11949,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution studied in the blood of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,BAO_0000218,10911,
In vivo,,A,,Intermediate,1,,50597,CHEMBL629806,178.0,11950,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution studied in the blood of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,,BAO_0000218,10911,
In vivo,,A,,Intermediate,1,,50597,CHEMBL629807,178.0,11951,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution studied in the blood of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,BAO_0000218,10911,
In vivo,,A,,Intermediate,1,,50597,CHEMBL629808,178.0,11952,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution studied in the blood of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,BAO_0000218,10911,
In vivo,,A,,Intermediate,1,,50597,CHEMBL629809,955.0,11953,Rattus norvegicus,,10116.0,N,Brain,1,,Biodistribution studied in the brain of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,BAO_0000218,10911,
In vivo,,A,,Intermediate,1,,50597,CHEMBL629810,955.0,11954,Rattus norvegicus,,10116.0,N,Brain,1,,Biodistribution studied in the brain of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,BAO_0000218,10911,
In vivo,,A,,Intermediate,1,,50597,CHEMBL629811,955.0,11955,Rattus norvegicus,,10116.0,N,Brain,1,,Biodistribution studied in the brain of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,,BAO_0000218,10911,
In vivo,,A,,Intermediate,1,,50597,CHEMBL629812,955.0,11956,Rattus norvegicus,,10116.0,N,Brain,1,,Biodistribution studied in the brain of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,BAO_0000218,10911,
In vivo,,A,,Intermediate,1,,50597,CHEMBL629813,955.0,11957,Rattus norvegicus,,10116.0,N,Brain,1,,Biodistribution studied in the brain of immature Fischer female rats at 5 hou; activity is expressed as inductive dose / gram,,BAO_0000218,10911,
In vivo,,A,,Intermediate,1,,50597,CHEMBL874460,955.0,11958,Rattus norvegicus,,10116.0,N,Brain,1,,Biodistribution studied in the brain of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,BAO_0000218,10911,
In vivo,,A,,Intermediate,1,,50597,CHEMBL629814,,11959,Rattus norvegicus,,10116.0,N,,1,,Biodistribution studied in the fat of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,BAO_0000218,10911,
In vivo,,A,,Intermediate,1,,50597,CHEMBL629815,,11960,Rattus norvegicus,,10116.0,N,,1,,Biodistribution studied in the fat of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,BAO_0000218,10911,
In vivo,,A,,Intermediate,1,,50597,CHEMBL629816,,11961,Rattus norvegicus,,10116.0,N,,1,,Biodistribution studied in the fat of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,BAO_0000218,10911,
In vivo,,A,,Intermediate,1,,50597,CHEMBL629817,,11962,Rattus norvegicus,,10116.0,N,,1,,Biodistribution studied in the fat of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,BAO_0000218,10911,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626643,2113.0,11963,Rattus norvegicus,,10116.0,N,Kidney,1,,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,BAO_0000218,10911,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626644,2113.0,11964,Rattus norvegicus,,10116.0,N,Kidney,1,,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,BAO_0000218,10911,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626806,2113.0,11965,Rattus norvegicus,,10116.0,N,Kidney,1,,Biodistribution studied in the kidneys of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,BAO_0000218,10911,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626807,2113.0,11966,Rattus norvegicus,,10116.0,N,Kidney,1,,Biodistribution studied in the kidneys of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,BAO_0000218,10911,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627261,2107.0,11967,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution studied in the liver of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,BAO_0000218,10911,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627262,2107.0,11968,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution studied in the liver of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,BAO_0000218,10911,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627263,2107.0,11969,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution studied in the liver of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,BAO_0000218,10911,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627264,2107.0,11970,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution studied in the liver of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,BAO_0000218,10911,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627265,2048.0,11971,Rattus norvegicus,,10116.0,N,Lung,1,,Biodistribution studied in the lungs of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,BAO_0000218,10911,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627266,2048.0,11972,Rattus norvegicus,,10116.0,N,Lung,1,,Biodistribution studied in the lungs of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,BAO_0000218,10911,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627267,2048.0,11973,Rattus norvegicus,,10116.0,N,Lung,1,,Biodistribution studied in the lungs of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,BAO_0000218,10911,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627268,2048.0,11974,Rattus norvegicus,,10116.0,N,Lung,1,,Biodistribution studied in the lungs of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,BAO_0000218,10911,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627269,2385.0,11975,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Biodistribution studied in the muscle of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,BAO_0000218,10911,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627270,2385.0,11976,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Biodistribution studied in the muscle of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,BAO_0000218,10911,
,,A,,Intermediate,1,,50597,CHEMBL627271,,11977,Rattus norvegicus,,10116.0,N,,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 0.95-1.44",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL627946,,11978,Rattus norvegicus,,10116.0,N,,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 1.39-2.43",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL875472,,11979,Rattus norvegicus,,10116.0,N,,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.47-2.96",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL627947,,11980,Rattus norvegicus,,10116.0,N,,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-3.69",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL627948,,11981,Rattus norvegicus,,10116.0,N,,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-4.31",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL628113,,11982,Rattus norvegicus,,10116.0,N,,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 3.17-4.70",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL628114,,11983,Rattus norvegicus,,10116.0,N,,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration.; dose/g, range 2.20-2.97",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL628115,,11984,Rattus norvegicus,,10116.0,N,,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 0.90-1.46",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL628116,,11985,Rattus norvegicus,,10116.0,N,,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.72-3.52",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL628117,,11986,Rattus norvegicus,,10116.0,N,,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.78-3.62",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL628118,,11987,Rattus norvegicus,,10116.0,N,,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.82-3.86",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL628119,,11988,Rattus norvegicus,,10116.0,N,,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 3.80-5.74",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL628120,,11989,Rattus norvegicus,,10116.0,N,,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.05-1.57",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL628121,,11990,Rattus norvegicus,,10116.0,N,,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.93-3.58",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL628122,,11991,Rattus norvegicus,,10116.0,N,,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 2.88-4.32",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL627297,,11992,Rattus norvegicus,,10116.0,N,,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3-3.70",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL627298,,11993,Rattus norvegicus,,10116.0,N,,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.21-3.92",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL627299,,11994,Rattus norvegicus,,10116.0,N,,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.51-5.44",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL627300,,11995,Rattus norvegicus,,10116.0,N,,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 0.24-0.31",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL627301,,11996,Rattus norvegicus,,10116.0,N,,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 10.5-14.4",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL627302,,11997,Rattus norvegicus,,10116.0,N,,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.28-7.41",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL627303,,11998,Rattus norvegicus,,10116.0,N,,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.47-10.2",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL627304,,11999,Rattus norvegicus,,10116.0,N,,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 7.21-7.95",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL627305,,12000,Rattus norvegicus,,10116.0,N,,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 8.28-10.72",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL627306,,12001,Rattus norvegicus,,10116.0,N,,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 1.04-2.56",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL623982,,12002,Rattus norvegicus,,10116.0,N,,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 10.7-16.9",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL623983,,12003,Rattus norvegicus,,10116.0,N,,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 11.7-14.6",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL623984,,12004,Rattus norvegicus,,10116.0,N,,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 14.4-20.1",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL623985,,12005,Rattus norvegicus,,10116.0,N,,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 4.78-9.72",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL623986,,12006,Rattus norvegicus,,10116.0,N,,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 9.87-11.9",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL623987,,12007,Rattus norvegicus,,10116.0,N,,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 0.17-0.25",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL623988,,12008,Rattus norvegicus,,10116.0,N,,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 3.33-4.68",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL623989,,12009,Rattus norvegicus,,10116.0,N,,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.59-8.81",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL622215,,12010,Rattus norvegicus,,10116.0,N,,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.62-5.60",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL622216,,12011,Rattus norvegicus,,10116.0,N,,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.02-6.57",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL877481,,12012,Rattus norvegicus,,10116.0,N,,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.67-8.41",,BAO_0000218,8608,
,,A,,Autocuration,0,,22224,CHEMBL622217,,12013,,,,U,,1,,Pharmacokinetic parameter was evaluated which is represented as AUC when administered orally a dose of 5 mg/kg; range (4.2-8.8),,BAO_0000218,16359,
,,A,,Intermediate,1,,50594,CHEMBL622218,,12014,Mus musculus,,10090.0,N,,1,,Pharmacokinetic parameters was measured at 55 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),,BAO_0000218,13701,
,,A,,Intermediate,1,,50597,CHEMBL622219,,12015,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic profile AUC was evaluated in rats,,BAO_0000218,14554,
,,A,,Autocuration,0,,22224,CHEMBL622220,,12016,,,,U,,1,,Pharmacokinetic property (Area under curve),,BAO_0000019,6241,
,,A,,Intermediate,1,,50588,CHEMBL622221,,12017,Canis lupus familiaris,,9615.0,N,,1,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in dog (25 mg/kg).",,BAO_0000218,11537,
,,A,,Intermediate,1,,50594,CHEMBL622222,,12018,Mus musculus,,10090.0,N,,1,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in mice (50 mg/kg).",,BAO_0000218,11537,
,,A,,Intermediate,1,,50588,CHEMBL622223,,12019,Canis lupus familiaris,,9615.0,N,,1,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to dog (25 mg/kg).",,BAO_0000218,11537,
,,A,,Intermediate,1,,50594,CHEMBL622224,,12020,Mus musculus,,10090.0,N,,1,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to mice (50 mg/kg).",,BAO_0000218,11537,
,,A,,Autocuration,0,,22224,CHEMBL622225,,12021,,,,U,,1,,Plasma concentration (AUC) was determined,,BAO_0000019,13118,
,,A,,Autocuration,0,,22224,CHEMBL622226,,12022,,,,U,,1,,Plasma concentration (AUC) was determined; Not detectable,,BAO_0000019,13118,
,,A,,Intermediate,1,,50512,CHEMBL624154,,12023,Cavia porcellus,,10141.0,N,,1,,Prolongation of time to collapse in guinea pig treated with aerosolized histamine was measured in vivo as area under curve (AUC),,BAO_0000218,9562,
,,A,,Intermediate,1,,50597,CHEMBL624155,,12024,Rattus norvegicus,,10116.0,N,,1,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg,,BAO_0000218,10363,
,,A,,Intermediate,1,,50597,CHEMBL624156,,12025,Rattus norvegicus,,10116.0,N,,1,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,,BAO_0000218,10363,
,,A,,Intermediate,1,,50597,CHEMBL624157,,12026,Rattus norvegicus,,10116.0,N,,1,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 60 mg/kg,,BAO_0000218,10363,
,,A,,Intermediate,1,,50597,CHEMBL624158,,12027,Rattus norvegicus,,10116.0,N,,1,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 7.5 mg/kg,,BAO_0000218,10363,
,,A,,Intermediate,1,,50597,CHEMBL624159,,12028,Rattus norvegicus,,10116.0,N,,1,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 1,,BAO_0000218,12504,
,,A,,Intermediate,1,,50597,CHEMBL624160,,12029,Rattus norvegicus,,10116.0,N,,1,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 2,,BAO_0000218,12504,
,,A,,Intermediate,1,,50597,CHEMBL624161,,12030,Rattus norvegicus,,10116.0,N,,1,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 3,,BAO_0000218,12504,
,,A,,Intermediate,1,,50597,CHEMBL624162,,12031,Rattus norvegicus,,10116.0,N,,1,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 4,,BAO_0000218,12504,
,,A,,Intermediate,1,,50588,CHEMBL624163,,12032,Canis lupus familiaris,,9615.0,N,,1,,Tested for pharmacokinetic parameter in fasted Beagle dogs (Area Under Curve value) iv administration.,,BAO_0000218,13317,
,,A,,Intermediate,1,,50597,CHEMBL624164,,12033,Rattus norvegicus,,10116.0,N,,1,,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",,BAO_0000218,15078,
,,A,,Intermediate,1,,50597,CHEMBL624165,,12034,Rattus norvegicus,,10116.0,N,,1,,The AUC(0-infinity) values in female wistar rats.,,BAO_0000218,14941,
,,A,,Intermediate,1,,50597,CHEMBL624166,,12035,Rattus norvegicus,,10116.0,N,,1,,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",,BAO_0000218,15078,
,,A,,Intermediate,1,,50597,CHEMBL624167,,12036,Rattus norvegicus,,10116.0,N,,1,,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose in mice",,BAO_0000218,15078,
,,A,,Intermediate,1,,50597,CHEMBL624168,,12037,Rattus norvegicus,,10116.0,N,,1,,The AUC(0-t)values in female wistar rats.,,BAO_0000218,14941,
,,A,,Intermediate,1,,50597,CHEMBL624169,,12038,Rattus norvegicus,,10116.0,N,,1,,The Area under the concentration time curve of compound was measured on rats,,BAO_0000218,14067,
,,A,,Intermediate,1,,50587,CHEMBL624170,,12039,Homo sapiens,,9606.0,N,,1,,The area under curve (100 mg/kg) administered orally in humans,,BAO_0000218,14215,
,,A,,Autocuration,0,,22224,CHEMBL624171,,12040,Callithrix,,9481.0,U,,1,,The area under curve (12.5 mg/kg) administered intravenously in marmoset,,BAO_0000218,14215,
,,A,,Autocuration,0,,22224,CHEMBL624172,,12041,Simiiformes,,314293.0,U,,1,,The area under curve (12.5 mg/kg) administered intravenously in monkey,,BAO_0000218,14215,
,,A,,Intermediate,1,,50588,CHEMBL624173,,12042,Canis lupus familiaris,,9615.0,N,,1,,The area under curve (15 mg/kg) administered intravenously in dog,,BAO_0000218,14215,
,,A,,Intermediate,1,,50587,CHEMBL877488,,12043,Homo sapiens,,9606.0,N,,1,,The area under curve (200 mg/kg) administered orally in humans,,BAO_0000218,14215,
,,A,,Intermediate,1,,50597,CHEMBL624174,,12044,Rattus norvegicus,,10116.0,N,,1,,The area under curve (25 mg/kg) administered intravenously in rat,,BAO_0000218,14215,
,,A,,Autocuration,0,,22224,CHEMBL624175,,12045,Callithrix,,9481.0,U,,1,,The area under curve (25 mg/kg) administered orally in marmoset,,BAO_0000218,14215,
,,A,,Autocuration,0,,22224,CHEMBL624176,,12046,Simiiformes,,314293.0,U,,1,,The area under curve (25 mg/kg) administered orally in monkey,,BAO_0000218,14215,
,,A,,Intermediate,1,,50588,CHEMBL624177,,12047,Canis lupus familiaris,,9615.0,N,,1,,The area under curve (30 mg/kg) administered orally in dog,,BAO_0000218,14215,
,,A,,Intermediate,1,,50587,CHEMBL624178,,12048,Homo sapiens,,9606.0,N,,1,,The area under curve (400 mg/kg) administered orally in humans,,BAO_0000218,14215,
,,A,,Intermediate,1,,50597,CHEMBL624179,,12049,Rattus norvegicus,,10116.0,N,,1,,The area under curve (50 mg/kg) administered orally in fasted rat,,BAO_0000218,14215,
,,A,,Intermediate,1,,50597,CHEMBL627689,,12050,Rattus norvegicus,,10116.0,N,,1,,The area under curve (50 mg/kg) administered orally in rat,,BAO_0000218,14215,
,,A,,Intermediate,1,,50587,CHEMBL627690,,12051,Homo sapiens,,9606.0,N,,1,,The area under curve (800 mg/kg) administered orally in humans,,BAO_0000218,14215,
,,A,,Autocuration,0,,22224,CHEMBL627691,,12052,,,,U,,1,,The compound was evaluated for area under the curve,,BAO_0000019,11324,
,,A,,Autocuration,0,,22224,CHEMBL627692,,12053,Callithrix,,9481.0,U,,1,,The compound was evaluated for area under the curve in marmosets,,BAO_0000019,11324,
,,A,,Autocuration,0,,22224,CHEMBL627693,,12054,Callithrix,,9481.0,U,,1,,The compound was evaluated for area under the curve in marmosets,,BAO_0000019,11324,
,,A,,Intermediate,1,,50597,CHEMBL627694,,12055,Rattus norvegicus,,10116.0,N,,1,,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,,BAO_0000218,13875,
,,A,,Intermediate,1,,50597,CHEMBL627695,,12056,Rattus norvegicus,,10116.0,N,,1,,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po) in conscious spontaneously hypertensive rat,,BAO_0000218,13875,
,,A,,Autocuration,0,,22224,CHEMBL627696,,12057,,,,U,,1,,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po),,BAO_0000218,13875,
,,A,,Intermediate,1,,50597,CHEMBL627697,,12058,Rattus norvegicus,,10116.0,N,,1,,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,,BAO_0000218,13875,
,,A,,Intermediate,1,,50597,CHEMBL627698,,12059,Rattus norvegicus,,10116.0,N,,1,,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,,BAO_0000218,13875,
,,A,,Intermediate,1,,50597,CHEMBL627699,,12060,Rattus norvegicus,,10116.0,N,,1,,The compound was tested for the area of the change in MABP versus time curve at dose 5 mg/kg (po) in conscious spontaneously hypertensive rat,,BAO_0000218,13875,
,,A,,Intermediate,1,,50597,CHEMBL627700,,12061,Rattus norvegicus,,10116.0,N,,1,,Total absorption was estimated by area under curve (AUC) after intravenous administration in rat,,BAO_0000218,13807,
,,A,,Intermediate,1,,50597,CHEMBL627701,,12062,Rattus norvegicus,,10116.0,N,,1,,Total drug exposure is determined after oral dosing in rats.,,BAO_0000218,14127,
,,A,,Autocuration,0,,22224,CHEMBL627702,,12063,,,,U,,1,,Total drug exposure (5 mg/kg) when administered intravenously,,BAO_0000218,15116,
,,A,,Autocuration,0,,22224,CHEMBL627703,,12064,,,,U,,1,,Total drug exposure (5 mg/kg) when administered orally,,BAO_0000218,15116,
,,A,,Autocuration,0,,22224,CHEMBL626873,,12065,Simiiformes,,314293.0,U,,1,,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,,BAO_0000218,15604,
,,A,,Intermediate,1,,50597,CHEMBL629583,,12066,Rattus norvegicus,,10116.0,N,,1,,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,,BAO_0000218,15604,
,,A,,Intermediate,1,,50588,CHEMBL629584,,12067,Canis lupus familiaris,,9615.0,N,,1,,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,,BAO_0000218,15604,
,,A,,Intermediate,1,,50588,CHEMBL629585,,12068,Canis lupus familiaris,,9615.0,N,,1,,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,,BAO_0000218,15604,
In vivo,,A,,Intermediate,1,,50597,CHEMBL629586,955.0,12069,Rattus norvegicus,,10116.0,N,Brain,1,,"Biodistribution in brain of mature female Dawley rat after 5min, expressed as percent injected dose/g",,BAO_0000218,13751,
In vivo,,A,,Intermediate,1,,50597,CHEMBL629587,955.0,12070,Rattus norvegicus,,10116.0,N,Brain,1,,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",,BAO_0000218,13751,
In vivo,,A,,Intermediate,1,,50597,CHEMBL629588,,12071,Rattus norvegicus,,10116.0,N,,1,,"Biodistribution in fat of mature female Dawley rat after 10min, expressed as percent injected dose/g",,BAO_0000218,13751,
In vivo,,A,,Intermediate,1,,50597,CHEMBL629589,,12072,Rattus norvegicus,,10116.0,N,,1,,"Biodistribution in fat of mature female Dawley rat after 15min, expressed as percent injected dose/g",,BAO_0000218,13751,
In vivo,,A,,Intermediate,1,,50597,CHEMBL629590,,12073,Rattus norvegicus,,10116.0,N,,1,,"Biodistribution in fat of mature female Dawley rat after 1h, expressed as percent injected dose/g",,BAO_0000218,13751,
In vivo,,A,,Intermediate,1,,50597,CHEMBL629591,,12074,Rattus norvegicus,,10116.0,N,,1,,"Biodistribution in fat of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,BAO_0000218,13751,
In vivo,,A,,Intermediate,1,,50597,CHEMBL629592,,12075,Rattus norvegicus,,10116.0,N,,1,,"Biodistribution in fat of mature female Dawley rat after 30min, expressed as percent injected dose/g",,BAO_0000218,13751,
In vivo,,A,,Intermediate,1,,50597,CHEMBL629593,,12076,Rattus norvegicus,,10116.0,N,,1,,"Biodistribution in fat of mature female Dawley rat after 45min, expressed as percent injected dose/g",,BAO_0000218,13751,
In vivo,,A,,Intermediate,1,,50597,CHEMBL629594,,12077,Rattus norvegicus,,10116.0,N,,1,,"Biodistribution in fat of mature female Dawley rat after 5min, expressed as percent injected dose/g",,BAO_0000218,13751,
In vivo,,A,,Intermediate,1,,50597,CHEMBL629595,948.0,12078,Rattus norvegicus,,10116.0,N,Heart,1,,"Biodistribution in heart of mature female Dawley rat after 10min, expressed as percent injected dose/g",,BAO_0000218,13751,
In vivo,,A,,Intermediate,1,,50597,CHEMBL630290,948.0,12079,Rattus norvegicus,,10116.0,N,Heart,1,,"Biodistribution in heart of mature female Dawley rat after 15min, expressed as percent injected dose/g",,BAO_0000218,13751,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627137,948.0,12080,Rattus norvegicus,,10116.0,N,Heart,1,,"Biodistribution in heart of mature female Dawley rat after 1h, expressed as percent injected dose/g",,BAO_0000218,13751,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627138,948.0,12081,Rattus norvegicus,,10116.0,N,Heart,1,,"Biodistribution in heart of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,BAO_0000218,13751,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627139,948.0,12082,Rattus norvegicus,,10116.0,N,Heart,1,,"Biodistribution in heart of mature female Dawley rat after 30min, expressed as percent injected dose/g",,BAO_0000218,13751,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627140,948.0,12083,Rattus norvegicus,,10116.0,N,Heart,1,,"Biodistribution in heart of mature female Dawley rat after 45min, expressed as percent injected dose/g",,BAO_0000218,13751,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627141,948.0,12084,Rattus norvegicus,,10116.0,N,Heart,1,,"Biodistribution in heart of mature female Dawley rat after 5min, expressed as percent injected dose/g",,BAO_0000218,13751,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627142,2113.0,12085,Rattus norvegicus,,10116.0,N,Kidney,1,,"Biodistribution in kidney of mature female Dawley rat after 10min, expressed as percent injected dose/g",,BAO_0000218,13751,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627143,2113.0,12086,Rattus norvegicus,,10116.0,N,Kidney,1,,"Biodistribution in kidney of mature female Dawley rat after 15min, expressed as percent injected dose/g",,BAO_0000218,13751,
In vivo,,A,,Intermediate,1,,50597,CHEMBL874449,2113.0,12087,Rattus norvegicus,,10116.0,N,Kidney,1,,"Biodistribution in kidney of mature female Dawley rat after 1h, expressed as percent injected dose/g",,BAO_0000218,13751,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627144,2113.0,12088,Rattus norvegicus,,10116.0,N,Kidney,1,,"Biodistribution in kidney of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,BAO_0000218,13751,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627145,2113.0,12089,Rattus norvegicus,,10116.0,N,Kidney,1,,"Biodistribution in kidney of mature female Dawley rat after 30min, expressed as percent injected dose/g",,BAO_0000218,13751,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627146,2113.0,12090,Rattus norvegicus,,10116.0,N,Kidney,1,,"Biodistribution in kidney of mature female Dawley rat after 45min, expressed as percent injected dose/g",,BAO_0000218,13751,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627147,2113.0,12091,Rattus norvegicus,,10116.0,N,Kidney,1,,"Biodistribution in kidney of mature female Dawley rat after 5min, expressed as percent injected dose/g",,BAO_0000218,13751,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627148,2107.0,12092,Rattus norvegicus,,10116.0,N,Liver,1,,"Biodistribution in liver of mature female Dawley rat after 10min, expressed as percent injected dose/g",,BAO_0000218,13751,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627149,2048.0,12093,Rattus norvegicus,,10116.0,N,Lung,1,,"Biodistribution in lung of mature female Dawley rat after 10min, expressed as percent injected dose/g",,BAO_0000218,13751,
In vivo,,A,,Intermediate,1,,50597,CHEMBL632160,2048.0,12094,Rattus norvegicus,,10116.0,N,Lung,1,,"Biodistribution in lung of mature female Dawley rat after 15min, expressed as percent injected dose/g",,BAO_0000218,13751,
In vivo,,A,,Intermediate,1,,50597,CHEMBL632161,2048.0,12095,Rattus norvegicus,,10116.0,N,Lung,1,,"Biodistribution in lung of mature female Dawley rat after 1h, expressed as percent injected dose/g",,BAO_0000218,13751,
In vivo,,A,,Intermediate,1,,50597,CHEMBL632162,2048.0,12096,Rattus norvegicus,,10116.0,N,Lung,1,,"Biodistribution in lung of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,BAO_0000218,13751,
In vivo,,A,,Intermediate,1,,50597,CHEMBL632163,2048.0,12097,Rattus norvegicus,,10116.0,N,Lung,1,,"Biodistribution in lung of mature female Dawley rat after 30min, expressed as percent injected dose/g",,BAO_0000218,13751,
In vivo,,A,,Intermediate,1,,50597,CHEMBL874469,2048.0,12098,Rattus norvegicus,,10116.0,N,Lung,1,,"Biodistribution in lung of mature female Dawley rat after 45min, expressed as percent injected dose/g",,BAO_0000218,13751,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627182,2048.0,12099,Rattus norvegicus,,10116.0,N,Lung,1,,"Biodistribution in lung of mature female Dawley rat after 5min, expressed as percent injected dose/g",,BAO_0000218,13751,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627183,2385.0,12100,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,"Biodistribution in muscle of mature female Dawley rat after 10min, expressed as percent injected dose/g",,BAO_0000218,13751,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627184,2385.0,12101,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,"Biodistribution in muscle of mature female Dawley rat after 15min, expressed as percent injected dose/g",,BAO_0000218,13751,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627185,2385.0,12102,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,"Biodistribution in muscle of mature female Dawley rat after 1h, expressed as percent injected dose/g",,BAO_0000218,13751,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627186,2385.0,12103,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,"Biodistribution in muscle of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,BAO_0000218,13751,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627187,2385.0,12104,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,"Biodistribution in muscle of mature female Dawley rat after 30min, expressed as percent injected dose/g",,BAO_0000218,13751,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627188,2385.0,12105,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,"Biodistribution in muscle of mature female Dawley rat after 45min, expressed as percent injected dose/g",,BAO_0000218,13751,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627189,2385.0,12106,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,"Biodistribution in muscle of mature female Dawley rat after 5min, expressed as percent injected dose/g",,BAO_0000218,13751,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627190,,12107,Rattus norvegicus,,10116.0,N,,1,,"Biodistribution inl ilver of mature female Dawley rat after 30min, expressed as percent injected dose/g",,BAO_0000218,13751,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627191,2107.0,12108,Rattus norvegicus,,10116.0,N,Liver,1,,"Biodistribution inl iver of mature female Dawley rat after 15min, expressed as percent injected dose/g",,BAO_0000218,13751,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627192,2107.0,12109,Rattus norvegicus,,10116.0,N,Liver,1,,"Biodistribution inl iver of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,BAO_0000218,13751,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627193,2107.0,12110,Rattus norvegicus,,10116.0,N,Liver,1,,"Biodistribution inl iver of mature female Dawley rat after 5min, expressed as percent injected dose/g",,BAO_0000218,13751,
In vivo,,A,,Intermediate,1,,50597,CHEMBL874590,2385.0,12111,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Biodistribution studied in the muscle of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,,BAO_0000218,10911,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627194,2385.0,12112,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Biodistribution studied in the muscle of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,BAO_0000218,10911,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627195,2385.0,12113,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Biodistribution studied in the muscle of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,BAO_0000218,10911,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627196,992.0,12114,Rattus norvegicus,,10116.0,N,Female gonad,1,,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,BAO_0000218,10911,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627197,992.0,12115,Rattus norvegicus,,10116.0,N,Female gonad,1,,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,BAO_0000218,10911,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627198,992.0,12116,Rattus norvegicus,,10116.0,N,Female gonad,1,,Biodistribution studied in the ovaries of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,BAO_0000218,10911,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627199,992.0,12117,Rattus norvegicus,,10116.0,N,Female gonad,1,,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour,,BAO_0000218,10911,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627200,992.0,12118,Rattus norvegicus,,10116.0,N,Female gonad,1,,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,BAO_0000218,10911,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627201,1969.0,12119,Rattus norvegicus,,10116.0,N,Plasma,1,,Biodistribution studied in the plasma of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,BAO_0000218,10911,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627202,1969.0,12120,Rattus norvegicus,,10116.0,N,Plasma,1,,Biodistribution studied in the plasma of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,BAO_0000218,10911,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627203,1969.0,12121,Rattus norvegicus,,10116.0,N,Plasma,1,,Biodistribution studied in the plasma of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,BAO_0000218,10911,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627204,1969.0,12122,Rattus norvegicus,,10116.0,N,Plasma,1,,Biodistribution studied in the plasma of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,BAO_0000218,10911,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627205,2106.0,12123,Rattus norvegicus,,10116.0,N,Spleen,1,,Biodistribution studied in the spleen of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,BAO_0000218,10911,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627206,2106.0,12124,Rattus norvegicus,,10116.0,N,Spleen,1,,Biodistribution studied in the spleen of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,BAO_0000218,10911,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627207,2106.0,12125,Rattus norvegicus,,10116.0,N,Spleen,1,,Biodistribution studied in the spleen of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,BAO_0000218,10911,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627208,2106.0,12126,Rattus norvegicus,,10116.0,N,Spleen,1,,Biodistribution studied in the spleen of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,BAO_0000218,10911,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627209,2046.0,12127,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,BAO_0000218,10911,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627210,2046.0,12128,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,BAO_0000218,10911,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627211,2046.0,12129,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,Biodistribution studied in the thyroid of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,BAO_0000218,10911,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627212,2046.0,12130,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,Biodistribution studied in the thyroid of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,BAO_0000218,10911,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627213,995.0,12131,Rattus norvegicus,,10116.0,N,Uterus,1,,Biodistribution studied in the uterus of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,BAO_0000218,10911,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626599,995.0,12132,Rattus norvegicus,,10116.0,N,Uterus,1,,Biodistribution studied in the uterus of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,BAO_0000218,10911,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626600,995.0,12133,Rattus norvegicus,,10116.0,N,Uterus,1,,Biodistribution studied in the uterus of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,BAO_0000218,10911,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626601,995.0,12134,Rattus norvegicus,,10116.0,N,Uterus,1,,Biodistribution studied in the uterus of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,BAO_0000218,10911,
,,A,,Autocuration,0,,22224,CHEMBL627484,,12135,,,,U,,1,,C(f=2) is the concentration at which the half life (t1/2) in the time course of inhibition of BChE by DFP increased by twofold in the presence of compound,,BAO_0000019,8081,
,,A,,Intermediate,1,,100710,CHEMBL627485,1969.0,12136,Macaca fascicularis,,9541.0,N,Plasma,1,,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg),,BAO_0000218,17248,
,,A,,Intermediate,1,,100710,CHEMBL628147,1969.0,12137,Macaca fascicularis,,9541.0,N,Plasma,1,,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not applicable,,BAO_0000218,17248,
,,A,,Intermediate,1,,100710,CHEMBL628148,1969.0,12138,Macaca fascicularis,,9541.0,N,Plasma,1,,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not determined,,BAO_0000218,17248,
,,A,,Intermediate,1,,50588,CHEMBL628149,1969.0,12139,Canis lupus familiaris,,9615.0,N,Plasma,1,,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg),,BAO_0000218,17248,
,,A,,Intermediate,1,,50588,CHEMBL628150,1969.0,12140,Canis lupus familiaris,,9615.0,N,Plasma,1,,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 1,,BAO_0000218,17248,
,,A,,Intermediate,1,,50588,CHEMBL628318,1969.0,12141,Canis lupus familiaris,,9615.0,N,Plasma,1,,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 2,,BAO_0000218,17248,
,,A,,Intermediate,1,,50588,CHEMBL628319,1969.0,12142,Canis lupus familiaris,,9615.0,N,Plasma,1,,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg); Not applicable,,BAO_0000218,17248,
,,A,,Intermediate,1,,50588,CHEMBL875609,,12143,Canis lupus familiaris,,9615.0,N,,1,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",,BAO_0000218,15592,
,,A,,Autocuration,0,,22224,CHEMBL628320,,12144,,,,U,,1,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10,,BAO_0000019,7040,
,,A,,Autocuration,0,,22224,CHEMBL628321,,12145,,,,U,,1,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10.5,,BAO_0000019,7040,
,,A,,Autocuration,0,,22224,CHEMBL628322,,12146,,,,U,,1,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 6.8,,BAO_0000019,7040,
,,A,,Autocuration,0,,22224,CHEMBL628323,,12147,,,,U,,1,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.2,,BAO_0000019,7040,
,,A,,Autocuration,0,,22224,CHEMBL628324,,12148,,,,U,,1,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.6,,BAO_0000019,7040,
,,A,,Autocuration,0,,22224,CHEMBL628325,,12149,,,,U,,1,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 8.2,,BAO_0000019,7040,
,,A,,Autocuration,0,,22224,CHEMBL628326,,12150,,,,U,,1,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 9.6,,BAO_0000019,7040,
,,A,,Intermediate,1,,50588,CHEMBL628327,1236.0,12151,Canis lupus familiaris,,9615.0,N,Adrenal medulla,1,,"Concentration of compound in adrenal medulla of dog 2, after administering intravenously",,BAO_0000218,9614,
,,A,,Intermediate,1,,50588,CHEMBL628328,1236.0,12152,Canis lupus familiaris,,9615.0,N,Adrenal medulla,1,,"Concentration of compound in adrenal medulla of dog1, after administering intravenously",,BAO_0000218,9614,
,,A,,Intermediate,1,,50588,CHEMBL628329,178.0,12153,Canis lupus familiaris,,9615.0,N,Blood,1,,"Concentration of compound in blood of dog 1, after administering intravenously",,BAO_0000218,9614,
,,A,,Intermediate,1,,50597,CHEMBL628330,2107.0,12154,Rattus norvegicus,,10116.0,N,Liver,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration.; dose/g, range 0.23-0.29",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL628331,2107.0,12155,Rattus norvegicus,,10116.0,N,Liver,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.22-0.30",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL628332,2107.0,12156,Rattus norvegicus,,10116.0,N,Liver,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.55-0.71",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL628333,2107.0,12157,Rattus norvegicus,,10116.0,N,Liver,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.57-0.72",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL628334,2107.0,12158,Rattus norvegicus,,10116.0,N,Liver,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 1.51-2.23",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL628335,2107.0,12159,Rattus norvegicus,,10116.0,N,Liver,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 2.30-3.12",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL628336,2107.0,12160,Rattus norvegicus,,10116.0,N,Liver,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 0.93-1.20",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL628337,2107.0,12161,Rattus norvegicus,,10116.0,N,Liver,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.04-2.56",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL628338,2107.0,12162,Rattus norvegicus,,10116.0,N,Liver,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.06-1.70",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL875610,2107.0,12163,Rattus norvegicus,,10116.0,N,Liver,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.26-2.45",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL628339,2107.0,12164,Rattus norvegicus,,10116.0,N,Liver,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 3.12-4.56",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL628340,2107.0,12165,Rattus norvegicus,,10116.0,N,Liver,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 4.12-6.30",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL628341,2107.0,12166,Rattus norvegicus,,10116.0,N,Liver,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.14-0.19",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL622214,2107.0,12167,Rattus norvegicus,,10116.0,N,Liver,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.15-0.19",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL623167,2107.0,12168,Rattus norvegicus,,10116.0,N,Liver,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.24-0.30",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL623168,2107.0,12169,Rattus norvegicus,,10116.0,N,Liver,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.44-0.54",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL623169,2107.0,12170,Rattus norvegicus,,10116.0,N,Liver,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.73-1.19",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL623170,2107.0,12171,Rattus norvegicus,,10116.0,N,Liver,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 1.08-2.31",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL627224,2048.0,12172,Rattus norvegicus,,10116.0,N,Lung,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration.; dose/g, range 0.34-0.47",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL875634,2048.0,12173,Rattus norvegicus,,10116.0,N,Lung,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.83-1.21",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL627225,2048.0,12174,Rattus norvegicus,,10116.0,N,Lung,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.91-1.74",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL627226,2048.0,12175,Rattus norvegicus,,10116.0,N,Lung,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.99-1.23",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL626083,2048.0,12176,Rattus norvegicus,,10116.0,N,Lung,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.07-1.30",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL626084,2048.0,12177,Rattus norvegicus,,10116.0,N,Lung,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.12-1.39",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL626085,2048.0,12178,Rattus norvegicus,,10116.0,N,Lung,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.51-0.66",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL626086,2048.0,12179,Rattus norvegicus,,10116.0,N,Lung,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.95-1.49",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL626087,2048.0,12180,Rattus norvegicus,,10116.0,N,Lung,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.96-1.35",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL626088,2048.0,12181,Rattus norvegicus,,10116.0,N,Lung,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.18-1.44",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL626089,2048.0,12182,Rattus norvegicus,,10116.0,N,Lung,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.20-1.52",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL626090,2048.0,12183,Rattus norvegicus,,10116.0,N,Lung,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.41-2.17",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL626091,2048.0,12184,Rattus norvegicus,,10116.0,N,Lung,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.28-0.33",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL626092,2048.0,12185,Rattus norvegicus,,10116.0,N,Lung,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.81-1.13",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL626093,2048.0,12186,Rattus norvegicus,,10116.0,N,Lung,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.83-2.11",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL626094,2048.0,12187,Rattus norvegicus,,10116.0,N,Lung,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.94-1.36",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL626095,2048.0,12188,Rattus norvegicus,,10116.0,N,Lung,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.97-1.54",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL626096,2048.0,12189,Rattus norvegicus,,10116.0,N,Lung,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 1.07-1.26",,BAO_0000218,8608,
,,A,,Autocuration,0,,22224,CHEMBL626097,,12190,Simiiformes,,314293.0,U,,1,,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,,BAO_0000218,15604,
,,A,,Intermediate,1,,50597,CHEMBL626098,,12191,Rattus norvegicus,,10116.0,N,,1,,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,,BAO_0000218,15604,
,,A,,Autocuration,0,,22224,CHEMBL626099,1969.0,12192,,,,U,Plasma,1,,compound was evaluated for area under the plasma concentration vs. time curve at different dose 27.5 mg/kg DMP323 equiv,,BAO_0000218,1806,
,,A,,Autocuration,0,,22224,CHEMBL626100,1969.0,12193,,,,U,Plasma,1,,compound was evaluated for area under the plasma concentration vs. time curve at different dose 7.7 mg/kg DMP323 equiv,,BAO_0000218,1806,
,,A,,Intermediate,1,,50588,CHEMBL626101,1969.0,12194,Canis lupus familiaris,,9615.0,N,Plasma,1,,AUC 0-inf in dog,,BAO_0000218,17237,
,,A,,Intermediate,1,,50512,CHEMBL626102,1969.0,12195,Cavia porcellus,,10141.0,N,Plasma,1,,AUC 0-inf in guinea pig,,BAO_0000218,17237,
,,A,,Intermediate,1,,50588,CHEMBL626103,1969.0,12196,Canis lupus familiaris,,9615.0,N,Plasma,1,,AUC 0-t in dog,,BAO_0000218,17237,
,,A,,Intermediate,1,,50512,CHEMBL628391,1969.0,12197,Cavia porcellus,,10141.0,N,Plasma,1,,AUC 0-t in guinea pig,,BAO_0000218,17237,
,,A,,Intermediate,1,,50597,CHEMBL628392,,12198,Rattus norvegicus,,10116.0,N,,1,,The compound was tested for brain to plasma partition in rat,,BAO_0000218,15194,
,,A,,Intermediate,1,,50597,CHEMBL628393,,12199,Rattus norvegicus,,10116.0,N,,1,,The compound was tested for brain to plasma partition in rat.,,BAO_0000218,15194,
,,A,,Autocuration,0,,22224,CHEMBL628394,178.0,12200,,,,U,Blood,1,,Area under curve was determined for 0-6 hr duration using dihydralazine as reference drug for the peak blood pressure,,BAO_0000019,8787,
,,A,,Intermediate,1,,50588,CHEMBL628395,,12201,Canis lupus familiaris,,9615.0,N,,1,,Area under concentration-time curve of compound was determined in dog at 5 mg/kg intravenously admn.,,BAO_0000218,17025,
,,A,,Autocuration,0,,22224,CHEMBL628396,,12202,Simiiformes,,314293.0,U,,1,,Area under concentration-time curve of compound was determined in monkey at 5 mg/kg intravenously admn.,,BAO_0000218,17025,
,,A,,Intermediate,1,,50592,CHEMBL628397,,12203,Oryctolagus cuniculus,,9986.0,N,,1,,Area under concentration-time curve of compound was determined in rabbit at 5 mg/kg intravenously admn.,,BAO_0000218,17025,
,,A,,Intermediate,1,,50597,CHEMBL628398,,12204,Rattus norvegicus,,10116.0,N,,1,,Area under concentration-time curve of compound was determined in rat at 5 mg/kg intravenously admn.,,BAO_0000218,17025,
,,A,,Intermediate,1,,50797,CHEMBL628399,,12205,Macaca mulatta,,9544.0,N,,1,,Area under curve obtained at a dose of 10 mg/kg when administered orally to rhesus monkey,,BAO_0000218,4236,
,,A,,Intermediate,1,,50588,CHEMBL628400,,12206,Canis lupus familiaris,,9615.0,N,,1,,The Plasma area under the compound concentration -time curve was measured in dogs after oral administration of 1 mg/kg dose,,BAO_0000218,15343,
,,A,,Intermediate,1,,50597,CHEMBL874907,,12207,Rattus norvegicus,,10116.0,N,,1,,The Plasma area under the compound concentration -time curve was measured in rats after oral administration of 1 mg/kg dose,,BAO_0000218,15343,
,,A,,Autocuration,0,,22224,CHEMBL628401,,12208,,,,U,,1,,Area under curve of the compound was determined,,BAO_0000019,17720,
,,A,,Autocuration,0,,22224,CHEMBL628402,1969.0,12209,Simiiformes,,314293.0,U,Plasma,1,,AUC in monkeys at a dose of 1 mg/kg,,BAO_0000218,17788,
,,A,,Intermediate,1,,50597,CHEMBL628403,1969.0,12210,Rattus norvegicus,,10116.0,N,Plasma,1,,AUC in rats at a dose of 1 mg/kg,,BAO_0000218,17788,
,,A,,Autocuration,0,,22224,CHEMBL628404,,12211,,,,U,,1,,Compound was evaluated for the overall absorbance loss at pH of 2,,BAO_0000019,8778,
,,A,,Autocuration,0,,22224,CHEMBL628405,,12212,,,,U,,1,,Compound was evaluated for the overall absorbance loss at pH of 4,,BAO_0000019,8778,
,,A,,Autocuration,0,,22224,CHEMBL628406,,12213,,,,U,,1,,Compound was evaluated for the overall absorbance loss at pH of 7,,BAO_0000019,8778,
,,A,,Intermediate,1,,50597,CHEMBL628407,,12214,Rattus norvegicus,,10116.0,N,,1,,Compound was evaluated for its absorption in the rats,,BAO_0000218,2249,
,,A,,Intermediate,1,,50597,CHEMBL628408,1088.0,12215,Rattus norvegicus,,10116.0,N,Urine,1,,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,,BAO_0000218,8881,
,,A,,Intermediate,1,,50597,CHEMBL629171,1088.0,12216,Rattus norvegicus,,10116.0,N,Urine,1,,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight.,,BAO_0000218,8881,
,,A,,Intermediate,1,,50597,CHEMBL629172,1088.0,12217,Rattus norvegicus,,10116.0,N,Urine,1,,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,,BAO_0000218,8881,
,,A,,Intermediate,1,,50597,CHEMBL629173,1088.0,12218,Rattus norvegicus,,10116.0,N,Urine,1,,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of per moiety tranexamic acid,,BAO_0000218,8881,
,,A,,Intermediate,1,,50597,CHEMBL629174,,12219,Rattus norvegicus,,10116.0,N,,1,,In vitro percent permeability into rat ileum,,BAO_0000218,15286,
,,A,,Intermediate,1,,50597,CHEMBL629175,,12220,Rattus norvegicus,,10116.0,N,,1,,In vitro percent permeability into rat ileum; Range is 10-17,,BAO_0000218,15286,
,,A,,Intermediate,1,,50597,CHEMBL629176,,12221,Rattus norvegicus,,10116.0,N,,1,,In vitro percent permeability into rat ileum; Range is 10-18,,BAO_0000218,15286,
,,A,,Intermediate,1,,50597,CHEMBL629177,,12222,Rattus norvegicus,,10116.0,N,,1,,In vitro percent permeability into rat ileum; Range is 10-19,,BAO_0000218,15286,
,,A,,Intermediate,1,,50597,CHEMBL629178,,12223,Rattus norvegicus,,10116.0,N,,1,,In vitro percent permeability into rat ileum; Range is 12-15,,BAO_0000218,15286,
,,A,,Intermediate,1,,50597,CHEMBL631869,,12224,Rattus norvegicus,,10116.0,N,,1,,In vitro percent permeability into rat ileum; Range is 13-19,,BAO_0000218,15286,
,,A,,Intermediate,1,,50597,CHEMBL631870,,12225,Rattus norvegicus,,10116.0,N,,1,,In vitro percent permeability into rat ileum; Range is 14-17,,BAO_0000218,15286,
,,A,,Intermediate,1,,50597,CHEMBL631871,,12226,Rattus norvegicus,,10116.0,N,,1,,In vitro percent permeability into rat ileum; Range is 15-18,,BAO_0000218,15286,
,,A,,Intermediate,1,,50597,CHEMBL631872,,12227,Rattus norvegicus,,10116.0,N,,1,,In vitro percent permeability into rat ileum; Range is 2-5,,BAO_0000218,15286,
,,A,,Autocuration,0,,22224,CHEMBL875775,2116.0,12228,,,,U,Ileum,1,,In vitro percent permeability into rat ileum; Range is 23-42,,BAO_0000221,15286,
,,A,,Intermediate,1,,50597,CHEMBL631873,,12229,Rattus norvegicus,,10116.0,N,,1,,In vitro percent permeability into rat ileum; Range is 28-36,,BAO_0000218,15286,
,,A,,Intermediate,1,,50597,CHEMBL631874,,12230,Rattus norvegicus,,10116.0,N,,1,,In vitro percent permeability into rat ileum; Range is 29-35,,BAO_0000218,15286,
,,A,,Intermediate,1,,50597,CHEMBL631875,,12231,Rattus norvegicus,,10116.0,N,,1,,In vitro percent permeability into rat ileum; Range is 46-66,,BAO_0000218,15286,
,,A,,Intermediate,1,,50597,CHEMBL631876,,12232,Rattus norvegicus,,10116.0,N,,1,,In vitro percent permeability into rat ileum; Range is 50-68,,BAO_0000218,15286,
,,A,,Intermediate,1,,50597,CHEMBL631877,,12233,Rattus norvegicus,,10116.0,N,,1,,In vitro percent permeability into rat ileum; Range is 78-81,,BAO_0000218,15286,
,,A,,Intermediate,1,,50597,CHEMBL631878,,12234,Rattus norvegicus,,10116.0,N,,1,,In vitro percent permeability into rat ileum; insol indicates not soluble in aqueous buffer,,BAO_0000218,15286,
,,A,,Intermediate,1,,50597,CHEMBL631879,,12235,Rattus norvegicus,,10116.0,N,,1,,In vitro percent permeability into rat ileum; nd indicates not detected,,BAO_0000218,15286,
,,A,,Intermediate,1,,50597,CHEMBL631880,,12236,Rattus norvegicus,,10116.0,N,,1,,In vitro percent permeability into rat ileum; nt indicates not detected,,BAO_0000218,15286,
,,A,,Intermediate,1,,50597,CHEMBL631881,,12237,Rattus norvegicus,,10116.0,N,,1,,In vitro percent permeability into rat ileum; nt indicates not tested,,BAO_0000218,15286,
,,A,,Intermediate,1,,50597,CHEMBL631882,,12238,Rattus norvegicus,,10116.0,N,,1,,Compound was tested for oral absorption in bile-duct cannulated rats,,BAO_0000218,13770,
,,A,,Intermediate,1,,50597,CHEMBL630749,,12239,Rattus norvegicus,,10116.0,N,,1,,Compound was tested for oral absorption in bile-duct cannulated rats.,,BAO_0000218,13770,
,,A,,Intermediate,1,,50587,CHEMBL630750,,12240,Homo sapiens,,9606.0,N,,1,,Oral absorption using Caco-2 cell monolayers.,,BAO_0000218,5202,
,,A,,Intermediate,1,,50587,CHEMBL630253,,12241,Homo sapiens,,9606.0,N,,1,,Percent of the drug absorbed after administration to humans was determined,,BAO_0000218,14920,
,,A,,Intermediate,1,,50597,CHEMBL630254,1969.0,12242,Rattus norvegicus,,10116.0,N,Plasma,1,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 120 minutes.,,BAO_0000218,14103,
,,A,,Intermediate,1,,50597,CHEMBL630255,1969.0,12243,Rattus norvegicus,,10116.0,N,Plasma,1,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 15 minutes.,,BAO_0000218,14103,
,,A,,Intermediate,1,,50597,CHEMBL630256,1969.0,12244,Rattus norvegicus,,10116.0,N,Plasma,1,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 180 minutes.,,BAO_0000218,14103,
In vivo,,A,,Intermediate,1,,50597,CHEMBL875781,2107.0,12245,Rattus norvegicus,,10116.0,N,Liver,1,,"Biodistribution inl liver of mature female Dawley rat after 1h, expressed as percent injected dose/g",,BAO_0000218,13751,
In vivo,,A,,Intermediate,1,,50597,CHEMBL630257,2107.0,12246,Rattus norvegicus,,10116.0,N,Liver,1,,"Biodistribution inl liver of mature female Dawley rat after 30min, expressed as percent injected dose/g",,BAO_0000218,13751,
In vivo,,A,,Intermediate,1,,50597,CHEMBL630258,2107.0,12247,Rattus norvegicus,,10116.0,N,Liver,1,,"Biodistribution inl liver of mature female Dawley rat after 45min, expressed as percent injected dose/g",,BAO_0000218,13751,
,,A,,Intermediate,1,,50597,CHEMBL630259,,12248,Rattus norvegicus,,10116.0,N,,1,,"Distribution of radioactivity in rat blood after 2 minutes of iv administration at the dose of 10.05-0.07 gram of tissue, expressed as percent injected dose per gram of tissue",,BAO_0000218,15807,
,,A,,Intermediate,1,,50597,CHEMBL630260,2435.0,12249,Rattus norvegicus,,10116.0,N,Striatum,1,,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 1.89-3.73 g of tissue, expressed as percent injected dose per gram of tissue",,BAO_0000218,15807,
,,A,,Intermediate,1,,50597,CHEMBL630261,2435.0,12250,Rattus norvegicus,,10116.0,N,Striatum,1,,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 3.44-4.80 g of tissue, expressed as percent injected dose per gram of tissue",,BAO_0000218,15807,
,,A,,Intermediate,1,,50597,CHEMBL630262,,12251,Rattus norvegicus,,10116.0,N,,1,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat and 5-alpha-DHT was reported,,BAO_0000218,14950,
,,A,,Intermediate,1,,50597,CHEMBL630263,,12252,Rattus norvegicus,,10116.0,N,,1,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 1 hour time,,BAO_0000218,14950,
,,A,,Intermediate,1,,50597,CHEMBL630264,,12253,Rattus norvegicus,,10116.0,N,,1,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 2 hours time,,BAO_0000218,14950,
,,A,,Intermediate,1,,50597,CHEMBL630265,,12254,Rattus norvegicus,,10116.0,N,,1,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 0.5 hours time,,BAO_0000218,14950,
,,A,,Intermediate,1,,50597,CHEMBL630266,,12255,Rattus norvegicus,,10116.0,N,,1,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 4 hours time,,BAO_0000218,14950,
,,A,,Intermediate,1,,50597,CHEMBL630267,2113.0,12256,Rattus norvegicus,,10116.0,N,Kidney,1,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 0.5 hours time,,BAO_0000218,14950,
,,A,,Intermediate,1,,50597,CHEMBL630268,2113.0,12257,Rattus norvegicus,,10116.0,N,Kidney,1,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 4 hours time,,BAO_0000218,14950,
,,A,,Intermediate,1,,50597,CHEMBL630269,,12258,Rattus norvegicus,,10116.0,N,,1,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 1 hour time,,BAO_0000218,14950,
,,A,,Intermediate,1,,50597,CHEMBL630270,,12259,Rattus norvegicus,,10116.0,N,,1,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 2 hours time,,BAO_0000218,14950,
,,A,,Intermediate,1,,50597,CHEMBL630141,2048.0,12260,Rattus norvegicus,,10116.0,N,Lung,1,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 1 hour time,,BAO_0000218,14950,
,,A,,Intermediate,1,,50597,CHEMBL630142,2048.0,12261,Rattus norvegicus,,10116.0,N,Lung,1,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 2 hours time,,BAO_0000218,14950,
,,A,,Intermediate,1,,50597,CHEMBL630143,2385.0,12262,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 0.5 hours time,,BAO_0000218,14950,
,,A,,Intermediate,1,,50597,CHEMBL630144,2385.0,12263,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 4 hours time,,BAO_0000218,14950,
,,A,,Intermediate,1,,50597,CHEMBL630145,2367.0,12264,Rattus norvegicus,,10116.0,N,Prostate gland,1,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 0.5 hours time,,BAO_0000218,14950,
,,A,,Intermediate,1,,50597,CHEMBL630146,2367.0,12265,Rattus norvegicus,,10116.0,N,Prostate gland,1,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 4 hours time,,BAO_0000218,14950,
,,A,,Intermediate,1,,50597,CHEMBL630147,,12266,Rattus norvegicus,,10116.0,N,,1,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood,,BAO_0000218,14950,
,,A,,Intermediate,1,,50597,CHEMBL630148,,12267,Rattus norvegicus,,10116.0,N,,1,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 1 hours time,,BAO_0000218,14950,
,,A,,Intermediate,1,,50597,CHEMBL630149,,12268,Rattus norvegicus,,10116.0,N,,1,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 2 hours time,,BAO_0000218,14950,
,,A,,Intermediate,1,,50597,CHEMBL630150,2106.0,12269,Rattus norvegicus,,10116.0,N,Spleen,1,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 1 hour time,,BAO_0000218,14950,
,,A,,Intermediate,1,,50597,CHEMBL630151,2106.0,12270,Rattus norvegicus,,10116.0,N,Spleen,1,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 2 hours time,,BAO_0000218,14950,
,,A,,Intermediate,1,,50597,CHEMBL632031,2046.0,12271,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 0.5 hours time,,BAO_0000218,14950,
,,A,,Intermediate,1,,50597,CHEMBL632032,2046.0,12272,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 4 hours time,,BAO_0000218,14950,
,,A,,Intermediate,1,,50597,CHEMBL632033,,12273,Rattus norvegicus,,10116.0,N,,1,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat fat at 1 hour time,,BAO_0000218,14950,
,,A,,Intermediate,1,,50597,CHEMBL632034,,12274,Rattus norvegicus,,10116.0,N,,1,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat kidney at 1 hour time,,BAO_0000218,14950,
,,A,,Intermediate,1,,50597,CHEMBL632035,2385.0,12275,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat muscle at 1 hour time,,BAO_0000218,14950,
,,A,,Intermediate,1,,50597,CHEMBL632036,,12276,Rattus norvegicus,,10116.0,N,,1,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat prostrateat 1 hour time,,BAO_0000218,14950,
,,A,,Intermediate,1,,50597,CHEMBL632037,2046.0,12277,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat thyroid at 1 hour time,,BAO_0000218,14950,
,,A,,Intermediate,1,,50597,CHEMBL632038,178.0,12278,Rattus norvegicus,,10116.0,N,Blood,1,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,,BAO_0000218,8631,
,,A,,Intermediate,1,,50597,CHEMBL632039,178.0,12279,Rattus norvegicus,,10116.0,N,Blood,1,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,,BAO_0000218,8631,
,,A,,Intermediate,1,,50597,CHEMBL632040,178.0,12280,Rattus norvegicus,,10116.0,N,Blood,1,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,,BAO_0000218,8631,
,,A,,Intermediate,1,,50597,CHEMBL632041,178.0,12281,Rattus norvegicus,,10116.0,N,Blood,1,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,,BAO_0000218,8631,
,,A,,Intermediate,1,,50588,CHEMBL632042,178.0,12282,Canis lupus familiaris,,9615.0,N,Blood,1,,"Concentration of compound in blood of dog 2, after administering intravenously",,BAO_0000218,9614,
,,A,,Intermediate,1,,50588,CHEMBL632043,,12283,Canis lupus familiaris,,9615.0,N,,1,,"Concentration of compound in left ventricle of dog 1, after administering intravenously",,BAO_0000218,9614,
,,A,,Intermediate,1,,50588,CHEMBL632044,,12284,Canis lupus familiaris,,9615.0,N,,1,,"Concentration of compound in left ventricle of dog 2, after administering intravenously",,BAO_0000218,9614,
,,A,,Intermediate,1,,50588,CHEMBL632045,2107.0,12285,Canis lupus familiaris,,9615.0,N,Liver,1,,"Concentration of compound in liver of dog 1, after administering intravenously",,BAO_0000218,9614,
,,A,,Intermediate,1,,50588,CHEMBL632046,2107.0,12286,Canis lupus familiaris,,9615.0,N,Liver,1,,"Concentration of compound in liver of dog 2, after administering intravenously",,BAO_0000218,9614,
,,A,,Intermediate,1,,50588,CHEMBL632047,2048.0,12287,Canis lupus familiaris,,9615.0,N,Lung,1,,"Concentration of compound in lung of dog 1, after administering intravenously",,BAO_0000218,9614,
,,A,,Intermediate,1,,50588,CHEMBL632048,2048.0,12288,Canis lupus familiaris,,9615.0,N,Lung,1,,"Concentration of compound in lung of dog 2, after administering intravenously",,BAO_0000218,9614,
,,A,,Intermediate,1,,50588,CHEMBL632049,2385.0,12289,Canis lupus familiaris,,9615.0,N,Muscle tissue,1,,"Concentration of compound in muscle of dog 1, after administering intravenously",,BAO_0000218,9614,
,,A,,Intermediate,1,,50588,CHEMBL876418,2385.0,12290,Canis lupus familiaris,,9615.0,N,Muscle tissue,1,,"Concentration of compound in muscle of dog 2, after administering intravenously",,BAO_0000218,9614,
,,A,,Intermediate,1,,50588,CHEMBL632050,2106.0,12291,Canis lupus familiaris,,9615.0,N,Spleen,1,,"Concentration of compound in spleen of dog 1,after administering intravenously",,BAO_0000218,9614,
,,A,,Intermediate,1,,50588,CHEMBL632051,2106.0,12292,Canis lupus familiaris,,9615.0,N,Spleen,1,,"Concentration of compound in spleen of dog 2, after administering intravenously",,BAO_0000218,9614,
,,F,,Autocuration,0,,22224,CHEMBL632052,,12293,,,,U,,1,,Concentration of liberated compound in serum after 120 min at the dose of 50 mg/kg (po).,,BAO_0000218,10353,
,,F,,Autocuration,0,,22224,CHEMBL632053,,12294,,,,U,,1,,Concentration of liberated compound in serum after 240 min at the dose of 50 mg/kg (po).,,BAO_0000218,10353,
,,A,,Autocuration,0,,22224,CHEMBL632054,,12295,,,,U,,1,,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,,BAO_0000218,10353,
,,F,,Autocuration,0,,22224,CHEMBL632055,,12296,,,,U,,1,,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,,BAO_0000218,10353,
,,F,,Autocuration,0,,22224,CHEMBL631181,,12297,,,,U,,1,,Concentration of liberated compound in serum after 60 min at the dose of 50 mg/kg (po).,,BAO_0000218,10353,
,,A,,Autocuration,0,,22224,CHEMBL631182,,12298,,,,U,,1,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous after 1.5 hr,,BAO_0000218,9196,
,,A,,Autocuration,0,,22224,CHEMBL631183,,12299,,,,U,,1,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,,BAO_0000218,9196,
,,A,,Autocuration,0,,22224,CHEMBL631184,,12300,,,,U,,1,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,BAO_0000218,9196,
,,A,,Autocuration,0,,22224,CHEMBL629774,,12301,,,,U,,1,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,BAO_0000218,9196,
,,A,,Autocuration,0,,22224,CHEMBL629775,,12302,,,,U,,1,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,BAO_0000218,9196,
,,A,,Autocuration,0,,22224,CHEMBL876549,,12303,,,,U,,1,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,BAO_0000218,9196,
,,A,,Autocuration,0,,22224,CHEMBL628172,,12304,,,,U,,1,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,BAO_0000218,9196,
,,A,,Autocuration,0,,22224,CHEMBL628173,,12305,,,,U,,1,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,,BAO_0000218,9196,
,,A,,Autocuration,0,,22224,CHEMBL628174,,12306,,,,U,,1,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous after 1.5 hr,,BAO_0000218,9196,
,,A,,Autocuration,0,,22224,CHEMBL628175,,12307,,,,U,,1,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 4.0 hr,,BAO_0000218,9196,
,,A,,Autocuration,0,,22224,CHEMBL628176,,12308,,,,U,,1,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,,BAO_0000218,9196,
,,A,,Autocuration,0,,22224,CHEMBL628177,,12309,,,,U,,1,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,,BAO_0000218,9196,
,,A,,Autocuration,0,,22224,CHEMBL628178,,12310,,,,U,,1,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,BAO_0000218,9196,
,,A,,Autocuration,0,,22224,CHEMBL628179,,12311,,,,U,,1,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,,BAO_0000218,9196,
,,A,,Autocuration,0,,22224,CHEMBL628180,,12312,,,,U,,1,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg i intravenous dosage after 1.0 hr; insufficient gastric juice produced,,BAO_0000218,9196,
,,A,,Autocuration,0,,22224,CHEMBL628181,,12313,,,,U,,1,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 2.5 hr,,BAO_0000218,9196,
,,A,,Autocuration,0,,22224,CHEMBL628182,,12314,,,,U,,1,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,BAO_0000218,9196,
,,A,,Autocuration,0,,22224,CHEMBL628183,,12315,,,,U,,1,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,BAO_0000218,9196,
,,A,,Autocuration,0,,22224,CHEMBL628184,,12316,,,,U,,1,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr; ND means not determined,,BAO_0000218,9196,
,,A,,Autocuration,0,,22224,CHEMBL628185,,12317,,,,U,,1,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,BAO_0000218,9196,
,,A,,Autocuration,0,,22224,CHEMBL875617,,12318,,,,U,,1,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,BAO_0000218,9196,
,,A,,Autocuration,0,,22224,CHEMBL628186,,12319,,,,U,,1,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr; ND means not determined,,BAO_0000218,9196,
,,A,,Autocuration,0,,22224,CHEMBL628187,,12320,,,,U,,1,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,BAO_0000218,9196,
,,A,,Autocuration,0,,22224,CHEMBL628188,,12321,,,,U,,1,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,,BAO_0000218,9196,
,,A,,Autocuration,0,,22224,CHEMBL628189,,12322,,,,U,,1,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,,BAO_0000218,9196,
,,A,,Autocuration,0,,22224,CHEMBL628190,,12323,,,,U,,1,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr; ND means not determined,,BAO_0000218,9196,
,,A,,Autocuration,0,,22224,CHEMBL628191,,12324,,,,U,,1,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,,BAO_0000218,9196,
,,A,,Autocuration,0,,22224,CHEMBL626513,,12325,,,,U,,1,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr; ND means not determined,,BAO_0000218,9196,
,,A,,Intermediate,1,,50597,CHEMBL626514,2046.0,12326,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 19-24",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL626515,2046.0,12327,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 26-40",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL626516,2046.0,12328,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 29-44",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL626517,2046.0,12329,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 32-42",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL626518,2046.0,12330,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 33-60",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL626519,2046.0,12331,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 4-7",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL626520,2046.0,12332,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 13-18",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL626521,2046.0,12333,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 16-32",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL626522,2046.0,12334,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 22-25",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL626523,2046.0,12335,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 26-49",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL626524,2046.0,12336,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 29-36",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL626688,2046.0,12337,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 5-8",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL626689,2046.0,12338,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 26-42",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL626690,2046.0,12339,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 30-53",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL626691,2046.0,12340,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 32-43",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL627319,2046.0,12341,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 35-53",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL624052,2046.0,12342,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 5-12",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL624053,2046.0,12343,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 55-102",,BAO_0000218,8608,
,,A,,Intermediate,1,,50597,CHEMBL624054,,12344,Rattus norvegicus,,10116.0,N,,1,,In vivo distribution of the drug in plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,BAO_0000218,8085,
,,A,,Intermediate,1,,50597,CHEMBL624055,,12345,Rattus norvegicus,,10116.0,N,,1,,In vivo distribution of the drug in plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,BAO_0000218,8085,
,,A,,Intermediate,1,,50597,CHEMBL624056,,12346,Rattus norvegicus,,10116.0,N,,1,,In vivo distribution of the drug in plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,,BAO_0000218,8085,
,,A,,Intermediate,1,,50597,CHEMBL624057,995.0,12347,Rattus norvegicus,,10116.0,N,Uterus,1,,In vivo distribution of the drug in uterus was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,BAO_0000218,8085,
,,A,,Intermediate,1,,50597,CHEMBL622281,995.0,12348,Rattus norvegicus,,10116.0,N,Uterus,1,,In vivo distribution of the drug in uterus was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,BAO_0000218,8085,
,,A,,Intermediate,1,,50597,CHEMBL622282,995.0,12349,Rattus norvegicus,,10116.0,N,Uterus,1,,In vivo distribution of the drug in uterus was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,,BAO_0000218,8085,
,,A,,Intermediate,1,,50597,CHEMBL622283,995.0,12350,Rattus norvegicus,,10116.0,N,Uterus,1,,In vivo distribution of the drug in uterus/plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,BAO_0000218,8085,
,,A,,Intermediate,1,,50597,CHEMBL622284,995.0,12351,Rattus norvegicus,,10116.0,N,Uterus,1,,In vivo distribution of the drug in uterus/plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,BAO_0000218,8085,
,,A,,Intermediate,1,,50597,CHEMBL622285,995.0,12352,Rattus norvegicus,,10116.0,N,Uterus,1,,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,,BAO_0000218,8085,
,,A,,Intermediate,1,,50597,CHEMBL622286,995.0,12353,Rattus norvegicus,,10116.0,N,Uterus,1,,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,,BAO_0000218,8085,
,,P,,Autocuration,0,,22224,CHEMBL622287,,12354,,,,U,,1,,Distribution coefficient (D %) between octanol and buffer of pH 7.4,,BAO_0000100,7657,
,,A,,Intermediate,1,,50594,CHEMBL622288,,12355,Mus musculus,,10090.0,N,,1,,Partition coefficient (logD7.4),,BAO_0000218,8935,
,,A,,Intermediate,1,,50594,CHEMBL622289,,12356,Mus musculus,,10090.0,N,,1,,"Percentage of radioactivity in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",,BAO_0000218,13792,
,,A,,Intermediate,1,,50594,CHEMBL622290,955.0,12357,Mus musculus,,10090.0,N,Brain,1,,"Percentage of radioactivity in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",,BAO_0000218,13792,
,,A,,Intermediate,1,,50594,CHEMBL622291,,12358,Mus musculus,,10090.0,N,,1,,Percentage of radioactivity in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,,BAO_0000218,13792,
,,A,,Intermediate,1,,50594,CHEMBL622292,955.0,12359,Mus musculus,,10090.0,N,Brain,1,,Percentage of radioactivity in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,,BAO_0000218,13792,
,,A,,Intermediate,1,,50594,CHEMBL622293,,12360,Mus musculus,,10090.0,N,,1,,"Percentage of total protein recovered in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",,BAO_0000218,13792,
,,A,,Intermediate,1,,50594,CHEMBL622294,955.0,12361,Mus musculus,,10090.0,N,Brain,1,,"Percentage of total protein recovered in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",,BAO_0000218,13792,
,,A,,Intermediate,1,,50594,CHEMBL622295,,12362,Mus musculus,,10090.0,N,,1,,Percentage of total protein recovered in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,,BAO_0000218,13792,
,,A,,Intermediate,1,,50597,CHEMBL622296,955.0,12363,Rattus norvegicus,,10116.0,N,Brain,1,,Percentage of total protein recovered in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,,BAO_0000218,13792,
,,A,,Intermediate,1,,50597,CHEMBL874409,1969.0,12364,Rattus norvegicus,,10116.0,N,Plasma,1,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 2 minutes.,,BAO_0000218,14103,
,,A,,Intermediate,1,,50597,CHEMBL622297,1969.0,12365,Rattus norvegicus,,10116.0,N,Plasma,1,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 240 minutes.,,BAO_0000218,14103,
,,A,,Intermediate,1,,50597,CHEMBL622298,1969.0,12366,Rattus norvegicus,,10116.0,N,Plasma,1,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 30 minutes.,,BAO_0000218,14103,
,,A,,Intermediate,1,,50597,CHEMBL622299,1969.0,12367,Rattus norvegicus,,10116.0,N,Plasma,1,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 45 minutes.,,BAO_0000218,14103,
,,A,,Intermediate,1,,50597,CHEMBL622300,1969.0,12368,Rattus norvegicus,,10116.0,N,Plasma,1,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 5 minutes.,,BAO_0000218,14103,
,,A,,Intermediate,1,,50597,CHEMBL622301,1969.0,12369,Rattus norvegicus,,10116.0,N,Plasma,1,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 60 minutes.,,BAO_0000218,14103,
,,A,,Intermediate,1,,50597,CHEMBL622302,1969.0,12370,Rattus norvegicus,,10116.0,N,Plasma,1,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 90 minutes.,,BAO_0000218,14103,
,,A,,Intermediate,1,,50597,CHEMBL622303,1969.0,12371,Rattus norvegicus,,10116.0,N,Plasma,1,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 120 minutes.,,BAO_0000218,14103,
,,A,,Intermediate,1,,50597,CHEMBL622304,1969.0,12372,Rattus norvegicus,,10116.0,N,Plasma,1,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes.,,BAO_0000218,14103,
,,A,,Intermediate,1,,50597,CHEMBL622305,1969.0,12373,Rattus norvegicus,,10116.0,N,Plasma,1,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes;nd=not determined,,BAO_0000218,14103,
,,A,,Intermediate,1,,50597,CHEMBL622306,1969.0,12374,Rattus norvegicus,,10116.0,N,Plasma,1,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 180 minutes.,,BAO_0000218,14103,
,,A,,Intermediate,1,,50597,CHEMBL626864,1969.0,12375,Rattus norvegicus,,10116.0,N,Plasma,1,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 2 minutes;nd=not determined,,BAO_0000218,14103,
,,A,,Intermediate,1,,50597,CHEMBL626865,1969.0,12376,Rattus norvegicus,,10116.0,N,Plasma,1,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes.,,BAO_0000218,14103,
,,A,,Intermediate,1,,50597,CHEMBL626866,1969.0,12377,Rattus norvegicus,,10116.0,N,Plasma,1,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes;nd=not determined,,BAO_0000218,14103,
,,A,,Intermediate,1,,50597,CHEMBL626867,1969.0,12378,Rattus norvegicus,,10116.0,N,Plasma,1,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 30 minutes.,,BAO_0000218,14103,
,,A,,Intermediate,1,,50597,CHEMBL626868,1969.0,12379,Rattus norvegicus,,10116.0,N,Plasma,1,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes.,,BAO_0000218,14103,
,,A,,Intermediate,1,,50597,CHEMBL626869,1969.0,12380,Rattus norvegicus,,10116.0,N,Plasma,1,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes;nd=not determined,,BAO_0000218,14103,
,,A,,Intermediate,1,,50597,CHEMBL626870,1969.0,12381,Rattus norvegicus,,10116.0,N,Plasma,1,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes.,,BAO_0000218,14103,
,,A,,Intermediate,1,,50597,CHEMBL626871,1969.0,12382,Rattus norvegicus,,10116.0,N,Plasma,1,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes;nd=not determined,,BAO_0000218,14103,
,,A,,Intermediate,1,,50597,CHEMBL626872,1969.0,12383,Rattus norvegicus,,10116.0,N,Plasma,1,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 60 minutes.,,BAO_0000218,14103,
,,A,,Intermediate,1,,50597,CHEMBL632185,1969.0,12384,Rattus norvegicus,,10116.0,N,Plasma,1,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes.,,BAO_0000218,14103,
,,A,,Intermediate,1,,50597,CHEMBL632186,1969.0,12385,Rattus norvegicus,,10116.0,N,Plasma,1,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes;nd=not determined,,BAO_0000218,14103,
,,A,,Autocuration,0,,22224,CHEMBL629310,,12386,,,,U,,1,,Amount of acetic acid produced by the compound,,BAO_0000019,12904,
,,A,,Autocuration,0,,22224,CHEMBL629311,,12387,,,,U,,1,,Apparent first-order rate of solvolysis for the bipinnatin-A(A4) was determined,,BAO_0000019,12904,
,,A,,Intermediate,1,,50597,CHEMBL629312,,12388,Rattus norvegicus,,10116.0,N,,1,,Log of (Cbrain/Cblood) in rats,,BAO_0000218,9663,
,,A,,Autocuration,0,,22224,CHEMBL629313,,12389,,,,U,,1,,Compound in absence of MPM cell homogenate at pH 3 to isolate compound 4 (ng),,BAO_0000221,7652,
,,A,,Autocuration,0,,22224,CHEMBL629314,,12390,,,,U,,1,,Compound in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),,BAO_0000221,7652,
,,A,,Autocuration,0,,22224,CHEMBL629315,,12391,,,,U,,1,,Compound in absence of MPM cell homogenate at pH 7 to isolate compound 4 (ng),,BAO_0000221,7652,
,,B,,Autocuration,0,,22224,CHEMBL629316,,12392,,,,U,,1,,Compound in presence of MPM cells and in absence of inactivator at pH 8 to isolate compound 4 (ng),,BAO_0000219,7652,
,,A,,Autocuration,0,,22224,CHEMBL629317,,12393,,,,U,,1,,Compound treated in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),,BAO_0000221,7652,
,,A,,Autocuration,0,,22224,CHEMBL629318,,12394,,,,U,,1,,Compound treated with MPM cell homogenate at pH 3 to isolate compound 4 (ng),,BAO_0000019,7652,
,,A,,Autocuration,0,,22224,CHEMBL877497,,12395,,,,U,,1,,Compound treated with MPM cell homogenate at pH 3.5 to isolate compound 4 (ng),,BAO_0000019,7652,
,,A,,Autocuration,0,,22224,CHEMBL629319,,12396,,,,U,,1,,Compound treated with MPM cell homogenate at pH 4 to isolate compound 4 (ng),,BAO_0000019,7652,
,,A,,Autocuration,0,,22224,CHEMBL629320,,12397,,,,U,,1,,Compound treated with MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),,BAO_0000019,7652,
,,A,,Autocuration,0,,22224,CHEMBL629496,,12398,,,,U,,1,,Compound treated with MPM cell homogenate at pH 5 to isolate compound 4 (ng),,BAO_0000019,7652,
,,A,,Autocuration,0,,22224,CHEMBL629497,,12399,,,,U,,1,,Compound treated with MPM cell homogenate at pH 5.5 to isolate compound 4 (ng),,BAO_0000019,7652,
,,A,,Autocuration,0,,22224,CHEMBL629498,,12400,,,,U,,1,,Compound treated with MPM cell homogenate at pH 6 to isolate compound 4 (ng),,BAO_0000019,7652,
,,A,,Autocuration,0,,22224,CHEMBL629499,,12401,,,,U,,1,,Compound treated with MPM cell homogenate at pH 6.5 to isolate compound 4 (ng),,BAO_0000019,7652,
,,A,,Autocuration,0,,22224,CHEMBL629500,,12402,,,,U,,1,,Compound treated with MPM cell homogenate at pH 7 to isolate compound 4 (ng),,BAO_0000019,7652,
,,A,,Autocuration,0,,22224,CHEMBL629501,,12403,,,,U,,1,,Compound treated with MPM cell homogenate at pH 7.5 to isolate compound 4 (ng),,BAO_0000019,7652,
,,A,,Autocuration,0,,22224,CHEMBL629502,,12404,,,,U,,1,,Compound treated with MPM cell homogenate at pH 8 to isolate compound 4 (ng),,BAO_0000019,7652,
In vivo,,F,,Autocuration,0,,22224,CHEMBL629503,,12405,,,,U,,1,,Compound was evaluated for its urinary recovery after oral administration (100 mg) to Beagle dogs,,BAO_0000218,8267,
,,A,,Intermediate,1,,50588,CHEMBL629504,,12406,Canis lupus familiaris,,9615.0,N,,1,,Compound was evaluated for its urinary recovery after oral administration (200 mg) to Beagle dogs,,BAO_0000218,8267,
,,A,,Autocuration,0,,22224,CHEMBL629505,,12407,,,,U,,1,,Compound was evaluated for the rate of degradation by Carboxypeptidase A.,,BAO_0000019,14479,
,,A,,Autocuration,0,,22224,CHEMBL629506,,12408,,,,U,,1,,Compound was evaluated for total body clearance,,BAO_0000019,17515,
,,A,,Autocuration,0,,22224,CHEMBL629507,,12409,,,,U,,1,,Compound was evaluated for volume of distribution at steady state,,BAO_0000019,17515,
,,A,,Autocuration,0,,22224,CHEMBL877498,,12410,,,,U,,1,,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant KOH- was reported.,,BAO_0000019,8142,
,,A,,Autocuration,0,,22224,CHEMBL629508,,12411,,,,U,,1,,Percentage of the diamine which is monoprotonated at pH 7.4,,BAO_0000019,14849,
,,A,,Autocuration,0,,22224,CHEMBL629509,,12412,,,,U,,1,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells,,BAO_0000019,7653,
,,A,,Intermediate,1,,50597,CHEMBL629510,178.0,12413,Rattus norvegicus,,10116.0,N,Blood,1,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,,BAO_0000218,8631,
,,A,,Intermediate,1,,50597,CHEMBL629511,178.0,12414,Rattus norvegicus,,10116.0,N,Blood,1,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,,BAO_0000218,8631,
,,A,,Intermediate,1,,50597,CHEMBL629512,178.0,12415,Rattus norvegicus,,10116.0,N,Blood,1,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,,BAO_0000218,8631,
,,A,,Intermediate,1,,50597,CHEMBL629513,178.0,12416,Rattus norvegicus,,10116.0,N,Blood,1,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,,BAO_0000218,8631,
,,A,,Intermediate,1,,50597,CHEMBL629514,178.0,12417,Rattus norvegicus,,10116.0,N,Blood,1,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,,BAO_0000218,8631,
,,A,,Intermediate,1,,50597,CHEMBL628447,178.0,12418,Rattus norvegicus,,10116.0,N,Blood,1,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,,BAO_0000218,8631,
,,A,,Intermediate,1,,50597,CHEMBL628448,178.0,12419,Rattus norvegicus,,10116.0,N,Blood,1,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,,BAO_0000218,8631,
,,A,,Intermediate,1,,50597,CHEMBL628449,178.0,12420,Rattus norvegicus,,10116.0,N,Blood,1,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,,BAO_0000218,8631,
,,A,,Intermediate,1,,50597,CHEMBL631119,178.0,12421,Rattus norvegicus,,10116.0,N,Blood,1,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,,BAO_0000218,8631,
,,A,,Intermediate,1,,50597,CHEMBL631120,178.0,12422,Rattus norvegicus,,10116.0,N,Blood,1,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,,BAO_0000218,8631,
,,A,,Intermediate,1,,50597,CHEMBL631121,178.0,12423,Rattus norvegicus,,10116.0,N,Blood,1,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,,BAO_0000218,8631,
,,A,,Intermediate,1,,50597,CHEMBL874458,178.0,12424,Rattus norvegicus,,10116.0,N,Blood,1,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 min,,BAO_0000218,8631,
,,A,,Intermediate,1,,50597,CHEMBL631122,178.0,12425,Rattus norvegicus,,10116.0,N,Blood,1,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,,BAO_0000218,8631,
,,A,,Intermediate,1,,50597,CHEMBL631123,178.0,12426,Rattus norvegicus,,10116.0,N,Blood,1,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,,BAO_0000218,8631,
,,A,,Intermediate,1,,50597,CHEMBL631124,178.0,12427,Rattus norvegicus,,10116.0,N,Blood,1,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,,BAO_0000218,8631,
,,A,,Intermediate,1,,50597,CHEMBL631125,178.0,12428,Rattus norvegicus,,10116.0,N,Blood,1,,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,,BAO_0000218,8631,
,,A,,Intermediate,1,,50597,CHEMBL631290,178.0,12429,Rattus norvegicus,,10116.0,N,Blood,1,,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,,BAO_0000218,8631,
,,A,,Intermediate,1,,50597,CHEMBL631291,178.0,12430,Rattus norvegicus,,10116.0,N,Blood,1,,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,,BAO_0000218,8631,
,,A,,Intermediate,1,,50597,CHEMBL631292,178.0,12431,Rattus norvegicus,,10116.0,N,Blood,1,,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,,BAO_0000218,8631,
,,A,,Intermediate,1,,50597,CHEMBL631293,178.0,12432,Rattus norvegicus,,10116.0,N,Blood,1,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,,BAO_0000218,8631,
,,A,,Intermediate,1,,50597,CHEMBL631294,178.0,12433,Rattus norvegicus,,10116.0,N,Blood,1,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,,BAO_0000218,8631,
,,A,,Intermediate,1,,50597,CHEMBL631295,178.0,12434,Rattus norvegicus,,10116.0,N,Blood,1,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,,BAO_0000218,8631,
,,A,,Intermediate,1,,50597,CHEMBL631296,178.0,12435,Rattus norvegicus,,10116.0,N,Blood,1,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,,BAO_0000218,8631,
,,A,,Intermediate,1,,50597,CHEMBL631297,178.0,12436,Rattus norvegicus,,10116.0,N,Blood,1,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,,BAO_0000218,8631,
,,A,,Autocuration,0,,22224,CHEMBL631298,,12437,,,,U,,1,,Maximum biodistribution (Bmax) was determined.,,BAO_0000218,10263,
,,A,,Intermediate,1,,50594,CHEMBL631299,,12438,Mus musculus,,10090.0,N,,1,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 1.5625 (mg/kg) intravenous dose in 6 mice,,BAO_0000218,12364,
,,A,,Intermediate,1,,50594,CHEMBL631300,,12439,Mus musculus,,10090.0,N,,1,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 10 (mg/kg) intravenous dose in 6 mice,,BAO_0000218,12364,
,,A,,Intermediate,1,,50594,CHEMBL631301,,12440,Mus musculus,,10090.0,N,,1,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 3.125 (mg/kg) intravenous dose in 6 mice,,BAO_0000218,12364,
,,A,,Intermediate,1,,50594,CHEMBL630291,,12441,Mus musculus,,10090.0,N,,1,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 6.25 (mg/kg) intravenous dose in 6 mice,,BAO_0000218,12364,
,,A,,Autocuration,0,,22224,CHEMBL630292,,12442,,,,U,,1,,Brain concentration after 0.25 hr at a dose of 10 mg/kg when administered intraperitoneally,,BAO_0000218,14793,
,,A,,Autocuration,0,,22224,CHEMBL630293,,12443,,,,U,,1,,Brain concentration after 0.25 h at a dose of 10 mg/kg when administered intravenously,,BAO_0000218,14793,
,,A,,Autocuration,0,,22224,CHEMBL630294,,12444,,,,U,,1,,Brain concentration after 0.5 h at a dose of 100 mg/kg when administered perorally,,BAO_0000218,14793,
,,A,,Autocuration,0,,22224,CHEMBL630295,,12445,,,,U,,1,,Brain concentration after 0.5 h at a dose of 10 mg/kg when administered intraperitoneally,,BAO_0000218,14793,
,,A,,Autocuration,0,,22224,CHEMBL630296,,12446,,,,U,,1,,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered intravenously,,BAO_0000218,14793,
,,A,,Autocuration,0,,22224,CHEMBL626782,,12447,,,,U,,1,,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered perorally,,BAO_0000218,14793,
,,A,,Autocuration,0,,22224,CHEMBL626783,,12448,,,,U,,1,,Brain concentration after 1 hr at a dose of 100 mg/kg when administered perorally,,BAO_0000218,14793,
,,A,,Autocuration,0,,22224,CHEMBL626784,,12449,,,,U,,1,,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intraperitoneally,,BAO_0000218,14793,
,,A,,Autocuration,0,,22224,CHEMBL626785,,12450,,,,U,,1,,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intravenously,,BAO_0000218,14793,
,,A,,Autocuration,0,,22224,CHEMBL626786,,12451,,,,U,,1,,Brain concentration after 1 hr at a dose of 10 mg/kg when administered perorally,,BAO_0000218,14793,
,,A,,Autocuration,0,,22224,CHEMBL626787,,12452,,,,U,,1,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,BAO_0000218,9196,
,,A,,Autocuration,0,,22224,CHEMBL626788,,12453,,,,U,,1,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr; ND means not determined,,BAO_0000218,9196,
,,A,,Autocuration,0,,22224,CHEMBL625927,,12454,,,,U,,1,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,,BAO_0000218,9196,
,,A,,Intermediate,1,,50597,CHEMBL625928,178.0,12455,Rattus norvegicus,,10116.0,N,Blood,1,,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,BAO_0000218,8374,
,,A,,Intermediate,1,,50597,CHEMBL625929,178.0,12456,Rattus norvegicus,,10116.0,N,Blood,1,,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,,BAO_0000218,8374,
,,A,,Intermediate,1,,50597,CHEMBL625930,178.0,12457,Rattus norvegicus,,10116.0,N,Blood,1,,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected.,,BAO_0000218,8374,
,,A,,Intermediate,1,,50597,CHEMBL625931,178.0,12458,Rattus norvegicus,,10116.0,N,Blood,1,,"Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound, Compound was found to be in trace amount.",,BAO_0000218,8374,
,,A,,Intermediate,1,,50597,CHEMBL627230,178.0,12459,Rattus norvegicus,,10116.0,N,Blood,1,,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected.,,BAO_0000218,8374,
,,A,,Intermediate,1,,50597,CHEMBL627231,178.0,12460,Rattus norvegicus,,10116.0,N,Blood,1,,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,BAO_0000218,8374,
,,A,,Intermediate,1,,50597,CHEMBL627232,178.0,12461,Rattus norvegicus,,10116.0,N,Blood,1,,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,,BAO_0000218,8374,
,,A,,Intermediate,1,,50597,CHEMBL627233,178.0,12462,Rattus norvegicus,,10116.0,N,Blood,1,,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected.,,BAO_0000218,8374,
,,A,,Intermediate,1,,50597,CHEMBL875470,178.0,12463,Rattus norvegicus,,10116.0,N,Blood,1,,Concentration 5a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,BAO_0000218,8374,
,,A,,Intermediate,1,,50597,CHEMBL627234,178.0,12464,Rattus norvegicus,,10116.0,N,Blood,1,,Concentration 5a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,BAO_0000218,8374,
,,A,,Intermediate,1,,50597,CHEMBL627235,178.0,12465,Rattus norvegicus,,10116.0,N,Blood,1,,Concentration 5b detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,BAO_0000218,8374,
,,A,,Intermediate,1,,50597,CHEMBL627236,178.0,12466,Rattus norvegicus,,10116.0,N,Blood,1,,Concentration 5b detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,BAO_0000218,8374,
,,A,,Intermediate,1,,50597,CHEMBL627237,178.0,12467,Rattus norvegicus,,10116.0,N,Blood,1,,Concentration 5c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,BAO_0000218,8374,
,,A,,Intermediate,1,,50597,CHEMBL627238,178.0,12468,Rattus norvegicus,,10116.0,N,Blood,1,,Concentration 5c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,BAO_0000218,8374,
,,A,,Intermediate,1,,50597,CHEMBL627239,178.0,12469,Rattus norvegicus,,10116.0,N,Blood,1,,Concentration 5d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,BAO_0000218,8374,
,,A,,Intermediate,1,,50597,CHEMBL627240,178.0,12470,Rattus norvegicus,,10116.0,N,Blood,1,,Concentration 5d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,BAO_0000218,8374,
,,A,,Intermediate,1,,50597,CHEMBL627241,178.0,12471,Rattus norvegicus,,10116.0,N,Blood,1,,Concentration 5e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,BAO_0000218,8374,
,,A,,Intermediate,1,,50597,CHEMBL627242,178.0,12472,Rattus norvegicus,,10116.0,N,Blood,1,,Concentration 5e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,BAO_0000218,8374,
,,A,,Intermediate,1,,50597,CHEMBL627243,178.0,12473,Rattus norvegicus,,10116.0,N,Blood,1,,Concentration 5f detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected,,BAO_0000218,8374,
,,A,,Intermediate,1,,50597,CHEMBL627244,178.0,12474,Rattus norvegicus,,10116.0,N,Blood,1,,Concentration 5f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,,BAO_0000218,8374,
,,A,,Intermediate,1,,50597,CHEMBL627245,178.0,12475,Rattus norvegicus,,10116.0,N,Blood,1,,Concentration 6a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,BAO_0000218,8374,
,,A,,Intermediate,1,,50597,CHEMBL627246,178.0,12476,Rattus norvegicus,,10116.0,N,Blood,1,,Concentration 6a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,BAO_0000218,8374,
,,A,,Intermediate,1,,50597,CHEMBL627247,178.0,12477,Rattus norvegicus,,10116.0,N,Blood,1,,Concentration 6c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,BAO_0000218,8374,
,,A,,Intermediate,1,,50597,CHEMBL627248,178.0,12478,Rattus norvegicus,,10116.0,N,Blood,1,,Concentration 6c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,BAO_0000218,8374,
,,A,,Intermediate,1,,50597,CHEMBL627249,178.0,12479,Rattus norvegicus,,10116.0,N,Blood,1,,Concentration 6d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,BAO_0000218,8374,
,,A,,Intermediate,1,,50597,CHEMBL625569,178.0,12480,Rattus norvegicus,,10116.0,N,Blood,1,,Concentration 6d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,BAO_0000218,8374,
,,A,,Intermediate,1,,50597,CHEMBL625570,178.0,12481,Rattus norvegicus,,10116.0,N,Blood,1,,Concentration 6e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,BAO_0000218,8374,
,,A,,Intermediate,1,,50597,CHEMBL625571,178.0,12482,Rattus norvegicus,,10116.0,N,Blood,1,,Concentration 6e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,BAO_0000218,8374,
,,A,,Intermediate,1,,50597,CHEMBL625572,178.0,12483,Rattus norvegicus,,10116.0,N,Blood,1,,Concentration 6f detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,,BAO_0000218,8374,
,,A,,Intermediate,1,,50597,CHEMBL625573,178.0,12484,Rattus norvegicus,,10116.0,N,Blood,1,,Concentration 6f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,,BAO_0000218,8374,
,,A,,Intermediate,1,,50597,CHEMBL625574,178.0,12485,Rattus norvegicus,,10116.0,N,Blood,1,,Concentration detected in blood of rat 1 hr after an oral dose of 200 mg/kg,,BAO_0000218,8374,
,,A,,Intermediate,1,,50597,CHEMBL626245,178.0,12486,Rattus norvegicus,,10116.0,N,Blood,1,,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,,BAO_0000218,8374,
,,A,,Intermediate,1,,50597,CHEMBL626246,178.0,12487,Rattus norvegicus,,10116.0,N,Blood,1,,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,BAO_0000218,8374,
,,A,,Autocuration,0,,22224,CHEMBL626247,,12488,,,,U,,1,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,BAO_0000218,9196,
,,A,,Autocuration,0,,22224,CHEMBL626248,,12489,,,,U,,1,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,BAO_0000218,9196,
,,A,,Autocuration,0,,22224,CHEMBL626249,,12490,,,,U,,1,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,,BAO_0000218,9196,
,,A,,Autocuration,0,,22224,CHEMBL626420,,12491,,,,U,,1,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,BAO_0000218,9196,
,,A,,Autocuration,0,,22224,CHEMBL626421,,12492,,,,U,,1,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,,BAO_0000218,9196,
,,A,,Autocuration,0,,22224,CHEMBL626422,,12493,,,,U,,1,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,,BAO_0000218,9196,
,,A,,Autocuration,0,,22224,CHEMBL626423,,12494,,,,U,,1,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,BAO_0000218,9196,
,,A,,Autocuration,0,,22224,CHEMBL626424,,12495,,,,U,,1,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,BAO_0000218,9196,
,,A,,Intermediate,1,,50588,CHEMBL626425,,12496,Canis lupus familiaris,,9615.0,N,,1,,Volume of distribution in Beagles dog at a dose of 1 mg/kg given intravenously,,BAO_0000218,12023,
,,A,,Intermediate,1,,50597,CHEMBL875476,,12497,Rattus norvegicus,,10116.0,N,,1,,Volume of distribution in CD rat at a dose of 5 mg/kg given intravenously,,BAO_0000218,12023,
,,A,,Intermediate,1,,100710,CHEMBL626426,,12498,Macaca fascicularis,,9541.0,N,,1,,Volume of distribution in Cynomolgus monkey at a dose of 5 mg/kg given intravenously,,BAO_0000218,12023,
,,P,,Autocuration,0,,22224,CHEMBL626427,,12499,,,,U,,1,,Distribution coefficient and iron(III) complex was measured at an aqueous phase buffered at pH 7.4 and octanol,,BAO_0000100,10580,
,,P,,Autocuration,0,,22224,CHEMBL626428,,12500,,,,U,,1,,Distribution coefficient was measured at an aqueous phase buffered at pH 7.4 and octanol,,BAO_0000100,10580,
,,A,,Autocuration,0,,22224,CHEMBL626429,,12501,,,,U,,1,,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in bile by subcutaneous dose of 150 umol/kg,,BAO_0000019,16032,
,,A,,Autocuration,0,,22224,CHEMBL625025,1088.0,12502,,,,U,Urine,1,,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in urine by subcutaneous dose of 150 umol/kg,,BAO_0000019,16032,
,,A,,Intermediate,1,,50597,CHEMBL625026,178.0,12503,Rattus norvegicus,,10116.0,N,Blood,1,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL625027,178.0,12504,Rattus norvegicus,,10116.0,N,Blood,1,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL874410,178.0,12505,Rattus norvegicus,,10116.0,N,Blood,1,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL625028,178.0,12506,Rattus norvegicus,,10116.0,N,Blood,1,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL625029,178.0,12507,Rattus norvegicus,,10116.0,N,Blood,1,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL625030,178.0,12508,Rattus norvegicus,,10116.0,N,Blood,1,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL625031,178.0,12509,Rattus norvegicus,,10116.0,N,Blood,1,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL625032,178.0,12510,Rattus norvegicus,,10116.0,N,Blood,1,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL625033,178.0,12511,Rattus norvegicus,,10116.0,N,Blood,1,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL625034,178.0,12512,Rattus norvegicus,,10116.0,N,Blood,1,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL624872,948.0,12513,Rattus norvegicus,,10116.0,N,Heart,1,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL624873,948.0,12514,Rattus norvegicus,,10116.0,N,Heart,1,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL624874,948.0,12515,Rattus norvegicus,,10116.0,N,Heart,1,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL624875,948.0,12516,Rattus norvegicus,,10116.0,N,Heart,1,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL624876,948.0,12517,Rattus norvegicus,,10116.0,N,Heart,1,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL624877,948.0,12518,Rattus norvegicus,,10116.0,N,Heart,1,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL624878,948.0,12519,Rattus norvegicus,,10116.0,N,Heart,1,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL624879,948.0,12520,Rattus norvegicus,,10116.0,N,Heart,1,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL624880,948.0,12521,Rattus norvegicus,,10116.0,N,Heart,1,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL624881,948.0,12522,Rattus norvegicus,,10116.0,N,Heart,1,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 10 min (radiolabeled with [125I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL624882,948.0,12523,Rattus norvegicus,,10116.0,N,Heart,1,,"Concentration was measured in heart tissue of unfasted Fischer 344 rats, administered intravenous, after 5 minute (radiolabeled with [125I]-",,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL624883,2113.0,12524,Rattus norvegicus,,10116.0,N,Kidney,1,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL624884,2113.0,12525,Rattus norvegicus,,10116.0,N,Kidney,1,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL624885,2113.0,12526,Rattus norvegicus,,10116.0,N,Kidney,1,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL624886,2113.0,12527,Rattus norvegicus,,10116.0,N,Kidney,1,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL624887,2113.0,12528,Rattus norvegicus,,10116.0,N,Kidney,1,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL624888,2113.0,12529,Rattus norvegicus,,10116.0,N,Kidney,1,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL624889,2113.0,12530,Rattus norvegicus,,10116.0,N,Kidney,1,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL624890,2113.0,12531,Rattus norvegicus,,10116.0,N,Kidney,1,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL621964,2113.0,12532,Rattus norvegicus,,10116.0,N,Kidney,1,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL621965,2113.0,12533,Rattus norvegicus,,10116.0,N,Kidney,1,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL621966,2107.0,12534,Rattus norvegicus,,10116.0,N,Liver,1,,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL621967,2107.0,12535,Rattus norvegicus,,10116.0,N,Liver,1,,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL622164,2107.0,12536,Rattus norvegicus,,10116.0,N,Liver,1,,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,BAO_0000218,8594,
,,A,,Autocuration,0,,22224,CHEMBL623097,,12537,,,,U,,1,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (nucleic acids),,BAO_0000019,7653,
,,A,,Autocuration,0,,22224,CHEMBL623098,,12538,,,,U,,1,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (protein),,BAO_0000019,7653,
,,A,,Autocuration,0,,22224,CHEMBL623099,,12539,,,,U,,1,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid soluble,,BAO_0000019,7653,
,,A,,Autocuration,0,,22224,CHEMBL623100,,12540,,,,U,,1,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; total uptake,,BAO_0000019,7653,
,,A,,Intermediate,1,,50597,CHEMBL628673,,12541,Rattus norvegicus,,10116.0,N,,1,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated Number of new tumors observed",,BAO_0000218,9104,
,,A,,Intermediate,1,,50597,CHEMBL628674,,12542,Rattus norvegicus,,10116.0,N,,1,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated complete percent remission indicates tumor not palpable.",,BAO_0000218,9104,
,,A,,Intermediate,1,,50597,CHEMBL628675,,12543,Rattus norvegicus,,10116.0,N,,1,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated number of tumors at the beginning of the test.",,BAO_0000218,9104,
,,A,,Intermediate,1,,50597,CHEMBL627644,,12544,Rattus norvegicus,,10116.0,N,,1,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated of percent static tumors indicates size of tumor 51-150% of the initial size",,BAO_0000218,9104,
,,A,,Intermediate,1,,50597,CHEMBL627645,,12545,Rattus norvegicus,,10116.0,N,,1,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated partial percent remission indicates reduction of initial tumor size <=50%.",,BAO_0000218,9104,
,,A,,Intermediate,1,,50597,CHEMBL627646,,12546,Rattus norvegicus,,10116.0,N,,1,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent progress in tumor size indicates >150% of the initial size",,BAO_0000218,9104,
,,A,,Intermediate,1,,50597,CHEMBL627647,,12547,Rattus norvegicus,,10116.0,N,,1,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent static tumors indicates size of tumor 51-150% of the initial size",,BAO_0000218,9104,
,,A,,Intermediate,1,,50597,CHEMBL627648,,12548,Rattus norvegicus,,10116.0,N,,1,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent tumor area measured as the average on the 28th day of therapy.",,BAO_0000218,9104,
,,A,,Intermediate,1,,50597,CHEMBL627649,,12549,Rattus norvegicus,,10116.0,N,,1,,Free level in rat plasma,,BAO_0000218,12902,
,,A,,Autocuration,0,,22224,CHEMBL628313,,12550,,,,U,,1,,Level reaching in blood plasma of rat or human was determined,,BAO_0000019,6614,
,,A,,Intermediate,1,,50597,CHEMBL628314,,12551,Rattus norvegicus,,10116.0,N,,1,,Log (Cbrain/Cblood) in rats,,BAO_0000218,9663,
,,A,,Autocuration,0,,22224,CHEMBL628315,,12552,,,,U,,1,,Mean percentage of compound transport through P-glycoprotein; expressed as p-glycoprotein affinity,,BAO_0000019,17658,
,,A,,Autocuration,0,,22224,CHEMBL628316,,12553,,,,U,,1,,Mean percentage of compound transport through membrane; expressed as membrane transport,,BAO_0000019,17658,
,,A,,Autocuration,0,,22224,CHEMBL628317,,12554,,,,U,,1,,Metabolic breakdown to the o-sulfate of p-chloroaniline (2-amino-5-chlorophenyl sulfate) by giving 100 mg/kg oral doses of the compound,,BAO_0000218,14314,
,,A,,Autocuration,0,,22224,CHEMBL628473,,12555,,,,U,,1,,Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5,,BAO_0000019,7385,
,,A,,Autocuration,0,,22224,CHEMBL628474,,12556,,,,U,,1,,"Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5, ND=Not determined",,BAO_0000019,7385,
,,A,,Autocuration,0,,22224,CHEMBL628475,,12557,,,,U,,1,,Michaelis-Menten constant was measured in the inactivation of trypsin; Km x 10 e5,,BAO_0000019,7385,
,,A,,Autocuration,0,,22224,CHEMBL628476,,12558,,,,U,,1,,Net water uptake by a carrier mediated transport (%cm) mechanism,,BAO_0000019,1329,
,,A,,Autocuration,0,,22224,CHEMBL628477,,12559,Simiiformes,,314293.0,U,,1,,Peak concentration was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,,BAO_0000218,12187,
,,A,,Intermediate,1,,50506,CHEMBL628478,,12560,Mustela putorius furo,,9669.0,N,,1,,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,,BAO_0000218,12187,
,,A,,Intermediate,1,,50506,CHEMBL628479,,12561,Mustela putorius furo,,9669.0,N,,1,,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",,BAO_0000218,12187,
,,A,,Autocuration,0,,22224,CHEMBL628480,,12562,Simiiformes,,314293.0,U,,1,,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,,BAO_0000218,12187,
,,A,,Autocuration,0,,22224,CHEMBL628481,,12563,Simiiformes,,314293.0,U,,1,,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey, determined by renin inhibition assay",,BAO_0000218,12187,
,,A,,Intermediate,1,,50597,CHEMBL628482,,12564,Rattus norvegicus,,10116.0,N,,1,,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,,BAO_0000218,12187,
,,A,,Intermediate,1,,50597,CHEMBL628483,,12565,Rattus norvegicus,,10116.0,N,,1,,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",,BAO_0000218,12187,
,,A,,Intermediate,1,,50597,CHEMBL628484,1969.0,12566,Rattus norvegicus,,10116.0,N,Plasma,1,,"Peak plasma concentration at a dose of 10 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",,BAO_0000218,9278,
,,A,,Intermediate,1,,50597,CHEMBL628485,1969.0,12567,Rattus norvegicus,,10116.0,N,Plasma,1,,"Peak plasma concentration at a dose of 100 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",,BAO_0000218,9278,
,,A,,Intermediate,1,,100710,CHEMBL628486,1969.0,12568,Macaca fascicularis,,9541.0,N,Plasma,1,,"Peak plasma concentration at a dose of 20 mg/kg, oral route in monkey (Macaca fascicularis) suspended in carboxymethyl cellulose (CMC);Range is between (5.5-6)",,BAO_0000218,9278,
,,A,,Intermediate,1,,50587,CHEMBL628487,1969.0,12569,Homo sapiens,,9606.0,N,Plasma,1,,"Peak plasma concentration at a dose of 200 mg/kg, oral route in human",,BAO_0000218,9278,
,,A,,Intermediate,1,,50597,CHEMBL628488,1969.0,12570,Rattus norvegicus,,10116.0,N,Plasma,1,,"Peak plasma concentration at a dose of 25 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",,BAO_0000218,9278,
,,A,,Intermediate,1,,50597,CHEMBL628489,1969.0,12571,Rattus norvegicus,,10116.0,N,Plasma,1,,"Peak plasma concentration at a dose of 25 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",,BAO_0000218,9278,
,,A,,Intermediate,1,,50597,CHEMBL628490,1969.0,12572,Rattus norvegicus,,10116.0,N,Plasma,1,,"Peak plasma concentration at a dose of 50 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",,BAO_0000218,9278,
,,A,,Intermediate,1,,100710,CHEMBL628491,,12573,Macaca fascicularis,,9541.0,N,,1,,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,,BAO_0000218,12186,
,,A,,Intermediate,1,,100710,CHEMBL877507,,12574,Macaca fascicularis,,9541.0,N,,1,,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,,BAO_0000218,12186,
,,A,,Autocuration,0,,22224,CHEMBL628492,,12575,,,,U,,1,,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,,BAO_0000218,12186,
,,A,,Autocuration,0,,22224,CHEMBL628493,,12576,Simiiformes,,314293.0,U,,1,,% metabolized in monkey S-9 after 2 hours (10 ug/mL),,BAO_0000019,12041,
,,A,,Autocuration,0,,22224,CHEMBL628494,,12577,Simiiformes,,314293.0,U,,1,,% metabolized in monkey S-9 after 2 hours (1 ug/ml),,BAO_0000019,12041,
,,A,,Autocuration,0,,22224,CHEMBL628495,,12578,Simiiformes,,314293.0,U,,1,,% metabolized in monkey S-9 after 2 hours (10 ug/ml),,BAO_0000019,12041,
,,A,,Intermediate,1,,50587,CHEMBL628496,,12579,Homo sapiens,,9606.0,N,,1,,Permeability in Caco-2 assay at 10E-6,,BAO_0000218,6737,
,,A,,Autocuration,0,,22224,CHEMBL628497,955.0,12580,,,,U,Brain,1,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,,BAO_0000218,13758,
,,A,,Autocuration,0,,22224,CHEMBL628498,955.0,12581,,,,U,Brain,1,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,,BAO_0000218,13758,
,,A,,Autocuration,0,,22224,CHEMBL628499,,12582,,,,U,,1,,Plasma protein binding was determined,,BAO_0000019,5676,
,,A,,Autocuration,0,,22224,CHEMBL627656,,12583,,,,U,,1,,Brain concentration after 2 hr at a dose of 100 mg/kg when administered perorally,,BAO_0000218,14793,
,,A,,Autocuration,0,,22224,CHEMBL627657,,12584,,,,U,,1,,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intraperitoneally,,BAO_0000218,14793,
,,A,,Autocuration,0,,22224,CHEMBL626808,,12585,,,,U,,1,,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intravenously,,BAO_0000218,14793,
,,A,,Autocuration,0,,22224,CHEMBL626809,,12586,,,,U,,1,,Brain concentration after 2 hr at a dose of 10 mg/kg when administered perorally,,BAO_0000218,14793,
,,A,,Autocuration,0,,22224,CHEMBL626810,,12587,,,,U,,1,,Brain concentration after 4 hr at a dose of 100 mg/kg when administered perorally,,BAO_0000218,14793,
,,A,,Autocuration,0,,22224,CHEMBL626811,,12588,,,,U,,1,,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intraperitoneally,,BAO_0000218,14793,
,,A,,Autocuration,0,,22224,CHEMBL874465,,12589,,,,U,,1,,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intravenously,,BAO_0000218,14793,
,,A,,Autocuration,0,,22224,CHEMBL626812,,12590,,,,U,,1,,Brain concentration after 4 hr at a dose of 10 mg/kg when administered perorally,,BAO_0000218,14793,
,,A,,Autocuration,0,,22224,CHEMBL626813,,12591,,,,U,,1,,Brain concentration after 6 hr at a dose of 100 mg/kg when administered perorally,,BAO_0000218,14793,
,,A,,Autocuration,0,,22224,CHEMBL626814,,12592,,,,U,,1,,Brain concentration after 6 hr at a dose of 10 mg/kg when administered perorally,,BAO_0000218,14793,
,,A,,Autocuration,0,,22224,CHEMBL626815,,12593,,,,U,,1,,Bullaticin index relates the IC50 values by normalizing to the value of bullatacin for easy comparison.,,BAO_0000019,14000,
,,A,,Autocuration,0,,22224,CHEMBL628566,,12594,,,,U,,1,,Partition coefficient (logP),,BAO_0000019,5948,
,,P,,Autocuration,0,,22229,CHEMBL628567,,12595,,,,U,,1,,Calculated partition coefficient (clogP) (CLOGP3 V3.4),,BAO_0000100,13824,
,,P,,Autocuration,0,,22229,CHEMBL628568,,12596,,,,U,,1,,Calculated partition coefficient (clogP),,BAO_0000100,10778,
In vivo,,A,,Intermediate,1,,50588,CHEMBL628569,,12597,Canis lupus familiaris,,9615.0,N,,1,,C max in dog,,BAO_0000218,17237,
In vivo,,A,,Intermediate,1,,50512,CHEMBL628570,,12598,Cavia porcellus,,10141.0,N,,1,,C max in guinea pig,,BAO_0000218,17237,
In vivo,,A,,Autocuration,0,,22224,CHEMBL628571,,12599,,,,U,,1,,C max value was evaluated,,BAO_0000218,2809,
In vivo,,A,,Autocuration,0,,22224,CHEMBL628572,,12600,,,,U,,1,,Cmax value after oral dose of 0.1 mg//kg,,BAO_0000218,11954,
In vivo,,A,,Autocuration,0,,22224,CHEMBL628573,,12601,,,,U,,1,,Cmax value after oral dose of 0.3 mg/kg,,BAO_0000218,11954,
In vivo,,A,,Autocuration,0,,22224,CHEMBL628574,,12602,,,,U,,1,,Cmax value after oral dose of 1 mg/kg,,BAO_0000218,11954,
In vivo,,A,,Autocuration,0,,22224,CHEMBL628575,,12603,,,,U,,1,,Cmax value after oral dose of 10 mg/kg,,BAO_0000218,11954,
In vivo,,A,,Autocuration,0,,22224,CHEMBL628576,,12604,,,,U,,1,,Cmax value after oral dose of 23.4 mg/kg,,BAO_0000218,11954,
In vivo,,A,,Autocuration,0,,22224,CHEMBL628577,,12605,,,,U,,1,,Cmax value after oral dose of 3 mg/kg,,BAO_0000218,11954,
In vivo,,A,,Autocuration,0,,22224,CHEMBL628578,,12606,,,,U,,1,,Cmax value after oral dose of 3.87 mg/kg,,BAO_0000218,11954,
In vivo,,A,,Intermediate,1,,50588,CHEMBL874466,,12607,Canis lupus familiaris,,9615.0,N,,1,,Cmax value in female Beagle dogs,,BAO_0000218,12768,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628579,,12608,Rattus norvegicus,,10116.0,N,,1,,Cmax value in male rats,,BAO_0000218,12768,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628580,1969.0,12609,Rattus norvegicus,,10116.0,N,Plasma,1,,Cmax value in rat plasma when administered 20 mg/kg perorally,,BAO_0000218,12780,
In vivo,,A,,Intermediate,1,,50588,CHEMBL628581,1969.0,12610,Canis lupus familiaris,,9615.0,N,Plasma,1,,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,,BAO_0000218,15592,
In vivo,,A,,Intermediate,1,,50588,CHEMBL628582,1969.0,12611,Canis lupus familiaris,,9615.0,N,Plasma,1,,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,,BAO_0000218,15592,
,,A,,Intermediate,1,,50588,CHEMBL628583,,12612,Canis lupus familiaris,,9615.0,N,,1,,Peak concentration of compound at Time = 0 was determined in dog at 5 mg/kg intravenously admn.,,BAO_0000218,17025,
,,A,,Autocuration,0,,22224,CHEMBL625782,,12613,Simiiformes,,314293.0,U,,1,,Peak concentration of compound at Time = 0 was determined in monkey at 5 mg/kg intravenously admn.,,BAO_0000218,17025,
,,A,,Intermediate,1,,50592,CHEMBL625783,,12614,Oryctolagus cuniculus,,9986.0,N,,1,,Peak concentration of compound at Time = 0 was determined in rabbit at 5 mg/kg intravenously admn.,,BAO_0000218,17025,
,,A,,Intermediate,1,,50597,CHEMBL625784,,12615,Rattus norvegicus,,10116.0,N,,1,,Peak concentration of compound at Time = 0 was determined in rat at 5 mg/kg intravenously admn.,,BAO_0000218,17025,
,,A,,Intermediate,1,,50797,CHEMBL625785,1969.0,12616,Macaca mulatta,,9544.0,N,Plasma,1,,Total plasma concentration at 24 hr at a dose of 10 mg/kg when administered orally to rhesus monkey,,BAO_0000218,4236,
,,A,,Intermediate,1,,50597,CHEMBL625786,,12617,Rattus norvegicus,,10116.0,N,,1,,C5min (nM) value was determined in rats after intravenous dose of 5 mg/kg,,BAO_0000218,15791,
,,A,,Autocuration,0,,22224,CHEMBL874467,,12618,,,,U,,1,,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate,,BAO_0000019,11149,
,,A,,Intermediate,1,,50588,CHEMBL625787,,12619,Canis lupus familiaris,,9615.0,N,,1,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",,BAO_0000218,15592,
,,A,,Intermediate,1,,50677,CHEMBL625964,,12620,Human immunodeficiency virus,,12721.0,N,,1,,cytotoxicity against HIV protease enzyme.,,BAO_0000218,15778,
,,A,,Intermediate,1,,50594,CHEMBL625965,,12621,Mus musculus,,10090.0,N,,1,,Apparent clearance in mice after intravenous administration of 105.1 mg/kg of dose,,BAO_0000218,12745,
,,A,,Intermediate,1,,50594,CHEMBL625966,,12622,Mus musculus,,10090.0,N,,1,,Apparent clearance in mice after oral administration of 100 mg/kg of dose,,BAO_0000218,12745,
In vivo,,A,,Intermediate,1,,50588,CHEMBL625967,1969.0,12623,Canis lupus familiaris,,9615.0,N,Plasma,1,,The plasma clearance in dog.,,BAO_0000218,13941,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625968,1969.0,12624,Rattus norvegicus,,10116.0,N,Plasma,1,,The plasma clearance in rat.,,BAO_0000218,13941,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625969,1969.0,12625,Rattus norvegicus,,10116.0,N,Plasma,1,,Clearance from plasma in male Sprague-Dawley rats,,BAO_0000218,16449,
In vivo,,A,,Intermediate,1,,100710,CHEMBL625970,1969.0,12626,Macaca fascicularis,,9541.0,N,Plasma,1,,Clearance from plasma in male cynomolgus monkeys,,BAO_0000218,16449,
In vivo,,A,,Intermediate,1,,50588,CHEMBL625971,1969.0,12627,Canis lupus familiaris,,9615.0,N,Plasma,1,,"Clearance of compound (5 mg/kg, intravenously), in dog plasma",,BAO_0000218,14224,
In vivo,,A,,Intermediate,1,,50588,CHEMBL625972,1969.0,12628,Canis lupus familiaris,,9615.0,N,Plasma,1,,Clearance of compound in dog plasma,,BAO_0000218,14224,
In vivo,,A,,Intermediate,1,,50587,CHEMBL625973,1969.0,12629,Homo sapiens,,9606.0,N,Plasma,1,,Clearance of compound in human plasma,,BAO_0000218,14224,
In vivo,,A,,Intermediate,1,,50588,CHEMBL625974,,12630,Canis lupus familiaris,,9615.0,N,,1,,Clearance of compound when administered intravenously as a mixture (five-in-one dose) to a single dog.,,BAO_0000218,14317,
In vivo,,A,,Intermediate,1,,50588,CHEMBL625975,,12631,Canis lupus familiaris,,9615.0,N,,1,,Clearance of compound when administered intravenously as an individual dose to a single dog.,,BAO_0000218,14317,
In vivo,,A,,Intermediate,1,,50588,CHEMBL625976,1969.0,12632,Canis lupus familiaris,,9615.0,N,Plasma,1,,"Clearance (10 mg/kg, intravenously) in dog plasma",,BAO_0000218,14224,
In vivo,,A,,Intermediate,1,,50588,CHEMBL625977,,12633,Canis lupus familiaris,,9615.0,N,,1,,Clearance value in dog,,BAO_0000218,17237,
In vivo,,A,,Intermediate,1,,50512,CHEMBL625978,,12634,Cavia porcellus,,10141.0,N,,1,,Clearance value in guinea pig,,BAO_0000218,17237,
In vivo,,A,,Intermediate,1,,50597,CHEMBL874468,,12635,Rattus norvegicus,,10116.0,N,,1,,Clearance values in rats after iv administration.,,BAO_0000218,14187,
In vivo,,A,,Autocuration,0,,22224,CHEMBL625421,1969.0,12636,,,,U,Plasma,1,,Compound was tested for plasma clearance on administered orally as aqueous solutions at 1 mpk and by iv at 0.2 mpk,,BAO_0000218,4806,
In vivo,,A,,Intermediate,1,,50592,CHEMBL625422,,12637,Oryctolagus cuniculus,,9986.0,N,,1,,In vivo clearance (5 mg/kg) was determined in rabbits,,BAO_0000218,15025,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625423,,12638,Rattus norvegicus,,10116.0,N,,1,,Plasma Clearance rate was determined for the compound in rats,,BAO_0000218,13197,
In vivo,,A,,Autocuration,0,,22224,CHEMBL625424,,12639,Saimiri,,9520.0,U,,1,,Plasma Clearance rate was determined for the compound in squirrel monkeys,,BAO_0000218,13197,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625425,,12640,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance in rat,,BAO_0000218,13960,
In vivo,,A,,Autocuration,0,,22224,CHEMBL625426,,12641,,,,U,,1,,Plasma clearance of the compound,,BAO_0000218,17820,
In vivo,,A,,Intermediate,1,,50512,CHEMBL625427,,12642,Cavia porcellus,,10141.0,N,,1,,Plasma clearance in guinea pigs at 2 mg/kg after iv administration,,BAO_0000218,14706,
In vivo,,A,,Intermediate,1,,50512,CHEMBL625428,,12643,Cavia porcellus,,10141.0,N,,1,,Plasma clearance in guinea pigs at 3 mg/kg after iv administration,,BAO_0000218,14706,
In vivo,,A,,Autocuration,0,,22224,CHEMBL625429,,12644,,,,U,,1,,Plasma clearance was determined,,BAO_0000218,6504,
In vivo,,A,,Intermediate,1,,50588,CHEMBL625430,,12645,Canis lupus familiaris,,9615.0,N,,1,,Plasma clearance rate (CL) was determined in dogs after intravenous administration of 25 mg/kg of the compound.,,BAO_0000218,14925,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625431,,12646,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance rate was determined for the compound in rats,,BAO_0000218,13197,
In vivo,,A,,Autocuration,0,,22224,CHEMBL627307,,12647,Saimiri,,9520.0,U,,1,,Plasma clearance rate was determined for the compound in squirrel monkeys,,BAO_0000218,13197,
In vivo,,A,,Autocuration,0,,22224,CHEMBL627308,,12648,,,,U,,1,,Slow clearance (CL) was determined,,BAO_0000218,3437,
,,A,,Autocuration,0,,22224,CHEMBL627309,,12649,,,,U,,1,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,,BAO_0000218,9196,
,,A,,Autocuration,0,,22224,CHEMBL627310,,12650,,,,U,,1,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr; insufficient gastric juice produced,,BAO_0000218,9196,
,,A,,Autocuration,0,,22224,CHEMBL627311,,12651,,,,U,,1,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,,BAO_0000218,9196,
,,A,,Autocuration,0,,22224,CHEMBL627312,,12652,,,,U,,1,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,,BAO_0000218,9196,
,,A,,Autocuration,0,,22224,CHEMBL627313,,12653,,,,U,,1,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,,BAO_0000218,9196,
,,A,,Autocuration,0,,22224,CHEMBL627314,,12654,,,,U,,1,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,,BAO_0000218,9196,
,,A,,Autocuration,0,,22224,CHEMBL627315,,12655,,,,U,,1,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,,BAO_0000218,9196,
,,A,,Autocuration,0,,22224,CHEMBL627316,,12656,,,,U,,1,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,BAO_0000218,9196,
,,A,,Autocuration,0,,22224,CHEMBL627317,,12657,,,,U,,1,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,BAO_0000218,9196,
,,A,,Autocuration,0,,22224,CHEMBL627318,,12658,,,,U,,1,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,BAO_0000218,9196,
,,A,,Autocuration,0,,22224,CHEMBL627999,,12659,,,,U,,1,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,,BAO_0000218,9196,
,,A,,Autocuration,0,,22224,CHEMBL628000,,12660,,,,U,,1,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,BAO_0000218,9196,
,,A,,Autocuration,0,,22224,CHEMBL628001,,12661,,,,U,,1,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,,BAO_0000218,9196,
,,A,,Autocuration,0,,22224,CHEMBL628002,,12662,,,,U,,1,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,BAO_0000218,9196,
,,A,,Autocuration,0,,22224,CHEMBL625610,,12663,,,,U,,1,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,,BAO_0000218,9196,
,,A,,Autocuration,0,,22224,CHEMBL625611,,12664,,,,U,,1,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,BAO_0000218,9196,
,,A,,Autocuration,0,,22224,CHEMBL625612,,12665,,,,U,,1,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,,BAO_0000218,9196,
,,A,,Autocuration,0,,22224,CHEMBL625613,,12666,,,,U,,1,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,,BAO_0000218,9196,
,,A,,Autocuration,0,,22224,CHEMBL875479,,12667,,,,U,,1,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,BAO_0000218,9196,
,,A,,Autocuration,0,,22224,CHEMBL625614,,12668,,,,U,,1,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,,BAO_0000218,9196,
,,A,,Autocuration,0,,22224,CHEMBL625615,,12669,,,,U,,1,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,,BAO_0000218,9196,
,,A,,Autocuration,0,,22224,CHEMBL626302,,12670,,,,U,,1,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,,BAO_0000218,9196,
,,A,,Intermediate,1,,50597,CHEMBL626303,178.0,12671,Rattus norvegicus,,10116.0,N,Blood,1,,Cumulative concentration 6b and compound 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,BAO_0000218,8374,
,,A,,Intermediate,1,,50597,CHEMBL627420,178.0,12672,Rattus norvegicus,,10116.0,N,Blood,1,,Cumulative concentration 6b and compound 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,BAO_0000218,8374,
,,A,,Intermediate,1,,50597,CHEMBL627421,,12673,Rattus norvegicus,,10116.0,N,,1,,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 1 hour relative to initial concentration of 1 uM,,BAO_0000218,13477,
,,A,,Intermediate,1,,50597,CHEMBL625695,,12674,Rattus norvegicus,,10116.0,N,,1,,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 24 hour relative to initial concentration of 1 uM,,BAO_0000218,13477,
,,A,,Intermediate,1,,50597,CHEMBL625696,,12675,Rattus norvegicus,,10116.0,N,,1,,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 4 hour relative to initial concentration of 1 uM,,BAO_0000218,13477,
,,A,,Intermediate,1,,50594,CHEMBL875606,955.0,12676,Mus musculus,,10090.0,N,Brain,1,,Distribution of compound in mice brain was measured after 1 hr,,BAO_0000218,10009,
,,A,,Intermediate,1,,50594,CHEMBL625697,955.0,12677,Mus musculus,,10090.0,N,Brain,1,,Distribution of compound in mice brain was measured after 24 hr r,,BAO_0000218,10009,
,,A,,Intermediate,1,,50594,CHEMBL625698,955.0,12678,Mus musculus,,10090.0,N,Brain,1,,Distribution of compound in mice brain was measured after 2 hr,,BAO_0000218,10009,
,,A,,Intermediate,1,,50594,CHEMBL625699,955.0,12679,Mus musculus,,10090.0,N,Brain,1,,Distribution of compound in mice brain was measured after 3 hr,,BAO_0000218,10009,
,,A,,Intermediate,1,,50594,CHEMBL625700,955.0,12680,Mus musculus,,10090.0,N,Brain,1,,Distribution of compound in mice brain was measured after 6 hr,,BAO_0000218,10009,
,,A,,Intermediate,1,,50594,CHEMBL625701,,12681,Mus musculus,,10090.0,N,,1,,Distribution of compound in mice liver was measured after 1 hr,,BAO_0000218,10009,
,,A,,Intermediate,1,,50594,CHEMBL625702,,12682,Mus musculus,,10090.0,N,,1,,Distribution of compound in mice liver was measured after 24 hr; b=Undetected,,BAO_0000218,10009,
,,A,,Intermediate,1,,50594,CHEMBL625703,,12683,Mus musculus,,10090.0,N,,1,,Distribution of compound in mice liver was measured after 2 hr,,BAO_0000218,10009,
,,A,,Intermediate,1,,50594,CHEMBL625704,,12684,Mus musculus,,10090.0,N,,1,,Distribution of compound in mice liver was measured after 3 hr,,BAO_0000218,10009,
,,A,,Intermediate,1,,50594,CHEMBL625705,,12685,Mus musculus,,10090.0,N,,1,,Distribution of compound in mice liver was measured after 6 hr,,BAO_0000218,10009,
,,A,,Intermediate,1,,50588,CHEMBL625706,1236.0,12686,Canis lupus familiaris,,9615.0,N,Adrenal medulla,1,,Distribution in dog adrenal medulla 30 min after administration.,,BAO_0000218,8170,
,,A,,Intermediate,1,,50588,CHEMBL625707,1236.0,12687,Canis lupus familiaris,,9615.0,N,Adrenal medulla,1,,Distribution in dog adrenal medulla 72 hours after administration.,,BAO_0000218,8170,
,,A,,Intermediate,1,,50588,CHEMBL625708,,12688,Canis lupus familiaris,,9615.0,N,,1,,Distribution in female dog Ovary 24 hours after administration.,,BAO_0000218,8170,
,,A,,Intermediate,1,,50588,CHEMBL625709,,12689,Canis lupus familiaris,,9615.0,N,,1,,Distribution in female dog Ovary 72 hours after administration.,,BAO_0000218,8170,
,,A,,Intermediate,1,,50588,CHEMBL624180,,12690,Canis lupus familiaris,,9615.0,N,,1,,Distribution in female dog adipose 24 hours after administration.,,BAO_0000218,8170,
,,A,,Intermediate,1,,50588,CHEMBL624181,,12691,Canis lupus familiaris,,9615.0,N,,1,,Distribution in female dog adipose 72 hours after administration.,,BAO_0000218,8170,
,,A,,Intermediate,1,,50588,CHEMBL624182,1235.0,12692,Canis lupus familiaris,,9615.0,N,Adrenal cortex,1,,Distribution in female dog adrenal cortex 72 hours after administration.,,BAO_0000218,8170,
,,A,,Intermediate,1,,50588,CHEMBL624183,1235.0,12693,Canis lupus familiaris,,9615.0,N,Adrenal cortex,1,,Distribution in female dog adrenal cortex 72 hours after administration.,,BAO_0000218,8170,
,,A,,Intermediate,1,,50597,CHEMBL624184,2107.0,12694,Rattus norvegicus,,10116.0,N,Liver,1,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL877489,2107.0,12695,Rattus norvegicus,,10116.0,N,Liver,1,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL624185,2107.0,12696,Rattus norvegicus,,10116.0,N,Liver,1,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL624186,2107.0,12697,Rattus norvegicus,,10116.0,N,Liver,1,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL624187,2107.0,12698,Rattus norvegicus,,10116.0,N,Liver,1,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL624188,2107.0,12699,Rattus norvegicus,,10116.0,N,Liver,1,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL624189,2048.0,12700,Rattus norvegicus,,10116.0,N,Lung,1,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL624190,2048.0,12701,Rattus norvegicus,,10116.0,N,Lung,1,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL624191,2048.0,12702,Rattus norvegicus,,10116.0,N,Lung,1,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL624192,2048.0,12703,Rattus norvegicus,,10116.0,N,Lung,1,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL624193,2048.0,12704,Rattus norvegicus,,10116.0,N,Lung,1,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL624194,2048.0,12705,Rattus norvegicus,,10116.0,N,Lung,1,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL624891,2048.0,12706,Rattus norvegicus,,10116.0,N,Lung,1,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL624892,2048.0,12707,Rattus norvegicus,,10116.0,N,Lung,1,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL624893,2048.0,12708,Rattus norvegicus,,10116.0,N,Lung,1,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL627632,2048.0,12709,Rattus norvegicus,,10116.0,N,Lung,1,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL627633,,12710,Rattus norvegicus,,10116.0,N,,1,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL627634,,12711,Rattus norvegicus,,10116.0,N,,1,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL627635,,12712,Rattus norvegicus,,10116.0,N,,1,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL627636,,12713,Rattus norvegicus,,10116.0,N,,1,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL626816,,12714,Rattus norvegicus,,10116.0,N,,1,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL626817,,12715,Rattus norvegicus,,10116.0,N,,1,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL626818,,12716,Rattus norvegicus,,10116.0,N,,1,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL626819,,12717,Rattus norvegicus,,10116.0,N,,1,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL626820,,12718,Rattus norvegicus,,10116.0,N,,1,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL626821,,12719,Rattus norvegicus,,10116.0,N,,1,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL626822,2046.0,12720,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL626823,2046.0,12721,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL626824,2046.0,12722,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL626825,2046.0,12723,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL626826,2046.0,12724,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL626827,2046.0,12725,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL626828,2046.0,12726,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL626829,2046.0,12727,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL626830,2046.0,12728,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL627150,,12729,Rattus norvegicus,,10116.0,N,,1,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL627151,,12730,Rattus norvegicus,,10116.0,N,,1,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL627152,,12731,Rattus norvegicus,,10116.0,N,,1,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL627153,,12732,Rattus norvegicus,,10116.0,N,,1,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,BAO_0000218,8594,
,,A,,Autocuration,0,,22224,CHEMBL627154,,12733,,,,U,,1,,Rate of acetate production by the compound was determined,,BAO_0000019,12904,
,,A,,Autocuration,0,,22224,CHEMBL627155,,12734,,,,U,,1,,Rate of acetate production by the compound was determined; Not determined,,BAO_0000019,12904,
,,A,,Autocuration,0,,22224,CHEMBL627156,,12735,,,,U,,1,,Rate of hydrolysis of nitrocefin by compound was evaluated in water,,BAO_0000019,3730,
,,A,,Autocuration,0,,22224,CHEMBL627157,,12736,,,,U,,1,,Reductive elimination of leaving group was determined at pH 7.4; expressed as loss of parent,,BAO_0000019,3627,
,,A,,Intermediate,1,,50592,CHEMBL627158,,12737,Oryctolagus cuniculus,,9986.0,N,,1,,Relative concentration of compound (70 mg/Kg) in brain compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,,BAO_0000218,13799,
,,A,,Intermediate,1,,50592,CHEMBL627159,1969.0,12738,Oryctolagus cuniculus,,9986.0,N,Plasma,1,,Relative concentration of compound (70 mg/Kg) in lung compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,,BAO_0000218,13799,
,,A,,Intermediate,1,,50594,CHEMBL627160,,12739,Mus musculus,,10090.0,N,,1,,Relative concentration of compound in brain compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,,BAO_0000218,13799,
,,A,,Intermediate,1,,50597,CHEMBL628540,,12740,Rattus norvegicus,,10116.0,N,,1,,Relative concentration of compound in brain compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,,BAO_0000218,13799,
,,A,,Intermediate,1,,50597,CHEMBL628541,1969.0,12741,Rattus norvegicus,,10116.0,N,Plasma,1,,Relative concentration of compound in lung compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,,BAO_0000218,13799,
,,A,,Intermediate,1,,50597,CHEMBL628542,1969.0,12742,Rattus norvegicus,,10116.0,N,Plasma,1,,Relative concentration of compound in lung compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,,BAO_0000218,13799,
,,P,,Autocuration,0,,22229,CHEMBL628543,,12743,,,,U,,1,,Solubility after at a pH 1.2,,BAO_0000100,6629,
,,P,,Autocuration,0,,22229,CHEMBL628544,,12744,,,,U,,1,,Solubility after at pH 1.2,,BAO_0000100,6629,
,,P,,Autocuration,0,,22229,CHEMBL628545,,12745,,,,U,,1,,Solubility after injection of water,,BAO_0000100,6629,
,,A,,Autocuration,0,,22224,CHEMBL628546,,12746,,,,U,,1,,Statistical significance of IC 50 values; Expressed as R value,,BAO_0000019,14000,
,,A,,Autocuration,0,,22224,CHEMBL874455,,12747,,,,U,,1,,Systemic availability with respect to methyldopa was determined,,BAO_0000019,8267,
,,A,,Intermediate,1,,50597,CHEMBL628547,,12748,Rattus norvegicus,,10116.0,N,,1,,Tissue distribution of the in rat brain relative to plasma concentration of 1 ug/kg; relative concentration,,BAO_0000218,13799,
,,A,,Intermediate,1,,50597,CHEMBL628548,1969.0,12749,Rattus norvegicus,,10116.0,N,Plasma,1,,Tissue distribution of the in rat lung relative to plasma concentration of 1 ug/kg; relative concentration,,BAO_0000218,13799,
,,A,,Intermediate,1,,50592,CHEMBL628549,1988.0,12750,Oryctolagus cuniculus,,9986.0,N,Feces,1,,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated",,BAO_0000218,7132,
,,A,,Intermediate,1,,50592,CHEMBL628550,1988.0,12751,Oryctolagus cuniculus,,9986.0,N,Feces,1,,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 liver, and radioactivity content in feces was estimated",,BAO_0000218,7132,
,,A,,Intermediate,1,,50592,CHEMBL628551,1988.0,12752,Oryctolagus cuniculus,,9986.0,N,Feces,1,,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit3, and radioactivity content in feces was estimated at total hours",,BAO_0000218,7132,
,,A,,Intermediate,1,,50592,CHEMBL628552,1088.0,12753,Oryctolagus cuniculus,,9986.0,N,Urine,1,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit1, and radioactivity content in urine was estimated at 0-2 hr",,BAO_0000218,7132,
,,A,,Intermediate,1,,50592,CHEMBL628553,1088.0,12754,Oryctolagus cuniculus,,9986.0,N,Urine,1,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-24 hr",,BAO_0000218,7132,
,,A,,Intermediate,1,,50592,CHEMBL628554,1088.0,12755,Oryctolagus cuniculus,,9986.0,N,Urine,1,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-48 hr",,BAO_0000218,7132,
,,A,,Intermediate,1,,50592,CHEMBL628555,1088.0,12756,Oryctolagus cuniculus,,9986.0,N,Urine,1,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 24-48 h",,BAO_0000218,7132,
,,A,,Intermediate,1,,50592,CHEMBL628556,1088.0,12757,Oryctolagus cuniculus,,9986.0,N,Urine,1,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 48-72 h",,BAO_0000218,7132,
,,A,,Intermediate,1,,50592,CHEMBL628557,2113.0,12758,Oryctolagus cuniculus,,9986.0,N,Kidney,1,,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit kidney, and radioactivity content in feces was estimated",,BAO_0000218,7132,
,,A,,Intermediate,1,,50592,CHEMBL628558,1988.0,12759,Oryctolagus cuniculus,,9986.0,N,Feces,1,,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated",,BAO_0000218,7132,
,,A,,Intermediate,1,,50592,CHEMBL628559,1988.0,12760,Oryctolagus cuniculus,,9986.0,N,Feces,1,,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated at",,BAO_0000218,7132,
,,A,,Intermediate,1,,50592,CHEMBL628560,1988.0,12761,Oryctolagus cuniculus,,9986.0,N,Feces,1,,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit1plasma, and radioactivity content in feces was estimated",,BAO_0000218,7132,
,,A,,Intermediate,1,,50592,CHEMBL874456,1088.0,12762,Oryctolagus cuniculus,,9986.0,N,Urine,1,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at total hours",,BAO_0000218,7132,
,,A,,Intermediate,1,,50592,CHEMBL628561,1988.0,12763,Oryctolagus cuniculus,,9986.0,N,Feces,1,,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at 0-48 hr",,BAO_0000218,7132,
,,A,,Intermediate,1,,50592,CHEMBL628562,1988.0,12764,Oryctolagus cuniculus,,9986.0,N,Feces,1,,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at total hours",,BAO_0000218,7132,
,,A,,Intermediate,1,,50592,CHEMBL628563,1088.0,12765,Oryctolagus cuniculus,,9986.0,N,Urine,1,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit2, and radioactivity content in urine was estimated at 0-4 hr",,BAO_0000218,7132,
,,A,,Intermediate,1,,50592,CHEMBL628564,1088.0,12766,Oryctolagus cuniculus,,9986.0,N,Urine,1,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at",,BAO_0000218,7132,
,,A,,Intermediate,1,,50592,CHEMBL628565,1088.0,12767,Oryctolagus cuniculus,,9986.0,N,Urine,1,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 24-48 h",,BAO_0000218,7132,
,,A,,Intermediate,1,,50592,CHEMBL631248,1088.0,12768,Oryctolagus cuniculus,,9986.0,N,Urine,1,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 48-72 h",,BAO_0000218,7132,
,,A,,Intermediate,1,,50592,CHEMBL631249,1088.0,12769,Oryctolagus cuniculus,,9986.0,N,Urine,1,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at total hours",,BAO_0000218,7132,
,,A,,Intermediate,1,,50592,CHEMBL627214,2113.0,12770,Oryctolagus cuniculus,,9986.0,N,Kidney,1,,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 kidney, and radioactivity content in feces was estimated",,BAO_0000218,7132,
,,A,,Intermediate,1,,50592,CHEMBL874591,1988.0,12771,Oryctolagus cuniculus,,9986.0,N,Feces,1,,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 liver, and radioactivity content in feces was estimated",,BAO_0000218,7132,
,,A,,Intermediate,1,,50592,CHEMBL627215,1988.0,12772,Oryctolagus cuniculus,,9986.0,N,Feces,1,,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 lung, and radioactivity content in feces was estimated",,BAO_0000218,7132,
,,A,,Intermediate,1,,50592,CHEMBL625471,1988.0,12773,Oryctolagus cuniculus,,9986.0,N,Feces,1,,200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 plasma and radioactivity content in feces was estimated,,BAO_0000218,7132,
,,A,,Intermediate,1,,50592,CHEMBL625472,,12774,Oryctolagus cuniculus,,9986.0,N,,1,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 1,,BAO_0000218,7132,
,,A,,Intermediate,1,,50592,CHEMBL625473,,12775,Oryctolagus cuniculus,,9986.0,N,,1,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 3 by Gas-liquid chromatographic analysis,,BAO_0000218,7132,
In vivo,,A,,Intermediate,1,,50588,CHEMBL625474,,12776,Canis lupus familiaris,,9615.0,N,,1,,Tested for pharmacokinetic parameter in fasted Beagle dogs (Clearance value of the compound) iv administration.,,BAO_0000218,13317,
In vivo,,A,,Intermediate,1,,50588,CHEMBL625475,,12777,Canis lupus familiaris,,9615.0,N,,1,,The clearance was measured in dog at dose 5 mg/kg after intravenous administration.,,BAO_0000218,15341,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625476,,12778,Rattus norvegicus,,10116.0,N,,1,,The clearance was measured in rat at dose 12 mg/kg after intravenous administration.,,BAO_0000218,15341,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625477,,12779,Rattus norvegicus,,10116.0,N,,1,,The clearance was measured in rat at dose 1 mg/kg after intravenous administration.,,BAO_0000218,15341,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625478,,12780,Rattus norvegicus,,10116.0,N,,1,,The clearance was measured in rat at dose 30 mg/kg after intravenous administration.,,BAO_0000218,15341,
In vitro,,A,,Intermediate,1,,50597,CHEMBL625479,,12781,Rattus norvegicus,,10116.0,N,esophageal tunica muscularis mucosae,1,,The compound was evaluated for clearance value in rat isolated esophageal tunica muscularis mucose,,BAO_0000218,12801,
In vitro,,A,,Intermediate,1,,50597,CHEMBL625480,,12782,Rattus norvegicus,,10116.0,N,esophageal tunica muscularis mucosae,1,,The compound was evaluated for the value in rat isolated esophageal tunica muscularis mucose,,BAO_0000218,12801,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625481,1969.0,12783,Rattus norvegicus,,10116.0,N,Plasma,1,,The compound was tested for systemic plasma clearance(CL) in rats and is expressed in mL/min/kg.,,BAO_0000218,14856,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625482,,12784,Rattus norvegicus,,10116.0,N,,1,,Total body clearance at an intravenous dose of 5.2 mg/kg in rat,,BAO_0000218,14062,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625483,,12785,Rattus norvegicus,,10116.0,N,,1,,Total body clearance at an intravenous dose of 5.5 mg/kg in rat,,BAO_0000218,14062,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625484,,12786,Rattus norvegicus,,10116.0,N,,1,,Total body clearance at an intravenous dose of 6.3 mg/kg in rat,,BAO_0000218,14062,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625485,,12787,Rattus norvegicus,,10116.0,N,,1,,Total body clearance at an intravenous dose of 6.5 mg/kg in rat,,BAO_0000218,14062,
In vivo,,A,,Intermediate,1,,50588,CHEMBL625486,1969.0,12788,Canis lupus familiaris,,9615.0,N,Plasma,1,,Total plasma clearance value was obtained after intravenous administration of 1.8 mg/kg of drug in male Beagle dogs,,BAO_0000218,14346,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625487,1969.0,12789,Rattus norvegicus,,10116.0,N,Plasma,1,,Total plasma clearance value was obtained after intravenous administration of 2.5 mg/kg of drug in male Dawley rats,,BAO_0000218,14346,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625488,1969.0,12790,Rattus norvegicus,,10116.0,N,Plasma,1,,Total plasma clearance value was obtained after intravenous administration of 2.6 mg/kg of drug in male Dawley rats,,BAO_0000218,14346,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625489,1969.0,12791,Rattus norvegicus,,10116.0,N,Plasma,1,,Total plasma clearance value was obtained after intravenous administration of 2.7 mg/kg of drug in male Dawley rats,,BAO_0000218,14346,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625490,1969.0,12792,Rattus norvegicus,,10116.0,N,Plasma,1,,Total plasma clearance value was obtained after intravenous administration of 2.8 mg/kg of drug in male Dawley rats,,BAO_0000218,14346,
In vivo,,A,,Intermediate,1,,50588,CHEMBL625491,1969.0,12793,Canis lupus familiaris,,9615.0,N,Plasma,1,,Total plasma clearance value was obtained after intravenous administration of 4.9 mg/kg of drug in male Beagle dogs,,BAO_0000218,14346,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625492,1969.0,12794,Rattus norvegicus,,10116.0,N,Plasma,1,,Total plasma clearance value was obtained after intravenous administration of 5.1 mg/kg of drug in male Dawley rats,,BAO_0000218,14346,
In vivo,,A,,Intermediate,1,,50587,CHEMBL625493,1969.0,12795,Homo sapiens,,9606.0,N,Plasma,1,,plasma clearance in human,,BAO_0000218,15711,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625494,,12796,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,,BAO_0000218,14886,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625495,,12797,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,,BAO_0000218,14886,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625496,,12798,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic parameter (CL/F) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,,BAO_0000218,14886,
,,P,,Autocuration,0,,22229,CHEMBL625497,,12799,,,,U,,1,,1-Octanol/water partition coefficient measured at 7.4,,BAO_0000100,4115,
,,P,,Autocuration,0,,22229,CHEMBL625498,,12800,,,,U,,1,,Calculated partition coefficient (clogP),,BAO_0000100,13733,
,,A,,Autocuration,0,,22224,CHEMBL625499,,12801,,,,U,,1,,Partition coefficient (logP),,BAO_0000019,12102,
,,P,,Autocuration,0,,22229,CHEMBL625500,,12802,,,,U,,1,,Calculated partition coefficient (clogP),,BAO_0000100,12676,
,,P,,Autocuration,0,,22229,CHEMBL625501,,12803,,,,U,,1,,Calculated partition coefficient (clogP),,BAO_0000100,13733,
,,P,,Autocuration,0,,22229,CHEMBL625502,,12804,,,,U,,1,,Calculated partition coefficient (clogP),,BAO_0000100,13740,
,,P,,Autocuration,0,,22229,CHEMBL625503,,12805,,,,U,,1,,Calculated partition coefficient (clogP) (relative to BAY K 8644),,BAO_0000100,12766,
,,P,,Autocuration,0,,22229,CHEMBL625504,,12806,,,,U,,1,,Calculated partition coefficient (clogP),,BAO_0000100,2764,
,,P,,Autocuration,0,,22229,CHEMBL625505,,12807,,,,U,,1,,Calculated partition coefficient (clogP),,BAO_0000100,12355,
,,P,,Autocuration,0,,22229,CHEMBL625506,,12808,,,,U,,1,,Calculated partition coefficient of the compound,,BAO_0000100,11314,
,,A,,Autocuration,0,,22224,CHEMBL625507,,12809,,,,U,,1,,Partition coefficient (logP),,BAO_0000019,12706,
,,P,,Autocuration,0,,22229,CHEMBL625508,,12810,,,,U,,1,,Calculated partition coefficient (clogP),,BAO_0000100,12645,
,,P,,Autocuration,0,,22229,CHEMBL625509,,12811,,,,U,,1,,Calculated partition coefficient (clogP),,BAO_0000100,13668,
,,P,,Autocuration,0,,22229,CHEMBL625510,,12812,,,,U,,1,,Calculated partition coefficient (clogP),,BAO_0000100,12819,
,,P,,Autocuration,0,,22229,CHEMBL883125,,12813,,,,U,,1,,Calculated partition coefficient (clogP),,BAO_0000100,13668,
,,P,,Autocuration,0,,22229,CHEMBL625511,,12814,,,,U,,1,,Calculated partition coefficient (clogP),,BAO_0000100,13017,
,,A,,Autocuration,0,,22224,CHEMBL874650,,12815,,,,U,,1,,Partition coefficient of the compound,,BAO_0000019,2448,
,,A,,Autocuration,0,,22224,CHEMBL625512,,12816,,,,U,,1,,Partition coefficient of the compound,,BAO_0000019,11526,
,,A,,Autocuration,0,,22224,CHEMBL625513,,12817,,,,U,,1,,Partition coefficient of compound was determined,,BAO_0000019,12426,
,,A,,Autocuration,0,,22224,CHEMBL625514,,12818,,,,U,,1,,Partition coefficient was determined,,BAO_0000019,2448,
,,P,,Autocuration,0,,22229,CHEMBL625515,,12819,,,,U,,1,,Calculated partition coefficient (clogP),,BAO_0000100,12001,
,,P,,Autocuration,0,,22229,CHEMBL625516,,12820,,,,U,,1,,partition coefficient of compound was determined,,BAO_0000100,12426,
In vivo,,A,,Intermediate,1,,50588,CHEMBL625517,,12821,Canis lupus familiaris,,9615.0,N,,1,,The total body administered intravenously in dog,,BAO_0000218,13204,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625518,,12822,Rattus norvegicus,,10116.0,N,,1,,The total body administered intravenously in rats,,BAO_0000218,13204,
,,A,,Intermediate,1,,50594,CHEMBL625519,,12823,Mus musculus,,10090.0,N,,1,,Time taken for the administration to female NIH mice weighing 25-30 g.,,BAO_0000218,13889,
,,A,,Autocuration,0,,22224,CHEMBL625520,,12824,,,,U,,1,,Time taken for the administration,,BAO_0000019,13889,
In vivo,,A,,Intermediate,1,,50588,CHEMBL874651,,12825,Canis lupus familiaris,,9615.0,N,,1,,Total clearance of compound was determined in dog at 5 mg/kg intravenously admn.,,BAO_0000218,17025,
In vivo,,A,,Autocuration,0,,22224,CHEMBL625521,,12826,Simiiformes,,314293.0,U,,1,,Total clearance of compound was determined in monkey at 5 mg/kg intravenously admn.,,BAO_0000218,17025,
In vivo,,A,,Intermediate,1,,50592,CHEMBL623171,,12827,Oryctolagus cuniculus,,9986.0,N,,1,,Total clearance of compound was determined in rabbit at 5 mg/kg intravenously admn.,,BAO_0000218,17025,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623853,,12828,Rattus norvegicus,,10116.0,N,,1,,Total clearance of compound was determined in rat at 5 mg/kg intravenously admn.,,BAO_0000218,17025,
,,A,,Autocuration,0,,22224,CHEMBL623854,,12829,,,,U,,1,,Plasma clearance for the compound was determined.,,BAO_0000019,15067,
,,P,,Autocuration,0,,22224,CHEMBL874405,,12830,,,,U,,1,,CLog P value of the compound,,BAO_0000100,3091,
,,P,,Autocuration,0,,22229,CHEMBL623855,,12831,,,,U,,1,,Calculated partition coefficient (clogP),,BAO_0000100,15592,
,,P,,Autocuration,0,,22229,CHEMBL623856,,12832,,,,U,,1,,Calculated partition coefficient (clogP),,BAO_0000100,14738,
,,P,,Autocuration,0,,22224,CHEMBL623857,,12833,,,,U,,1,,ClogP value of the compound; nd ='no data',,BAO_0000100,14738,
,,P,,Autocuration,0,,22224,CHEMBL623858,,12834,,,,U,,1,,ClogP value of the compound; nd ='not determined',,BAO_0000100,14738,
,,P,,Autocuration,0,,22224,CHEMBL623859,,12835,,,,U,,1,,CLog P was determined,,BAO_0000100,6076,
,,P,,Autocuration,0,,22229,CHEMBL839829,,12836,,,,U,,1,,Calculated partition coefficient (clogP),,BAO_0000100,17840,
,,A,,Autocuration,0,,22224,CHEMBL623860,,12837,,,,U,,1,,CLogP was calculated,,BAO_0000019,13589,
,,A,,Autocuration,0,,22224,CHEMBL623861,,12838,,,,U,,1,,CLogP value was determined,,BAO_0000019,17655,
,,A,,Autocuration,0,,22224,CHEMBL623862,,12839,,,,U,,1,,CLogP value was evaluated using http://esc.syrres.com/interkow/kowdemo.htm.,,BAO_0000019,5867,
,,P,,Autocuration,0,,22229,CHEMBL874406,,12840,,,,U,,1,,Calculated partition coefficient (clogP),,BAO_0000100,5867,
,,P,,Autocuration,0,,22229,CHEMBL623863,,12841,,,,U,,1,,Calculated partition coefficient (clogP),,BAO_0000100,10783,
,,P,,Autocuration,0,,22229,CHEMBL624021,,12842,,,,U,,1,,Calculated partition coefficient (clogP),,BAO_0000100,14849,
,,A,,Intermediate,1,,50588,CHEMBL624022,1236.0,12843,Canis lupus familiaris,,9615.0,N,Adrenal medulla,1,,Distribution in female dog adrenal medulla 24 hours after administration.,,BAO_0000218,8170,
,,A,,Intermediate,1,,50588,CHEMBL624023,1236.0,12844,Canis lupus familiaris,,9615.0,N,Adrenal medulla,1,,Distribution in female dog adrenal medulla 72 hours after administration.,,BAO_0000218,8170,
,,A,,Intermediate,1,,50588,CHEMBL624024,,12845,Canis lupus familiaris,,9615.0,N,,1,,Distribution in female dog bile 24 hours after administration.,,BAO_0000218,8170,
,,A,,Intermediate,1,,50588,CHEMBL624025,,12846,Canis lupus familiaris,,9615.0,N,,1,,Distribution in female dog bile 72 hr after administration.,,BAO_0000218,8170,
,,A,,Intermediate,1,,50588,CHEMBL624026,,12847,Canis lupus familiaris,,9615.0,N,,1,,Distribution in female dog blood 24 hours after administration.,,BAO_0000218,8170,
,,A,,Intermediate,1,,50588,CHEMBL624027,,12848,Canis lupus familiaris,,9615.0,N,,1,,Distribution in female dog blood 72 hours after administration.,,BAO_0000218,8170,
,,A,,Intermediate,1,,50588,CHEMBL624028,,12849,Canis lupus familiaris,,9615.0,N,,1,,Distribution in female dog heart 24 hours after administration.,,BAO_0000218,8170,
,,A,,Intermediate,1,,50588,CHEMBL624029,,12850,Canis lupus familiaris,,9615.0,N,,1,,Distribution in female dog heart 72 hours after administration.,,BAO_0000218,8170,
,,A,,Intermediate,1,,50588,CHEMBL624030,,12851,Canis lupus familiaris,,9615.0,N,,1,,Distribution in female dog kidney 24 hours after administration.,,BAO_0000218,8170,
,,A,,Intermediate,1,,50588,CHEMBL624031,,12852,Canis lupus familiaris,,9615.0,N,,1,,Distribution in female dog kidney 72 hours after administration.,,BAO_0000218,8170,
,,A,,Intermediate,1,,50588,CHEMBL624032,160.0,12853,Canis lupus familiaris,,9615.0,N,Intestine,1,,Distribution in female dog large intestine 24 hours after administration.,,BAO_0000218,8170,
,,A,,Intermediate,1,,50588,CHEMBL874407,160.0,12854,Canis lupus familiaris,,9615.0,N,Intestine,1,,Distribution in female dog large intestine 72 hours after administration.,,BAO_0000218,8170,
,,A,,Intermediate,1,,50588,CHEMBL624033,,12855,Canis lupus familiaris,,9615.0,N,,1,,Distribution in female dog liver 24 hours after administration.,,BAO_0000218,8170,
,,A,,Intermediate,1,,50588,CHEMBL624034,,12856,Canis lupus familiaris,,9615.0,N,,1,,Distribution in female dog liver 72 hours after administration.,,BAO_0000218,8170,
,,A,,Intermediate,1,,50588,CHEMBL624035,,12857,Canis lupus familiaris,,9615.0,N,,1,,Distribution in female dog lung 24 hours after administration.,,BAO_0000218,8170,
,,A,,Intermediate,1,,50588,CHEMBL624036,,12858,Canis lupus familiaris,,9615.0,N,,1,,Distribution in female dog lung 72 hours after administration.,,BAO_0000218,8170,
,,A,,Intermediate,1,,50588,CHEMBL624037,2385.0,12859,Canis lupus familiaris,,9615.0,N,Muscle tissue,1,,Distribution in female dog muscle 24 hours after administration.,,BAO_0000218,8170,
,,A,,Intermediate,1,,50588,CHEMBL624038,2385.0,12860,Canis lupus familiaris,,9615.0,N,Muscle tissue,1,,Distribution in female dog muscle 72 hours after administration.,,BAO_0000218,8170,
,,A,,Intermediate,1,,50588,CHEMBL624039,,12861,Canis lupus familiaris,,9615.0,N,,1,,Distribution in female dog pancreas 24 hours after administration.,,BAO_0000218,8170,
,,A,,Intermediate,1,,50588,CHEMBL624040,,12862,Canis lupus familiaris,,9615.0,N,,1,,Distribution in female dog pancreas 72 hours after administration.,,BAO_0000218,8170,
,,A,,Intermediate,1,,50588,CHEMBL624041,160.0,12863,Canis lupus familiaris,,9615.0,N,Intestine,1,,Distribution in female dog small intestine 24 hours after administration.,,BAO_0000218,8170,
,,A,,Intermediate,1,,50588,CHEMBL624042,160.0,12864,Canis lupus familiaris,,9615.0,N,Intestine,1,,Distribution in female dog small intestine 72 hours after administration.,,BAO_0000218,8170,
,,A,,Intermediate,1,,50588,CHEMBL624043,2106.0,12865,Canis lupus familiaris,,9615.0,N,Spleen,1,,Distribution in female dog spleen 24 hours after administration.,,BAO_0000218,8170,
,,A,,Intermediate,1,,50588,CHEMBL624044,2106.0,12866,Canis lupus familiaris,,9615.0,N,Spleen,1,,Distribution in female dog spleen 72 hours after administration.,,BAO_0000218,8170,
,,A,,Intermediate,1,,50588,CHEMBL624045,945.0,12867,Canis lupus familiaris,,9615.0,N,Stomach,1,,Distribution in female dog stomach 24 hours after administration.,,BAO_0000218,8170,
,,A,,Intermediate,1,,50588,CHEMBL624046,945.0,12868,Canis lupus familiaris,,9615.0,N,Stomach,1,,Distribution in female dog stomach 72 hours after administration.,,BAO_0000218,8170,
,,A,,Intermediate,1,,50588,CHEMBL624047,2046.0,12869,Canis lupus familiaris,,9615.0,N,Thyroid gland,1,,Distribution in female dog thyroid 24 hours after administration.,,BAO_0000218,8170,
,,A,,Intermediate,1,,50588,CHEMBL624048,2046.0,12870,Canis lupus familiaris,,9615.0,N,Thyroid gland,1,,Distribution in female dog thyroid 72 hours after administration.,,BAO_0000218,8170,
,,A,,Intermediate,1,,50588,CHEMBL874408,1088.0,12871,Canis lupus familiaris,,9615.0,N,Urine,1,,Distribution in female dog urine 24 hours after administration.,,BAO_0000218,8170,
,,A,,Intermediate,1,,50588,CHEMBL624049,1088.0,12872,Canis lupus familiaris,,9615.0,N,Urine,1,,Distribution in female dog urine 72 hr after administration.,,BAO_0000218,8170,
,,A,,Autocuration,0,,22224,CHEMBL624050,1969.0,12873,,,,U,Plasma,1,,Mean plasma concentration measured 1 h following an oral dose of 30 mg/kg,,BAO_0000218,14283,
,,A,,Autocuration,0,,22224,CHEMBL624051,,12874,,,,U,,1,,Plasma concentration at 7 hr after intravenous dosing,,BAO_0000019,5623,
,,A,,Intermediate,1,,50597,CHEMBL623278,,12875,Rattus norvegicus,,10116.0,N,,1,,Plasma concentration of 3 mg/kg iv after 0.25 hr in rats,,BAO_0000218,13477,
,,A,,Intermediate,1,,50597,CHEMBL623279,,12876,Rattus norvegicus,,10116.0,N,,1,,Plasma concentration of 3 mg/kg iv after 0.5 hr in rats,,BAO_0000218,13477,
,,A,,Intermediate,1,,50597,CHEMBL623280,,12877,Rattus norvegicus,,10116.0,N,,1,,Plasma concentration of 3 mg/kg iv after 1 hr in rats,,BAO_0000218,13477,
,,A,,Intermediate,1,,50597,CHEMBL623963,,12878,Rattus norvegicus,,10116.0,N,,1,,Plasma concentration of 3 mg/kg iv after 2 hr in rats,,BAO_0000218,13477,
,,A,,Intermediate,1,,50597,CHEMBL623964,,12879,Rattus norvegicus,,10116.0,N,,1,,Plasma concentration of 3 mg/kg iv after 4 hr in rats,,BAO_0000218,13477,
,,A,,Intermediate,1,,50597,CHEMBL623965,,12880,Rattus norvegicus,,10116.0,N,,1,,Plasma concentration of 3 mg/kg iv after 6 hr in rats,,BAO_0000218,13477,
,,A,,Intermediate,1,,50597,CHEMBL623966,,12881,Rattus norvegicus,,10116.0,N,,1,,Plasma concentration of 3 mg/kg po after 0.083 hr in rats,,BAO_0000218,13477,
,,A,,Intermediate,1,,50597,CHEMBL874415,,12882,Rattus norvegicus,,10116.0,N,,1,,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.083 h,,BAO_0000218,13477,
,,A,,Intermediate,1,,50597,CHEMBL623967,,12883,Rattus norvegicus,,10116.0,N,,1,,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.25 hr,,BAO_0000218,13477,
,,A,,Intermediate,1,,50597,CHEMBL623968,,12884,Rattus norvegicus,,10116.0,N,,1,,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.5 hr,,BAO_0000218,13477,
,,A,,Intermediate,1,,50597,CHEMBL623969,,12885,Rattus norvegicus,,10116.0,N,,1,,Plasma concentration after 3 mg/kg peroral dosing in rat at 1 hr,,BAO_0000218,13477,
,,A,,Intermediate,1,,50597,CHEMBL628409,,12886,Rattus norvegicus,,10116.0,N,,1,,Plasma concentration after 3 mg/kg peroral dosing in rat at 2 hr,,BAO_0000218,13477,
,,A,,Intermediate,1,,50597,CHEMBL628410,,12887,Rattus norvegicus,,10116.0,N,,1,,Plasma concentration after 3 mg/kg peroral dosing in rat at 4 hr,,BAO_0000218,13477,
,,A,,Intermediate,1,,50597,CHEMBL628411,,12888,Rattus norvegicus,,10116.0,N,,1,,Plasma concentration after 3 mg/kg peroral dosing in rat at 6 hr,,BAO_0000218,13477,
,,A,,Intermediate,1,,50597,CHEMBL628412,,12889,Rattus norvegicus,,10116.0,N,,1,,Plasma concentration after 3 mg/kg peroral dosing in rat at 8 hr,,BAO_0000218,13477,
,,A,,Autocuration,0,,22224,CHEMBL628413,,12890,,,,U,,1,,Tested for the highest concentration at which toxicity was not observed or the concentration which provided the highest number of net grain counts,,BAO_0000019,12553,
,,A,,Autocuration,0,,22224,CHEMBL628414,1969.0,12891,,,,U,Plasma,1,,The concentration in plasmat; Not determined,,BAO_0000019,14548,
,,A,,Intermediate,1,,50597,CHEMBL628415,,12892,Rattus norvegicus,,10116.0,N,,1,,Tissue level at 10 mg/kg/po in wistar rats in blood,,BAO_0000218,14393,
,,A,,Intermediate,1,,50597,CHEMBL628416,,12893,Rattus norvegicus,,10116.0,N,,1,,Tissue level at 10 mg/kg/po in wistar rats in brown fat,,BAO_0000218,14393,
,,A,,Intermediate,1,,50597,CHEMBL628417,,12894,Rattus norvegicus,,10116.0,N,,1,,Tissue level at 10 mg/kg/po in wistar rats in heart,,BAO_0000218,14393,
,,A,,Intermediate,1,,50597,CHEMBL874908,2107.0,12895,Rattus norvegicus,,10116.0,N,Liver,1,,Tissue level at 10 mg/kg/po in wistar rats in liver,,BAO_0000218,14393,
,,A,,Intermediate,1,,50597,CHEMBL628418,,12896,Rattus norvegicus,,10116.0,N,,1,,Tissue level at 10 mg/kg/po in wistar rats in plasma,,BAO_0000218,14393,
,,A,,Intermediate,1,,50597,CHEMBL628419,2385.0,12897,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Tissue level at 10 mg/kg/po in wistar rats in skeletal muscle,,BAO_0000218,14393,
,,A,,Intermediate,1,,50597,CHEMBL628420,,12898,Rattus norvegicus,,10116.0,N,,1,,Tissue level at 10 mg/kg/po in wistar rats in subcutaneous fat,,BAO_0000218,14393,
,,A,,Autocuration,0,,22224,CHEMBL628421,,12899,,,,U,,1,,Water solubility at 37 degree C.,,BAO_0000019,1629,
,,P,,Autocuration,0,,22229,CHEMBL626726,,12900,,,,U,,1,,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,,BAO_0000100,8194,
,,P,,Autocuration,0,,22229,CHEMBL626727,,12901,,,,U,,1,,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,,BAO_0000100,8194,
,,A,,Intermediate,1,,50597,CHEMBL626728,178.0,12902,Rattus norvegicus,,10116.0,N,Blood,1,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL626729,178.0,12903,Rattus norvegicus,,10116.0,N,Blood,1,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL626730,178.0,12904,Rattus norvegicus,,10116.0,N,Blood,1,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL626731,178.0,12905,Rattus norvegicus,,10116.0,N,Blood,1,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL626732,178.0,12906,Rattus norvegicus,,10116.0,N,Blood,1,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL626733,948.0,12907,Rattus norvegicus,,10116.0,N,Heart,1,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL626734,948.0,12908,Rattus norvegicus,,10116.0,N,Heart,1,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL626735,948.0,12909,Rattus norvegicus,,10116.0,N,Heart,1,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL874909,948.0,12910,Rattus norvegicus,,10116.0,N,Heart,1,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL626736,948.0,12911,Rattus norvegicus,,10116.0,N,Heart,1,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL626737,2113.0,12912,Rattus norvegicus,,10116.0,N,Kidney,1,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL630999,2113.0,12913,Rattus norvegicus,,10116.0,N,Kidney,1,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL631000,2113.0,12914,Rattus norvegicus,,10116.0,N,Kidney,1,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL631001,2113.0,12915,Rattus norvegicus,,10116.0,N,Kidney,1,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL631002,2113.0,12916,Rattus norvegicus,,10116.0,N,Kidney,1,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL631003,2107.0,12917,Rattus norvegicus,,10116.0,N,Liver,1,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL631004,2107.0,12918,Rattus norvegicus,,10116.0,N,Liver,1,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL631005,2107.0,12919,Rattus norvegicus,,10116.0,N,Liver,1,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL631006,2107.0,12920,Rattus norvegicus,,10116.0,N,Liver,1,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL631007,2107.0,12921,Rattus norvegicus,,10116.0,N,Liver,1,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL631008,2048.0,12922,Rattus norvegicus,,10116.0,N,Lung,1,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL631009,2048.0,12923,Rattus norvegicus,,10116.0,N,Lung,1,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL631010,2048.0,12924,Rattus norvegicus,,10116.0,N,Lung,1,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL631011,2048.0,12925,Rattus norvegicus,,10116.0,N,Lung,1,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL631012,2048.0,12926,Rattus norvegicus,,10116.0,N,Lung,1,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL630271,2046.0,12927,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL630272,2046.0,12928,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL630273,2046.0,12929,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL630274,2046.0,12930,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL630275,2046.0,12931,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL875782,,12932,Rattus norvegicus,,10116.0,N,,1,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 15 minutes (radiolabeled with [125I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL630276,,12933,Rattus norvegicus,,10116.0,N,,1,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 2 minutes (radiolabeled with [125I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL630277,,12934,Rattus norvegicus,,10116.0,N,,1,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 30 minutes (radiolabeled with [125I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL630278,,12935,Rattus norvegicus,,10116.0,N,,1,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 5 minutes (radiolabeled with [125I]-,,BAO_0000218,8594,
,,A,,Intermediate,1,,50597,CHEMBL630279,,12936,Rattus norvegicus,,10116.0,N,,1,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 60 minutes (radiolabeled with [125I]-,,BAO_0000218,8594,
,,A,,Autocuration,0,,22224,CHEMBL630280,,12937,,,,U,,1,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg,,BAO_0000019,8151,
,,A,,Autocuration,0,,22224,CHEMBL630281,,12938,,,,U,,1,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,BAO_0000019,8151,
,,A,,Intermediate,1,,50592,CHEMBL630282,,12939,Oryctolagus cuniculus,,9986.0,N,,1,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 4 by Gas-liquid chromatographic analysis,,BAO_0000218,7132,
,,A,,Intermediate,1,,50592,CHEMBL630283,,12940,Oryctolagus cuniculus,,9986.0,N,,1,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 2,,BAO_0000218,7132,
,,A,,Autocuration,0,,22224,CHEMBL630284,,12941,,,,U,,1,,Alkylating activity (0.1 mM) was determined at pH 7.4; expressed as OD (540n m)/mM of drug),,BAO_0000019,5797,
,,A,,Autocuration,0,,22224,CHEMBL630285,,12942,,,,U,,1,,Alkylating activity was determined,,BAO_0000019,7849,
,,A,,Autocuration,0,,22224,CHEMBL630286,,12943,,,,U,,1,,Amount of metabolites in the microsomal medium after 90 min incubation of BTCP (500 uM),Microsomes,BAO_0000251,14220,
,,A,,Intermediate,1,,50592,CHEMBL630069,,12944,Oryctolagus cuniculus,,9986.0,N,,1,,"Formation of metabolite by rabbit liver microsomal preparation in absence of NADPH, at 2 hours",,BAO_0000218,8650,
,,A,,Intermediate,1,,50592,CHEMBL630070,,12945,Oryctolagus cuniculus,,9986.0,N,,1,,"Formation of metabolite by rabbit liver microsomal preparation in presence of Co-O2 (90:10),at 2 hour",,BAO_0000218,8650,
,,A,,Intermediate,1,,50592,CHEMBL630071,,12946,Oryctolagus cuniculus,,9986.0,N,,1,,"Formation of metabolite by rabbit liver microsomal preparation in presence of N2,at 2 hour",,BAO_0000218,8650,
,,A,,Intermediate,1,,50592,CHEMBL630072,,12947,Oryctolagus cuniculus,,9986.0,N,,1,,"Formation of metabolite by rabbit liver microsomal preparation in presence of NADPH, at 2 hours",,BAO_0000218,8650,
,,A,,Intermediate,1,,50592,CHEMBL875110,,12948,Oryctolagus cuniculus,,9986.0,N,,1,,"Formation of metabolite by rabbit liver microsomal preparation in presence of SKF525A,at 2 hour",,BAO_0000218,8650,
,,A,,Intermediate,1,,50597,CHEMBL630073,,12949,Rattus norvegicus,,10116.0,N,,1,,Compound was tested for antidiuretic activity in rats,,BAO_0000218,7116,
,,A,,Autocuration,0,,22224,CHEMBL630074,,12950,,,,U,,1,,Compound was tested for inactivation kinetic values,,BAO_0000019,14131,
In vivo,,A,,Autocuration,0,,22224,CHEMBL630075,,12951,,,,U,,1,,Compound was evaluated for the average apparent volume of distribution when administered through intravenous route,,BAO_0000218,7415,
,,A,,Autocuration,0,,22224,CHEMBL630076,,12952,,,,U,,1,,Dissociation rate calculated from the first-order equation using the t1/2 value,,BAO_0000019,13178,
,,P,,Autocuration,0,,22229,CHEMBL630077,,12953,,,,U,,1,,Compound was evaluated for pKa by titration of the compounds in 1:2 methyl alcohol and water,,BAO_0000100,8815,
,,P,,Autocuration,0,,22229,CHEMBL630078,,12954,,,,U,,1,,Aqueous solubility was measured,,BAO_0000100,1450,
,,P,,Autocuration,0,,22229,CHEMBL630079,,12955,,,,U,,1,,Aqueous solubility was measured at a pH 4,,BAO_0000100,1450,
,,P,,Autocuration,0,,22229,CHEMBL630080,,12956,,,,U,,1,,Aqueous solubility (pH 7),,BAO_0000100,1450,
,,P,,Autocuration,0,,22229,CHEMBL630081,,12957,,,,U,,1,,Aqueous solubility was measured at a pH 9,,BAO_0000100,1450,
,,A,,Autocuration,0,,22224,CHEMBL630082,,12958,,,,U,,1,,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents",,BAO_0000019,12711,
,,A,,Autocuration,0,,22224,CHEMBL630083,,12959,,,,U,,1,,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",,BAO_0000019,12711,
,,A,,Autocuration,0,,22224,CHEMBL630084,,12960,,,,U,,1,,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",,BAO_0000019,12711,
,,P,,Autocuration,0,,22229,CHEMBL629198,,12961,,,,U,,1,,Aqueous solubility of the compound,,BAO_0000100,15032,
,,P,,Autocuration,0,,22229,CHEMBL629199,,12962,,,,U,,1,,Aqueous solubility at 37 degree Celsius at pH 7.38,,BAO_0000100,9964,
,,P,,Autocuration,0,,22229,CHEMBL629200,,12963,,,,U,,1,,Aqueous solubility in pH 7.4 phosphate buffer,,BAO_0000100,14962,
,,A,,Intermediate,1,,50588,CHEMBL629201,,12964,Canis lupus familiaris,,9615.0,N,,1,,Mean arterial pressure response following 10 mg/kg intraduodenal administration to salt depleted dog,,BAO_0000218,12487,
,,A,,Intermediate,1,,50588,CHEMBL629202,,12965,Canis lupus familiaris,,9615.0,N,,1,,Mean arterial pressure response following 1 mg/kg intravenous administration to salt depleted dog,,BAO_0000218,12487,
,,A,,Intermediate,1,,50587,CHEMBL875111,,12966,Homo sapiens,,9606.0,N,,1,,Percentage of aspirin formed during hydrolysis in 10% human plasma at pH 7.4 at 37 degrees celsius,,BAO_0000218,10026,
,,A,,Intermediate,1,,50587,CHEMBL629203,,12967,Homo sapiens,,9606.0,N,,1,,Percentage of aspirin formed during hydrolysis in undiluted human plasma at pH 7.4 at 37 degrees celsius,,BAO_0000218,10026,
,,A,,Intermediate,1,,50587,CHEMBL629204,,12968,Homo sapiens,,9606.0,N,,1,,The percentage of aspirin formed during hydrolysis in 100% human plasma at pH 7.4 at 37 degrees celsius,,BAO_0000218,10026,
,,A,,Intermediate,1,,50587,CHEMBL629205,,12969,Homo sapiens,,9606.0,N,,1,,The percentage of aspirin formed during hydrolysis in 20% human plasma at pH 7.4 at 37 degrees celsius,,BAO_0000218,10026,
,,A,,Intermediate,1,,50587,CHEMBL629206,,12970,Homo sapiens,,9606.0,N,,1,,The percentage of aspirin formed during hydrolysis in 60% human plasma at pH 7.4 at 37 degrees celsius,,BAO_0000218,10026,
,,A,,Autocuration,0,,22224,CHEMBL631185,,12971,,,,U,,1,,The percentage of aspirin formed during hydrolysis in 80% human plasma at pH 7.4 at 37 degrees celsius,,BAO_0000019,10026,
,,A,,Intermediate,1,,50597,CHEMBL631186,,12972,Rattus norvegicus,,10116.0,N,,1,,Compound was evaluated for the average bile flow rat in rats,,BAO_0000218,7415,
,,A,,Intermediate,1,,50592,CHEMBL631187,,12973,Oryctolagus cuniculus,,9986.0,N,,1,,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 15 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",,BAO_0000218,17025,
,,A,,Intermediate,1,,50592,CHEMBL631188,,12974,Oryctolagus cuniculus,,9986.0,N,,1,,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 25 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",,BAO_0000218,17025,
,,A,,Autocuration,0,,22224,CHEMBL876419,,12975,,,,U,,1,,Average half life period was determined,,BAO_0000019,10184,
,,A,,Autocuration,0,,22224,CHEMBL631189,,12976,,,,U,,1,,Average half life period was determined,,BAO_0000019,10184,
,,A,,Intermediate,1,,50602,CHEMBL631190,,12977,Human herpesvirus 1,,10298.0,N,,1,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,,BAO_0000218,8613,
,,A,,Intermediate,1,,50602,CHEMBL631191,,12978,Human herpesvirus 1,,10298.0,N,,1,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,,BAO_0000218,8613,
,,A,,Intermediate,1,,50602,CHEMBL631192,,12979,Human herpesvirus 1,,10298.0,N,,1,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day.,,BAO_0000218,8613,
,,A,,Intermediate,1,,50602,CHEMBL632400,,12980,Human herpesvirus 1,,10298.0,N,,1,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day.,,BAO_0000218,8613,
,,A,,Intermediate,1,,50602,CHEMBL630564,,12981,Human herpesvirus 1,,10298.0,N,,1,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,,BAO_0000218,8613,
,,A,,Intermediate,1,,50602,CHEMBL630565,,12982,Human herpesvirus 1,,10298.0,N,,1,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,,BAO_0000218,8613,
,,A,,Intermediate,1,,50602,CHEMBL630566,,12983,Human herpesvirus 1,,10298.0,N,,1,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day.,,BAO_0000218,8613,
,,A,,Intermediate,1,,50602,CHEMBL631229,,12984,Human herpesvirus 1,,10298.0,N,,1,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day.,,BAO_0000218,8613,
,,A,,Intermediate,1,,50602,CHEMBL631230,,12985,Human herpesvirus 1,,10298.0,N,,1,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day.,,BAO_0000218,8613,
,,P,,Autocuration,0,,22229,CHEMBL876428,,12986,,,,U,,1,,Calculated partition coefficient (clogP),,BAO_0000100,6030,
,,P,,Autocuration,0,,22229,CHEMBL631231,,12987,,,,U,,1,,Calculated partition coefficient (clogP),,BAO_0000100,6147,
,,P,,Autocuration,0,,22229,CHEMBL631232,,12988,,,,U,,1,,Calculated partition coefficient (clogP) (MacLogP),,BAO_0000100,14556,
,,A,,Autocuration,0,,22224,CHEMBL631233,,12989,,,,U,,1,,Hydrophilicity was determined,,BAO_0000019,768,
,,P,,Autocuration,0,,22229,CHEMBL631234,,12990,,,,U,,1,,Calculated partition coefficient (clogP),,BAO_0000100,14452,
,,A,,Autocuration,0,,22224,CHEMBL883126,,12991,,,,U,,1,,Increased absorption was determined,,BAO_0000019,5237,
,,P,,Autocuration,0,,22224,CHEMBL631235,,12992,,,,U,,1,,Lipophilicity value was evaluated,,BAO_0000100,14378,
,,P,,Autocuration,0,,22224,CHEMBL631236,,12993,,,,U,,1,,Log P value of the compound.,,BAO_0000100,14418,
,,A,,Autocuration,0,,22224,CHEMBL631237,,12994,,,,U,,1,,Partition coefficient of compound was determined,,BAO_0000019,5249,
,,P,,Autocuration,0,,22229,CHEMBL631238,,12995,,,,U,,1,,Calculated partition coefficient (clogP),,BAO_0000100,14621,
,,P,,Autocuration,0,,22229,CHEMBL876429,,12996,,,,U,,1,,Calculated partition coefficient (clogP),,BAO_0000100,12542,
,,A,,Autocuration,0,,22224,CHEMBL631414,,12997,,,,U,,1,,Partition coefficient was measured by medchem software; Not calculated,,BAO_0000019,12542,
,,P,,Autocuration,0,,22224,CHEMBL631415,,12998,,,,U,,1,,Partition coefficient was measured by octanol-water using standard shake-flask method,,BAO_0000100,12542,
,,P,,Autocuration,0,,22229,CHEMBL631416,,12999,,,,U,,1,,Calculated partition coefficient (clogP),,BAO_0000100,15462,
,,A,,Autocuration,0,,22224,CHEMBL631417,,13000,,,,U,,1,,Partition coefficient (logP),,BAO_0000019,14884,
,,P,,Autocuration,0,,22229,CHEMBL631418,,13001,,,,U,,1,,Calculated partition coefficient (clogP),,BAO_0000100,16526,
,,P,,Autocuration,0,,22229,CHEMBL631419,,13002,,,,U,,1,,The Octanol/Water partition coefficient CLogP,,BAO_0000100,13693,
,,A,,Autocuration,0,,22224,CHEMBL631420,,13003,,,,U,,1,,The pharmacokinetic parameter C Log p was reported,,BAO_0000019,13693,
,,P,,Autocuration,0,,22229,CHEMBL631421,,13004,,,,U,,1,,Calculated partition coefficient (clogP),,BAO_0000100,13779,
,,P,,Autocuration,0,,22229,CHEMBL631422,,13005,,,,U,,1,,Calculated partition coefficient (clogP),,BAO_0000100,14772,
,,P,,Autocuration,0,,22229,CHEMBL631423,,13006,,,,U,,1,,Calculated partition coefficient (clogP),,BAO_0000100,14393,
In vivo,,A,,Intermediate,1,,50597,CHEMBL876430,1969.0,13007,Rattus norvegicus,,10116.0,N,Plasma,1,,Clearance rate in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,,BAO_0000218,14793,
In vivo,,A,,Intermediate,1,,50597,CHEMBL631424,1969.0,13008,Rattus norvegicus,,10116.0,N,Plasma,1,,Clearance rate in rat plasma when administered intravenously at a dose of 10 mg/kg,,BAO_0000218,14793,
In vivo,,A,,Intermediate,1,,50588,CHEMBL631425,1969.0,13009,Canis lupus familiaris,,9615.0,N,Plasma,1,,Compound was administered intravenously in dog to evaluate plasma clearance values,,BAO_0000218,13744,
In vivo,,A,,Autocuration,0,,22224,CHEMBL631426,1969.0,13010,Simiiformes,,314293.0,U,Plasma,1,,Compound was administered intravenously in monkey to evaluate plasma clearance values,,BAO_0000218,13744,
In vivo,,A,,Intermediate,1,,50594,CHEMBL631427,1969.0,13011,Mus musculus,,10090.0,N,Plasma,1,,Compound was administered intravenously in mouse to evaluate plasma clearance values,,BAO_0000218,13744,
In vivo,,A,,Intermediate,1,,50588,CHEMBL631428,1969.0,13012,Canis lupus familiaris,,9615.0,N,Plasma,1,,Compound was evaluated in vivo for plasma clearance in dog after intravenous dose at 2 mg/Kg,,BAO_0000218,13207,
In vitro,,A,,Intermediate,1,,50797,CHEMBL631429,2107.0,13013,Macaca mulatta,,9544.0,N,Liver,1,,Intrinsic clearance in Rhesus liver microsome,Microsomes,BAO_0000218,5669,
In vitro,,A,,Intermediate,1,,50588,CHEMBL631430,2107.0,13014,Canis lupus familiaris,,9615.0,N,Liver,1,,Intrinsic clearance in dog liver microsome,Microsomes,BAO_0000218,5669,
In vitro,,A,,Intermediate,1,,50597,CHEMBL631431,2107.0,13015,Rattus norvegicus,,10116.0,N,Liver,1,,Intrinsic clearance in rat liver microsome,Microsomes,BAO_0000218,5669,
In vivo,,A,,Intermediate,1,,50797,CHEMBL631432,1969.0,13016,Macaca mulatta,,9544.0,N,Plasma,1,,Low plasma clearance was calculated in rhesus monkey,,BAO_0000218,4853,
In vivo,,A,,Intermediate,1,,50588,CHEMBL631433,,13017,Canis lupus familiaris,,9615.0,N,,1,,Pharmacokinetic data at 0.5 mg/kg dose given to dogs intravenously.,,BAO_0000218,16452,
In vivo,,A,,Autocuration,0,,22224,CHEMBL631434,,13018,,,,U,,1,,Plasma clearance after intravenous dose of 0.3 mg/kg,,BAO_0000218,11954,
In vivo,,A,,Autocuration,0,,22224,CHEMBL631435,,13019,,,,U,,1,,Plasma clearance after intravenous dose of 1 mg/kg,,BAO_0000218,11954,
In vivo,,A,,Autocuration,0,,22224,CHEMBL631436,,13020,,,,U,,1,,Plasma clearance after intravenous dose of 3 mg/kg,,BAO_0000218,11954,
In vivo,,A,,Autocuration,0,,22224,CHEMBL631437,,13021,,,,U,,1,,Plasma clearance after intravenous dose of 3.87 mg/kg,,BAO_0000218,11954,
In vivo,,A,,Intermediate,1,,50597,CHEMBL631438,,13022,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance after peroral administration at 10 mpk in Rat,,BAO_0000218,5669,
In vivo,,A,,Intermediate,1,,50797,CHEMBL876431,,13023,Macaca mulatta,,9544.0,N,,1,,Plasma clearance after peroral administration at 10 mpk in Rhesus,,BAO_0000218,5669,
In vivo,,A,,Intermediate,1,,50588,CHEMBL631439,,13024,Canis lupus familiaris,,9615.0,N,,1,,Plasma clearance after peroral administration at 10 mpk in dog,,BAO_0000218,5669,
In vivo,,A,,Intermediate,1,,50597,CHEMBL631440,,13025,Rattus norvegicus,,10116.0,N,,1,,Totla clearance of compound reported after 5 mg/kg i.v. dose in rat,,BAO_0000218,13662,
,,A,,Autocuration,0,,22224,CHEMBL631441,,13026,,,,U,,1,,Compound was evaluated for physico-chemical property of Critical micellar concentration (CMC),,BAO_0000019,8272,
,,A,,Autocuration,0,,22224,CHEMBL631442,,13027,,,,U,,1,,Critical Micellar concentration was determined,,BAO_0000019,13410,
,,A,,Autocuration,0,,22224,CHEMBL626525,,13028,,,,U,,1,,Critical Micellar concentration of the compound. was determined,,BAO_0000019,13410,
,,A,,Autocuration,0,,22224,CHEMBL627168,,13029,,,,U,,1,,Critical micelle concentration determined from the plots of the fluorescence intensity as a function of compound concentration,,BAO_0000019,12628,
,,A,,Autocuration,0,,22224,CHEMBL875618,,13030,,,,U,,1,,Critical micellar concentration was measured in water by the dye solubilization method,,BAO_0000019,9675,
,,B,,Autocuration,0,,22224,CHEMBL626612,,13031,,,,U,,1,,Hydrolysis turn over determined from the plots of the fluorescence assay quantified by HPLC,,BAO_0000019,12628,
,,A,,Autocuration,0,,22224,CHEMBL626613,,13032,,,,U,,1,,CMR value (relative to BAY K 8644),,BAO_0000019,12766,
,,A,,Autocuration,0,,22224,CHEMBL626614,,13033,,,,U,,1,,Carbamoylating activity was determined,,BAO_0000019,7849,
,,A,,Autocuration,0,,22224,CHEMBL626615,,13034,Simiiformes,,314293.0,U,,1,,Hypotension peak is percentage change from predose baseline pressure observed after intraduodenal dose of 10 mg/kg in monkey,,BAO_0000218,12187,
,,A,,Autocuration,0,,22224,CHEMBL626616,,13035,,,,U,,1,,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:10 at 0.1 to 0.2 degrees Centigrade.,,BAO_0000019,2040,
,,A,,Autocuration,0,,22224,CHEMBL626617,,13036,,,,U,,1,,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:5 at 0.1 to 0.2 degrees Centigrade.,,BAO_0000019,2040,
In vivo,,A,,Intermediate,1,,50588,CHEMBL626618,1969.0,13037,Canis lupus familiaris,,9615.0,N,Plasma,1,,Clearance from dog plasma after intravenous injection of 1 mg/kg of compound,,BAO_0000218,14180,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626619,1969.0,13038,Rattus norvegicus,,10116.0,N,Plasma,1,,Clearance from rat plasma after intravenous injection of 1 mg/kg of compound,,BAO_0000218,14180,
In vivo,,A,,Intermediate,1,,50588,CHEMBL626620,,13039,Canis lupus familiaris,,9615.0,N,,1,,"Clearance rate at 0.46 mg/kg, iv, in dogs",,BAO_0000218,14474,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626621,,13040,Rattus norvegicus,,10116.0,N,,1,,"Clearance rate at 5.5 mg/kg, iv, in rat",,BAO_0000218,14474,
In vivo,,A,,Intermediate,1,,100710,CHEMBL626622,,13041,Macaca fascicularis,,9541.0,N,,1,,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,,BAO_0000218,14548,
In vivo,,A,,Intermediate,1,,100710,CHEMBL626623,,13042,Macaca fascicularis,,9541.0,N,,1,,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,,BAO_0000218,14548,
In vivo,,A,,Intermediate,1,,50588,CHEMBL626624,,13043,Canis lupus familiaris,,9615.0,N,,1,,Pharmacokinetic parameter Cl calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,,BAO_0000218,14548,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626625,,13044,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic parameter Cl calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,,BAO_0000218,14548,
Ex vivo,,A,,Intermediate,1,,50597,CHEMBL626626,2107.0,13045,Rattus norvegicus,,10116.0,N,Liver,1,,Clearance rate constant using isolated perfused rat liver (IPRL) assay,,BAO_0000218,6125,
In vivo,,A,,Autocuration,0,,22224,CHEMBL626627,,13046,,,,U,,1,,Tested for the total clearance of the compound,,BAO_0000218,6874,
In vivo,,A,,Intermediate,1,,50588,CHEMBL626628,,13047,Canis lupus familiaris,,9615.0,N,,1,,The clearance was measured in dogs after intravenous administration of 1 mg/kg dose,,BAO_0000218,15343,
In vivo,,A,,Autocuration,0,,22224,CHEMBL626629,,13048,,,,U,,1,,Total body clearance was determined,,BAO_0000218,6236,
,,A,,Intermediate,1,,50597,CHEMBL626630,,13049,Rattus norvegicus,,10116.0,N,,1,,Mean Chlorine excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL626631,,13050,Rattus norvegicus,,10116.0,N,,1,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,,BAO_0000218,11510,
,,P,,Autocuration,0,,22229,CHEMBL626632,,13051,,,,U,,1,,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,,BAO_0000100,8194,
,,P,,Autocuration,0,,22229,CHEMBL626633,,13052,,,,U,,1,,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,,BAO_0000100,8194,
,,P,,Autocuration,0,,22229,CHEMBL626634,,13053,,,,U,,1,,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 8.0 hr,,BAO_0000100,8194,
,,P,,Autocuration,0,,22229,CHEMBL626635,,13054,,,,U,,1,,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,,BAO_0000100,8194,
,,P,,Autocuration,0,,22229,CHEMBL626636,,13055,,,,U,,1,,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,,BAO_0000100,8194,
,,P,,Autocuration,0,,22229,CHEMBL626637,,13056,,,,U,,1,,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,,BAO_0000100,8194,
,,A,,Intermediate,1,,50339,CHEMBL626638,,13057,Pneumocystis carinii,,4754.0,N,,1,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 10.9 uM/Kg/day),,BAO_0000218,13273,
,,A,,Intermediate,1,,50339,CHEMBL626639,,13058,Pneumocystis carinii,,4754.0,N,,1,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.3 uM/Kg/day,,BAO_0000218,13273,
,,A,,Intermediate,1,,50339,CHEMBL626640,,13059,Pneumocystis carinii,,4754.0,N,,1,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 23.3 uM/Kg/day,,BAO_0000218,13273,
,,A,,Intermediate,1,,50339,CHEMBL626641,,13060,Pneumocystis carinii,,4754.0,N,,1,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 4.8 uM/Kg/day,,BAO_0000218,13273,
,,A,,Intermediate,1,,50339,CHEMBL627272,,13061,Pneumocystis carinii,,4754.0,N,,1,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 9.2 uM/Kg/day,,BAO_0000218,13273,
,,A,,Intermediate,1,,50339,CHEMBL627273,,13062,Pneumocystis carinii,,4754.0,N,,1,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted uM/Kg/day,,BAO_0000218,13273,
,,A,,Intermediate,1,,50339,CHEMBL627441,,13063,Pneumocystis carinii,,4754.0,N,,1,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.027 (uM/kg/day),,BAO_0000218,13273,
,,A,,Intermediate,1,,50339,CHEMBL628355,,13064,Pneumocystis carinii,,4754.0,N,,1,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.27 (uM/kg/day),,BAO_0000218,13273,
,,A,,Intermediate,1,,50339,CHEMBL628356,,13065,Pneumocystis carinii,,4754.0,N,,1,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 13.3 (uM/kg/day),,BAO_0000218,13273,
,,A,,Intermediate,1,,50339,CHEMBL628357,,13066,Pneumocystis carinii,,4754.0,N,,1,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.7 (uM/kg/day),,BAO_0000218,13273,
,,A,,Intermediate,1,,50339,CHEMBL628358,,13067,Pneumocystis carinii,,4754.0,N,,1,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 22.1 (uM/kg/day),,BAO_0000218,13273,
,,A,,Intermediate,1,,50339,CHEMBL622307,,13068,Pneumocystis carinii,,4754.0,N,,1,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 66.3 (uM/kg/day),,BAO_0000218,13273,
,,A,,Autocuration,0,,22224,CHEMBL622527,,13069,,,,U,,1,,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0,,BAO_0000019,13118,
,,A,,Autocuration,0,,22224,CHEMBL622528,,13070,,,,U,,1,,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0; Not detectable,,BAO_0000019,13118,
,,A,,Autocuration,0,,22224,CHEMBL622529,,13071,,,,U,,1,,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4,,BAO_0000019,13118,
,,A,,Autocuration,0,,22224,CHEMBL622992,,13072,,,,U,,1,,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4; Not detectable,,BAO_0000019,13118,
,,A,,Autocuration,0,,22224,CHEMBL622993,,13073,,,,U,,1,,Conversion rate by hydrolysis of compound in plasma after 6 hr. ,,BAO_0000019,13118,
,,A,,Autocuration,0,,22224,CHEMBL622994,,13074,,,,U,,1,,Conversion rate by hydrolysis of compound in plasma after 6 h; Not detectable,,BAO_0000019,13118,
,,A,,Intermediate,1,,50597,CHEMBL622995,,13075,Rattus norvegicus,,10116.0,N,,1,,"In vitro rate constant, correlation coefficient for the conversion to progesterone in rat liver homogenate",,BAO_0000218,10633,
,,A,,Intermediate,1,,50597,CHEMBL622996,,13076,Rattus norvegicus,,10116.0,N,,1,,"In vitro rate constant, correlation coefficient for the conversion to progesterone in whole rat blood.",,BAO_0000218,10633,
,,A,,Intermediate,1,,50597,CHEMBL622997,,13077,Rattus norvegicus,,10116.0,N,,1,,"In vitro rate constant, correlation coefficient for the disappearance in rat liver homogenate",,BAO_0000218,10633,
,,A,,Intermediate,1,,50597,CHEMBL622998,,13078,Rattus norvegicus,,10116.0,N,,1,,"In vitro rate constant, correlation coefficient for the disappearance in rat brain homogenate",,BAO_0000218,10633,
,,A,,Autocuration,0,,22224,CHEMBL622999,,13079,,,,U,,1,,Cp max following ip administration at 1 mg/kg,,BAO_0000218,5767,
In vivo,,A,,Autocuration,0,,22224,CHEMBL623000,1969.0,13080,,,,U,Plasma,1,,Maximum concentration in plasma was reported at 0.5 hour,,BAO_0000218,3302,
In vivo,,A,,Autocuration,0,,22224,CHEMBL623001,1969.0,13081,,,,U,Plasma,1,,Maximum concentration in plasma was reported at 2 hour,,BAO_0000218,3302,
,,A,,Intermediate,1,,50594,CHEMBL623002,,13082,Mus musculus,,10090.0,N,,1,,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK3 murine fibrosarcoma cells,,BAO_0000218,12467,
,,P,,Autocuration,0,,22229,CHEMBL623003,,13083,,,,U,,1,,Aqueous solubility in 25 mM N-glycyl-glycine and 10 mM MgSO4 (pH 7.8),,BAO_0000100,11778,
,,A,,Autocuration,0,,22224,CHEMBL623004,,13084,,,,U,,1,,Steady state concentration was evaluated,,BAO_0000019,4321,
,,A,,Autocuration,0,,22224,CHEMBL623005,,13085,,,,U,,1,,Partition coefficient (logP),,BAO_0000019,14884,
,,A,,Autocuration,0,,22224,CHEMBL623006,,13086,,,,U,,1,,Partition coefficient (logD7.4),,BAO_0000019,15234,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623007,2107.0,13087,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution of {18]Fluoro-CGP 12388 (60 minutes post injection) in liver of male wistar rats,,BAO_0000218,14198,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623008,10000001.0,13088,Rattus norvegicus,,10116.0,N,Bone,1,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in bone of male wistar rats,,BAO_0000218,14198,
In vivo,,A,,Intermediate,1,,50597,CHEMBL876654,2037.0,13089,Rattus norvegicus,,10116.0,N,Cerebellum,1,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cerebellum of male wistar rats,,BAO_0000218,14198,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623009,,13090,Rattus norvegicus,,10116.0,N,,1,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cortex of male wistar rats,,BAO_0000218,14198,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623010,,13091,Rattus norvegicus,,10116.0,N,,1,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in fat of male wistar rats,,BAO_0000218,14198,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623011,948.0,13092,Rattus norvegicus,,10116.0,N,Heart,1,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in heart of male wistar rats,,BAO_0000218,14198,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623012,160.0,13093,Rattus norvegicus,,10116.0,N,Intestine,1,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in intestine of male wistar rats,,BAO_0000218,14198,
,,A,,Autocuration,0,,22224,CHEMBL623013,,13094,,,,U,,1,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,,BAO_0000019,8151,
,,A,,Autocuration,0,,22224,CHEMBL623014,,13095,,,,U,,1,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,BAO_0000019,8151,
,,A,,Autocuration,0,,22224,CHEMBL623015,1088.0,13096,,,,U,Urine,1,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 10 mg/Kg,,BAO_0000019,8151,
,,A,,Autocuration,0,,22224,CHEMBL623016,1088.0,13097,,,,U,Urine,1,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,,BAO_0000019,8151,
,,A,,Autocuration,0,,22224,CHEMBL624858,1088.0,13098,,,,U,Urine,1,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 25 mg/Kg,,BAO_0000019,8151,
,,A,,Intermediate,1,,50597,CHEMBL624859,,13099,Rattus norvegicus,,10116.0,N,,1,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg.,,BAO_0000218,8151,
,,A,,Intermediate,1,,50597,CHEMBL624860,,13100,Rattus norvegicus,,10116.0,N,,1,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,BAO_0000218,8151,
,,A,,Intermediate,1,,50597,CHEMBL624861,,13101,Rattus norvegicus,,10116.0,N,,1,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,,BAO_0000218,8151,
,,A,,Intermediate,1,,50597,CHEMBL624862,,13102,Rattus norvegicus,,10116.0,N,,1,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,,BAO_0000218,8151,
,,A,,Intermediate,1,,50597,CHEMBL624863,,13103,Rattus norvegicus,,10116.0,N,,1,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg.,,BAO_0000218,8151,
,,A,,Intermediate,1,,50597,CHEMBL876655,,13104,Rattus norvegicus,,10116.0,N,,1,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,,BAO_0000218,8151,
,,A,,Intermediate,1,,50588,CHEMBL624864,,13105,Canis lupus familiaris,,9615.0,N,,1,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,,BAO_0000218,6996,
,,A,,Intermediate,1,,50588,CHEMBL624865,,13106,Canis lupus familiaris,,9615.0,N,,1,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,,BAO_0000218,6996,
,,A,,Intermediate,1,,50588,CHEMBL624866,,13107,Canis lupus familiaris,,9615.0,N,,1,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,,BAO_0000218,6996,
,,F,,Expert,1,,50588,CHEMBL624867,,13108,Canis lupus familiaris,,9615.0,N,,1,,Salidiuretic activity in dog following i.v. dosing at 5 mg/kg,,BAO_0000218,6996,
,,A,,Intermediate,1,,50588,CHEMBL624868,,13109,Canis lupus familiaris,,9615.0,N,,1,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,,BAO_0000218,6996,
,,A,,Intermediate,1,,50588,CHEMBL628450,,13110,Canis lupus familiaris,,9615.0,N,,1,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600- 799,,BAO_0000218,6996,
,,A,,Intermediate,1,,50588,CHEMBL628451,,13111,Canis lupus familiaris,,9615.0,N,,1,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,,BAO_0000218,6996,
,,A,,Intermediate,1,,50588,CHEMBL628452,,13112,Canis lupus familiaris,,9615.0,N,,1,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,,BAO_0000218,6996,
,,A,,Intermediate,1,,50588,CHEMBL628453,,13113,Canis lupus familiaris,,9615.0,N,,1,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,,BAO_0000218,6996,
,,A,,Intermediate,1,,50588,CHEMBL628454,,13114,Canis lupus familiaris,,9615.0,N,,1,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; act above 5 mg/kg,,BAO_0000218,6996,
,,A,,Intermediate,1,,50588,CHEMBL628455,,13115,Canis lupus familiaris,,9615.0,N,,1,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,,BAO_0000218,6996,
,,A,,Intermediate,1,,50588,CHEMBL628456,,13116,Canis lupus familiaris,,9615.0,N,,1,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,,BAO_0000218,6996,
,,A,,Intermediate,1,,50588,CHEMBL628457,,13117,Canis lupus familiaris,,9615.0,N,,1,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,,BAO_0000218,6996,
,,A,,Intermediate,1,,50588,CHEMBL877505,,13118,Canis lupus familiaris,,9615.0,N,,1,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-299,,BAO_0000218,6996,
,,A,,Intermediate,1,,50588,CHEMBL628458,,13119,Canis lupus familiaris,,9615.0,N,,1,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 250-399,,BAO_0000218,6996,
,,A,,Intermediate,1,,50588,CHEMBL628459,,13120,Canis lupus familiaris,,9615.0,N,,1,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,,BAO_0000218,6996,
,,A,,Intermediate,1,,50588,CHEMBL628460,,13121,Canis lupus familiaris,,9615.0,N,,1,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,,BAO_0000218,6996,
,,A,,Intermediate,1,,50588,CHEMBL628461,,13122,Canis lupus familiaris,,9615.0,N,,1,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,,BAO_0000218,6996,
,,B,,Autocuration,0,,22224,CHEMBL628462,,13123,,,,U,,1,,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 16.5 mg/kg",,BAO_0000218,6996,
,,A,,Intermediate,1,,50588,CHEMBL628463,,13124,Canis lupus familiaris,,9615.0,N,,1,,Compound administered orally at a dose of 1 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,BAO_0000218,6996,
,,F,,Expert,1,,50597,CHEMBL625666,,13125,Rattus norvegicus,,10116.0,N,,1,,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 50 mg/kg",,BAO_0000218,6996,
,,B,,Autocuration,0,,22224,CHEMBL625667,,13126,,,,U,,1,,Compound administered orally at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,BAO_0000218,6996,
,,A,,Expert,1,,50597,CHEMBL625668,,13127,Rattus norvegicus,,10116.0,N,,1,,Compound administered orally at a dose of 81 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,BAO_0000218,6996,
,,A,,Intermediate,1,,50597,CHEMBL625669,,13128,Rattus norvegicus,,10116.0,N,,1,,Compound administered orally was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,BAO_0000218,6996,
,,A,,Autocuration,0,,22224,CHEMBL625670,,13129,,,,U,,1,,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry,,BAO_0000019,7114,
,,A,,Intermediate,1,,50597,CHEMBL625671,,13130,Rattus norvegicus,,10116.0,N,,1,,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry in rat,,BAO_0000218,7114,
,,A,,Intermediate,1,,50602,CHEMBL625672,,13131,Human herpesvirus 1,,10298.0,N,,1,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day.,,BAO_0000218,8613,
,,A,,Intermediate,1,,50602,CHEMBL625673,,13132,Human herpesvirus 1,,10298.0,N,,1,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously,,BAO_0000218,8613,
,,A,,Intermediate,1,,50602,CHEMBL625674,,13133,Human herpesvirus 1,,10298.0,N,,1,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously.,,BAO_0000218,8613,
,,A,,Intermediate,1,,50602,CHEMBL625675,,13134,Human herpesvirus 1,,10298.0,N,,1,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously,,BAO_0000218,8613,
,,A,,Intermediate,1,,50602,CHEMBL627637,,13135,Human herpesvirus 1,,10298.0,N,,1,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,,BAO_0000218,8613,
,,A,,Intermediate,1,,50602,CHEMBL627638,,13136,Human herpesvirus 1,,10298.0,N,,1,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered orally.,,BAO_0000218,8613,
,,A,,Intermediate,1,,50602,CHEMBL627639,,13137,Human herpesvirus 1,,10298.0,N,,1,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously,,BAO_0000218,8613,
,,A,,Intermediate,1,,50602,CHEMBL627640,,13138,Human herpesvirus 1,,10298.0,N,,1,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously.,,BAO_0000218,8613,
,,A,,Intermediate,1,,50602,CHEMBL627641,,13139,Human herpesvirus 1,,10298.0,N,,1,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered orally.,,BAO_0000218,8613,
,,A,,Intermediate,1,,50602,CHEMBL627642,,13140,Human herpesvirus 1,,10298.0,N,,1,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,,BAO_0000218,8613,
,,A,,Intermediate,1,,50602,CHEMBL877506,,13141,Human herpesvirus 1,,10298.0,N,,1,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,,BAO_0000218,8613,
,,A,,Intermediate,1,,50594,CHEMBL627275,,13142,Mus musculus,,10090.0,N,,1,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,,BAO_0000218,8613,
,,A,,Intermediate,1,,50506,CHEMBL627643,,13143,Mustela putorius furo,,9669.0,N,,1,,"Average area under curve value dosed at 0.3 mg/kg, iv in ferrets.",,BAO_0000218,11219,
,,A,,Intermediate,1,,50506,CHEMBL631246,,13144,Mustela putorius furo,,9669.0,N,,1,,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",,BAO_0000218,11219,
,,A,,Intermediate,1,,50506,CHEMBL631247,,13145,Mustela putorius furo,,9669.0,N,,1,,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",,BAO_0000218,11219,
,,A,,Intermediate,1,,50506,CHEMBL629532,,13146,Mustela putorius furo,,9669.0,N,,1,,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,,BAO_0000218,11219,
,,A,,Intermediate,1,,50506,CHEMBL629533,,13147,Mustela putorius furo,,9669.0,N,,1,,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from arterial blood).,,BAO_0000218,11219,
,,A,,Intermediate,1,,50506,CHEMBL629534,,13148,Mustela putorius furo,,9669.0,N,,1,,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,,BAO_0000218,11219,
,,A,,Intermediate,1,,50506,CHEMBL629535,,13149,Mustela putorius furo,,9669.0,N,,1,,Average peak plasma drug concentration after iv dose of 0.3 mg/kg in ferrets.,,BAO_0000218,11219,
,,A,,Autocuration,0,,22224,CHEMBL625932,,13150,,,,U,,1,,Pharmacokinetic parameter :drug bound to plasma was reported,,BAO_0000019,14837,
,,A,,Autocuration,0,,22224,CHEMBL625933,,13151,,,,U,,1,,compound was evaluated for drug bound in plasma,,BAO_0000019,14837,
,,A,,Intermediate,1,,50597,CHEMBL625934,,13152,Rattus norvegicus,,10116.0,N,,1,,The Brain concentration compared to plasma concentration in rats after oral administration of 1 mg/kg dose,,BAO_0000218,15343,
,,A,,Autocuration,0,,22224,CHEMBL625935,,13153,Eutheria,,9347.0,U,,1,,Bioavailability,,BAO_0000218,13761,
,,A,,Intermediate,1,,50597,CHEMBL625936,,13154,Rattus norvegicus,,10116.0,N,,1,,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported,,BAO_0000218,14810,
,,A,,Intermediate,1,,50597,CHEMBL625937,,13155,Rattus norvegicus,,10116.0,N,,1,,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported; Not tested,,BAO_0000218,14810,
,,A,,Intermediate,1,,50588,CHEMBL625938,,13156,Canis lupus familiaris,,9615.0,N,,1,,Oral bioavailability in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,,BAO_0000218,13249,
,,A,,Intermediate,1,,50597,CHEMBL625939,1970.0,13157,Rattus norvegicus,,10116.0,N,Bile,1,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-1 hr after the treatment.,,BAO_0000218,9267,
,,A,,Intermediate,1,,50597,CHEMBL625940,1970.0,13158,Rattus norvegicus,,10116.0,N,Bile,1,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-2 hr after the treatment.,,BAO_0000218,9267,
,,A,,Intermediate,1,,50597,CHEMBL874464,1970.0,13159,Rattus norvegicus,,10116.0,N,Bile,1,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-3 hr after the treatment.,,BAO_0000218,9267,
,,A,,Intermediate,1,,50597,CHEMBL625941,1970.0,13160,Rattus norvegicus,,10116.0,N,Bile,1,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-4 hr after the treatment.,,BAO_0000218,9267,
,,A,,Intermediate,1,,50597,CHEMBL625942,1970.0,13161,Rattus norvegicus,,10116.0,N,Bile,1,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-5 hr after the treatment.,,BAO_0000218,9267,
,,A,,Intermediate,1,,50597,CHEMBL625943,1970.0,13162,Rattus norvegicus,,10116.0,N,Bile,1,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-6 hr after the treatment.,,BAO_0000218,9267,
,,A,,Intermediate,1,,50587,CHEMBL625944,1977.0,13163,Homo sapiens,,9606.0,N,Serum,1,,In vitro protein binding in human serum at 5 ug/ml,,BAO_0000218,15549,
,,A,,Autocuration,0,,22224,CHEMBL625945,,13164,,,,U,,1,,Serum protein binding ability was measured,,BAO_0000019,10929,
,,A,,Autocuration,0,,22224,CHEMBL625946,,13165,,,,U,,1,,The ability binding to plasma (Binding classified based on injection of compound at 80 concentration.),,BAO_0000019,15444,
In vivo,,A,,Autocuration,0,,22224,CHEMBL625947,,13166,Canis lupus familiaris,,9615.0,U,,1,,Oral bioavailability in dog,,BAO_0000218,12860,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625948,,13167,Rattus norvegicus,,10116.0,N,,1,,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,,BAO_0000218,12170,
In vivo,,A,,Autocuration,0,,22224,CHEMBL625949,,13168,,,,U,,1,,Absolute oral bioavailability at an iv dose of 14 mg/kg,,BAO_0000218,15173,
In vivo,,A,,Autocuration,0,,22224,CHEMBL625950,,13169,,,,U,,1,,Absolute oral bioavailability at an iv dose of 15.2 mg/kg,,BAO_0000218,15173,
In vivo,,A,,Autocuration,0,,22224,CHEMBL625951,,13170,Eutheria,,9347.0,U,,1,,Oral bioavailability (dose 15 mg/kg i.v.),,BAO_0000218,15173,
In vivo,,A,,Autocuration,0,,22224,CHEMBL625952,,13171,,,,U,,1,,Absolute oral bioavailability at an peroral dose of 15 mg/kg orally.,,BAO_0000218,15173,
In vivo,,A,,Autocuration,0,,22224,CHEMBL625953,,13172,,,,U,,1,,Absolute oral bioavailability at an peroral dose of 30 mg/kg orally,,BAO_0000218,15173,
In vivo,,A,,Autocuration,0,,22224,CHEMBL625954,,13173,,,,U,,1,,Absolute oral bioavailability at an peroral dose of 30.2 mg/kg orally.,,BAO_0000218,15173,
In vivo,,A,,Autocuration,0,,22224,CHEMBL882959,,13174,,,,U,,1,,Absolute oral bioavailability at an peroral dose of 30.3 mg/kg orally.,,BAO_0000218,15173,
In vivo,,A,,Intermediate,1,,50588,CHEMBL625955,,13175,Canis lupus familiaris,,9615.0,N,,1,,Apparent bioavailability in dogs at 15 mg/kg in an iv vs po dosing regimen,,BAO_0000218,11767,
In vivo,,A,,Autocuration,0,,22224,CHEMBL625956,,13176,Mustela putorius furo,,9669.0,U,,1,,Bioavailability in ferret,,BAO_0000218,11219,
In vivo,,A,,Intermediate,1,,100710,CHEMBL625957,,13177,Macaca fascicularis,,9541.0,N,,1,,Bioavailability after intraduodenal administration at a dose 10 mg/kg in cynomolgus monkeys using renin inhibition assay,,BAO_0000218,12186,
,,A,,Intermediate,1,,50597,CHEMBL625958,,13178,Rattus norvegicus,,10116.0,N,,1,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL625959,,13179,Rattus norvegicus,,10116.0,N,,1,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL626642,,13180,Rattus norvegicus,,10116.0,N,,1,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL631330,,13181,Rattus norvegicus,,10116.0,N,,1,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL631331,,13182,Rattus norvegicus,,10116.0,N,,1,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL631332,,13183,Rattus norvegicus,,10116.0,N,,1,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL631333,,13184,Rattus norvegicus,,10116.0,N,,1,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL632018,,13185,Rattus norvegicus,,10116.0,N,,1,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL632019,,13186,Rattus norvegicus,,10116.0,N,,1,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL632020,,13187,Rattus norvegicus,,10116.0,N,,1,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL632021,,13188,Rattus norvegicus,,10116.0,N,,1,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL632022,,13189,Rattus norvegicus,,10116.0,N,,1,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL632023,,13190,Rattus norvegicus,,10116.0,N,,1,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL632024,,13191,Rattus norvegicus,,10116.0,N,,1,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL874472,,13192,Rattus norvegicus,,10116.0,N,,1,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL632025,,13193,Rattus norvegicus,,10116.0,N,,1,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL632026,,13194,Rattus norvegicus,,10116.0,N,,1,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL632027,,13195,Rattus norvegicus,,10116.0,N,,1,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL632028,,13196,Rattus norvegicus,,10116.0,N,,1,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL626430,,13197,Rattus norvegicus,,10116.0,N,,1,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL626431,,13198,Rattus norvegicus,,10116.0,N,,1,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL626432,,13199,Rattus norvegicus,,10116.0,N,,1,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL626433,,13200,Rattus norvegicus,,10116.0,N,,1,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL626434,,13201,Rattus norvegicus,,10116.0,N,,1,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL627280,,13202,Rattus norvegicus,,10116.0,N,,1,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL627281,,13203,Rattus norvegicus,,10116.0,N,,1,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL627282,,13204,Rattus norvegicus,,10116.0,N,,1,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,,BAO_0000218,11510,
,,A,,Autocuration,0,,22224,CHEMBL627283,,13205,,,,U,,1,,Total body clearance was measured at given dose,,BAO_0000019,7199,
,,A,,Autocuration,0,,22224,CHEMBL627284,,13206,,,,U,,1,,Total body clearance was measured at given dose.,,BAO_0000218,7199,
,,A,,Intermediate,1,,50597,CHEMBL627285,,13207,Rattus norvegicus,,10116.0,N,,1,,Metabolic clearance from the body in rat,,BAO_0000218,7095,
In vivo,,A,,Autocuration,0,,22224,CHEMBL627286,,13208,,,,U,,1,,Renal clearance from the body,,BAO_0000218,7095,
In vivo,,A,,Intermediate,1,,50597,CHEMBL875477,,13209,Rattus norvegicus,,10116.0,N,,1,,Renal clearance from the body in rat,,BAO_0000218,7095,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627287,,13210,Rattus norvegicus,,10116.0,N,,1,,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 12 mg/kg in rat,,BAO_0000218,12528,
In vivo,,A,,Intermediate,1,,50588,CHEMBL627288,,13211,Canis lupus familiaris,,9615.0,N,,1,,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 2.5 mg/kg in dog,,BAO_0000218,12528,
,,A,,Intermediate,1,,50597,CHEMBL627289,,13212,Rattus norvegicus,,10116.0,N,,1,,Total clearance from the body in rat,,BAO_0000218,7095,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627290,1969.0,13213,Rattus norvegicus,,10116.0,N,Plasma,1,,Clearance into cortex from rat plasma or PBS,,BAO_0000218,14223,
In vivo,,A,,Autocuration,0,,22224,CHEMBL627291,,13214,,,,U,,1,,Clearance at an iv dose of 15 mg/Kg and po dose of 120 mg/Kg,,BAO_0000218,13569,
In vivo,,A,,Autocuration,0,,22224,CHEMBL627292,,13215,,,,U,,1,,Clearance at an iv dose of 15 mg/Kg and po dose of 240 mg/Kg,,BAO_0000218,13569,
In vivo,,A,,Autocuration,0,,22224,CHEMBL627293,,13216,,,,U,,1,,Clearance at an iv dose of 15 mg/Kg and po dose of 29.1 mg/Kg,,BAO_0000218,13569,
In vivo,,A,,Autocuration,0,,22224,CHEMBL627294,,13217,,,,U,,1,,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,,BAO_0000218,13569,
In vivo,,A,,Autocuration,0,,22224,CHEMBL875478,,13218,,,,U,,1,,Clearance at an iv dose of 15 mg/Kg and po dose of 60 mg/Kg,,BAO_0000218,13569,
In vivo,,A,,Autocuration,0,,22224,CHEMBL627295,,13219,,,,U,,1,,Clearance was determined,,BAO_0000218,13979,
In vivo,,A,,Intermediate,1,,50594,CHEMBL627296,,13220,Mus musculus,,10090.0,N,,1,,Clearance was measured in mouse after administration of compound 20 mg/kg intravenously,,BAO_0000218,14315,
In vivo,,A,,Intermediate,1,,50592,CHEMBL626119,,13221,Oryctolagus cuniculus,,9986.0,N,,1,,Clearance was measured in rabbit after administration of compound 20 mg/kg intravenously,,BAO_0000218,14315,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626120,,13222,Rattus norvegicus,,10116.0,N,,1,,Clearance was measured in rat after administration of compound 20 mg/kg intravenously,,BAO_0000218,14315,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626121,,13223,Rattus norvegicus,,10116.0,N,,1,,Clearance in rat after iv dose (100 ug/kg),,BAO_0000218,12174,
In vivo,,A,,Autocuration,0,,22224,CHEMBL626122,,13224,Cavia porcellus,,10141.0,U,,1,,Clearance in guinea pig,,BAO_0000218,12797,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626123,,13225,Rattus norvegicus,,10116.0,N,,1,,Compound was evaluated for clearance in rat,,BAO_0000218,12797,
In vivo,,A,,Intermediate,1,,50588,CHEMBL623456,,13226,Canis lupus familiaris,,9615.0,N,,1,,Compound was evaluated for the clearance in dog,,BAO_0000218,12797,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623457,,13227,Rattus norvegicus,,10116.0,N,,1,,Compound was evaluated for the clearance in rat,,BAO_0000218,12797,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623458,,13228,Rattus norvegicus,,10116.0,N,,1,,Compound was tested in vivo for clearance after iv administration in the rat,,BAO_0000218,11500,
In vivo,,A,,Autocuration,0,,22224,CHEMBL623459,,13229,,,,U,,1,,IV clearance determined at an iv dose of 14 mg/kg,,BAO_0000218,15173,
In vivo,,A,,Autocuration,0,,22224,CHEMBL875484,,13230,,,,U,,1,,IV clearance determined at an iv dose of 15.2 mg/kg,,BAO_0000218,15173,
In vivo,,A,,Autocuration,0,,22224,CHEMBL623460,,13231,,,,U,,1,,IV clearance determined at an iv dose of 15 mg/kg,,BAO_0000218,15173,
In vivo,,A,,Autocuration,0,,22224,CHEMBL623461,,13232,,,,U,,1,,IV clearance determined at an peroral dose of 30 mg/kg.,,BAO_0000218,15173,
In vivo,,A,,Autocuration,0,,22224,CHEMBL623462,,13233,,,,U,,1,,IV clearance determined at an peroral dose of 30.2 mg/kg.,,BAO_0000218,15173,
In vivo,,A,,Autocuration,0,,22224,CHEMBL627386,,13234,,,,U,,1,,IV clearance determined at an peroral dose of 30.3 mg/kg.,,BAO_0000218,15173,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627387,2113.0,13235,Rattus norvegicus,,10116.0,N,Kidney,1,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in kidney of male wistar rats,,BAO_0000218,14198,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627388,2107.0,13236,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in liver of male wistar rats,,BAO_0000218,14198,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627389,2048.0,13237,Rattus norvegicus,,10116.0,N,Lung,1,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in lung of male wistar rats,,BAO_0000218,14198,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627390,2385.0,13238,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in muscle of male wistar rats,,BAO_0000218,14198,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627391,1969.0,13239,Rattus norvegicus,,10116.0,N,Plasma,1,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in plasma of male wistar rats,,BAO_0000218,14198,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627392,,13240,Rattus norvegicus,,10116.0,N,,1,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in red blood cells of male wistar rats,,BAO_0000218,14198,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627393,2106.0,13241,Rattus norvegicus,,10116.0,N,Spleen,1,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in spleen of male wistar rats,,BAO_0000218,14198,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627394,3126.0,13242,Rattus norvegicus,,10116.0,N,Trachea,1,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in trachea of male wistar rats,,BAO_0000218,14198,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627395,10000001.0,13243,Rattus norvegicus,,10116.0,N,Bone,1,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in bone of male wistar rats,,BAO_0000218,14198,
In vivo,,A,,Intermediate,1,,50597,CHEMBL875485,2037.0,13244,Rattus norvegicus,,10116.0,N,Cerebellum,1,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cerebellum of male wistar rats,,BAO_0000218,14198,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627396,,13245,Rattus norvegicus,,10116.0,N,,1,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cortex of male wistar rats,,BAO_0000218,14198,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627397,,13246,Rattus norvegicus,,10116.0,N,,1,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in fat of male wistar rats,,BAO_0000218,14198,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627398,948.0,13247,Rattus norvegicus,,10116.0,N,Heart,1,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in heart of male wistar rats,,BAO_0000218,14198,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627399,10000001.0,13248,Rattus norvegicus,,10116.0,N,Bone,1,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in intestine bone of male wistar rats,,BAO_0000218,14198,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627400,2113.0,13249,Rattus norvegicus,,10116.0,N,Kidney,1,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in kidney of male wistar rats,,BAO_0000218,14198,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627401,2107.0,13250,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in liver of male wistar rats,,BAO_0000218,14198,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627402,2048.0,13251,Rattus norvegicus,,10116.0,N,Lung,1,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in lung of male wistar rats,,BAO_0000218,14198,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627403,2385.0,13252,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in muscle of male wistar rats,,BAO_0000218,14198,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627404,1969.0,13253,Rattus norvegicus,,10116.0,N,Plasma,1,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in plasma of male wistar rats,,BAO_0000218,14198,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623101,,13254,Rattus norvegicus,,10116.0,N,,1,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in red blood cells of male wistar rats,,BAO_0000218,14198,
In vivo,,A,,Intermediate,1,,50597,CHEMBL877480,2106.0,13255,Rattus norvegicus,,10116.0,N,Spleen,1,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in spleen of male wistar rats,,BAO_0000218,14198,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623102,3126.0,13256,Rattus norvegicus,,10116.0,N,Trachea,1,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in trachea of male wistar rats,,BAO_0000218,14198,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623103,10000001.0,13257,Rattus norvegicus,,10116.0,N,Bone,1,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in bone of male wistar rats,,BAO_0000218,14198,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623104,2037.0,13258,Rattus norvegicus,,10116.0,N,Cerebellum,1,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cerebellum of male wistar rats,,BAO_0000218,14198,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623105,,13259,Rattus norvegicus,,10116.0,N,,1,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cortex of male wistar rats,,BAO_0000218,14198,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623106,,13260,Rattus norvegicus,,10116.0,N,,1,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in fat of male wistar rats,,BAO_0000218,14198,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623107,948.0,13261,Rattus norvegicus,,10116.0,N,Heart,1,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in heart of male wistar rats,,BAO_0000218,14198,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623108,160.0,13262,Rattus norvegicus,,10116.0,N,Intestine,1,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in intestine of male wistar rats,,BAO_0000218,14198,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623109,2113.0,13263,Rattus norvegicus,,10116.0,N,Kidney,1,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in kidney of male wistar rats,,BAO_0000218,14198,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623110,2107.0,13264,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in liver of male wistar rats,,BAO_0000218,14198,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623111,2048.0,13265,Rattus norvegicus,,10116.0,N,Lung,1,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in lung of male wistar rats,,BAO_0000218,14198,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625060,2385.0,13266,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in muscle of male wistar rats,,BAO_0000218,14198,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625061,1969.0,13267,Rattus norvegicus,,10116.0,N,Plasma,1,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in plasma of male wistar rats,,BAO_0000218,14198,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625062,,13268,Rattus norvegicus,,10116.0,N,,1,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in red blood cells of male wistar rats,,BAO_0000218,14198,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625063,2106.0,13269,Rattus norvegicus,,10116.0,N,Spleen,1,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in spleen of male wistar rats,,BAO_0000218,14198,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625064,3126.0,13270,Rattus norvegicus,,10116.0,N,Trachea,1,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in trachea of male wistar rats,,BAO_0000218,14198,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625065,10000001.0,13271,Rattus norvegicus,,10116.0,N,Bone,1,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in bone of male wistar rats,,BAO_0000218,14198,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625066,2037.0,13272,Rattus norvegicus,,10116.0,N,Cerebellum,1,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cerebellum of male wistar rats,,BAO_0000218,14198,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625067,,13273,Rattus norvegicus,,10116.0,N,,1,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cortex of male wistar rats,,BAO_0000218,14198,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625068,,13274,Rattus norvegicus,,10116.0,N,,1,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in fat of male wistar rats,,BAO_0000218,14198,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622159,948.0,13275,Rattus norvegicus,,10116.0,N,Heart,1,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in heart of male wistar rats,,BAO_0000218,14198,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622160,160.0,13276,Rattus norvegicus,,10116.0,N,Intestine,1,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in intestine of male wistar rats,,BAO_0000218,14198,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622161,2113.0,13277,Rattus norvegicus,,10116.0,N,Kidney,1,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in kidney of male wistar rats,,BAO_0000218,14198,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622162,2048.0,13278,Rattus norvegicus,,10116.0,N,Lung,1,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in lung of male wistar rats,,BAO_0000218,14198,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622163,2385.0,13279,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in muscle of male wistar rats,,BAO_0000218,14198,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622313,1969.0,13280,Rattus norvegicus,,10116.0,N,Plasma,1,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in plasma of male wistar rats,,BAO_0000218,14198,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622314,,13281,Rattus norvegicus,,10116.0,N,,1,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in red blood cells of male wistar rats,,BAO_0000218,14198,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622315,2106.0,13282,Rattus norvegicus,,10116.0,N,Spleen,1,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in spleen of male wistar rats,,BAO_0000218,14198,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622316,3126.0,13283,Rattus norvegicus,,10116.0,N,Trachea,1,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in trachea of male wistar rats,,BAO_0000218,14198,
,,A,,Intermediate,1,,50212,CHEMBL877486,,13284,Escherichia coli,,562.0,N,,1,,Normal diffusion coefficient in water for Escherichia coli,,BAO_0000218,15599,
,,A,,Autocuration,0,,22224,CHEMBL622317,,13285,,,,U,,1,,Average max percent decrease in RVR (renal vascular resistance) was determined,,BAO_0000019,8204,
,,A,,Autocuration,0,,22224,CHEMBL622318,,13286,,,,U,,1,,Average max percent decrease in RVR (renal vascular resistance) was determined.,,BAO_0000019,8204,
,,A,,Autocuration,0,,22224,CHEMBL622319,,13287,,,,U,,1,,In vitro stability to pepsin promoting hydrolysis after 1 hr incubation time,,BAO_0000019,6154,
,,A,,Autocuration,0,,22224,CHEMBL622320,,13288,,,,U,,1,,In vitro stability to pepsin promoting hydrolysis after 2 hr incubation time,,BAO_0000019,6154,
,,A,,Autocuration,0,,22224,CHEMBL622321,,13289,,,,U,,1,,In vitro stability to pepsin promoting hydrolysis after 64h incubation time,,BAO_0000019,6154,
,,A,,Autocuration,0,,22224,CHEMBL622322,,13290,,,,U,,1,,In vitro stability to pepsin promoting hydrolysis after 84 hr incubation time,,BAO_0000019,6154,
,,A,,Autocuration,0,,22224,CHEMBL622323,,13291,,,,U,,1,,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry,,BAO_0000019,7114,
,,A,,Intermediate,1,,50597,CHEMBL622324,,13292,Rattus norvegicus,,10116.0,N,,1,,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry in rat,,BAO_0000218,7114,
,,A,,Intermediate,1,,50588,CHEMBL622325,1088.0,13293,Canis lupus familiaris,,9615.0,N,Urine,1,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",,BAO_0000218,8133,
,,A,,Intermediate,1,,50588,CHEMBL622326,1088.0,13294,Canis lupus familiaris,,9615.0,N,Urine,1,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",,BAO_0000218,8133,
,,A,,Intermediate,1,,50588,CHEMBL877487,1088.0,13295,Canis lupus familiaris,,9615.0,N,Urine,1,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 10.0 mg/kg, po",,BAO_0000218,8133,
,,A,,Intermediate,1,,50588,CHEMBL622327,1088.0,13296,Canis lupus familiaris,,9615.0,N,Urine,1,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",,BAO_0000218,8133,
,,A,,Intermediate,1,,50588,CHEMBL622328,1088.0,13297,Canis lupus familiaris,,9615.0,N,Urine,1,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3.0 mg/kg, po",,BAO_0000218,8133,
,,A,,Intermediate,1,,50588,CHEMBL622329,1088.0,13298,Canis lupus familiaris,,9615.0,N,Urine,1,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",,BAO_0000218,8133,
,,A,,Intermediate,1,,50588,CHEMBL622330,1088.0,13299,Canis lupus familiaris,,9615.0,N,Urine,1,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",,BAO_0000218,8133,
,,A,,Intermediate,1,,50588,CHEMBL622331,1088.0,13300,Canis lupus familiaris,,9615.0,N,Urine,1,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 0.3mg/kg, po",,BAO_0000218,8133,
,,A,,Intermediate,1,,50588,CHEMBL622332,1088.0,13301,Canis lupus familiaris,,9615.0,N,Urine,1,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",,BAO_0000218,8133,
,,A,,Intermediate,1,,50588,CHEMBL622333,1088.0,13302,Canis lupus familiaris,,9615.0,N,Urine,1,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3 mg/kg, po",,BAO_0000218,8133,
,,A,,Autocuration,0,,22224,CHEMBL627658,1088.0,13303,Simiiformes,,314293.0,U,Urine,1,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",,BAO_0000218,8133,
,,A,,Autocuration,0,,22224,CHEMBL630428,1088.0,13304,Simiiformes,,314293.0,U,Urine,1,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 10mg/kg, po",,BAO_0000218,8133,
,,A,,Autocuration,0,,22224,CHEMBL630429,1088.0,13305,Simiiformes,,314293.0,U,Urine,1,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",,BAO_0000218,8133,
,,A,,Autocuration,0,,22224,CHEMBL630430,1088.0,13306,Simiiformes,,314293.0,U,Urine,1,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 30 mg/kg, po",,BAO_0000218,8133,
,,A,,Autocuration,0,,22224,CHEMBL630431,1088.0,13307,Simiiformes,,314293.0,U,Urine,1,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 3 mg/kg, po",,BAO_0000218,8133,
,,A,,Intermediate,1,,50597,CHEMBL630432,1088.0,13308,Rattus norvegicus,,10116.0,N,Urine,1,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",,BAO_0000218,8133,
,,A,,Intermediate,1,,50597,CHEMBL630433,1088.0,13309,Rattus norvegicus,,10116.0,N,Urine,1,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",,BAO_0000218,8133,
,,A,,Intermediate,1,,50597,CHEMBL630434,1088.0,13310,Rattus norvegicus,,10116.0,N,Urine,1,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",,BAO_0000218,8133,
,,A,,Intermediate,1,,50597,CHEMBL629372,1088.0,13311,Rattus norvegicus,,10116.0,N,Urine,1,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",,BAO_0000218,8133,
,,A,,Intermediate,1,,50597,CHEMBL629553,1088.0,13312,Rattus norvegicus,,10116.0,N,Urine,1,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 100.0mg/kg, po",,BAO_0000218,8133,
,,A,,Intermediate,1,,50597,CHEMBL629554,1088.0,13313,Rattus norvegicus,,10116.0,N,Urine,1,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",,BAO_0000218,8133,
,,A,,Intermediate,1,,50597,CHEMBL874447,1088.0,13314,Rattus norvegicus,,10116.0,N,Urine,1,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",,BAO_0000218,8133,
,,A,,Intermediate,1,,50597,CHEMBL629555,1088.0,13315,Rattus norvegicus,,10116.0,N,Urine,1,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",,BAO_0000218,8133,
,,A,,Intermediate,1,,50597,CHEMBL629556,1088.0,13316,Rattus norvegicus,,10116.0,N,Urine,1,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",,BAO_0000218,8133,
,,A,,Intermediate,1,,50597,CHEMBL629557,1088.0,13317,Rattus norvegicus,,10116.0,N,Urine,1,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded rats at 30.0 mg/kg, po",,BAO_0000218,8133,
,,A,,Intermediate,1,,50597,CHEMBL629558,1088.0,13318,Rattus norvegicus,,10116.0,N,Urine,1,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",,BAO_0000218,8133,
,,A,,Intermediate,1,,50597,CHEMBL629559,1088.0,13319,Rattus norvegicus,,10116.0,N,Urine,1,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",,BAO_0000218,8133,
,,A,,Intermediate,1,,50597,CHEMBL629560,1088.0,13320,Rattus norvegicus,,10116.0,N,Urine,1,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",,BAO_0000218,8133,
,,A,,Intermediate,1,,50588,CHEMBL629561,1088.0,13321,Canis lupus familiaris,,9615.0,N,Urine,1,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",,BAO_0000218,8133,
,,A,,Intermediate,1,,50588,CHEMBL629562,1088.0,13322,Canis lupus familiaris,,9615.0,N,Urine,1,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",,BAO_0000218,8133,
,,A,,Intermediate,1,,50588,CHEMBL629563,1088.0,13323,Canis lupus familiaris,,9615.0,N,Urine,1,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.3mg/kg, po",,BAO_0000218,8133,
,,A,,Intermediate,1,,50588,CHEMBL629564,1088.0,13324,Canis lupus familiaris,,9615.0,N,Urine,1,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",,BAO_0000218,8133,
,,A,,Intermediate,1,,50588,CHEMBL629565,1088.0,13325,Canis lupus familiaris,,9615.0,N,Urine,1,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10.0mg/kg, po",,BAO_0000218,8133,
,,A,,Intermediate,1,,50588,CHEMBL629566,1088.0,13326,Canis lupus familiaris,,9615.0,N,Urine,1,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",,BAO_0000218,8133,
,,A,,Intermediate,1,,50588,CHEMBL629567,1088.0,13327,Canis lupus familiaris,,9615.0,N,Urine,1,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1 mg/kg, po",,BAO_0000218,8133,
,,A,,Intermediate,1,,50588,CHEMBL629568,1088.0,13328,Canis lupus familiaris,,9615.0,N,Urine,1,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",,BAO_0000218,8133,
,,A,,Intermediate,1,,50588,CHEMBL629569,1088.0,13329,Canis lupus familiaris,,9615.0,N,Urine,1,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 30mg/kg, po",,BAO_0000218,8133,
,,A,,Intermediate,1,,50588,CHEMBL629570,1088.0,13330,Canis lupus familiaris,,9615.0,N,Urine,1,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",,BAO_0000218,8133,
,,A,,Autocuration,0,,22224,CHEMBL629571,1088.0,13331,Simiiformes,,314293.0,U,Urine,1,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",,BAO_0000218,8133,
In vivo,,A,,Autocuration,0,,22224,CHEMBL629572,,13332,Rattus norvegicus,,10116.0,U,,1,,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,,BAO_0000218,12170,
In vivo,,A,,Autocuration,0,,22224,CHEMBL629573,,13333,Rattus norvegicus,,10116.0,U,,1,,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,,BAO_0000218,12170,
In vivo,,A,,Autocuration,0,,22224,CHEMBL629574,,13334,Eutheria,,9347.0,U,,1,,Bioavailability (dose 20 mg/kg),,BAO_0000218,4985,
In vivo,,A,,Autocuration,0,,22224,CHEMBL629575,,13335,Canis lupus familiaris,,9615.0,U,,1,,Bioavailability in dog,,BAO_0000218,15145,
In vivo,,A,,Autocuration,0,,22224,CHEMBL874448,,13336,Rattus norvegicus,,10116.0,U,,1,,Bioavailability in rat (Sprague-Dawley) (male),,BAO_0000218,14080,
In vivo,,A,,Autocuration,0,,22224,CHEMBL629576,,13337,Primates,,9443.0,U,,1,,Bioavailability in monkey (dose 10 mg/kg i.d.),,BAO_0000218,11219,
In vivo,,A,,Autocuration,0,,22224,CHEMBL629577,,13338,Rattus norvegicus,,10116.0,U,,1,,Bioavailability in rat,,BAO_0000218,15145,
In vivo,,A,,Autocuration,0,,22224,CHEMBL629578,,13339,Rattus norvegicus,,10116.0,U,,1,,Bioavailability in rat,,BAO_0000218,15145,
In vivo,,A,,Autocuration,0,,22224,CHEMBL629579,,13340,Canis lupus familiaris,,9615.0,U,,1,,Bioavailability in dog (dose 3.0 mg/kg p.o.),,BAO_0000218,1202,
In vivo,,A,,Autocuration,0,,22224,CHEMBL882958,,13341,Canis lupus familiaris,,9615.0,U,,1,,Bioavailability in dog (dose of 1.0 mg/kg i.v.) 0.5 hr,,BAO_0000218,1202,
In vivo,,A,,Intermediate,1,,50505,CHEMBL629580,,13342,Pan troglodytes,,9598.0,N,,1,,Bioavailability was calculated after peroral dose of 10 mg/Kg in chimp,,BAO_0000218,1202,
In vivo,,A,,Autocuration,0,,22224,CHEMBL629581,,13343,Eutheria,,9347.0,U,,1,,Bioavailability,,BAO_0000218,4026,
In vivo,,A,,Autocuration,0,,22224,CHEMBL629582,,13344,Saimiri,,9520.0,U,,1,,Bioavailability in squirrel monkey,,BAO_0000218,1492,
In vivo,,A,,Intermediate,1,,50588,CHEMBL628522,,13345,Canis lupus familiaris,,9615.0,N,,1,,Bioavailability was evaluated in dog,,BAO_0000218,12793,
In vivo,,A,,Intermediate,1,,100712,CHEMBL625432,,13346,Cricetinae,,10026.0,N,,1,,Bioavailability was evaluated in hamster,,BAO_0000218,12793,
In vivo,,A,,Autocuration,0,,22224,CHEMBL625433,,13347,Rattus norvegicus,,10116.0,U,,1,,Bioavailability in rat,,BAO_0000218,12793,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625434,1969.0,13348,Rattus norvegicus,,10116.0,N,Plasma,1,,Bioavailability was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,,BAO_0000218,14793,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625435,1969.0,13349,Rattus norvegicus,,10116.0,N,Plasma,1,,Bioavailability was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg; <Tr>,,BAO_0000218,14793,
In vivo,,A,,Autocuration,0,,22224,CHEMBL625436,,13350,Rattus norvegicus,,10116.0,U,,1,,Bioavailability in rat (dose 10 mg/kg p.o.),,BAO_0000218,14793,
In vivo,,A,,Intermediate,1,,100710,CHEMBL874588,,13351,Macaca fascicularis,,9541.0,N,,1,,Bioavailability was measured in cynomolgus monkeys.,,BAO_0000218,14731,
In vivo,,A,,Intermediate,1,,50594,CHEMBL625437,,13352,Mus musculus,,10090.0,N,,1,,Bioavailability was measured in nude mice.,,BAO_0000218,14731,
In vivo,,A,,Autocuration,0,,22224,CHEMBL625438,,13353,Mustela putorius furo,,9669.0,U,,1,,Bioavailability in ferret (dose 10 mg/kg i.d.),,BAO_0000218,12187,
In vivo,,A,,Autocuration,0,,22224,CHEMBL625439,,13354,Simiiformes,,314293.0,U,,1,,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose),,BAO_0000218,12187,
In vivo,,A,,Autocuration,0,,22224,CHEMBL625440,,13355,Simiiformes,,314293.0,U,,1,,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose), determined by renin inhibition assay",,BAO_0000218,12187,
In vivo,,A,,Autocuration,0,,22224,CHEMBL625441,,13356,Simiiformes,,314293.0,U,,1,,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 1 mg/kg intravenous dose),,BAO_0000218,12187,
In vivo,,A,,Autocuration,0,,22224,CHEMBL625442,,13357,Rattus norvegicus,,10116.0,U,,1,,Bioavailability in rat (dose 10 mg/kg i.d.),,BAO_0000218,12187,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625443,,13358,Rattus norvegicus,,10116.0,N,,1,,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",,BAO_0000218,12187,
In vivo,,A,,Autocuration,0,,22224,CHEMBL625444,,13359,,,,U,,1,,Bioavailability was determined; extremely poor,,BAO_0000218,17431,
In vivo,,A,,Intermediate,1,,50594,CHEMBL625445,,13360,Mus musculus,,10090.0,N,,1,,% bioavailability in mice after oral administration of prodrug,,BAO_0000218,13318,
In vivo,,A,,Intermediate,1,,50588,CHEMBL625446,,13361,Canis lupus familiaris,,9615.0,N,,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose 10/30 range (low/high); -21/-5,,BAO_0000218,9025,
In vivo,,A,,Intermediate,1,,50588,CHEMBL882960,,13362,Canis lupus familiaris,,9615.0,N,,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -2/6,,BAO_0000218,9025,
In vivo,,A,,Intermediate,1,,50588,CHEMBL625447,,13363,Canis lupus familiaris,,9615.0,N,,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -4/-14,,BAO_0000218,9025,
In vivo,,A,,Intermediate,1,,50588,CHEMBL625448,,13364,Canis lupus familiaris,,9615.0,N,,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -5/-12,,BAO_0000218,9025,
In vivo,,A,,Intermediate,1,,50588,CHEMBL625449,,13365,Canis lupus familiaris,,9615.0,N,,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3/10 range (low/high); -1/-7/-11,,BAO_0000218,9025,
In vivo,,A,,Intermediate,1,,50588,CHEMBL874589,,13366,Canis lupus familiaris,,9615.0,N,,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high),,BAO_0000218,9025,
In vivo,,A,,Intermediate,1,,50588,CHEMBL625450,,13367,Canis lupus familiaris,,9615.0,N,,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -1/-9,,BAO_0000218,9025,
In vivo,,A,,Intermediate,1,,50588,CHEMBL625451,,13368,Canis lupus familiaris,,9615.0,N,,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -11/-28,,BAO_0000218,9025,
In vivo,,A,,Intermediate,1,,50588,CHEMBL626584,,13369,Canis lupus familiaris,,9615.0,N,,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/-29,,BAO_0000218,9025,
In vivo,,A,,Intermediate,1,,50588,CHEMBL626585,,13370,Canis lupus familiaris,,9615.0,N,,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/30,,BAO_0000218,9025,
In vivo,,A,,Intermediate,1,,50588,CHEMBL626586,,13371,Canis lupus familiaris,,9615.0,N,,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-18,,BAO_0000218,9025,
In vivo,,A,,Intermediate,1,,50588,CHEMBL626587,,13372,Canis lupus familiaris,,9615.0,N,,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-35,,BAO_0000218,9025,
In vivo,,A,,Intermediate,1,,50588,CHEMBL626588,,13373,Canis lupus familiaris,,9615.0,N,,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -19/-50,,BAO_0000218,9025,
In vivo,,A,,Intermediate,1,,50588,CHEMBL626589,,13374,Canis lupus familiaris,,9615.0,N,,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -21/-29,,BAO_0000218,9025,
In vivo,,A,,Intermediate,1,,50588,CHEMBL626590,,13375,Canis lupus familiaris,,9615.0,N,,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -24/-56,,BAO_0000218,9025,
In vivo,,A,,Intermediate,1,,50588,CHEMBL626591,,13376,Canis lupus familiaris,,9615.0,N,,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -25/-33,,BAO_0000218,9025,
In vivo,,A,,Intermediate,1,,50588,CHEMBL627181,,13377,Canis lupus familiaris,,9615.0,N,,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -3/-13,,BAO_0000218,9025,
In vivo,,A,,Intermediate,1,,50588,CHEMBL628083,,13378,Canis lupus familiaris,,9615.0,N,,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -5/-47,,BAO_0000218,9025,
In vivo,,A,,Autocuration,0,,22224,CHEMBL628084,,13379,,,,U,,1,,IV clearance determined at an peroral dose of 15 mg/kg.,,BAO_0000218,15173,
In vivo,,F,,Expert,1,,50064,CHEMBL628085,,13380,Hymenolepis nana,,102285.0,N,,1,,Mouse oral clearance was measured against Hymenolepiasis nana.,,BAO_0000218,7732,
In vivo,,F,,Expert,1,,50545,CHEMBL628086,,13381,Heligmosomoides polygyrus,,6339.0,N,,1,,Mouse oral clearance was measured against Nematospiroides dubius,,BAO_0000218,7732,
In vivo,,F,,Autocuration,0,,22224,CHEMBL628087,,13382,,,,U,,1,,Mouse oral clearance was measured against N. dubius; NT is Not Tested,,BAO_0000218,7732,
In vivo,,A,,Intermediate,1,,50594,CHEMBL628088,,13383,Mus musculus,,10090.0,N,,1,,Mouse oral clearance was measured against N. nana; NT is Not Tested,,BAO_0000218,7732,
In vivo,,B,,Autocuration,0,,22224,CHEMBL628089,,13384,,,,U,,1,,Mouse oral clearance was measured against N. nana; NT is Not Tested,,BAO_0000218,7732,
In vivo,,A,,Autocuration,0,,22224,CHEMBL628090,,13385,,,,U,,1,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 10 J/cm e2 ultraviolet-A radiation,,BAO_0000218,8328,
In vivo,,A,,Autocuration,0,,22224,CHEMBL628091,,13386,,,,U,,1,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 6 J/cm e2 ultraviolet-A radiation,,BAO_0000218,8328,
In vivo,,A,,Autocuration,0,,22224,CHEMBL628092,,13387,,,,U,,1,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 8 J/cm e2 ultraviolet-A radiation,,BAO_0000218,8328,
In vivo,,A,,Autocuration,0,,22224,CHEMBL628093,,13388,,,,U,,1,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 9 J/cm e2 ultraviolet-A radiation,,BAO_0000218,8328,
In vivo,,A,,Autocuration,0,,22224,CHEMBL875607,,13389,,,,U,,1,,Percentage of clearance of psoriatic lesions by the compound at dose of 10 J/cm e2 ultraviolet-A radiation,,BAO_0000218,8328,
In vivo,,A,,Autocuration,0,,22224,CHEMBL625710,,13390,,,,U,,1,,Percentage of clearance of psoriatic lesions by the compound at dose of 4 J/cm e2 ultraviolet-A radiation,,BAO_0000218,8328,
In vivo,,A,,Autocuration,0,,22224,CHEMBL625711,,13391,,,,U,,1,,Percentage of clearance of psoriatic lesions by the compound at dose of 6 J/cm e2 ultraviolet-A radiation,,BAO_0000218,8328,
In vivo,,A,,Autocuration,0,,22224,CHEMBL625712,,13392,,,,U,,1,,Percentage of clearance of psoriatic lesions by the compound at dose of 8 J/cm e2 ultraviolet-A radiation,,BAO_0000218,8328,
In vivo,,A,,Autocuration,0,,22224,CHEMBL625713,,13393,,,,U,,1,,Percentage of clearance of psoriatic lesions by the compound at dose of 9 J/cm e2 ultraviolet-A radiation,,BAO_0000218,8328,
In vivo,,A,,Intermediate,1,,50588,CHEMBL625714,,13394,Canis lupus familiaris,,9615.0,N,,1,,Pharmacokinetic parameter clearance was determined in fed Beagle dogs after iv administration of 1.5 mg/kg,,BAO_0000218,13376,
In vivo,,A,,Intermediate,1,,50797,CHEMBL625715,,13395,Macaca mulatta,,9544.0,N,,1,,Plasma clearance after intravenous administration dosing (30 mg/kg) in Rhesus monkey,,BAO_0000218,13477,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625716,,13396,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance after intravenous administration dosing (30 mg/kg) in rat,,BAO_0000218,13477,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625717,,13397,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance after intravenous administration iv dosing of 3 mg/kg in rat,,BAO_0000218,13477,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625718,,13398,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance was determined for the compound in rats,,BAO_0000218,13313,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625719,,13399,Rattus norvegicus,,10116.0,N,,1,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 1,,BAO_0000218,12504,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625720,,13400,Rattus norvegicus,,10116.0,N,,1,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 2,,BAO_0000218,12504,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625721,,13401,Rattus norvegicus,,10116.0,N,,1,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 3,,BAO_0000218,12504,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625722,,13402,Rattus norvegicus,,10116.0,N,,1,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 4,,BAO_0000218,12504,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625723,,13403,Rattus norvegicus,,10116.0,N,,1,,The compound was tested for systemic clearance pharmacokinetic parameter in the male Sprague-Dawley rat.,,BAO_0000218,13129,
In vivo,,A,,Intermediate,1,,50545,CHEMBL625724,,13404,Heligmosomoides polygyrus,,6339.0,N,,1,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.0125 concentration of diet.,,BAO_0000218,7732,
In vivo,,A,,Intermediate,1,,50545,CHEMBL625725,,13405,Heligmosomoides polygyrus,,6339.0,N,,1,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.025 concentration of diet.,,BAO_0000218,7732,
In vivo,,A,,Intermediate,1,,50545,CHEMBL625726,,13406,Heligmosomoides polygyrus,,6339.0,N,,1,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.05 concentration of diet.,,BAO_0000218,7732,
In vivo,,A,,Intermediate,1,,50545,CHEMBL875608,,13407,Heligmosomoides polygyrus,,6339.0,N,,1,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.1 concentration of diet.,,BAO_0000218,7732,
In vivo,,A,,Intermediate,1,,50545,CHEMBL625727,,13408,Heligmosomoides polygyrus,,6339.0,N,,1,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.2 concentration of diet.,,BAO_0000218,7732,
In vivo,,A,,Autocuration,0,,22224,CHEMBL625728,1088.0,13409,Rattus norvegicus,,10116.0,U,Urine,1,,Urinary clearance was determined in rat at 100 mg/kg os dosage;ND is defined as no-data.,,BAO_0000218,9278,
In vivo,,A,,Autocuration,0,,22224,CHEMBL625729,,13410,Rattus norvegicus,,10116.0,U,,1,,Total clearance was determined in rat at 10 mg/kg intraperitoneal dosage,,BAO_0000218,9278,
In vivo,,A,,Autocuration,0,,22224,CHEMBL625730,,13411,Rattus norvegicus,,10116.0,U,,1,,Total clearance was determined in rat at 25 mg/kg os dosage;ND is defined as no-data.,,BAO_0000218,9278,
In vivo,,A,,Autocuration,0,,22224,CHEMBL625731,1088.0,13412,Rattus norvegicus,,10116.0,U,Urine,1,,Urinary clearance was determined in rat at 10 mg/kg intraperitoneal dosage,,BAO_0000218,9278,
In vivo,,A,,Autocuration,0,,22224,CHEMBL626417,1088.0,13413,Rattus norvegicus,,10116.0,U,Urine,1,,Urinary clearance was determined in rat at 25 mg/kg os dosage,,BAO_0000218,9278,
In vivo,,A,,Intermediate,1,,50587,CHEMBL626418,1088.0,13414,Homo sapiens,,9606.0,N,Urine,1,,Urinary clearance was determined at 100 mg/kg oral dosage in human,,BAO_0000218,9278,
In vivo,,A,,Intermediate,1,,50588,CHEMBL626419,1088.0,13415,Canis lupus familiaris,,9615.0,N,Urine,1,,Urinary clearance was determined at 20 mg/kg oral dosage in dog(beagle);ND is defined as no-data.,,BAO_0000218,9278,
In vivo,,A,,Intermediate,1,,50588,CHEMBL626592,1969.0,13416,Canis lupus familiaris,,9615.0,N,Plasma,1,,Plasma concentration in dogs after 2 hr at 30mg/kg oral dose,,BAO_0000218,5932,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626593,1969.0,13417,Rattus norvegicus,,10116.0,N,Plasma,1,,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,,BAO_0000218,5932,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626594,,13418,Rattus norvegicus,,10116.0,N,,1,,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,,BAO_0000218,5182,
In vivo,,A,,Intermediate,1,,50588,CHEMBL625035,,13419,Canis lupus familiaris,,9615.0,N,,1,,Clearance rate in dogs,,BAO_0000218,10499,
In vitro,,A,,Autocuration,0,,22224,CHEMBL625036,,13420,,,,U,,1,,Compound was measured for intrinsic clearance,,BAO_0000019,6051,
,,P,,Autocuration,0,,22229,CHEMBL625037,,13421,,,,U,,1,,Calculated partition coefficient (clogP),,BAO_0000100,17508,
,,P,,Autocuration,0,,22229,CHEMBL625038,,13422,,,,U,,1,,Calculated partition coefficient (clogP),,BAO_0000100,6228,
,,P,,Autocuration,0,,22229,CHEMBL625039,,13423,,,,U,,1,,Calculated partition coefficient (clogP),,BAO_0000100,6231,
,,P,,Autocuration,0,,22229,CHEMBL625040,,13424,,,,U,,1,,Calculated partition coefficient (clogP),,BAO_0000100,17740,
,,P,,Autocuration,0,,22229,CHEMBL625041,,13425,,,,U,,1,,Calculated partition coefficient (clogP),,BAO_0000100,6495,
,,P,,Autocuration,0,,22229,CHEMBL625042,,13426,,,,U,,1,,Calculated partition coefficient (clogP),,BAO_0000100,2171,
,,A,,Autocuration,0,,22224,CHEMBL874411,,13427,,,,U,,1,,Partition coefficient of the compound,,BAO_0000019,3255,
,,A,,Autocuration,0,,22224,CHEMBL625043,,13428,,,,U,,1,,Permeability,,BAO_0000019,6821,
,,P,,Autocuration,0,,22229,CHEMBL625044,,13429,,,,U,,1,,Calculated partition coefficient (clogP),,BAO_0000100,2685,
,,A,,Autocuration,0,,22224,CHEMBL625045,,13430,,,,U,,1,,Partition coefficient (logD),,BAO_0000019,17584,
,,P,,Autocuration,0,,22229,CHEMBL625046,,13431,,,,U,,1,,Calculated partition coefficient (clogP) (CLOGP3 V3.4),,BAO_0000100,13824,
,,P,,Autocuration,0,,22229,CHEMBL625047,,13432,,,,U,,1,,Calculated partition coefficient (clogP) (CLOGP3 V3.4),,BAO_0000100,13824,
,,P,,Autocuration,0,,22229,CHEMBL625048,,13433,,,,U,,1,,Calculated partition coefficient (clogP),,BAO_0000100,16479,
,,P,,Autocuration,0,,22229,CHEMBL625049,,13434,,,,U,,1,,Calculated partition coefficient (clogP),,BAO_0000100,11997,
,,P,,Autocuration,0,,22229,CHEMBL625050,,13435,,,,U,,1,,Calculated logarithm of partition coefficient (P) was determined,,BAO_0000100,2988,
,,P,,Autocuration,0,,22229,CHEMBL625051,,13436,,,,U,,1,,Calculated partition coefficient (clogP),,BAO_0000100,931,
,,P,,Autocuration,0,,22229,CHEMBL874412,,13437,,,,U,,1,,Calculated partition coefficient (clogP),,BAO_0000100,4381,
,,P,,Autocuration,0,,22229,CHEMBL625052,,13438,,,,U,,1,,Calculated partition coefficient (clogP),,BAO_0000100,4397,
,,P,,Autocuration,0,,22229,CHEMBL625053,,13439,,,,U,,1,,Calculated partition coefficient (clogP),,BAO_0000100,5889,
,,A,,Autocuration,0,,22224,CHEMBL623250,,13440,,,,U,,1,,In vitro stability to pepsin promoting hydrolysis after 8 hr incubation time,,BAO_0000019,6154,
,,A,,Autocuration,0,,22224,CHEMBL623251,,13441,,,,U,,1,,In vitro stability to trypsin promoting hydrolysis after 1 hr incubation time,,BAO_0000019,6154,
,,A,,Autocuration,0,,22224,CHEMBL623252,,13442,,,,U,,1,,In vitro stability to trypsin promoting hydrolysis after 2 hr incubation time,,BAO_0000019,6154,
,,A,,Autocuration,0,,22224,CHEMBL623253,,13443,,,,U,,1,,In vitro stability to trypsin promoting hydrolysis after 64h incubation time,,BAO_0000019,6154,
,,A,,Autocuration,0,,22224,CHEMBL623254,,13444,,,,U,,1,,In vitro stability to trypsin promoting hydrolysis after 84 hr incubation time,,BAO_0000019,6154,
,,A,,Autocuration,0,,22224,CHEMBL623255,,13445,,,,U,,1,,In vitro stability to trypsin promoting hydrolysis after 8 hr incubation time,,BAO_0000019,6154,
,,A,,Autocuration,0,,22224,CHEMBL626831,,13446,,,,U,,1,,Percent degradation of compound at a pH of 1 over a 18 hr period,,BAO_0000019,6887,
,,A,,Autocuration,0,,22224,CHEMBL877494,,13447,,,,U,,1,,Percent degradation of compound at pH of 1 over an 18 hr period,,BAO_0000019,6887,
,,A,,Autocuration,0,,22224,CHEMBL626832,,13448,,,,U,,1,,Delta Logarithm of Partition Coefficient value was determined.,,BAO_0000019,14116,
,,A,,Autocuration,0,,22224,CHEMBL626833,,13449,,,,U,,1,,Delta logPoct-cyc,,BAO_0000019,11137,
,,P,,Autocuration,0,,22224,CHEMBL626834,,13450,,,,U,,1,,Lipophilicity estimated on reversed phase TLC,,BAO_0000100,7230,
,,A,,Autocuration,0,,22224,CHEMBL626835,,13451,,,,U,,1,,Delta Tm value ( Tmdrug-DNA )-TmDNA ) was obtained for the covalently cross-linked compound in the absence of formaldehyde using calf thymus DNA.,,BAO_0000019,15741,
,,A,,Autocuration,0,,22224,CHEMBL626836,,13452,,,,U,,1,,Delta logPoct-cyc,,BAO_0000019,9663,
,,P,,Autocuration,0,,22229,CHEMBL626837,,13453,,,,U,,1,,Change in logarithm of partition coefficient of the compound,,BAO_0000100,9663,
,,A,,Autocuration,0,,22224,CHEMBL626838,,13454,,,,U,,1,,Delta logD (pH 6.5),,BAO_0000019,13807,
,,P,,Autocuration,0,,22224,CHEMBL626839,,13455,,,,U,,1,,"Partition coefficient by standard shake-flask techniquesat 37 C, using octanol and cyclohexane",,BAO_0000100,13807,
,,A,,Autocuration,0,,22224,CHEMBL626840,,13456,,,,U,,1,,Oxygen pressure at which hemoglobin is 50% oxygenated; negative sign indicates that P50 of modified Hb is lower than that of unmodified Hb,,BAO_0000019,17425,
,,A,,Autocuration,0,,22224,CHEMBL626841,,13457,,,,U,,1,,Deoxyribose-damaging property as a measure of hydroxyl-radical formation (uM of malondialdehyde/mmol of deoxyribose released by 75 uM test compound),,BAO_0000019,12143,
,,A,,Autocuration,0,,22224,CHEMBL626842,,13458,,,,U,,1,,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in nine cells,,BAO_0000219,12608,
,,A,,Autocuration,0,,22224,CHEMBL626843,,13459,,,,U,,1,,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in six cells,,BAO_0000219,12608,
,,A,,Intermediate,1,,50597,CHEMBL626844,,13460,Rattus norvegicus,,10116.0,N,,1,,Amount of deuterium retained was reported after normal workup in beta-naphthoflavone-treated male rats with the substrate rac 7-D,,BAO_0000218,8649,
,,A,,Intermediate,1,,50597,CHEMBL877495,,13461,Rattus norvegicus,,10116.0,N,,1,,Amount of deuterium retained was reported after normal workup in rats,,BAO_0000218,8649,
,,A,,Intermediate,1,,50597,CHEMBL626845,,13462,Rattus norvegicus,,10116.0,N,,1,,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats,,BAO_0000218,8649,
,,A,,Intermediate,1,,50597,CHEMBL626846,,13463,Rattus norvegicus,,10116.0,N,,1,,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats with rac 8-D,,BAO_0000218,8649,
,,A,,Intermediate,1,,50597,CHEMBL626847,,13464,Rattus norvegicus,,10116.0,N,,1,,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,,BAO_0000218,8649,
,,A,,Intermediate,1,,50597,CHEMBL628677,,13465,Rattus norvegicus,,10116.0,N,,1,,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,,BAO_0000218,8649,
,,A,,Intermediate,1,,50597,CHEMBL628678,,13466,Rattus norvegicus,,10116.0,N,,1,,Compound incubated with microsomal preparations from phenobarbital treated male rats with the substrate rac 8-D and the amount of deuterium retained was reported after normal workup,,BAO_0000218,8649,
,,A,,Autocuration,0,,22224,CHEMBL628679,,13467,,,,U,,1,,Compound was subjected to electrochemical oxidation,,BAO_0000019,9659,
,,A,,Autocuration,0,,22224,CHEMBL628680,,13468,,,,U,,1,,Compound was subjected to photochemical oxidation,,BAO_0000019,9659,
,,A,,Autocuration,0,,22224,CHEMBL628681,,13469,,,,U,,1,,Oxidation of compound by Chloroperoxidase in presence of ethylperoxide,,BAO_0000019,9659,
,,A,,Autocuration,0,,22224,CHEMBL628682,,13470,,,,U,,1,,Oxidation of compound by horseradish peroxidase in presence of hydroperoxide,,BAO_0000019,9659,
,,A,,Autocuration,0,,22224,CHEMBL628683,,13471,,,,U,,1,,Oxidation of compound by methemoglobin in presence of hydroperoxide,,BAO_0000019,9659,
,,A,,Intermediate,1,,50597,CHEMBL628684,,13472,Rattus norvegicus,,10116.0,N,,1,,Percent diffusion through fuzzy rat skin after 48 h of incubation,,BAO_0000218,9607,
,,P,,Autocuration,0,,22229,CHEMBL877501,,13473,,,,U,,1,,Dissociation constant (pKa),,BAO_0000100,7057,
,,P,,Autocuration,0,,22224,CHEMBL628685,,13474,,,,U,,1,,Dissociation constant value of the compound; ND means not determined.,,BAO_0000100,7057,
,,A,,Intermediate,1,,50597,CHEMBL628686,178.0,13475,Rattus norvegicus,,10116.0,N,Blood,1,,% distribution of the radioiron in blood of rat followed by intravenous injection of chelating agent,,BAO_0000218,7911,
,,A,,Intermediate,1,,50597,CHEMBL628687,178.0,13476,Rattus norvegicus,,10116.0,N,Blood,1,,% distribution of the radioiron in blood of rats followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,,BAO_0000218,7911,
,,A,,Intermediate,1,,50597,CHEMBL628688,,13477,Rattus norvegicus,,10116.0,N,,1,,% distribution of the radioiron in rat kidney followed by intravenous injection of chelating agent,,BAO_0000218,7911,
,,A,,Intermediate,1,,50597,CHEMBL628689,,13478,Rattus norvegicus,,10116.0,N,,1,,% distribution of the radioiron in rat kidney followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,,BAO_0000218,7911,
,,A,,Intermediate,1,,50597,CHEMBL628690,2107.0,13479,Rattus norvegicus,,10116.0,N,Liver,1,,% distribution of the radioiron in rat liver followed by intravenous injection of chelating agent,,BAO_0000218,7911,
,,A,,Intermediate,1,,50597,CHEMBL629363,2107.0,13480,Rattus norvegicus,,10116.0,N,Liver,1,,% distribution of the radioiron in rat liver followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,,BAO_0000218,7911,
,,A,,Intermediate,1,,50597,CHEMBL629364,2106.0,13481,Rattus norvegicus,,10116.0,N,Spleen,1,,% distribution of the radioiron in rat spleen followed by intravenous injection of chelating agent,,BAO_0000218,7911,
,,A,,Intermediate,1,,50597,CHEMBL629365,2106.0,13482,Rattus norvegicus,,10116.0,N,Spleen,1,,% distribution of the radioiron in rat spleen followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,,BAO_0000218,7911,
,,A,,Intermediate,1,,50597,CHEMBL629366,,13483,Rattus norvegicus,,10116.0,N,,1,,% excretion of ferritin determined in faces of rat followed by intravenous injection of chelating agent,,BAO_0000218,7911,
,,A,,Intermediate,1,,50597,CHEMBL629367,1088.0,13484,Rattus norvegicus,,10116.0,N,Urine,1,,% excretion of ferritin determined in urine of rat followed by intravenous injection of chelating agent,,BAO_0000218,7911,
,,A,,Intermediate,1,,50597,CHEMBL629368,1988.0,13485,Rattus norvegicus,,10116.0,N,Feces,1,,% excretion of radioiron determined in feces of rat followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,,BAO_0000218,7911,
,,A,,Intermediate,1,,50597,CHEMBL877502,1088.0,13486,Rattus norvegicus,,10116.0,N,Urine,1,,% excretion of radioiron determined in urine of rat followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,,BAO_0000218,7911,
,,A,,Intermediate,1,,50594,CHEMBL629369,2037.0,13487,Mus musculus,,10090.0,N,Cerebellum,1,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cerebellum,,BAO_0000218,13792,
,,A,,Intermediate,1,,50594,CHEMBL629370,955.0,13488,Mus musculus,,10090.0,N,Brain,1,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cortex,,BAO_0000218,13792,
,,A,,Autocuration,0,,22224,CHEMBL629371,1088.0,13489,Simiiformes,,314293.0,U,Urine,1,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded monkey at 10 mg/kg, po",,BAO_0000218,8133,
,,A,,Autocuration,0,,22224,CHEMBL626276,1088.0,13490,Simiiformes,,314293.0,U,Urine,1,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",,BAO_0000218,8133,
,,A,,Autocuration,0,,22224,CHEMBL626277,1088.0,13491,Simiiformes,,314293.0,U,Urine,1,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",,BAO_0000218,8133,
,,A,,Autocuration,0,,22224,CHEMBL631250,1088.0,13492,Simiiformes,,314293.0,U,Urine,1,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",,BAO_0000218,8133,
,,A,,Intermediate,1,,50597,CHEMBL631251,1088.0,13493,Rattus norvegicus,,10116.0,N,Urine,1,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",,BAO_0000218,8133,
,,A,,Intermediate,1,,50597,CHEMBL631252,1088.0,13494,Rattus norvegicus,,10116.0,N,Urine,1,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",,BAO_0000218,8133,
,,A,,Intermediate,1,,50597,CHEMBL631253,1088.0,13495,Rattus norvegicus,,10116.0,N,Urine,1,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 1.0 mg/kg, po",,BAO_0000218,8133,
,,A,,Intermediate,1,,50597,CHEMBL631254,1088.0,13496,Rattus norvegicus,,10116.0,N,Urine,1,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",,BAO_0000218,8133,
,,A,,Intermediate,1,,50597,CHEMBL631255,1088.0,13497,Rattus norvegicus,,10116.0,N,Urine,1,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",,BAO_0000218,8133,
,,A,,Intermediate,1,,50597,CHEMBL631256,1088.0,13498,Rattus norvegicus,,10116.0,N,Urine,1,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",,BAO_0000218,8133,
,,A,,Intermediate,1,,50597,CHEMBL631257,1088.0,13499,Rattus norvegicus,,10116.0,N,Urine,1,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",,BAO_0000218,8133,
,,A,,Intermediate,1,,50597,CHEMBL628009,1088.0,13500,Rattus norvegicus,,10116.0,N,Urine,1,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 207.6 mg/kg, po",,BAO_0000218,8133,
,,A,,Intermediate,1,,50597,CHEMBL628010,1088.0,13501,Rattus norvegicus,,10116.0,N,Urine,1,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",,BAO_0000218,8133,
,,A,,Intermediate,1,,50597,CHEMBL628011,1088.0,13502,Rattus norvegicus,,10116.0,N,Urine,1,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",,BAO_0000218,8133,
,,A,,Intermediate,1,,50597,CHEMBL628012,1088.0,13503,Rattus norvegicus,,10116.0,N,Urine,1,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 6.9 mg/kg, po",,BAO_0000218,8133,
,,A,,Intermediate,1,,50597,CHEMBL628013,1088.0,13504,Rattus norvegicus,,10116.0,N,Urine,1,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",,BAO_0000218,8133,
,,A,,Intermediate,1,,50597,CHEMBL628014,1088.0,13505,Rattus norvegicus,,10116.0,N,Urine,1,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",,BAO_0000218,8133,
,,A,,Intermediate,1,,50588,CHEMBL628015,1088.0,13506,Canis lupus familiaris,,9615.0,N,Urine,1,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.03 mg/kg, po",,BAO_0000218,8133,
,,A,,Intermediate,1,,50588,CHEMBL628016,1088.0,13507,Canis lupus familiaris,,9615.0,N,Urine,1,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",,BAO_0000218,8133,
,,A,,Intermediate,1,,50588,CHEMBL874461,1088.0,13508,Canis lupus familiaris,,9615.0,N,Urine,1,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.3 mg/kg, po",,BAO_0000218,8133,
,,A,,Intermediate,1,,50588,CHEMBL628017,1088.0,13509,Canis lupus familiaris,,9615.0,N,Urine,1,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",,BAO_0000218,8133,
,,A,,Intermediate,1,,50588,CHEMBL628018,1088.0,13510,Canis lupus familiaris,,9615.0,N,Urine,1,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 10.0mg/kg, po",,BAO_0000218,8133,
,,A,,Intermediate,1,,50588,CHEMBL628019,1088.0,13511,Canis lupus familiaris,,9615.0,N,Urine,1,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",,BAO_0000218,8133,
,,A,,Intermediate,1,,50588,CHEMBL628020,1088.0,13512,Canis lupus familiaris,,9615.0,N,Urine,1,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",,BAO_0000218,8133,
,,A,,Intermediate,1,,50588,CHEMBL628021,1088.0,13513,Canis lupus familiaris,,9615.0,N,Urine,1,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",,BAO_0000218,8133,
,,A,,Intermediate,1,,50588,CHEMBL628022,1088.0,13514,Canis lupus familiaris,,9615.0,N,Urine,1,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",,BAO_0000218,8133,
,,A,,Intermediate,1,,50588,CHEMBL628023,1088.0,13515,Canis lupus familiaris,,9615.0,N,Urine,1,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",,BAO_0000218,8133,
,,A,,Autocuration,0,,22224,CHEMBL628024,1088.0,13516,Simiiformes,,314293.0,U,Urine,1,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",,BAO_0000218,8133,
,,A,,Autocuration,0,,22224,CHEMBL628025,1088.0,13517,Simiiformes,,314293.0,U,Urine,1,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 10mg/kg, po",,BAO_0000218,8133,
,,A,,Autocuration,0,,22224,CHEMBL628026,1088.0,13518,Simiiformes,,314293.0,U,Urine,1,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",,BAO_0000218,8133,
,,A,,Autocuration,0,,22224,CHEMBL628027,1088.0,13519,Simiiformes,,314293.0,U,Urine,1,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",,BAO_0000218,8133,
,,A,,Autocuration,0,,22224,CHEMBL628028,1088.0,13520,Simiiformes,,314293.0,U,Urine,1,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",,BAO_0000218,8133,
,,A,,Intermediate,1,,50597,CHEMBL628029,1088.0,13521,Rattus norvegicus,,10116.0,N,Urine,1,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",,BAO_0000218,8133,
,,A,,Intermediate,1,,50597,CHEMBL628030,1088.0,13522,Rattus norvegicus,,10116.0,N,Urine,1,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 0.3 mg/kg, po",,BAO_0000218,8133,
,,A,,Intermediate,1,,50597,CHEMBL628031,1088.0,13523,Rattus norvegicus,,10116.0,N,Urine,1,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",,BAO_0000218,8133,
,,A,,Intermediate,1,,50597,CHEMBL628032,1088.0,13524,Rattus norvegicus,,10116.0,N,Urine,1,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 10.0 mg/kg, po",,BAO_0000218,8133,
,,A,,Intermediate,1,,50597,CHEMBL628033,1088.0,13525,Rattus norvegicus,,10116.0,N,Urine,1,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",,BAO_0000218,8133,
,,A,,Intermediate,1,,50597,CHEMBL628034,1088.0,13526,Rattus norvegicus,,10116.0,N,Urine,1,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 2.08 mg/kg, po",,BAO_0000218,8133,
,,A,,Intermediate,1,,50597,CHEMBL628035,1088.0,13527,Rattus norvegicus,,10116.0,N,Urine,1,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",,BAO_0000218,8133,
,,A,,Intermediate,1,,50597,CHEMBL628036,1088.0,13528,Rattus norvegicus,,10116.0,N,Urine,1,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 3.0 mg/kg, po",,BAO_0000218,8133,
,,A,,Intermediate,1,,50597,CHEMBL874462,1088.0,13529,Rattus norvegicus,,10116.0,N,Urine,1,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",,BAO_0000218,8133,
In vivo,,A,,Intermediate,1,,50588,CHEMBL628037,,13530,Canis lupus familiaris,,9615.0,N,,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -8/-38,,BAO_0000218,9025,
In vivo,,A,,Intermediate,1,,50588,CHEMBL628123,,13531,Canis lupus familiaris,,9615.0,N,,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 13/-25,,BAO_0000218,9025,
In vivo,,A,,Intermediate,1,,50588,CHEMBL628124,,13532,Canis lupus familiaris,,9615.0,N,,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 27/-15,,BAO_0000218,9025,
In vivo,,A,,Intermediate,1,,50588,CHEMBL628125,,13533,Canis lupus familiaris,,9615.0,N,,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -2/-19,,BAO_0000218,9025,
In vivo,,A,,Intermediate,1,,50588,CHEMBL628126,,13534,Canis lupus familiaris,,9615.0,N,,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/60 range (low/high); -3/-4,,BAO_0000218,9025,
In vivo,,A,,Intermediate,1,,50588,CHEMBL628127,,13535,Canis lupus familiaris,,9615.0,N,,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3 range (low/high),,BAO_0000218,9025,
In vivo,,A,,Intermediate,1,,50588,CHEMBL628128,,13536,Canis lupus familiaris,,9615.0,N,,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); -9/24,,BAO_0000218,9025,
In vivo,,A,,Intermediate,1,,50588,CHEMBL628129,,13537,Canis lupus familiaris,,9615.0,N,,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); 3/-1,,BAO_0000218,9025,
In vivo,,A,,Intermediate,1,,50588,CHEMBL628130,,13538,Canis lupus familiaris,,9615.0,N,,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/030 range (low/high); 12/23,,BAO_0000218,9025,
In vivo,,A,,Intermediate,1,,50588,CHEMBL628131,,13539,Canis lupus familiaris,,9615.0,N,,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 1/3,,BAO_0000218,9025,
In vivo,,A,,Intermediate,1,,50588,CHEMBL628132,,13540,Canis lupus familiaris,,9615.0,N,,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 6/16,,BAO_0000218,9025,
In vivo,,A,,Intermediate,1,,50588,CHEMBL628133,,13541,Canis lupus familiaris,,9615.0,N,,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 7/14,,BAO_0000218,9025,
In vivo,,A,,Intermediate,1,,50588,CHEMBL628134,,13542,Canis lupus familiaris,,9615.0,N,,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3/10 range (low/high); 4/4/23,,BAO_0000218,9025,
In vivo,,A,,Intermediate,1,,50588,CHEMBL628135,,13543,Canis lupus familiaris,,9615.0,N,,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 10/14,,BAO_0000218,9025,
In vivo,,A,,Intermediate,1,,50588,CHEMBL628136,,13544,Canis lupus familiaris,,9615.0,N,,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/15,,BAO_0000218,9025,
In vivo,,A,,Intermediate,1,,50588,CHEMBL628137,,13545,Canis lupus familiaris,,9615.0,N,,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/44,,BAO_0000218,9025,
In vivo,,A,,Intermediate,1,,50588,CHEMBL628138,,13546,Canis lupus familiaris,,9615.0,N,,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 14/28,,BAO_0000218,9025,
In vivo,,A,,Intermediate,1,,50588,CHEMBL628139,,13547,Canis lupus familiaris,,9615.0,N,,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 15-28,,BAO_0000218,9025,
In vivo,,A,,Intermediate,1,,50588,CHEMBL628140,,13548,Canis lupus familiaris,,9615.0,N,,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 2/3,,BAO_0000218,9025,
In vivo,,A,,Intermediate,1,,50588,CHEMBL628141,,13549,Canis lupus familiaris,,9615.0,N,,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 26/32,,BAO_0000218,9025,
In vivo,,A,,Intermediate,1,,50588,CHEMBL628142,,13550,Canis lupus familiaris,,9615.0,N,,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/1,,BAO_0000218,9025,
In vivo,,A,,Intermediate,1,,50588,CHEMBL628143,,13551,Canis lupus familiaris,,9615.0,N,,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/12,,BAO_0000218,9025,
In vivo,,A,,Intermediate,1,,50588,CHEMBL628144,,13552,Canis lupus familiaris,,9615.0,N,,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 6/7,,BAO_0000218,9025,
In vivo,,A,,Intermediate,1,,50588,CHEMBL628145,,13553,Canis lupus familiaris,,9615.0,N,,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 7/6,,BAO_0000218,9025,
In vivo,,A,,Intermediate,1,,50588,CHEMBL628146,,13554,Canis lupus familiaris,,9615.0,N,,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/12,,BAO_0000218,9025,
In vivo,,A,,Intermediate,1,,50588,CHEMBL625355,,13555,Canis lupus familiaris,,9615.0,N,,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/27,,BAO_0000218,9025,
In vivo,,A,,Intermediate,1,,50588,CHEMBL625356,,13556,Canis lupus familiaris,,9615.0,N,,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/14,,BAO_0000218,9025,
In vivo,,A,,Intermediate,1,,50588,CHEMBL625357,,13557,Canis lupus familiaris,,9615.0,N,,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/16,,BAO_0000218,9025,
In vivo,,A,,Intermediate,1,,50588,CHEMBL625527,,13558,Canis lupus familiaris,,9615.0,N,,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/60 range (low/high); 12/23,,BAO_0000218,9025,
In vivo,,A,,Intermediate,1,,50588,CHEMBL875473,,13559,Canis lupus familiaris,,9615.0,N,,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3 range (low/high),,BAO_0000218,9025,
In vivo,,A,,Intermediate,1,,50588,CHEMBL625528,,13560,Canis lupus familiaris,,9615.0,N,,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 10/22,,BAO_0000218,9025,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626304,,13561,Rattus norvegicus,,10116.0,N,,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 4/12,,BAO_0000218,9025,
In vivo,,A,,Intermediate,1,,50588,CHEMBL624138,1637.0,13562,Canis lupus familiaris,,9615.0,N,Artery,1,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a 10/30 dose range; 11/-11,,BAO_0000218,9025,
,,P,,Autocuration,0,,22229,CHEMBL624139,,13563,,,,U,,1,,Calculated partition coefficient (clogP),,BAO_0000100,6448,
,,P,,Autocuration,0,,22229,CHEMBL624140,,13564,,,,U,,1,,Calculated partition coefficient (clogP),,BAO_0000100,17221,
,,P,,Autocuration,0,,22229,CHEMBL624141,,13565,,,,U,,1,,Calculated partition coefficient (clogP),,BAO_0000100,6545,
,,P,,Autocuration,0,,22229,CHEMBL624142,,13566,,,,U,,1,,Calculated partition coefficient (clogP),,BAO_0000100,577,
,,P,,Autocuration,0,,22229,CHEMBL624143,,13567,,,,U,,1,,Calculated partition coefficient (clogP),,BAO_0000100,6285,
,,P,,Autocuration,0,,22229,CHEMBL624144,,13568,,,,U,,1,,Calculated partition coefficient (clogP),,BAO_0000100,6500,
,,P,,Autocuration,0,,22229,CHEMBL624145,,13569,,,,U,,1,,Calculated partition coefficient (clogP),,BAO_0000100,6716,
,,P,,Autocuration,0,,22229,CHEMBL624146,,13570,,,,U,,1,,Calculated partition coefficient (clogP),,BAO_0000100,13658,
,,P,,Autocuration,0,,22229,CHEMBL624147,,13571,,,,U,,1,,Calculated partition coefficient (clogP),,BAO_0000100,6549,
,,P,,Autocuration,0,,22229,CHEMBL883123,,13572,,,,U,,1,,Calculated partition coefficient (clogP) (MacLogP),,BAO_0000100,14685,
,,A,,Autocuration,0,,22224,CHEMBL624148,,13573,,,,U,,1,,Partition coefficient (logP),,BAO_0000019,6893,
,,A,,Autocuration,0,,22224,CHEMBL874416,,13574,,,,U,,1,,Kinetic parameter was determined,,BAO_0000019,3687,
,,P,,Autocuration,0,,22229,CHEMBL624149,,13575,,,,U,,1,,Calculated partition coefficient (clogP),,BAO_0000100,4207,
,,P,,Autocuration,0,,22229,CHEMBL624150,,13576,,,,U,,1,,Calculated partition coefficient (clogP),,BAO_0000100,4626,
,,P,,Autocuration,0,,22224,CHEMBL624151,,13577,,,,U,,1,,Lipophilicity was determined,,BAO_0000100,1021,
,,P,,Autocuration,0,,22224,CHEMBL624152,,13578,,,,U,,1,,Lipophilicity was determined,,BAO_0000100,3777,
,,P,,Autocuration,0,,22224,CHEMBL622139,,13579,,,,U,,1,,Lipophilicity was determined,,BAO_0000100,17533,
,,P,,Autocuration,0,,22229,CHEMBL622140,,13580,,,,U,,1,,Calculated partition coefficient (clogP),,BAO_0000100,6524,
,,P,,Autocuration,0,,22224,CHEMBL622141,,13581,,,,U,,1,,Lipophilicity was determined,,BAO_0000100,17533,
,,P,,Autocuration,0,,22224,CHEMBL622142,,13582,,,,U,,1,,Lipophilicity in octanol-water,,BAO_0000100,6480,
,,P,,Autocuration,0,,22229,CHEMBL622143,,13583,,,,U,,1,,Calculated partition coefficient (clogP),,BAO_0000100,17606,
,,P,,Autocuration,0,,22229,CHEMBL622144,,13584,,,,U,,1,,Octanol-water partition coefficient was determined,,BAO_0000100,6863,
,,A,,Autocuration,0,,22224,CHEMBL877473,,13585,,,,U,,1,,Partition coefficient (logP),,BAO_0000019,1356,
,,P,,Autocuration,0,,22229,CHEMBL622145,,13586,,,,U,,1,,Calculated partition coefficient (clogP),,BAO_0000100,3326,
,,A,,Autocuration,0,,22224,CHEMBL622146,,13587,,,,U,,1,,Partition coefficient was determined; ND means not determined,,BAO_0000019,1356,
,,P,,Autocuration,0,,22229,CHEMBL622147,,13588,,,,U,,1,,Calculated partition coefficient (clogP),,BAO_0000100,12984,
,,A,,Autocuration,0,,22224,CHEMBL622148,,13589,,,,U,,1,,Partition coefficient of the compound,,BAO_0000019,17363,
,,A,,Autocuration,0,,22224,CHEMBL883124,,13590,,,,U,,1,,Permeability was determined,,BAO_0000019,6827,
,,P,,Autocuration,0,,22229,CHEMBL622149,,13591,,,,U,,1,,The compound was evaluated for the partition coefficient,,BAO_0000100,261,
,,A,,Autocuration,0,,22224,CHEMBL622150,,13592,,,,U,,1,,Partition coefficient (logP),,BAO_0000019,2685,
,,P,,Autocuration,0,,22224,CHEMBL622151,,13593,,,,U,,1,,The lipophilicity was reported,,BAO_0000100,414,
,,P,,Autocuration,0,,22229,CHEMBL622152,,13594,,,,U,,1,,logarithm of the octanol-water partition coefficient for the compound,,BAO_0000100,15769,
,,A,,Autocuration,0,,22224,CHEMBL622153,,13595,,,,U,,1,,Clogp value was determined,,BAO_0000019,17248,
In vivo,,A,,Autocuration,0,,22224,CHEMBL877474,,13596,,,,U,,1,,Clp at a dose of 1.5 mg/kg,,BAO_0000218,16935,
In vivo,,A,,Autocuration,0,,22224,CHEMBL622154,,13597,,,,U,,1,,Clp at a dose of 2.0 mg/kg,,BAO_0000218,16935,
In vivo,,A,,Autocuration,0,,22224,CHEMBL622155,1969.0,13598,,,,U,Plasma,1,,"Clp, plasma clearance at a dose of 10 mg/kg",,BAO_0000218,14832,
In vivo,,A,,Autocuration,0,,22224,CHEMBL622156,1969.0,13599,,,,U,Plasma,1,,"Clp, plasma clearance at a dose of 50 mg/kg",,BAO_0000218,14832,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622157,1969.0,13600,Rattus norvegicus,,10116.0,N,Plasma,1,,Compound was tested for plasma clearance in rat,,BAO_0000218,2399,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622158,1969.0,13601,Rattus norvegicus,,10116.0,N,Plasma,1,,Compound was tested for plasma clearance in rat; Not determined,,BAO_0000218,2399,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622807,,13602,Rattus norvegicus,,10116.0,N,,1,,Plasma clearance (pharmacokinetic parameter) in rat (in vivo) at a dose of 10 mg/kg,,BAO_0000218,6227,
In vivo,,A,,Intermediate,1,,50797,CHEMBL622808,,13603,Macaca mulatta,,9544.0,N,,1,,Plasma clearance (pharmacokinetic parameter) in rhesus (in vivo) at a dose of 5 mg/kg,,BAO_0000218,6227,
In vivo,,A,,Autocuration,0,,22224,CHEMBL622809,,13604,,,,U,,1,,Plasma clearance by iv administration at a dose 0.003 ug/mL,,BAO_0000218,5623,
In vivo,,A,,Autocuration,0,,22224,CHEMBL622810,,13605,,,,U,,1,,Plasma clearance determined,,BAO_0000218,4854,
In vivo,,A,,Intermediate,1,,100712,CHEMBL876653,,13606,Cricetinae,,10026.0,N,,1,,Plasma clearance after iv administration at 3 mg/kg in hamster,,BAO_0000218,4493,
In vivo,,A,,Intermediate,1,,100712,CHEMBL622811,,13607,Cricetinae,,10026.0,N,,1,,Plasma clearance after iv administration at 4 mg/kg in hamster,,BAO_0000218,4493,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622986,,13608,Rattus norvegicus,,10116.0,N,,1,,Rate of clearance in rat was determined,,BAO_0000218,14956,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622987,1969.0,13609,Rattus norvegicus,,10116.0,N,Plasma,1,,Total plasma clearance Clp was determined for the compound after iv dose of 5.06 mg/kg in rats,,BAO_0000218,15372,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622988,1969.0,13610,Rattus norvegicus,,10116.0,N,Plasma,1,,Total plasma clearance after iv dose of 5.10 mg/kg in rats,,BAO_0000218,15372,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622989,1969.0,13611,Rattus norvegicus,,10116.0,N,Plasma,1,,Total plasma clearance was determined for the compound after iv dose of 4.74 mg/kg in rats,,BAO_0000218,15372,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622990,1969.0,13612,Rattus norvegicus,,10116.0,N,Plasma,1,,Total plasma clearance was determined for the compound after iv dose of 4.97 mg/kg in rats,,BAO_0000218,15372,
In vivo,,A,,Autocuration,0,,22224,CHEMBL622991,1969.0,13613,Simiiformes,,314293.0,U,Plasma,1,,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,,BAO_0000218,15604,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622227,1969.0,13614,Rattus norvegicus,,10116.0,N,Plasma,1,,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,,BAO_0000218,15604,
In vivo,,A,,Intermediate,1,,50588,CHEMBL622228,1969.0,13615,Canis lupus familiaris,,9615.0,N,Plasma,1,,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,,BAO_0000218,15604,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622229,,13616,Rattus norvegicus,,10116.0,N,,1,,Clpl value in rat,,BAO_0000218,14964,
In vivo,,A,,Intermediate,1,,50512,CHEMBL622230,,13617,Cavia porcellus,,10141.0,N,,1,,Cmax (ng /mL) value after oral administration of 10 mg/kg in guinea pig.,,BAO_0000218,15240,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622231,,13618,Rattus norvegicus,,10116.0,N,,1,,Cmax after an oral dose of 10 uM/Kg in male Sprague-Dawley rats,,BAO_0000218,16449,
In vivo,,A,,Intermediate,1,,100710,CHEMBL622232,,13619,Macaca fascicularis,,9541.0,N,,1,,Cmax after an oral dose of 10 uM/Kg in male cynomolgus monkeys,,BAO_0000218,16449,
In vivo,,A,,Autocuration,0,,22224,CHEMBL622233,,13620,,,,U,,1,,Cmax in minutes at a iv dose of 1.0(pmol/g/h).,,BAO_0000218,12902,
In vivo,,A,,Autocuration,0,,22224,CHEMBL622234,,13621,,,,U,,1,,Cmax in minutes at a iv dose of 2.0(pmol/g/h).,,BAO_0000218,12902,
In vivo,,A,,Autocuration,0,,22224,CHEMBL622235,,13622,,,,U,,1,,Cmax in minutes at a iv dose of 4.0(pmol/g/h).,,BAO_0000218,12902,
In vivo,,A,,Autocuration,0,,22224,CHEMBL622236,,13623,,,,U,,1,,Cmax in minutes at a iv dose of 5.0(pmol/g/h).,,BAO_0000218,12902,
In vivo,,A,,Autocuration,0,,22224,CHEMBL622237,,13624,,,,U,,1,,Cmax in minutes at a iv dose of 54.0(pmol/g/h).,,BAO_0000218,12902,
In vivo,,A,,Autocuration,0,,22224,CHEMBL877482,,13625,,,,U,,1,,Cmax in minutes at a po dose of 10.0(pmol/g/h).,,BAO_0000218,12902,
In vivo,,A,,Autocuration,0,,22224,CHEMBL622238,,13626,,,,U,,1,,Cmax in minutes at a po dose of 20.0(pmol/g/h).,,BAO_0000218,12902,
In vivo,,A,,Autocuration,0,,22224,CHEMBL622239,,13627,,,,U,,1,,Cmax in minutes at a po dose of 40.0(pmol/g/h).,,BAO_0000218,12902,
In vivo,,A,,Autocuration,0,,22224,CHEMBL622240,178.0,13628,,,,U,Blood,1,,Cmax was calculated as maximum concentration reached in the blood,,BAO_0000218,11149,
In vivo,,A,,Autocuration,0,,22224,CHEMBL622241,178.0,13629,,,,U,Blood,1,,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate,,BAO_0000218,11149,
In vivo,,A,,Intermediate,1,,50597,CHEMBL631013,,13630,Rattus norvegicus,,10116.0,N,,1,,Cmax was determine after peroral administration at 10 mpk in Rat,,BAO_0000218,5669,
In vivo,,A,,Intermediate,1,,50797,CHEMBL631014,,13631,Macaca mulatta,,9544.0,N,,1,,Cmax was determine after peroral administration at 10 mpk in Rhesus,,BAO_0000218,5669,
In vivo,,A,,Intermediate,1,,50588,CHEMBL631015,,13632,Canis lupus familiaris,,9615.0,N,,1,,Cmax was determine after peroral administration at 10 mpk in dog,,BAO_0000218,5669,
In vivo,,A,,Intermediate,1,,50597,CHEMBL631016,,13633,Rattus norvegicus,,10116.0,N,,1,,Cmax was determine after peroral administration at 160 mpk in Rat,,BAO_0000218,5669,
In vivo,,A,,Intermediate,1,,50597,CHEMBL631017,,13634,Rattus norvegicus,,10116.0,N,,1,,Cmax was determine after peroral administration at 20 mpk in Rat,,BAO_0000218,5669,
In vivo,,A,,Intermediate,1,,50597,CHEMBL631018,,13635,Rattus norvegicus,,10116.0,N,,1,,Cmax was determine after peroral administration at 50 mpk in Rat,,BAO_0000218,5669,
In vivo,,A,,Autocuration,0,,22224,CHEMBL631019,,13636,,,,U,,1,,Cmax was determined,,BAO_0000218,4236,
,,A,,Intermediate,1,,50594,CHEMBL875761,955.0,13637,Mus musculus,,10090.0,N,Brain,1,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hippocampus,,BAO_0000218,13792,
,,A,,Intermediate,1,,50594,CHEMBL631020,955.0,13638,Mus musculus,,10090.0,N,Brain,1,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hypothalamus,,BAO_0000218,13792,
,,A,,Intermediate,1,,50594,CHEMBL631669,955.0,13639,Mus musculus,,10090.0,N,Brain,1,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into pons and medulla,,BAO_0000218,13792,
,,A,,Intermediate,1,,50594,CHEMBL631670,955.0,13640,Mus musculus,,10090.0,N,Brain,1,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into rest of the brain,,BAO_0000218,13792,
,,A,,Intermediate,1,,50594,CHEMBL631671,2435.0,13641,Mus musculus,,10090.0,N,Striatum,1,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into striatum,,BAO_0000218,13792,
,,A,,Intermediate,1,,50597,CHEMBL631672,178.0,13642,Rattus norvegicus,,10116.0,N,Blood,1,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.31-0.4,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL631673,178.0,13643,Rattus norvegicus,,10116.0,N,Blood,1,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.97-1.12,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL631856,178.0,13644,Rattus norvegicus,,10116.0,N,Blood,1,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.35-0.37,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL631857,178.0,13645,Rattus norvegicus,,10116.0,N,Blood,1,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.72-1.03,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL631858,178.0,13646,Rattus norvegicus,,10116.0,N,Blood,1,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.95-1.06,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL631859,178.0,13647,Rattus norvegicus,,10116.0,N,Blood,1,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.35-0.4,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL631860,178.0,13648,Rattus norvegicus,,10116.0,N,Blood,1,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.73-0.85,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL631861,178.0,13649,Rattus norvegicus,,10116.0,N,Blood,1,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.65-0.83,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL631862,178.0,13650,Rattus norvegicus,,10116.0,N,Blood,1,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.69-0.84,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL631863,178.0,13651,Rattus norvegicus,,10116.0,N,Blood,1,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.46,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL631864,178.0,13652,Rattus norvegicus,,10116.0,N,Blood,1,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.38-1.5,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL631865,178.0,13653,Rattus norvegicus,,10116.0,N,Blood,1,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.34-0.48,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL631866,178.0,13654,Rattus norvegicus,,10116.0,N,Blood,1,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.58-1.17,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL629360,178.0,13655,Rattus norvegicus,,10116.0,N,Blood,1,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.0-1.24,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL629361,178.0,13656,Rattus norvegicus,,10116.0,N,Blood,1,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.28-0.37,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL629362,178.0,13657,Rattus norvegicus,,10116.0,N,Blood,1,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.54-0.63,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL630740,178.0,13658,Rattus norvegicus,,10116.0,N,Blood,1,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.25-0.32,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL630741,178.0,13659,Rattus norvegicus,,10116.0,N,Blood,1,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.58,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL630742,178.0,13660,Rattus norvegicus,,10116.0,N,Blood,1,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.77,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL630743,,13661,Rattus norvegicus,,10116.0,N,,1,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.20-0.25,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL630744,,13662,Rattus norvegicus,,10116.0,N,,1,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.25,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL630745,,13663,Rattus norvegicus,,10116.0,N,,1,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.03,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL630746,,13664,Rattus norvegicus,,10116.0,N,,1,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.06,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL630747,,13665,Rattus norvegicus,,10116.0,N,,1,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.34-0.5,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL630748,,13666,Rattus norvegicus,,10116.0,N,,1,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.17-0.20,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL632056,,13667,Rattus norvegicus,,10116.0,N,,1,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.81-1.26,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL632057,,13668,Rattus norvegicus,,10116.0,N,,1,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.03-0.06,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL632058,,13669,Rattus norvegicus,,10116.0,N,,1,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.18-0.36,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL632059,,13670,Rattus norvegicus,,10116.0,N,,1,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.37,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL632060,,13671,Rattus norvegicus,,10116.0,N,,1,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.97-2.17,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL632061,,13672,Rattus norvegicus,,10116.0,N,,1,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.02-0.03,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL629207,,13673,Rattus norvegicus,,10116.0,N,,1,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.05-0.07,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL629208,,13674,Rattus norvegicus,,10116.0,N,,1,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.35-0.72,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL629209,,13675,Rattus norvegicus,,10116.0,N,,1,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.15-0.19,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL629210,,13676,Rattus norvegicus,,10116.0,N,,1,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.76-1.42,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL629211,,13677,Rattus norvegicus,,10116.0,N,,1,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.02-0.03,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL629212,,13678,Rattus norvegicus,,10116.0,N,,1,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.03-0.06,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL629213,,13679,Rattus norvegicus,,10116.0,N,,1,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.05-0.06,,BAO_0000218,8418,
,,A,,Intermediate,1,,50597,CHEMBL629214,1088.0,13680,Rattus norvegicus,,10116.0,N,Urine,1,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",,BAO_0000218,8133,
,,A,,Intermediate,1,,50597,CHEMBL629215,1088.0,13681,Rattus norvegicus,,10116.0,N,Urine,1,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 69.2 mg/kg, po",,BAO_0000218,8133,
,,A,,Intermediate,1,,50597,CHEMBL635154,1088.0,13682,Rattus norvegicus,,10116.0,N,Urine,1,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 691.9 mg/kg, po",,BAO_0000218,8133,
,,A,,Intermediate,1,,50597,CHEMBL629216,,13683,Rattus norvegicus,,10116.0,N,,1,,Oral diuretic activity measured by Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50597,CHEMBL629217,,13684,Rattus norvegicus,,10116.0,N,,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration,,BAO_0000218,6996,
,,A,,Intermediate,1,,50597,CHEMBL629218,,13685,Rattus norvegicus,,10116.0,N,,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50597,CHEMBL629219,,13686,Rattus norvegicus,,10116.0,N,,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration (0-5 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50597,CHEMBL629220,,13687,Rattus norvegicus,,10116.0,N,,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50597,CHEMBL629221,,13688,Rattus norvegicus,,10116.0,N,,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),,BAO_0000218,6996,
,,A,,Intermediate,1,,50597,CHEMBL631127,,13689,Rattus norvegicus,,10116.0,N,,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50597,CHEMBL631128,,13690,Rattus norvegicus,,10116.0,N,,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration,,BAO_0000218,6996,
,,A,,Intermediate,1,,50597,CHEMBL631129,,13691,Rattus norvegicus,,10116.0,N,,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50597,CHEMBL631130,,13692,Rattus norvegicus,,10116.0,N,,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration (0-5 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50597,CHEMBL631131,,13693,Rattus norvegicus,,10116.0,N,,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50597,CHEMBL631132,,13694,Rattus norvegicus,,10116.0,N,,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),,BAO_0000218,6996,
,,A,,Intermediate,1,,50597,CHEMBL631133,,13695,Rattus norvegicus,,10116.0,N,,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50597,CHEMBL631134,,13696,Rattus norvegicus,,10116.0,N,,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration,,BAO_0000218,6996,
,,A,,Intermediate,1,,50597,CHEMBL875120,,13697,Rattus norvegicus,,10116.0,N,,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50597,CHEMBL631135,,13698,Rattus norvegicus,,10116.0,N,,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration (0-5 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50597,CHEMBL631136,,13699,Rattus norvegicus,,10116.0,N,,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50597,CHEMBL631137,,13700,Rattus norvegicus,,10116.0,N,,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),,BAO_0000218,6996,
,,A,,Intermediate,1,,50597,CHEMBL631138,,13701,Rattus norvegicus,,10116.0,N,,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50597,CHEMBL631139,,13702,Rattus norvegicus,,10116.0,N,,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration,,BAO_0000218,6996,
,,A,,Intermediate,1,,50597,CHEMBL631140,,13703,Rattus norvegicus,,10116.0,N,,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50597,CHEMBL631141,,13704,Rattus norvegicus,,10116.0,N,,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50597,CHEMBL631142,,13705,Rattus norvegicus,,10116.0,N,,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50597,CHEMBL631143,,13706,Rattus norvegicus,,10116.0,N,,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),,BAO_0000218,6996,
,,A,,Intermediate,1,,50597,CHEMBL631144,,13707,Rattus norvegicus,,10116.0,N,,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50588,CHEMBL631145,,13708,Canis lupus familiaris,,9615.0,N,,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.312 mg/kg after ip administration,,BAO_0000218,6996,
,,A,,Intermediate,1,,50588,CHEMBL631146,,13709,Canis lupus familiaris,,9615.0,N,,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50588,CHEMBL631147,,13710,Canis lupus familiaris,,9615.0,N,,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.625 mg/kg after ip administration,,BAO_0000218,6996,
,,A,,Intermediate,1,,50588,CHEMBL631148,,13711,Canis lupus familiaris,,9615.0,N,,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50588,CHEMBL631149,,13712,Canis lupus familiaris,,9615.0,N,,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50588,CHEMBL631150,,13713,Canis lupus familiaris,,9615.0,N,,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration (0-6 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50588,CHEMBL631151,,13714,Canis lupus familiaris,,9615.0,N,,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50588,CHEMBL631152,,13715,Canis lupus familiaris,,9615.0,N,,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50588,CHEMBL631443,,13716,Canis lupus familiaris,,9615.0,N,,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50588,CHEMBL631444,,13717,Canis lupus familiaris,,9615.0,N,,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration (0-6 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50588,CHEMBL631445,,13718,Canis lupus familiaris,,9615.0,N,,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50588,CHEMBL631446,,13719,Canis lupus familiaris,,9615.0,N,,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),,BAO_0000218,6996,
,,A,,Intermediate,1,,50588,CHEMBL631447,,13720,Canis lupus familiaris,,9615.0,N,,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg g after ip administration (0-6 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50588,CHEMBL631448,,13721,Canis lupus familiaris,,9615.0,N,,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50588,CHEMBL631449,,13722,Canis lupus familiaris,,9615.0,N,,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration,,BAO_0000218,6996,
,,A,,Intermediate,1,,50588,CHEMBL631450,,13723,Canis lupus familiaris,,9615.0,N,,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration (0-6 hr),,BAO_0000218,6996,
,,A,,Intermediate,1,,50588,CHEMBL629724,,13724,Canis lupus familiaris,,9615.0,N,,1,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),,BAO_0000218,6996,
In vivo,,A,,Intermediate,1,,50594,CHEMBL629725,14.0,13725,Mus musculus,,10090.0,N,Zone of skin,1,,"Biodistribution in mice skin, after 24 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,BAO_0000218,9716,
In vivo,,A,,Intermediate,1,,50594,CHEMBL629726,14.0,13726,Mus musculus,,10090.0,N,Zone of skin,1,,"Biodistribution in mice skin, after 48 hr of intravenous administration of 1-2 ug ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,BAO_0000218,9716,
In vivo,,A,,Intermediate,1,,50594,CHEMBL629727,2106.0,13727,Mus musculus,,10090.0,N,Spleen,1,,"Biodistribution in mice spleen, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,BAO_0000218,9716,
In vivo,,A,,Intermediate,1,,50594,CHEMBL630404,2106.0,13728,Mus musculus,,10090.0,N,Spleen,1,,"Biodistribution in mice spleen, after 1 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,BAO_0000218,9716,
In vivo,,A,,Intermediate,1,,50594,CHEMBL630405,2106.0,13729,Mus musculus,,10090.0,N,Spleen,1,,"Biodistribution in mice spleen, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,BAO_0000218,9716,
In vivo,,A,,Intermediate,1,,50594,CHEMBL630406,2106.0,13730,Mus musculus,,10090.0,N,Spleen,1,,"Biodistribution in mice spleen, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,BAO_0000218,9716,
In vivo,,A,,Intermediate,1,,50594,CHEMBL630407,945.0,13731,Mus musculus,,10090.0,N,Stomach,1,,"Biodistribution in mice stomach, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,BAO_0000218,9716,
In vivo,,A,,Intermediate,1,,50594,CHEMBL630573,945.0,13732,Mus musculus,,10090.0,N,Stomach,1,,"Biodistribution in mice stomach, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,BAO_0000218,9716,
In vivo,,A,,Intermediate,1,,50594,CHEMBL630574,945.0,13733,Mus musculus,,10090.0,N,Stomach,1,,"Biodistribution in mice stomach, after 24 hr of intravenous administration of 1-2 ug of ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,BAO_0000218,9716,
In vivo,,A,,Intermediate,1,,50594,CHEMBL630575,945.0,13734,Mus musculus,,10090.0,N,Stomach,1,,"Biodistribution in mice stomach, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,BAO_0000218,9716,
In vivo,,A,,Intermediate,1,,50594,CHEMBL630576,,13735,Mus musculus,,10090.0,N,,1,,"Biodistribution in mice tail, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,BAO_0000218,9716,
In vivo,,A,,Intermediate,1,,50594,CHEMBL630577,,13736,Mus musculus,,10090.0,N,,1,,"Biodistribution in mice tail, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,BAO_0000218,9716,
In vivo,,A,,Intermediate,1,,50594,CHEMBL630578,,13737,Mus musculus,,10090.0,N,,1,,"Biodistribution in mice tail, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,BAO_0000218,9716,
In vivo,,A,,Intermediate,1,,50594,CHEMBL630579,,13738,Mus musculus,,10090.0,N,,1,,"Biodistribution in mice tail, after 48 hr of intravenous administration of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,BAO_0000218,9716,
,,A,,Intermediate,1,,50594,CHEMBL630580,2113.0,13739,Mus musculus,,10090.0,N,Kidney,1,,Percent of injected 238-Plutonium(IV) in mice kidney at 24 hr (orally administered),,BAO_0000218,12192,
,,A,,Intermediate,1,,50594,CHEMBL630581,2113.0,13740,Mus musculus,,10090.0,N,Kidney,1,,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 h,,BAO_0000218,12192,
,,A,,Intermediate,1,,50594,CHEMBL630582,2113.0,13741,Mus musculus,,10090.0,N,Kidney,1,,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 hr (orally administered),,BAO_0000218,12192,
,,A,,Intermediate,1,,50594,CHEMBL630583,,13742,Mus musculus,,10090.0,N,,1,,Percent of injected 238-Plutonium(IV) in mice liver at 24 h,,BAO_0000218,12192,
,,A,,Intermediate,1,,50594,CHEMBL630584,,13743,Mus musculus,,10090.0,N,,1,,Percent of injected 238-Plutonium(IV) in mice liver at 24 hr (orally administered),,BAO_0000218,12192,
,,A,,Intermediate,1,,50594,CHEMBL630585,,13744,Mus musculus,,10090.0,N,,1,,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 h,,BAO_0000218,12192,
,,A,,Intermediate,1,,50594,CHEMBL630586,,13745,Mus musculus,,10090.0,N,,1,,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 hr (orally administered),,BAO_0000218,12192,
,,A,,Intermediate,1,,50594,CHEMBL630587,,13746,Mus musculus,,10090.0,N,,1,,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 h,,BAO_0000218,12192,
,,A,,Intermediate,1,,50594,CHEMBL630588,,13747,Mus musculus,,10090.0,N,,1,,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 hr (orally administered),,BAO_0000218,12192,
,,A,,Intermediate,1,,50594,CHEMBL630589,,13748,Mus musculus,,10090.0,N,,1,,Percent of injected 238-Plutonium(IV) in mice whole body at 24 h,,BAO_0000218,12192,
,,A,,Intermediate,1,,50594,CHEMBL630590,,13749,Mus musculus,,10090.0,N,,1,,Percent of injected 238-Plutonium(IV) in mice whole body at 24 hr (orally administered),,BAO_0000218,12192,
,,A,,Autocuration,0,,22224,CHEMBL630591,1988.0,13750,,,,U,Feces,1,,Removal of 238-Plutonium(IV) in feces at 24 h,,BAO_0000019,12192,
,,A,,Autocuration,0,,22224,CHEMBL630592,1988.0,13751,,,,U,Feces,1,,Removal of 238-Plutonium(IV) in feces at 24 hr (orally administered),,BAO_0000019,12192,
,,A,,Autocuration,0,,22224,CHEMBL630593,,13752,,,,U,,1,,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 h,,BAO_0000019,12192,
,,A,,Autocuration,0,,22224,CHEMBL630594,,13753,,,,U,,1,,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 hr (orally administered),,BAO_0000019,12192,
,,A,,Autocuration,0,,22224,CHEMBL630595,1088.0,13754,,,,U,Urine,1,,Removal of 238-Plutonium(IV) in urine 0-4 h (orally administered),,BAO_0000019,12192,
,,A,,Autocuration,0,,22224,CHEMBL630596,1088.0,13755,,,,U,Urine,1,,Removal of 238-Plutonium(IV) in urine 4-24 hr (orally administered),,BAO_0000019,12192,
,,A,,Autocuration,0,,22224,CHEMBL630597,1088.0,13756,,,,U,Urine,1,,Removal of 238-Plutonium(IV) in urine after 0-24 h,,BAO_0000019,12192,
,,A,,Autocuration,0,,22224,CHEMBL630598,1088.0,13757,,,,U,Urine,1,,Removal of 238-Plutonium(IV) in urine after 0-24 hr (orally administered),,BAO_0000019,12192,
,,A,,Autocuration,0,,22224,CHEMBL630599,1088.0,13758,,,,U,Urine,1,,Removal of 238-Plutonium(IV) in urine after 0-4 h,,BAO_0000019,12192,
,,A,,Autocuration,0,,22224,CHEMBL630600,1088.0,13759,,,,U,Urine,1,,Removal of 238-Plutonium(IV) in urine after 0-4 hr (orally administered),,BAO_0000019,12192,
,,A,,Autocuration,0,,22224,CHEMBL630601,1088.0,13760,,,,U,Urine,1,,Removal of 238-Plutonium(IV) in urine after 4-24 h,,BAO_0000019,12192,
,,A,,Autocuration,0,,22224,CHEMBL630602,1088.0,13761,,,,U,Urine,1,,Removal of 238-Plutonium(IV) in urine after 4-24 hr (orally administered),,BAO_0000019,12192,
,,A,,Autocuration,0,,22224,CHEMBL630603,1088.0,13762,,,,U,Urine,1,,Removal of 238-Plutonium(IV) in urine at 0-4 hr (orally administered),,BAO_0000019,12192,
,,A,,Autocuration,0,,22224,CHEMBL630604,1088.0,13763,,,,U,Urine,1,,Removal of 238-Plutonium(IV) in urine at 4-24 hr (orally administered),,BAO_0000019,12192,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624869,178.0,13764,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624870,178.0,13765,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623189,178.0,13766,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623190,178.0,13767,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623191,178.0,13768,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623192,,13769,Rattus norvegicus,,10116.0,N,,1,,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623193,,13770,Rattus norvegicus,,10116.0,N,,1,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623194,,13771,Rattus norvegicus,,10116.0,N,,1,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623195,,13772,Rattus norvegicus,,10116.0,N,,1,,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623196,,13773,Rattus norvegicus,,10116.0,N,,1,,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
,,A,,Intermediate,1,,50597,CHEMBL623197,,13774,Rattus norvegicus,,10116.0,N,,1,,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 15 microCi of the drug and 15 micro g of estradiol,,BAO_0000218,11836,
,,A,,Intermediate,1,,50597,CHEMBL623198,,13775,Rattus norvegicus,,10116.0,N,,1,,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,,BAO_0000218,11836,
,,A,,Intermediate,1,,50597,CHEMBL623199,,13776,Rattus norvegicus,,10116.0,N,,1,,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,,BAO_0000218,11836,
,,A,,Intermediate,1,,50597,CHEMBL623200,2385.0,13777,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 100 microCi of drug in 10%ethanol saline,,BAO_0000218,11836,
,,A,,Intermediate,1,,50597,CHEMBL623201,2385.0,13778,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 120 microCi of drug in 10%ethanol saline,,BAO_0000218,11836,
,,A,,Intermediate,1,,50597,CHEMBL623202,2385.0,13779,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 15 microCi of drug in 10%ethanol saline,,BAO_0000218,11836,
,,A,,Intermediate,1,,50597,CHEMBL623203,2385.0,13780,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 50 microCi of drug in 10%ethanol saline,,BAO_0000218,11836,
,,A,,Intermediate,1,,50597,CHEMBL623204,2385.0,13781,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of drug in 10%ethanol saline,,BAO_0000218,11836,
,,A,,Intermediate,1,,50597,CHEMBL623205,2385.0,13782,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of the drug and 15 ug of estradiol,,BAO_0000218,11836,
,,A,,Intermediate,1,,50597,CHEMBL623206,2385.0,13783,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,,BAO_0000218,11836,
,,A,,Intermediate,1,,50597,CHEMBL623207,2385.0,13784,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of the drug and 15 micro g of estradiol,,BAO_0000218,11836,
,,A,,Intermediate,1,,50597,CHEMBL623208,2385.0,13785,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 15 microCi of the drug and 15 ug of estradiol,,BAO_0000218,11836,
,,A,,Intermediate,1,,50597,CHEMBL623209,2385.0,13786,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,,BAO_0000218,11836,
,,A,,Intermediate,1,,50597,CHEMBL623210,2385.0,13787,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,,BAO_0000218,11836,
,,A,,Intermediate,1,,50597,CHEMBL623211,,13788,Rattus norvegicus,,10116.0,N,,1,,Tested in vivo for the biodistribution in rat fat at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,,BAO_0000218,11836,
,,A,,Intermediate,1,,50597,CHEMBL623212,995.0,13789,Rattus norvegicus,,10116.0,N,Uterus,1,,Tested in vivo for the biodistribution in rat uterus at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,,BAO_0000218,11836,
,,A,,Autocuration,0,,22224,CHEMBL623213,,13790,,,,U,,1,,Tested in vitro for intrinsic activity relative to quinpirole,,BAO_0000019,12640,
,,A,,Autocuration,0,,22224,CHEMBL623214,,13791,,,,U,,1,,"Relative ion enhancement, determined in pulsed ultrafiltration",,BAO_0000019,14218,
,,A,,Autocuration,0,,22224,CHEMBL623215,,13792,,,,U,,1,,% ionization at the pH 7.4 at 37 degree Centigrade,,BAO_0000019,11296,
,,A,,Autocuration,0,,22224,CHEMBL623216,,13793,,,,U,,1,,Percentage ionization was measured,,BAO_0000019,10929,
,,A,,Intermediate,1,,50591,CHEMBL623217,,13794,Bos taurus,,9913.0,N,,1,,Association constant of binding of compound with calf thymus DNA was determined by using equilibrium dialysis.,,BAO_0000218,13841,
,,A,,Autocuration,0,,22224,CHEMBL623218,,13795,,,,U,,1,,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 Pseudo-first-order rate constant,,BAO_0000019,10431,
,,A,,Autocuration,0,,22224,CHEMBL623913,,13796,,,,U,,1,,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer Pseudo-first-order rate constant,,BAO_0000019,10431,
,,A,,Autocuration,0,,22224,CHEMBL623914,,13797,,,,U,,1,,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer pseudo-first-order rate constant 0.1 mM EDTA,,BAO_0000019,10431,
,,P,,Autocuration,0,,22229,CHEMBL623915,,13798,,,,U,,1,,Compound was evaluated for the partition coefficient in octanol/water,,BAO_0000100,8826,
,,P,,Autocuration,0,,22229,CHEMBL624080,,13799,,,,U,,1,,Compound was evaluated for the partition coefficient in octanol/water (1-octanol / 10 mM phosphate buffer at pH 7.4),,BAO_0000100,8826,
,,A,,Autocuration,0,,22224,CHEMBL624081,,13800,,,,U,,1,,Equilibrium constant measured by the pulse radiolysis at pH 7,,BAO_0000019,9884,
,,A,,Intermediate,1,,50587,CHEMBL624082,,13801,Homo sapiens,,9606.0,N,,1,,In vitro hydrolytic rate constant determined in human blood,,BAO_0000218,9827,
,,A,,Intermediate,1,,50587,CHEMBL625054,,13802,Homo sapiens,,9606.0,N,,1,,In vitro oxidation of compound to its pyridinium salt (3) in presence of human plasma,,BAO_0000218,10009,
,,A,,Autocuration,0,,22224,CHEMBL877485,,13803,,,,U,,1,,In vitro oxidation of compound to its pyridinium salt (3) in presence of hydrogen peroxide,,BAO_0000019,10009,
,,A,,Intermediate,1,,50594,CHEMBL625055,,13804,Mus musculus,,10090.0,N,,1,,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse brain homogenate,,BAO_0000218,10009,
,,A,,Intermediate,1,,50594,CHEMBL625056,,13805,Mus musculus,,10090.0,N,,1,,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse liver homogenate,,BAO_0000218,10009,
,,A,,Intermediate,1,,50587,CHEMBL625057,,13806,Homo sapiens,,9606.0,N,,1,,In vitro oxidation of compound in presence of human plasma,,BAO_0000218,10009,
,,A,,Autocuration,0,,22224,CHEMBL625058,,13807,,,,U,,1,,In vitro oxidation of compound in presence of hydrogen peroxide,,BAO_0000019,10009,
,,A,,Intermediate,1,,50594,CHEMBL625059,,13808,Mus musculus,,10090.0,N,,1,,In vitro oxidation of compound in presence of mouse brain homogenate,,BAO_0000218,10009,
,,A,,Intermediate,1,,50594,CHEMBL629536,,13809,Mus musculus,,10090.0,N,,1,,In vitro oxidation of compound in presence of mouse liver homogenate,,BAO_0000218,10009,
,,A,,Intermediate,1,,50597,CHEMBL629537,,13810,Rattus norvegicus,,10116.0,N,,1,,Mean potassium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL629538,,13811,Rattus norvegicus,,10116.0,N,,1,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL629539,,13812,Rattus norvegicus,,10116.0,N,,1,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL874445,,13813,Rattus norvegicus,,10116.0,N,,1,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL629540,,13814,Rattus norvegicus,,10116.0,N,,1,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL629541,,13815,Rattus norvegicus,,10116.0,N,,1,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL629542,,13816,Rattus norvegicus,,10116.0,N,,1,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL630243,,13817,Rattus norvegicus,,10116.0,N,,1,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL630244,,13818,Rattus norvegicus,,10116.0,N,,1,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL630245,,13819,Rattus norvegicus,,10116.0,N,,1,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL630246,,13820,Rattus norvegicus,,10116.0,N,,1,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL630247,,13821,Rattus norvegicus,,10116.0,N,,1,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL630248,,13822,Rattus norvegicus,,10116.0,N,,1,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,,BAO_0000218,11510,
In vivo,,A,,Intermediate,1,,50597,CHEMBL630249,178.0,13823,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution in rat blood at 240 minutes after dose administration.,,BAO_0000218,13100,
In vivo,,A,,Intermediate,1,,50597,CHEMBL630250,178.0,13824,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution in rat blood at 30 minutes after dose administration.,,BAO_0000218,13100,
In vivo,,A,,Intermediate,1,,50597,CHEMBL630251,178.0,13825,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution in rat blood at 360 minutes after dose administration.,,BAO_0000218,13100,
In vivo,,A,,Intermediate,1,,50597,CHEMBL630252,178.0,13826,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution in rat blood at 3 hr after dose administration.,,BAO_0000218,13100,
In vivo,,A,,Intermediate,1,,50597,CHEMBL630408,178.0,13827,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution in rat blood at 60 minutes after dose administration.,,BAO_0000218,13100,
In vivo,,A,,Intermediate,1,,50597,CHEMBL630409,2037.0,13828,Rattus norvegicus,,10116.0,N,Cerebellum,1,,Biodistribution in rat cerebellum at 120 minutes after dose administration.,,BAO_0000218,13100,
In vivo,,A,,Intermediate,1,,50597,CHEMBL874446,2037.0,13829,Rattus norvegicus,,10116.0,N,Cerebellum,1,,Biodistribution in rat cerebellum at 1440 minutes after dose administration.,,BAO_0000218,13100,
In vivo,,A,,Intermediate,1,,50597,CHEMBL630410,2037.0,13830,Rattus norvegicus,,10116.0,N,Cerebellum,1,,Biodistribution in rat cerebellum at 15 minutes after dose administration.,,BAO_0000218,13100,
In vivo,,A,,Intermediate,1,,50597,CHEMBL630411,2037.0,13831,Rattus norvegicus,,10116.0,N,Cerebellum,1,,Biodistribution in rat cerebellum at 240 minutes after dose administration.,,BAO_0000218,13100,
In vivo,,A,,Intermediate,1,,50597,CHEMBL630412,2037.0,13832,Rattus norvegicus,,10116.0,N,Cerebellum,1,,Biodistribution in rat cerebellum at 30 minutes after dose administration.,,BAO_0000218,13100,
In vivo,,A,,Intermediate,1,,50597,CHEMBL630413,2037.0,13833,Rattus norvegicus,,10116.0,N,Cerebellum,1,,Biodistribution in rat cerebellum at 360 minutes after dose administration.,,BAO_0000218,13100,
In vivo,,A,,Intermediate,1,,50597,CHEMBL630414,2037.0,13834,Rattus norvegicus,,10116.0,N,Cerebellum,1,,Biodistribution in rat cerebellum at 3 hr after dose administration.,,BAO_0000218,13100,
In vivo,,A,,Intermediate,1,,50597,CHEMBL630415,2037.0,13835,Rattus norvegicus,,10116.0,N,Cerebellum,1,,Biodistribution in rat cerebellum at 60 minutes after dose administration.,,BAO_0000218,13100,
In vivo,,A,,Intermediate,1,,50597,CHEMBL630416,,13836,Rattus norvegicus,,10116.0,N,,1,,Biodistribution in rat cortex at 120 minutes after dose administration.,,BAO_0000218,13100,
In vivo,,A,,Intermediate,1,,50597,CHEMBL630417,,13837,Rattus norvegicus,,10116.0,N,,1,,Biodistribution in rat cortex at 1440 minutes after dose administration.,,BAO_0000218,13100,
In vivo,,A,,Intermediate,1,,50597,CHEMBL630418,,13838,Rattus norvegicus,,10116.0,N,,1,,Biodistribution in rat cortex at 15 minutes after dose administration.,,BAO_0000218,13100,
In vivo,,A,,Intermediate,1,,50597,CHEMBL630419,,13839,Rattus norvegicus,,10116.0,N,,1,,Biodistribution in rat cortex at 240 minutes after dose administration.,,BAO_0000218,13100,
In vivo,,A,,Intermediate,1,,50597,CHEMBL630420,,13840,Rattus norvegicus,,10116.0,N,,1,,Biodistribution in rat cortex at 30 minutes after dose administration.,,BAO_0000218,13100,
In vivo,,A,,Intermediate,1,,50597,CHEMBL630421,,13841,Rattus norvegicus,,10116.0,N,,1,,Biodistribution in rat cortex at 360 minutes after dose administration.,,BAO_0000218,13100,
In vivo,,A,,Intermediate,1,,50597,CHEMBL630422,,13842,Rattus norvegicus,,10116.0,N,,1,,Biodistribution in rat cortex at 3 hr after dose administration.,,BAO_0000218,13100,
In vivo,,A,,Intermediate,1,,50597,CHEMBL630423,,13843,Rattus norvegicus,,10116.0,N,,1,,Biodistribution in rat cortex at 60 minutes after dose administration.,,BAO_0000218,13100,
In vivo,,A,,Intermediate,1,,50597,CHEMBL630424,948.0,13844,Rattus norvegicus,,10116.0,N,Heart,1,,Biodistribution in rat heart at 120 minutes after dose administration.,,BAO_0000218,13100,
In vivo,,A,,Intermediate,1,,50597,CHEMBL630425,948.0,13845,Rattus norvegicus,,10116.0,N,Heart,1,,Biodistribution in rat heart at 15 minutes after dose administration.,,BAO_0000218,13100,
In vivo,,A,,Intermediate,1,,50597,CHEMBL629462,948.0,13846,Rattus norvegicus,,10116.0,N,Heart,1,,Biodistribution in rat heart at 240 minutes after dose administration.,,BAO_0000218,13100,
In vivo,,A,,Intermediate,1,,50597,CHEMBL630426,948.0,13847,Rattus norvegicus,,10116.0,N,Heart,1,,Biodistribution in rat heart at 30 minutes after dose administration.,,BAO_0000218,13100,
In vivo,,A,,Intermediate,1,,50597,CHEMBL630427,948.0,13848,Rattus norvegicus,,10116.0,N,Heart,1,,Biodistribution in rat heart at 360 minutes after dose administration.,,BAO_0000218,13100,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625877,948.0,13849,Rattus norvegicus,,10116.0,N,Heart,1,,Biodistribution in rat heart at 3 hr after dose administration.,,BAO_0000218,13100,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625878,948.0,13850,Rattus norvegicus,,10116.0,N,Heart,1,,Biodistribution in rat heart at 60 minutes after dose administration.,,BAO_0000218,13100,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625879,10000000.0,13851,Rattus norvegicus,,10116.0,N,Hippocampus,1,,Biodistribution in rat hippocampus at 1440 minutes after dose administration.,,BAO_0000218,13100,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625880,10000000.0,13852,Rattus norvegicus,,10116.0,N,Hippocampus,1,,Biodistribution in rat hippocampus at 240 minutes after dose administration.,,BAO_0000218,13100,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625881,10000000.0,13853,Rattus norvegicus,,10116.0,N,Hippocampus,1,,Biodistribution in rat hippocampus at 30 minutes after dose administration.,,BAO_0000218,13100,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625882,10000000.0,13854,Rattus norvegicus,,10116.0,N,Hippocampus,1,,Biodistribution in rat hippocampus at 360 minutes after dose administration.,,BAO_0000218,13100,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625883,10000000.0,13855,Rattus norvegicus,,10116.0,N,Hippocampus,1,,Biodistribution in rat hippocampus at 15 minutes after dose administration.,,BAO_0000218,13100,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625884,2113.0,13856,Rattus norvegicus,,10116.0,N,Kidney,1,,Biodistribution in rat kidney at 120 minutes after dose administration.,,BAO_0000218,13100,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625885,2113.0,13857,Rattus norvegicus,,10116.0,N,Kidney,1,,Biodistribution in rat kidney at 1440 minutes after dose administration.,,BAO_0000218,13100,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628649,2113.0,13858,Rattus norvegicus,,10116.0,N,Kidney,1,,Biodistribution in rat kidney at 15 minutes after dose administration.,,BAO_0000218,13100,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628650,2113.0,13859,Rattus norvegicus,,10116.0,N,Kidney,1,,Biodistribution in rat kidney at 240 minutes after dose administration.,,BAO_0000218,13100,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628651,2113.0,13860,Rattus norvegicus,,10116.0,N,Kidney,1,,Biodistribution in rat kidney at 30 minutes after dose administration.,,BAO_0000218,13100,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628652,2113.0,13861,Rattus norvegicus,,10116.0,N,Kidney,1,,Biodistribution in rat kidney at 360 minutes after dose administration.,,BAO_0000218,13100,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628653,2113.0,13862,Rattus norvegicus,,10116.0,N,Kidney,1,,Biodistribution in rat kidney at 60 minutes after dose administration.,,BAO_0000218,13100,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628654,2107.0,13863,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution in rat liver at 120 minutes after dose administration.,,BAO_0000218,13100,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628655,2107.0,13864,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution in rat liver at 1440 minutes after dose administration.,,BAO_0000218,13100,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625238,2107.0,13865,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution in rat liver at 15 minutes after dose administration.,,BAO_0000218,13100,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625239,2107.0,13866,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution in rat liver at 240 minutes after dose administration.,,BAO_0000218,13100,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625240,2107.0,13867,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution in rat liver at 30 minutes after dose administration.,,BAO_0000218,13100,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625241,2107.0,13868,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution in rat liver at 360 minutes after dose administration.,,BAO_0000218,13100,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625242,2107.0,13869,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution in rat liver at 60 minutes after dose administration.,,BAO_0000218,13100,
In vivo,,A,,Intermediate,1,,50597,CHEMBL874587,2048.0,13870,Rattus norvegicus,,10116.0,N,Lung,1,,Biodistribution in rat lung at 120 minutes after dose administration.,,BAO_0000218,13100,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625405,2048.0,13871,Rattus norvegicus,,10116.0,N,Lung,1,,Biodistribution in rat lung at 1440 minutes after dose administration.,,BAO_0000218,13100,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625406,2048.0,13872,Rattus norvegicus,,10116.0,N,Lung,1,,Biodistribution in rat lung at 15 minutes after dose administration.,,BAO_0000218,13100,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625407,2048.0,13873,Rattus norvegicus,,10116.0,N,Lung,1,,Biodistribution in rat lung at 240 minutes after dose administration.,,BAO_0000218,13100,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625408,2048.0,13874,Rattus norvegicus,,10116.0,N,Lung,1,,Biodistribution in rat lung at 30 minutes after dose administration.,,BAO_0000218,13100,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625409,2048.0,13875,Rattus norvegicus,,10116.0,N,Lung,1,,Biodistribution in rat lung at 360 minutes after dose administration.,,BAO_0000218,13100,
,,A,,Intermediate,1,,50597,CHEMBL625410,1515.0,13876,Rattus norvegicus,,10116.0,N,Thoracic aorta,1,,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of calcium deficient buffer,,BAO_0000218,12361,
,,A,,Intermediate,1,,50597,CHEMBL625411,1515.0,13877,Rattus norvegicus,,10116.0,N,Thoracic aorta,1,,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of nifedipine,,BAO_0000218,12361,
,,A,,Intermediate,1,,50597,CHEMBL625412,1515.0,13878,Rattus norvegicus,,10116.0,N,Thoracic aorta,1,,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of verapamil,,BAO_0000218,12361,
,,A,,Intermediate,1,,50597,CHEMBL625413,1515.0,13879,Rattus norvegicus,,10116.0,N,Thoracic aorta,1,,Percent of maximal contractile response to compound in rat thoracic aorta strips presence of PBZ and CIR,,BAO_0000218,12361,
,,A,,Intermediate,1,,50597,CHEMBL625414,1515.0,13880,Rattus norvegicus,,10116.0,N,Thoracic aorta,1,,Percent of maximal contractile response to compound in rat thoracic aorta strips v,,BAO_0000218,12361,
,,A,,Intermediate,1,,50597,CHEMBL625415,1515.0,13881,Rattus norvegicus,,10116.0,N,Thoracic aorta,1,,Percent of maximal contractile response to compound with phenoxybenzamine pretreatment on rat thoracic aorta strips,,BAO_0000218,12361,
,,A,,Intermediate,1,,50597,CHEMBL625416,1515.0,13882,Rattus norvegicus,,10116.0,N,Thoracic aorta,1,,Percent of maximal contractile response to compound without phenoxybenzamine pretreatment on rat thoracic aorta strips,,BAO_0000218,12361,
,,A,,Intermediate,1,,50597,CHEMBL625417,1088.0,13883,Rattus norvegicus,,10116.0,N,Urine,1,,% of the total radioactive dose of compound present in the 0-24 hour urine after a single 5 mg/kg dose administered intravenously in rats,,BAO_0000218,12712,
,,A,,Intermediate,1,,50597,CHEMBL625418,1988.0,13884,Rattus norvegicus,,10116.0,N,Feces,1,,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through feces,,BAO_0000218,7415,
,,A,,Intermediate,1,,50597,CHEMBL625419,1088.0,13885,Rattus norvegicus,,10116.0,N,Urine,1,,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through urine,,BAO_0000218,7415,
,,A,,Intermediate,1,,50597,CHEMBL625420,,13886,Rattus norvegicus,,10116.0,N,,1,,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 1 mg/kg,,BAO_0000218,7415,
,,A,,Intermediate,1,,50597,CHEMBL626996,,13887,Rattus norvegicus,,10116.0,N,,1,,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 10 mg/kg,,BAO_0000218,7415,
,,A,,Intermediate,1,,50597,CHEMBL626997,1988.0,13888,Rattus norvegicus,,10116.0,N,Feces,1,,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through feces",,BAO_0000218,7415,
,,A,,Intermediate,1,,50597,CHEMBL626998,1088.0,13889,Rattus norvegicus,,10116.0,N,Urine,1,,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through urine",,BAO_0000218,7415,
,,A,,Intermediate,1,,50597,CHEMBL626999,,13890,Rattus norvegicus,,10116.0,N,,1,,"Compound was evaluated for the in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour biliary excretion",,BAO_0000218,7415,
,,A,,Intermediate,1,,50594,CHEMBL627000,,13891,Mus musculus,,10090.0,N,,1,,faecal levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-30h,,BAO_0000218,8050,
,,A,,Intermediate,1,,50594,CHEMBL627001,,13892,Mus musculus,,10090.0,N,,1,,fecal levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-30h,,BAO_0000218,8050,
,,A,,Intermediate,1,,50594,CHEMBL627002,,13893,Mus musculus,,10090.0,N,,1,,fecal levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-30h,,BAO_0000218,8050,
,,A,,Intermediate,1,,50594,CHEMBL627003,,13894,Mus musculus,,10090.0,N,,1,,fecal levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-30h,,BAO_0000218,8050,
,,A,,Intermediate,1,,50594,CHEMBL627004,1088.0,13895,Mus musculus,,10090.0,N,Urine,1,,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-24 hr,,BAO_0000218,8050,
,,A,,Intermediate,1,,50594,CHEMBL627005,1088.0,13896,Mus musculus,,10090.0,N,Urine,1,,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-6 hr,,BAO_0000218,8050,
,,A,,Intermediate,1,,50594,CHEMBL874594,1088.0,13897,Mus musculus,,10090.0,N,Urine,1,,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 24-30 hr,,BAO_0000218,8050,
,,A,,Intermediate,1,,50594,CHEMBL627006,1088.0,13898,Mus musculus,,10090.0,N,Urine,1,,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-24 hr,,BAO_0000218,8050,
,,A,,Intermediate,1,,50594,CHEMBL627007,1088.0,13899,Mus musculus,,10090.0,N,Urine,1,,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-6 hr,,BAO_0000218,8050,
,,A,,Intermediate,1,,50594,CHEMBL627884,1088.0,13900,Mus musculus,,10090.0,N,Urine,1,,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 24-30 hr,,BAO_0000218,8050,
,,A,,Intermediate,1,,50594,CHEMBL627885,1088.0,13901,Mus musculus,,10090.0,N,Urine,1,,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-24 hr,,BAO_0000218,8050,
,,A,,Intermediate,1,,50594,CHEMBL627886,1088.0,13902,Mus musculus,,10090.0,N,Urine,1,,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-6 hr,,BAO_0000218,8050,
,,A,,Intermediate,1,,50594,CHEMBL627887,1088.0,13903,Mus musculus,,10090.0,N,Urine,1,,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 24-30 hr,,BAO_0000218,8050,
,,A,,Intermediate,1,,50594,CHEMBL627888,1088.0,13904,Mus musculus,,10090.0,N,Urine,1,,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-24 hr,,BAO_0000218,8050,
,,A,,Intermediate,1,,50594,CHEMBL628057,1088.0,13905,Mus musculus,,10090.0,N,Urine,1,,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-6 hr,,BAO_0000218,8050,
,,A,,Intermediate,1,,50594,CHEMBL627405,1088.0,13906,Mus musculus,,10090.0,N,Urine,1,,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 24-30 hr,,BAO_0000218,8050,
,,A,,Intermediate,1,,50588,CHEMBL627406,1088.0,13907,Canis lupus familiaris,,9615.0,N,Urine,1,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50588,CHEMBL627407,1088.0,13908,Canis lupus familiaris,,9615.0,N,Urine,1,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50588,CHEMBL627408,1088.0,13909,Canis lupus familiaris,,9615.0,N,Urine,1,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50588,CHEMBL627409,1088.0,13910,Canis lupus familiaris,,9615.0,N,Urine,1,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50588,CHEMBL875486,1088.0,13911,Canis lupus familiaris,,9615.0,N,Urine,1,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50588,CHEMBL627410,1088.0,13912,Canis lupus familiaris,,9615.0,N,Urine,1,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50588,CHEMBL627411,1088.0,13913,Canis lupus familiaris,,9615.0,N,Urine,1,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50588,CHEMBL627412,1088.0,13914,Canis lupus familiaris,,9615.0,N,Urine,1,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50588,CHEMBL627413,1088.0,13915,Canis lupus familiaris,,9615.0,N,Urine,1,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50588,CHEMBL627414,1088.0,13916,Canis lupus familiaris,,9615.0,N,Urine,1,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50588,CHEMBL627415,1088.0,13917,Canis lupus familiaris,,9615.0,N,Urine,1,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 10.1 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50588,CHEMBL627416,1088.0,13918,Canis lupus familiaris,,9615.0,N,Urine,1,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 102 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50588,CHEMBL627417,1088.0,13919,Canis lupus familiaris,,9615.0,N,Urine,1,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.40 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50588,CHEMBL627418,1088.0,13920,Canis lupus familiaris,,9615.0,N,Urine,1,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.76 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50588,CHEMBL627419,1088.0,13921,Canis lupus familiaris,,9615.0,N,Urine,1,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 34.1 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50588,CHEMBL627320,1088.0,13922,Canis lupus familiaris,,9615.0,N,Urine,1,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 50.8 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50588,CHEMBL627321,1088.0,13923,Canis lupus familiaris,,9615.0,N,Urine,1,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 68.1 uM/Kg of drug,,BAO_0000218,12582,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627322,2113.0,13924,Rattus norvegicus,,10116.0,N,Kidney,1,,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627323,2113.0,13925,Rattus norvegicus,,10116.0,N,Kidney,1,,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627491,2113.0,13926,Rattus norvegicus,,10116.0,N,Kidney,1,,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627492,2113.0,13927,Rattus norvegicus,,10116.0,N,Kidney,1,,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627493,2113.0,13928,Rattus norvegicus,,10116.0,N,Kidney,1,,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627494,2107.0,13929,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627495,2107.0,13930,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627496,2107.0,13931,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627497,2107.0,13932,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627498,2107.0,13933,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627499,2048.0,13934,Rattus norvegicus,,10116.0,N,Lung,1,,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627500,2048.0,13935,Rattus norvegicus,,10116.0,N,Lung,1,,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627501,2048.0,13936,Rattus norvegicus,,10116.0,N,Lung,1,,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625616,2048.0,13937,Rattus norvegicus,,10116.0,N,Lung,1,,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625617,2048.0,13938,Rattus norvegicus,,10116.0,N,Lung,1,,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625618,2385.0,13939,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625619,2385.0,13940,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625620,2385.0,13941,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625621,2385.0,13942,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625622,2385.0,13943,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625788,2106.0,13944,Rattus norvegicus,,10116.0,N,Spleen,1,,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625789,2106.0,13945,Rattus norvegicus,,10116.0,N,Spleen,1,,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625790,2106.0,13946,Rattus norvegicus,,10116.0,N,Spleen,1,,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625791,2106.0,13947,Rattus norvegicus,,10116.0,N,Spleen,1,,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622334,2106.0,13948,Rattus norvegicus,,10116.0,N,Spleen,1,,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622335,2046.0,13949,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622336,2046.0,13950,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622337,2046.0,13951,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622338,2046.0,13952,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,Biodistribution in thyroid of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL622339,2046.0,13953,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,Biodistribution in thyroid of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL624153,,13954,Rattus norvegicus,,10116.0,N,,1,,Biodistribution in uterus / blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628430,,13955,Rattus norvegicus,,10116.0,N,,1,,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628431,,13956,Rattus norvegicus,,10116.0,N,,1,,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628432,,13957,Rattus norvegicus,,10116.0,N,,1,,Biodistribution in uterus / blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628433,,13958,Rattus norvegicus,,10116.0,N,,1,,Biodistribution in uterus / blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628434,2106.0,13959,Rattus norvegicus,,10116.0,N,Spleen,1,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626789,2106.0,13960,Rattus norvegicus,,10116.0,N,Spleen,1,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626790,2106.0,13961,Rattus norvegicus,,10116.0,N,Spleen,1,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2)",,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626791,2106.0,13962,Rattus norvegicus,,10116.0,N,Spleen,1,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626792,2106.0,13963,Rattus norvegicus,,10116.0,N,Spleen,1,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626793,2106.0,13964,Rattus norvegicus,,10116.0,N,Spleen,1,,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,BAO_0000218,12017,
,,A,,Intermediate,1,,50597,CHEMBL627436,,13965,Rattus norvegicus,,10116.0,N,,1,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL627437,,13966,Rattus norvegicus,,10116.0,N,,1,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL627438,,13967,Rattus norvegicus,,10116.0,N,,1,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL627439,,13968,Rattus norvegicus,,10116.0,N,,1,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL627440,,13969,Rattus norvegicus,,10116.0,N,,1,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL627602,,13970,Rattus norvegicus,,10116.0,N,,1,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL627603,,13971,Rattus norvegicus,,10116.0,N,,1,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL627604,,13972,Rattus norvegicus,,10116.0,N,,1,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL627605,,13973,Rattus norvegicus,,10116.0,N,,1,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL627606,,13974,Rattus norvegicus,,10116.0,N,,1,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL627607,,13975,Rattus norvegicus,,10116.0,N,,1,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL627608,,13976,Rattus norvegicus,,10116.0,N,,1,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL627609,,13977,Rattus norvegicus,,10116.0,N,,1,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL627610,,13978,Rattus norvegicus,,10116.0,N,,1,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL627611,,13979,Rattus norvegicus,,10116.0,N,,1,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL627612,,13980,Rattus norvegicus,,10116.0,N,,1,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,,BAO_0000218,11510,
,,P,,Autocuration,0,,22229,CHEMBL627613,,13981,,,,U,,1,,Octanol:water partition coefficient is evaluated,,BAO_0000100,8362,
,,P,,Autocuration,0,,22224,CHEMBL627614,,13982,,,,U,,1,,Partition coefficient in 1-octanol/water system,,BAO_0000100,8257,
,,P,,Autocuration,0,,22224,CHEMBL627615,,13983,,,,U,,1,,Partition coefficient in 1-octanol/water system measured using radio active compounds,,BAO_0000100,8257,
,,P,,Autocuration,0,,22224,CHEMBL627616,,13984,,,,U,,1,,Partition coefficient in octanol/water system was determined,,BAO_0000100,9468,
,,P,,Autocuration,0,,22224,CHEMBL627617,,13985,,,,U,,1,,Partition coefficient in octanol/water system was determined using [14C]-labeled compounds.,,BAO_0000100,9468,
,,A,,Autocuration,0,,22224,CHEMBL627618,,13986,,,,U,,1,,Pseudo-first-order rate constant at pH 10 and 35 degrees Centigrade,,BAO_0000019,10568,
,,A,,Autocuration,0,,22224,CHEMBL627619,,13987,,,,U,,1,,"Pseudo-first-order rate constant at pH 10, micro=0.5, 35 degrees Centigrade",,BAO_0000019,10568,
,,A,,Autocuration,0,,22224,CHEMBL627620,,13988,,,,U,,1,,Pseudo-first-order rate constant of the compound,,BAO_0000019,15359,
,,A,,Autocuration,0,,22224,CHEMBL627621,,13989,,,,U,,1,,Pseudo-first-order rate constant with 1-min time point,,BAO_0000019,15359,
,,A,,Autocuration,0,,22224,CHEMBL627622,,13990,,,,U,,1,,Pseudo-first-order rate constant without 1-min time point,,BAO_0000019,15359,
,,A,,Autocuration,0,,22224,CHEMBL627623,,13991,,,,U,,1,,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 0.5 mM EDTA,,BAO_0000019,10431,
,,A,,Autocuration,0,,22224,CHEMBL627624,,13992,,,,U,,1,,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 50 mM EDTA,,BAO_0000019,10431,
,,A,,Autocuration,0,,22224,CHEMBL627625,,13993,,,,U,,1,,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 70 mM EDTA,,BAO_0000019,10431,
,,A,,Autocuration,0,,22224,CHEMBL628523,,13994,,,,U,,1,,Rate constants determined using 31P NMR Kinetics experiments at 37 degrees Centigrade,,BAO_0000019,15704,
,,A,,Autocuration,0,,22224,CHEMBL628524,,13995,,,,U,,1,,The alkaline hydrolysis second order rate constant(K OH) of the compound,,BAO_0000019,15287,
,,A,,Autocuration,0,,22224,CHEMBL628525,,13996,,,,U,,1,,The efflux rate constant of the compound,,BAO_0000019,7516,
,,A,,Autocuration,0,,22224,CHEMBL625732,,13997,,,,U,,1,,The reaction rate constant (K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,,BAO_0000019,12973,
,,A,,Autocuration,0,,22224,CHEMBL625733,,13998,,,,U,,1,,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,,BAO_0000019,12973,
,,F,,Autocuration,0,,22224,CHEMBL625734,,13999,,,,U,,1,,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,,BAO_0000019,12973,
,,A,,Autocuration,0,,22224,CHEMBL625913,,14000,,,,U,,1,,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine; ND= not determined,,BAO_0000019,12973,
,,A,,Autocuration,0,,22224,CHEMBL625914,,14001,,,,U,,1,,Association constant was evaluated towards synthetic peptidoglycan analogue Ac2-Lys-D-Ala-D-Ala,,BAO_0000019,8696,
,,A,,Autocuration,0,,22224,CHEMBL625915,,14002,,,,U,,1,,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of electroneutral DMPC in PBSbuffer at pH 7.4 and 37 C,,BAO_0000019,15052,
,,A,,Autocuration,0,,22224,CHEMBL625916,,14003,,,,U,,1,,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of negatively charged DMPG in PBS buffer at pH 7.4 and 37 C,,BAO_0000019,15052,
,,A,,Autocuration,0,,22224,CHEMBL625917,,14004,,,,U,,1,,Evaluated for the mustard reactivity by determining rate constant for hydrolysis of mustard in aqueous acetone (K H),,BAO_0000019,10503,
,,A,,Autocuration,0,,22224,CHEMBL625918,,14005,,,,U,,1,,"Effective biomolecular rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,BAO_0000019,8354,
,,A,,Autocuration,0,,22224,CHEMBL625919,,14006,,,,U,,1,,"Effective biomolecular rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,BAO_0000019,8354,
,,A,,Autocuration,0,,22224,CHEMBL625920,,14007,,,,U,,1,,"Effective biomolecular rate constant at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",,BAO_0000019,8354,
,,A,,Autocuration,0,,22224,CHEMBL874453,,14008,,,,U,,1,,"Effective biomolecular rate constant at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",,BAO_0000019,8354,
,,A,,Autocuration,0,,22224,CHEMBL625921,,14009,,,,U,,1,,"Effective biomolecular rate constant in the conditions of 25degreeC,pH 7.6",,BAO_0000019,8354,
,,A,,Autocuration,0,,22224,CHEMBL625922,,14010,,,,U,,1,,Evaluated for the mustard reactivity by determining rate constant for alkylation of 4-(4-nitrobenzyl)pyridine using NBP alkylation assay,,BAO_0000019,10503,
,,A,,Autocuration,0,,22224,CHEMBL625923,,14011,,,,U,,1,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,BAO_0000019,8354,
,,A,,Autocuration,0,,22224,CHEMBL625924,,14012,,,,U,,1,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,BAO_0000019,8354,
,,A,,Autocuration,0,,22224,CHEMBL625925,,14013,,,,U,,1,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",,BAO_0000019,8354,
,,A,,Autocuration,0,,22224,CHEMBL625926,,14014,,,,U,,1,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",,BAO_0000019,8354,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627704,2048.0,14015,Rattus norvegicus,,10116.0,N,Lung,1,,Biodistribution in rat lung at 60 minutes after dose administration.,,BAO_0000218,13100,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627705,,14016,Rattus norvegicus,,10116.0,N,,1,,Biodistribution in rat pons/medulla at 120 minutes after dose administration.,,BAO_0000218,13100,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627706,,14017,Rattus norvegicus,,10116.0,N,,1,,Biodistribution in rat pons/medulla at 15 minutes after dose administration.,,BAO_0000218,13100,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627707,,14018,Rattus norvegicus,,10116.0,N,,1,,Biodistribution in rat pons/medulla at 240 minutes after dose administration.,,BAO_0000218,13100,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627708,,14019,Rattus norvegicus,,10116.0,N,,1,,Biodistribution in rat pons/medulla at 30 minutes after dose administration.,,BAO_0000218,13100,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628361,,14020,Rattus norvegicus,,10116.0,N,,1,,Biodistribution in rat pons/medulla at 360 minutes after dose administration.,,BAO_0000218,13100,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628362,,14021,Rattus norvegicus,,10116.0,N,,1,,Biodistribution in rat pons/medulla at 60 minutes after dose administration.,,BAO_0000218,13100,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628363,2435.0,14022,Rattus norvegicus,,10116.0,N,Striatum,1,,Biodistribution in rat striatum at 120 minutes after dose administration.,,BAO_0000218,13100,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628364,2435.0,14023,Rattus norvegicus,,10116.0,N,Striatum,1,,Biodistribution in rat striatum at 1440 minutes after dose administration.,,BAO_0000218,13100,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628365,2435.0,14024,Rattus norvegicus,,10116.0,N,Striatum,1,,Biodistribution in rat striatum at 15 minutes after dose administration.,,BAO_0000218,13100,
In vivo,,A,,Intermediate,1,,50597,CHEMBL874454,2435.0,14025,Rattus norvegicus,,10116.0,N,Striatum,1,,Biodistribution in rat striatum at 240 minutes after dose administration.,,BAO_0000218,13100,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628531,2435.0,14026,Rattus norvegicus,,10116.0,N,Striatum,1,,Biodistribution in rat striatum at 30 minutes after dose administration.,,BAO_0000218,13100,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628532,2435.0,14027,Rattus norvegicus,,10116.0,N,Striatum,1,,Biodistribution in rat striatum at 360 minutes after dose administration.,,BAO_0000218,13100,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628533,2435.0,14028,Rattus norvegicus,,10116.0,N,Striatum,1,,Biodistribution in rat striatum at 3 hr after dose administration.,,BAO_0000218,13100,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628534,2435.0,14029,Rattus norvegicus,,10116.0,N,Striatum,1,,Biodistribution in rat striatum at 60 minutes after dose administration.,,BAO_0000218,13100,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628535,2046.0,14030,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,Biodistribution in rat thyroid at 120 minutes after dose administration.,,BAO_0000218,13100,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628536,2046.0,14031,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,Biodistribution in rat thyroid at 1440 minutes after dose administration.,,BAO_0000218,13100,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628537,2046.0,14032,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,Biodistribution in rat thyroid at 15 minutes after dose administration.,,BAO_0000218,13100,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628538,2046.0,14033,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,Biodistribution in rat thyroid at 240 minutes after dose administration.,,BAO_0000218,13100,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628539,2046.0,14034,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,Biodistribution in rat thyroid at 30 minutes after dose administration.,,BAO_0000218,13100,
In vivo,,A,,Intermediate,1,,50597,CHEMBL630297,2046.0,14035,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,Biodistribution in rat thyroid at 360 minutes after dose administration.,,BAO_0000218,13100,
In vivo,,A,,Intermediate,1,,50597,CHEMBL630298,2046.0,14036,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,Biodistribution in rat thyroid at 60 minutes after dose administration.,,BAO_0000218,13100,
In vivo,,A,,Intermediate,1,,50597,CHEMBL630299,955.0,14037,Rattus norvegicus,,10116.0,N,Brain,1,,Biodistribution in rest of brain of rat 120 minutes after dose administration.,,BAO_0000218,13100,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628094,955.0,14038,Rattus norvegicus,,10116.0,N,Brain,1,,Biodistribution in rest of brain of rat at 1440 minutes after dose administration.,,BAO_0000218,13100,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628095,955.0,14039,Rattus norvegicus,,10116.0,N,Brain,1,,Biodistribution in rest of brain of rat at 15 minutes after dose administration.,,BAO_0000218,13100,
In vivo,,A,,Intermediate,1,,50597,CHEMBL874648,955.0,14040,Rattus norvegicus,,10116.0,N,Brain,1,,Biodistribution in rest of brain of rat at 240 minutes after dose administration.,,BAO_0000218,13100,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628096,955.0,14041,Rattus norvegicus,,10116.0,N,Brain,1,,Biodistribution in rest of brain of rat at 30 minutes after dose administration.,,BAO_0000218,13100,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628097,955.0,14042,Rattus norvegicus,,10116.0,N,Brain,1,,Biodistribution in rest of brain of rat at 360 minutes after dose administration.,,BAO_0000218,13100,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628098,955.0,14043,Rattus norvegicus,,10116.0,N,Brain,1,,Biodistribution in rest of brain of rat at 60 minutes after dose administration.,,BAO_0000218,13100,
,,A,,Autocuration,0,,22224,CHEMBL628099,,14044,,,,U,,1,,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (10:1)",,BAO_0000019,13331,
,,A,,Autocuration,0,,22224,CHEMBL628100,,14045,,,,U,,1,,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",,BAO_0000019,13331,
,,A,,Autocuration,0,,22224,CHEMBL628101,,14046,,,,U,,1,,Mean rate constant for the hydrolysis of compound in buffers at pH 7.4 at 37 degrees Centigrade in incubation mixture - d(A)-d(T) (10:!),,BAO_0000019,13331,
,,A,,Autocuration,0,,22224,CHEMBL628102,,14047,,,,U,,1,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - 5'-GMP/5'-CMP (1:1)",,BAO_0000019,13331,
,,A,,Autocuration,0,,22224,CHEMBL628103,,14048,,,,U,,1,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (1:1)",,BAO_0000019,13331,
,,A,,Autocuration,0,,22224,CHEMBL628104,,14049,,,,U,,1,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",,BAO_0000019,13331,
,,A,,Autocuration,0,,22224,CHEMBL628105,,14050,,,,U,,1,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (1:1)",,BAO_0000019,13331,
,,A,,Autocuration,0,,22224,CHEMBL628106,,14051,,,,U,,1,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(T) (10:1)",,BAO_0000019,13331,
,,A,,Intermediate,1,,50597,CHEMBL628107,1088.0,14052,Rattus norvegicus,,10116.0,N,Urine,1,,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,,BAO_0000218,10086,
,,F,,Autocuration,0,,22224,CHEMBL628108,1088.0,14053,,,,U,Urine,1,,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,,BAO_0000218,10086,
,,A,,Intermediate,1,,50597,CHEMBL628109,1088.0,14054,Rattus norvegicus,,10116.0,N,Urine,1,,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,,BAO_0000218,10086,
,,F,,Autocuration,0,,22224,CHEMBL625299,1088.0,14055,,,,U,Urine,1,,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,,BAO_0000218,10086,
,,A,,Intermediate,1,,50597,CHEMBL625300,1088.0,14056,Rattus norvegicus,,10116.0,N,Urine,1,,Mean urine volume excretion in conscious rats at a dose of 10 mg/kg given orally,,BAO_0000218,10086,
,,A,,Intermediate,1,,50597,CHEMBL625301,1088.0,14057,Rattus norvegicus,,10116.0,N,Urine,1,,Mean urine volume excretion in conscious rats at a dose of 100 mg/kg given orally,,BAO_0000218,10086,
,,A,,Intermediate,1,,50597,CHEMBL625302,1088.0,14058,Rattus norvegicus,,10116.0,N,Urine,1,,Mean urine volume excretion in conscious rats at a dose of 3.0 mg/kg given orally,,BAO_0000218,10086,
,,A,,Intermediate,1,,50597,CHEMBL874649,1088.0,14059,Rattus norvegicus,,10116.0,N,Urine,1,,Mean urine volume excretion in conscious rats at a dose of 30 mg/kg given orally,,BAO_0000218,10086,
,,A,,Intermediate,1,,50597,CHEMBL625303,,14060,Rattus norvegicus,,10116.0,N,,1,,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes,,BAO_0000218,13248,
,,A,,Intermediate,1,,50597,CHEMBL625463,,14061,Rattus norvegicus,,10116.0,N,,1,,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes; NA= Not tested,,BAO_0000218,13248,
,,A,,Intermediate,1,,50587,CHEMBL625464,2107.0,14062,Homo sapiens,,9606.0,N,Liver,1,,In vitro metabolism in human liver microsomes,,BAO_0000218,14527,
,,A,,Intermediate,1,,50587,CHEMBL625465,,14063,Homo sapiens,,9606.0,N,,1,,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated.,,BAO_0000218,3008,
,,A,,Intermediate,1,,50588,CHEMBL625466,1088.0,14064,Canis lupus familiaris,,9615.0,N,Urine,1,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.06 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50588,CHEMBL625467,1088.0,14065,Canis lupus familiaris,,9615.0,N,Urine,1,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.6 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL625468,1088.0,14066,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of chlorine in urine of rats after intravenous administration of 7.94 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL625469,1088.0,14067,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 0 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL625470,1088.0,14068,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.01 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL632418,1088.0,14069,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.13 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL627250,1088.0,14070,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 10.1 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL627251,1088.0,14071,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 102 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL627252,1088.0,14072,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 105 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL627253,1088.0,14073,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 11.3 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL627254,1088.0,14074,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 113 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL875471,1088.0,14075,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 19.5 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL627255,1088.0,14076,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 195 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL627256,1088.0,14077,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 21.7 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL627257,1088.0,14078,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 217 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL627258,1088.0,14079,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 23.9 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL627259,1088.0,14080,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 239 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL627260,1088.0,14081,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 24.9 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL623256,1088.0,14082,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 249 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL874413,1088.0,14083,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 25.9 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL623257,1088.0,14084,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 259 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL623258,1088.0,14085,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 26.5 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL623259,1088.0,14086,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 265 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL623260,1088.0,14087,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL623261,1088.0,14088,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27.9 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL623262,1088.0,14089,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 270 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL623263,1088.0,14090,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 279 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL623264,1088.0,14091,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.2 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL623265,1088.0,14092,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.22 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL623266,1088.0,14093,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.9 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL623267,1088.0,14094,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 282 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL623268,1088.0,14095,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 289 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL623269,1088.0,14096,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.40 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL623270,1088.0,14097,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.76 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL623271,1088.0,14098,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 30.2 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL623272,1088.0,14099,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 302 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL623273,1088.0,14100,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 31.6 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL623274,1088.0,14101,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 316 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL874414,1088.0,14102,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 32.4 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL623275,1088.0,14103,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 324 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL629150,1088.0,14104,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.0 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL623276,1088.0,14105,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.1 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL623277,1088.0,14106,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.8 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL623112,1088.0,14107,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 341 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL623113,1088.0,14108,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 348 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL623800,1088.0,14109,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 37.6 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL623801,1088.0,14110,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 58.4 uM/Kg of drug,,BAO_0000218,12582,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623802,2106.0,14111,Rattus norvegicus,,10116.0,N,Spleen,1,,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623803,995.0,14112,Rattus norvegicus,,10116.0,N,Uterus,1,,Biodistribution in uterus of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623970,995.0,14113,Rattus norvegicus,,10116.0,N,Uterus,1,,Biodistribution in uterus of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623971,995.0,14114,Rattus norvegicus,,10116.0,N,Uterus,1,,Biodistribution in uterus of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623972,178.0,14115,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 10 min post injection (Average of three to five animals),,BAO_0000218,14045,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623973,178.0,14116,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 30 min post injection (Average of three to five animals),,BAO_0000218,14045,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623974,178.0,14117,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 5 min post injection (Average of three to five animals),,BAO_0000218,14045,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623975,178.0,14118,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 60 min post injection (Average of three to five animals),,BAO_0000218,14045,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623976,955.0,14119,Rattus norvegicus,,10116.0,N,Brain,1,,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 10 min post injection (Average of three to five animals),,BAO_0000218,14045,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623977,955.0,14120,Rattus norvegicus,,10116.0,N,Brain,1,,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 30 min post injection (Average of three to five animals),,BAO_0000218,14045,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623978,955.0,14121,Rattus norvegicus,,10116.0,N,Brain,1,,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 5 min post injection (Average of three to five animals),,BAO_0000218,14045,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623979,955.0,14122,Rattus norvegicus,,10116.0,N,Brain,1,,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 60 min post injection (Average of three to five animals),,BAO_0000218,14045,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623980,,14123,Rattus norvegicus,,10116.0,N,,1,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 10 min post injection (Average of three to five animals),,BAO_0000218,14045,
In vivo,,A,,Intermediate,1,,50597,CHEMBL623981,,14124,Rattus norvegicus,,10116.0,N,,1,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 30 min post injection (Average of three to five animals),,BAO_0000218,14045,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626278,,14125,Rattus norvegicus,,10116.0,N,,1,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 5 min post injection (Average of three to five animals),,BAO_0000218,14045,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626279,,14126,Rattus norvegicus,,10116.0,N,,1,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 60 min post injection (Average of three to five animals),,BAO_0000218,14045,
In vivo,,A,,Intermediate,1,,50594,CHEMBL626280,,14127,Mus musculus,,10090.0,N,,1,,Biodistribution in mice bladder plus excreted urine was determined,,BAO_0000218,14045,
,,A,,Intermediate,1,,50594,CHEMBL626281,,14128,Mus musculus,,10090.0,N,,1,,"Percentage biodistribution in mouse blood, 10 minutes post injection",,BAO_0000218,14045,
,,A,,Intermediate,1,,50594,CHEMBL626282,,14129,Mus musculus,,10090.0,N,,1,,"Percentage biodistribution in mouse blood, 30 minutes post injection",,BAO_0000218,14045,
,,A,,Intermediate,1,,50594,CHEMBL626283,,14130,Mus musculus,,10090.0,N,,1,,"Percentage biodistribution in mouse blood, 5 minutes post injection",,BAO_0000218,14045,
,,A,,Intermediate,1,,50594,CHEMBL626284,,14131,Mus musculus,,10090.0,N,,1,,"Percentage biodistribution in mouse blood, 60 minutes post injection",,BAO_0000218,14045,
,,A,,Intermediate,1,,50594,CHEMBL626285,955.0,14132,Mus musculus,,10090.0,N,Brain,1,,"Percentage biodistribution in mouse brain, 10 minutes post injection",,BAO_0000218,14045,
,,A,,Intermediate,1,,50594,CHEMBL626286,955.0,14133,Mus musculus,,10090.0,N,Brain,1,,"Percentage biodistribution in mouse brain, 30 minutes post injection",,BAO_0000218,14045,
,,A,,Intermediate,1,,50594,CHEMBL626287,955.0,14134,Mus musculus,,10090.0,N,Brain,1,,"Percentage biodistribution in mouse brain, 5 minutes post injection",,BAO_0000218,14045,
,,A,,Intermediate,1,,50594,CHEMBL626288,955.0,14135,Mus musculus,,10090.0,N,Brain,1,,"Percentage biodistribution in mouse brain, 60 minutes post injection",,BAO_0000218,14045,
,,A,,Intermediate,1,,50594,CHEMBL626289,,14136,Mus musculus,,10090.0,N,,1,,"Percentage biodistribution in mouse heart, 10 minutes post injection",,BAO_0000218,14045,
,,A,,Intermediate,1,,50594,CHEMBL626290,,14137,Mus musculus,,10090.0,N,,1,,"Percentage biodistribution in mouse heart, 30 minutes post injection",,BAO_0000218,14045,
,,A,,Intermediate,1,,50594,CHEMBL626291,,14138,Mus musculus,,10090.0,N,,1,,"Percentage biodistribution in mouse heart, 5 minutes post injection",,BAO_0000218,14045,
,,A,,Intermediate,1,,50594,CHEMBL839888,,14139,Mus musculus,,10090.0,N,,1,,"Percentage biodistribution in mouse heart, 60 minutes post injection",,BAO_0000218,14045,
,,A,,Intermediate,1,,50594,CHEMBL626292,160.0,14140,Mus musculus,,10090.0,N,Intestine,1,,"Percentage biodistribution in mouse intestine, 10 minutes post injection",,BAO_0000218,14045,
,,A,,Intermediate,1,,50594,CHEMBL626293,160.0,14141,Mus musculus,,10090.0,N,Intestine,1,,"Percentage biodistribution in mouse intestine, 30 minutes post injection",,BAO_0000218,14045,
,,A,,Intermediate,1,,50594,CHEMBL626294,160.0,14142,Mus musculus,,10090.0,N,Intestine,1,,"Percentage biodistribution in mouse intestine, 5 minutes post injection",,BAO_0000218,14045,
,,A,,Intermediate,1,,50594,CHEMBL626295,160.0,14143,Mus musculus,,10090.0,N,Intestine,1,,"Percentage biodistribution in mouse intestine, 60 minutes post injection",,BAO_0000218,14045,
,,A,,Intermediate,1,,50594,CHEMBL627659,2107.0,14144,Mus musculus,,10090.0,N,Liver,1,,"Percentage biodistribution in mouse liver, 10 minutes post injection",,BAO_0000218,14045,
,,A,,Intermediate,1,,50594,CHEMBL627660,2107.0,14145,Mus musculus,,10090.0,N,Liver,1,,"Percentage biodistribution in mouse liver, 30 minutes of post injection",,BAO_0000218,14045,
,,A,,Intermediate,1,,50594,CHEMBL627661,2107.0,14146,Mus musculus,,10090.0,N,Liver,1,,"Percentage biodistribution in mouse liver, 5 minutes post injection",,BAO_0000218,14045,
In vivo,,A,,Intermediate,1,,50594,CHEMBL627662,2107.0,14147,Mus musculus,,10090.0,N,Liver,1,,Biodistribution in mice liver at 60 minutes of post injection,,BAO_0000218,14045,
In vivo,,A,,Intermediate,1,,50594,CHEMBL627663,2048.0,14148,Mus musculus,,10090.0,N,Lung,1,,Biodistribution in mice lungs at 10 min of post injection,,BAO_0000218,14045,
,,A,,Intermediate,1,,50594,CHEMBL627664,,14149,Mus musculus,,10090.0,N,,1,,"Percentage biodistribution in mouse lung, 30 minutes post injection",,BAO_0000218,14045,
,,A,,Intermediate,1,,50594,CHEMBL627665,,14150,Mus musculus,,10090.0,N,,1,,"Percentage biodistribution in mousee lung, 5 minutes post injection",,BAO_0000218,14045,
In vivo,,A,,Intermediate,1,,50594,CHEMBL627666,2048.0,14151,Mus musculus,,10090.0,N,Lung,1,,Biodistribution in mice lungs at 60 min of post injection,,BAO_0000218,14045,
,,A,,Intermediate,1,,50594,CHEMBL627667,2106.0,14152,Mus musculus,,10090.0,N,Spleen,1,,Percentage biodistribution in mouse spleen,,BAO_0000218,14045,
,,A,,Intermediate,1,,50594,CHEMBL627668,945.0,14153,Mus musculus,,10090.0,N,Stomach,1,,Percentage biodistribution in mouse stomach,,BAO_0000218,14045,
,,A,,Intermediate,1,,50594,CHEMBL627669,1088.0,14154,Mus musculus,,10090.0,N,Urine,1,,Mean biodistribution and elimination data in urine was reported 24 h after administering compound intravenously in tumor-bearing female BALB-C mice.,,BAO_0000218,11745,
In vivo,,A,,Autocuration,0,,22224,CHEMBL627670,1255.0,14155,,,,U,Urinary bladder,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bladder,,BAO_0000218,13257,
In vivo,,A,,Autocuration,0,,22224,CHEMBL627671,178.0,14156,,,,U,Blood,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in blood,,BAO_0000218,13257,
In vivo,,A,,Autocuration,0,,22224,CHEMBL627672,1474.0,14157,,,,U,Bone element,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bone,,BAO_0000218,13257,
In vivo,,A,,Autocuration,0,,22224,CHEMBL627673,,14158,,,,U,,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in fat,,BAO_0000218,13257,
In vivo,,A,,Autocuration,0,,22224,CHEMBL627674,2113.0,14159,,,,U,Kidney,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in kidney,,BAO_0000218,13257,
In vivo,,A,,Autocuration,0,,22224,CHEMBL627675,2107.0,14160,,,,U,Liver,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in liver,,BAO_0000218,13257,
In vivo,,A,,Autocuration,0,,22224,CHEMBL627676,2048.0,14161,,,,U,Lung,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in lung,,BAO_0000218,13257,
In vivo,,A,,Autocuration,0,,22224,CHEMBL627677,2385.0,14162,,,,U,Muscle tissue,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in muscle,,BAO_0000218,13257,
,,A,,Autocuration,0,,22224,CHEMBL627678,,14163,,,,U,,1,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator in the conditions of 25degreeC,pH 7.6",,BAO_0000019,8354,
,,A,,Intermediate,1,,50597,CHEMBL627679,1977.0,14164,Rattus norvegicus,,10116.0,N,Serum,1,,Affinity for protein binding expressed as association constant in fresh rat serum,,BAO_0000218,7095,
,,A,,Autocuration,0,,22224,CHEMBL627680,,14165,,,,U,,1,,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,,BAO_0000019,12185,
,,A,,Autocuration,0,,22224,CHEMBL627681,,14166,,,,U,,1,,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,,BAO_0000019,12185,
,,A,,Autocuration,0,,22224,CHEMBL627682,,14167,,,,U,,1,,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,,BAO_0000019,12185,
,,A,,Autocuration,0,,22224,CHEMBL627683,,14168,,,,U,,1,,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,,BAO_0000019,12185,
,,A,,Autocuration,0,,22224,CHEMBL627684,,14169,,,,U,,1,,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4,,BAO_0000019,12686,
,,A,,Autocuration,0,,22224,CHEMBL874441,,14170,,,,U,,1,,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",,BAO_0000019,12686,
,,A,,Autocuration,0,,22224,CHEMBL627685,,14171,,,,U,,1,,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; No cyclization detected over 4 h,,BAO_0000019,12686,
,,A,,Autocuration,0,,22224,CHEMBL627686,,14172,,,,U,,1,,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",,BAO_0000019,12686,
,,A,,Autocuration,0,,22224,CHEMBL627687,,14173,,,,U,,1,,Apparent rate constant Koff for inactivation of dTMP synthase.,,BAO_0000019,8057,
,,A,,Autocuration,0,,22224,CHEMBL627688,,14174,,,,U,,1,,The irreversible inhibitor activity by second order rate equation.,,BAO_0000019,15778,
,,A,,Intermediate,1,,50597,CHEMBL628038,,14175,Rattus norvegicus,,10116.0,N,,1,,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 1 mg/kg concentration,,BAO_0000218,12375,
,,A,,Intermediate,1,,50597,CHEMBL628039,,14176,Rattus norvegicus,,10116.0,N,,1,,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 5 mg/kg concentration,,BAO_0000218,12375,
,,A,,Intermediate,1,,50597,CHEMBL628040,,14177,Rattus norvegicus,,10116.0,N,,1,,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at vehicle concentration,,BAO_0000218,12375,
,,A,,Autocuration,0,,22224,CHEMBL628041,,14178,,,,U,,1,,Dissociation rate calculated from the first-order equation using t1/2 value,,BAO_0000019,13588,
,,A,,Autocuration,0,,22224,CHEMBL630226,,14179,,,,U,,1,,The compound was tested for Binding constant against DNA,,BAO_0000019,15039,
,,A,,Autocuration,0,,22224,CHEMBL628042,,14180,,,,U,,1,,First order rate constant for cyclization of the compound,,BAO_0000019,9500,
,,A,,Autocuration,0,,22224,CHEMBL625232,,14181,,,,U,,1,,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,,BAO_0000019,10014,
,,A,,Autocuration,0,,22224,CHEMBL625233,,14182,,,,U,,1,,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,,BAO_0000019,10014,
,,A,,Autocuration,0,,22224,CHEMBL625979,,14183,,,,U,,1,,Hydrolysis rate constant was determined,,BAO_0000019,568,
,,A,,Autocuration,0,,22224,CHEMBL625980,,14184,,,,U,,1,,Observed first order rate constant,,BAO_0000019,10026,
,,A,,Autocuration,0,,22224,CHEMBL625981,,14185,,,,U,,1,,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,,BAO_0000019,10281,
,,A,,Autocuration,0,,22224,CHEMBL625982,,14186,,,,U,,1,,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,,BAO_0000019,10281,
,,A,,Autocuration,0,,22224,CHEMBL625983,,14187,,,,U,,1,,Second-order rate constant for attack on PNPA at 25 degree Centigrade,,BAO_0000019,9680,
,,A,,Autocuration,0,,22224,CHEMBL625984,,14188,,,,U,,1,,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,BAO_0000019,13028,
,,A,,Autocuration,0,,22224,CHEMBL625985,,14189,,,,U,,1,,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,BAO_0000019,13028,
,,A,,Autocuration,0,,22224,CHEMBL625986,,14190,,,,U,,1,,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,BAO_0000019,13028,
,,A,,Autocuration,0,,22224,CHEMBL625987,,14191,,,,U,,1,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,BAO_0000019,13028,
,,A,,Autocuration,0,,22224,CHEMBL625988,,14192,,,,U,,1,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,BAO_0000019,13028,
,,A,,Autocuration,0,,22224,CHEMBL625989,,14193,,,,U,,1,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,,BAO_0000019,13028,
,,A,,Autocuration,0,,22224,CHEMBL625990,,14194,,,,U,,1,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,,BAO_0000019,13028,
,,A,,Autocuration,0,,22224,CHEMBL625991,,14195,,,,U,,1,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,BAO_0000019,13028,
,,A,,Autocuration,0,,22224,CHEMBL625992,,14196,,,,U,,1,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,BAO_0000019,13028,
,,A,,Autocuration,0,,22224,CHEMBL625993,,14197,,,,U,,1,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,BAO_0000019,13028,
,,A,,Autocuration,0,,22224,CHEMBL631973,,14198,,,,U,,1,,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,BAO_0000019,13028,
,,A,,Autocuration,0,,22224,CHEMBL632143,,14199,,,,U,,1,,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,BAO_0000019,13028,
,,A,,Autocuration,0,,22224,CHEMBL632144,,14200,,,,U,,1,,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,BAO_0000019,13028,
,,A,,Autocuration,0,,22224,CHEMBL632145,,14201,,,,U,,1,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,BAO_0000019,13028,
,,A,,Autocuration,0,,22224,CHEMBL632146,,14202,,,,U,,1,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,BAO_0000019,13028,
,,A,,Autocuration,0,,22224,CHEMBL632147,,14203,,,,U,,1,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,,BAO_0000019,13028,
,,A,,Autocuration,0,,22224,CHEMBL632148,,14204,,,,U,,1,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,,BAO_0000019,13028,
,,A,,Autocuration,0,,22224,CHEMBL632149,,14205,,,,U,,1,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,BAO_0000019,13028,
,,A,,Autocuration,0,,22224,CHEMBL632150,,14206,,,,U,,1,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,BAO_0000019,13028,
,,A,,Autocuration,0,,22224,CHEMBL632151,,14207,,,,U,,1,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,BAO_0000019,13028,
,,A,,Intermediate,1,,50587,CHEMBL632152,,14208,Homo sapiens,,9606.0,N,,1,,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated; not detected,,BAO_0000218,3008,
,,A,,Intermediate,1,,50587,CHEMBL632153,,14209,Homo sapiens,,9606.0,N,,1,,Metabolism after 30 min of incubation with human liver microsomes in the absence of cofactor NADH (2.0 mM) at a concentration of 25 uM,,BAO_0000218,4509,
,,A,,Intermediate,1,,50587,CHEMBL632154,,14210,Homo sapiens,,9606.0,N,,1,,Metabolism after 30 min of incubation with human liver microsomes in the presence of cofactor NADH (2.0 mM) at a concentration of 25 uM,,BAO_0000218,4509,
,,A,,Intermediate,1,,50602,CHEMBL632155,,14211,Human herpesvirus 1,,10298.0,N,,1,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Tested mice 10,,BAO_0000218,8613,
,,A,,Intermediate,1,,50602,CHEMBL632156,,14212,Human herpesvirus 1,,10298.0,N,,1,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Total mice tested 10,,BAO_0000218,8613,
,,A,,Intermediate,1,,50602,CHEMBL632157,,14213,Human herpesvirus 1,,10298.0,N,,1,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day; Tested mice 10,,BAO_0000218,8613,
,,A,,Intermediate,1,,50602,CHEMBL632158,,14214,Human herpesvirus 1,,10298.0,N,,1,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Tested mice 10,,BAO_0000218,8613,
,,A,,Intermediate,1,,50602,CHEMBL632159,,14215,Human herpesvirus 1,,10298.0,N,,1,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Total mice tested 10,,BAO_0000218,8613,
,,A,,Intermediate,1,,50602,CHEMBL626305,,14216,Human herpesvirus 1,,10298.0,N,,1,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 0.8 mg/kg per day; Tested mice 10,,BAO_0000218,8613,
,,A,,Intermediate,1,,50602,CHEMBL626306,,14217,Human herpesvirus 1,,10298.0,N,,1,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 3.1 mg/kg per day; Total mice tested 10,,BAO_0000218,8613,
,,A,,Intermediate,1,,50602,CHEMBL626307,,14218,Human herpesvirus 1,,10298.0,N,,1,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day; Tested mice 10,,BAO_0000218,8613,
,,A,,Intermediate,1,,50602,CHEMBL626308,,14219,Human herpesvirus 1,,10298.0,N,,1,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day; Tested mice 10,,BAO_0000218,8613,
,,A,,Intermediate,1,,50602,CHEMBL626479,,14220,Human herpesvirus 1,,10298.0,N,,1,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day; Tested mice 10,,BAO_0000218,8613,
,,A,,Intermediate,1,,50602,CHEMBL626480,,14221,Human herpesvirus 1,,10298.0,N,,1,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day; Tested mice 10,,BAO_0000218,8613,
,,P,,Autocuration,0,,22229,CHEMBL626481,,14222,,,,U,,1,,Calculated partition coefficient (clogP) (MlogP),,BAO_0000100,6021,
,,A,,Autocuration,0,,22224,CHEMBL626482,,14223,,,,U,,1,,Equipotent potent ratio relative to carbachol (nicotinic activity),,BAO_0000019,9348,
,,A,,Intermediate,1,,50588,CHEMBL626483,,14224,Canis lupus familiaris,,9615.0,N,,1,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 ); NA denotes not available",,BAO_0000218,15592,
,,A,,Intermediate,1,,50588,CHEMBL626484,,14225,Canis lupus familiaris,,9615.0,N,,1,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 );NA denotes not available",,BAO_0000218,15592,
,,P,,Autocuration,0,,22229,CHEMBL626485,,14226,,,,U,,1,,Solubility at pH 7.4 in micro g/mL;NA denotes available,,BAO_0000100,15592,
,,P,,Autocuration,0,,22229,CHEMBL626486,,14227,,,,U,,1,,Solubility at pH 7.4 in micro g/mL;NA denotes not available,,BAO_0000100,15592,
,,P,,Autocuration,0,,22229,CHEMBL626487,,14228,,,,U,,1,,Solubility at pH 7.4 in ug/mL;NA denotes not available,,BAO_0000100,15592,
In vivo,,A,,Intermediate,1,,50588,CHEMBL626488,1969.0,14229,Canis lupus familiaris,,9615.0,N,Plasma,1,,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,,BAO_0000218,15592,
,,A,,Intermediate,1,,50597,CHEMBL626489,1977.0,14230,Rattus norvegicus,,10116.0,N,Serum,1,,Affinity for protein binding expressed as association constant in fresh rat serum; ND is Not Determined.,,BAO_0000218,7095,
,,A,,Autocuration,0,,22224,CHEMBL626490,,14231,,,,U,,1,,Area under the MAP curve measured over 5 min; ND means Not determined,,BAO_0000019,16618,
,,P,,Autocuration,0,,22224,CHEMBL626491,,14232,,,,U,,1,,Lipophilicity expressed as the negative logarithm of the equilibrium constant; ND denotes no data.,,BAO_0000100,16835,
,,P,,Autocuration,0,,22229,CHEMBL626492,,14233,,,,U,,1,,The apparent partition coefficient(D) in cyclohexane-0.05 M phosphate buffer (pH 7.4) at 21 degree celsius; not determined,,BAO_0000100,15284,
,,A,,Autocuration,0,,22224,CHEMBL626493,,14234,,,,U,,1,,Half-life was measured in the presence of NADPH at 20 uM; No inhibition,,BAO_0000019,15750,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626494,,14235,Rattus norvegicus,,10116.0,N,,1,,Half life after oral administration to Sprague-Dawley rats; NT is Not tested,,BAO_0000218,16618,
In vivo,,A,,Autocuration,0,,22224,CHEMBL626495,,14236,,,,U,,1,,Half life after oral tested,,BAO_0000218,16618,
,,A,,Intermediate,1,,50597,CHEMBL626496,1969.0,14237,Rattus norvegicus,,10116.0,N,Plasma,1,,Half life was determined in plasma of rat; NT indicates not tested,,BAO_0000218,15812,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626497,,14238,Rattus norvegicus,,10116.0,N,,1,,Oral bioavailability after oral administration to Sprague-Dawley rats; NT is Not tested,,BAO_0000218,16618,
In vivo,,A,,Autocuration,0,,22224,CHEMBL626498,,14239,,,,U,,1,,Oral bioavailability after oral tested,,BAO_0000218,16618,
,,A,,Intermediate,1,,50597,CHEMBL626499,,14240,Rattus norvegicus,,10116.0,N,,1,,The bioavailability in rats at 15.9 uM/Kg after intravenous administration; NT=Not tested (F),,BAO_0000218,13098,
,,A,,Intermediate,1,,50597,CHEMBL626500,,14241,Rattus norvegicus,,10116.0,N,,1,,The compound was tested for volume of distribution in rat at 15.9 uM/Kg after peroral administration; NT=Not tested (Vd L/Kg),,BAO_0000218,13098,
,,A,,Intermediate,1,,50597,CHEMBL626501,1969.0,14242,Rattus norvegicus,,10116.0,N,Plasma,1,,half life was determined in plasma of rat; NT indicates not tested,,BAO_0000218,15812,
,,A,,Intermediate,1,,50597,CHEMBL626502,1969.0,14243,Rattus norvegicus,,10116.0,N,Plasma,1,,half life was determined in plasma of rat; NT means not tested,,BAO_0000218,15812,
,,A,,Intermediate,1,,50597,CHEMBL626503,,14244,Rattus norvegicus,,10116.0,N,,1,,Mean sodium excretion in rats (Control/Drug treatment value); Value 0.41/2.32,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL626504,,14245,Rattus norvegicus,,10116.0,N,,1,,Mean sodium excretion in rats (Control/Drug treatment value); inactive,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL626505,,14246,Rattus norvegicus,,10116.0,N,,1,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.17/0.43,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL626506,,14247,Rattus norvegicus,,10116.0,N,,1,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.2/0.38,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL626507,,14248,Rattus norvegicus,,10116.0,N,,1,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.26/0.23,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL626508,,14249,Rattus norvegicus,,10116.0,N,,1,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.28/0.26,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL626509,,14250,Rattus norvegicus,,10116.0,N,,1,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.31/0.35,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL875480,,14251,Rattus norvegicus,,10116.0,N,,1,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.35/2.88,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL626510,,14252,Rattus norvegicus,,10116.0,N,,1,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.29,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL626511,,14253,Rattus norvegicus,,10116.0,N,,1,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.47,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL626512,,14254,Rattus norvegicus,,10116.0,N,,1,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.49,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL628208,,14255,Rattus norvegicus,,10116.0,N,,1,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.38/0.23,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL628209,,14256,Rattus norvegicus,,10116.0,N,,1,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.39/0.22,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL628210,,14257,Rattus norvegicus,,10116.0,N,,1,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/0.48,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL628211,,14258,Rattus norvegicus,,10116.0,N,,1,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/1.49,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL628212,,14259,Rattus norvegicus,,10116.0,N,,1,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/2.06,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL628213,,14260,Rattus norvegicus,,10116.0,N,,1,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.42/0.65,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL628214,1088.0,14261,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 65.2 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL628215,1088.0,14262,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.6 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL628216,1088.0,14263,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.8 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL626595,1088.0,14264,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 74.8 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL626596,1088.0,14265,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 77.5 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL626597,1088.0,14266,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 79.4 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL626598,1088.0,14267,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 80.9 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL622242,1088.0,14268,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 83.8 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL622243,1088.0,14269,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.5 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL622244,1088.0,14270,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.7 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL622245,1088.0,14271,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.7 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL622246,1088.0,14272,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.9 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL622247,1088.0,14273,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 9.06 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL622248,1088.0,14274,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 90.6 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL877483,1088.0,14275,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 94.9 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL622249,1088.0,14276,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 97.1 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50588,CHEMBL622250,1088.0,14277,Canis lupus familiaris,,9615.0,N,Urine,1,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50588,CHEMBL622251,1088.0,14278,Canis lupus familiaris,,9615.0,N,Urine,1,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50588,CHEMBL622252,1088.0,14279,Canis lupus familiaris,,9615.0,N,Urine,1,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50588,CHEMBL622253,1088.0,14280,Canis lupus familiaris,,9615.0,N,Urine,1,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50588,CHEMBL622254,1088.0,14281,Canis lupus familiaris,,9615.0,N,Urine,1,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50588,CHEMBL622255,1088.0,14282,Canis lupus familiaris,,9615.0,N,Urine,1,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50588,CHEMBL622256,1088.0,14283,Canis lupus familiaris,,9615.0,N,Urine,1,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50588,CHEMBL622257,1088.0,14284,Canis lupus familiaris,,9615.0,N,Urine,1,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50588,CHEMBL622258,1088.0,14285,Canis lupus familiaris,,9615.0,N,Urine,1,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50588,CHEMBL622259,1088.0,14286,Canis lupus familiaris,,9615.0,N,Urine,1,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50588,CHEMBL622927,1088.0,14287,Canis lupus familiaris,,9615.0,N,Urine,1,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50588,CHEMBL622928,1088.0,14288,Canis lupus familiaris,,9615.0,N,Urine,1,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50588,CHEMBL622929,1088.0,14289,Canis lupus familiaris,,9615.0,N,Urine,1,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50588,CHEMBL623182,1088.0,14290,Canis lupus familiaris,,9615.0,N,Urine,1,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.06 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50588,CHEMBL623183,1088.0,14291,Canis lupus familiaris,,9615.0,N,Urine,1,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL623184,1088.0,14292,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 0 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL623185,1088.0,14293,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.01 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL877484,1088.0,14294,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.13 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL627274,1088.0,14295,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 10.1 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL623186,1088.0,14296,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 102 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL623187,1088.0,14297,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 105 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL623188,1088.0,14298,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 11.3 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL628055,1088.0,14299,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 113 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL628056,1088.0,14300,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 19.5 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL628200,1088.0,14301,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 195 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL628201,1088.0,14302,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 21.7 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL628202,1088.0,14303,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 217 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL628203,1088.0,14304,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 23.9 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL628204,1088.0,14305,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 239 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL628205,1088.0,14306,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 24.9 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL628206,1088.0,14307,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 249 uM/Kg of drug,,BAO_0000218,12582,
In vivo,,A,,Autocuration,0,,22224,CHEMBL628207,2367.0,14308,,,,U,Prostate gland,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d),,BAO_0000218,13257,
In vivo,,A,,Autocuration,0,,22224,CHEMBL627220,2367.0,14309,,,,U,Prostate gland,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/biood,,BAO_0000218,13257,
In vivo,,A,,Autocuration,0,,22224,CHEMBL627221,2385.0,14310,,,,U,Muscle tissue,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/muscle,,BAO_0000218,13257,
In vivo,,A,,Autocuration,0,,22224,CHEMBL627222,2367.0,14311,,,,U,Prostate gland,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v),,BAO_0000218,13257,
In vivo,,A,,Autocuration,0,,22224,CHEMBL627223,,14312,,,,U,,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/blood,,BAO_0000218,13257,
In vivo,,A,,Autocuration,0,,22224,CHEMBL632062,2385.0,14313,,,,U,Muscle tissue,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/muscle,,BAO_0000218,13257,
In vivo,,A,,Autocuration,0,,22224,CHEMBL632063,2106.0,14314,,,,U,Spleen,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in spleen,,BAO_0000218,13257,
In vivo,,A,,Autocuration,0,,22224,CHEMBL632064,1255.0,14315,,,,U,Urinary bladder,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bladder,,BAO_0000218,13257,
In vivo,,A,,Autocuration,0,,22224,CHEMBL632065,178.0,14316,,,,U,Blood,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in blood,,BAO_0000218,13257,
In vivo,,A,,Autocuration,0,,22224,CHEMBL632066,1474.0,14317,,,,U,Bone element,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bone,,BAO_0000218,13257,
In vivo,,A,,Autocuration,0,,22224,CHEMBL632067,,14318,,,,U,,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in fat,,BAO_0000218,13257,
In vivo,,A,,Autocuration,0,,22224,CHEMBL629188,2113.0,14319,,,,U,Kidney,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in kidney,,BAO_0000218,13257,
In vivo,,A,,Autocuration,0,,22224,CHEMBL629189,2107.0,14320,,,,U,Liver,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in liver,,BAO_0000218,13257,
In vivo,,A,,Autocuration,0,,22224,CHEMBL629190,2048.0,14321,,,,U,Lung,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in lung,,BAO_0000218,13257,
In vivo,,A,,Autocuration,0,,22224,CHEMBL629191,2385.0,14322,,,,U,Muscle tissue,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in muscle,,BAO_0000218,13257,
In vivo,,A,,Autocuration,0,,22224,CHEMBL629192,2367.0,14323,,,,U,Prostate gland,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d),,BAO_0000218,13257,
In vivo,,A,,Autocuration,0,,22224,CHEMBL629193,2385.0,14324,,,,U,Muscle tissue,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d)/muscle,,BAO_0000218,13257,
In vivo,,A,,Autocuration,0,,22224,CHEMBL629194,2367.0,14325,,,,U,Prostate gland,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v),,BAO_0000218,13257,
In vivo,,A,,Autocuration,0,,22224,CHEMBL629195,,14326,,,,U,,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/blood,,BAO_0000218,13257,
In vivo,,A,,Autocuration,0,,22224,CHEMBL629373,2385.0,14327,,,,U,Muscle tissue,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/muscle,,BAO_0000218,13257,
In vivo,,A,,Autocuration,0,,22224,CHEMBL629374,2106.0,14328,,,,U,Spleen,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in spleen,,BAO_0000218,13257,
In vivo,,A,,Autocuration,0,,22224,CHEMBL629375,2367.0,14329,,,,U,Prostate gland,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked)i n prostate (d)/biood,,BAO_0000218,13257,
In vivo,,A,,Autocuration,0,,22224,CHEMBL629376,1255.0,14330,,,,U,Urinary bladder,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bladder,,BAO_0000218,13257,
In vivo,,A,,Autocuration,0,,22224,CHEMBL629377,178.0,14331,,,,U,Blood,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in blood,,BAO_0000218,13257,
In vivo,,A,,Autocuration,0,,22224,CHEMBL629378,1474.0,14332,,,,U,Bone element,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bone,,BAO_0000218,13257,
In vivo,,A,,Autocuration,0,,22224,CHEMBL629379,,14333,,,,U,,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in fat,,BAO_0000218,13257,
In vivo,,A,,Autocuration,0,,22224,CHEMBL629151,2113.0,14334,,,,U,Kidney,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in kidney,,BAO_0000218,13257,
In vivo,,A,,Autocuration,0,,22224,CHEMBL629152,2107.0,14335,,,,U,Liver,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in liver,,BAO_0000218,13257,
In vivo,,A,,Autocuration,0,,22224,CHEMBL629153,2048.0,14336,,,,U,Lung,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in lung,,BAO_0000218,13257,
In vivo,,A,,Autocuration,0,,22224,CHEMBL629154,2385.0,14337,,,,U,Muscle tissue,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in muscle,,BAO_0000218,13257,
In vivo,,A,,Autocuration,0,,22224,CHEMBL629155,2367.0,14338,,,,U,Prostate gland,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d),,BAO_0000218,13257,
In vivo,,A,,Autocuration,0,,22224,CHEMBL629156,2367.0,14339,,,,U,Prostate gland,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/biood,,BAO_0000218,13257,
In vivo,,A,,Autocuration,0,,22224,CHEMBL629157,2385.0,14340,,,,U,Muscle tissue,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/muscle,,BAO_0000218,13257,
In vivo,,A,,Autocuration,0,,22224,CHEMBL629158,2367.0,14341,,,,U,Prostate gland,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v),,BAO_0000218,13257,
In vivo,,A,,Autocuration,0,,22224,CHEMBL629159,,14342,,,,U,,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/blood,,BAO_0000218,13257,
In vivo,,A,,Autocuration,0,,22224,CHEMBL629160,2385.0,14343,,,,U,Muscle tissue,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/muscle,,BAO_0000218,13257,
In vivo,,A,,Autocuration,0,,22224,CHEMBL629161,2106.0,14344,,,,U,Spleen,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in spleen,,BAO_0000218,13257,
In vivo,,A,,Autocuration,0,,22224,CHEMBL629162,1255.0,14345,,,,U,Urinary bladder,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bladder,,BAO_0000218,13257,
In vivo,,A,,Autocuration,0,,22224,CHEMBL629163,178.0,14346,,,,U,Blood,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in blood,,BAO_0000218,13257,
In vivo,,A,,Autocuration,0,,22224,CHEMBL629164,1474.0,14347,,,,U,Bone element,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bone,,BAO_0000218,13257,
In vivo,,A,,Autocuration,0,,22224,CHEMBL629165,,14348,,,,U,,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in fat,,BAO_0000218,13257,
In vivo,,A,,Autocuration,0,,22224,CHEMBL629166,2107.0,14349,,,,U,Liver,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in liver,,BAO_0000218,13257,
In vivo,,A,,Autocuration,0,,22224,CHEMBL629167,2048.0,14350,,,,U,Lung,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in lung,,BAO_0000218,13257,
In vivo,,A,,Autocuration,0,,22224,CHEMBL629168,2385.0,14351,,,,U,Muscle tissue,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in muscle,,BAO_0000218,13257,
,,A,,Autocuration,0,,22224,CHEMBL629169,,14352,,,,U,,1,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM,,BAO_0000019,2193,
,,A,,Autocuration,0,,22224,CHEMBL629170,,14353,,,,U,,1,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM; no inhibition is observed at this concentration,,BAO_0000019,2193,
,,A,,Autocuration,0,,22224,CHEMBL631153,,14354,,,,U,,1,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM,,BAO_0000019,2193,
,,A,,Autocuration,0,,22224,CHEMBL875121,,14355,,,,U,,1,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM; too active and complete inhibition is observed,,BAO_0000019,2193,
,,A,,Autocuration,0,,22224,CHEMBL631154,,14356,,,,U,,1,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM,,BAO_0000019,2193,
,,A,,Autocuration,0,,22224,CHEMBL631155,,14357,,,,U,,1,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM; too active and complete inhibition is observed,,BAO_0000019,2193,
,,A,,Autocuration,0,,22224,CHEMBL631156,,14358,,,,U,,1,,Hydrolysis rate constant was determined,,BAO_0000019,568,
,,A,,Autocuration,0,,22224,CHEMBL631157,,14359,,,,U,,1,,"K2, The intrinsic biomolecular reactivation rate constant on VX at 25 degree Centigrade",,BAO_0000019,9680,
,,A,,Autocuration,0,,22224,CHEMBL631158,,14360,,,,U,,1,,"K2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",,BAO_0000019,9680,
,,A,,Autocuration,0,,22224,CHEMBL631159,,14361,,,,U,,1,,"K2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",,BAO_0000019,9680,
,,A,,Autocuration,0,,22224,CHEMBL631160,,14362,,,,U,,1,,Observed second order rate constant,,BAO_0000019,10026,
,,A,,Autocuration,0,,22224,CHEMBL631161,,14363,,,,U,,1,,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,,BAO_0000019,10281,
,,A,,Autocuration,0,,22224,CHEMBL631162,,14364,,,,U,,1,,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,,BAO_0000019,10014,
,,A,,Autocuration,0,,22224,CHEMBL630313,,14365,,,,U,,1,,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,,BAO_0000019,10014,
,,A,,Autocuration,0,,22224,CHEMBL630314,,14366,,,,U,,1,,"k2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",,BAO_0000019,9680,
,,A,,Autocuration,0,,22224,CHEMBL630315,,14367,,,,U,,1,,"k2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",,BAO_0000019,9680,
,,A,,Autocuration,0,,22224,CHEMBL630316,,14368,,,,U,,1,,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,BAO_0000019,13028,
,,A,,Autocuration,0,,22224,CHEMBL630986,,14369,,,,U,,1,,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,BAO_0000019,13028,
,,A,,Autocuration,0,,22224,CHEMBL630987,,14370,,,,U,,1,,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,BAO_0000019,13028,
,,A,,Autocuration,0,,22224,CHEMBL630988,,14371,,,,U,,1,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0(or )in RMPI 1640 cell culture medium containing 10%FCS,,BAO_0000019,13028,
,,A,,Autocuration,0,,22224,CHEMBL630989,,14372,,,,U,,1,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,BAO_0000019,13028,
,,A,,Autocuration,0,,22224,CHEMBL630990,,14373,,,,U,,1,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,,BAO_0000019,13028,
,,A,,Autocuration,0,,22224,CHEMBL630991,,14374,,,,U,,1,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,,BAO_0000019,13028,
,,A,,Autocuration,0,,22224,CHEMBL630992,,14375,,,,U,,1,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,BAO_0000019,13028,
,,A,,Autocuration,0,,22224,CHEMBL630993,,14376,,,,U,,1,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,BAO_0000019,13028,
,,A,,Autocuration,0,,22224,CHEMBL630994,,14377,,,,U,,1,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,BAO_0000019,13028,
,,A,,Intermediate,1,,50597,CHEMBL630995,,14378,Rattus norvegicus,,10116.0,N,,1,,Rate constants of compound was determined at muscarinic receptor in the rat cerebral cortex,,BAO_0000218,10014,
,,A,,Autocuration,0,,22224,CHEMBL629252,,14379,,,,U,,1,,Association constant for compound at 31 degree C was determined,,BAO_0000019,9962,
,,A,,Autocuration,0,,22224,CHEMBL629253,,14380,,,,U,,1,,Calculated antagonist equilibrium dissociation constant of the compound,,BAO_0000019,12029,
,,A,,Autocuration,0,,22224,CHEMBL629944,,14381,,,,U,,1,,Calculated antagonist equilibrium dissociation constant of the compound; No statistically significant antagonism observed,,BAO_0000019,12029,
,,A,,Intermediate,1,,50512,CHEMBL629945,3126.0,14382,Cavia porcellus,,10141.0,N,Trachea,1,,Dissociation constants vs LTE4 on guinea pig trachea,,BAO_0000218,10583,
,,A,,Autocuration,0,,22224,CHEMBL629946,,14383,,,,U,,1,,"Tested for hydrolysis in presence of boric acid by UV spectrophotometry, dissociation constant was evaluated at the pH < 8",,BAO_0000019,568,
,,A,,Autocuration,0,,22224,CHEMBL629947,,14384,,,,U,,1,,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 8.5",,BAO_0000019,568,
,,A,,Autocuration,0,,22224,CHEMBL629948,,14385,,,,U,,1,,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 9.5",,BAO_0000019,568,
,,A,,Autocuration,0,,22224,CHEMBL856024,,14386,,,,U,,1,,"Tested for hydrolysis in presence of phenylboronic acid, rate constant was evaluated at the pH 9.5",,BAO_0000019,568,
,,A,,Autocuration,0,,22224,CHEMBL629949,,14387,,,,U,,1,,Affinity constant KD value was derived from TMP,,BAO_0000019,7493,
,,A,,Autocuration,0,,22224,CHEMBL629950,,14388,,,,U,,1,,Apparent dissociation (binding) rate constant was evaluated,,BAO_0000019,8371,
,,P,,Autocuration,0,,22224,CHEMBL630127,,14389,,,,U,,1,,Dissociation constant (KD) of the compound,,BAO_0000100,13114,
,,P,,Autocuration,0,,22224,CHEMBL630128,,14390,,,,U,,1,,Dissociation constant determined by heteronuclear 1H/15N correlation NMR spectroscopy,,BAO_0000100,15515,
,,P,,Autocuration,0,,22224,CHEMBL630129,,14391,,,,U,,1,,Dissociation constant from ESR titration experiments,,BAO_0000100,522,
,,,,Autocuration,0,,22224,CHEMBL630130,,14392,,,,U,,1,,Dissociation constant was evaluated which is similar to Ki (inhibitory constant),,BAO_0000019,13888,
,,P,,Autocuration,0,,22224,CHEMBL875234,,14393,,,,U,,1,,Dissociation constant was evaluated.,,BAO_0000100,2616,
,,P,,Autocuration,0,,22224,CHEMBL630131,,14394,,,,U,,1,,Dissociation constant was reported,,BAO_0000100,3798,
,,A,,Intermediate,1,,50597,CHEMBL630132,,14395,Rattus norvegicus,,10116.0,N,,1,,Dissociation constant was determined in rat pituitary cells.,,BAO_0000218,8731,
,,A,,Autocuration,0,,22224,CHEMBL630133,,14396,,,,U,,1,,Equilibrium dissociation constant of CA complex for enantiomer 1 of compound,,BAO_0000019,11892,
,,A,,Autocuration,0,,22224,CHEMBL630134,,14397,,,,U,,1,,Equilibrium dissociation constant of CA complex for enantiomer 2 of compound,,BAO_0000019,11892,
,,A,,Autocuration,0,,22224,CHEMBL630135,,14398,,,,U,,1,,Equilibrium dissociation constant of the compound,,BAO_0000019,2582,
,,A,,Autocuration,0,,22224,CHEMBL630136,,14399,,,,U,,1,,Equilibrium dissociation constant was determined,,BAO_0000019,11892,
,,A,,Autocuration,0,,22224,CHEMBL630137,,14400,,,,U,,1,,Kinetic constant KD was evaluated,,BAO_0000019,13396,
,,A,,Autocuration,0,,22224,CHEMBL630138,,14401,,,,U,,1,,Tested for dissociation constant of the compound; Value ranges from 0.1-0.3,,BAO_0000019,603,
,,A,,Autocuration,0,,22224,CHEMBL630139,,14402,,,,U,,1,,Equilibrium association constant interacting with unilamellar vesicles of electroneutral in PBS buffer at pH 7.4,,BAO_0000019,15673,
,,A,,Autocuration,0,,22224,CHEMBL630140,,14403,,,,U,,1,,Rate constant for hydrolysis in aqueous acetone.,,BAO_0000019,10368,
,,A,,Autocuration,0,,22224,CHEMBL875235,,14404,,,,U,,1,,Disassociation constant (KI) was obtained from Cheng and Prusoff equation for quercetin trypsin complex,,BAO_0000019,14228,
,,A,,Intermediate,1,,50597,CHEMBL876439,,14405,Rattus norvegicus,,10116.0,N,,1,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.43/2.86,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL630605,,14406,Rattus norvegicus,,10116.0,N,,1,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.44/2.68,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL630606,,14407,Rattus norvegicus,,10116.0,N,,1,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.45/1.55,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL630607,,14408,Rattus norvegicus,,10116.0,N,,1,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.48/0.95,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL630608,,14409,Rattus norvegicus,,10116.0,N,,1,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.5/1.79,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL630609,,14410,Rattus norvegicus,,10116.0,N,,1,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.51/0.66,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL630610,,14411,Rattus norvegicus,,10116.0,N,,1,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.52/2.02,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL630611,,14412,Rattus norvegicus,,10116.0,N,,1,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.61//0.37,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL629552,,14413,Rattus norvegicus,,10116.0,N,,1,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.71/0.36,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL629733,,14414,Rattus norvegicus,,10116.0,N,,1,,Mean sodium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL629734,,14415,Rattus norvegicus,,10116.0,N,,1,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL629735,,14416,Rattus norvegicus,,10116.0,N,,1,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL629736,,14417,Rattus norvegicus,,10116.0,N,,1,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL629737,,14418,Rattus norvegicus,,10116.0,N,,1,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL629738,,14419,Rattus norvegicus,,10116.0,N,,1,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL629739,,14420,Rattus norvegicus,,10116.0,N,,1,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL629740,,14421,Rattus norvegicus,,10116.0,N,,1,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL629741,,14422,Rattus norvegicus,,10116.0,N,,1,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL629742,,14423,Rattus norvegicus,,10116.0,N,,1,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL629743,,14424,Rattus norvegicus,,10116.0,N,,1,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL629744,,14425,Rattus norvegicus,,10116.0,N,,1,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL629745,,14426,Rattus norvegicus,,10116.0,N,,1,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL629746,,14427,Rattus norvegicus,,10116.0,N,,1,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL629747,,14428,Rattus norvegicus,,10116.0,N,,1,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL629748,,14429,Rattus norvegicus,,10116.0,N,,1,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL629749,,14430,Rattus norvegicus,,10116.0,N,,1,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL629750,,14431,Rattus norvegicus,,10116.0,N,,1,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL629751,,14432,Rattus norvegicus,,10116.0,N,,1,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL629752,,14433,Rattus norvegicus,,10116.0,N,,1,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL629753,,14434,Rattus norvegicus,,10116.0,N,,1,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL629754,,14435,Rattus norvegicus,,10116.0,N,,1,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL629755,,14436,Rattus norvegicus,,10116.0,N,,1,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL629756,,14437,Rattus norvegicus,,10116.0,N,,1,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL629757,,14438,Rattus norvegicus,,10116.0,N,,1,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL629758,,14439,Rattus norvegicus,,10116.0,N,,1,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL629759,,14440,Rattus norvegicus,,10116.0,N,,1,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL629760,,14441,Rattus norvegicus,,10116.0,N,,1,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,,BAO_0000218,11510,
,,A,,Intermediate,1,,50597,CHEMBL876443,,14442,Rattus norvegicus,,10116.0,N,,1,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,,BAO_0000218,11510,
,,A,,Intermediate,1,,50588,CHEMBL629761,,14443,Canis lupus familiaris,,9615.0,N,,1,,Na+ excretion mequiv /kg in 6 conscious female dogs administered perorally during 0-6 hr,,BAO_0000218,8310,
,,A,,Intermediate,1,,50588,CHEMBL629762,,14444,Canis lupus familiaris,,9615.0,N,,1,,Na+ excretion mequiv /kg in conscious female dogs administered perorally during 0-6 hr,,BAO_0000218,8310,
,,A,,Intermediate,1,,50594,CHEMBL629763,,14445,Mus musculus,,10090.0,N,,1,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,BAO_0000218,8310,
,,A,,Intermediate,1,,50594,CHEMBL629764,,14446,Mus musculus,,10090.0,N,,1,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,,BAO_0000218,8310,
,,A,,Intermediate,1,,50594,CHEMBL629765,,14447,Mus musculus,,10090.0,N,,1,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,,BAO_0000218,8310,
,,A,,Intermediate,1,,50594,CHEMBL629766,,14448,Mus musculus,,10090.0,N,,1,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 50 ml/kg perorally,,BAO_0000218,8310,
,,A,,Intermediate,1,,50594,CHEMBL629767,,14449,Mus musculus,,10090.0,N,,1,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,BAO_0000218,8310,
,,A,,Intermediate,1,,50588,CHEMBL629768,,14450,Canis lupus familiaris,,9615.0,N,,1,,Na+ excretion mequiv/kg in 4 conscious female dogs administered perorally during 0-6 hr,,BAO_0000218,8310,
,,A,,Intermediate,1,,50594,CHEMBL629769,,14451,Mus musculus,,10090.0,N,,1,,Na+ excretion mequiv/kg in 4 saline-loaded mice administered at a dose 50 ml/kg perorally,,BAO_0000218,8310,
,,A,,Intermediate,1,,50588,CHEMBL629770,,14452,Canis lupus familiaris,,9615.0,N,,1,,Na+ excretion mequiv/kg in 6 conscious female dogs administered perorally during 0-6 hr,,BAO_0000218,8310,
,,A,,Intermediate,1,,50588,CHEMBL629771,,14453,Canis lupus familiaris,,9615.0,N,,1,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 0.3 ml/kg perorally,,BAO_0000218,8310,
,,A,,Intermediate,1,,50594,CHEMBL629772,,14454,Mus musculus,,10090.0,N,,1,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,BAO_0000218,8310,
,,A,,Intermediate,1,,50594,CHEMBL629773,,14455,Mus musculus,,10090.0,N,,1,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,BAO_0000218,8310,
,,A,,Intermediate,1,,50594,CHEMBL625455,,14456,Mus musculus,,10090.0,N,,1,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 2 ml/kg perorally,,BAO_0000218,8310,
,,A,,Intermediate,1,,50594,CHEMBL625456,,14457,Mus musculus,,10090.0,N,,1,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 250 ml/kg perorally,,BAO_0000218,8310,
,,A,,Intermediate,1,,50594,CHEMBL625457,,14458,Mus musculus,,10090.0,N,,1,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 3 ml/kg perorally,,BAO_0000218,8310,
,,A,,Intermediate,1,,50597,CHEMBL625458,1088.0,14459,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 25.9 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL625459,1088.0,14460,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 259 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL875483,1088.0,14461,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 26.5 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL634779,1088.0,14462,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 265 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL625460,1088.0,14463,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL626117,1088.0,14464,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27.9 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL626118,1088.0,14465,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 270 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL628342,1088.0,14466,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 279 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL628343,1088.0,14467,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.2 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL628344,1088.0,14468,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.22 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL628345,1088.0,14469,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.9 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL628346,1088.0,14470,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 282 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL628347,1088.0,14471,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 289 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL628348,1088.0,14472,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.40 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL628349,1088.0,14473,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.76 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL875611,1088.0,14474,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 30.2 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL628350,1088.0,14475,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 302 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL628351,1088.0,14476,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 31.6 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL628352,1088.0,14477,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 316 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL628353,1088.0,14478,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 32.4 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL628354,1088.0,14479,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 324 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL626667,1088.0,14480,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.0 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL626668,1088.0,14481,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.1 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL626669,1088.0,14482,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.8 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL626670,1088.0,14483,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 341 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL626671,1088.0,14484,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 348 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL626672,1088.0,14485,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 37.6 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL626673,1088.0,14486,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 50.8 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL626674,1088.0,14487,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 58.4 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL626675,1088.0,14488,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 65.2 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL626676,1088.0,14489,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 68.1 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL626677,1088.0,14490,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 7.94 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL626678,1088.0,14491,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.6 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL626679,1088.0,14492,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.8 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL875612,1088.0,14493,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 74.8 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL626680,1088.0,14494,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 77.5 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL626681,1088.0,14495,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 79.4 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL626682,1088.0,14496,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 80.9 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL626683,1088.0,14497,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 83.8 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL626684,1088.0,14498,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.5 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL626685,1088.0,14499,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.7 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL626686,1088.0,14500,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.7 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL626687,1088.0,14501,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.9 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL624978,1088.0,14502,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 9.06 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL624979,1088.0,14503,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 90.6 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL624980,1088.0,14504,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 94.9 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL624981,1088.0,14505,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 97.1 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50588,CHEMBL624982,1088.0,14506,Canis lupus familiaris,,9615.0,N,Urine,1,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,,BAO_0000218,12582,
In vivo,,A,,Autocuration,0,,22224,CHEMBL627564,2367.0,14507,,,,U,Prostate gland,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d),,BAO_0000218,13257,
In vivo,,A,,Autocuration,0,,22224,CHEMBL627565,2367.0,14508,,,,U,Prostate gland,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v),,BAO_0000218,13257,
In vivo,,A,,Autocuration,0,,22224,CHEMBL627566,,14509,,,,U,,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/blood,,BAO_0000218,13257,
In vivo,,A,,Autocuration,0,,22224,CHEMBL627567,2385.0,14510,,,,U,Muscle tissue,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/muscle,,BAO_0000218,13257,
In vivo,,A,,Autocuration,0,,22224,CHEMBL627568,2106.0,14511,,,,U,Spleen,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in spleen,,BAO_0000218,13257,
In vivo,,A,,Autocuration,0,,22224,CHEMBL627569,2113.0,14512,,,,U,Kidney,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hr in kidney,,BAO_0000218,13257,
In vivo,,A,,Autocuration,0,,22224,CHEMBL627570,1255.0,14513,,,,U,Urinary bladder,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bladder,,BAO_0000218,13257,
In vivo,,A,,Autocuration,0,,22224,CHEMBL627571,178.0,14514,,,,U,Blood,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in blood,,BAO_0000218,13257,
In vivo,,A,,Autocuration,0,,22224,CHEMBL627572,1474.0,14515,,,,U,Bone element,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bone,,BAO_0000218,13257,
In vivo,,A,,Autocuration,0,,22224,CHEMBL627573,,14516,,,,U,,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in fat,,BAO_0000218,13257,
In vivo,,A,,Autocuration,0,,22224,CHEMBL627574,2113.0,14517,,,,U,Kidney,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in kidney,,BAO_0000218,13257,
In vivo,,A,,Autocuration,0,,22224,CHEMBL627575,2107.0,14518,,,,U,Liver,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in liver,,BAO_0000218,13257,
In vivo,,A,,Autocuration,0,,22224,CHEMBL627576,2048.0,14519,,,,U,Lung,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in lung,,BAO_0000218,13257,
In vivo,,A,,Autocuration,0,,22224,CHEMBL627577,2385.0,14520,,,,U,Muscle tissue,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in muscle,,BAO_0000218,13257,
In vivo,,A,,Autocuration,0,,22224,CHEMBL627578,2367.0,14521,,,,U,Prostate gland,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d),,BAO_0000218,13257,
In vivo,,A,,Autocuration,0,,22224,CHEMBL627579,2367.0,14522,,,,U,Prostate gland,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/biood,,BAO_0000218,13257,
In vivo,,A,,Autocuration,0,,22224,CHEMBL627580,2385.0,14523,,,,U,Muscle tissue,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/muscle,,BAO_0000218,13257,
In vivo,,A,,Autocuration,0,,22224,CHEMBL627581,2367.0,14524,,,,U,Prostate gland,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v),,BAO_0000218,13257,
In vivo,,A,,Autocuration,0,,22224,CHEMBL627582,,14525,,,,U,,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/blood,,BAO_0000218,13257,
In vivo,,A,,Autocuration,0,,22224,CHEMBL627583,2385.0,14526,,,,U,Muscle tissue,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/muscle,,BAO_0000218,13257,
In vivo,,A,,Autocuration,0,,22224,CHEMBL627584,2106.0,14527,,,,U,Spleen,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in spleen,,BAO_0000218,13257,
In vivo,,A,,Autocuration,0,,22224,CHEMBL627585,2367.0,14528,,,,U,Prostate gland,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/biood,,BAO_0000218,13257,
In vivo,,A,,Autocuration,0,,22224,CHEMBL627586,2385.0,14529,,,,U,Muscle tissue,1,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/muscle,,BAO_0000218,13257,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627587,,14530,Rattus norvegicus,,10116.0,N,,1,,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 200 nmol of WAY 100635,,BAO_0000218,15413,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627588,,14531,Rattus norvegicus,,10116.0,N,,1,,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,,BAO_0000218,15413,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628250,,14532,Rattus norvegicus,,10116.0,N,,1,,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 200 nmol of WAY 100635,,BAO_0000218,15413,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628251,,14533,Rattus norvegicus,,10116.0,N,,1,,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,,BAO_0000218,15413,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628252,10000000.0,14534,Rattus norvegicus,,10116.0,N,Hippocampus,1,,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 200 nmol of WAY 100635,,BAO_0000218,15413,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628253,10000000.0,14535,Rattus norvegicus,,10116.0,N,Hippocampus,1,,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,,BAO_0000218,15413,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628254,1898.0,14536,Rattus norvegicus,,10116.0,N,Hypothalamus,1,,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 200 nmol of WAY 100635,,BAO_0000218,15413,
In vivo,,A,,Intermediate,1,,50597,CHEMBL877493,1898.0,14537,Rattus norvegicus,,10116.0,N,Hypothalamus,1,,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,,BAO_0000218,15413,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628255,,14538,Rattus norvegicus,,10116.0,N,,1,,Biodistribution of the Radiolabeled FCWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,,BAO_0000218,15413,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628256,,14539,Rattus norvegicus,,10116.0,N,,1,,Biodistribution of the Radiolabeled FCWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,,BAO_0000218,15413,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628257,10000000.0,14540,Rattus norvegicus,,10116.0,N,Hippocampus,1,,Biodistribution of the Radiolabeled FCWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,,BAO_0000218,15413,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628258,1898.0,14541,Rattus norvegicus,,10116.0,N,Hypothalamus,1,,Biodistribution of the Radiolabeled FCWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,,BAO_0000218,15413,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628259,,14542,Rattus norvegicus,,10116.0,N,,1,,Biodistribution of the Radiolabeled MeFBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,,BAO_0000218,15413,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628429,,14543,Rattus norvegicus,,10116.0,N,,1,,Biodistribution of the Radiolabeled MeFBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,,BAO_0000218,15413,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626862,10000000.0,14544,Rattus norvegicus,,10116.0,N,Hippocampus,1,,Biodistribution of the Radiolabeled MeFBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,,BAO_0000218,15413,
In vivo,,A,,Intermediate,1,,50597,CHEMBL626863,1898.0,14545,Rattus norvegicus,,10116.0,N,Hypothalamus,1,,Biodistribution of the Radiolabeled MeFBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635; Not determined,,BAO_0000218,15413,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625886,2037.0,14546,Rattus norvegicus,,10116.0,N,Cerebellum,1,,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum,,BAO_0000218,15413,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625887,2037.0,14547,Rattus norvegicus,,10116.0,N,Cerebellum,1,,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum co-injected with 50 nM of WAY 100635.,,BAO_0000218,15413,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625888,,14548,Rattus norvegicus,,10116.0,N,,1,,Biodistribution of the [11C]-radiolabeled compound in rat cortex,,BAO_0000218,15413,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625889,,14549,Rattus norvegicus,,10116.0,N,,1,,Biodistribution of the [11C]-radiolabeled compound in rat cortex co-injected with 50 nM of WAY 100635.,,BAO_0000218,15413,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625890,10000000.0,14550,Rattus norvegicus,,10116.0,N,Hippocampus,1,,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus,,BAO_0000218,15413,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625891,10000000.0,14551,Rattus norvegicus,,10116.0,N,Hippocampus,1,,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus co-injected with 50 nM of WAY 100635.,,BAO_0000218,15413,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625892,1898.0,14552,Rattus norvegicus,,10116.0,N,Hypothalamus,1,,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus,,BAO_0000218,15413,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625893,1898.0,14553,Rattus norvegicus,,10116.0,N,Hypothalamus,1,,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus co-injected with 50 nM of WAY 100635.,,BAO_0000218,15413,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625894,2037.0,14554,Rattus norvegicus,,10116.0,N,Cerebellum,1,,Biodistribution of the [18F]-radiolabeled compound in rat cerebellum,,BAO_0000218,15413,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625895,,14555,Rattus norvegicus,,10116.0,N,,1,,Biodistribution of the [18F]-radiolabeled compound in rat cortex,,BAO_0000218,15413,
,,A,,Autocuration,0,,22224,CHEMBL625896,,14556,,,,U,,1,,Reaction rate parameter value for phosphate with transfer with respect to ATP,,BAO_0000019,12404,
,,A,,Autocuration,0,,22224,CHEMBL625897,,14557,,,,U,,1,,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 8.5(Apparent inhibition constant)",,BAO_0000019,568,
,,A,,Autocuration,0,,22224,CHEMBL625898,,14558,,,,U,,1,,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",,BAO_0000019,568,
,,A,,Autocuration,0,,22224,CHEMBL625899,,14559,,,,U,,1,,"Tested for hydrolysis in presence of phenylboronic acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",,BAO_0000019,568,
,,A,,Autocuration,0,,22224,CHEMBL626124,,14560,,,,U,,1,,Reaction rate parameter value for phosphate with transfer with respect to ATP,,BAO_0000019,12404,
,,A,,Intermediate,1,,50212,CHEMBL628500,,14561,Escherichia coli,,562.0,N,,1,,Ability to inhibit Escherichia coli adenylate kinase II activity expressed as half maximal velocity,,BAO_0000218,7624,
,,A,,Intermediate,1,,50597,CHEMBL857856,,14562,Rattus norvegicus,,10116.0,N,,1,,"Ability to inhibit rat adenylate kinase II, activity expressed as half-maximal velocity",,BAO_0000218,7624,
,,A,,Intermediate,1,,50597,CHEMBL628501,,14563,Rattus norvegicus,,10116.0,N,,1,,"Ability to inhibit rat adenylate kinase III, activity expressed as half-maximal velocity",,BAO_0000218,7624,
,,A,,Autocuration,0,,22224,CHEMBL628502,,14564,,,,U,,1,,"Compound was evaluated for the Michaelis-Menten constant, Km in a generic protein phosphatase stopped assay system",,BAO_0000019,4643,
,,A,,Autocuration,0,,22224,CHEMBL628503,,14565,,,,U,,1,,Kinetic parameter KM (nM) for the MAO-B catalyzed oxidation of the compound.,,BAO_0000019,11532,
,,A,,Autocuration,0,,22224,CHEMBL628504,,14566,,,,U,,1,,Kinetic parameter KM at pH 7.4 and 37 degree Centigrade,,BAO_0000019,11018,
,,A,,Autocuration,0,,22224,CHEMBL628505,,14567,,,,U,,1,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",,BAO_0000019,2276,
,,A,,Autocuration,0,,22224,CHEMBL874452,,14568,,,,U,,1,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as KM",,BAO_0000019,2276,
,,A,,Autocuration,0,,22224,CHEMBL628506,,14569,,,,U,,1,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as KM; Not determined",,BAO_0000019,2276,
,,A,,Autocuration,0,,22224,CHEMBL628507,,14570,,,,U,,1,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",,BAO_0000019,2276,
,,A,,Autocuration,0,,22224,CHEMBL628508,,14571,,,,U,,1,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as KM",,BAO_0000019,2276,
,,A,,Autocuration,0,,22224,CHEMBL628509,,14572,,,,U,,1,,Michaelis constant (KM) was evaluated,,BAO_0000019,8949,
,,A,,Autocuration,0,,22224,CHEMBL628510,,14573,,,,U,,1,,Reaction rate parameter value for phosphate with transfer with respect to ATP,,BAO_0000019,12404,
,,B,,Autocuration,0,,22224,CHEMBL628511,,14574,,,,U,,1,,Substrate concentration for half maximal velocity was reported for rat hexokinase I,,BAO_0000019,7625,
,,B,,Autocuration,0,,22224,CHEMBL628512,,14575,,,,U,,1,,Substrate concentration for half maximal velocity was reported for rat hexokinase II,,BAO_0000019,7625,
,,B,,Autocuration,0,,22224,CHEMBL628513,,14576,,,,U,,1,,Substrate concentration for half maximal velocity was reported for rat hexokinase III,,BAO_0000019,7625,
,,B,,Autocuration,0,,22224,CHEMBL628514,,14577,,,,U,,1,,Substrate concentration for half maximal velocity was reported for yeast hexokinase,,BAO_0000019,7625,
,,A,,Autocuration,0,,22224,CHEMBL628515,,14578,,,,U,,1,,Pseudo-first-order rate constant for alkylation of NBP in 50% aqueous acetone at 66 degrees celsius with 50 uM and 25 uM of NBP.,,BAO_0000019,12908,
,,A,,Autocuration,0,,22224,CHEMBL628516,,14579,,,,U,,1,,Rate constant for alkylation of 4-(4-nitrobenzyl)pyridine,,BAO_0000019,10368,
,,A,,Autocuration,0,,22224,CHEMBL628517,,14580,,,,U,,1,,Bimolecular rate constant (KOH) at 25 degree C (m = 0.5),,BAO_0000019,13108,
,,A,,Autocuration,0,,22224,CHEMBL628518,,14581,,,,U,,1,,its bimolecular rate constant (KOH) at 25 degree C (m = 0.5),,BAO_0000019,13108,
,,A,,Autocuration,0,,22224,CHEMBL628519,,14582,,,,U,,1,,Acid dissociation constant evaluated towards Hematin mu-oxo dimer,,BAO_0000019,15217,
,,A,,Autocuration,0,,22224,CHEMBL628520,,14583,,,,U,,1,,Acid dissociation constant evaluated towards Hematin mu-oxo dimer; Not available,,BAO_0000019,15217,
,,A,,Autocuration,0,,22224,CHEMBL628521,,14584,,,,U,,1,,Binding constant was determined,,BAO_0000019,10933,
,,A,,Autocuration,0,,22224,CHEMBL630443,,14585,,,,U,,1,,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree Centigrade,,BAO_0000019,2363,
,,A,,Autocuration,0,,22224,CHEMBL630444,,14586,,,,U,,1,,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree centigrade; Not determined,,BAO_0000019,2363,
,,A,,Autocuration,0,,22224,CHEMBL857732,,14587,,,,U,,1,,Rate constant with triethylamine at 30 degree C in 0.1 M potassium chloride was expressed as Kamine,,BAO_0000019,2276,
,,P,,Autocuration,0,,22224,CHEMBL630445,,14588,,,,U,,1,,Octanol-water apparent distribution coefficient measured in TRIS buffer at a pH 7.4.,,BAO_0000100,14915,
,,A,,Autocuration,0,,22224,CHEMBL630446,,14589,,,,U,,1,,Catalytic rate constant of the compound,,BAO_0000019,8847,
,,B,,Autocuration,0,,22224,CHEMBL630447,,14590,,,,U,,1,,inactivation rate constant calculated from experimental IC50 value for dipeptidyl peptidase IV inhibition,,BAO_0000019,15357,
,,A,,Autocuration,0,,22224,CHEMBL630448,,14591,,,,U,,1,,Catalytic constant expressed as Kinetic behavior of enzyme (PicK/6-His),,BAO_0000019,2869,
,,A,,Autocuration,0,,22224,CHEMBL630449,,14592,,,,U,,1,,Catalytic rate constant against phospholipase A2 was determined,,BAO_0000019,3484,
,,A,,Autocuration,0,,22224,CHEMBL630450,,14593,,,,U,,1,,"Compound was evaluated for catalytic constant, Kcat",,BAO_0000019,1373,
,,A,,Autocuration,0,,22224,CHEMBL630451,,14594,,,,U,,1,,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant (kcat) which is a first-order rate constant was determined,,BAO_0000019,8142,
,,A,,Autocuration,0,,22224,CHEMBL630452,,14595,,,,U,,1,,Kcat calculated from 0.693/T1/2,,BAO_0000019,14131,
,,A,,Autocuration,0,,22224,CHEMBL630453,,14596,,,,U,,1,,Kcat was determined,,BAO_0000019,17269,
,,A,,Autocuration,0,,22224,CHEMBL630454,,14597,,,,U,,1,,Kcat against class A PCI beta-lactamase catalyzed lactone hydrolysis,,BAO_0000019,3485,
,,A,,Autocuration,0,,22224,CHEMBL630455,,14598,,,,U,,1,,Kcat against class A TEM beta-lactamase catalyzed lactone hydrolysis,,BAO_0000019,3485,
,,A,,Autocuration,0,,22224,CHEMBL631487,,14599,,,,U,,1,,Kcat against class C P99 beta-lactamase catalyzed lactone hydrolysis,,BAO_0000019,3485,
,,A,,Autocuration,0,,22224,CHEMBL631488,,14600,,,,U,,1,,Kcat value was determined,,BAO_0000019,5962,
,,A,,Autocuration,0,,22224,CHEMBL876440,,14601,,,,U,,1,,Kinetic constant for the hydrolysis by the catalyst CPA was evaluated,,BAO_0000019,3133,
,,A,,Autocuration,0,,22224,CHEMBL631489,,14602,,,,U,,1,,Kinetic constant for the hydrolysis by the catalyst McAbIIF9D8 was evaluated,,BAO_0000019,3133,
,,A,,Autocuration,0,,22224,CHEMBL857742,,14603,,,,U,,1,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",,BAO_0000019,2276,
,,A,,Autocuration,0,,22224,CHEMBL631490,,14604,,,,U,,1,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat",,BAO_0000019,2276,
,,A,,Autocuration,0,,22224,CHEMBL631491,,14605,,,,U,,1,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat; Not determined",,BAO_0000019,2276,
,,A,,Autocuration,0,,22224,CHEMBL631492,,14606,,,,U,,1,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",,BAO_0000019,2276,
,,A,,Autocuration,0,,22224,CHEMBL631493,,14607,,,,U,,1,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat",,BAO_0000019,2276,
,,A,,Autocuration,0,,22224,CHEMBL631494,,14608,,,,U,,1,,Kinetic parameter for rate of conversion to PABA was determined,,BAO_0000019,4892,
,,A,,Autocuration,0,,22224,CHEMBL631495,,14609,,,,U,,1,,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,,BAO_0000019,3133,
,,A,,Intermediate,1,,50597,CHEMBL631496,1988.0,14610,Rattus norvegicus,,10116.0,N,Feces,1,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",,BAO_0000218,11488,
,,A,,Intermediate,1,,50597,CHEMBL631497,1088.0,14611,Rattus norvegicus,,10116.0,N,Urine,1,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",,BAO_0000218,11488,
,,A,,Intermediate,1,,50597,CHEMBL631498,1088.0,14612,Rattus norvegicus,,10116.0,N,Urine,1,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",,BAO_0000218,11488,
,,A,,Intermediate,1,,50597,CHEMBL629776,1088.0,14613,Rattus norvegicus,,10116.0,N,Urine,1,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",,BAO_0000218,11488,
,,A,,Intermediate,1,,50597,CHEMBL629777,1088.0,14614,Rattus norvegicus,,10116.0,N,Urine,1,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",,BAO_0000218,11488,
,,A,,Intermediate,1,,50597,CHEMBL629778,1088.0,14615,Rattus norvegicus,,10116.0,N,Urine,1,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",,BAO_0000218,11488,
,,A,,Intermediate,1,,50597,CHEMBL630456,,14616,Rattus norvegicus,,10116.0,N,,1,,Cumulative dose excreted after intraduodenal administration at 0-0.5 hours in rats,,BAO_0000218,11488,
,,A,,Intermediate,1,,50597,CHEMBL630457,,14617,Rattus norvegicus,,10116.0,N,,1,,Cumulative dose excreted after intraduodenal administration at 0.5-1.0 hours in rats,,BAO_0000218,11488,
,,A,,Intermediate,1,,50597,CHEMBL630458,,14618,Rattus norvegicus,,10116.0,N,,1,,Cumulative dose excreted after intraduodenal administration at 1.0-1.5 hours in rats,,BAO_0000218,11488,
,,A,,Intermediate,1,,50597,CHEMBL630459,,14619,Rattus norvegicus,,10116.0,N,,1,,Cumulative dose excreted after intraduodenal administration at 1.5-2.0 hours in rats,,BAO_0000218,11488,
,,A,,Intermediate,1,,50597,CHEMBL630460,,14620,Rattus norvegicus,,10116.0,N,,1,,Cumulative dose excreted after intraduodenal administration at 2-3 hours in rats,,BAO_0000218,11488,
,,A,,Intermediate,1,,50597,CHEMBL876550,,14621,Rattus norvegicus,,10116.0,N,,1,,Cumulative dose excreted after intraduodenal administration at 3-4 hours in rats,,BAO_0000218,11488,
,,A,,Intermediate,1,,50597,CHEMBL630461,,14622,Rattus norvegicus,,10116.0,N,,1,,Cumulative dose excreted after intraduodenal administration at 4-6 hours in rats,,BAO_0000218,11488,
,,A,,Intermediate,1,,50597,CHEMBL630462,,14623,Rattus norvegicus,,10116.0,N,,1,,Cumulative dose excreted after intraduodenal administration at 6-8 hours in rats,,BAO_0000218,11488,
,,A,,Intermediate,1,,50597,CHEMBL630463,,14624,Rattus norvegicus,,10116.0,N,,1,,Cumulative dose excreted after intraduodenal administration at 8-24 hours in rats,,BAO_0000218,11488,
,,A,,Intermediate,1,,50597,CHEMBL630464,,14625,Rattus norvegicus,,10116.0,N,,1,,Cumulative dose excreted after intravenous administration at 0-0.5 hours in rats,,BAO_0000218,11488,
,,A,,Intermediate,1,,50597,CHEMBL630465,,14626,Rattus norvegicus,,10116.0,N,,1,,Cumulative dose excreted after intravenous administration at 0.5-1 hours in rats,,BAO_0000218,11488,
,,A,,Intermediate,1,,50597,CHEMBL630466,,14627,Rattus norvegicus,,10116.0,N,,1,,Cumulative dose excreted after intravenous administration at 1.0-1.5 hours in rats,,BAO_0000218,11488,
,,A,,Intermediate,1,,50597,CHEMBL630467,,14628,Rattus norvegicus,,10116.0,N,,1,,Cumulative dose excreted after intravenous administration at 1.5-2 hours in rats,,BAO_0000218,11488,
,,A,,Intermediate,1,,50597,CHEMBL630633,,14629,Rattus norvegicus,,10116.0,N,,1,,Cumulative dose excreted after intravenous administration at 2-3 hours in rats,,BAO_0000218,11488,
,,A,,Intermediate,1,,50597,CHEMBL630634,,14630,Rattus norvegicus,,10116.0,N,,1,,Cumulative dose excreted after intravenous administration at 3-4 hours in rats,,BAO_0000218,11488,
,,A,,Intermediate,1,,50597,CHEMBL630635,,14631,Rattus norvegicus,,10116.0,N,,1,,Cumulative dose excreted after intravenous administration at 4-6 hours in rats,,BAO_0000218,11488,
,,A,,Intermediate,1,,50597,CHEMBL630636,,14632,Rattus norvegicus,,10116.0,N,,1,,Cumulative dose excreted after intravenous administration at 6-8 hours in rats,,BAO_0000218,11488,
,,A,,Intermediate,1,,50597,CHEMBL630637,,14633,Rattus norvegicus,,10116.0,N,,1,,Cumulative dose excreted after intravenous administration at 8-24 hours in rats,,BAO_0000218,11488,
,,A,,Intermediate,1,,50592,CHEMBL630638,1988.0,14634,Oryctolagus cuniculus,,9986.0,N,Feces,1,,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",,BAO_0000218,7132,
,,A,,Intermediate,1,,50592,CHEMBL630639,1988.0,14635,Oryctolagus cuniculus,,9986.0,N,Feces,1,,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",,BAO_0000218,7132,
,,A,,Intermediate,1,,50592,CHEMBL630640,1988.0,14636,Oryctolagus cuniculus,,9986.0,N,Feces,1,,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",,BAO_0000218,7132,
,,A,,Intermediate,1,,50592,CHEMBL876551,1988.0,14637,Oryctolagus cuniculus,,9986.0,N,Feces,1,,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",,BAO_0000218,7132,
,,A,,Intermediate,1,,50592,CHEMBL630641,1088.0,14638,Oryctolagus cuniculus,,9986.0,N,Urine,1,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated (total)",,BAO_0000218,7132,
,,A,,Intermediate,1,,50592,CHEMBL630642,1088.0,14639,Oryctolagus cuniculus,,9986.0,N,Urine,1,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",,BAO_0000218,7132,
,,A,,Intermediate,1,,50592,CHEMBL630643,1088.0,14640,Oryctolagus cuniculus,,9986.0,N,Urine,1,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",,BAO_0000218,7132,
,,A,,Intermediate,1,,50592,CHEMBL630644,1088.0,14641,Oryctolagus cuniculus,,9986.0,N,Urine,1,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",,BAO_0000218,7132,
,,A,,Intermediate,1,,50592,CHEMBL630645,1088.0,14642,Oryctolagus cuniculus,,9986.0,N,Urine,1,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",,BAO_0000218,7132,
,,A,,Intermediate,1,,50592,CHEMBL625599,1988.0,14643,Oryctolagus cuniculus,,9986.0,N,Feces,1,,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",,BAO_0000218,7132,
,,A,,Intermediate,1,,50592,CHEMBL625600,1988.0,14644,Oryctolagus cuniculus,,9986.0,N,Feces,1,,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",,BAO_0000218,7132,
,,A,,Intermediate,1,,50592,CHEMBL625601,1988.0,14645,Oryctolagus cuniculus,,9986.0,N,Feces,1,,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",,BAO_0000218,7132,
,,A,,Intermediate,1,,50592,CHEMBL625602,1988.0,14646,Oryctolagus cuniculus,,9986.0,N,Feces,1,,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",,BAO_0000218,7132,
,,A,,Intermediate,1,,50592,CHEMBL627470,1088.0,14647,Oryctolagus cuniculus,,9986.0,N,Urine,1,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated (total)",,BAO_0000218,7132,
,,A,,Intermediate,1,,50592,CHEMBL627471,1088.0,14648,Oryctolagus cuniculus,,9986.0,N,Urine,1,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",,BAO_0000218,7132,
,,A,,Intermediate,1,,50592,CHEMBL627472,1088.0,14649,Oryctolagus cuniculus,,9986.0,N,Urine,1,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",,BAO_0000218,7132,
,,A,,Intermediate,1,,50592,CHEMBL627473,1088.0,14650,Oryctolagus cuniculus,,9986.0,N,Urine,1,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",,BAO_0000218,7132,
,,A,,Intermediate,1,,50592,CHEMBL627474,1088.0,14651,Oryctolagus cuniculus,,9986.0,N,Urine,1,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",,BAO_0000218,7132,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627475,178.0,14652,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution in rat blood post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,BAO_0000218,13925,
In vivo,,A,,Intermediate,1,,50597,CHEMBL627476,178.0,14653,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution in rat blood post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,BAO_0000218,13925,
,,A,,Intermediate,1,,50588,CHEMBL627477,1088.0,14654,Canis lupus familiaris,,9615.0,N,Urine,1,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50588,CHEMBL627478,1088.0,14655,Canis lupus familiaris,,9615.0,N,Urine,1,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50588,CHEMBL627479,1088.0,14656,Canis lupus familiaris,,9615.0,N,Urine,1,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50588,CHEMBL627480,1088.0,14657,Canis lupus familiaris,,9615.0,N,Urine,1,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50588,CHEMBL627481,1088.0,14658,Canis lupus familiaris,,9615.0,N,Urine,1,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50588,CHEMBL627482,1088.0,14659,Canis lupus familiaris,,9615.0,N,Urine,1,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50588,CHEMBL627483,1088.0,14660,Canis lupus familiaris,,9615.0,N,Urine,1,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50588,CHEMBL875636,1088.0,14661,Canis lupus familiaris,,9615.0,N,Urine,1,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50588,CHEMBL625764,1088.0,14662,Canis lupus familiaris,,9615.0,N,Urine,1,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50588,CHEMBL625765,1088.0,14663,Canis lupus familiaris,,9615.0,N,Urine,1,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50588,CHEMBL625766,1088.0,14664,Canis lupus familiaris,,9615.0,N,Urine,1,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 102 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50588,CHEMBL625767,1088.0,14665,Canis lupus familiaris,,9615.0,N,Urine,1,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50588,CHEMBL625768,1088.0,14666,Canis lupus familiaris,,9615.0,N,Urine,1,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50588,CHEMBL625769,1088.0,14667,Canis lupus familiaris,,9615.0,N,Urine,1,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 34.1 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50588,CHEMBL625770,1088.0,14668,Canis lupus familiaris,,9615.0,N,Urine,1,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 50.8 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50588,CHEMBL625771,1088.0,14669,Canis lupus familiaris,,9615.0,N,Urine,1,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 68.1 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50588,CHEMBL625772,1088.0,14670,Canis lupus familiaris,,9615.0,N,Urine,1,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.060 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50588,CHEMBL625773,1088.0,14671,Canis lupus familiaris,,9615.0,N,Urine,1,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL625774,1088.0,14672,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of sodium in urine of rats after intravenous administration of 7.94 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL625775,1088.0,14673,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 0 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL625776,1088.0,14674,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.01 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL625777,1088.0,14675,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.13 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL625778,1088.0,14676,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 10.1 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL625779,1088.0,14677,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 102 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL625780,1088.0,14678,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 105 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL625781,1088.0,14679,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 11.3 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL875637,1088.0,14680,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 113 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL626473,1088.0,14681,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 19.5 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL626474,1088.0,14682,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 195 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL626475,1088.0,14683,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 21.7 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL626476,1088.0,14684,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 217 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL634397,1088.0,14685,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 23.9 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL626477,1088.0,14686,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 239 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL631069,1088.0,14687,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 24.9 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL631070,1088.0,14688,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 249 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL631071,1088.0,14689,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 25.9 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL631072,1088.0,14690,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 259 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL631073,1088.0,14691,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 26.5 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL631074,1088.0,14692,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 265 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL631075,1088.0,14693,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL631725,1088.0,14694,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27.9 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL631726,1088.0,14695,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 270 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL631727,1088.0,14696,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 279 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL631728,1088.0,14697,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.2 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL631729,1088.0,14698,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.9 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL631730,1088.0,14699,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 282 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL631731,1088.0,14700,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 289 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL631910,1088.0,14701,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.40 uM/Kg of drug,,BAO_0000218,12582,
In vivo,,A,,Intermediate,1,,50597,CHEMBL631911,10000000.0,14702,Rattus norvegicus,,10116.0,N,Hippocampus,1,,Biodistribution of the [18F]-radiolabeled compound in rat hippocampus,,BAO_0000218,15413,
In vivo,,A,,Intermediate,1,,50597,CHEMBL631912,1898.0,14703,Rattus norvegicus,,10116.0,N,Hypothalamus,1,,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus,,BAO_0000218,15413,
In vivo,,A,,Intermediate,1,,50597,CHEMBL631913,1898.0,14704,Rattus norvegicus,,10116.0,N,Hypothalamus,1,,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus; Not determined,,BAO_0000218,15413,
In vivo,,A,,Intermediate,1,,50597,CHEMBL631914,178.0,14705,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL631915,178.0,14706,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL875778,178.0,14707,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL631916,178.0,14708,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL631917,178.0,14709,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL631918,178.0,14710,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution in blood of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL631919,178.0,14711,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL631920,178.0,14712,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL631921,178.0,14713,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution in blood of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL631922,178.0,14714,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution in blood of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL631923,178.0,14715,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution in blood of immature femalee rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL631924,,14716,Rattus norvegicus,,10116.0,N,,1,,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL630234,,14717,Rattus norvegicus,,10116.0,N,,1,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL630235,,14718,Rattus norvegicus,,10116.0,N,,1,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL630236,,14719,Rattus norvegicus,,10116.0,N,,1,,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL630237,,14720,Rattus norvegicus,,10116.0,N,,1,,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL630238,,14721,Rattus norvegicus,,10116.0,N,,1,,Biodistribution in fat of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL630239,,14722,Rattus norvegicus,,10116.0,N,,1,,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL630303,,14723,Rattus norvegicus,,10116.0,N,,1,,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL630304,,14724,Rattus norvegicus,,10116.0,N,,1,,Biodistribution in fat of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL630305,,14725,Rattus norvegicus,,10116.0,N,,1,,Biodistribution in fat of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL630306,2113.0,14726,Rattus norvegicus,,10116.0,N,Kidney,1,,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL630307,2113.0,14727,Rattus norvegicus,,10116.0,N,Kidney,1,,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL630308,2113.0,14728,Rattus norvegicus,,10116.0,N,Kidney,1,,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL630309,2113.0,14729,Rattus norvegicus,,10116.0,N,Kidney,1,,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL629309,2113.0,14730,Rattus norvegicus,,10116.0,N,Kidney,1,,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL629993,2113.0,14731,Rattus norvegicus,,10116.0,N,Kidney,1,,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL629994,2113.0,14732,Rattus norvegicus,,10116.0,N,Kidney,1,,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL629995,2113.0,14733,Rattus norvegicus,,10116.0,N,Kidney,1,,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL631993,2113.0,14734,Rattus norvegicus,,10116.0,N,Kidney,1,,Biodistribution in kidney of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL631994,2113.0,14735,Rattus norvegicus,,10116.0,N,Kidney,1,,Biodistribution in kidney of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL631995,2113.0,14736,Rattus norvegicus,,10116.0,N,Kidney,1,,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL631996,2107.0,14737,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution in liver of Iimmature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL631997,2107.0,14738,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution in liver of Iimmature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL631998,2107.0,14739,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL631999,2107.0,14740,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL632000,2107.0,14741,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL632001,2107.0,14742,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL874424,2107.0,14743,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL632002,2107.0,14744,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution in liver of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL632003,2107.0,14745,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
,,A,,Autocuration,0,,22224,CHEMBL632004,,14746,,,,U,,1,,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,,BAO_0000019,3133,
,,A,,Autocuration,0,,22224,CHEMBL632005,,14747,,,,U,,1,,Compound was tested for amidase rate in the presence of N62C fully characterised enzyme,,BAO_0000019,2742,
,,A,,Autocuration,0,,22224,CHEMBL632006,,14748,,,,U,,1,,Compound was tested for amidase rate in the presence of N62C screen enzyme,,BAO_0000019,2742,
,,A,,Autocuration,0,,22224,CHEMBL632007,,14749,,,,U,,1,,Compound was tested for amidase rate in the presence of S166C fully characterised enzyme,,BAO_0000019,2742,
,,A,,Autocuration,0,,22224,CHEMBL632008,,14750,,,,U,,1,,Compound was tested for amidase rate in the presence of S166C screen enzyme,,BAO_0000019,2742,
,,A,,Autocuration,0,,22224,CHEMBL632009,,14751,,,,U,,1,,Compound was tested for esterase rate in the presence of N62C fully characterised enzyme,,BAO_0000019,2742,
,,A,,Autocuration,0,,22224,CHEMBL632010,,14752,,,,U,,1,,Compound was tested for esterase rate in the presence of N62C screen enzyme,,BAO_0000019,2742,
,,A,,Autocuration,0,,22224,CHEMBL857750,,14753,,,,U,,1,,Compound was tested for esterase rate in the presence of S166C fully characterised enzyme,,BAO_0000019,2742,
,,A,,Autocuration,0,,22224,CHEMBL632011,,14754,,,,U,,1,,Compound was tested for esterase rate in the presence of S166C screen enzyme,,BAO_0000019,2742,
,,A,,Autocuration,0,,22224,CHEMBL632012,,14755,,,,U,,1,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,BAO_0000019,2276,
,,A,,Autocuration,0,,22224,CHEMBL632013,,14756,,,,U,,1,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,BAO_0000019,2276,
,,A,,Autocuration,0,,22224,CHEMBL632014,,14757,,,,U,,1,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat/KM",,BAO_0000019,2276,
,,A,,Autocuration,0,,22224,CHEMBL629622,,14758,,,,U,,1,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,BAO_0000019,2276,
,,A,,Autocuration,0,,22224,CHEMBL629623,,14759,,,,U,,1,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,BAO_0000019,2276,
,,A,,Autocuration,0,,22224,CHEMBL629624,,14760,,,,U,,1,,"Rate constant at 30 degree C in phosphate buffer pH 7.1, 0.5 % acetonitrile was expressed as Kcat/KM",,BAO_0000019,2276,
,,A,,Autocuration,0,,22224,CHEMBL629625,,14761,,,,U,,1,,Ratio of Kcat to that of Km was determined,,BAO_0000019,17269,
,,A,,Autocuration,0,,22224,CHEMBL629626,,14762,,,,U,,1,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",,BAO_0000019,2276,
,,A,,Autocuration,0,,22224,CHEMBL629627,,14763,,,,U,,1,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",,BAO_0000019,2276,
,,A,,Autocuration,0,,22224,CHEMBL629628,,14764,,,,U,,1,,"Compound was evaluated for constant, Kd",,BAO_0000019,15917,
,,A,,Autocuration,0,,22224,CHEMBL629629,,14765,,,,U,,1,,Deacylation rate constant(Kd fast) was determined by proflavin displacement assay,,BAO_0000019,10933,
,,A,,Autocuration,0,,22224,CHEMBL629630,,14766,,,,U,,1,,Deacylation rate constant(Kd slow) was determined by proflavin displacement assay,,BAO_0000019,10933,
,,A,,Autocuration,0,,22224,CHEMBL856030,,14767,,,,U,,1,,Dissociation Constant of compound determined,,BAO_0000019,14293,
,,B,,Autocuration,0,,22224,CHEMBL629631,,14768,,,,U,,1,,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined,,BAO_0000019,6698,
,,B,,Autocuration,0,,22224,CHEMBL629632,,14769,,,,U,,1,,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined; No data,,BAO_0000019,6698,
,,P,,Autocuration,0,,22224,CHEMBL629633,,14770,,,,U,,1,,Dissociation constant of compound with Fructose was determined,,BAO_0000100,4318,
,,P,,Autocuration,0,,22224,CHEMBL629634,,14771,,,,U,,1,,Dissociation constant of compound with Fructose was determined; Not determined,,BAO_0000100,4318,
,,P,,Autocuration,0,,22224,CHEMBL629635,,14772,,,,U,,1,,Dissociation constant of compound with Lactulose was determined,,BAO_0000100,4318,
,,P,,Autocuration,0,,22224,CHEMBL629636,,14773,,,,U,,1,,Dissociation constant of compound with Lactulose was determined; Not determined,,BAO_0000100,4318,
,,P,,Autocuration,0,,22224,CHEMBL629637,,14774,,,,U,,1,,Dissociation constant of the Compound,,BAO_0000100,14959,
,,P,,Autocuration,0,,22224,CHEMBL629638,,14775,,,,U,,1,,Dissociation constant by non-linear regression analysis,,BAO_0000100,5913,
,,P,,Autocuration,0,,22224,CHEMBL629639,,14776,,,,U,,1,,Dissociation constant was determined,,BAO_0000100,14218,
,,P,,Autocuration,0,,22224,CHEMBL629640,,14777,,,,U,,1,,Dissociation constant of the compound; value ranges from 0.81-1.2 nM,,BAO_0000100,10689,
,,P,,Autocuration,0,,22224,CHEMBL629641,,14778,,,,U,,1,,Dissociation constant was determined,,BAO_0000100,13925,
,,P,,Autocuration,0,,22224,CHEMBL631344,,14779,,,,U,,1,,Dissociation constant was determined,,BAO_0000100,16359,
,,A,,Intermediate,1,,50597,CHEMBL631345,2385.0,14780,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Equilibrium dissociation constant based on membrane concentration in rat smooth muscle,,BAO_0000218,10944,
,,A,,Autocuration,0,,22224,CHEMBL631346,,14781,,,,U,,1,,The dissociation constant determined by fluorescence displacement assay,,BAO_0000019,11080,
,,A,,Autocuration,0,,22224,CHEMBL631524,,14782,,,,U,,1,,kd value surface plasmon resonance (SPR) method,,BAO_0000019,17805,
,,A,,Intermediate,1,,50597,CHEMBL631525,2385.0,14783,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Equilibrium dissociation constant based on aqueous concentration in rat smooth muscle,,BAO_0000218,10944,
,,F,,Autocuration,0,,22224,CHEMBL631526,,14784,,,,U,,1,,First dissociation constant of the binding of compound to V30M TTR,,BAO_0000019,16645,
,,F,,Autocuration,0,,22224,CHEMBL631527,,14785,,,,U,,1,,Second dissociation constant of the binding of compound to V30M TTR,,BAO_0000019,16645,
,,A,,Autocuration,0,,22224,CHEMBL631528,,14786,,,,U,,1,,"Compound was evaluated for equilibrium constant, Ke",,BAO_0000019,7793,
,,A,,Autocuration,0,,22224,CHEMBL631529,1898.0,14787,,,,U,Hypothalamus,1,,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus,,BAO_0000019,12199,
,,A,,Autocuration,0,,22224,CHEMBL631530,1898.0,14788,,,,U,Hypothalamus,1,,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus; inactive,,BAO_0000019,12199,
,,A,,Autocuration,0,,22224,CHEMBL631531,,14789,,,,U,,1,,Keff is the effective biomolecular rate constant on VX for reactivation at pH 7.8 at 25 degree Centigrade,,BAO_0000019,9680,
,,A,,Autocuration,0,,22224,CHEMBL631532,,14790,,,,U,,1,,Keff is the effective biomolecular rate constant on paraxon for reactivation at pH 7.8 at 25 degree Centigrade,,BAO_0000019,9680,
,,A,,Autocuration,0,,22224,CHEMBL631533,,14791,,,,U,,1,,Keff is the effective biomolecular rate constant on sarin for reactivation at pH 7.8 at 25 degree Centigrade,,BAO_0000019,9680,
,,A,,Intermediate,1,,50594,CHEMBL876552,,14792,Mus musculus,,10090.0,N,,1,,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,BAO_0000218,13758,
,,A,,Intermediate,1,,50594,CHEMBL631534,,14793,Mus musculus,,10090.0,N,,1,,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,,BAO_0000218,13758,
,,A,,Intermediate,1,,50594,CHEMBL631535,,14794,Mus musculus,,10090.0,N,,1,,In vitro biotransformation of compound in mice brain homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,BAO_0000218,13758,
,,A,,Intermediate,1,,50594,CHEMBL631536,,14795,Mus musculus,,10090.0,N,,1,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,BAO_0000218,13758,
,,A,,Intermediate,1,,50594,CHEMBL631537,,14796,Mus musculus,,10090.0,N,,1,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-hypoxanthine(ara-H) analyte,,BAO_0000218,13758,
,,A,,Intermediate,1,,50594,CHEMBL631538,,14797,Mus musculus,,10090.0,N,,1,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,,BAO_0000218,13758,
,,A,,Intermediate,1,,50594,CHEMBL631539,,14798,Mus musculus,,10090.0,N,,1,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-H) analyte,,BAO_0000218,13758,
,,A,,Intermediate,1,,50594,CHEMBL631540,,14799,Mus musculus,,10090.0,N,,1,,In vitro biotransformation of compound in mice serum 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,BAO_0000218,13758,
,,A,,Intermediate,1,,50597,CHEMBL625637,,14800,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic Parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,BAO_0000218,14393,
,,A,,Intermediate,1,,50597,CHEMBL625638,,14801,Rattus norvegicus,,10116.0,N,,1,,Pharmacokinetic parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,BAO_0000218,14393,
,,A,,Intermediate,1,,50597,CHEMBL625639,,14802,Rattus norvegicus,,10116.0,N,,1,,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",,BAO_0000218,15078,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625640,955.0,14803,Rattus norvegicus,,10116.0,N,Brain,1,,Biodistribution in rat brain post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,BAO_0000218,13925,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625641,955.0,14804,Rattus norvegicus,,10116.0,N,Brain,1,,Biodistribution in rat brain post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,BAO_0000218,13925,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625642,948.0,14805,Rattus norvegicus,,10116.0,N,Heart,1,,Biodistribution in rat heart post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,BAO_0000218,13925,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625643,948.0,14806,Rattus norvegicus,,10116.0,N,Heart,1,,Biodistribution in rat heart post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,BAO_0000218,13925,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625644,2113.0,14807,Rattus norvegicus,,10116.0,N,Kidney,1,,Biodistribution in rat kidney post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,BAO_0000218,13925,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625645,2113.0,14808,Rattus norvegicus,,10116.0,N,Kidney,1,,Biodistribution in rat kidney post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,BAO_0000218,13925,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625646,2107.0,14809,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution in rat liver post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,BAO_0000218,13925,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625647,2107.0,14810,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution in rat liver post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,BAO_0000218,13925,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625648,2048.0,14811,Rattus norvegicus,,10116.0,N,Lung,1,,Biodistribution in rat lung post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,BAO_0000218,13925,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625649,2048.0,14812,Rattus norvegicus,,10116.0,N,Lung,1,,Biodistribution in rat lung post intravenous injection for 60 min of [99mTc]-TRODAT ligand expressed as percent dose per organ,,BAO_0000218,13925,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625650,2385.0,14813,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Biodistribution in rat muscle post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,BAO_0000218,13925,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625651,2385.0,14814,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Biodistribution in rat muscle post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,BAO_0000218,13925,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625652,14.0,14815,Rattus norvegicus,,10116.0,N,Zone of skin,1,,Biodistribution in rat skin post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,BAO_0000218,13925,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625653,14.0,14816,Rattus norvegicus,,10116.0,N,Zone of skin,1,,Biodistribution in rat skin post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,BAO_0000218,13925,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625654,2106.0,14817,Rattus norvegicus,,10116.0,N,Spleen,1,,Biodistribution in rat spleen post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,BAO_0000218,13925,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625655,2106.0,14818,Rattus norvegicus,,10116.0,N,Spleen,1,,Biodistribution in rat spleen post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,BAO_0000218,13925,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625656,178.0,14819,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution of Compound in rat blood after 15 minutes of administration,,BAO_0000218,9712,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625657,178.0,14820,Rattus norvegicus,,10116.0,N,Blood,1,,Biodistribution of Compound in rat blood after 2 minutes of administration,,BAO_0000218,9712,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625658,955.0,14821,Rattus norvegicus,,10116.0,N,Brain,1,,Biodistribution of Compound in rat brain after 15 minutes of administration,,BAO_0000218,9712,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625659,955.0,14822,Rattus norvegicus,,10116.0,N,Brain,1,,Biodistribution of Compound in rat brain after 2 minutes of administration,,BAO_0000218,9712,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625660,948.0,14823,Rattus norvegicus,,10116.0,N,Heart,1,,Biodistribution of Compound in rat heart after 15 minutes of administration,,BAO_0000218,9712,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625661,948.0,14824,Rattus norvegicus,,10116.0,N,Heart,1,,Biodistribution of Compound in rat heart after 2 minutes of administration,,BAO_0000218,9712,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625662,2107.0,14825,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution of Compound in rat liver after 15 minutes of administration,,BAO_0000218,9712,
In vivo,,A,,Intermediate,1,,50597,CHEMBL625663,2107.0,14826,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution of Compound in rat liver after 2 minutes of administration,,BAO_0000218,9712,
In vivo,,A,,Intermediate,1,,50597,CHEMBL875621,2048.0,14827,Rattus norvegicus,,10116.0,N,Lung,1,,Biodistribution of Compound in rat lung after 15 minutes of administration,,BAO_0000218,9712,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628382,2048.0,14828,Rattus norvegicus,,10116.0,N,Lung,1,,Biodistribution of Compound in rat lung after 2 minutes of administration,,BAO_0000218,9712,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628383,2385.0,14829,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Biodistribution of Compound in rat muscle after 15 minutes of administration,,BAO_0000218,9712,
In vivo,,A,,Intermediate,1,,50597,CHEMBL628384,2385.0,14830,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Biodistribution of Compound in rat muscle after 2 minutes of administration,,BAO_0000218,9712,
,,A,,Intermediate,1,,50597,CHEMBL628385,,14831,Rattus norvegicus,,10116.0,N,,1,,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 2 mins,,BAO_0000218,13925,
,,A,,Intermediate,1,,50597,CHEMBL875753,,14832,Rattus norvegicus,,10116.0,N,,1,,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 30 mins,,BAO_0000218,13925,
,,A,,Intermediate,1,,50597,CHEMBL628386,,14833,Rattus norvegicus,,10116.0,N,,1,,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 60 mins,,BAO_0000218,13925,
,,A,,Intermediate,1,,50597,CHEMBL628387,,14834,Rattus norvegicus,,10116.0,N,,1,,Organ distribution in rat blood 2 minutes after intravenous injection,,BAO_0000218,6941,
,,A,,Intermediate,1,,50597,CHEMBL628388,,14835,Rattus norvegicus,,10116.0,N,,1,,Organ distribution in rat blood 2 hr after intravenous injection,,BAO_0000218,6941,
,,A,,Intermediate,1,,50597,CHEMBL628389,,14836,Rattus norvegicus,,10116.0,N,,1,,Organ distribution in rat blood 30 minutes after intravenous injection,,BAO_0000218,6941,
,,A,,Intermediate,1,,50597,CHEMBL632756,,14837,Rattus norvegicus,,10116.0,N,,1,,Organ distribution in rat blood 30 min after intravenous injection,,BAO_0000218,6941,
,,A,,Intermediate,1,,50597,CHEMBL628390,,14838,Rattus norvegicus,,10116.0,N,,1,,Organ distribution in rat brain 2 minutes after intravenous injection,,BAO_0000218,6941,
,,A,,Intermediate,1,,50597,CHEMBL631811,,14839,Rattus norvegicus,,10116.0,N,,1,,Organ distribution in rat brain 2 hr after intravenous injection,,BAO_0000218,6941,
,,A,,Intermediate,1,,50597,CHEMBL631812,,14840,Rattus norvegicus,,10116.0,N,,1,,Organ distribution in rat brain 30 minutes after intravenous injection,,BAO_0000218,6941,
,,A,,Intermediate,1,,50597,CHEMBL631813,,14841,Rattus norvegicus,,10116.0,N,,1,,Organ distribution in rat heart 2 minutes after intravenous injection,,BAO_0000218,6941,
,,A,,Intermediate,1,,50597,CHEMBL631814,,14842,Rattus norvegicus,,10116.0,N,,1,,Organ distribution in rat heart 2 hr after intravenous injection,,BAO_0000218,6941,
,,A,,Intermediate,1,,50597,CHEMBL631815,,14843,Rattus norvegicus,,10116.0,N,,1,,Organ distribution in rat heart 30 minutes after intravenous injection,,BAO_0000218,6941,
,,A,,Intermediate,1,,50597,CHEMBL631816,,14844,Rattus norvegicus,,10116.0,N,,1,,Organ distribution in rat kidney 2 minutes after intravenous injection,,BAO_0000218,6941,
,,A,,Intermediate,1,,50597,CHEMBL875758,,14845,Rattus norvegicus,,10116.0,N,,1,,Organ distribution in rat kidney 2 hr after intravenous injection,,BAO_0000218,6941,
,,A,,Intermediate,1,,50597,CHEMBL631817,,14846,Rattus norvegicus,,10116.0,N,,1,,Organ distribution in rat kidney 30 minutes after intravenous injection,,BAO_0000218,6941,
,,A,,Intermediate,1,,50597,CHEMBL631818,2107.0,14847,Rattus norvegicus,,10116.0,N,Liver,1,,Organ distribution in rat liver 2 minutes after intravenous injection,,BAO_0000218,6941,
,,A,,Intermediate,1,,50597,CHEMBL631819,2107.0,14848,Rattus norvegicus,,10116.0,N,Liver,1,,Organ distribution in rat liver 2 hr after intravenous injection,,BAO_0000218,6941,
,,A,,Intermediate,1,,50597,CHEMBL631820,2107.0,14849,Rattus norvegicus,,10116.0,N,Liver,1,,Organ distribution in rat liver 30 minutes after intravenous injection,,BAO_0000218,6941,
,,A,,Intermediate,1,,50597,CHEMBL631821,,14850,Rattus norvegicus,,10116.0,N,,1,,Organ distribution in rat lung 2 minutes after intravenous injection,,BAO_0000218,6941,
,,A,,Intermediate,1,,50597,CHEMBL631822,,14851,Rattus norvegicus,,10116.0,N,,1,,Organ distribution in rat lung 2 hr after intravenous injection,,BAO_0000218,6941,
,,A,,Intermediate,1,,50597,CHEMBL631823,,14852,Rattus norvegicus,,10116.0,N,,1,,Organ distribution in rat lung 30 minutes after intravenous injection,,BAO_0000218,6941,
,,A,,Intermediate,1,,50597,CHEMBL631824,2385.0,14853,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Organ distribution in rat muscle 2 minutes after intravenous injection,,BAO_0000218,6941,
,,A,,Intermediate,1,,50597,CHEMBL631825,2385.0,14854,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Organ distribution in rat muscle 2 hr after intravenous injection,,BAO_0000218,6941,
,,A,,Intermediate,1,,50597,CHEMBL631826,2385.0,14855,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Organ distribution in rat muscle 30 minutes after intravenous injection,,BAO_0000218,6941,
In vivo,,A,,Intermediate,1,,50594,CHEMBL631827,,14856,Mus musculus,,10090.0,N,,1,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Blood (B),,BAO_0000218,14439,
In vivo,,A,,Intermediate,1,,50594,CHEMBL631828,,14857,Mus musculus,,10090.0,N,,1,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Heart (H),,BAO_0000218,14439,
In vivo,,A,,Intermediate,1,,50594,CHEMBL631829,,14858,Mus musculus,,10090.0,N,,1,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Lung (L),,BAO_0000218,14439,
,,A,,Intermediate,1,,50597,CHEMBL875759,1088.0,14859,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.76 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL631830,1088.0,14860,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 30.20 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL631831,1088.0,14861,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 302 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL631832,1088.0,14862,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 31.6 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL631833,1088.0,14863,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 316 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL631834,1088.0,14864,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 32.4 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL631835,1088.0,14865,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 324 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL631836,1088.0,14866,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.0 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL631837,1088.0,14867,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.1 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL631838,1088.0,14868,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.8 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL631839,1088.0,14869,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 341 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL631840,1088.0,14870,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 348 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL631841,1088.0,14871,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 37.6 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL631842,1088.0,14872,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 58.4 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL631843,1088.0,14873,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 65.2 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL631844,1088.0,14874,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.6 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL631845,1088.0,14875,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.8 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL631846,1088.0,14876,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 74.8 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL875760,1088.0,14877,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 77.5 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL632199,1088.0,14878,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 79.4 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL631847,1088.0,14879,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 80.9 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL631848,1088.0,14880,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 83.8 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL628707,1088.0,14881,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.5 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL628708,1088.0,14882,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.7 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL628709,1088.0,14883,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.7 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL628710,1088.0,14884,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.9 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL628711,1088.0,14885,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 9.06 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL628712,1088.0,14886,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 90.6 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL628713,1088.0,14887,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 94.9 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL628714,1088.0,14888,Rattus norvegicus,,10116.0,N,Urine,1,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 97.1 uM/Kg of drug,,BAO_0000218,12582,
,,A,,Intermediate,1,,50597,CHEMBL628715,,14889,Rattus norvegicus,,10116.0,N,,1,,"excretion rate in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour Rate of biliary excretion; 0.06-0.15%/h",,BAO_0000218,7415,
,,A,,Autocuration,0,,22224,CHEMBL629179,,14890,,,,U,,1,,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 3.75-120 uM,,BAO_0000019,7313,
,,A,,Autocuration,0,,22224,CHEMBL629180,,14891,,,,U,,1,,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 30 uM,,BAO_0000019,7313,
,,A,,Autocuration,0,,22224,CHEMBL875108,,14892,,,,U,,1,,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 7.5-120 uM,,BAO_0000019,7313,
,,A,,Autocuration,0,,22224,CHEMBL629181,1235.0,14893,,,,U,Adrenal cortex,1,,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,,BAO_0000019,7570,
,,A,,Autocuration,0,,22224,CHEMBL629182,1235.0,14894,,,,U,Adrenal cortex,1,,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,,BAO_0000019,7570,
,,A,,Autocuration,0,,22224,CHEMBL629183,,14895,,,,U,,1,,Percent lipid extracted at 0.5 hr from liver plasma using CHCl3/CH3OH.,,BAO_0000019,7570,
,,A,,Autocuration,0,,22224,CHEMBL629184,,14896,,,,U,,1,,Percent lipid extracted at 0.5 hr from liver using CHCl3/CH3OH.,,BAO_0000019,7570,
,,A,,Autocuration,0,,22224,CHEMBL629185,1235.0,14897,,,,U,Adrenal cortex,1,,Percent lipid extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,,BAO_0000019,7570,
,,A,,Autocuration,0,,22224,CHEMBL629186,1235.0,14898,,,,U,Adrenal cortex,1,,Percent lipid extracted at 24 hours from adrenal cortex liver using CHCl3/CH3OH.,,BAO_0000019,7570,
,,A,,Autocuration,0,,22224,CHEMBL629187,,14899,,,,U,,1,,Percent lipid extracted at 24 hours from liverliver using CHCl3/CH3OH.,,BAO_0000019,7570,
,,A,,Autocuration,0,,22224,CHEMBL629887,,14900,,,,U,,1,,Percent lipid extracted at 24 hours from plasma using CHCl3/CH3OH.,,BAO_0000019,7570,
,,A,,Autocuration,0,,22224,CHEMBL629888,,14901,,,,U,,1,,Percent lipid extracted at 24 hours from plasmaliver using CHCl3/CH3OH.,,BAO_0000019,7570,
,,A,,Autocuration,0,,22224,CHEMBL629889,,14902,,,,U,,1,,Percent lipid extracted at 24 hr from liver using CHCl3/CH3OH.,,BAO_0000019,7570,
,,A,,Autocuration,0,,22224,CHEMBL629890,1235.0,14903,,,,U,Adrenal cortex,1,,Percent parent compound extracted at 0.5 hr from adrenal cortex using CHCl3/CH3OH.,,BAO_0000019,7570,
,,A,,Autocuration,0,,22224,CHEMBL629891,,14904,,,,U,,1,,Percent parent compound extracted at 0.5 hr from liver using CHCl3/CH3OH.,,BAO_0000019,7570,
,,A,,Autocuration,0,,22224,CHEMBL629892,,14905,,,,U,,1,,Percent parent compound extracted at 0.5 hr from plasma using CHCl3/CH3OH.,,BAO_0000019,7570,
,,A,,Autocuration,0,,22224,CHEMBL629893,1235.0,14906,,,,U,Adrenal cortex,1,,Percent parent compound extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,,BAO_0000019,7570,
,,A,,Autocuration,0,,22224,CHEMBL629894,,14907,,,,U,,1,,Percent parent compound extracted at 24 hours from liver using CHCl3/CH3OH.,,BAO_0000019,7570,
,,A,,Autocuration,0,,22224,CHEMBL629895,,14908,,,,U,,1,,Percent parent compound extracted at 24 hours from plasma using CHCl3/CH3OH.,,BAO_0000019,7570,
In vivo,,A,,Autocuration,0,,22224,CHEMBL875109,,14909,Canis lupus familiaris,,9615.0,U,,1,,"+Ratio of intravenous to oral integrated area under the concentration vs time curve, for compound in dog plasma",,BAO_0000218,14122,
In vivo,,A,,Autocuration,0,,22224,CHEMBL629896,,14910,Macaca fascicularis,,9541.0,U,,1,,Absolute bioavailability in male cynomolgus monkeys,,BAO_0000218,16449,
In vivo,,A,,Autocuration,0,,22224,CHEMBL629897,,14911,Rattus norvegicus,,10116.0,U,,1,,Absolute bioavailability in maleSprague-Dawley rats,,BAO_0000218,16449,
In vivo,,A,,Intermediate,1,,50597,CHEMBL629898,2107.0,14912,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL630057,2107.0,14913,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution in liver of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL630058,2107.0,14914,Rattus norvegicus,,10116.0,N,Liver,1,,Biodistribution in liver of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL630059,2048.0,14915,Rattus norvegicus,,10116.0,N,Lung,1,,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL630060,2048.0,14916,Rattus norvegicus,,10116.0,N,Lung,1,,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL630061,2048.0,14917,Rattus norvegicus,,10116.0,N,Lung,1,,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL630062,2048.0,14918,Rattus norvegicus,,10116.0,N,Lung,1,,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL630063,2048.0,14919,Rattus norvegicus,,10116.0,N,Lung,1,,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL630064,2048.0,14920,Rattus norvegicus,,10116.0,N,Lung,1,,Biodistribution in lungs of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL630065,2048.0,14921,Rattus norvegicus,,10116.0,N,Lung,1,,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL630066,2048.0,14922,Rattus norvegicus,,10116.0,N,Lung,1,,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL630067,2048.0,14923,Rattus norvegicus,,10116.0,N,Lung,1,,Biodistribution in lungs of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL630068,2048.0,14924,Rattus norvegicus,,10116.0,N,Lung,1,,Biodistribution in lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL631113,2385.0,14925,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL631114,2385.0,14926,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL631115,2385.0,14927,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL631116,2385.0,14928,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL630528,2385.0,14929,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL630529,2385.0,14930,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Biodistribution in muscle of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL630530,2385.0,14931,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL630531,2385.0,14932,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL630532,2385.0,14933,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Biodistribution in muscle of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL630533,2385.0,14934,Rattus norvegicus,,10116.0,N,Muscle tissue,1,,Biodistribution in muscle of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50594,CHEMBL630534,178.0,14935,Mus musculus,,10090.0,N,Blood,1,,Biodistribution in normal mice blood after 120 hr,,BAO_0000218,15045,
In vivo,,A,,Intermediate,1,,50594,CHEMBL630535,178.0,14936,Mus musculus,,10090.0,N,Blood,1,,Biodistribution in normal mice blood after 24 hr,,BAO_0000218,15045,
In vivo,,A,,Intermediate,1,,50594,CHEMBL630536,178.0,14937,Mus musculus,,10090.0,N,Blood,1,,Biodistribution in normal mice blood after 4 hr,,BAO_0000218,15045,
In vivo,,A,,Intermediate,1,,50594,CHEMBL630537,10000001.0,14938,Mus musculus,,10090.0,N,Bone,1,,Biodistribution in normal mice bone after 120 hr,,BAO_0000218,15045,
In vivo,,A,,Intermediate,1,,50594,CHEMBL630538,10000001.0,14939,Mus musculus,,10090.0,N,Bone,1,,Biodistribution in normal mice bone after 24 hr,,BAO_0000218,15045,
In vivo,,A,,Intermediate,1,,50594,CHEMBL630539,10000001.0,14940,Mus musculus,,10090.0,N,Bone,1,,Biodistribution in normal mice bone after 4 hr,,BAO_0000218,15045,
In vivo,,A,,Intermediate,1,,50594,CHEMBL630540,948.0,14941,Mus musculus,,10090.0,N,Heart,1,,Biodistribution in normal mice heart after 120 hr,,BAO_0000218,15045,
In vivo,,A,,Intermediate,1,,50594,CHEMBL630541,948.0,14942,Mus musculus,,10090.0,N,Heart,1,,Biodistribution in normal mice heart after 24 hr,,BAO_0000218,15045,
In vivo,,A,,Intermediate,1,,50594,CHEMBL630542,948.0,14943,Mus musculus,,10090.0,N,Heart,1,,Biodistribution in normal mice heart after 4 hr,,BAO_0000218,15045,
In vivo,,A,,Intermediate,1,,50594,CHEMBL630543,2113.0,14944,Mus musculus,,10090.0,N,Kidney,1,,Biodistribution in normal mice kidney after 120 hr,,BAO_0000218,15045,
In vivo,,A,,Intermediate,1,,50594,CHEMBL630544,2113.0,14945,Mus musculus,,10090.0,N,Kidney,1,,Biodistribution in normal mice kidney after 24 hr,,BAO_0000218,15045,
In vivo,,A,,Intermediate,1,,50594,CHEMBL630545,2113.0,14946,Mus musculus,,10090.0,N,Kidney,1,,Biodistribution in normal mice kidney after 4 hr,,BAO_0000218,15045,
In vivo,,A,,Intermediate,1,,50594,CHEMBL630546,2107.0,14947,Mus musculus,,10090.0,N,Liver,1,,Biodistribution in normal mice liver after 120 hr,,BAO_0000218,15045,
In vivo,,A,,Intermediate,1,,50594,CHEMBL630547,2107.0,14948,Mus musculus,,10090.0,N,Liver,1,,Biodistribution in normal mice liver after 24 hr,,BAO_0000218,15045,
In vivo,,A,,Intermediate,1,,50594,CHEMBL630548,2107.0,14949,Mus musculus,,10090.0,N,Liver,1,,Biodistribution in normal mice liver after 4 hr,,BAO_0000218,15045,
In vivo,,A,,Intermediate,1,,50594,CHEMBL630549,2106.0,14950,Mus musculus,,10090.0,N,Spleen,1,,Biodistribution in normal mice spleen after 120 hr,,BAO_0000218,15045,
In vivo,,A,,Intermediate,1,,50594,CHEMBL630550,2106.0,14951,Mus musculus,,10090.0,N,Spleen,1,,Biodistribution in normal mice spleen after 24 hr,,BAO_0000218,15045,
In vivo,,A,,Intermediate,1,,50594,CHEMBL876426,2106.0,14952,Mus musculus,,10090.0,N,Spleen,1,,Biodistribution in normal mice spleen after 4 hr,,BAO_0000218,15045,
In vivo,,A,,Intermediate,1,,50597,CHEMBL630551,2106.0,14953,Rattus norvegicus,,10116.0,N,Spleen,1,,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL630552,2106.0,14954,Rattus norvegicus,,10116.0,N,Spleen,1,,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL630553,2106.0,14955,Rattus norvegicus,,10116.0,N,Spleen,1,,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL630554,2106.0,14956,Rattus norvegicus,,10116.0,N,Spleen,1,,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL630555,2106.0,14957,Rattus norvegicus,,10116.0,N,Spleen,1,,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL630556,2106.0,14958,Rattus norvegicus,,10116.0,N,Spleen,1,,Biodistribution in spleen of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL630557,2106.0,14959,Rattus norvegicus,,10116.0,N,Spleen,1,,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL630558,2106.0,14960,Rattus norvegicus,,10116.0,N,Spleen,1,,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL630559,2106.0,14961,Rattus norvegicus,,10116.0,N,Spleen,1,,Biodistribution in spleen of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL630560,2106.0,14962,Rattus norvegicus,,10116.0,N,Spleen,1,,Biodistribution in spleen of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
In vivo,,A,,Intermediate,1,,50597,CHEMBL876427,2046.0,14963,Rattus norvegicus,,10116.0,N,Thyroid gland,1,,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,12017,
,,A,,Intermediate,1,,50597,CHEMBL630561,,14964,Rattus norvegicus,,10116.0,N,,1,,The Kel values in female wistar rats.,,BAO_0000218,14941,
,,A,,Autocuration,0,,22224,CHEMBL630562,,14965,,,,U,,1,,The equilibrium constant pair at a pH of 7.0 and temperature of 25 degree Centigrade,,BAO_0000019,4646,
,,A,,Autocuration,0,,22224,CHEMBL630563,,14966,,,,U,,1,,Hydrolysis rate constant of the compound,,BAO_0000019,8847,
,,P,,Autocuration,0,,22229,CHEMBL629673,,14967,,,,U,,1,,Headecane/water partition coefficient expressed as the equilibrium ratio of the molar concentration in n-hexadecane to that in the buffer,,BAO_0000100,11778,
,,A,,Autocuration,0,,22224,CHEMBL629674,,14968,,,,U,,1,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0, T=66 degree Centigrade",,BAO_0000019,2363,
,,A,,Autocuration,0,,22224,CHEMBL629675,,14969,,,,U,,1,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree Centigrade",,BAO_0000019,2363,
,,A,,Autocuration,0,,22224,CHEMBL629676,,14970,,,,U,,1,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; No data",,BAO_0000019,2363,
,,A,,Autocuration,0,,22224,CHEMBL629677,,14971,,,,U,,1,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; Not determined",,BAO_0000019,2363,
,,A,,Autocuration,0,,22224,CHEMBL629678,,14972,,,,U,,1,,Apparent inactivation rate constant was evaluated,,BAO_0000019,8371,
,,A,,Autocuration,0,,22224,CHEMBL629679,,14973,,,,U,,1,,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 25 degree Centigrade.,,BAO_0000019,14883,
,,A,,Autocuration,0,,22224,CHEMBL629680,,14974,,,,U,,1,,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 37 degree Centigrade,,BAO_0000019,14883,
,,A,,Autocuration,0,,22224,CHEMBL629681,,14975,,,,U,,1,,Compound was evaluated for the Ki value for peptide alcohol for competitive inhibition in the presence of Mn2+ ions at pH 7.5,,BAO_0000019,4643,
,,A,,Autocuration,0,,22224,CHEMBL629682,,14976,,,,U,,1,,Compound was tested for the inhibition of antibody-catalyzed hydrolysis.,,BAO_0000019,3519,
,,A,,Autocuration,0,,22224,CHEMBL629683,,14977,,,,U,,1,,DBH (dopamine beta-hydroxylase) activity expressed as Ki value determined by degree to which compound inhibited conversion of tyramine to octopamine,,BAO_0000019,10600,
,,F,,Autocuration,0,,22224,CHEMBL629684,,14978,,,,U,,1,,Dissociation constant against constrictor response to the compound blocked competitively by phentolamine for alpha-mediated events,,BAO_0000019,8501,
,,P,,Autocuration,0,,22224,CHEMBL629685,,14979,,,,U,,1,,Dissociation constant was determined,,BAO_0000100,8505,
,,P,,Autocuration,0,,22224,CHEMBL629686,,14980,,,,U,,1,,Dissociation constant was determined,,BAO_0000100,9778,
,,P,,Autocuration,0,,22224,CHEMBL872932,,14981,,,,U,,1,,Dissociation constant at pH 7.4,,BAO_0000100,9778,
,,P,,Autocuration,0,,22224,CHEMBL629687,,14982,,,,U,,1,,Dissociation constant in presence of 1 mM dithiothreitol,,BAO_0000100,9778,
,,A,,Autocuration,0,,22224,CHEMBL872931,,14983,,,,U,,1,,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,,BAO_0000019,13007,
,,A,,Autocuration,0,,22224,CHEMBL628151,,14984,,,,U,,1,,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,,BAO_0000019,13007,
,,A,,Autocuration,0,,22224,CHEMBL628152,,14985,,,,U,,1,,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,,BAO_0000019,13007,
,,A,,Autocuration,0,,22224,CHEMBL628153,,14986,,,,U,,1,,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,,BAO_0000019,13007,
,,A,,Autocuration,0,,22224,CHEMBL628154,,14987,,,,U,,1,,Kinetic constant for aromatization of androstenedione,,BAO_0000019,11482,
,,A,,Autocuration,0,,22224,CHEMBL628155,,14988,,,,U,,1,,Kinetic constant for aromatization of testosterone,,BAO_0000019,11482,
,,A,,Autocuration,0,,22224,CHEMBL628156,,14989,,,,U,,1,,Kinetic parameter for hydrolysis of 1 by Antibody 2D10 after addition of compound 12,,BAO_0000019,2303,
,,A,,Autocuration,0,,22224,CHEMBL628157,,14990,,,,U,,1,,Local inhibition constant was determined,,BAO_0000019,11964,
,,A,,Intermediate,1,,50347,CHEMBL857533,,14991,Saccharomyces cerevisiae,,4932.0,N,,1,,Rate of inactivation of sterol methyl transferase from Saccharomyces cerevisiae using mechanism based inhibitor,,BAO_0000218,3140,
,,P,,Autocuration,0,,22224,CHEMBL628158,,14992,,,,U,,1,,Dissociation constant value of the compound,,BAO_0000100,10650,
,,A,,Autocuration,0,,22224,CHEMBL628159,964.0,14993,,,,U,Cornea,1,,In vitro permeability through cornea without epithelium,,BAO_0000019,4667,
,,A,,Autocuration,0,,22224,CHEMBL875616,964.0,14994,,,,U,Cornea,1,,In vitro permeability through intact cornea,,BAO_0000019,4667,
,,A,,Intermediate,1,,50592,CHEMBL628160,964.0,14995,Oryctolagus cuniculus,,9986.0,N,Cornea,1,,Evaluated for first order rate constant (Kin) for transcorneal penetration in anesthetized rabbits,,BAO_0000218,9199,
,,A,,Autocuration,0,,22224,CHEMBL628161,,14996,,,,U,,1,,Rate of enzyme inactivation for the compound was determined,,BAO_0000019,11966,
,,A,,Autocuration,0,,22224,CHEMBL628162,964.0,14997,,,,U,Cornea,1,,In vitro permeability through cornea without epithelium,,BAO_0000019,4667,
,,A,,Autocuration,0,,22224,CHEMBL628163,964.0,14998,,,,U,Cornea,1,,In vitro permeability through intact cornea,,BAO_0000019,4667,
,,A,,Autocuration,0,,22224,CHEMBL628164,,14999,,,,U,,1,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0300 mM [HOX] in the conditions of 25degreeC,pH 7.6",,BAO_0000019,8354,
,,A,,Autocuration,0,,22224,CHEMBL628165,,15000,,,,U,,1,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0384 mM [HOX] in the conditions of 25degreeC,pH 7.6",,BAO_0000019,8354,
,,A,,Autocuration,0,,22224,CHEMBL628166,,15001,,,,U,,1,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0395 mM [HOX] in the conditions of 25degreeC,pH 7.6",,BAO_0000019,8354,
,,A,,Autocuration,0,,22224,CHEMBL628167,,15002,,,,U,,1,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,BAO_0000019,8354,
,,A,,Autocuration,0,,22224,CHEMBL628168,,15003,,,,U,,1,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.050 mM [HOX] in the conditions of 25degreeC,pH 7.6",,BAO_0000019,8354,
,,A,,Autocuration,0,,22224,CHEMBL628169,,15004,,,,U,,1,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,BAO_0000019,8354,
,,A,,Autocuration,0,,22224,CHEMBL628170,,15005,,,,U,,1,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0790 mM [HOX] in the conditions of 25degreeC,pH 7.6",,BAO_0000019,8354,
,,A,,Autocuration,0,,22224,CHEMBL628171,,15006,,,,U,,1,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0800 mM [HOX] in the conditions of 25degreeC,pH 7.6",,BAO_0000019,8354,
,,A,,Autocuration,0,,22224,CHEMBL627434,,15007,,,,U,,1,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.100 mM [HOX] in the conditions of 25degreeC,pH 7.6",,BAO_0000019,8354,
,,A,,Autocuration,0,,22224,CHEMBL627435,,15008,,,,U,,1,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.200 mM [HOX] in the conditions of 25degreeC,pH 7.6",,BAO_0000019,8354,
,,A,,Autocuration,0,,22224,CHEMBL628110,,15009,,,,U,,1,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.300 mM [HOX] in the conditions of 25degreeC,pH 7.6",,BAO_0000019,8354,
,,A,,Autocuration,0,,22224,CHEMBL628111,,15010,,,,U,,1,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.384 mM [HOX] in the conditions of 25degreeC,pH 7.6",,BAO_0000019,8354,
,,A,,Autocuration,0,,22224,CHEMBL628112,,15011,,,,U,,1,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.395 mM [HOX] in the conditions of 25degreeC,pH 7.6",,BAO_0000019,8354,
,,A,,Autocuration,0,,22224,CHEMBL628260,,15012,,,,U,,1,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,BAO_0000019,8354,
,,A,,Autocuration,0,,22224,CHEMBL628261,,15013,,,,U,,1,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,BAO_0000019,8354,
In vivo,,A,,Intermediate,1,,50594,CHEMBL628262,,15014,Mus musculus,,10090.0,N,,1,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Muscle (M),,BAO_0000218,14439,
In vivo,,A,,Intermediate,1,,50587,CHEMBL628263,,15015,Homo sapiens,,9606.0,N,,1,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Tumor (T) cells,,BAO_0000218,14439,
In vivo,,A,,Intermediate,1,,50594,CHEMBL628264,,15016,Mus musculus,,10090.0,N,,1,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Blood (B),,BAO_0000218,14439,
In vivo,,A,,Intermediate,1,,50594,CHEMBL628265,,15017,Mus musculus,,10090.0,N,,1,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Heart (H),,BAO_0000218,14439,
In vivo,,A,,Intermediate,1,,50594,CHEMBL628266,,15018,Mus musculus,,10090.0,N,,1,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Lung (L),,BAO_0000218,14439,
In vivo,,A,,Intermediate,1,,50594,CHEMBL628267,,15019,Mus musculus,,10090.0,N,,1,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Muscle (M),,BAO_0000218,14439,
In vivo,,A,,Intermediate,1,,50594,CHEMBL628268,,15020,Mus musculus,,10090.0,N,,1,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Tumor (T) cells,,BAO_0000218,14439,
In vivo,,A,,Intermediate,1,,50594,CHEMBL628269,,15021,Mus musculus,,10090.0,N,,1,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Blood (B),,BAO_0000218,14439,
In vivo,,A,,Intermediate,1,,50594,CHEMBL628270,,15022,Mus musculus,,10090.0,N,,1,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Heart (H),,BAO_0000218,14439,
In vivo,,A,,Intermediate,1,,50594,CHEMBL628271,,15023,Mus musculus,,10090.0,N,,1,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Lung (L),,BAO_0000218,14439,
In vivo,,A,,Intermediate,1,,50594,CHEMBL628272,,15024,Mus musculus,,10090.0,N,,1,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Muscle (M),,BAO_0000218,14439,
